102920	O
||||	O
176	O
||||	O
2167	O
||||	O
echo	O
_	O
report	O
||||	O
2013	O
-	O
09	O
-	O
23	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
pericardial	B
effusion	I
.	O

height	O
:	O
(	O
in	O
)	O
68	O

weight	O
(	O
lb	O
)	O
:	O
184	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
97	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
140	O
/	O
80	O

hr	O
(	O
bpm	O
)	O
:	O
70	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2013	O
-	O
09	O
-	O
23	O
*	O
*	O
]	O
at	O
10	O
:	O
20	O

test	O
:	O
tte	O
(	O
focused	O
views	O
)	O

doppler	O
:	O
no	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

the	O
left	O
atrium	O
is	O
elongated	B
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
the	O
right	O
atrium	O
is	O
moderately	O
dilated	O
.	O

left	O
ventricle	O
:	O
there	O
is	O
severe	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
low	O
normal	O
(	O
lvef	O
50	O
-	O
55%	O
)	O
.	O

lv	O
wall	O
motion	O
:	O
the	O
following	O
resting	O
regional	O
left	B
ventricular	I
wall	I
motion	I
abnormalities	I
are	O
seen	O
:	O
basal	O
inferoseptal	O
-	O
hypokinetic	B
;	O
mid	O
inferoseptal	O
-	O
hypokinetic	B
;	O
basal	O
inferior	O
-	O
hypokinetic	B
;	O
mid	O
inferior	O
-	O
hypokinetic	B
;	O

right	O
ventricle	O
:	O
the	O
right	O
ventricular	O
free	O
wall	O
is	O
hypertrophied	O
.	O

right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
.	O

right	O
ventricular	O
systolic	O
function	O
is	O
normal	O
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
mild	O
mitral	B
annular	I
calcification	I
.	O

tricuspid	O
valve	O
:	O
mild	O
tricuspid	O
[	O
1	O
+	O
]	O
regurgitation	O
is	O
seen	O
.	O

there	O
is	O
mild	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

pericardium	O
:	O
there	O
is	O
a	O
trivial	O
/	O
physiologic	O
pericardial	B
effusion	I
.	O

the	O
effusion	B
appears	O
circumferential	B
.	O

conclusions	O
:	O

1	O
.	O
limited	O
focused	O
study	O
.	O

2	O
.	O
the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

the	O
left	O
atrium	O
is	O
elongated	B
.	O

3	O
.	O
the	O
right	O
atrium	O
is	O
moderately	O
dilated	O
.	O

4	O
.	O
there	O
is	O
severe	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
low	O
normal	O
(	O
lvef	O
50	O
-	O
55%	O
)	O
.	O

resting	O
regional	O
wall	B
motion	I
abnormalities	I
include	O
basal	O
and	O
mid	O
septal	O
hypokinesis	B
.	O

5	O
.	O
the	O
right	O
ventricular	O
free	O
wall	O
is	O
hypertrophied	O
.	O

right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
.	O

right	O
ventricular	O
systolic	O
function	O
is	O
normal	O
.	O

6	O
.	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

no	O
color	O
doppler	O
study	O
was	O
done	O
to	O
assess	O
for	O
the	O
presence	O
of	O
mr	B
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
4	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
15	O
*	O
*	O
]	O
.	O

7	O
.	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

8	O
.	O
there	O
is	O
mild	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

there	O
is	O
a	O
trivial	O
/	O
physiologic	O
pericardial	B
effusion	I
.	O

the	O
effusion	B
appears	O
circumferential	B
.	O

9	O
.	O
an	O
echogenic	O
density	B
in	O
the	O
right	O
ventricle	O
is	O
present	O
consistent	O
with	O
a	O
pacemaker	O
lead	O
.	O

compared	O
with	O
the	O
findings	O
of	O
the	O
prior	O
study	O
(	O
tape	O
reviewed	O
)	O
of	O
[	O
*	O
*	O
2013	O
-	O
09	O
-	O
12	O
*	O
*	O
]	O
,	O
the	O
pericardial	B
effusion	I
is	O
much	O
less	O
.	O

the	O
overall	O
function	O
is	O
unchanged	O
.	O

6281	O
||||	O
381	O
||||	O
17672	O
||||	O
discharge	O
_	O
summary	O
||||	O
2018	O
-	O
05	O
-	O
22	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
05	O
-	O
16	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
05	O
-	O
22	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1973	O
-	O
02	O
-	O
21	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
surgery	O

allergies	O
:	O

penicillins	O
/	O
flagyl	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
311	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

abdominal	B
pain	I
/	O
abcess	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

ultrasound	O
guided	O
abdominal	O
drain	O
[	O
*	O
*	O
2018	O
-	O
05	O
-	O
17	O
*	O
*	O
]	O

history	O
of	O
present	O
illness	O
:	O

44	O
yo	O
female	O
transfer	O
here	O
from	O
[	O
*	O
*	O
hospital	O
369	O
*	O
*	O
]	O
complaining	O
of	O
mid	O
abdominal	B
pain	I
and	O
redness	B
.	O

over	O
the	O
last	O
2	O
weeks	O
,	O
she	O
noticed	O
night	B
sweats	I
and	O
subjective	O
fever	B
at	O
home	O
.	O

she	O
was	O
transfered	O
to	O
[	O
*	O
*	O
hospital1	O
27	O
*	O
*	O
]	O
per	O
recommendation	O
of	O
her	O
gi	O
specialist	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
5060	O
*	O
*	O
]	O
.	O

the	O
ct	O
showed	O
mainly	O
anechoic	O
(	O
cystic	B
)	O
collection	O
in	O
the	O
deep	O
subcutaneous	O
tissues	O
of	O
the	O
lower	O
midline	O
abdominal	O
wall	O
,	O
which	O
measures	O
up	O
to	O
3	O
.	O
4	O
cm	O
sagittal	O
x	O
3	O
cm	O
ap	O
x	O
3	O
.	O
8	O
cm	O
transverse	O
.	O

some	O
heterogenous	O
hyperechoic	O
material	O
is	O
noted	O
within	O
this	O
mainly	O
cystic	B
collectionan	I
abdominal	I
abcess	I
was	O
noted	O
.	O

past	O
medical	O
history	O
:	O

crohns	B
s	O
/	O
p	O
17	O
surgeries	O

ileostomy	O
1993	O
;	O
left	O
abdominal	B
stoma	I

ventral	I
hernia	I
repain	O
x	O
2	O

peripheral	B
neuropathy	I

anxiety	I

depression	I

social	O
history	O
:	O

disabled	O

no	O
etoh	O
,	O
no	O
smoking	O
(	O
quit	O
3	O
months	O
ago	O
;	O
30	O
pack	O
year	O
history	O
)	O

family	O
history	O
:	O

non	O
-	O
contributory	O

physical	O
exam	O
:	O

vs	O
:	O
97	O
.	O
8	O
,	O
88	O
,	O
104	O
/	O
70	O
,	O
20	O

gen	O
:	O
nad	B

head	O
:	O
no	O
oral	O
lesions	B

chest	O
:	O
cta	O
bilat	O
.	O

cv	O
:	O
rrr	O
,	O
no	O
m	B
/	O
r	B
/	O
g	B

gi	O
/	O
abd	O
:	O
10	O
cm	O
epigastric	B
mass	I
with	O
mild	O
erythema	B
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
:	O
tender	B
to	I
palpation	I
,	O
ostomy	O
in	O
place	O
,	O
no	O
signs	O
of	O
infection	B
musc	O
:	O
multiple	O
abdominla	B
scars	I

skin	O
:	O
no	O
jaundice	B

neuro	O
a	O
+	O
o	O
x	O
3	O

[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
:	O
not	O
depressed	B

pertinent	O
results	O
:	O

us	O
abd	O
limit	O
,	O
single	O
organ	O
[	O
*	O
*	O
2018	O
-	O
05	O
-	O
17	O
*	O
*	O
]	O
2	O
:	O
48	O
pm	O

us	O
abd	O
limit	O
,	O
single	O
organ	O
;	O
guidance	O
for	O
abscess	B
(	O
75989	O
)	O

reason	O
:	O
please	O
drain	O
abdominal	O
wall	O
fluid	B
collects	I
(	O
x	O
2	O
)	O
with	O
ultras	O

underlying	O
medical	O
condition	O
:	O

45	O
year	O
old	O
woman	O
with	O
crohn's	B
&	O
abdominal	O
wall	O
fluid	B
collections	I
on	O
ct	O
.	O

reason	O
for	O
this	O
examination	O
:	O

please	O
drain	O
abdominal	O
wall	O
fluid	B
collects	I
(	O
x	O
2	O
)	O
with	O
ultrasound	O
guidance	O

ultrasound	O
drainage	O
of	O
anterior	O
abdominal	B
wall	I
collection	I
.	O

clinical	O
details	O
:	O
background	O
history	O
of	O
crohn's	B
disease	I
.	O

collection	B
in	O
the	O
deep	O
subcutaneous	O
tissues	O
of	O
the	O
lower	O
midline	O
abdominal	O
wall	O
on	O
outside	O
ct	O
.	O

procedure	O
:	O

the	O
patient's	O
outside	O
ct	O
was	O
reviewed	O
for	O
comparison	O
.	O

preprocedure	O
ultrasound	O
images	O
show	O
a	O
mainly	O
anechoic	O
(	O
cystic	B
)	O
collection	O
in	O
the	O
deep	O
subcutaneous	O
tissues	O
of	O
the	O
lower	O
midline	O
abdominal	O
wall	O
,	O
which	O
measures	O
up	O
to	O
3	O
.	O
4	O
cm	O
sagittal	O
x	O
3	O
cm	O
ap	O
x	O
3	O
.	O
8	O
cm	O
transverse	O
.	O

some	O
heterogenous	O
hyperechoic	O
material	O
is	O
noted	O
within	O
this	O
mainly	O
cystic	B
collection	I
.	O

preprocedure	O
written	O
consent	O
and	O
confirmation	O
of	O
patient	O
identity	O
and	O
nature	O
of	O
procedure	O
was	O
performed	O
.	O

following	O
usual	O
aseptic	O
technique	O
and	O
local	O
and	O
intravenous	O
analgesia	O
,	O
an	O
8	O
-	O
[	O
*	O
*	O
ethnicity	O
665	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
1981	O
*	O
*	O
]	O
multipurpose	O
pigtail	O
catheter	O
was	O
advanced	O
under	O
realtime	O
ultrasound	O
guidance	O
into	O
this	O
collection	O
via	O
a	O
right	O
paramedian	O
approach	O
.	O

aspiration	O
yielded	O
purulent	O
material	O
,	O
a	O
sample	O
of	O
which	O
has	O
been	O
sent	O
for	O
microbiological	O
analysis	O
.	O

the	O
pigtail	O
catheter	O
was	O
formed	O
within	O
this	O
collection	O
,	O
which	O
was	O
then	O
aspirated	O
until	O
empty	O
yielding	O
in	O
total	O
24	O
cc	O
of	O
purulent	O
material	O
.	O

no	O
residual	O
collection	O
on	O
the	O
post	O
-	O
aspiration	O
images	O
.	O

catheter	O
is	O
held	O
in	O
place	O
with	O
a	O
pigtail	O
devise	O
and	O
stat	O
-	O
lock	O
dressing	O
.	O

no	O
immediate	O
complications	B
.	O

dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
(	O
attending	O
radiologist	O
)	O
was	O
present	O
.	O

[	O
*	O
*	O
2018	O
-	O
05	O
-	O
15	O
*	O
*	O
]	O
09	O
:	O
45pm	O
glucose	O
-	O
82	O
urea	O
n	O
-	O
7	O
creat	O
-	O
0	O
.	O
8	O
sodium	O
-	O
139	O

potassium	O
-	O
3	O
.	O
7	O
chloride	O
-	O
103	O
total	O
co2	O
-	O
22	O
anion	O
gap	O
-	O
18	O

brief	O
hospital	O
course	O
:	O

upon	O
arrival	O
at	O
[	O
*	O
*	O
hospital1	O
27	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2018	O
-	O
05	O
-	O
16	O
*	O
*	O
]	O
,	O
the	O
patient	O
recieved	O
dilaudid	O
iv	O
to	O
help	O
control	O
pain	B
and	O
ns	O
bolus	O
to	O
treat	O
her	O
hypotension	B
80	O
/	O
45mm	O
hg	O
.	O

the	O
patient	O
reported	O
that	O
her	O
normal	O
blood	O
pressure	O
tends	O
to	O
be	O
on	O
the	O
low	O
side	O
.	O

she	O
was	O
transfered	O
to	O
the	O
icu	O
.	O

she	O
was	O
made	O
npo	O
,	O
started	O
on	O
ivf	O
and	O
ceftriaxone	O
1	O
gm	O
iv	O
q24h	O
,	O
empirically	O
.	O

she	O
was	O
then	O
transfered	O
to	O
the	O
floor	O
.	O

on	O
[	O
*	O
*	O
2018	O
-	O
05	O
-	O
17	O
*	O
*	O
]	O
she	O
was	O
advanced	O
to	O
a	O
regular	O
diet	O
,	O
her	O
dilaudid	O
was	O
changed	O
to	O
1	O
-	O
2mg	O
subcutaneous	O
q4	O
-	O
6	O
prn	O
,	O
her	O
abdomen	O
remained	O
red	B
,	O
warm	O
and	O
tender	O
.	O

an	O
ultra	O
sound	O
guided	O
pigtail	O
catheter	O
was	O
placed	O
.	O

aspiration	O
yielded	O
purulent	O
material	O
,	O
a	O
sample	O
of	O
which	O
was	O
for	O
microbiological	O
analysis	O
.	O

she	O
remained	O
stable	O
with	O
improved	O
pain	B
control	O
.	O

her	O
diet	O
was	O
advanced	O
which	O
she	O
tolerated	O
.	O

cultures	O
from	O
her	O
abdominal	O
wound	B
returned	O
staph	O
species	O
sensitive	O
to	O
vancomycin	O
.	O

a	O
picc	O
line	O
was	O
placed	O
for	O
iv	O
antibiotics	O
.	O

her	O
drain	O
put	O
out	O
scant	O
amounts	O
of	O
reddish	O
fluid	O
and	O
it	O
was	O
removed	O
prior	O
to	O
her	O
discharge	O
without	O
complication	B
.	O

she	O
was	O
out	O
of	O
bed	O
,	O
tolerating	O
a	O
regular	O
diet	O
and	O
with	O
adequate	O
pain	B
control	O
.	O

she	O
was	O
discharged	O
to	O
home	O
with	O
services	O
and	O
instructed	O
to	O
continue	O
a	O
10	O
day	O
course	O
of	O
vancomycin	O
.	O

she	O
will	O
follow	O
up	O
in	O
clinic	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
.	O

medications	O
on	O
admission	O
:	O

neurontin	O
800	O
tid	O
,	O
mercaptopurine	O
75	O
daily	O
,	O
klonopin	O
0	O
.	O
5	O
tid	O
,	O
cymbalta	O
120	O
bid	O
,	O
remicade	O
q6weeks	O

discharge	O
medications	O
:	O

1	O
.	O
gabapentin	O
400	O
mg	O
capsule	O
sig	O
:	O
two	O
(	O
2	O
)	O
capsule	O
po	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
180	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
clonazepam	O
0	O
.	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

disp	O
:	O
*	O
qs	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

3	O
.	O
mercaptopurine	O
50	O
mg	O
tablet	O
sig	O
:	O
1	O
.	O
5	O
tablets	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
qs	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

4	O
.	O
duloxetine	O
30	O
mg	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
two	O
(	O
2	O
)	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
120	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

5	O
.	O
trazodone	O
100	O
mg	O
tablet	O
sig	O
:	O
four	O
(	O
4	O
)	O
tablet	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
as	O
needed	O
.	O

disp	O
:	O
*	O
qs	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

6	O
.	O
oxycodone	O
40	O
mg	O
tablet	O
sustained	O
release	O
12hr	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
sustained	O
release	O
12hr	O
po	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
sustained	O
release	O
12hr	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

7	O
.	O
hydromorphone	O
2	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q3	O
-	O
4h	O
(	O
every	O
3	O
to	O
4	O
hours	O
)	O
as	O
needed	O
.	O

disp	O
:	O
*	O
50	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

8	O
.	O
vancomycin	O
in	O
dextrose	O
1	O
g	O
/	O
200	O
ml	O
piggyback	O
sig	O
:	O
one	O
(	O
1	O
)	O
gram	O
intravenous	O
q	O
12h	O
(	O
every	O
12	O
hours	O
)	O
for	O
10	O
days	O
.	O

disp	O
:	O
*	O
20	O
doses	O
*	O
refills	O
:	O
*	O
0	O
*	O

9	O
.	O
heparin	O
flush	O
100	O
unit	O
/	O
ml	O
kit	O
sig	O
:	O
two	O
(	O
2	O
)	O
ml	O
intravenous	O
once	O
a	O
day	O
:	O
10cc	O
ns	O
followed	O
by	O
2cc	O
heparing	O
flush	O
qday	O
and	O
prn	O
.	O

disp	O
:	O
*	O
15	O
kits	O
*	O
refills	O
:	O
*	O
1	O
*	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

abdominal	B
wall	I
abscess	I

crohn's	I
disease	I

discharge	O
condition	O
:	O

good	O

discharge	O
instructions	O
:	O

monitor	O
your	O
drain	O
and	O
drainage	B
site	I
for	O
redness	B
,	O
pain	B
,	O
swelling	B
,	O
and	O
discharge	B
.	O

do	O
not	O
drive	O
while	O
taking	O
pain	B
medications	O
.	O

take	O
a	O
stool	O
softener	O
while	O
taking	O
pain	B
medications	O
.	O

you	O
should	O
contact	O
your	O
md	O
if	O
you	O
experience	O
:	O
*	O
increasing	O
pain	B

*	O
fever	B
(	O
>101	O
.	O
5	O
f	O
)	O
or	O
vomiting	B

*	O
inability	B
to	I
eat	I
or	O
drink	O

*	O
inability	B
to	I
pass	I
gas	I
or	O
stool	O

*	O
redness	O
/	O
swelling	O
/	O
drainage	O
from	O
wounds	O

*	O
other	O
symptoms	B
concerning	O
to	O
you	O

followup	O
instructions	O
:	O

please	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
06	O
-	O
04	O
*	O
*	O
]	O
.	O

call	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1259	O
*	O
*	O
]	O
for	O
an	O
appointment	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
323	O
*	O
*	O
]	O
md	O
,	O
phd	O
02	O
-	O
239	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
4147	O
*	O
*	O
]	O
[	O
*	O
*	O
2018	O
-	O
05	O
-	O
22	O
*	O
*	O
]	O
@	O
1158	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2018	O
-	O
05	O
-	O
23	O
*	O
*	O
]	O
6	O
:	O
45	O
am	O

(	O
end	O
of	O
report	O
)	O

17453	O
||||	O
534	O
||||	O
4395	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
02	O
-	O
11	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
02	O
-	O
02	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
02	O
-	O
11	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1947	O
-	O
11	O
-	O
02	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O

admission	O
diagnosis	O
:	O
bicuspid	B
aortic	I
valve	I
and	O
aortic	B
stenosis	I
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
bicuspid	B
aortic	I
valve	I
and	O
aortic	B
stenosis	I
.	O

2	O
.	O
status	O
post	O
aortic	O
valve	O
replacement	O
with	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
64	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
doctor	O
last	O
name	O
65	O
*	O
*	O
]	O
valve	O
.	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
a	O
67	O
-	O
year	O
-	O
old	O
woman	O
with	O
a	O
known	O
congenital	O
bicuspid	B
aortic	I
valve	I
who	O
has	O
now	O
developed	O
a	O
critical	O
stenosis	O
.	O

she	O
presents	O
with	O
a	O
presyncopal	B
episode	I
.	O

the	O
patient	O
had	O
a	O
transthoracic	O
echocardiogram	O
in	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
which	O
demonstrated	O
an	O
increased	B
peak	I
aortic	I
gradient	I
of	O
77	O
mmhg	O
.	O

following	O
a	O
second	O
presyncopal	B
episode	I
,	O
the	O
patient	O
underwent	O
cardiac	O
catheterization	O
in	O
[	O
*	O
*	O
2015	O
-	O
01	O
-	O
07	O
*	O
*	O
]	O
which	O
showed	O
a	O
calculated	O
aortic	O
valve	O
area	O
of	O
0	O
.	O
7	O
cm2	O
and	O
a	O
relatively	O
preserved	O
ejection	O
fraction	O
of	O
50%	O
.	O

the	O
patient	O
subjectively	O
reports	O
progressive	O
fatigue	B
and	O
mild	O
dyspnea	B
on	I
exertion	I
times	O
several	O
months	O
.	O

no	O
shortness	B
of	I
breath	I
,	O
chest	B
pain	I
,	O
paroxysmal	B
nocturnal	I
dyspnea	I
,	O
or	O
orthopnea	B
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
bicuspid	B
aortic	I
valve	I
.	O

2	O
.	O
asthma	B
.	O

3	O
.	O
factor	B
xi	I
deficiency	I
.	O

4	O
.	O
hypertension	B
.	O

5	O
.	O
hypercholesterolemia	B
.	O

6	O
.	O
polymyalgia	B
rheumatica	I
.	O

7	O
.	O
osteoarthritis	B
.	O

8	O
.	O
status	O
post	O
appendectomy	O
.	O

9	O
.	O
status	O
post	O
left	O
knee	O
arthroscopy	O
.	O

10	O
.	O

status	O
post	O
left	O
donor	O
nephrectomy	O
.	O

11	O
.	O

status	O
post	O
tubal	O
ligation	O
.	O

12	O
.	O

status	O
post	O
incisional	B
hernia	I
repair	O
.	O

13	O
.	O

left	B
bundle	I
-	I
branch	I
block	I
.	O

allergies	O
:	O
penicillin	O
(	O
gives	O
swelling	B
)	O
.	O

contrast	O
dye	O
(	O
gives	O
hives	B
)	O
.	O

medications	O
on	O
admission	O
:	O

1	O
.	O
prednisone	O
6	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

2	O
.	O
fosamax	O
70	O
mg	O
p	O
.	O
o	O
.	O
every	O
thursday	O
.	O

3	O
.	O
singulair	O
10	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

4	O
.	O
hydrochlorothiazide	O
12	O
.	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

5	O
.	O
combivent	O
as	O
needed	O
.	O

6	O
.	O
advair	O
as	O
needed	O
.	O

7	O
.	O
vitamin	O
e	O
.	O

8	O
.	O
vitamin	O
c	O
.	O

9	O
.	O
calcium	O
.	O

10	O
.	O

multivitamin	O
supplement	O
.	O

physical	O
examination	O
on	O
presentation	O
:	O
the	O
patient	O
was	O
an	O
elderly	O
woman	O
in	O
no	O
acute	B
distress	I
.	O

head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
and	O
throat	O
examination	O
revealed	O
normocephalic	O
and	O
atraumatic	O
.	O

pupils	O
were	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

extraocular	O
movements	O
were	O
intact	O
.	O

sclerae	O
were	O
anicteric	B
.	O

the	O
throat	O
was	O
clear	O
.	O

the	O
neck	O
was	O
supple	O
without	O
lymphadenopathy	B
or	O
masses	B
.	O

the	O
chest	O
was	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

cardiovascular	O
examination	O
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	O
3	O
/	O
6	O
systolic	B
ejection	I
murmur	I
.	O

the	O
abdomen	O
was	O
soft	O
,	O
nontender	O
,	O
and	O
nondistended	O
,	O
without	O
masses	B
or	O
organomegaly	B
.	O

extremities	O
were	O
warm	O
.	O

not	O
cyanotic	B
and	O
not	O
edematous	B
times	O
four	O
.	O

neurologic	O
examination	O
was	O
intact	O
.	O

pertinent	O
laboratory	O
values	O
on	O
presentation	O
:	O
admission	O
laboratories	O
revealed	O
complete	O
blood	O
count	O
with	O
a	O
white	O
blood	O
cell	O
count	O
of	O
9	O
.	O
1	O
,	O
hematocrit	O
was	O
35	O
.	O
9	O
,	O
and	O
platelets	O
were	O

311	O
.	O

chemistries	O
revealed	O
sodium	O
was	O
140	O
,	O
potassium	O
was	O
4	O
,	O
chloride	O
was	O
103	O
,	O
bicarbonate	O
was	O
28	O
,	O
blood	O
urea	O
nitrogen	O
was	O
16	O
,	O
creatinine	O
was	O
0	O
.	O
7	O
,	O
and	O
blood	O
glucose	O
was	O
108	O
.	O

alt	O
was	O
37	O
,	O
ast	O
was	O
26	O
,	O
alkaline	O
phosphatase	O
was	O
56	O
,	O
total	O
bilirubin	O
was	O
0	O
.	O
2	O
.	O

prothrombin	O
time	O
was	O
12	O
,	O
inr	O
was	O
1	O
,	O
and	O
partial	O
thromboplastin	O
time	O
was	O
37	O
.	O
3	O
.	O

urinalysis	O
was	O
negative	O
.	O

radiology	O
/	O
imaging	O
:	O
a	O
chest	O
x	O
-	O
ray	O
showed	O
no	O
acute	B
process	I
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
for	O
semi	O
-	O
elective	O
aortic	B
stenosis	I
repair	O
.	O

preoperatively	O
,	O
the	O
patient	O
was	O
evaluated	O
for	O
her	O
factor	B
xi	I
deficiency	I
and	O
was	O
cleared	O
by	O
the	O
hematology	O
/	O
oncology	O
service	O
in	O
order	O
for	O
surgery	O
.	O

they	O
investigated	O
the	O
past	O
records	O
surrounding	O
her	O
past	O
surgeries	O
;	O
including	O
her	O
donor	O
nephrectomy	O
as	O
well	O
as	O
knee	O
arthroscopy	O
,	O
and	O
made	O
the	O
suggestion	O
for	O
a	O
bioprosthetic	O
valve	O
to	O
be	O
preferential	O
.	O

they	O
also	O
remarked	O
that	O
postoperative	B
bleeding	I
may	O
be	O
a	O
significant	O
complication	B
.	O

they	O
did	O
note	O
,	O
however	O
,	O
that	O
she	O
had	O
tolerated	O
her	O
past	O
surgeries	O
very	O
well	O
.	O

on	O
[	O
*	O
*	O
2015	O
-	O
02	O
-	O
03	O
*	O
*	O
]	O
,	O
the	O
patient	O
underwent	O
aortic	O
valve	O
replacement	O
(	O
minimally	O
invasive	O
)	O
with	O
a	O
21	O
-	O
mm	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
64	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
doctor	O
last	O
name	O
65	O
*	O
*	O
]	O
valve	O
.	O

the	O
patient	O
tolerated	O
the	O
procedure	O
well	O
and	O
was	O
transferred	O
to	O
the	O
postanesthesia	O
care	O
unit	O
with	O
levophed	O
and	O
propofol	O
drips	O
.	O

there	O
was	O
some	O
bleeding	B
in	O
the	O
case	O
,	O
and	O
the	O
patient	O
was	O
transfused	O
9	O
units	O
of	O
fresh	O
frozen	O
plasma	O
and	O
1	O
unit	O
of	O
packed	O
red	O
blood	O
cells	O
in	O
the	O
operating	O
room	O
.	O

in	O
the	O
unit	O
,	O
the	O
patient	O
was	O
started	O
on	O
a	O
nitroglycerin	O
drip	O
and	O
propofol	O
was	O
increased	O
.	O

the	O
patient	O
was	O
extubated	O
in	O
the	O
evening	O
on	O
postoperative	O
day	O
zero	O
.	O

on	O
postoperative	O
day	O
one	O
,	O
the	O
patient	O
had	O
her	O
nipride	O
drip	O
weaned	O
off	O
as	O
well	O
as	O
beginning	O
moving	O
to	O
the	O
chair	O
with	O
assistance	O
.	O

here	O
,	O
it	O
was	O
noted	O
that	O
she	O
had	O
an	O
approximately	O
20	O
-	O
beat	O
run	O
of	O
ventricular	B
tachycardia	I
which	O
was	O
asymptomatic	B
and	O
spontaneously	O
resolved	O
.	O

the	O
patient	O
was	O
sleeping	O
while	O
this	O
occurred	O
.	O

on	O
the	O
following	O
days	O
on	O
the	O
floor	O
,	O
the	O
patient	O
continued	O
to	O
work	O
with	O
physical	O
therapy	O
in	O
regaining	O
her	O
strength	O
and	O
mobility	O
.	O

on	O
the	O
evening	O
on	O
postoperative	O
day	O
three	O
,	O
the	O
patient	O
had	O
another	O
short	O
7	O
-	O
beat	O
run	O
of	O
ventricular	B
tachycardia	I
.	O

again	O
,	O
she	O
was	O
sleeping	O
and	O
symptomatic	O
.	O

cardiology	O
was	O
consulted	O
for	O
evaluation	O
and	O
had	O
no	O
changes	O
in	O
management	O
to	O
recommend	O
.	O

the	O
patient	O
stayed	O
on	O
the	O
floor	O
and	O
worked	O
again	O
with	O

physical	O
therapy	O
and	O
was	O
ambulating	O
quite	O
well	O
.	O

on	O
the	O
evening	O
on	O
postoperative	O
day	O
six	O
,	O
the	O
patient	O
again	O
had	O
two	O
short	O
runs	O
of	O
ventricular	B
tachycardia	I
of	O
approximately	O
6	O
beats	O
and	O
4	O
beats	O
while	O
she	O
was	O
sleeping	O
.	O

the	O
patient	O
was	O
clinically	O
asymptomatic	B
.	O

the	O

electrophysiology	O
service	O
was	O
consulted	O
and	O
had	O
no	O
further	O
recommendations	O
.	O

they	O
stressed	O
only	O
continuing	O
beta	O
blockade	O
with	O
metoprolol	O
as	O
we	O
were	O
doing	O
.	O

on	O
the	O
evening	O
on	O
postoperative	O
day	O
seven	O
,	O
the	O
patient	O
had	O
a	O
short	O
run	O
of	O
supraventricular	B
tachycardia	I
.	O

again	O
,	O
the	O
patient	O
was	O
asymptomatic	B
.	O

discharge	O
disposition	O
:	O
on	O
postoperative	O
day	O
eight	O
,	O
the	O
patient	O
was	O
discharged	O
to	O
home	O
tolerating	O
a	O
regular	O
diet	O
,	O
adequate	O
pain	B
control	O
on	O
oral	O
pain	B
medications	O
,	O
and	O
having	O
no	O
more	O
presyncopal	B
events	I
.	O

physical	O
examination	O
on	O
discharge	O
:	O
physical	O
examination	O
on	O
discharge	O
revealed	O
the	O
patient	O
was	O
in	O
no	O
acute	B
distress	I
.	O

the	O
chest	O
was	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

no	O
sternal	B
click	I
.	O

no	O
drainage	O
from	O
the	O
incision	O
site	O
.	O

a	O
regular	O
rate	O
and	O
rhythm	O
without	O
murmurs	B
,	O
rubs	B
,	O
or	O
gallops	B
.	O

there	O
was	O
1	O
+	O
pedal	B
edema	I
bilaterally	O
.	O

pertinent	O
laboratory	O
values	O
on	O
discharge	O
:	O
laboratories	O
on	O
discharge	O
revealed	O
complete	O
blood	O
count	O
with	O
white	O
blood	O
cell	O
count	O
of	O
11	O
,	O
hematocrit	O
was	O
31	O
.	O
6	O
,	O
and	O
platelets	O
were	O
333	O
.	O

chemistry	O
panel	O
revealed	O
sodium	O
was	O
141	O
,	O
potassium	O
was	O
4	O
.	O
7	O
,	O
chloride	O
was	O
100	O
,	O
bicarbonate	O
was	O
30	O
,	O
blood	O
urea	O
nitrogen	O
was	O
19	O
,	O
creatinine	O
was	O
0	O
.	O
9	O
,	O
and	O
blood	O
glucose	O
was	O
91	O
.	O

magnesium	O
was	O
2	O
.	O
1	O
.	O

medications	O
on	O
discharge	O
:	O

1	O
.	O
aspirin	O
325	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

2	O
.	O
percocet	O
5	O
/	O
325	O
p	O
.	O
o	O
.	O
as	O
needed	O
.	O

3	O
.	O
colace	O
100	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

4	O
.	O
prednisone	O
6	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

5	O
.	O
singulair	O
10	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
h	O
.	O
s	O
.	O

6	O
.	O
lasix	O
20	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
(	O
times	O
seven	O
days	O
)	O
.	O

7	O
.	O
potassium	O
chloride	O
20	O
meq	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
(	O
times	O
seven	O
days	O
)	O
.	O

8	O
.	O
lopressor	O
25	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

9	O
.	O
combivent	O
1	O
to	O
2	O
puffs	O
inhaled	O
q	O
.	O
4	O
-	O
6h	O
.	O
as	O
needed	O
.	O

10	O
.	O

oxazepam	O
5	O
mg	O
to	O
10	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
h	O
.	O
s	O
.	O
as	O
needed	O
.	O

condition	O
at	O
discharge	O
:	O
condition	O
on	O
discharge	O
was	O
good	O
.	O

discharge	O
status	O
:	O
discharge	O
status	O
was	O
to	O
home	O
with	O
visiting	O
nurse	O
association	O
.	O

discharge	O
diet	O
:	O
discharge	O
diet	O
is	O
cardiac	O
.	O

discharge	O
instructions	O
/	O
followup	O
:	O

1	O
.	O
the	O
patient	O
should	O
follow	O
up	O
with	O
cardiology	O
(	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
)	O
in	O
one	O
to	O
two	O
weeks	O
.	O

2	O
.	O
the	O
patient	O
should	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
72	O
*	O
*	O
]	O
in	O
four	O
weeks	O
;	O
address	O
the	O
need	O
for	O
diuretics	O
and	O
cardiac	O
medications	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
58	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
73	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1248	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2015	O
-	O
02	O
-	O
11	O
*	O
*	O
]	O
16	O
:	O
22	O

t	O
:	O
[	O
*	O
*	O
2015	O
-	O
02	O
-	O
11	O
*	O
*	O
]	O
16	O
:	O
31	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
4729	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
58	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2015	O
-	O
04	O
-	O
21	O
*	O
*	O
]	O
4	O
:	O
10	O
pm	O

(	O
end	O
of	O
report	O
)	O

100076	O
||||	O
534	O
||||	O
4395	O
||||	O
echo	O
_	O
report	O
||||	O
2015	O
-	O
02	O
-	O
13	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
syncope	B
;	O
s	O
/	O
p	O
recent	O
bovine	O
pericardial	O
avr	O
.	O

height	O
:	O
(	O
in	O
)	O
66	O

weight	O
(	O
lb	O
)	O
:	O
165	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
84	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
105	O
/	O
57	O

hr	O
(	O
bpm	O
)	O
:	O
80	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2015	O
-	O
02	O
-	O
13	O
*	O
*	O
]	O
at	O
17	O
:	O
03	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
complete	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
the	O
right	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

left	O
ventricle	O
:	O
left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

right	O
ventricle	O
:	O
right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

aorta	O
:	O
the	O
aortic	O
root	O
is	O
normal	O
in	O
diameter	O
.	O

aortic	O
valve	O
:	O
a	O
bioprosthetic	O
aortic	O
valve	O
prosthesis	O
is	O
present	O
.	O

the	O
transaortic	O
gradient	O
is	O
normal	O
for	O
this	O
prosthesis	O
.	O

trace	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
mild	O
mitral	B
annular	I
calcification	I
.	O

tricuspid	O
valve	O
:	O
mild	O
tricuspid	O
[	O
1	O
+	O
]	O
regurgitation	O
is	O
seen	O
.	O

the	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
normal	O
.	O

pericardium	O
:	O
there	O
is	O
no	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

a	O
bioprosthetic	O
aortic	O
valve	O
prosthesis	O
is	O
present	O
.	O

the	O
transaortic	O
gradient	O
is	O
normal	O
for	O
this	O
prosthesis	O
.	O

trace	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

the	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
normal	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

compared	O
with	O
the	O
prior	O
report	O
(	O
tape	O
unavailable	O
)	O
of	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
30	O
*	O
*	O
]	O
,	O
a	O
biorosthetic	O
aortic	O
valve	O
is	O
present	O
.	O

945	O
||||	O
1160	O
||||	O
20323	O
||||	O
discharge	O
_	O
summary	O
||||	O
2010	O
-	O
02	O
-	O
02	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2010	O
-	O
02	O
-	O
02	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
sex	O
:	O
f	O

service	O
:	O

history	O
of	O
present	O
illness	O
:	O
ms	O
.	O
[	O
*	O
*	O
lastname	O
2880	O
*	O
*	O
]	O
is	O
a	O
41	O
year	O
-	O
old	O
female	O
who	O
was	O
a	O
bicyclist	O
on	O
[	O
*	O
*	O
2009	O
-	O
09	O
-	O
30	O
*	O
*	O
]	O
when	O
she	O
was	O
hit	O
by	O
an	O
automobile	O
that	O
resulted	O
in	O
a	O
sucking	B
chest	I
wall	I
wound	I
,	O
which	O
was	O
repaired	O
in	O
a	O
severe	O
peroneal	B
injury	I
.	O

the	O
injury	B
required	O
anal	O
sphincter	O
repair	O
and	O
diverting	O
colostomy	O
.	O

she	O
was	O
admitted	O
for	O
repair	O
of	O
her	O
bowel	O
diversion	O
.	O

past	O
medical	O
history	O
:	O
notable	O
for	O
being	O
overall	O
healthy	O
with	O
no	O
history	O
of	O
hypertension	B
,	O
diabetes	B
,	O
asthma	B
,	O
bleeding	B
disorder	I
,	O
shortness	B
of	I
breath	I
or	O
palpitations	B
.	O

past	O
surgical	O
history	O
:	O
notable	O
for	O
colostomy	O
in	O
[	O
*	O
*	O
2009	O
-	O
09	O
-	O
30	O
*	O
*	O
]	O
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

medications	O
:	O
none	O
.	O

social	O
history	O
:	O
no	O
smoking	O
and	O
occasional	O
ethanol	O
and	O
no	O
recreational	O
drugs	O
.	O

physical	O
examination	O
on	O
admission	O
:	O
the	O
patient	O
was	O
regular	O
rate	O
and	O
rhythm	O
.	O

nontender	B
,	O
nondistended	B
.	O

lungs	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

stoma	O
intact	O
and	O
pink	O
.	O

hospital	O
course	O
:	O
on	O
[	O
*	O
*	O
2010	O
-	O
01	O
-	O
29	O
*	O
*	O
]	O
the	O
patient	O
underwent	O
an	O
elective	O
take	O
down	O
colostomy	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
with	O
1650	O
of	O
intravenous	O
fluids	O
and	O
100	O
of	O
estimated	O
blood	B
loss	I
with	O
no	O
untoward	O
events	O
during	O
the	O
operation	O
.	O

this	O
operation	O
was	O
performed	O
at	O
8	O
:	O
00	O
a	O
.	O
m	O
.	O

at	O
2	O
:	O
00	O
p	O
.	O
m	O
.	O
the	O
patient	O
underwent	O
postoperative	O
check	O
,	O
which	O
demonstrated	O
vital	O
signs	O
at	O
98	O
.	O
7	O
,	O
122	O
/	O
67	O
,	O
73	O
,	O
13	O
and	O
94%	O
on	O
room	O
air	O
.	O

the	O
patient	O
was	O
being	O
maintained	O
on	O
a	O
morphine	O
sulfate	O
pca	O
at	O
1	O
mg	O
q	O
6	O
minutes	O
with	O
a	O
10	O
mg	O
hourly	O
maximum	O
.	O

she	O
also	O
received	O
100	O
mg	O
of	O
fentanyl	O
in	O
the	O
operating	O
room	O
and	O
received	O
7	O
mg	O
of	O
morphine	O
sulfate	O
in	O
the	O
pacu	O
before	O
having	O
her	O
pca	O
begun	O
.	O

in	O
the	O
pacu	O
it	O
was	O
noted	O
that	O
the	O
patient's	O
respiratory	O
rate	O
ranged	O
around	O
the	O
20s	O
and	O
diminished	O
to	O
the	O
15s	O
and	O
then	O
10	O
while	O
the	O
patient	O
maintained	O
excellent	O
oxygen	O
saturations	O
from	O
100%	O
down	O
to	O
92%	O
by	O
3	O
:	O
00	O
p	O
.	O
m	O
.	O

the	O
patient	O
was	O
transferred	O
to	O
the	O
floor	O
,	O
but	O
at	O
7	O
:	O
38	O
p	O
.	O
m	O
.	O
a	O
respiratory	B
arrest	I
was	O
called	O
.	O

the	O
patient	O
was	O
found	O
unresponsive	B
and	O
not	B
breathing	I
with	O
patent	B
airway	I
.	O

the	O
patient	O
was	O
bag	O
ventilated	O
to	O
raise	O
her	O
saturations	O
to	O
89	O
to	O
100%	O
on	O
room	O
air	O
with	O
a	O
blood	O
pressure	O
of	O
116	O
/	O
77	O
and	O
the	O
patient	O
was	O
given	O
narcan	O
.	O
4	O
mg	O
intravenous	O
and	O
began	O
breathing	O
on	O
her	O
own	O
with	O
improved	O
oxygen	O
saturations	O
.	O

the	O
patient	O
had	O
serial	O
arterial	O
blood	O
gases	O
performed	O
.	O

the	O
first	O
one	O
was	O
7	O
.	O
00	O
,	O
103	O
,	O
335	O
,	O
27	O
and	O
negative	O
7	O
.	O
the	O
second	O
blood	O
gas	O
when	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
unit	O
was	O
7	O
.	O
32	O
,	O
43	O
,	O
326	O
,	O
23	O
,	O
negative	O
3	O
.	O

the	O
patient	O
was	O
started	O
on	O
a	O
narcan	O
drip	O
and	O
transferred	O
to	O
the	O
surgical	O
intensive	O
care	O
unit	O
and	O
began	O
on	O
neurological	O
checks	O
and	O
given	O
toradol	O
to	O
help	O
control	O
her	O
pain	B
.	O

that	O
following	O
morning	O
the	O
patient	O
improved	O
.	O

her	O
vital	O
signs	O
the	O
following	O
day	O
,	O
she	O
had	O
heart	O
rate	O
of	O
66	O
,	O
blood	O
pressure	O
120	O
/	O
63	O
,	O
respiratory	O
rate	O
14	O
,	O
100%	O
on	O
5	O
liters	O
nasal	O
cannula	O
.	O

her	O
lungs	O
were	O
clear	O
to	O
auscultation	O
bilaterally	O
and	O
heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
.	O

s1	O
and	O
s2	O
.	O

the	O
patient	O
also	O
had	O
one	O
set	O
of	O
enzymes	O
,	O
which	O
were	O
negative	O
for	O
cardiac	B
event	I
.	O

the	O
patient	O
did	O
well	O
the	O
following	O
day	O
and	O
was	O
transferred	O
to	O
the	O
floor	O
postoperative	O
day	O
one	O
.	O

postoperative	O
day	O
two	O
the	O
patient	O
did	O
well	O
.	O

she	O
remained	O
stable	O
on	O
the	O
floor	O
with	O
no	O
events	B
.	O

she	O
began	O
passing	B
flatus	I
on	O
postoperative	O
day	O
four	O
.	O

her	O
diet	O
was	O
advanced	O
.	O

she	O
continued	O
to	O
be	O
stable	O
respiratory	O
wise	O
and	O
she	O
remained	O
afebrile	B
.	O

she	O
tolerated	O
a	O
regular	O
diet	O
and	O
diuresed	O
her	O
fluids	O
well	O
.	O

she	O
was	O
mentating	O
well	O
by	O
report	O
.	O

she	O
was	O
discharged	O
home	O
on	O
[	O
*	O
*	O
2011	O
-	O
02	O
-	O
02	O
*	O
*	O
]	O
after	O
being	O
seen	O
and	O
evaluated	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
for	O
a	O
final	O
time	O
and	O
with	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
the	O
thursday	O
of	O
the	O
week	O
for	O
staple	O
removal	O
.	O

she	O
was	O
instructed	O
not	O
to	O
drive	O
or	O
lift	O
greater	O
then	O
15	O
pounds	O
and	O
the	O
patient	O
was	O
discharged	O
also	O
because	O
she	O
lived	O
in	O
very	O
close	O
proximity	O
to	O
the	O
hospital	O
and	O
had	O
adequate	O
home	O
assistance	O
.	O

the	O
patient	O
tolerated	O
a	O
regular	O
diet	O
and	O
remained	O
afebrile	B
throughout	O
the	O
remainder	O
of	O
her	O
course	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
581	O
*	O
*	O
]	O
[	O
*	O
*	O
initial	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
697	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
698	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
544	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2010	O
-	O
06	O
-	O
25	O
*	O
*	O
]	O
16	O
:	O
29	O

t	O
:	O
[	O
*	O
*	O
2010	O
-	O
06	O
-	O
28	O
*	O
*	O
]	O
07	O
:	O
32	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
2881	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
581	O
*	O
*	O
]	O
moorman	O
on	O
:	O
tue	O
[	O
*	O
*	O
2010	O
-	O
06	O
-	O
29	O
*	O
*	O
]	O
3	O
:	O
14	O
pm	O

(	O
end	O
of	O
report	O
)	O

1840	O
||||	O
1163	O
||||	O
29384	O
||||	O
discharge	O
_	O
summary	O
||||	O
2014	O
-	O
10	O
-	O
06	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
01	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
06	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1958	O
-	O
06	O
-	O
16	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
3220	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

shortness	B
of	I
breath	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
is	O
a	O
56	O
year	O
old	O
man	O
who	O
was	O
discharged	O
on	O
[	O
*	O
*	O
09	O
-	O
18	O
*	O
*	O
]	O
after	O
plasmapheresis	O
x	O
5	O
for	O
[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
5981	O
*	O
*	O
]	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
*	O
*	O
]	O
syndrome	O
complicated	O
by	O
ileus	B
.	O

he	O
was	O
recovering	O
at	O
[	O
*	O
*	O
hospital	O
154	O
*	O
*	O
]	O
rehab	O
when	O
he	O
woke	O
on	O
day	O
of	O
admission	O
(	O
[	O
*	O
*	O
10	O
-	O
01	O
*	O
*	O
]	O
)	O
with	O
dyspnea	B
.	O

vital	O
signs	O
were	O
obtained	O
and	O
he	O
was	O
found	O
to	O
be	O
sating	O
82%	O
on	O
4l	O
nc	O
.	O

he	O
improved	O
to	O
90%	O
on	O
ventimask	O
.	O

patient	O
was	O
sent	O
to	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
at	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
01	O
*	O
*	O
]	O
and	O
went	O
to	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
74	O
*	O
*	O
]	O
overnight	O
prior	O
to	O
transfer	O
to	O
medicine	O
due	O
to	O
respiratory	B
improvement	I
.	O

patient	O
says	O
he	O
has	O
had	O
sob	B
for	O
6	O
days	O
,	O
when	O
he	O
developed	O
sob	B
at	O
rest	O
and	O
while	O
lying	O
down	O
.	O

patient	O
has	O
not	B
ambulated	I
since	O
discharge	O
secondary	O
to	O
weakness	B
in	O
le	O
from	O
gb	B
.	O

he	O
says	O
he	O
has	O
difficulty	B
eating	I
secondary	O
to	O
reflux	B
,	O
coughing	B
,	O
and	O
choking	B
on	O
food	O
,	O
and	O
difficulty	B
swallowing	I
.	O

his	O
sob	B
worsened	O
through	O
the	O
day	O
of	O
admission	O
.	O

cxr	O
on	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
29	O
*	O
*	O
]	O
at	O
[	O
*	O
*	O
hospital1	O
154	O
*	O
*	O
]	O
revealed	O
infiltrates	B
in	O
the	O
lower	O
lobes	O
in	O
addition	O
to	O
the	O
rml	O
.	O

he	O
was	O
treated	O
with	O
levofloxacin	O
and	O
timentin	O
at	O
[	O
*	O
*	O
hospital1	O
154	O
*	O
*	O
]	O
.	O

he	O
also	O
developed	O
a	O
cough	B
productive	I
of	O
yellowish	O
sputum	O
.	O

he	O
complains	O
of	O
reflux	B
that	O
worsens	O
his	O
dyspnea	B
.	O

the	O
cxr	O
at	O
[	O
*	O
*	O
hospital1	O
154	O
*	O
*	O
]	O
was	O
also	O
thought	O
to	O
be	O
consistent	O
with	O
chf	B
so	O
he	O
was	O
diuresed	O
with	O
80	O
mg	O
iv	O
lasix	O
resulting	O
with	O
a	O
uop	O
of	O
850	O
cc	O
at	O
[	O
*	O
*	O
hospital1	O
154	O
*	O
*	O
]	O
.	O

patient	O
was	O
receiving	O
standing	O
dose	O
of	O
80	O
mg	O
po	O
qd	O
lasix	O
at	O
[	O
*	O
*	O
hospital1	O
154	O
*	O
*	O
]	O
.	O

a	O
wbc	O
count	O
was	O
obtained	O
and	O
was	O
elevated	O
at	O
10	O
.	O
9	O
on	O
day	O
of	O
admission	O
to	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
74	O
*	O
*	O
]	O
.	O

bilateral	O
lenis	O
were	O
obtained	O
that	O
were	O
negative	O
for	O
dvt	B
.	O

an	O
ekg	O
was	O
obtained	O
that	O
showed	O
fist	B
degree	I
av	I
block	I
,	O
and	O
nonspecific	B
st	I
changes	I
.	O

bnp	O
2	O
days	O
prior	O
to	O
admission	O
was	O
high	O
at	O
140	O
(	O
upper	O
limit	O
of	O
normal	O
is	O
99	O
)	O
.	O

on	O
the	O
day	O
of	O
admission	O
,	O
an	O
abg	O
was	O
obtained	O
that	O
showed	O
7	O
.	O
46	O
/	O
47	O
/	O
117	O
.	O

as	O
the	O
patient	O
had	O
abdominal	B
pain	I
,	O
an	O
ultrasound	O
was	O
obtained	O
on	O
[	O
*	O
*	O
09	O
-	O
29	O
*	O
*	O
]	O
which	O
showed	O
normal	O
gallbladder	O
,	O
kidneys	O
,	O
common	O
hepatic	O
duct	O
,	O
pancreas	O
,	O
and	O
spleen	O
.	O

it	O
was	O
remarkable	O
for	O
a	O
mild	O
right	O
sided	O
hydronephrosis	B
and	O
bilateral	O
renal	B
cysts	I
.	O

kub	O
was	O
negative	O
for	O
obstruction	B
.	O

a	O
day	O
prior	O
to	O
admission	O
,	O
his	O
lipase	O
was	O
found	O
to	O
be	O
elevated	O
at	O
107	O
but	O
his	O
amylase	O
was	O
normal	O
.	O

in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
,	O
he	O
was	O
given	O
vanco	O
and	O
flagyl	O
.	O

prior	O
to	O
this	O
,	O
he	O
received	O
levofloxacin	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
cystinuria	B
,	O
on	O
penicillamine	O
for	O
25	O
years	O

2	O
.	O
htn	B

3	O
.	O
remote	O
afib	B
,	O
has	O
had	O
none	O
for	O
15	O
-	O
20	O
yrs	O

4	O
.	O
chf	B
,	O
diastolic	O
,	O
thought	O
secondary	O
to	O
penicillamine	O

5	O
.	O
primary	B
pulmonary	I
htn	I

6	O
.	O
chronic	B
renal	I
insufficiency	I
,	O
baseline	O
cr	O
1	O
.	O
9	O
-	O
2	O
.	O
2	O

7	O
.	O
gout	B

8	O
.	O
multiple	B
renal	I
cysts	I

9	O
.	O
h	O
/	O
o	O
pancreatic	B
mass	I

10	O
.	O

chronic	B
gastritis	I
,	O
gerd	B

11	O
.	O

anemia	B

12	O
.	O
h	O
/	O
o	O
elevated	B
psa	I
,	O
prostae	O
bx	O
negative	O
2003	O

13	O
.	O

cutis	B
laxa	I
secondary	O
to	O
penicillamine	O

14	O
.	O

restless	B
legs	I
syndrome	I

social	O
history	O
:	O

lives	O
with	O
fiancee	O
,	O
works	O
as	O
software	O
engineer	O
.	O

no	O
tobacco	O
,	O
[	O
*	O
*	O
02	O
-	O
13	O
*	O
*	O
]	O
drinks	O
(	O
glass	O
wine	O
)	O
with	O
dinner	O
/	O
week	O
,	O
no	O
other	O
drugs	O
.	O

family	O
history	O
:	O

maternal	O
aunt	O
with	O
dm	B
,	O
stroke	B
in	O
70s	O
,	O
pgm	O
with	O
dm	B
.	O

no	O
cystinuria	B
.	O

physical	O
exam	O
:	O

pe	O
:	O

tm	O
98	O
.	O
4	O
tc	O
97	O
.	O
2	O
hr	O
79	O
bp	O
115	O
/	O
64	O
rr	O
16	O
o2	O
95%	O
on	O
4	O
l	O
nc	O

gen	O
:	O
pleasant	O
and	O
cooperative	O
,	O
sitting	O
up	O
conversant	O
,	O
nasal	O
cannula	O
in	O
place	O

heent	O
:	O
mmm	O
ncat	O
,	O
hoarse	B
voice	I
(	O
chronic	O
)	O
,	O
throat	O
-	O
mmw	O
,	O
no	O
erythema	B
,	O
exudates	O

neck	O
:	O
no	O
lad	B
supple	O
,	O
thyroid	B
enlarged	I

cor	O
:	O
rrr	O
no	O
murmurs	B

pulm	O
:	O
dull	O
at	O
right	O
base	O
with	O
crackles	B
bl	O
in	O
lower	O
lobes	O
and	O
rml	O
back	O
:	O
no	O
costovertebral	B
tenderness	I

abd	O
:	O
distended	O
but	O
no	O
guarding	B
,	O
no	O
tenderness	O
,	O
+	O
bs	O

ext	O
:	O
wwp	O
,	O
dp	O
,	O
pt	O
2	O
+	O
bilaterally	O
,	O
strength	O
ankle	O
flexors	O
and	O
extensors	O
[	O
*	O
*	O
05	O
-	O
15	O
*	O
*	O
]	O
bilaterally	O
,	O
upper	O
and	O
lower	O
extremities	O
[	O
*	O
*	O
05	O
-	O
15	O
*	O
*	O
]	O
bilaterally	O
;	O
1	O
+	O
patellar	O
reflexes	O
bl	O
,	O
2	O
+	O
biceps	O
reflexes	O
bl	O
,	O
reflexes	O
in	O
achilles	O
bl	O
not	O
able	O
to	O
obtain	O

neuro	O
:	O
cn	O
ii	O
-	O
xii	O
intact	O
.	O

ambulation	O
not	O
tested	O
as	O
patient	O
says	O
he	O
can't	B
walk	I

derm	O
:	O
skin	O
at	O
neck	O
and	O
axilla	O
with	O
thick	O
consistency	O
and	O
hyperpigmented	B
macules	I
consistent	O
with	O
penicillamine	O
rectal	O
:	O
guiac	O
negative	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2014	O
-	O
10	O
-	O
03	O
*	O
*	O
]	O
05	O
:	O
51am	O
blood	O
wbc	O
-	O
6	O
.	O
9	O
rbc	O
-	O
2	O
.	O
74	O
*	O
hgb	O
-	O
7	O
.	O
9	O
*	O
hct	O
-	O
24	O
.	O
5	O
*	O
mcv	O
-	O
90	O
mch	O
-	O
28	O
.	O
8	O
mchc	O
-	O
32	O
.	O
2	O
rdw	O
-	O
17	O
.	O
5	O
*	O
plt	O
ct	O
-	O
369	O

[	O
*	O
*	O
2014	O
-	O
10	O
-	O
03	O
*	O
*	O
]	O
05	O
:	O
51am	O
blood	O
glucose	O
-	O
88	O
urean	O
-	O
34	O
*	O
creat	O
-	O
1	O
.	O
3	O
*	O
na	O
-	O
139	O
k	O
-	O
4	O
.	O
3	O
cl	O
-	O
102	O
hco3	O
-	O
27	O
angap	O
-	O
14	O

[	O
*	O
*	O
2014	O
-	O
10	O
-	O
01	O
*	O
*	O
]	O
02	O
:	O
40pm	O
blood	O
glucose	O
-	O
126	O
*	O
urean	O
-	O
45	O
*	O
creat	O
-	O
1	O
.	O
6	O
*	O
na	O
-	O
136	O
k	O
-	O
4	O
.	O
6	O
cl	O
-	O
96	O
hco3	O
-	O
29	O
angap	O
-	O
16	O

[	O
*	O
*	O
2014	O
-	O
10	O
-	O
02	O
*	O
*	O
]	O
05	O
:	O
24am	O
blood	O
amylase	O
-	O
150	O
*	O

[	O
*	O
*	O
2014	O
-	O
10	O
-	O
02	O
*	O
*	O
]	O
05	O
:	O
24am	O
blood	O
lipase	O
-	O
102	O
*	O

[	O
*	O
*	O
2014	O
-	O
10	O
-	O
03	O
*	O
*	O
]	O
05	O
:	O
51am	O
blood	O
calcium	O
-	O
9	O
.	O
4	O
phos	O
-	O
3	O
.	O
5	O
mg	O
-	O
2	O
.	O
0	O

[	O
*	O
*	O
2014	O
-	O
10	O
-	O
01	O
*	O
*	O
]	O
02	O
:	O
40pm	O
blood	O
caltibc	O
-	O
278	O
vitb12	O
-	O
699	O
folate	O
-	O
grater	O
tha	O
ferritn	O
-	O
36	O
trf	O
-	O
214	O

[	O
*	O
*	O
2014	O
-	O
10	O
-	O
01	O
*	O
*	O
]	O
05	O
:	O
15pm	O
blood	O
type	O
-	O
art	O
po2	O
-	O
143	O
*	O
pco2	O
-	O
44	O
ph	O
-	O
7	O
.	O
46	O
*	O
calhco3	O
-	O
32	O
*	O
base	O
xs	O
-	O
7	O

brief	O
hospital	O
course	O
:	O

#	O
respiratory	O
.	O

patient	O
was	O
sent	O
to	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
74	O
*	O
*	O
]	O
for	O
o2	O
saturation	O
in	O
80's	O
on	O
ra	O
.	O

he	O
was	O
treated	O
on	O
4l	O
of	O
02	O
and	O
his	O
respiratory	B
status	I
improved	O
.	O

his	O
po	O
medications	O
were	O
held	O
,	O
as	O
the	O
patient	O
was	O
found	O
to	O
have	O
an	O
aspiration	B
risk	O
given	O
his	O
dysphagia	B
.	O

patient	O
was	O
treated	O
for	O
likely	O
aspiration	B
pna	I
confirmed	O
on	O
cxr	O
.	O

he	O
was	O
started	O
on	O
iv	O
500	O
mg	O
qd	O
levofloxacin	O
and	O
500	O
mg	O
tid	O
iv	O
flagyl	O
x	O
14	O
days	O
(	O
day	O
1	O
:	O
[	O
*	O
*	O
10	O
-	O
01	O
*	O
*	O
]	O
)	O
.	O

patient	O
was	O
transferred	O
to	O
the	O
medicine	O
floor	O
the	O
following	O
day	O
due	O
to	O
improvement	O
in	O
respiratory	B
status	I
and	O
an	O
abg	O
within	O
normal	O
limits	O
.	O

patient	O
was	O
evaluated	O
by	O
speech	O
and	O
swallow	O
given	O
his	O
difficulty	B
swallowing	I
secondary	O
to	O
his	O
recent	O
[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
5981	O
*	O
*	O
]	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
*	O
*	O
]	O
syndrome	O
and	O
was	O
placed	O
on	O
aspiration	B
precautions	O
.	O

he	O
was	O
transitioned	O
to	O
po	O
500	O
mg	O
qd	O
levofloxacin	O
and	O
po	O
500	O
mg	O
tid	O
flagyl	O
after	O
he	O
was	O
evaluated	O
and	O
taught	O
by	O
speech	O
and	O
swallow	O
andtransitioned	O
to	O
pureed	O
solids	O
and	O
nectar	O
thick	O
liquids	O
,	O
later	O
advanced	O
to	O
thin	O
liquids	O
after	O
repeat	O
video	O
swallow	O
.	O

patient	O
was	O
initially	O
requiring	O
4l	O
nc	O
with	O
an	O
02	O
sat	O
of	O
95%	O
and	O
his	O
02	O
requirement	O
decreased	O
during	O
his	O
hospital	O
stay	O
and	O
he	O
was	O
sating	O
95	O
/	O
ra	O
on	O
[	O
*	O
*	O
10	O
-	O
03	O
*	O
*	O
]	O
.	O

#	O
neuro	O
:	O
patient	O
was	O
followed	O
for	O
his	O
recent	O
diagnosis	O
of	O
[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
5982	O
*	O
*	O
]	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
*	O
*	O
]	O
and	O
was	O
status	O
post	O
plasmapheresis	O
x	O
5	O
prior	O
to	O
readmission	O
.	O

on	O
exam	O
,	O
the	O
patient	O
had	O
4	O
+	O
strength	O
in	O
his	O
le's	O
and	O
1	O
+	O
reflexes	O
in	O
his	O
le's	O
.	O

the	O
neurology	O
service	O
followed	O
the	O
patient	O
during	O
his	O
admission	O
to	O
ensure	O
clinical	O
improvement	O
of	O
his	O
symptoms	B
and	O
recommended	O
pain	B
control	O
for	O
his	O
le	O
pain	B
related	O
to	O
[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
5982	O
*	O
*	O
]	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
*	O
*	O
]	O
with	O
ketorlac	O
and	O
morphine	O
.	O

a	O
lyme	O
titer	O
was	O
sent	O
and	O
was	O
pending	O
upon	O
time	O
of	O
discharge	O
,	O
this	O
lab	O
should	O
be	O
followed	O
up	O
outpatient	O
.	O

patient	O
was	O
kept	O
on	O
gabapentin	O
for	O
pain	B
symptoms	O
.	O

patient	O
states	O
neurontin	O
makes	O
him	O
drowsy	B
in	O
the	O
am	O
so	O
dosage	O
given	O
in	O
the	O
afternoon	O
.	O

patient	O
given	O
300mg	O
at	O
6pm	O
and	O
11pm	O
.	O

if	O
needed	O
and	O
patient	O
stable	O
can	O
titrate	O
neurotin	O
to	O
300mg	O
at	O
6pm	O
and	O
600mg	O
at	O
11pm	O
.	O

#	O
renal	O
:	O
patient	O
has	O
a	O
history	O
of	O
chronic	B
renal	I
failure	I
with	O
baseline	O
1	O
.	O
6	O
secondary	O
to	O
cystinuria	B
for	O
which	O
he	O
was	O
taking	O
penicillamine	O
.	O

his	O
bun	O
and	O
cr	O
trended	O
down	O
during	O
the	O
course	O
of	O
the	O
admission	O
and	O
he	O
was	O
transitioned	O
to	O
oral	O
captopril	O
,	O
allopurinol	O
and	O
polycitra	O
-	O
k	O
for	O
his	O
cystinuria	B
once	O
he	O
was	O
transitioned	O
from	O
npo	O
to	O
liquids	O
and	O
pureed	O
solids	O
.	O

patient	O
acei	O
and	O
lasix	O
were	O
held	O
secondary	O
to	O
increased	O
cre	O
,	O
however	O
acei	O
restarted	O
when	O
cre	O
back	O
to	O
normal	O
.	O

lasix	O
continued	O
to	O
be	O
held	O
.	O

acei	O
was	O
restarted	O
at	O
lower	O
dose	O
25mg	O
tid	O
from	O
50mg	O
tid	O
,	O
can	O
be	O
titrated	O
up	O
if	O
patient	O
tolerates	O
.	O

since	O
lasix	O
being	O
held	O
would	O
closely	O
watch	O
volume	O
status	O
as	O
patient	O
with	O
history	O
of	O
flash	B
pulmonary	I
edema	I
.	O

#anemia	O
:	O
the	O
patient	O
has	O
a	O
documented	O
baseline	O
hct	O
of	O
30	O
-	O
35	O
and	O
a	O
history	O
of	O
iron	B
deficiency	I
anemia	I
.	O

the	O
patient	O
discontinued	O
use	O
of	O
iron	O
supplementation	O
since	O
his	O
previous	O
admission	O
given	O
his	O
intolerance	B
of	I
iron	I
and	O
constipation	B
.	O

his	O
pcp	O
scheduled	O
the	O
patient	O
for	O
a	O
capsule	O
study	O
and	O
evaluation	O
for	O
anal	O
nodularity	B
as	O
an	O
outpatient	O
but	O
it	O
was	O
delayed	O
due	O
to	O
hospitalization	O
.	O

his	O
hct	O
on	O
[	O
*	O
*	O
10	O
-	O
03	O
*	O
*	O
]	O
dropped	O
to	O
24	O
.	O
5	O
from	O
25	O
.	O
1	O
from	O
the	O
day	O
before	O
.	O

he	O
was	O
found	O
to	O
be	O
guiac	O
negative	O
the	O
evening	O
of	O
9	O
/	O
22	O
.	O

the	O
patient	O
was	O
transfused	O
1	O
unit	O
of	O
prbc	O
.	O

he	O
was	O
told	O
to	O
follow	O
up	O
with	O
his	O
pcp	O
regarding	O
further	O
workup	O
of	O
his	O
anemia	B
.	O

this	O
was	O
discussed	O
with	O
his	O
pcp	O
.	O

#	O
fen	O
/	O
gi	O
:	O
the	O
patient	O
had	O
a	O
lipase	O
of	O
102	O
and	O
amylase	O
150	O
during	O
his	O
hospital	O
stay	O
,	O
although	O
he	O
denied	O
abdominal	B
pain	I
.	O

his	O
abdominal	O
exam	O
was	O
followed	O
routinely	O
throughout	O
his	O
hospital	O
stay	O
.	O

patient	O
was	O
given	O
iv	O
fluids	O
when	O
npo	O
for	O
his	O
risk	O
of	O
kidney	B
stones	I
given	O
his	O
diagnosis	O
of	O
cystinuria	B
.	O

#	O
cv	O
/	O
htn	B
:	O
patient	O
has	O
a	O
history	O
of	O
diastolic	B
dysfunction	I
and	O
flash	B
pulmonary	I
edema	I
.	O

a	O
cardiac	O
catheterization	O
in	O
[	O
*	O
*	O
2014	O
-	O
08	O
-	O
05	O
*	O
*	O
]	O
showed	O
normal	O
coronaries	O
.	O

echo	O
on	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
15	O
*	O
*	O
]	O
showed	O
ef	O
>	O
65%	O
and	O
moderate	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

the	O
patient's	O
po	O
meds	O
were	O
held	O
until	O
[	O
*	O
*	O
10	O
-	O
03	O
*	O
*	O
]	O
due	O
to	O
his	O
dysphagia	B
and	O
he	O
was	O
transitioned	O
to	O
po	O
norvasc	O
,	O
captopril	O
,	O
asa	O
,	O
lasix	O
,	O
and	O
aldactone	O
on	O
[	O
*	O
*	O
10	O
-	O
03	O
*	O
*	O
]	O
after	O
his	O
evaluation	O
by	O
speech	O
and	O
swallow	O
.	O

his	O
blood	O
pressure	O
and	O
fluid	O
status	O
remained	O
stable	O
during	O
the	O
course	O
of	O
his	O
admission	O
.	O

lasix	O
was	O
held	O
upon	O
discharge	O
given	O
rise	O
in	O
cre	O
,	O
this	O
can	O
be	O
slowly	O
restarted	O
as	O
tolerated	O
.	O

#h	O
/	O
o	O
restless	B
legs	I
:	O
the	O
patient	O
was	O
restarted	O
on	O
mirapex	O
when	O
patient	O
was	O
able	O
to	O
take	O
po's	O
on	O
[	O
*	O
*	O
10	O
-	O
03	O
*	O
*	O
]	O
.	O

medications	O
on	O
admission	O
:	O

1	O
.	O
allopurinol	O
300	O
mg	O
qd	O
.	O

2	O
.	O
amlodipine	O
2	O
.	O
5	O
mg	O
qd	O
.	O

3	O
.	O
folic	O
acid	O
1	O
mg	O
po	O
bid	O
.	O

4	O
.	O
pramipexole	O
0	O
.	O
25	O
mg	O
qd	O
.	O

5	O
.	O
aspirin	O
325	O
mg	O
qd	O
.	O

6	O
.	O
acetaminophen	O
325	O
mg	O
prn	O

7	O
.	O
spironolactone	O
25	O
mg	O
qd	O

8	O
.	O
omeprazole	O
20	O
mg	O
qd	O

9	O
.	O
sodium	O
citrate	O
-	O
citric	O
acid	O
500	O
-	O
334	O
mg	O
/	O
5	O
ml	O
15	O
ml	O
po	O
qid	O
prn	O
.	O

10	O
.	O

furosemide	O
120	O
mg	O
po	O
qpm	O

11	O
.	O

zolpidem	O
tartrate	O
10	O
mg	O
hs	O
prn	O

12	O
.	O

clonazepam	O
0	O
.	O
5	O
mg	O
po	O
q8h	O

13	O
.	O

heparin	O
sq	O
tid	O

14	O
.	O

docusate	O
sodium	O
100	O
bid	O

15	O
.	O

phenol	O
-	O
phenolate	O
sodium	O
1	O
.	O
4	O
%	O
mouthwash	O
prn	O

16	O
.	O

morphine	O
15	O
mg	O
tablet	O
sustained	O
release	O
qpm	O

17	O
.	O

gabapentin	O
300	O
mg	O
bid	O
6	O
pm	O
10	O
pm	O
.	O

18	O
.	O

captopril	O
50	O
mg	O
tid	O

19	O
.	O

morphine	O
2	O
mg	O
injection	O
q4h	O
prn	O

20	O
.	O

senna	O
8	O
.	O
6	O
mg	O
prn	O
.	O

21	O
.	O

dulcolax	O
10	O
mg	O
prn	O

levofloxacin	O
(	O
started	O
[	O
*	O
*	O
09	O
-	O
29	O
*	O
*	O
]	O
)	O

timentin	O
(	O
started	O
[	O
*	O
*	O
09	O
-	O
29	O
*	O
*	O
]	O
)	O

discharge	O
medications	O
:	O

1	O
.	O
heparin	O
(	O
porcine	O
)	O
5	O
,	O
000	O
unit	O
/	O
ml	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O

injection	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

2	O
.	O
acetaminophen	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

3	O
.	O
amlodipine	O
2	O
.	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

4	O
.	O
folic	O
acid	O
1	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

5	O
.	O
pramipexole	O
0	O
.	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
qhs	O
(	O
)	O
.	O

6	O
.	O
aspirin	O
325	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

7	O
.	O
spironolactone	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

8	O
.	O
zolpidem	O
5	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
as	O
needed	O
.	O

9	O
.	O
captopril	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

10	O
.	O

senna	O
8	O
.	O
6	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

11	O
.	O

metronidazole	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
for	O
8	O
days	O
.	O

12	O
.	O

levofloxacin	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q24h	O
(	O
every	O
24	O
hours	O
)	O
for	O
8	O
days	O
.	O

13	O
.	O

sodium	O
chloride	O
0	O
.	O
65	O
%	O
aerosol	O
,	O
spray	O
sig	O
:	O
[	O
*	O
*	O
01	O
-	O
12	O
*	O
*	O
]	O
sprays	O
nasal	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

14	O
.	O

allopurinol	O
100	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

15	O
.	O

morphine	O
sulfate	O
1	O
-	O
5	O
mg	O
iv	O
q4h	O
:	O
prn	O

16	O
.	O

pantoprazole	O
40	O
mg	O
recon	O
soln	O
sig	O
:	O
one	O
(	O
1	O
)	O
intravenous	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
.	O

17	O
.	O

gabapentin	O
300	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
q6pm	O
(	O
)	O
.	O

18	O
.	O

gabapentin	O
300	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
q11pm	O
(	O
)	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

[	O
*	O
*	O
hospital	O
3028	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
3029	O
*	O
*	O
]	O

discharge	O
diagnosis	O
:	O

primary	O
diagnosis	O

aspiration	B
pneumonia	I

secondary	O
diagnoses	O

[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
5981	O
*	O
*	O
]	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
*	O
*	O
]	O

cystinuria	B
,	O
on	O
penicillamine	O
for	O
25	O
years	O

htn	B

remote	O
afib	B
,	O
has	O
had	O
none	O
for	O
15	O
-	O
20	O
yrs	O

chf	B
,	O
diastolic	O
,	O
thought	O
secondary	O
to	O
penicillamine	O

primary	B
pulmonary	I
htn	I
-	O
s	O
/	O
p	O
cath	O
on	O
[	O
*	O
*	O
2014	O
-	O
08	O
-	O
05	O
*	O
*	O
]	O
,	O
which	O
demonstrated	O
normal	O
coronary	O
arteries	O
and	O
normal	O
lv	O
function	O
with	O
primary	B
pulmonary	I
hypertension	I
,	O
treated	O
w	O
/	O
lasix	O
,	O
aldactone	O
,	O
lopressor	O
(	O
which	O
pt	O
did	O
not	O
tolerate	O
secondary	O
to	O
dizziness	B
)	O

chronic	B
renal	I
insufficiency	I
,	O
baseline	O
cr	O
1	O
.	O
9	O
-	O
2	O
.	O
2	O

gout	B

multiple	I
renal	I
cysts	I

h	O
/	O
o	O
pancreatic	B
mass	I

chronic	I
gastritis	I
,	O
gerd	B

anemia	I

h	O
/	O
o	O
elevated	B
psa	I
,	O
prostae	O
bx	O
negative	O
2003	O

cutis	B
laxa	I
secondary	O
to	O
penicillamine	O

restless	B
legs	I
syndrome	I

discharge	O
condition	O
:	O

good	O

discharge	O
instructions	O
:	O

please	O
follow	O
up	O
with	O
your	O
pcp	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
67	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
5983	O
*	O
*	O
]	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
5984	O
*	O
*	O
]	O
upon	O
discharge	O
.	O

please	O
take	O
all	O
your	O
medications	O
as	O
described	O
,	O
including	O
the	O
levofloxacin	O
and	O
flagyl	O
for	O
your	O
pneumonia	B
(	O
last	O
dose	O
on	O
[	O
*	O
*	O
10	O
-	O
14	O
*	O
*	O
]	O
)	O
.	O

please	O
follow	O
up	O
with	O
your	O
pcp	O
regarding	O
your	O
low	O
hematocrit	O
levels	O
.	O

please	O
follow	O
the	O
instructions	O
outlined	O
for	O
you	O
regarding	O
eating	O
thin	O
liquids	O
and	O
pureed	O
solids	O
.	O

please	O
follow	O
up	O
with	O
speech	O
and	O
swallow	O
for	O
further	O
evaluation	O
at	O
your	O
rehabilitation	O
facility	O
.	O

followup	O
instructions	O
:	O

please	O
follow	O
up	O
with	O
your	O
pcp	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
67	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
5983	O
*	O
*	O
]	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
5984	O
*	O
*	O
]	O
upon	O
discharge	O
.	O

please	O
follow	O
up	O
with	O
your	O
gi	O
doctor	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
4750	O
*	O
*	O
]	O
regarding	O
your	O
low	O
hematocrit	O
levels	O
and	O
further	O
workup	O
.	O

please	O
follow	O
up	O
with	O
your	O
neurologist	O
as	O
an	O
outpatient	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
811	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
3225	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
813	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
5985	O
*	O
*	O
]	O
[	O
*	O
*	O
name6	O
(	O
md	O
)	O
5986	O
*	O
*	O
]	O
[	O
*	O
*	O
name8	O
(	O
md	O
)	O
5987	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
5988	O
*	O
*	O
]	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
06	O
*	O
*	O
]	O
@	O
1513	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
811	O
*	O
*	O
]	O
parks	O
on	O
:	O
mon	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
06	O
*	O
*	O
]	O
5	O
:	O
59	O
pm	O

(	O
end	O
of	O
report	O
)	O

104065	O
||||	O
1222	O
||||	O
3771	O
||||	O
echo	O
_	O
report	O
||||	O
2011	O
-	O
08	O
-	O
29	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
endocarditis	B
.	O

history	O
of	O
rheumatic	B
fever	I

height	O
:	O
(	O
in	O
)	O
68	O

weight	O
(	O
lb	O
)	O
:	O
234	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
19	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
83	O
/	O
47	O

hr	O
(	O
bpm	O
)	O
:	O
110	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2011	O
-	O
08	O
-	O
29	O
*	O
*	O
]	O
at	O
11	O
:	O
36	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
complete	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
suboptimal	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
ventricle	O
:	O
left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal	O
.	O

due	O
to	O
suboptimal	O
technical	O
quality	O
,	O
a	O
focal	O
wall	B
motion	I
abnormality	I
cannot	O
be	O
fully	O
excluded	O
.	O

overall	O
left	B
ventricular	I
systolic	I
function	I
cannot	O
be	O
reliably	O
assessed	O
.	O

there	O
is	O
no	O
resting	O
left	B
ventricular	I
outflow	I
tract	I
obstruction	I
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	B
.	O

mild	O
(	O
1	O
+	O
)	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
is	O
not	O
well	O
seen	O
.	O

there	O
is	O
moderate	O
thickening	B
of	O
the	O
mitral	O
valve	O
chordae	O
.	O

there	O
is	O
no	O
significant	O
mitral	B
stenosis	I
.	O

mitral	B
regurgitation	I
is	O
present	O
but	O
cannot	O
be	O
quantified	O
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
due	O
to	O
poor	O
echo	O
windows	O
.	O

the	O
echocardiographic	O
results	O
were	O
reviewed	O
by	O
telephone	O
with	O
the	O
houseofficer	O
caring	O
for	O
the	O
patient	O
.	O

conclusions	O
:	O

technically	O
suboptimal	O
study	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal	O
.	O

global	O
and	O
regional	B
systolic	I
function	I
could	O
not	O
be	O
adequately	O
assessed	O
.	O

the	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	B
.	O

mild	O
(	O
1	O
+	O
)	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
is	O
not	O
well	O
seen	O
.	O

there	O
is	O
moderate	O
thickening	B
of	O
the	O
mitral	O
valve	O
chordae	O
.	O

mitral	B
regurgitation	I
is	O
present	O
but	O
cannot	O
be	O
quantified	O
-	O
?mild	O
.	O

there	O
is	O
no	O
obvious	O
pericardial	B
effusion	I
.	O

if	O
the	O
clinical	O
suspicion	O
for	O
endocarditis	B
is	O
high	O
,	O
a	O
tee	O
is	O
suggested	O
.	O

24700	O
||||	O
2740	O
||||	O
1004	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
04	O
-	O
28	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
26	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
28	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1930	O
-	O
08	O
-	O
20	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
ccu	O

history	O
of	O
present	O
illness	O
:	O
patient	O
is	O
an	O
81	O
-	O
year	O
-	O
old	O
female	O
with	O
history	O
of	O
hypertension	B
who	O
presented	O
with	O
two	O
-	O
week	O
history	O
of	O
dizziness	B
and	O
fatigue	B
.	O

in	O
the	O
emergency	O
room	O
the	O
patient	O
was	O
found	O
to	O
have	O
2	O
:	O
1	O
heart	B
block	I
.	O

patient	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
prior	O
to	O
this	O
.	O

she	O
was	O
active	O
daily	O
until	O
two	O
weeks	O
ago	O
when	O
she	O
became	O
fatigued	B
and	O
lightheaded	B
.	O

the	O
patient	O
denied	O
syncope	B
and	O
denied	O
chest	B
pain	I
.	O

patient	O
was	O
seen	O
by	O
her	O
primary	O
cardiologist	O
who	O
noted	O
2	O
:	O
1	O
heart	B
block	I
and	O
referred	O
her	O
to	O
[	O
*	O
*	O
hospital	O
1990	O
*	O
*	O
]	O
.	O

also	O
of	O
note	O
,	O
the	O
patient	O
was	O
treated	O
for	O
a	O
urinary	B
tract	I
infection	I
for	O
the	O
past	O
seven	O
days	O
.	O

the	O
patient	O
currently	O
denied	O
any	O
symptoms	B
.	O

in	O
particular	O
,	O
she	O
denied	O
any	O
burning	B
,	O
frequency	B
,	O
or	O
urgency	B
.	O

she	O
also	O
denied	O
any	O
shortness	B
of	I
breath	I
.	O

she	O
denied	O
bright	B
red	I
blood	I
or	O
melena	B
.	O

she	O
also	O
denied	O
paroxysmal	B
nocturnal	I
dyspnea	I
or	O
orthopnea	B
.	O

she	O
denied	O
shortness	B
of	I
breath	I
but	O
did	O
report	O
some	O
dyspnea	B
on	I
exertion	I
with	O
two	O
flights	O
of	O
stairs	O
,	O
which	O
was	O
unchanged	O
from	O
her	O
baseline	O
.	O

she	O
denied	O
any	O
lower	B
extremity	I
edema	I
or	O
palpitations	B
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
hypertension	B
.	O

2	O
.	O
status	O
post	O
appendectomy	O
.	O

3	O
.	O
colovesicular	B
fistula	I
in	O
[	O
*	O
*	O
2010	O
*	O
*	O
]	O
secondary	O
to	O
diverticulitis	B
for	O
which	O
she	O
had	O
an	O
lar	O
.	O

allergies	O
:	O

1	O
.	O
ciprofloxacin	O
causes	O
a	O
rash	B
.	O

2	O
.	O
sulfa	O
causes	O
a	O
rash	B
.	O

medications	O
:	O

1	O
.	O
amoxicillin	O
250	O
t	O
.	O
i	O
.	O
d	O
.	O
day	O
seven	O
of	O
10	O
.	O

2	O
.	O
toprol	O
xl	O
75	O
q	O
.	O
day	O
.	O

3	O
.	O
synthroid	O
.	O

4	O
.	O
hydrochlorothiazide	O
37	O
.	O
5	O
.	O

5	O
.	O
triamterene	O
25	O
.	O

social	O
history	O
:	O
the	O
patient	O
is	O
a	O
homemaker	O
.	O

she	O
is	O
widowed	O
.	O

she	O
has	O
one	O
child	O
and	O
three	O
grandchildren	O
.	O

she	O
denies	O
tobacco	O
use	O
,	O
reports	O
only	O
occasional	O
alcohol	O
use	O
,	O
and	O
denies	O
drug	O
use	O
.	O

physical	O
examination	O
on	O
admission	O
:	O
temperature	O
98	O
.	O
3	O
,	O
blood	O
pressure	O
164	O
/	O
36	O
,	O
heart	O
rate	O
of	O
36	O
,	O
respirations	O
18	O
,	O
satting	O
98%	O
on	O
room	O
air	O
.	O

general	O
:	O
this	O
is	O
a	O
well	O
appearing	O
,	O
elderly	O
female	O
in	O
no	O
acute	B
distress	I
.	O

heent	O
:	O
pupils	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

oropharynx	O
is	O
clear	O
.	O

mucous	O
membranes	O
moist	O
are	O
moist	O
.	O

cardiovascular	O
exam	O
reveals	O
regular	O
rhythm	O
but	O
bradycardiac	B
;	O
normal	O
s1	O
,	O
s2	O
with	O
ii	O
-	O
iii	O
/	O
vi	O
systolic	B
murmur	I
.	O

her	O
lungs	O
are	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

abdomen	O
is	O
soft	O
,	O
nontender	O
,	O
nondistended	O
with	O
good	O
bowel	O
sounds	O
.	O

extremities	O
:	O
no	O
clubbing	B
,	O
cyanosis	B
,	O
or	O
edema	B
;	O
dorsalis	O
pedis	O
are	O
2	O
+	O
.	O

laboratory	O
data	O
:	O
ekg	O
on	O
admission	O
reveals	O
sinus	B
rhythm	I
at	O
70	O
with	O
a	O
right	B
bundle	I
branch	I
block	I
morphology	O
than	O
subsequent	O

ekg	O
which	O
revealed	O
a	O
2	O
:	O
1	O
conduction	O
with	O
an	O
atrial	O
rate	O
of	O
80	O
and	O
a	O
ventricular	O
conducted	O
rate	O
of	O
40	O
.	O

laboratory	O
values	O
on	O
admission	O
:	O
white	O
count	O
7	O
.	O
3	O
,	O
hematocrit	O
33	O
,	O
platelets	O
199	O
,	O
inr	O
was	O
1	O
.	O
1	O
,	O
sodium	O
was	O
142	O
,	O
potassium	O

3	O
.	O
9	O
,	O
creatinine	O
was	O
1	O
.	O
1	O
,	O
ck	O
was	O
87	O
.	O

summary	O
of	O
hospital	O
course	O
:	O

1	O
.	O
cardiac	O
rhythm	O
:	O
the	O
patient	O
presented	O
with	O
2	O
:	O
1	O
heart	B
block	I
at	O
rates	O
faster	O
than	O
75	O
.	O

the	O
patient	O
had	O
a	O
conduction	B
abnormality	I
which	O
seemed	O
to	O
originate	O
in	O
the	O
his	O
system	O
rather	O
than	O
at	O
the	O
atrioventricular	O
node	O
.	O

the	O
patient	O
had	O
a	O
stable	O
pr	O
interval	O
prior	O
to	O
the	O
heart	B
block	I
.	O

in	O
addition	O
to	O
this	O
,	O
the	O
patient	O
also	O
converted	O
to	O
1	O
:	O
1	O
conduction	O
with	O
carotid	O
massage	O
.	O

patient	O
remained	O
stable	O
overnight	O
and	O
was	O
asymptomatic	O
with	O
a	O
rate	O
of	O
36	O
to	O
38	O
.	O

patient	O
then	O
went	O
for	O
pacemaker	O
clinic	O
pacemaker	O
implantation	O
and	O
tolerated	O
this	O
procedure	O
well	O
.	O

patient	O
remained	O
in	O
stable	O
paced	O
rhythm	O
at	O
the	O
time	O
of	O
discharge	O
.	O

2	O
.	O
pump	O
:	O
patient	O
has	O
an	O
unknown	O
ejection	O
fraction	O
which	O
will	O
be	O
further	O
followed	O
up	O
as	O
an	O
outpatient	O
.	O

3	O
.	O
urinary	B
tract	I
infection	I
:	O
the	O
patient	O
had	O
evidence	O
of	O
a	O
urinary	B
tract	I
infection	I
on	O
admission	O
,	O
and	O
therefore	O
her	O

amoxicillin	O
was	O
changed	O
to	O
augmentin	O
for	O
further	O
coverage	O
.	O

this	O
will	O
be	O
further	O
followed	O
by	O
her	O
primary	O
care	O
physician	O
at	O
the	O
time	O
of	O
discharge	O
.	O

discharge	O
condition	O
:	O
stable	O
.	O

disposition	O
:	O
to	O
home	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
atrioventricular	B
conduction	I
block	I
.	O

2	O
.	O
status	O
post	O
pacemaker	O
placement	O
.	O

3	O
.	O
hypertension	B
.	O

4	O
.	O
hypothyroidism	B
.	O

discharge	O
medications	O
:	O

1	O
.	O
toprol	O
xl	O
75	O
q	O
.	O
day	O
.	O

2	O
.	O
augmentin	O
one	O
tab	O
q	O
.	O

12	O
hours	O
for	O
seven	O
days	O
.	O

3	O
.	O
synthroid	O
per	O
previous	O
dose	O
.	O

discharge	O
instructions	O
:	O

1	O
.	O
patient	O
will	O
follow	O
up	O
in	O
device	O
clinic	O
on	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
03	O
*	O
*	O
]	O
.	O

2	O
.	O
in	O
addition	O
to	O
this	O
,	O
she	O
will	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
,	O
within	O
the	O
week	O
following	O
discharge	O
.	O

3	O
.	O
she	O
will	O
also	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
,	O
her	O
cardiologist	O
,	O
for	O
further	O
management	O
.	O

[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
pinto	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
4966	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
5111	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
02	O
*	O
*	O
]	O
21	O
:	O
27	O

t	O
:	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
02	O
*	O
*	O
]	O
21	O
:	O
49	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
5630	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
pinto	O
on	O
:	O
fri	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
11	O
*	O
*	O
]	O
5	O
:	O
35	O
pm	O

(	O
end	O
of	O
report	O
)	O

26480	O
||||	O
3087	O
||||	O
14255	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
07	O
-	O
06	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
27	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
06	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1954	O
-	O
08	O
-	O
29	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
cardiothoracic	O

allergies	O
:	O

lisinopril	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
342	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

dyspnea	B
on	I
exertion	I
.	O

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

mitral	O
valve	O
repair	O
with	O
resection	O
of	O
posterior	O
leaflet	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
27	O
*	O
*	O
]	O
.	O

history	O
of	O
present	O
illness	O
:	O

this	O
is	O
a	O
57	O
year	O
old	O
male	O
patient	O
with	O
known	O
heart	B
murmurs	I
who	O
has	O
been	O
followed	O
by	O
serial	O
echos	O
since	O
[	O
*	O
*	O
1997	O
*	O
*	O
]	O
.	O

in	O
10	O
/	O
04	O
he	O
saw	O
his	O
primary	O
care	O
physician	O
with	O
the	O
complaint	O
of	O
progressive	O
dyspnea	B
.	O

a	O
cardiac	O
catheterization	O
in	O
1	O
/	O
05	O
showed	O
severe	O
mitral	B
regurgitation	I
,	O
an	O
ejection	O
fraction	O
of	O
66%	O
and	O
a	O
right	O
coronary	O
artery	O
with	O
a	O
70%	O
lesion	B
which	O
was	O
stented	O
.	O

he	O
was	O
subsequently	O
referred	O
for	O
a	O
minimally	O
invasive	O
mitral	O
valve	O
repair	O

past	O
medical	O
history	O
:	O

hypertension	B
.	O

addison's	B
disease	I
.	O

hypothyroidism	B
.	O

melanoma	B
.	O

bph	B
.	O

social	O
history	O
:	O

works	O
as	O
mechanical	O
engineer	O
.	O

lives	O
with	O
wife	O
.	O
[	O
*	O
*	O
name	O
(	O
ni	O
)	O
1381	O
*	O
*	O
]	O
[	O
*	O
*	O
name2	O
(	O
ni	O
)	O
*	O
*	O
]	O
use	O
,	O
reports	O
[	O
*	O
*	O
04	O
-	O
05	O
*	O
*	O
]	O
drinks	O
of	O
alcohol	O
per	O
week	O
.	O

family	O
history	O
:	O

noncontributory	O

physical	O
exam	O
:	O

bp	O
:	O
(	O
r	O
)	O
135	O
/	O
76	O
(	O
l	O
)	O
149	O
/	O
79	O
hr	O
68	O
weight	O
225	O

gen	O
:	O
tall	O
young	O
lad	O
in	O
no	O
acute	B
distress	I

skin	O
:	O
well	O
healed	O
right	O
shoulder	O
incision	O

heent	O
:	O
eomi	O
intact	O
,	O
nl	O
buccal	O
mucosa	O
,	O
anicteric	O
,	O
oropharynx	O
benign	O
.	O

neck	O
:	O
supple	O
,	O
murmur	B
transmitted	O
,	O
no	O
jvd	B

chest	O
:	O
clear	O

heart	O
:	O
rrr	O
,	O
iii	O
/	O
vi	O
systolic	B
murmur	I
.	O

abdomen	O
:	O
soft	O
,	O
nontender	O
,	O
nondistended	O

ext	O
:	O
warm	O
and	O
well	O
perfused	O

neuro	O
:	O
grossly	O
intact	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2012	O
-	O
07	O
-	O
03	O
*	O
*	O
]	O
08	O
:	O
50am	O
blood	O
wbc	O
-	O
10	O
.	O
8	O
rbc	O
-	O
2	O
.	O
60	O
*	O
hgb	O
-	O
8	O
.	O
0	O
*	O
hct	O
-	O
23	O
.	O
3	O
*	O
mcv	O
-	O
90	O
mch	O
-	O
30	O
.	O
9	O
mchc	O
-	O
34	O
.	O
5	O
rdw	O
-	O
15	O
.	O
0	O
plt	O
ct	O
-	O
203	O

[	O
*	O
*	O
2012	O
-	O
07	O
-	O
03	O
*	O
*	O
]	O
08	O
:	O
50am	O
blood	O
plt	O
ct	O
-	O
203	O

[	O
*	O
*	O
2012	O
-	O
06	O
-	O
28	O
*	O
*	O
]	O
03	O
:	O
04am	O
blood	O
pt	O
-	O
12	O
.	O
9	O
ptt	O
-	O
30	O
.	O
5	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
1	O

[	O
*	O
*	O
2012	O
-	O
07	O
-	O
03	O
*	O
*	O
]	O
08	O
:	O
50am	O
blood	O
glucose	O
-	O
81	O
urean	O
-	O
15	O
creat	O
-	O
0	O
.	O
9	O
na	O
-	O
133	O
k	O
-	O
3	O
.	O
7	O
cl	O
-	O
95	O
*	O
hco3	O
-	O
28	O
angap	O
-	O
14	O

[	O
*	O
*	O
2012	O
-	O
07	O
-	O
02	O
*	O
*	O
]	O
04	O
:	O
46am	O
blood	O
calcium	O
-	O
8	O
.	O
0	O
*	O
phos	O
-	O
3	O
.	O
9	O
mg	O
-	O
1	O
.	O
9	O

[	O
*	O
*	O
2012	O
-	O
07	O
-	O
05	O
*	O
*	O
]	O
11	O
:	O
30am	O
blood	O
wbc	O
-	O
9	O
.	O
8	O
rbc	O
-	O
4	O
.	O
04	O
*	O
hgb	O
-	O
12	O
.	O
1	O
*	O
hct	O
-	O
36	O
.	O
4	O
*	O
mcv	O
-	O
90	O
mch	O
-	O
30	O
.	O
0	O
mchc	O
-	O
33	O
.	O
3	O
rdw	O
-	O
15	O
.	O
3	O
plt	O
ct	O
-	O
407#	O

[	O
*	O
*	O
2012	O
-	O
07	O
-	O
05	O
*	O
*	O
]	O
11	O
:	O
30am	O
blood	O
plt	O
ct	O
-	O
407#	O

[	O
*	O
*	O
2012	O
-	O
07	O
-	O
05	O
*	O
*	O
]	O
11	O
:	O
30am	O
blood	O
glucose	O
-	O
102	O
urean	O
-	O
19	O
creat	O
-	O
1	O
.	O
0	O
na	O
-	O
136	O
k	O
-	O
4	O
.	O
6	O
cl	O
-	O
96	O
hco3	O
-	O
27	O
angap	O
-	O
18	O

[	O
*	O
*	O
2012	O
-	O
07	O
-	O
02	O
*	O
*	O
]	O
04	O
:	O
46am	O
blood	O
calcium	O
-	O
8	O
.	O
0	O
*	O
phos	O
-	O
3	O
.	O
9	O
mg	O
-	O
1	O
.	O
9	O

[	O
*	O
*	O
2012	O
-	O
06	O
-	O
29	O
*	O
*	O
]	O
cxr	O

no	O
evidence	O
of	O
pneumothorax	B
,	O
no	O
significant	O
chf	B
but	O
bilateral	O
moderate	O
amount	O
of	O
pleural	O
effusions	O
as	O
seen	O
on	O
single	O
view	O
chest	O
examination	O
.	O

brief	O
hospital	O
course	O
:	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
1382	O
*	O
*	O
]	O
was	O
admitted	O
the	O
morning	O
of	O
4	O
/	O
27	O
and	O
proceeded	O
directly	O
to	O
the	O
operating	O
room	O
.	O

he	O
underwent	O
a	O
mitral	O
valve	O
repair	O
with	O
resection	O
of	O
the	O
posterior	O
leaflet	O
with	O
a	O
28	O
mm	O
[	O
*	O
*	O
doctor	O
last	O
name	O
1383	O
*	O
*	O
]	O
band	O
with	O
dr	O
.	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
3	O
*	O
*	O
]	O
.	O

please	O
see	O
op	O
note	O
for	O
full	O
details	O
.	O

he	O
was	O
successfully	O
weened	O
and	O
extubated	O
on	O
his	O
operative	O
evening	O
and	O
was	O
placed	O
on	O
a	O
steroid	O
taper	O
with	O
the	O
help	O
of	O
endocrinology	O
given	O
his	O
addisons	B
disease	I
.	O

on	O
postoperative	O
day	O
two	O
he	O
was	O
transferred	O
to	O
the	O
inpatient	O
telemetry	O
floor	O
for	O
ongoing	O
management	O
and	O
rehabilitation	O
.	O

on	O
postoperative	O
day	O
four	O
he	O
had	O
a	O
burst	O
of	O
atrial	B
fibrillation	I
-	O
-	O
converted	O
spontaneously	O
and	O
was	O
noted	O
to	O
have	O
a	O
first	B
degree	I
av	I
-	I
block	I
.	O

due	O
to	O
this	O
av	B
block	I
,	O
his	O
beta	O
blockade	O
was	O
held	O
.	O

on	O
postoperative	O
day	O
five	O
,	O
with	O
no	O
furtehr	O
episodes	O
of	O
afib	B
but	O
with	O
elevated	B
bp	I
and	O
hr	O
,	O
a	O
low	O
dose	O
beta	O
-	O
blocker	O
was	O
added	O
with	O
no	O
change	O
in	O
his	O
av	B
block	I
.	O

he	O
also	O
continued	O
to	O
be	O
significantly	O
edamatous	B
,	O
nearly	O
14	O
kg	O
up	O
from	O
his	O
pre	O
-	O
op	O
weight	O
and	O
he	O
was	O
actively	O
diureses	O
with	O
lasix	O
.	O

on	O
postoperative	O
days	O
six	O
and	O
seven	O
,	O
we	O
continued	O
to	O
diurese	O
him	O
heavily	O
.	O

endocrine	O
also	O
continued	O
to	O
follow	O
with	O
regards	O
for	O
his	O
steroid	O
taper	O
.	O

on	O
postoperative	O
eight	O
,	O
he	O
cleared	O
physical	O
therapy	O
and	O
was	O
discahrged	O
home	O
with	O
a	O
visiting	O
nurse	O
to	O
follow	O
.	O

medications	O
on	O
admission	O
:	O

plavix	O
75	O
daily	O
.	O

prednisone	O
12	O
.	O
5	O
mg	O
daily	O
.	O

flurinef	O
0	O
.	O
1	O
mg	O
daily	O
.	O

levoxyl	O
0	O
.	O
025	O
mg	O
daily	O
.	O

enalapril	O
10	O
mh	O
bid	O
.	O

lipitor	O
20	O
mg	O
daily	O
.	O

aspirin	O
325	O
mg	O
daily	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

2	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

3	O
.	O
atorvastatin	O
calcium	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

4	O
.	O
levothyroxine	O
sodium	O
25	O
mcg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

5	O
.	O
clopidogrel	O
bisulfate	O
75	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

6	O
.	O
fludrocortisone	O
acetate	O
0	O
.	O
1	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

7	O
.	O
enalapril	O
maleate	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

8	O
.	O
ascorbic	O
acid	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

9	O
.	O
polysaccharide	O
iron	O
complex	O
150	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O

capsule	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

10	O
.	O

metoprolol	O
tartrate	O
25	O
mg	O
tablet	O
sig	O
:	O
0	O
.	O
5	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

11	O
.	O

oxycodone	O
hcl	O
5	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
every	O
[	O
*	O
*	O
06	O
-	O
06	O
*	O
*	O
]	O
hours	O
as	O
needed	O
.	O

disp	O
:	O
*	O
40	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

12	O
.	O

potassium	O
chloride	O
20	O
meq	O
tab	O
sust	O
.	O
rel	O
.	O

particle	O
/	O
crystal	O
sig	O
:	O
two	O
(	O
2	O
)	O
tab	O
sust	O
.	O
rel	O
.	O

particle	O
/	O
crystal	O
po	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
for	O
2	O
weeks	O
.	O

disp	O
:	O
*	O
56	O
tab	O
sust	O
.	O
rel	O
.	O

particle	O
/	O
crystal	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

13	O
.	O

lasix	O
40	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
twice	O
a	O
day	O
for	O
2	O
weeks	O
.	O

disp	O
:	O
*	O
28	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

14	O
.	O

prednisone	O
5	O
mg	O
tablet	O
sig	O
:	O
1	O
.	O
5	O
tablets	O
po	O
qam	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
morning	O
)	O
)	O
:	O
5	O
mg	O
on	O
the	O
pm	O
.	O

disp	O
:	O
*	O
45	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

15	O
.	O

metoprolol	O
tartrate	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

mitral	B
regurgitation	I
.	O

hypertension	B
.	O

addison's	B
disease	I
.	O

hypothyroidism	B
.	O

discharge	O
condition	O
:	O

stable	O
.	O

discharge	O
instructions	O
:	O

shower	O
daily	O
with	O
soap	O
and	O
water	O
.	O

rinse	O
well	O
.	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
not	O
apply	O
any	O
creams	O
,	O
lotions	O
,	O
powders	O
,	O
or	O
ointments	O
.	O

take	O
all	O
new	O
medications	O
as	O
prescribed	O
.	O

make	O
follow	O
-	O
up	O
appointments	O
as	O
directed	O
.	O

no	O
heavy	O
lifting	O
,	O
greater	O
than	O
10	O
pounds	O
.	O

no	O
driving	O
x	O
6	O
weeks	O
.	O

[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
742	O
*	O
*	O
]	O
p	O
instructions	O
:	O

call	O
to	O
schedule	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
3	O
*	O
*	O
]	O
.	O

call	O
to	O
schedule	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
.	O

[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
351	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
745	O
*	O
*	O
]	O
pa	O
80	O
-	O
bye	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
06	O
*	O
*	O
]	O
@	O
1046	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
13	O
*	O
*	O
]	O
10	O
:	O
57	O
am	O

(	O
end	O
of	O
report	O
)	O

14440	O
||||	O
3298	O
||||	O
4795	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
08	O
-	O
09	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
23	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
08	O
-	O
09	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1935	O
-	O
05	O
-	O
14	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O

history	O
of	O
the	O
present	O
illness	O
:	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
originally	O
presented	O
to	O
an	O
outside	O
hospital	O
on	O
[	O
*	O
*	O
07	O
-	O
15	O
*	O
*	O
]	O
with	O
bright	B
red	I
blood	I
per	I
rectum	I
,	O
where	O
he	O
underwent	O
a	O
colonoscopy	O
.	O

this	O
did	O
not	O
show	O
any	O
evidence	O
of	O
bleeding	B
.	O

he	O
was	O
sent	O
home	O
,	O
but	O
he	O
was	O
readmitted	O
on	O
the	O
[	O
*	O
*	O
07	O
-	O
17	O
*	O
*	O
]	O
with	O
an	O
increase	O
in	O
volume	B
of	I
stools	I
,	O
and	O
he	O
underwent	O
a	O
repeat	O
colonoscopy	O
at	O
the	O
outside	O
hospital	O
.	O

he	O
was	O
again	O
negative	O
by	O
colonoscopy	O
and	O
he	O
was	O
discharged	O
home	O
and	O
he	O
was	O
hemodynamically	O
stable	O
.	O

on	O
the	O
[	O
*	O
*	O
07	O
-	O
23	O
*	O
*	O
]	O
,	O
he	O
passed	B
bowel	I
movement	I
and	O
clots	O
in	O
large	O
amounts	O
to	O
a	O
total	O
output	O
of	O
1700	O
cubic	O
centimeters	O
.	O

he	O
became	O
hemodynamically	O
stable	O
and	O
he	O
was	O
transferred	O
to	O
the	O
[	O
*	O
*	O
hospital	O
1026	O
*	O
*	O
]	O
,	O
where	O
he	O
had	O
a	O
bleeding	B

scan	O
,	O
egd	O
,	O
upper	O
gi	O
series	O
and	O
a	O
small	O
bowel	O
follow	O
through	O
.	O

all	O
of	O
these	O
studies	O
were	O
negative	O
.	O

he	O
then	O
underwent	O
a	O
bleeding	B
scan	O
at	O
[	O
*	O
*	O
hospital	O
1026	O
*	O
*	O
]	O
,	O
which	O
was	O
negative	O
for	O
acute	B
bleeding	I
,	O
but	O
which	O
showed	O
pooling	B
blood	I
.	O

he	O
then	O
underwent	O
an	O
angiography	O
in	O
an	O
attempt	O
to	O
identify	O
the	O
bleeding	B
vessels	I
.	O

angiography	O
was	O
also	O
undertaken	O
to	O
identify	O
the	O
bleeding	B
vessel	I
to	O
guide	O
surgical	O
intervention	O
and	O
to	O
attempt	O
occlusion	O
of	O
the	O
bleeding	B
vessel	I
.	O

at	O
intervention	O
radiology	O
/	O
angiography	O
,	O
the	O
bleeding	B
vessel	I
was	O
identified	O
,	O
however	O
,	O
attempted	O
occlusion	O
of	O
this	O
bleeding	B
blood	I
vessel	I
was	O
unsuccessful	O
.	O

after	O
being	O
transferred	O
to	O
the	O
medical	O
intensive	O
care	O
unit	O
,	O
where	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
received	O
numerous	O
transfusion	O
of	O
packed	O
red	O
blood	O
cells	O
and	O
crystalloid	O
,	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
was	O
prepared	O
for	O
surgery	O
and	O
underwent	O
a	O
subtotal	O
colectomy	O
on	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
27	O
*	O
*	O
]	O
.	O

intraoperatively	O
,	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
received	O
7	O
.	O
2	O
liters	O
crystalloid	O
,	O
had	O
an	O
estimated	O
blood	O
loss	O
of	O
500	O
cc	O
and	O
urine	O
output	O
of	O
350	O
cc	O
.	O

incidental	O
finding	O
at	O
the	O
time	O
of	O
surgery	O
was	O
that	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
was	O
asplenic	B
,	O
presumably	O
because	O
his	O
spleen	O
had	O
been	O
removed	O
at	O
the	O
time	O
of	O
his	O
prior	O
surgery	O
for	O
bleeding	B
diverticula	I
-	O
a	O
right	O
hemicolectomy	O
.	O

the	O
procedure	O
was	O
without	O
complication	B
.	O

the	O
patient	O
was	O
transferred	O
to	O
the	O
post	O
anesthesia	O
care	O
unit	O
in	O
stable	O
condition	O
.	O

mr	O
.	O
[	O
*	O
*	O
name13	O
(	O
stitle	O
)	O
6879	O
*	O
*	O
]	O
past	O
medical	O
history	O
was	O
significant	O
for	O
diverticulosis	B
with	O
recurrent	O
lower	B
gi	I
bleeding	I
for	O
which	O
he	O
was	O
treated	O
with	O
a	O
right	O
hemicolectomy	O
in	O
[	O
*	O
*	O
2009	O
*	O
*	O
]	O
at	O
an	O
outside	O
hospital	O
.	O

past	O
medical	O
history	O
also	O
was	O
significant	O
for	O
hypertension	B
,	O
glaucoma	B
,	O
rheumatic	B
heart	I
disease	I
and	O
hemorrhoids	B
.	O

home	O
medications	O
:	O

1	O
.	O
hydrochlorothiazide	O
.	O

2	O
.	O
zestril	O
.	O

3	O
.	O
timolol	O
for	O
his	O
glaucoma	B
.	O

4	O
.	O
proton	O
pump	O
inhibitor	O
,	O
protonix	O
.	O

allergies	O
:	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
had	O
no	O
known	O
drug	O
allergies	O
.	O

mr	O
.	O
[	O
*	O
*	O
name13	O
(	O
stitle	O
)	O
6879	O
*	O
*	O
]	O
postoperative	O
course	O
was	O
largely	O
uneventful	O
and	O
characterized	O
by	O
a	O
slow	O
,	O
but	O
steady	O
recovery	O
from	O
his	O
surgery	O
.	O

he	O
followed	O
a	O
conservative	O
postoperative	O
regimen	O
,	O
which	O
included	O
post	O
-	O
surgical	O
bowel	O
rest	O
,	O
routine	O
labs	O
,	O
and	O
chemistries	O
.	O

on	O
postoperative	O
day	O
#4	O
,	O
a	O
series	O
of	O
lasix	O
doses	O
were	O
started	O
in	O
an	O
attempt	O
to	O
gently	O
diurese	O
the	O
fluid	O
that	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
had	O
received	O
during	O
his	O
surgery	O
.	O

this	O
was	O
intended	O
to	O
augment	O
the	O
normal	O
diuresis	O
of	O
third	O
space	O
fluid	O
following	O
his	O
surgery	O
.	O

as	O
mr	O
.	O
[	O
*	O
*	O
name13	O
(	O
stitle	O
)	O
6879	O
*	O
*	O
]	O
abdomen	O
remained	O
distended	O
,	O
through	O
postoperative	O
day	O
#7	O
,	O
he	O
was	O
started	O
on	O
total	O
parenteral	O
nutrition	O
on	O
that	O
day	O
and	O
this	O
continued	O
until	O
he	O
was	O
taking	O
adequate	O
nutrition	O
po	O
.	O

on	O
postoperative	O
day	O
#9	O
,	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
was	O
started	O
on	O
a	O
diet	O
of	O
clear	O
liquids	O
,	O
which	O
he	O
tolerated	O
fairly	O
well	O
.	O

but	O
,	O
he	O
continued	O
to	O
have	O
mild	O
to	O
moderate	O
abdominal	B
distention	I
with	O
minimal	O
tenderness	O
.	O

he	O
was	O
continued	O
on	O
a	O
regimen	O
of	O
iv	O
and	O
then	O
po	O
lasix	O
to	O
continue	O
his	O
diuresis	O
of	O
fluids	O
and	O
the	O
abdominal	O
examination	O
was	O
followed	O
serially	O
until	O
it	O
was	O
felt	O
that	O
he	O
was	O
tolerating	O
the	O
clear	O
diet	O
well	O
and	O
solid	O
foods	O
could	O
be	O
reintroduced	O
.	O

on	O
postoperative	O
day	O
#11	O
,	O
as	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
was	O
being	O
screened	O
for	O
discharge	O
from	O
the	O
[	O
*	O
*	O
hospital	O
1026	O
*	O
*	O
]	O
,	O
it	O
was	O
noted	O
that	O
he	O
continued	O
to	O
have	O
an	O
oxygen	O
requirement	O
,	O
which	O
he	O
did	O
not	O
have	O
prior	O
to	O
his	O
admission	O
to	O
the	O
hospital	O
.	O

portable	O
chest	O
x	O
-	O
ray	O
taken	O
at	O
that	O
time	O
showed	O
no	O
pneumonia	B
,	O
but	O
some	O
suggestion	O
of	O
pulmonary	B
edema	I
.	O

more	O
vigorous	O
diuresis	O
using	O
lasix	O
(	O
furosemide	O
)	O
was	O
started	O
and	O
by	O
postoperative	O
day	O
#12	O
,	O
mr	O
.	O
[	O
*	O
*	O
name13	O
(	O
stitle	O
)	O
6879	O
*	O
*	O
]	O
room	O
air	O
oxygen	O
saturation	O
was	O
98%	O
.	O

he	O
was	O
discharged	O
on	O
postoperative	O
day	O
#12	O
.	O

at	O
the	O
time	O
of	O
discharge	O
,	O
mr	O
.	O
[	O
*	O
*	O
name13	O
(	O
stitle	O
)	O
6879	O
*	O
*	O
]	O
condition	O
was	O
good	O
.	O

discharge	O
diagnoses	O
:	O
lower	B
gi	I
bleed	I
/	O
bleeding	B
diverticula	I
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initial	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
6880	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
6881	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
6882	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2013	O
-	O
08	O
-	O
09	O
*	O
*	O
]	O
13	O
:	O
03	O

t	O
:	O
[	O
*	O
*	O
2013	O
-	O
08	O
-	O
09	O
*	O
*	O
]	O
13	O
:	O
11	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
6883	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initial	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2014	O
-	O
04	O
-	O
23	O
*	O
*	O
]	O
11	O
:	O
11	O
am	O
signed	O
by	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initial	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
in	O
the	O
absence	O
of	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
steer	O
)	O
(	O
end	O
of	O
report	O
)	O

23268	O
||||	O
3628	O
||||	O
5561	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
08	O
-	O
05	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
31	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
08	O
-	O
05	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1943	O
-	O
12	O
-	O
24	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O

history	O
of	O
present	O
illness	O
:	O
this	O
68	O
-	O
year	O
-	O
old	O
gentleman	O
had	O
a	O
chief	O
complaint	O
of	O
chest	B
pain	I
with	I
exertion	I
x	O
six	O
months	O
.	O

he	O
had	O
a	O
known	O
history	O
of	O
aortic	B
stenosis	I
with	O
a	O
murmur	B
and	O
a	O
bicuspid	B
aortic	I
valve	I
with	O
a	O
history	O
of	O
chest	B
pain	I
with	I
exertion	I
x	O
six	O
months	O
.	O

he	O
has	O
been	O
followed	O
with	O
echocardiograms	O
x	O
10	O
years	O
and	O
recently	O
began	O
to	O
have	O
symptoms	B
.	O

preoperative	O
echocardiogram	O
showed	O
the	O
following	O
:	O
mild	O
tricuspid	B
regurgitation	I
,	O
mild	O
mitral	B
regurgitation	I
,	O
left	B
ventricular	I
hypertrophy	I
with	O
an	O
ejection	O
fraction	O
of	O
60	O
percent	O
,	O
aortic	O
root	O
of	O
4	O
.	O
8	O
cm	O
,	O
aortic	O
valve	O
area	O
of	O
0	O
.	O
8	O
cm	O
squared	O
,	O
the	O
right	O
atrium	O
was	O
mildly	O
enlarged	B
.	O

the	O
patient	O
had	O
mild	O
aortic	B
insufficiency	I
and	O
severe	O
aortic	B
stenosis	I
with	O
a	O
peak	O
gradient	O
of	O
87	O
mm	O
and	O
a	O
mean	O
gradient	O
of	O
53	O
mm	O
.	O

preoperative	O
cardiac	O
catheterization	O
showed	O
severe	O
aortic	B
stenosis	I
with	O
an	O
aortic	O
valve	O
area	O
of	O
0	O
.	O
5	O
cm	O
squared	O
,	O
a	O
peak	O
gradient	O
of	O
75	O
,	O
and	O
normal	O
coronary	O
artery	O
.	O

past	O
medical	O
history	O
:	O
history	O
of	O
bicuspid	B
aortic	I
valve	I
,	O
known	O
x	O
10	O
years	O
.	O

history	O
of	O
hypothyroidism	B
x	O
4	O
to	O
5	O
years	O
.	O

past	O
surgical	O
history	O
:	O
turp	O
x	O
2	O
.	O

tonsillectomy	O
.	O

adenoidectomy	O
.	O

medications	O
prior	O
to	O
admission	O
:	O
synthroid	O
0	O
.	O
75	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

allergies	O
:	O
the	O
patient	O
had	O
no	O
known	O
allergies	O
.	O

family	O
history	O
:	O
the	O
patient	O
was	O
cleared	O
by	O
dental	O
exam	O
prior	O
to	O
admission	O
.	O

he	O
had	O
a	O
positive	O
family	O
history	O
for	O
cad	B
.	O

the	O
patient	O
is	O
a	O
retired	O
engineer	O
who	O
lives	O
with	O
his	O
wife	O
and	O
had	O
no	O
tobacco	O
history	O
and	O
no	O
alcohol	O
history	O
.	O

review	O
of	O
systems	O
:	O
his	O
review	O
of	O
systems	O
was	O
unremarkable	O
with	O
the	O
exception	O
of	O
nocturia	B
for	O
one	O
time	O
per	O
night	O
.	O

physical	O
examination	O
:	O
on	O
exam	O
,	O
his	O
heart	O
rate	O
was	O
65	O
with	O
a	O
blood	O
pressure	O
in	O
the	O
right	O
arm	O
of	O
104	O
/	O
64	O
.	O

he	O
appeared	O
to	O
be	O
in	O
no	O
apparent	B
distress	I
.	O

his	O
skin	O
was	O
clear	O
.	O

the	O
patient	O
was	O
normocephalic	O
and	O
atraumatic	O
.	O

pupils	O
were	O
equally	O
round	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

the	O
extraocular	O
movements	O
were	O
intact	O
.	O

the	O
oropharynx	O
was	O
benign	O
.	O

the	O
neck	O
was	O
supple	O
with	O
no	O
lymphadenopathy	B
and	O
thyromegaly	B
.	O

there	O
was	O
bilateral	O
murmur	B
radiation	I
to	O
the	O
carotid	O
artery	O
.	O

the	O
chest	O
was	O
clear	O
to	O
auscultation	O
anterior	O
and	O
posterior	O
.	O

the	O
patient	O
had	O
a	O
grade	O
[	O
*	O
*	O
04	O
-	O
28	O
*	O
*	O
]	O
holosystolic	B
murmur	I
.	O

the	O
patient	O
had	O
positive	O
bowel	O
sounds	O
.	O

his	O
abdomen	O
was	O
soft	O
and	O
nontender	O
without	O
any	O
masses	B
or	O
hepatosplenomegaly	B
.	O

extremities	O
were	O
without	O
any	O
cyanosis	B
,	O
clubbing	B
,	O
or	O
edema	B
.	O

no	O
varicosities	B
were	O
noted	O
,	O
and	O
neurologic	O
exam	O
was	O
nonfocal	O
.	O

pulses	O
were	O
1	O
plus	O
bilaterally	O
on	O
the	O
femorals	O
,	O
dps	O
,	O
pts	O
,	O
and	O
radial	O
arteries	O
.	O

there	O
was	O
1	O
plus	O
carotid	O
pulses	O
.	O

preoperative	O
laboratory	O
data	O
:	O
preoperative	O
labs	O
were	O
as	O
follows	O
:	O
sodium	O
140	O
,	O
potassium	O
4	O
.	O
3	O
,	O
bun	O
23	O
,	O
creatinine	O
0	O
.	O
7	O
,	O
blood	O
sugar	O
73	O
.	O

white	O
count	O
6	O
.	O
4	O
,	O
hematocrit	O
41	O
.	O
9	O
,	O
platelet	O
count	O
207	O
,	O
000	O
,	O
pt	O
13	O
.	O
0	O
,	O
ptt	O
32	O
.	O
3	O
,	O
inr	O
1	O
.	O
1	O
.	O

alt	O
13	O
,	O
ast	O
19	O
,	O
alkaline	O
phosphatase	O
84	O
,	O
total	O
bilirubin	O
0	O
.	O
2	O
,	O
albumin	O
4	O
.	O
5	O
.	O

urinalysis	O
was	O
negative	O
.	O

carotid	O
studies	O
showed	O
a	O
normal	O
study	O
with	O
no	O
blockages	B
.	O

preoperative	O
chest	O
x	O
-	O
ray	O
revealed	O
a	O
left	O
ventricular	O
configuration	O
of	O
the	O
heart	O
with	O
a	O
tortuous	B
and	O
dilated	B
ascending	I
aorta	I
.	O

preoperative	O
ekg	O
showed	O
sinus	B
bradycardia	I
at	O
57	O
with	O
left	B
ventricular	I
hypertrophy	I
and	O
left	B
anterior	I
hemi	I
-	I
block	I
.	O

additional	O
labs	O
were	O
as	O
follows	O
:	O
chloride	O
103	O
,	O
co2	O
27	O
.	O

ho	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
course	O
:	O
the	O
patient	O
was	O
referred	O
to	O
dr	O
.	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
161	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
162	O
*	O
*	O
]	O
for	O
aortic	O
valve	O
replacement	O
and	O
possible	O
aortic	B
aneurysm	I
resection	O
.	O

on	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
31	O
*	O
*	O
]	O
,	O
the	O
patient	O
underwent	O
repair	O
of	O
his	O
aortic	B
root	I
dilatation	I
with	O
a	O
supracoronary	O
tube	O
graft	O
,	O
24	O
mm	O
gel	O
-	O
weave	O
,	O
and	O
an	O
aortic	O
valve	O
replacement	O
with	O
a	O
25	O
mm	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
610	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
doctor	O
last	O
name	O
371	O
*	O
*	O
]	O
pericardial	O
broad	O
bioprosthetic	O
valve	O
.	O

the	O
patient	O
was	O
transferred	O
to	O
the	O
cardiothoracic	O
icu	O
in	O
stable	O
condition	O
on	O
a	O
neo	O
-	O
synephrine	O
drip	O
at	O
0	O
.	O
7	O
mcg	O
per	O
kilogram	O
per	O
minute	O
and	O
a	O
propofol	O
drip	O
at	O
25	O
mcg	O
per	O
kilogram	O
per	O
minute	O
.	O

on	O
postoperative	O
day	O
one	O
,	O
the	O
patient	O
had	O
been	O
extubated	O
overnight	O
,	O
was	O
on	O
a	O
neo	O
-	O
synephrine	O
drip	O
at	O
0	O
.	O
2	O
mcg	O
per	O
kilogram	O
per	O
minute	O
.	O

he	O
was	O
hemodynamically	O
stable	O
with	O
a	O
blood	O
pressure	O
of	O
111	O
/	O
46	O
in	O
sinus	O
rhythm	O
at	O
72	O
.	O

the	O
patient	O
had	O
a	O
cardiac	O
index	O
of	O
2	O
.	O
64	O
and	O
was	O
saturating	O
99	O
percent	O
on	O
2	O
liters	O
nasal	O
cannula	O
.	O

postoperative	O
labs	O
were	O
as	O
follows	O
:	O
white	O
count	O
11	O
.	O
4	O
,	O
hematocrit	O
32	O
.	O
3	O
,	O
platelet	O
count	O
151	O
,	O
000	O
,	O
potassium	O
4	O
.	O
0	O
,	O
bun	O
13	O
,	O
creatinine	O
0	O
.	O
7	O
,	O
low	B
blood	I
sugar	I
of	O

119	O
.	O

the	O
patient	O
was	O
awake	O
,	O
alert	O
,	O
and	O
oriented	O
x	O
3	O
.	O
his	O
heart	O
was	O
regular	O
in	O
rate	O
and	O
rhythm	O
without	O
any	O
murmurs	B
.	O

his	O
breath	O
sounds	O
were	O
clear	O
bilaterally	O
.	O

he	O
had	O
hypoactive	B
bowel	I
sounds	I
,	O
but	O
his	O
abdomen	O
was	O
soft	O
,	O
nontender	O
,	O
and	O
nondistended	O
.	O

his	O
extremities	O
were	O
warm	O
and	O
well	O
perfused	O
.	O

the	O
patient	O
continued	O
to	O
have	O
his	O
neo	O
-	O
synephrine	O
weaned	O
and	O
was	O
encouraged	O
to	O
be	O
out	O
of	O
bed	O
.	O

the	O
swan	O
was	O
discontinued	O
.	O

the	O
patient	O
was	O
seen	O
by	O
case	O
management	O
for	O
evaluation	O
.	O

on	O
postoperative	O
day	O
two	O
,	O
the	O
patient	O
was	O
off	O
all	O
drips	O
,	O
began	O
his	O
aspirin	O
,	O
finished	O
his	O
perioperative	O
antibiotics	O
,	O
and	O
was	O
continued	O
on	O
his	O
preoperative	O
synthroid	O
.	O

he	O
had	O
a	O
t	O
-	O
max	O
of	O
100	O
.	O
6	O
degrees	O
,	O
remained	O
in	O
sinus	O
rhythm	O
in	O
the	O
70s	O
with	O
a	O
good	O
blood	O
pressure	O
.	O

he	O
was	O
saturating	O
95	O
percent	O
on	O
room	O
air	O
.	O

his	O
labs	O
were	O
unremarkable	O
with	O
the	O
exception	O
of	O
a	O
slight	O
drop	O
in	O
his	O
hematocrit	O
to	O
28	O
.	O
1	O
and	O
a	O
drop	O
in	O
his	O
platelets	O
to	O
113	O
,	O
000	O
.	O

he	O
remained	O
oriented	O
.	O

his	O
exam	O
was	O
unremarkable	O
.	O

his	O
chest	O
tubes	O
were	O
discontinued	O
.	O

he	O
began	O
his	O
beta	O
blockade	O
with	O
lopressor	O
at	O
12	O
.	O
5	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

he	O
resumed	O
his	O
synthroid	O
as	O
previously	O
noted	O
and	O
was	O
transferred	O
to	O
[	O
*	O
*	O
wardname	O
683	O
*	O
*	O
]	O
.	O

on	O
postoperative	O
day	O
three	O
,	O
the	O
patient	O
had	O
no	O
events	B
overnight	O
,	O
had	O
a	O
good	O
blood	O
pressure	O
of	O
110	O
/	O
63	O
,	O
in	O
sinus	O
rhythm	O
in	O
the	O
80s	O
,	O
saturating	O
95	O
percent	O
on	O
room	O
air	O
.	O

his	O
exam	O
was	O
unremarkable	O
.	O

his	O
post	O
chest	O
tube	O
pull	O
x	O
-	O
ray	O
showed	O
a	O
small	O
right	O
apical	O
pneumothorax	B
.	O

please	O
refer	O
to	O
the	O
final	O
x	O
-	O
ray	O
report	O
.	O

the	O
patient	O
was	O
doing	O
well	O
and	O
was	O
working	O
with	O
physical	O
therapy	O
and	O
out	O
of	O
bed	O
for	O
ambulation	O
.	O

the	O
patient	O
was	O
re	O
-	O
evaluated	O
on	O
postoperative	O
day	O
three	O
by	O
physical	O
therapy	O
and	O
was	O
deemed	O
safe	O
to	O
go	O
home	O
with	O
vna	O
services	O
.	O

on	O
postoperative	O
day	O
four	O
,	O
the	O
patient	O
again	O
had	O
no	O
events	B
overnight	O
,	O
was	O
saturating	O
93	O
percent	O
on	O
room	O
air	O
,	O
was	O
hemodynamically	O
stable	O
in	O
sinus	O
rhythm	O
.	O

the	O
patient	O
did	O
have	O
some	O
desaturation	O
with	O
ambulation	O
.	O

he	O
was	O
doing	O
a	O
physical	O
therapy	O
level	O
4	O
.	O
repeat	O
chest	O
x	O
-	O
ray	O
showed	O
no	O
changes	O
with	O
some	O
subcutaneous	O
air	O
at	O
his	O
left	O
shoulder	O
.	O

he	O
continued	O
to	O
do	O
well	O
.	O

his	O
magnesium	O
was	O
repleted	O
.	O

repeat	O
labs	O
were	O
drawn	O
.	O

repeat	O
chest	O
x	O
-	O
ray	O
was	O
ordered	O
in	O
preparation	O
for	O
allowing	O
him	O
to	O
be	O
discharged	O
the	O
following	O
day	O
.	O

his	O
pacing	O
wires	O
were	O
removed	O
on	O
postoperative	O
day	O
four	O
.	O

on	O
postoperative	O
day	O
five	O
,	O
the	O
day	O
of	O
discharge	O
,	O
the	O
patient	O
was	O
hemodynamically	O
stable	O
with	O
a	O
blood	O
pressure	O
of	O
96	O
/	O
50	O
,	O
in	O
sinus	O
rhythm	O
in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
5	O
*	O
*	O
]	O
,	O
saturating	O
96	O
percent	O
on	O
room	O
air	O
.	O

the	O
patient's	O
beta	O
blockade	O
had	O
been	O
increased	O
to	O
metoprolol	O
25	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

the	O
patient	O
had	O
some	O
subcutaneous	B
air	I
at	O
the	O
left	O
area	O
of	O
his	O
neck	O
still	O
,	O
but	O
repeat	O
chest	O
x	O
-	O
ray	O
showed	O
that	O
his	O
lungs	O
were	O
clear	O
with	O
no	O
pneumothorax	B
and	O
did	O
comment	O
on	O
the	O
ongoing	O
subcutaneous	B
air	I
.	O

the	O
patient	O
,	O
however	O
,	O
was	O
doing	O
very	O
well	O
.	O

the	O
patient	O
was	O
discharged	O
to	O
home	O
on	O
[	O
*	O
*	O
2012	O
-	O
08	O
-	O
05	O
*	O
*	O
]	O
with	O
vna	O
services	O
with	O
the	O
following	O
discharge	O
diagnoses	O
.	O

discharge	O
diagnoses	O
:	O
status	O
post	O
bentall	O
procedure	O
with	O
replacement	O
of	O
ascending	O
aorta	O
and	O
aortic	O
valve	O
replacement	O
.	O

history	O
of	O
bicuspid	B
aortic	I
valve	I
.	O

hypothyroidism	B
.	O

status	O
post	O
transurethral	O
resection	O
of	O
prostate	O
x	O
2	O
.	O

status	O
post	O
tonsillectomy	O
and	O
adenoidectomy	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
lasix	O
20	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
for	O
7	O
days	O
.	O

2	O
.	O
potassium	O
chloride	O
20	O
meq	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
for	O
7	O
days	O
.	O

3	O
.	O
colace	O
100	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

4	O
.	O
ranitidine	O
150	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

5	O
.	O
enteric	O
-	O
coated	O
aspirin	O
325	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

6	O
.	O
levothyroxine	O
sodium	O
75	O
mcg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

7	O
.	O
dilaudid	O
2	O
mg	O
p	O
.	O
o	O
.	O
p	O
.	O
r	O
.	O
n	O
.	O
q	O
.	O
[	O
*	O
*	O
07	O
-	O
31	O
*	O
*	O
]	O
h	O
.	O
for	O
pain	B
.	O

8	O
.	O
metoprolol	O
25	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

fo	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
565	O
*	O
*	O
]	O
p	O
:	O
the	O
patient	O
was	O
instructed	O
to	O
follow	O
up	O
with	O
his	O
primary	O
care	O
physician	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1545	O
*	O
*	O
]	O
,	O
in	O
approximately	O
two	O
to	O
three	O
weeks	O
and	O
to	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
161	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
162	O
*	O
*	O
]	O
,	O
his	O
surgeon	O
,	O
in	O
the	O
office	O
for	O
his	O
postoperative	O
visit	O
at	O
three	O
to	O
four	O
weeks	O
.	O

discharge	O
disposition	O
:	O
the	O
patient	O
was	O
discharged	O
in	O
stable	O
condition	O
to	O
home	O
with	O
vna	O
services	O
on	O
[	O
*	O
*	O
2012	O
-	O
08	O
-	O
05	O
*	O
*	O
]	O
.	O

[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
160	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
161	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
162	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
02351	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
239	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2012	O
-	O
10	O
-	O
17	O
*	O
*	O
]	O
10	O
:	O
47	O
:	O
41	O

t	O
:	O
[	O
*	O
*	O
2012	O
-	O
10	O
-	O
17	O
*	O
*	O
]	O
14	O
:	O
51	O
:	O
10	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
1546	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2012	O
-	O
12	O
-	O
07	O
*	O
*	O
]	O
4	O
:	O
07	O
pm	O

(	O
end	O
of	O
report	O
)	O

28462	O
||||	O
3835	O
||||	O
13568	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
03	O
-	O
08	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
03	O
-	O
03	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
03	O
-	O
08	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1938	O
-	O
10	O
-	O
13	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
885	O
*	O
*	O
]	O

addendum	O
:	O

pt	O
was	O
started	O
on	O
norvasc	O
5	O
mg	O
daily	O
for	O
better	O
blood	O
pressure	O
control	O
.	O

acei	O
was	O
initially	O
added	O
however	O
d	O
/	O
c'ed	O
secondary	O
to	O
increase	O
in	O
creatinine	O
.	O

given	O
his	O
cad	B
and	O
cva	B
history	O
,	O
consider	O
placing	O
him	O
on	O
a	O
statin	O
.	O

it	O
is	O
unclear	O
at	O
this	O
point	O
why	O
he	O
had	O
a	O
cva	B
.	O

etiology	O
may	O
be	O
pafib	B
in	O
which	O
case	O
he	O
would	O
benefit	O
from	O
anti	O
-	O
coagulation	O
.	O

a	O
neurology	O
follow	O
-	O
up	O
for	O
workup	O
of	O
his	O
recent	O
cva	B
may	O
be	O
beneficial	O
.	O

if	O
he	O
had	O
a	O
lacunar	B
infarct	I
he	O
would	O
benefit	O
from	O
plavix	O
or	O
aggrenox	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
levofloxacin	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q24h	O
(	O
every	O
24	O
hours	O
)	O
for	O
9	O
days	O
:	O
please	O
take	O
until	O
all	O
pills	O
are	O
gone	O
.	O
.	O

disp	O
:	O
*	O
9	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

2	O
.	O
metoprolol	O
tartrate	O
50	O
mg	O
tablet	O
sig	O
:	O
1	O
.	O
5	O
tablets	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
90	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

3	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
chewable	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
chewable	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
chewable	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

4	O
.	O
tamsulosin	O
hcl	O
0	O
.	O
4	O
mg	O
capsule	O
,	O
sust	O
.	O

release	O
24hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
,	O
sust	O
.	O

release	O
24hr	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
.	O

disp	O
:	O
*	O
30	O
capsule	O
,	O
sust	O
.	O

release	O
24hr	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

5	O
.	O
dorzolamide	O
-	O
timolol	O
2	O
-	O
0	O
.	O
5	O
%	O
drops	O
sig	O
:	O
one	O
(	O
1	O
)	O
drop	O

ophthalmic	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

6	O
.	O
multivitamin	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
cap	O
po	O
daily	O
(	O
daily	O
)	O
.	O

7	O
.	O
epoetin	O
alfa	O
20	O
,	O
000	O
unit	O
/	O
ml	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
injection	O
once	O
a	O
week	O
.	O

8	O
.	O
folic	O
acid	O
1	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

9	O
.	O
norvasc	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

10	O
.	O

omeprazole	O
20	O
mg	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
)	O
.	O

11	O
.	O

insulin	O
nph	O
human	O
recomb	O
100	O
unit	O
/	O
ml	O
syringe	O
sig	O
:	O
one	O
(	O
1	O
)	O
subcutaneous	O
twice	O
a	O
day	O
:	O
insulin	O
nph	O
human	O
100	O
u	O
/	O
ml	O
inj	O
novolin	O
n	O
inject	O
6	O
units	O
under	O
the	O
skin	O
at	O
bedtime	O
and	O
inject	O
24	O
units	O
every	O
morning	O
.	O

12	O
.	O

travoprost	O
0	O
.	O
004	O
%	O
drops	O
sig	O
:	O
one	O
(	O
1	O
)	O
drop	O
each	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
82	O
*	O
*	O
]	O
ophthalmic	O
once	O
a	O
day	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

[	O
*	O
*	O
hospital	O
978	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
981	O
*	O
*	O
]	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
31	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
892	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
893	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
143	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
144	O
*	O
*	O
]	O
[	O
*	O
*	O
2013	O
-	O
03	O
-	O
08	O
*	O
*	O
]	O
@	O
1700	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
31	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2013	O
-	O
04	O
-	O
30	O
*	O
*	O
]	O
6	O
:	O
40	O
pm	O

(	O
end	O
of	O
report	O
)	O

167766	O
||||	O
4082	O
||||	O
24716	O
||||	O
radiology	O
_	O
report	O
||||	O
2014	O
-	O
10	O
-	O
22	O
12	O
:	O
56	O
:	O
00	O
.	O
0	O
||||	O
v99111	O
36569	O
picc	O
w	O
/	O
o	O
port	O
||||	O
||||	O
clip	O
#	O
384	O
-	O
8086	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
22	O
*	O
*	O
]	O
12	O
:	O
56	O
pm	O

picc	O
line	O
placment	O
sch	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
2379	O
*	O
*	O
]	O
reason	O
:	O
needs	O
midline	O
placed	O
for	O
access	O
admitting	O
diagnosis	O
:	O
airway	B
obstruction	I
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
cpt	O
codes	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
36569	O
picc	O
w	O
/	O
o	O
[	O
*	O
*	O
state	O
/	O
zipcode	O
73	O
*	O
*	O
]	O
fluor	O
guid	O
plct	O
/	O
replct	O
/	O
remove	O
*	O
*	O
c1751	O
cath	O
[	O
*	O
*	O
last	O
name	O
(	O
lf	O
)	O
74	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name3	O
(	O
lf	O
)	O
75	O
*	O
*	O
]	O
/	O
cent	O
/	O
mid	O
(	O
not	O
d	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

62	O
year	O
old	O
man	O
with	O
nsclc	B
and	O
svc	B
syndrome	I
.	O

reason	O
for	O
this	O
examination	O
:	O
needs	O
midline	O
placed	O
for	O
access	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

history	O
:	O
62	O
-	O
year	O
-	O
old	O
man	O
with	O
svc	B
syndrome	I
.	O

radiologists	O
:	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
779	O
*	O
*	O
]	O
and	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
77	O
*	O
*	O
]	O
.	O

dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
77	O
*	O
*	O
]	O
,	O
the	O
attending	O
radiologist	O
,	O
was	O
present	O
throughout	O
the	O
procedure	O
.	O

findings	O
/	O
technique	O
:	O
the	O
patient	O
was	O
placed	O
supine	O
on	O
the	O
angiographic	O
table	O
and	O
the	O
left	O
arm	O
was	O
prepped	O
and	O
draped	O
in	O
the	O
sterile	O
fashion	O
.	O

there	O
was	O
in	O
situ	O
peripheral	O
venous	O
catheter	O
angiocath	O
placed	O
in	O
the	O
antecubital	O
vein	O
.	O

a	O
0	O
.	O
018	O
wire	O
was	O
advanced	O
into	O
the	O
angiocath	O
and	O
the	O
angiocath	O
was	O
exchanged	O
for	O
a	O
4	O
.	O
5	O
introducer	O
sheath	O
under	O
flouroscopic	O
guidance	O
.	O

appropriate	O
length	O
of	O
the	O
midline	O
was	O
measured	O
for	O
the	O
tip	O
to	O
be	O
positioned	O
within	O
the	O
axillary	O
vein	O
.	O

the	O
picc	O
line	O
was	O
trimmed	O
to	O
the	O
appropriate	O
length	O
and	O
advanced	O
over	O
the	O
0	O
.	O
018	O
wire	O
with	O
the	O
tip	O
in	O
the	O
axillary	O
vein	O
.	O

the	O
catheter	O
was	O
secured	O
to	O
the	O
skin	O
with	O
statlock	O
and	O
dressed	O
with	O
sterile	O
dressing	O
.	O

impression	O
:	O
successful	O
placement	O
of	O
a	O
midline	O
via	O
in	O
situ	O
peripheral	O
venous	O
line	O
with	O
the	O
tip	O
in	O
the	O
left	O
axillary	O
vein	O
.	O

3099	O
||||	O
4525	O
||||	O
18345	O
||||	O
discharge	O
_	O
summary	O
||||	O
2014	O
-	O
09	O
-	O
19	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
18	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
19	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1933	O
-	O
02	O
-	O
26	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
2003	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

transfer	O
from	O
osh	O
for	O
bradycardia	B
and	O
cath	O

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

81	O
y	O
/	O
o	O
female	O
with	O
h	O
/	O
o	O
htn	B
and	O
t2dm	B
who	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
2	O
*	O
*	O
]	O
for	O
evaluation	O
of	O
bradycardia	B
and	O
possible	O
cardiac	O
cath	O
.	O

the	O
patient	O
was	O
found	O
at	O
home	O
by	O
family	O
dizzy	B
,	O
confused	B
,	O
and	O
diaphoretic	B
(	O
presyncope	B
)	O
and	O
the	O
family	O
attempted	O
to	O
move	O
her	O
and	O
she	O
syncopized	B
.	O

she	O
was	O
brought	O
to	O
[	O
*	O
*	O
hospital1	O
569	O
*	O
*	O
]	O
[	O
*	O
*	O
doctor	O
first	O
name	O
3	O
*	O
*	O
]	O
by	O
ambulance	O
on	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
.	O

her	O
hr	O
was	O
found	O
to	O
be	O
in	O
the	O
40s	O
and	O
sbp	O
60's	O
.	O

ekg	O
sent	O
from	O
[	O
*	O
*	O
hospital1	O
569	O
*	O
*	O
]	O
reveals	O
junctional	B
escape	I
rhythm	I
in	O
the	O
40s	O
.	O
a	O
temporary	O
pacer	O
wire	O
was	O
placed	O
in	O
the	O
r	O
ij	O
at	O
the	O
osh	O
[	O
*	O
*	O
doctor	O
first	O
name	O
3	O
*	O
*	O
]	O
.	O

she	O
was	O
admitted	O
to	O
osh	O
ccu	O
where	O
she	O
was	O
monitored	O
.	O

troponins	O
were	O
initially	O
4	O
.	O
1	O
/	O
8	O
.	O
5	O
/	O
3	O
.	O
9	O
.	O

she	O
was	O
given	O
atropine	O
/	O
dopamine	O
,	O
neo	O
,	O
and	O
was	O
100%	O
paced	O
overnight	O
.	O

on	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
17	O
*	O
*	O
]	O
her	O
pacer	O
rate	O
was	O
decreased	O
from	O
70	O
to	O
60	O
and	O
her	O
bp	B
improved	O
while	O
in	O
nsr	B
60's	O
so	O
pressors	O
were	O
weaned	O
off	O
quickly	O
.	O

per	O
records	O
,	O
there	O
is	O
mention	O
of	O
a	O
recent	O
h	O
/	O
o	O
of	O
right	O
le	B
cellulitis	I
.	O

she	O
was	O
treated	O
as	O
op	O
for	O
aforementioned	O
rle	O
cellulitis	B
with	O
keflex	O
x	O
5	O
days	O
.	O

at	O
osh	O
,	O
she	O
was	O
started	O
on	O
vanco	O
/	O
unasyn	O
then	O
switched	O
to	O
ceftriaxone	O
at	O
treatment	O
dose	O
to	O
cover	O
lyme	B
disease	I
as	O
well	O
.	O

there	O
is	O
a	O
question	O
of	O
baseline	O
dementia	B
since	O
patient	O
recently	O
had	O
w	O
/	O
u	O
for	O
ad	B
.	O

she	O
lives	O
alone	O
but	O
has	O
family	O
around	O
the	O
corner	O
.	O

lyme	B
titer	O
was	O
sent	O
.	O

she	O
has	O
been	O
intermittently	O
,	O
pleasantly	O
confused	B
at	O
home	O
and	O
at	O
osh	O
per	O
records	O
.	O

she	O
was	O
given	O
asa	O
325	O
and	O
plavix	O
(	O
load	O
of	O
300	O
mg	O
and	O
then	O
75	O
mg	O
)	O
.	O

she	O
was	O
started	O
on	O
heparin	O
@	O
700u	O
/	O
hr	O
.	O

records	O
mention	O
question	O
of	O
lll	O
infiltrate	B
vs	O
.	O
left	O
pleural	B
effusion	I
and	O
she	O
was	O
given	O
one	O
dose	O
of	O
moxifloxacin	O
.	O

in	O
addition	O
,	O
she	O
had	O
a	O
platelet	B
drop	I
of	O
213	O
to	O
168	O
.	O

on	O
arrival	O
to	O
[	O
*	O
*	O
hospital1	O
2	O
*	O
*	O
]	O
ccu	O
,	O
she	O
was	O
hemodynamically	O
stable	O
and	O
in	O
nsrs	O
70	O
-	O
80s	O
.	O

her	O
pacer	O
was	O
set	O
at	O
60	O
with	O
threshold	O
of	O
10	O
.	O

of	O
note	O
,	O
the	O
patient	O
is	O
a	O
poor	O
historian	O
and	O
has	O
baseline	O
dementia	B
.	O

after	O
speaking	O
with	O
family	O
on	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
19	O
*	O
*	O
]	O
,	O
they	O
stated	O
patient	O
was	O
in	O
usual	O
state	O
of	O
health	O
on	O
the	O
day	O
of	O
her	O
syncope	B
.	O

they	O
left	O
her	O
in	O
the	O
morning	O
and	O
stated	O
she	O
carried	O
out	O
her	O
normal	O
activities	O
such	O
as	O
going	O
to	O
the	O
store	O
and	O
working	O
in	O
her	O
garden	O
.	O

also	O
,	O
they	O
confirmed	O
the	O
patient	O
administers	O
her	O
own	O
medication	O
,	O
but	O
has	O
not	O
been	O
checking	O
her	O
blood	O
glucose	O
level	O
as	O
indicated	O
.	O

she	O
never	O
complained	O
of	O
chest	B
pain	I
.	O

further	O
,	O
the	O
family	O
stated	O
in	O
past	O
few	O
weeks	O
they	O
have	O
noticed	O
the	O
patient	O
to	O
be	O
getting	O
more	O
forgetful	B
,	O
but	O
not	O
as	O
confused	B
as	O
she	O
presently	O
is	O
.	O

prior	O
to	O
this	O
episode	O
,	O
she	O
had	O
an	O
appoitment	O
scheduled	O
to	O
assess	O
her	O
mental	B
condition	I
.	O

cardiac	O
ros	O
:	O

positive	O
for	O
cp	B
,	O
syncope	B
,	O
presyncope	B
,	O
and	O
doe	B

negative	O
for	O
pnd	B
,	O
orthopnea	B
,	O
edema	B
,	O
or	O
palpitations	B

past	O
medical	O
history	O
:	O

1	O
)	O
htn	B

2	O
)	O
diabetes	B
mellitus	I
type	I
2	I

3	O
)	O
s	O
/	O
p	O
ptca	O
approx	O
10yrs	O
ago	O
.	O

social	O
history	O
:	O

lives	O
at	O
home	O
with	O
son	O
and	O
grandaughter	O
.	O

denies	O
tobacco	O
,	O
etoh	O
,	O
or	O
illicit	O
drug	O
use	O
.	O

family	O
history	O
:	O

non	O
-	O
contributory	O
.	O

physical	O
exam	O
:	O

pe	O
:	O

vitals	O
:	O
147	O
/	O
69	O
92	O
22	O
97%ra	O

general	O
:	O
oriented	O
to	O
person	O
,	O
thought	O
she	O
was	O
still	O
at	O
osh	O
,	O
unsure	O
of	O
date	O
/	O
time	O
,	O
nad	B

heent	O
:	O
perrla	O
,	O
eomi	O
.	O

mm	B
dry	I
.	O

op	O
clear	O
.	O

neck	O
:	O
no	O
jvd	B
.	O

jvp	B
7	O
cm	O
.	O

no	O
carotid	B
bruits	I
.	O

cv	O
:	O
s1	O
,	O
s2	O
with	O
grade	O
ii	O
/	O
vi	O
sem	B
best	O
heard	O
rusb	O
radiating	O
to	O
carotids	O

pulm	O
:	O
ctab	O
,	O
no	O
wheezes	B
or	O
crackles	B

abd	O
:	O
soft	O
,	O
nt	O
/	O
nd	O
with	O
normoactive	O
bs	O
.	O

ext	O
:	O
no	O
c	B
/	O
c	B
/	O
e	B
.	O

dp	O
1	O
+	O
b	O
/	O
l	O
.	O

good	O
rom	O
and	O
strength	O
.	O

evidence	O
of	O
scaling	B
plaque	I
r	O
shin	O
.	O

no	O
warmth	B
/	O
induration	B
/	O
tracking	B
.	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2014	O
-	O
09	O
-	O
18	O
*	O
*	O
]	O
tsh	O
-	O
4	O
.	O
0	O

[	O
*	O
*	O
2014	O
-	O
09	O
-	O
18	O
*	O
*	O
]	O
glucose	O
-	O
99	O
urea	O
n	O
-	O
14	O
creat	O
-	O
0	O
.	O
8	O
sodium	O
-	O
141	O
potassium	O
-	O
4	O
.	O
0	O

chloride	O
-	O

111	O
*	O
total	O
co2	O
-	O
22	O
anion	O
gap	O
-	O
12	O

[	O
*	O
*	O
2014	O
-	O
09	O
-	O
18	O
*	O
*	O
]	O
alt	O
(	O
sgpt	O
)	O
-	O
63	O
*	O
ast	O
(	O
sgot	O
)	O
-	O
50	O
*	O
ld	O
(	O
ldh	O
)	O
-	O
217	O
ck	O
(	O
cpk	O
)	O
-	O
121	O
alk	O
phos	O
-	O
101	O
tot	O
bili	O
-	O
0	O
.	O
5	O

[	O
*	O
*	O
2014	O
-	O
09	O
-	O
18	O
*	O
*	O
]	O
urine	O
blood	O
-	O
mod	O
nitrite	O
-	O
neg	O
protein	O
-	O
neg	O
glucose	O
-	O
neg	O
ketone	O
-	O
15	O
bilirubin	O
-	O
neg	O
urobilngn	O
-	O
neg	O
ph	O
-	O
5	O
.	O
0	O
leuk	O
-	O
neg	O

[	O
*	O
*	O
2014	O
-	O
09	O
-	O
18	O
*	O
*	O
]	O
ck	O
-	O
mb	O
-	O
6	O
ctropnt	O
-	O
0	O
.	O
38	O
*	O

[	O
*	O
*	O
2014	O
-	O
09	O
-	O
18	O
*	O
*	O
]	O
albumin	O
-	O
3	O
.	O
5	O
calcium	O
-	O
8	O
.	O
9	O
phosphate	O
-	O
2	O
.	O
6	O
*	O
magnesium	O
-	O
2	O
.	O
2	O

[	O
*	O
*	O
2014	O
-	O
09	O
-	O
18	O
*	O
*	O
]	O
wbc	O
-	O
6	O
.	O
2	O
rbc	O
-	O
3	O
.	O
55	O
*	O
hgb	O
-	O
10	O
.	O
8	O
*	O
hct	O
-	O
31	O
.	O
2	O
*	O
mcv	O
-	O
88	O
mch	O
-	O
30	O
.	O
3	O
mchc	O
-	O
34	O
.	O
5	O
rdw	O
-	O
14	O
.	O
2	O

[	O
*	O
*	O
2014	O
-	O
09	O
-	O
18	O
*	O
*	O
]	O
plt	O
count	O
-	O
164	O

cxr	O
(	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
18	O
*	O
*	O
]	O
)	O
:	O

impression	O
:	O
bilateral	B
effusions	I
.	O

no	O
infiltrates	B
.	O

severe	O
scoliosis	B
of	O

thoracolumbar	O
spine	O
.	O

echo	O
(	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
19	O
*	O
*	O
]	O
)	O
:	O

the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

no	O
atrial	B
septal	I
defect	I
is	O
seen	O
by	O
2d	O
or	O
color	O
doppler	O
.	O

there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
with	O
normal	O
cavity	O
size	O
and	O
systolic	O
function	O
(	O
lvef>55%	O
)	O
.	O

regional	O
left	O
ventricular	O
wall	O
motion	O
is	O
normal	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
but	O
aortic	B
stenosis	I
is	O
not	O
present	O
.	O

no	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

moderate	O
(	O
2	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
mild	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

ct	O
head	O
(	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
19	O
*	O
*	O
]	O
)	O
prelim	O
:	O
atrophy	B
,	O
old	O
lacunar	B
infarcts	I
.	O

brief	O
hospital	O
course	O
:	O

81	O
y	O
/	O
o	O
female	O
with	O
h	O
/	O
o	O
htn	B
and	O
t2dm	B
who	O
presented	O
upon	O
transfer	O
from	O
osh	O
for	O
evaluation	O
and	O
treatment	O
of	O
bradycardia	B
and	O
possible	O
cardiac	O
cath	O
.	O

now	O
in	O
nsr	O
80	O
-	O
100s	O
and	O
sbp	O
140	O
-	O
150s	O
without	O
temporary	O
pacer	O
activity	O
.	O

1	O
)	O
bradycardia	B
:	O
upon	O
admission	O
to	O
osh	O
,	O
patient	O
found	O
to	O
be	O
severely	O
bradycardic	B
40s	O
with	O
low	O
sbp	O
(	O
60s	O
)	O
likely	O
secondary	O
to	O
bb	B
toxicity	I
.	O

ekg	O
indicated	O
patient	O
to	O
be	O
in	O
junctional	B
escape	I
rhythm	I
temporary	O
pacing	O
device	O
was	O
inserted	O
through	O
r	O
ij	O
.	O

after	O
insertion	O
,	O
patient	O
became	O
hemodynamically	O
stable	O
.	O

transferred	O
to	O
[	O
*	O
*	O
hospital1	O
2	O
*	O
*	O
]	O
for	O
possible	O
catherization	O
.	O

upon	O
arrival	O
,	O
the	O
attending	O
cardiologist	O
felt	O
additional	O
workup	O
was	O
needed	O
before	O
cath	O
and	O
patient	O
was	O
admitted	O
to	O
ccu	O
.	O

subsequent	O
ekgs	O
taken	O
after	O
admission	O
indicated	O
patient	O
to	O
be	O
in	O
nsr	B
with	O
no	O
abnormal	B
changes	I
.	O

due	O
to	O
suspected	O
bb	B
toxicity	I
,	O
patient	O
put	O
on	O
hydralazine	O
for	O
blood	O
pressure	O
control	O
.	O

the	O
decision	O
was	O
made	O
that	O
patient	O
did	O
not	O
need	O
catherization	O
or	O
permanment	O
pacemaker	O
insertion	O
.	O

the	O
temporary	O
pacing	O
device	O
was	O
removed	O
on	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
19	O
*	O
*	O
]	O
.	O

an	O
echocardiogram	O
was	O
performed	O
to	O
assess	O
cardiac	O
function	O
which	O
showed	O
ef	O
>55%	O
,	O
aortic	B
sclerosis	I
,	O
mild	O
mr	B
.	O
[	O
*	O
*	O
name13	O
(	O
stitle	O
)	O
*	O
*	O
]	O
remained	O
hemodynamically	O
stable	O
without	O
any	O
change	O
in	O
medical	O
management	O
.	O

2	O
)	O
elevated	B
cardiac	I
enzymes	I
:	O
patient	O
noted	O
to	O
have	O
elevated	B
troponins	I
at	O
osh	O
after	O
receiving	O
temporary	O
pacing	O
device	O
.	O

since	O
admission	O
to	O
[	O
*	O
*	O
hospital1	O
2	O
*	O
*	O
]	O
,	O
patient	O
without	O
complaints	O
of	O
chest	B
pain	I
and	O
noted	O
to	O
have	O
decreasing	B
trop	I
levels	O
.	O

initial	O
elevation	O
of	O
cardiac	O
enzymes	O
likely	O
due	O
to	O
severe	O
hypotension	B
.	O

catheterization	O
not	O
indicated	O
at	O
this	O
time	O
per	O
ccu	O
attending	O
and	O
team	O
.	O

3	O
)	O
htn	B
:	O
patient	O
treated	O
with	O
hydralazine	O
10mg	O
in	O
anticipation	O
of	O
cath	O
.	O

patient	O
will	O
be	O
restarted	O
on	O
home	O
meds	O
which	O
include	O
hctz	O
and	O
univasc	O
.	O

currently	O
,	O
patient	O
with	O
stable	O
blood	O
pressures	O
off	O
hydral	O
,	O
hctz	O
restarted	O
.	O

4	O
)	O
thrombocytopenia	B
:	O
patient	O
was	O
started	O
on	O
heparin	O
gtt	O
at	O
osh	O
.	O

upon	O
arrival	O
to	O
[	O
*	O
*	O
hospital1	O
2	O
*	O
*	O
]	O
in	O
preparation	O
for	O
cath	O
,	O
patient	O
noted	O
to	O
be	O
thrombocytopenic	B
to	O
140	O
.	O

due	O
to	O
suspected	O
heparin	B
induced	I
thrombocytopenia	I
,	O
all	O
heparin	O
products	O
including	O
heparin	O
flushes	O
have	O
been	O
withheld	O
.	O

lab	O
tests	O
for	O
heparin	O
antibodies	O
were	O
sent	O
.	O

5	O
)	O
confusion	B
/	O
dementia	B
:	O
since	O
admission	O
,	O
patient	O
has	O
been	O
confused	B
,	O
hallucinating	B
,	O
and	O
in	O
constant	O
need	O
of	O
redirection	O
.	O

overnight	O
,	O
patient	O
was	O
agitated	B
and	O
repeatedly	O
attempted	O
to	O
pull	O
out	O
ivs	O
,	O
pacemaker	O
line	O
in	O
r	O
ij	O
,	O
and	O
pulse	O
monitor	O
.	O

initially	O
,	O
patient	O
was	O
zyprexax	O
2	O
without	O
relief	B
,	O
then	O
haldol	O
iv	O
without	O
much	O
improvement	O
.	O

after	O
speaking	O
with	O
family	O
,	O
dementia	B
appears	O
to	O
be	O
a	O
sudden	O
deterioration	B
of	I
mental	I
status	I
.	O

dementia	B
workup	O
was	O
initiated	O
including	O
tsh	O
(	O
normal	O
)	O
,	O
rpr	O
(	O
pending	O
)	O
,	O
b12	O
(	O
pending	O
)	O
,	O
and	O
head	O
ct	O
(	O
no	O
acute	B
change	I
,	O
old	B
infarcts	I
)	O
.	O

after	O
head	O
ct	O
,	O
patient	O
to	O
be	O
transferred	O
per	O
family	O
request	O
back	O
to	O
[	O
*	O
*	O
hospital	O
569	O
*	O
*	O
]	O
hospital	O
.	O

medications	O
on	O
admission	O
:	O

medications	O
at	O
home	O

isordil	O

hctz	O

glyburide	O

atenolol	O

univasc	O

medications	O
upon	O
transfer	O

asa	O
325	O

riss	O

protonix	O
40	O

heparin	O
gtt	O

plavix	O
(	O
300	O
x	O
1	O
then	O
75	O
)	O

haldol	O
prn	O
agitation	B

keflex	O
500	O
g	O
q6h	O
x	O
5	O
days	O

moxifloxacin	O
400	O
mg	O
po	O
once	O

discharge	O
medications	O
:	O

1	O
.	O
insulin	O
regular	O
human	O
100	O
unit	O
/	O
ml	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
injection	O
asdir	O
(	O
as	O
directed	O
)	O
.	O

2	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
constipation	B
.	O

3	O
.	O
senna	O
8	O
.	O
6	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
as	O
needed	O
for	O
constipation	B
.	O

4	O
.	O
hydrochlorothiazide	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

5	O
.	O
haloperidol	O
lactate	O
5	O
mg	O
/	O
ml	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
injection	O
q6	O
-	O
8h	O
(	O
every	O
6	O
to	O
8	O
hours	O
)	O
as	O
needed	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

discharge	O
diagnosis	O
:	O

bradycardia	B
secondary	O
to	O
beta	B
-	I
blocker	I
toxicity	I
.	O

discharge	O
condition	O
:	O

fair	O
,	O
vital	O
signs	O
stable	O
,	O
patient	O
ambulating	O
.	O

discharge	O
instructions	O
:	O

back	O
to	O
[	O
*	O
*	O
hospital1	O
569	O
*	O
*	O
]	O

followup	O
instructions	O
:	O

transfer	O
to	O
outside	O
hospital	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
618	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2007	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
968	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
2190	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
2191	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
2192	O
*	O
*	O
]	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
19	O
*	O
*	O
]	O
@	O
1517	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
618	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
67	O
*	O
*	O
]	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
16	O
*	O
*	O
]	O
3	O
:	O
36	O
pm	O
(	O
end	O
of	O
report	O
)	O

4677	O
||||	O
4882	O
||||	O
28225	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
09	O
-	O
10	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
09	O
-	O
01	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
09	O
-	O
10	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1937	O
-	O
08	O
-	O
10	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
cardiothoracic	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
181	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

dyspnea	B
on	I
exertion	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

[	O
*	O
*	O
2013	O
-	O
09	O
-	O
02	O
*	O
*	O
]	O
aortic	O
valve	O
replacement	O
(	O
pericardial	O
)	O
,	O
mitral	O
valve	O
replacement	O
(	O
pericardial	O
)	O
,	O
coronary	O
artery	O
bypass	O
graft	O
x	O
1	O
(	O
svg	O
-	O
>pda	O
)	O

history	O
of	O
present	O
illness	O
:	O

76	O
y	O
/	O
o	O
male	O
with	O
extensive	O
past	O
medical	O
history	O
and	O
multiple	O
cardiac	O
risk	O
factors	O
who	O
has	O
been	O
followed	O
by	O
serial	O
echocardiograms	O
for	O
his	O
valvular	B
disease	I
.	O

now	O
has	O
severe	O
aortic	B
stenosis	I
and	O
mild	O
congestive	B
heart	I
failure	I
.	O
presented	O
for	O
surgical	O
evaluation	O
.	O

past	O
medical	O
history	O
:	O

aortic	B
stenosis	I
,	O
congestive	B
heart	I
failure	I
,	O
atrial	B
fibrillation	I
s	O
/	O
p	O
attempted	O
cardioversion	O
,	O
thyroid	B
cancer	I
s	O
/	O
p	O
thyroidectomy	O
&	O
radioactive	O
iodine	O
,	O
hypothyroidism	B
,	O
h	O
/	O
o	O
pulmonary	B
nodules	I
,	O
diabetes	B
mellitus	I
,	O
hyperlipidemia	B
,	O
adrenal	B
insufficiency	I
,	O
h	O
/	O
o	O
bladder	B
cancer	I
s	O
/	O
p	O
turp	O
,	O
s	O
/	O
p	O
appendectomy	O

social	O
history	O
:	O

lives	O
with	O
wife	O
.	O

contractor	O
.	O

former	O
smoker	O
.	O

quit	O
drinking	O
etoh	O
.	O

family	O
history	O
:	O

non	O
-	O
contributory	O

physical	O
exam	O
:	O

vs	O
:	O
52	O
irreg	O
,	O
12	O
155	O
/	O
74	O
150	O
/	O
70	O
72"	O
220#	O

general	O
:	O
wdwn	O
male	O
in	O
nad	B

skin	O
:	O
warm	O
,	O
dry	O
-	O
lesions	O

heent	O
:	O
ncat	O
,	O
eomi	O
,	O
perrl	O
,	O
opbenign	O
,	O
anicteric	B
sclera	O

neck	O
:	O
supple	O
,	O
from	O
-	O
jvd	B
w	O
/	O
well	O
-	O
healed	O
thyroidectomy	O
scar	B

chest	O
:	O
ctab	O
-	O
w	B
/	O
r	B
/	O
r	B
,	O
large	O
nevi	B
and	O
birthmark	B
mid	O
sternum	O

heart	O
:	O
irreg	B
,	O
irreg	B
4	O
/	O
6	O
sem	B

abd	O
:	O
soft	O
,	O
nt	O
/	O
nd	O
+	O
bs	O

ext	O
:	O
warm	O
,	O
well	O
-	O
perfused	O
trace	O
edema	B
,	O
small	O
right	O
varicosities	B
,	O
2	O
+	O
pulses	O

neuro	O
:	O
non	O
-	O
focal	O
,	O
a&ox3	O
,	O
mae	O
,	O
[	O
*	O
*	O
05	O
-	O
10	O
*	O
*	O
]	O
strengths	O

pertinent	O
results	O
:	O

echo	O
[	O
*	O
*	O
10	O
-	O
03	O
*	O
*	O
]	O
:	O
prebypass	O
:	O
the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

regional	O
left	O
ventricular	O
wall	O
motion	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

there	O
are	O
simple	O
atheroma	B
in	O
the	O
ascending	O
aorta	O
.	O

there	O
are	O
complex	O
(	O
mobile	O
)	O
atheroma	B
in	O
the	O
aortic	O
arch	O
.	O

the	O
descending	O
thoracic	O
aorta	O
is	O
mildly	O
dilated	B
.	O

there	O
are	O
complex	O
(	O
mobile	O
)	O
atheroma	B
in	O
the	O
descending	O
aorta	O
.	O

epiaortic	O
scan	O
done	O
to	O
assess	O
cannulation	O
site	O
on	O
the	O
ascending	O
aorta	O
.	O

there	O
are	O
three	O
aortic	O
valve	O
leaflets	O
.	O

the	O
aortic	O
valve	O
leaflets	O
are	O
severely	O
thickened	B
/	O
deformed	B
.	O

there	O
is	O
severe	O
aortic	B
valve	I
stenosis	I
.	O

no	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
moderately	O
thickened	O
.	O

there	O
is	O
moderate	O
thickening	B
of	O
the	O
mitral	O
valve	O
chordae	O
.	O

moderate	O
to	O
severe	O
(	O
3	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	B
regurgitation	I
jet	O
is	O
eccentric	O
and	O
posteriorly	O
directed	O
.	O

post	O
bypass	O
:	O
lv	O
systolic	O
function	O
is	O
mildly	O
depressed	O
.	O

ef	O
45%	O
.	O

there	O
is	O
mild	O
hypokinesia	B
of	O
the	O
inferior	O
wall	O
.	O

rv	O
function	O
is	O
unchanged	O
.	O

there	O
is	O
bioprosthetic	O
valve	O
seen	O
in	O
the	O
mitral	O
posiiton	O
.	O

the	O
valve	O
appears	O
well	O
seated	O
and	O
the	O
leaflets	O
move	O
well	O
.	O

there	O
is	O
mild	O
mr	B
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
1955	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
6773	O
*	O
*	O
]	O
with	O
the	O
administration	O
of	O
protamine	O
.	O

there	O
is	O
a	O
bioprosthetic	O
valve	O
seen	O
in	O
the	O
aortic	O
position	O
.	O

the	O
valve	O
appears	O
well	O
seated	O
and	O
the	O
leaflets	O
move	O
well	O
.	O

trace	O
aortic	B
insufficiency	I
present	O
.	O

cxr	O
[	O
*	O
*	O
09	O
-	O
06	O
*	O
*	O
]	O
:	O
comparison	O
is	O
made	O
to	O
[	O
*	O
*	O
2013	O
-	O
09	O
-	O
04	O
*	O
*	O
]	O
.	O

the	O
patient	O
is	O
status	O
post	O
cabg	O
and	O
avr	O
and	O
mvr	O
.	O

the	O
cardiac	O
silhouette	O
,	O
mediastinal	O
and	O
hilar	O
contours	O
appears	O
stable	O
.	O

bilateral	O
small	O
pleural	O
effusions	O
are	O
again	O
seen	O
,	O
slightly	O
increased	O
on	O
the	O
right	O
in	O
the	O
interval	O
.	O

again	O
noted	O
is	O
left	O
basilar	O
discoid	B
atelectasis	I
.	O

the	O
lungs	O
are	O
otherwise	O
clear	O
.	O

no	O
consolidations	B
are	O
seen	O
.	O

there	O
is	O
no	O
pneumothorax	B
.	O

[	O
*	O
*	O
2013	O
-	O
09	O
-	O
02	O
*	O
*	O
]	O
03	O
:	O
06am	O
blood	O
wbc	O
-	O
4	O
.	O
5	O
rbc	O
-	O
4	O
.	O
10	O
*	O
hgb	O
-	O
11	O
.	O
7	O
*	O
hct	O
-	O
32	O
.	O
6	O
*	O
mcv	O
-	O
80	O
*	O
mch	O
-	O
28	O
.	O
6	O
mchc	O
-	O
36	O
.	O
0	O
*	O
rdw	O
-	O
16	O
.	O
3	O
*	O
plt	O
ct	O
-	O
176	O

[	O
*	O
*	O
2013	O
-	O
09	O
-	O
06	O
*	O
*	O
]	O
06	O
:	O
10am	O
blood	O
wbc	O
-	O
4	O
.	O
4	O
rbc	O
-	O
2	O
.	O
91	O
*	O
hgb	O
-	O
8	O
.	O
4	O
*	O
hct	O
-	O
23	O
.	O
7	O
*	O
mcv	O
-	O
81	O
*	O
mch	O
-	O
28	O
.	O
7	O
mchc	O
-	O
35	O
.	O
3	O
*	O
rdw	O
-	O
16	O
.	O
8	O
*	O
plt	O
ct	O
-	O
108	O
*	O

[	O
*	O
*	O
2013	O
-	O
09	O
-	O
10	O
*	O
*	O
]	O
06	O
:	O
20am	O
blood	O
wbc	O
-	O
5	O
.	O
8	O
rbc	O
-	O
2	O
.	O
98	O
*	O
hgb	O
-	O
8	O
.	O
4	O
*	O
hct	O
-	O
24	O
.	O
3	O
*	O
mcv	O
-	O
81	O
*	O
mch	O
-	O
28	O
.	O
2	O
mchc	O
-	O
34	O
.	O
7	O
rdw	O
-	O
16	O
.	O
8	O
*	O
plt	O
ct	O
-	O
247#	O

[	O
*	O
*	O
2013	O
-	O
09	O
-	O
02	O
*	O
*	O
]	O
03	O
:	O
06am	O
blood	O
pt	O
-	O
14	O
.	O
4	O
*	O
ptt	O
-	O
34	O
.	O
3	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
3	O
*	O

[	O
*	O
*	O
2013	O
-	O
09	O
-	O
10	O
*	O
*	O
]	O
12	O
:	O
45pm	O
blood	O
pt	O
-	O
16	O
.	O
2	O
*	O
ptt	O
-	O
83	O
.	O
7	O
*	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
5	O
*	O

[	O
*	O
*	O
2013	O
-	O
09	O
-	O
02	O
*	O
*	O
]	O
03	O
:	O
06am	O
blood	O
glucose	O
-	O
115	O
*	O
urean	O
-	O
15	O
creat	O
-	O
0	O
.	O
8	O
na	O
-	O
138	O
k	O
-	O
4	O
.	O
0	O
cl	O
-	O
103	O
hco3	O
-	O
27	O
angap	O
-	O
12	O

[	O
*	O
*	O
2013	O
-	O
09	O
-	O
09	O
*	O
*	O
]	O
06	O
:	O
40am	O
blood	O
glucose	O
-	O
94	O
urean	O
-	O
15	O
creat	O
-	O
1	O
.	O
1	O
na	O
-	O
136	O
k	O
-	O
4	O
.	O
2	O
cl	O
-	O
98	O
hco3	O
-	O
32	O
angap	O
-	O
10	O

brief	O
hospital	O
course	O
:	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
6774	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
902	O
*	O
*	O
]	O
all	O
pre	O
-	O
operative	O
work	O
-	O
up	O
as	O
an	O
outpatient	O
.	O

he	O
was	O
found	O
to	O
also	O
have	O
coronary	B
artery	I
disease	I
and	O
mitral	B
valve	I
disease	I
.	O

he	O
was	O
admitted	O
one	O
day	O
prior	O
to	O
surgery	O
secondary	O
to	O
being	O
on	O
coumadin	O
(	O
which	O
was	O
stopped	O
5	O
days	O
ago	O
)	O
.	O

he	O
was	O
started	O
on	O
heparin	O
and	O
usual	O
lab	O
work	O
was	O
performed	O
.	O

on	O
[	O
*	O
*	O
09	O
-	O
02	O
*	O
*	O
]	O
he	O
was	O
brought	O
to	O
the	O
operating	O
room	O
where	O
he	O
underwent	O
a	O
aortic	O
valve	O
replacement	O
,	O
mitral	O
valve	O
replacement	O
,	O
and	O
coronary	O
artery	O
bypass	O
graft	O
x	O
1	O
.	O
please	O
see	O
operative	O
report	O
for	O
surgical	O
details	O
.	O

surgery	O
was	O
uneventful	O
and	O
he	O
was	O
brought	O
to	O
the	O
csru	O
for	O
invasive	O
monitoring	O
in	O
stable	O
condition	O
.	O

later	O
on	O
op	O
day	O
he	O
was	O
weaned	O
from	O
sedation	O
,	O
awoke	O
neurologically	O
intact	O
and	O
was	O
extubated	O
.	O

by	O
post	O
-	O
operative	O
day	O
one	O
he	O
was	O
weaned	O
off	O
of	O
any	O
pressors	O
.	O

he	O
was	O
started	O
on	O
beta	O
blockers	O
and	O
diuretics	O
and	O
was	O
transferred	O
to	O
the	O
sdu	O
.	O

he	O
was	O
gently	O
diuresed	O
towards	O
his	O
pre	O
-	O
op	O
weight	O
during	O
his	O
post	O
-	O
op	O
course	O
.	O

on	O
post	O
-	O
op	O
day	O
two	O
his	O
chest	O
tubes	O
and	O
epicardial	O
pacing	O
wires	O
were	O
removed	O
.	O

coumadin	O
was	O
restarted	O
for	O
his	O
chronic	B
atrial	I
fibrillation	I
.	O

over	O
the	O
next	O
several	O
days	O
his	O
platelet	B
count	I
decreased	I
but	O
a	O
hit	B
panel	O
was	O
negative	O
.	O

after	O
this	O
,	O
post	O
op	O
day	O
5	O
,	O
he	O
was	O
started	O
on	O
low	O
dose	O
heparin	O
while	O
awaiting	O
his	O
inr	O
to	O
increase	O
with	O
coumadin	O
.	O

he	O
remained	O
stable	O
over	O
the	O
next	O
several	O
days	O
and	O
worked	O
with	O
physical	O
therapy	O
for	O
strength	O
and	O
mobility	O
.	O

his	O
inr	O
became	O
therapeutic	O
on	O
post	O
-	O
op	O
day	O
eight	O
and	O
he	O
was	O
discharged	O
home	O
with	O
vna	O
services	O
and	O
the	O
appropriate	O
follow	O
-	O
up	O
appointments	O
.	O

medications	O
on	O
admission	O
:	O

levoxyl	O
,	O
zestril	O
,	O
digoxin	O
,	O
hydrocortisone	O
,	O
lipitor	O
,	O
coumadin	O
(	O
stopped	O
5	O
days	O
ago	O
)	O
,	O
coreg	O
,	O
niacin	O
,	O
mvi	O
,	O
zanax	O
,	O
diovan	O
,	O

cardizem	O

discharge	O
medications	O
:	O

1	O
.	O
metoprolol	O
tartrate	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

3	O
.	O
potassium	O
chloride	O
20	O
meq	O
packet	O
sig	O
:	O
one	O
(	O
1	O
)	O
packet	O
po	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
for	O
7	O
days	O
.	O

disp	O
:	O
*	O
20	O
packet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

4	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

5	O
.	O
oxycodone	O
-	O
acetaminophen	O
5	O
-	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4h	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B
.	O

disp	O
:	O
*	O
35	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

6	O
.	O
clopidogrel	O
75	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
1	O
*	O

7	O
.	O
atorvastatin	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

8	O
.	O
levothyroxine	O
200	O
mcg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
:	O
use	O
home	O
meds	O
.	O

9	O
.	O
hydrocortisone	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
qam	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
morning	O
)	O
)	O
.	O

10	O
.	O

hydrocortisone	O
5	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
qpm	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
evening	O
)	O
)	O
.	O

11	O
.	O

lisinopril	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

12	O
.	O

multivitamin	O
,	O
tx	O
-	O
minerals	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

13	O
.	O

furosemide	O
40	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
for	O
7	O
days	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

14	O
.	O

pantoprazole	O
40	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
q24h	O
(	O
every	O
24	O
hours	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

15	O
.	O

warfarin	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
for	O
2	O
doses	O
:	O
please	O
have	O
inr	O
checked	O
on	O
[	O
*	O
*	O
09	O
-	O
12	O
*	O
*	O
]	O
with	O
results	O
to	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

16	O
.	O

ferrous	O
gluconate	O
300	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

17	O
.	O

ascorbic	O
acid	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

aortic	B
stenosis	I
,	O
mitral	B
regurgitation	I
,	O
coronary	B
artery	I
disease	I
s	O
/	O
p	O
aortic	O
valve	O
replacment	O
,	O
mitral	O
valve	O
replacement	O
,	O
coronary	O
artery	O
bypass	O
graft	O
x	O
1	O

pmh	O
:	O
congestive	B
heart	I
failure	I
,	O
atrial	B
fibrillation	I
s	O
/	O
p	O
attempted	O
cardioversion	O
,	O
thyroid	B
cancer	I
s	O
/	O
p	O
thyroidectomy	O
&	O
radioactive	O
iodine	O
,	O
hypothyroidism	B
,	O
h	O
/	O
o	O
pulmonary	B
nodules	I
,	O
diabetes	B
mellitus	I
,	O
hyperlipidemia	B
,	O
adrenal	B
insufficiency	I
,	O
h	O
/	O
o	O
bladder	B
cancer	I
s	O
/	O
p	O
turp	O
,	O
s	O
/	O
p	O
appendectomy	O

discharge	O
condition	O
:	O

good	O

discharge	O
instructions	O
:	O

call	O
with	O
fever	B
,	O
redness	B
or	O
drainage	B
from	I
incision	I
or	O
weight	B
gain	I
more	O
than	O
2	O
pounds	O
in	O
one	O
day	O
or	O
five	O
in	O
one	O
week	O
.	O

shower	O
,	O
no	O
baths	O
,	O
no	O
lotions	O
,	O
creams	O
or	O
powders	O
to	O
incisions	O
.	O

no	O
heavy	O
lifting	O
or	O
driving	O
until	O
follow	O
up	O
with	O
surgeon	O
.	O

followup	O
instructions	O
:	O

provider	O
:	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name3	O
(	O
lf	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
101	O
*	O
*	O
]	O
4	O
weeks	O
call	O
to	O
schedule	O
appointment	O

provider	O
:	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
name11	O
(	O
nameis	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
5682	O
*	O
*	O
]	O
2	O
weeks	O
call	O
to	O
schedule	O
appointment	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
2	O
weeks	O
and	O
for	O
coumadin	O
dosing	O
.	O

[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
185	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
57	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
pa	O
80	O
-	O
bmd	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
03	O
*	O
*	O
]	O
@	O
1006	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
11	O
*	O
*	O
]	O
3	O
:	O
29	O
pm	O

(	O
end	O
of	O
report	O
)	O

28156	O
||||	O
4995	O
||||	O
6466	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
12	O
-	O
13	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
04	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
13	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1934	O
-	O
04	O
-	O
16	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
cardiothoracic	O

allergies	O
:	O

penicillins	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
342	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

79	O
year	O
old	O
white	O
female	O
with	O
2	O
year	O
history	O
of	O
shortness	B
of	I
breath	I
.	O

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

avr	O
with	O
21mm	O
ce	O
valve	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
04	O
*	O
*	O
]	O

past	O
medical	O
history	O
:	O

chf	B

aortic	I
stenosis	I

right	O
upper	O
lobe	O
bullae	B

anxiety	I

diverticulosis	I

l	O
carotid	B
disease	I

peripheral	I
vascular	I
disease	I

obesity	I

s	O
/	O
p	O
tah	O
/	O
bso	O

s	O
/	O
p	O
cataract	B
surgery	O

s	O
/	O
p	O
foot	O
surgery	O

pertinent	O
results	O
:	O

hematology	O

complete	O
blood	O
count	O
wbc	O
rbc	O
hgb	O
hct	O
mcv	O
mch	O
mchc	O
rdw	O
plt	O
ct	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
09	O
*	O
*	O
]	O
05	O
:	O
40am	O
14	O
.	O
0	O
*	O
4	O
.	O
41	O
12	O
.	O
0	O
36	O
.	O
9	O
84	O
27	O
.	O
3	O
32	O
.	O
6	O
15	O
.	O
3	O
240	O

basic	O
coagulation	O
pt	O
ptt	O
plt	O
ct	O
inr	O
(	O
pt	O
)	O

[	O
*	O
*	O
2013	O
-	O
12	O
-	O
10	O
*	O
*	O
]	O
06	O
:	O
05am	O
13	O
.	O
41	O
24	O
.	O
0	O
1	O
.	O
1	O
1	O
note	O
new	O
normal	O
range	O
as	O
of	O
12a	O
of	O
[	O
*	O
*	O
2013	O
-	O
09	O
-	O
03	O
*	O
*	O
]	O

chemistry	O

renal	O
&	O
glucose	O
glucose	O
urean	O
creat	O
na	O
k	O
cl	O
hco3	O
angap	O

[	O
*	O
*	O
2013	O
-	O
12	O
-	O
10	O
*	O
*	O
]	O
06	O
:	O
05am	O
107	O
*	O
43	O
*	O
0	O
.	O
8	O
137	O
5	O
.	O
1	O
96	O
36	O
*	O
10	O

chemistry	O
totprot	O
albumin	O
globuln	O
calcium	O
phos	O
mg	O
uricacd	O
iron	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
09	O
*	O
*	O
]	O
05	O
:	O
40am	O
8	O
.	O
9	O
3	O
.	O
9	O
2	O
.	O
8	O
*	O

[	O
*	O
*	O
2013	O
-	O
12	O
-	O
12	O
*	O
*	O
]	O
06	O
:	O
25am	O
blood	O
wbc	O
-	O
13	O
.	O
4	O
*	O
rbc	O
-	O
4	O
.	O
19	O
*	O
hgb	O
-	O
11	O
.	O
3	O
*	O
hct	O
-	O
35	O
.	O
4	O
*	O

mcv	O
-	O
85	O
mch	O
-	O
26	O
.	O
9	O
*	O
mchc	O
-	O
31	O
.	O
8	O
rdw	O
-	O
15	O
.	O
3	O
plt	O
ct	O
-	O
310	O

[	O
*	O
*	O
2013	O
-	O
12	O
-	O
12	O
*	O
*	O
]	O
06	O
:	O
25am	O
blood	O
plt	O
ct	O
-	O
310	O

[	O
*	O
*	O
2013	O
-	O
12	O
-	O
12	O
*	O
*	O
]	O
06	O
:	O
25am	O
blood	O
pt	O
-	O
14	O
.	O
0	O
*	O
ptt	O
-	O
25	O
.	O
3	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
2	O

[	O
*	O
*	O
2013	O
-	O
12	O
-	O
12	O
*	O
*	O
]	O
06	O
:	O
25am	O
blood	O
urean	O
-	O
36	O
*	O
creat	O
-	O
1	O
.	O
0	O
k	O
-	O
5	O
.	O
2	O
*	O

[	O
*	O
*	O
2013	O
-	O
12	O
-	O
13	O
*	O
*	O
]	O
06	O
:	O
15am	O
blood	O
wbc	O
-	O
14	O
.	O
0	O
*	O
rbc	O
-	O
4	O
.	O
23	O
hgb	O
-	O
11	O
.	O
2	O
*	O
hct	O
-	O
35	O
.	O
0	O
*	O
mcv	O
-	O
83	O
mch	O
-	O
26	O
.	O
6	O
*	O
mchc	O
-	O
32	O
.	O
2	O
rdw	O
-	O
15	O
.	O
3	O
plt	O
ct	O
-	O
329	O

[	O
*	O
*	O
2013	O
-	O
12	O
-	O
13	O
*	O
*	O
]	O
06	O
:	O
15am	O
blood	O
plt	O
ct	O
-	O
329	O

[	O
*	O
*	O
2013	O
-	O
12	O
-	O
13	O
*	O
*	O
]	O
06	O
:	O
15am	O
blood	O
pt	O
-	O
14	O
.	O
0	O
*	O
ptt	O
-	O
24	O
.	O
7	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
2	O

[	O
*	O
*	O
2013	O
-	O
12	O
-	O
13	O
*	O
*	O
]	O
06	O
:	O
15am	O
blood	O
glucose	O
-	O
100	O
urean	O
-	O
35	O
*	O
creat	O
-	O
0	O
.	O
9	O
na	O
-	O
142	O
k	O
-	O
4	O
.	O
1	O
cl	O
-	O
94	O
*	O
hco3	O
-	O
43	O
*	O
angap	O
-	O
9	O

brief	O
hospital	O
course	O
:	O

mrs	O
.	O
[	O
*	O
*	O
lastname	O
6424	O
*	O
*	O
]	O
was	O
admitted	O
to	O
bidmcon	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
04	O
*	O
*	O
]	O
and	O
taken	O
to	O
the	O
operating	O
room	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
347	O
*	O
*	O
]	O
for	O
an	O
avr	O
with	O
a	O
21mm	O
ce	O
pericardial	O
tissue	O
valve	O
.	O

she	O
tolerated	O
the	O
procedure	O
well	O
and	O
was	O
transferred	O
to	O
the	O
icu	O
in	O
stable	O
condition	O
.	O

postoperatively	O
she	O
remained	O
intubated	O
on	O
mechanical	O
ventilation	O
due	O
to	O
co2	B
retention	I
,	O
and	O
was	O
extubated	O
on	O
the	O
evening	O
of	O
pod#2	O
.	O
she	O
continued	O
to	O
have	O
elevated	B
co2	I
with	O
a	O
normal	O
ph	O
,	O
which	O
was	O
thought	O
to	O
be	O
her	O
baseline	O
.	O

she	O
was	O
noted	O
to	O
have	O
a	O
prolonged	B
pr	I
interval	I
of	O
about	O
.	O
33	O
.	O

she	O
was	O
transferred	O
from	O
the	O
icu	O
to	O
the	O
regular	O
floor	O
on	O
pod#2	O
.	O
she	O
developed	O
fib	B
on	O
pod#4	O
,	O
was	O
started	O
on	O
amiodarone	O
on	O
pod#5	O
.	O
she	O
converted	O
into	O
sr	B
,	O
but	O
continued	O
to	O
have	O
a	O
very	O
prolonged	B
pr	I
interval	I
.	O

an	O
ep	O
consult	O
was	O
obtained	O
and	O
the	O
team	O
was	O
concerned	O
that	O
she	O
was	O
having	O
heart	B
block	I
with	O
the	O
atrial	B
fibrillation	I
.	O

she	O
was	O
taken	O
to	O
the	O
electrophysiology	O
lab	O
for	O
a	O
study	O
on	O
pod#7	O
where	O
it	O
was	O
determined	O
that	O
she	O
had	O
some	O
av	B
nodal	I
disease	I
with	O
a	O
lbbb	B
,	O
but	O
she	O
was	O
at	O
very	O
low	O
risk	O
for	O
progression	O
to	O
chb	B
and	O
it	O
was	O
decided	O
that	O
there	O
was	O
no	O
indication	O
for	O
a	O
permanent	O
pacer	O
.	O

she	O
was	O
also	O
cardioverted	O
into	O
sinus	B
rhythm	I
.	O

the	O
ep	O
service	O
recommended	O
lo	O
dose	O
beta	O
blocker	O
and	O
anticoagulation	O
and	O
no	O
amiodarone	O
therapy	O
.	O

she	O
was	O
started	O
on	O
12	O
.	O
5mg	O
of	O
lopressor	O
bid	O
and	O
tolerated	O
it	O
well	O
.	O

her	O
pr	O
interval	O
remains	O
2	O
.	O
5	O
-	O
.	O
3	O
.	O

on	O
the	O
morning	O
of	O
discharge	O
,	O
she	O
developed	O
periods	O
of	O
slower	B
heart	I
rates	I
into	O
the	O
60s	O
.	O

ep	O
service	O
evaluated	O
her	O
rhythm	B
and	O
determined	O
that	O
it	O
was	O
due	O
to	O
blocked	B
premature	I
atrial	I
contractions	I
and	O
recommended	O
continuing	O
her	O
lopressor	O
and	O
continue	O
with	O
plan	O
for	O
discharge	O
to	O
rehab	O
with	O
a	O
monitored	O
bed	O
.	O

she	O
has	O
continued	O
to	O
require	O
oxygen	O
thru	O
out	O
her	O
hospital	O
stay	O
,	O
4l	O
nasal	O
cannula	O
to	O
maintain	O
a	O
sp	O
o2	O
of	O
96%	O
.	O

her	O
cxr	O
shows	O
a	O
large	O
right	O
upper	O
lobe	O
bullae	B
,	O
small	O
bilateral	B
pleural	I
effusions	I
.	O

the	O
rul	O
bullae	B
is	O
consistent	O
with	O
her	O
preoperative	O
cxr	O
,	O
and	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
347	O
*	O
*	O
]	O
has	O
requested	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
6425	O
*	O
*	O
]	O
/	O
thoracic	O
surgery	O
to	O
consult	O
regarding	O
management	O
of	O
her	O
bullous	B
disease	I
.	O

she	O
is	O
being	O
anticoagulated	O
with	O
coumadin	O
to	O
achieve	O
an	O
inr	O
of	O
2	O
.	O
0	O
-	O
2	O
.	O
5	O
for	O
the	O
atrial	B
fibrillation	I
.	O

medications	O
on	O
admission	O
:	O

digoxin	O
0	O
.	O
25	O
mg	O
po	O
daily	O

hctz	O
/	O
triam	O
.	O

37	O
.	O
5	O
/	O
25	O
po	O
daily	O

detrol	O
4	O
mg	O
po	O
daily	O

premarin	O
0	O
.	O
625	O
mg	O
po	O
daily	O

candesartan	O
16	O
mg	O
po	O
daily	O

discharge	O
medications	O
:	O

1	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

2	O
.	O
ranitidine	O
hcl	O
150	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

3	O
.	O
acetaminophen	O
325	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
q4h	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
.	O

4	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

5	O
.	O
alprazolam	O
0	O
.	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
as	O
needed	O
.	O

7	O
.	O
lipitor	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

8	O
.	O
premarin	O
0	O
.	O
625	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

9	O
.	O
furosemide	O
10	O
mg	O
/	O
ml	O
solution	O
sig	O
:	O
40	O
mg	O
iv	O
injection	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
:	O
wean	O
to	O
po	O
lasix	O
when	O
fluid	O
status	O
decreases	O
.	O

10	O
.	O

captopril	O
12	O
.	O
5	O
mg	O
tablet	O
sig	O
:	O
0	O
.	O
5	O
tablet	O
po	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

11	O
.	O

metoprolol	O
tartrate	O
25	O
mg	O
tablet	O
sig	O
:	O
0	O
.	O
5	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
:	O
hold	O
hr<60	O
.	O

12	O
.	O

oxycodone	O
-	O
acetaminophen	O
5	O
-	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4h	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B
.	O

13	O
.	O

warfarin	O
sodium	O
1	O
mg	O
tablet	O
sig	O
:	O
five	O
(	O
5	O
)	O
tablet	O
po	O
once	O
[	O
*	O
*	O
12	O
-	O
13	O
*	O
*	O
]	O
:	O
titrate	O
for	O
inr	O
2	O
.	O
0	O
-	O
2	O
.	O
5	O
.	O

14	O
.	O

magnesium	O
hydroxide	O
400	O
mg	O
/	O
5	O
ml	O
suspension	O
sig	O
:	O
thirty	O
(	O
30	O
)	O
ml	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
as	O
needed	O
for	O
constipation	B
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

[	O
*	O
*	O
hospital	O
1754	O
*	O
*	O
]	O
medical	O
center	O
-	O
[	O
*	O
*	O
hospital1	O
1755	O
*	O
*	O
]	O

discharge	O
diagnosis	O
:	O

critical	B
aortic	I
stenosis	I

congestive	I
heart	I
failure	I

peripheral	I
vascular	I
disease	I

obesity	I

s	O
/	O
p	O
avr	O

atrial	B
fibrillation	I

rul	O
bullous	B
disease	I

first	I
degree	I
av	I
block	I

anxiety	I

discharge	O
condition	O
:	O

good	O
.	O

discharge	O
instructions	O
:	O

follow	O
medications	O
on	O
discharge	O
instructions	O
.	O

you	O
may	O
not	O
drive	O
for	O
4	O
weeks	O
.	O

you	O
may	O
not	O
lift	O
more	O
than	O
10	O
lbs	O
.	O
for	O
3	O
months	O
.	O

you	O
should	O
shower	O
,	O
let	O
water	O
flow	O
over	O
wounds	B
,	O
pat	O
dry	O
with	O
a	O
towel	O
.	O

followup	O
instructions	O
:	O

make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
6426	O
*	O
*	O
]	O
for	O
1	O
-	O
2	O
weeks	O
.	O

make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
for	O
4	O
weeks	O
.	O

please	O
consult	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
6427	O
*	O
*	O
]	O
upon	O
arrival	O
to	O
rehab	O
re	O
:	O
rul	O
bullous	B
disease	I

[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
351	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
352	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
353	O
*	O
*	O
]	O
pa	O
80	O
-	O
axp	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
13	O
*	O
*	O
]	O
@	O
1015	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
24	O
*	O
*	O
]	O
2	O
:	O
44	O
pm	O

(	O
end	O
of	O
report	O
)	O

11493	O
||||	O
5065	O
||||	O
8597	O
||||	O
discharge	O
_	O
summary	O
||||	O
2019	O
-	O
02	O
-	O
01	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1936	O
-	O
04	O
-	O
09	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
236	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

sepsis	B
,	O
aspiration	B
,	O
altered	B
mental	I
status	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

intubation	O
-	O
mechanical	O
ventilation	O

internal	O
jugular	O
central	O
venous	O
line	O
.	O

picc	O
.	O

history	O
of	O
present	O
illness	O
:	O

patient	O
is	O
an	O
82	O
year	O
old	O
portugese	O
speaking	O
male	O
with	O
recent	O
l	O
mca	O
cva	B
2	O
weeks	O
ago	O
(	O
d	O
/	O
c	O
to	O
[	O
*	O
*	O
hospital1	O
707	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
01	O
*	O
*	O
]	O
)	O
,	O
pna	B
(	O
treated	O
with	O
unasyn	O
/	O
zosyn	O
last	O
2	O
days	O
)	O
,	O
hip	B
fracture	I
,	O
osteomyelitis	B
of	O
left	O
hip	O
,	O
delerium	B
,	O
aphasia	B
who	O
was	O
vomiting	B
x	O
2	O
days	O
,	O
shivering	B
,	O
depressed	B
ms	I
,	O
hypoxic	B
to	O
65	O
,	O
and	O
he	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital	O
800	O
*	O
*	O
]	O
hospital	O
.	O

on	O
arrival	O
to	O
[	O
*	O
*	O
hospital1	O
800	O
*	O
*	O
]	O
vitals	O
were	O
103	O
.	O
2	O
,	O
148	O
,	O
85	O
/	O
41	O
(	O
all	O
subsequent	O
ones	O
demonstrated	O
htn	B
)	O
,	O
42	O
,	O
83%	O
-	O
placed	O
on	O
nonrebreather	O
with	O
little	O
improvement	O
and	O
was	O
found	O
to	O
be	O
tachypneic	B
with	O
labored	B
breathing	I
and	O
was	O
intubated	O
(	O
received	O
versed	O
,	O
lidocaine	O
,	O
rocuronium	O
)	O
.	O

also	O
received	O
cipro	O
400	O
mg	O
iv	O
x	O
1	O
,	O
vanc	O
1	O
g	O
iv	O
x	O
1	O
,	O
cefepime	O
2g	O
iv	O
x	O
1	O
,	O
2l	O
ns	O
.	O

noted	O
to	O
have	O
facial	B
movement	I
and	O
with	O
history	O
of	O
left	O
mca	B
infarct	I
2	O
weeks	O
prior	O
patient	O
had	O
ct	O
head	O
which	O
showed	O
hemorrhagic	B
conversion	I
of	O
left	O
mca	B
infarct	I
.	O

no	O
neurosurgery	O
on	O
call	O
at	O
[	O
*	O
*	O
hospital1	O
800	O
*	O
*	O
]	O
and	O
was	O
therefore	O
transferred	O
for	O
further	O
management	O
.	O

upon	O
arrival	O
to	O
[	O
*	O
*	O
hospital1	O
16	O
*	O
*	O
]	O
vitals	O
were	O
102	O
.	O
3	O
,	O
129	O
,	O
129	O
/	O
54	O
,	O
22	O
,	O
97%	O
on	O
ac	O
500	O
/	O
16	O
/	O
1%	O
/	O
5	O
.	O
lactate	O
elevated	O
at	O
6	O
and	O
code	O
sepsis	B
called	O
.	O

right	O
ij	O
sepsis	B
line	O
placed	O
,	O
3l	O
ns	O
administered	O
,	O
and	O
ativan	O
1mg	O
given	O
.	O

transferred	O
to	O
icu	O
for	O
further	O
management	O
.	O

patient	O
intubated	O
and	O
unresponsive	B
,	O
unable	O
to	O
obtain	O
further	O
history	O
upon	O
arrival	O
.	O

past	O
medical	O
history	O
:	O

#	O
cva	B
-	O
presented	O
on	O
[	O
*	O
*	O
12	O
-	O
27	O
*	O
*	O
]	O
with	O
2wks	O
ms	B
changes	I
,	O
slurred	B
speech	I
-	O
found	O
to	O
have	O
cva	B
in	O
left	O
temporal	O
region	O
by	O
ct	O
on	O
[	O
*	O
*	O
12	O
-	O
29	O
*	O
*	O
]	O
(	O
no	O

tpa	O
)	O
.	O

-	O
no	O
paralysis	B
,	O
able	O
to	O
move	O
arms	O
and	O
legs	O
,	O
unable	O
to	O
feed	O
himself	O
,	O
working	O
on	O
getting	O
him	O
up	O
at	O
[	O
*	O
*	O
hospital1	O
707	O
*	O
*	O
]	O
,	O
follows	O
commands	O
-	O
memory	B
loss	I
/	O
aphagia	B

-	O
nml	O
carotid	O
u	O
/	O
s	O
in	O
12	O
/	O
06	O

-	O
improved	O
motor	O
to	O
[	O
*	O
*	O
05	O
-	O
04	O
*	O
*	O
]	O
in	O
ue	O

-	O
intermittent	O
fevers	B
,	O
lp	O
pending	O
with	O
vdrl	O
,	O
hsv	O
,	O
afb	O
,	O
fungal	O
cx	O
pending	O
at	O
time	O
of	O
transfer	O
to	O
[	O
*	O
*	O
hospital1	O
707	O
*	O
*	O
]	O
#	O
seizures	B
-	O
developed	O
after	O
recent	O
cva	B
,	O
controlled	O
with	O
valium	O
and	O
phenytoin	O
#	O
htn	B
-	O
was	O
on	O
atenolol	O
,	O
lisinopril	O
,	O
hctz	O
prior	O
to	O
cva	B
,	O
on	O
hold	O
since	O

#	O
pna	B

#	O
sepsis	B

#	O
l	O
hip	B
fracture	I
s	O
/	O
p	O
open	O
reduction	O
/	O
internal	O
fixation	O
in	O
1970s	O
with	O
ongoing	O
drainage	O
-	O
wound	O
+	O
for	O
staph	O
aureus	O
and	O
staph	O
epi	O
in	O
past	O
#	O
osteomyelitis	B
of	O
left	O
hip	O
[	O
*	O
*	O
2018	O
-	O
03	O
-	O
31	O
*	O
*	O
]	O
(	O
had	O
continuous	O
drainage	B
from	O
hip	O
since	O
[	O
*	O
*	O
1981	O
*	O
*	O
]	O
's	O
)	O

#	O
stress	O
mibi	O
was	O
neg	O
in	O
[	O
*	O
*	O
2012	O
*	O
*	O
]	O

social	O
history	O
:	O

patient	O
was	O
previously	O
fully	O
independent	O
prior	O
to	O
cva	B
.	O

no	O
etoh	O
,	O
no	O
tobacco	O
.	O

2	O
sons	O
,	O
2	O
daughters	O
(	O
one	O
in	O
[	O
*	O
*	O
country	O
351	O
*	O
*	O
]	O
)	O
.	O

family	O
history	O
:	O

mother	O
died	O
of	O
cva	B
suddenly	O

physical	O
exam	O
:	O

vitals	O
:	O
101	O
.	O
4	O
,	O
122	O
,	O
112	O
/	O
52	O
,	O
40	O
,	O
98%	O

vent	O
:	O
ac	O
500	O
/	O
16	O
/	O
0	O
.	O
7	O
/	O
5	O
,	O
pip	O
20	O
,	O
abg	O
7	O
.	O
31	O
/	O
35	O
/	O
268	O
(	O
on	O
fio2	O
100%	O
)	O
heent	O
:	O
perrl	O
,	O
left	O
ovaloid	O
,	O
unable	O
to	O
assess	O
eom	O
,	O
anicteric	B
sclera	O
,	O
op	O
clear	O

neck	O
:	O
supple	O
,	O
no	O
lad	B
,	O
no	O
jvd	B

cardiac	O
:	O
tachy	B
,	O
regular	O
,	O
nl	O
s1	O
and	O
s2	O
,	O
no	O
mrgs	B

lungs	O
:	O
ctab	O
anteriorly	O
with	O
course	B
upper	I
airway	I
sounds	I

abd	O
:	O
soft	O
,	O
ntnd	B
,	O
nabs	O
,	O
no	O
hsm	B
,	O
no	O
rebound	B
or	O
guarding	B

skin	O
:	O
erythema	B
overlying	O
left	O
hip	O
,	O
dimples	B
,	O
one	O
of	O
which	O
is	O
draining	O

ext	O
:	O
warm	O
,	O
1	O
+	O
right	O
dp	O
pulse	O
,	O
2	O
+	O
left	O
pt	O
pulse	O
,	O
no	O
c	B
/	O
c	B
/	O
e	B

neuro	O
:	O
sedated	O
,	O
toes	O
equivaqual	O
,	O
not	O
moving	O

by	O
discharge	O
,	O
patient	O
was	O
extubated	O
,	O
alert	O
,	O
moving	O
all	O
four	O
extremiteis	O
well	O
,	O
speaking	O
occasional	O
words	O
,	O
following	O
commands	O

pertinent	O
results	O
:	O

ekg	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
11	O
*	O
*	O
]	O
osh	O
:	O
rbbb	B
,	O
tachcardia	B
,	O
lad	B
,	O
st	B
changes	I
opposite	O
major	O
deflection	O
.	O

ekg	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
:	O
sinus	B
tachy	I
,	O
rbbb	B
,	O
nml	O
axis	O

radiology	O
:	O

head	O
ct	O
osh	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
11	O
*	O
*	O
]	O
:	O
acute	O
to	O
subacute	O
infarct	B
l	O
temporal	O
lobe	O
with	O
interval	O
development	O
of	O
parenchymal	B
hemorrhage	I
.	O

head	O
ct	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
:	O
large	O
left	O
mca	O
?fusiform?	O
aneurysm	B
without	O
definite	O
evidence	O
of	O
rupture	B
.	O

large	O
left	O
mca	O
territory	O
subacute	O
infarction	O
.	O

overread	O
:	O
agree	O
.	O

mri	O
/	O
mra	O
has	O
been	O
recommended	O
to	O
confirm	O
that	O
the	O
lesion	B
is	O
aneurysm	B
and	O
not	O
other	O
pathology	O
such	O
as	O
mass	B
or	O
unusual	O
bleed	B
cta	O
may	O
also	O
be	O
helpful	O
.	O

cxr	O
at	O
osh	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
11	O
*	O
*	O
]	O
:	O
bilobar	O
pna	B

cxr	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
:	O
bilateral	O
lower	O
lobe	O
opacities	B
,	O
r>l	O
(	O
right	O
middle	O
and	O
lower	O
,	O
left	O
lower	O
)	O
,	O
with	O
vascular	B
redistribution	I
,	O
deep	B
sulcus	I
sign	I
and	O
hyperlucency	B
in	O
rul	O

ct	O
head	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
17	O
*	O
*	O
]	O
:	O

1	O
.	O
no	O
significant	O
change	O
in	O
the	O
appearance	O
of	O
the	O
left	O
mca	O
territory	O
subacute	O
infarction	O
with	O
an	O
18	O
x	O
11	O
mm	O
hyperdense	B
focus	I
medially	O
within	O
the	O
temporal	O
lobe	O
consistent	O
with	O
hemorrhagic	B
infarction	I
.	O

2	O
.	O
no	O
evidence	O
for	O
midline	B
shift	I
or	O
herniation	B
.	O

eeg	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
18	O
*	O
*	O
]	O
:	O

this	O
is	O
an	O
abnormal	B
eeg	I
due	O
to	O
the	O
frequent	B
spike	I
and	O
wave	B
discharges	I
,	O
primarily	O
from	O
the	O
left	O
frontal	O
region	O
with	O
spread	O
to	O
the	O
left	O
and	O
right	O
hemispheres	O
independently	O
.	O

these	O
discharges	O
suggest	O
a	O
left	O
frontal	O
region	O
of	O
cortical	B
irritability	I
.	O

the	O
second	O
abnormality	O
suggests	O
diffuse	O
encephalopathy	B
,	O
which	O
may	O
be	O
seen	O
with	O
infections	B
,	O

toxic	B
metabolic	I
abnormalities	I
,	O
medications	O
and	O
ischemia	B
.	O

mri	O
/	O
mra	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
18	O
*	O
*	O
]	O
:	O

1	O
.	O
there	O
are	O
confluent	O
areas	O
of	O
abnormal	O
signal	O
consistent	O
with	O
the	O
history	O
of	O
herpes	B
encephalitis	I
.	O

there	O
is	O
involvement	O
of	O
the	O
medial	O
and	O
lateral	O
aspect	O
of	O
the	O
left	O
temporal	O
lobe	O
,	O
the	O
left	O
gyrus	O
rectus	O
,	O
the	O
left	O
hippocampus	O
,	O
and	O
both	O
cingulate	O
gyri	O
.	O

2	O
.	O
there	O
is	O
a	O
stable	O
nearly	O
2	O
cm	O
hemorrhage	B
at	O
the	O
anteromedial	O
aspect	O
of	O
left	O
temporal	O
lobe	O
near	O
the	O
mca	O
and	O
there	O
is	O
a	O
stable	O
small	O
amount	O
of	O
intraventricular	B
hemorrhage	I
.	O

3	O
.	O
there	O
is	O
good	O
flow	O
in	O
the	O
distal	O
internal	O
carotid	O
arteries	O
,	O
the	O
distal	O
vertebral	O
arteries	O
,	O
and	O
the	O
basilar	O
artery	O
.	O

there	O
is	O
mild	O
distal	B
asymmetry	I
of	O
the	O
pcas	O
,	O
which	O
is	O
commonly	O
seen	O
.	O

there	O
is	O
probably	O
slight	O
elevation	B
of	I
the	I
left	I
mca	I
by	O
the	O
hemorrhage	B
but	O
no	O
stenosis	B
of	O
it	O
is	O
seen	O
.	O

impression	O
:	O
there	O
is	O
no	O
significant	O
stenosis	B
of	O
the	O
left	O
mca	O
from	O
the	O
adjacent	O
hemorrhage	B
.	O

cxr	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
27	O
*	O
*	O
]	O
:	O
worsening	O
left	O
lower	O
two	O
foci	O
of	O
consolidation	B
which	O
might	O
represent	O
worsening	O
infection	B
or	O
aspiration	B
,	O
with	O
otherwise	O
unchanged	O
appearance	O
of	O
the	O
lungs	O
.	O

brief	O
hospital	O
course	O
:	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
4829	O
*	O
*	O
]	O
is	O
an	O
82	O
year	O
old	O
male	O
who	O
was	O
transferred	O
from	O
an	O
outside	O
hospital	O
for	O
hypoxic	B
respiratory	I
failure	I
.	O

#	O
pneumonia	B
and	O
sepsis	B
:	O
the	O
patient	O
likely	O
experienced	O
an	O
aspiration	B
event	O
resulting	O
in	O
either	O
aspiration	B
pneumonia	I
or	O
chemical	B
pneumonitis	I
and	O
hypoxia	B
.	O

upon	O
transfer	O
,	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
[	O
*	O
*	O
hospital1	O
16	O
*	O
*	O
]	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
154	O
*	O
*	O
]	O
.	O

a	O
cxr	O
showed	O
evidence	O
of	O
chf	B
(	O
iatrogenic	O
due	O
to	O
fluid	O
resuscitation	O
)	O
and	O
possible	O
pna	B
.	O

an	O
ekg	O
showed	O
rbbb	B
and	O
no	O
concordant	O
st	B
changes	I
.	O

cardiac	O
enzymes	O
were	O
negative	O
for	O
mi	B
.	O

he	O
was	O
intubated	O
on	O
the	O
day	O
of	O
admission	O
and	O
started	O
on	O
vancomycin	O
and	O
zosyn	O
.	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
4829	O
*	O
*	O
]	O
qualified	O
for	O
the	O
sepsis	B
protocol	O
and	O
was	O
treated	O
as	O
such	O
with	O
mixed	O
venous	O
o2	O
monitoring	O
,	O
maintaining	O
map	O
>	O
65	O
(	O
pressors	O
)	O
,	O
cvp	O
10	O
-	O
12	O
(	O
fluids	O
)	O
,	O
following	O
uop	O
and	O
high	O
-	O
dose	O
steroids	O
.	O

his	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
154	O
*	O
*	O
]	O
course	O
was	O
complicated	O
by	O
development	O
of	O
pansensitive	O
klebsiella	B
pneumonia	I
that	O
was	O
treated	O
with	O

meropenem	O
/	O
vancomycin	O
/	O
flagyl	O
.	O

the	O
patient's	O
family	O
decided	O
that	O
they	O
wanted	O
the	O
patient	O
to	O
be	O
extubated	O
despite	O
risb	O
>	O
100	O
.	O

he	O
was	O
subsequently	O
transferred	O
to	O
the	O
floor	O
and	O
oxygen	O
requirement	O
weaned	O
.	O

the	O
patient	O
is	O
being	O
converted	O
to	O
oral	O
antibiotic	O
coverage	O
upon	O
discharge	O
with	O
levofloxacin	O
and	O
will	O
require	O
2	O
more	O
days	O
of	O
treatment	O
.	O

#	O
altered	B
mental	I
status	I
:	O
the	O
patient	O
had	O
a	O
recent	O
history	O
of	O
hemorrhagic	B
stroke	I
and	O
hsv	B
encephalitis	I
.	O

the	O
patient	O
was	O
continued	O
on	O
acyclovir	O
for	O
hsv	B
encephalitis	I
for	O
21	O
day	O
course	O
total	O
.	O

the	O
patient's	O
sbps	O
were	O
maintained	O
between	O
100	O
-	O
140	O
in	O
setting	O
of	O
possible	O
intracranial	B
bleed	I
.	O

aspirin	O
was	O
held	O
.	O

an	O
mri	O
was	O
performed	O
which	O
showed	O
similar	O
findings	O
to	O
the	O
previous	O
mri	O
.	O

neuro	O
recommended	O
an	O
additional	O
month	O
of	O
dilantin	O
after	O
discharge	O
and	O
after	O
a	O
repeat	O
eeg	O
.	O

#	O
seizure	B
history	O
:	O
the	O
patient	O
had	O
a	O
known	O
history	O
of	O
seizures	B
during	O
his	O
last	O
hospital	O
admission	O
,	O
and	O
he	O
was	O
maintained	O
on	O
dilantin	O
.	O

his	O
target	O
therapeutic	O
range	O
is	O
15	O
-	O
20	O
as	O
per	O

neurology	O
recommendations	O
.	O

the	O
patient	O
showed	O
no	O
evidence	O
of	O
seizure	B
activity	O
during	O
this	O
hospitalization	O
.	O

#	O
thrombocytosis	B
:	O
the	O
patient's	O
platelet	O
count	O
reached	O
1100	O
during	O
this	O
admission	O
and	O
it	O
was	O
thought	O
to	O
be	O
related	O
to	O
an	O
acute	O
inflammatory	B
reaction	I
.	O

esr	O
,	O
crp	O
,	O
ferritin	O
,	O
fibrinogen	O
were	O
also	O
significantly	O
elevated	O
.	O

the	O
patient's	O
platelet	O
count	O
was	O
decreasing	O
at	O
the	O
time	O
of	O
discharge	O
.	O

#	O
hyperglycemia	B
:	O
the	O
patient	O
developed	O
elevated	B
blood	I
sugars	I
in	O
the	O
setting	O
of	O
high	O
dose	O
steroid	O
administration	O
.	O

although	O
,	O
high	O
dose	O
steroids	O
were	O
stopped	O
,	O
he	O
continued	O
to	O
have	O
some	O
isolated	O
elevations	O
.	O

the	O
patient's	O
blood	O
sugars	O
should	O
be	O
monitored	O
and	O
covered	O
with	O
sliding	O
scale	O
insulin	O
until	O
further	O
work	O
-	O
up	O
or	O
resolution	O
.	O

#	O
sacral	B
decubitus	I
ulcer	I
:	O
the	O
patient	O
was	O
noted	O
to	O
have	O
a	O
stage	O
ii	O
sacral	B
decubitus	I
ulcer	I
during	O
this	O
hospitalization	O
.	O

it	O
did	O
not	O
appear	O
to	O
be	O
infected	B
.	O

wound	B
care	O
was	O
consulted	O
.	O

it	O
was	O
treated	O
with	O
duoderm	O
dressing	O
,	O
air	O
mattress	O
,	O
frequent	O
position	O
changes	O
and	O
physical	O
therapy	O
.	O

#	O
osteomyelitis	B
:	O
the	O
patient	O
has	O
a	O
chronically	B
infected	I
hip	O
for	O
approximately	O
40	O
years	O
,	O
per	O
his	O
family	O
.	O

this	O
was	O
unlikely	O
to	O
be	O
the	O
predominant	O
infectious	B
source	I
given	O
it's	O
appearance	O
on	O
this	O
admission	O
.	O

wound	B
care	O
was	O
consulted	O
to	O
provide	O
recommendations	O
.	O

#	O
nutrition	O
:	O
given	O
the	O
patient's	O
altered	B
mental	I
status	I
and	O
concern	O
for	O
aspiration	B
,	O
a	O
speech	O
and	O
swallow	O
examination	O
was	O
performed	O
.	O

the	O
patient	O
was	O
cleared	O
for	O
nectar	O
thick	O
liquids	O
and	O
regular	O
solids	O
.	O

medications	O
on	O
admission	O
:	O

aspirin	O
325	O
qd	O

dilantin	O
300	O
po	O
qd	O

pravastatin	O
20	O
qd	O

bacitracin	O
oint	O

dalteparin	O
/	O
fragmin	O
5000	O
units	O
sq	O
qd	O

colace	O

fluoxetine	O
20	O
qd	O

mvi	O

pantoprazole	O
40	O
qd	O

acet	O
prn	O
,	O
bisacodyl	O
prn	O
,	O
zofran	O
prn	O
,	O
compazine	O
prn	O

discharge	O
medications	O
:	O

1	O
.	O
fluoxetine	O
20	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
daily	O
(	O
daily	O
)	O
.	O

2	O
.	O
olanzapine	O
5	O
mg	O
tablet	O
,	O
rapid	O
dissolve	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
rapid	O
dissolve	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
agitation	B
.	O

3	O
.	O
phenytoin	O
100	O
mg	O
/	O
4	O
ml	O
suspension	O
sig	O
:	O
eight	O
(	O
8	O
)	O
ml	O
po	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

4	O
.	O
nystatin	O
100	O
,	O
000	O
unit	O
/	O
ml	O
suspension	O
sig	O
:	O
five	O
(	O
5	O
)	O
ml	O
po	O
qid	O
(	O
4	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

5	O
.	O
pravastatin	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

6	O
.	O
docusate	O
sodium	O
50	O
mg	O
/	O
5	O
ml	O
liquid	O
sig	O
:	O
ten	O
(	O
10	O
)	O
ml	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
constipation	B
.	O

7	O
.	O
albuterol	O
sulfate	O
0	O
.	O
083	O
%	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
neb	O

inhalation	O
every	O
4	O
-	O
6	O
hours	O
as	O
needed	O
for	O
shortness	B
of	I
breath	I
or	O
wheezing	B
.	O

8	O
.	O
senna	O
8	O
.	O
6	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
constipation	B
.	O

9	O
.	O
insulin	O
regular	O
human	O
100	O
unit	O
/	O
ml	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
qid	O
injection	O
asdir	O
(	O
as	O
directed	O
)	O
:	O
see	O
attached	O
sliding	O
scale	O
.	O

10	O
.	O

levaquin	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
for	O
2	O
days	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

discharge	O
diagnosis	O
:	O

primary	O
:	O

1	O
.	O
hsv	B
encephalitis	I
w	O
/	O
hemmorhage	B
.	O

2	O
.	O
generalize	B
seizure	I
.	O

3	O
.	O
sepsis	B
nos	O
.	O

4	O
.	O
respiratory	B
failure	I
.	O

5	O
.	O
ventilator	B
associated	I
pneumonia	I
-	O
klebsiella	O
.	O

6	O
.	O
steroid	B
induced	I
diabetes	I
mellitus	I
.	O

7	O
.	O
anemia	B
of	O
chronic	B
inflammation	I
.	O

8	O
.	O
malnutrition	B
-	O
moderate	O
degree	O
.	O

9	O
.	O
delirium	B
.	O

10	O
.	O

reactive	B
thrombocytosis	I
.	O

secondary	O
:	O

1	O
.	O
s	O
/	O
p	O
left	O
hip	O
orif	O
c	O
/	O
b	O
osteomyelitis	B
1970	O
.	O

2	O
.	O
recurrent	O
osteomyelitis	B
left	O
hip	O
,	O
4	O
/	O
2006	O
.	O

3	O
.	O
depression	B
.	O

4	O
.	O
hyperlipidemia	B
.	O

discharge	O
condition	O
:	O

stable	O
.	O

afebrile	B
.	O

tolerating	O
po	O
.	O

discharge	O
instructions	O
:	O

you	O
were	O
admitted	O
to	O
the	O
hospital	O
for	O
an	O
infection	B
in	O
your	O
brain	O
called	O
hsv	B
encephalitis	I
.	O

you	O
received	O
a	O
course	O
of	O
antibiotics	O
.	O

during	O
your	O
hospitalization	O
,	O
you	O
also	O
developed	O
pneumonia	B
.	O

this	O
was	O
treated	O
with	O
antibiotics	O
.	O

please	O
return	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
or	O
call	O
your	O
doctor	O
if	O
you	O
have	O
any	O
of	O
the	O
following	O
symptoms	O
:	O
fever	B
>	O
101	O
.	O
5	O
,	O
severe	B
pain	I
,	O
difficulty	B
breathing	I
,	O
intractable	O
nausea	B
/	O
vomiting	B
or	O
any	O
other	O
concerning	O
symptoms	B
.	O

please	O
take	O
all	O
medications	O
as	O
prescribed	O
.	O

please	O
follow	O
-	O
up	O
with	O
all	O
appointments	O
as	O
scheduled	O
.	O

followup	O
instructions	O
:	O

1	O
.	O
check	O
albumin	O
and	O
dilantin	O
level	O
2	O
days	O
from	O
discharge	O
.	O

adjust	O
dilantin	O
dose	O
as	O
needed	O
,	O
then	O
check	O
weekly	O
when	O
therapeutic	O
(	O
~15	O
-	O
20	O
)	O
.	O

2	O
.	O
check	O
phosphate	O
.	O

3	O
.	O
check	O
blood	O
sugars	O
and	O
give	O
insulin	O
per	O
sliding	O
scale	O
.	O

3	O
.	O
please	O
make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
5946	O
*	O
*	O
]	O
after	O
you	O
are	O
discharged	O
from	O
the	O
extended	O
care	O
facility	O
.	O

you	O
can	O
call	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
5947	O
*	O
*	O
]	O
to	O
make	O
the	O
appointment	O
.	O

4	O
.	O
the	O
patient	O
will	O
need	O
to	O
follow	O
-	O
up	O
with	O
a	O
neurologist	O
in	O
in	O
4	O
weeks	O
.	O

he	O
can	O
call	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
3236	O
*	O
*	O
]	O
to	O
make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1643	O
*	O
*	O
]	O
.	O

alternatively	O
,	O
he	O
can	O
be	O
seen	O
by	O
the	O
neurologist	O
at	O
[	O
*	O
*	O
hospital1	O
707	O
*	O
*	O
]	O
.	O

5	O
.	O
repeat	O
eeg	O
in	O
one	O
month	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
242	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
243	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
63	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1668	O
*	O
*	O
]	O
[	O
*	O
*	O
2019	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
@	O
1718	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2019	O
-	O
02	O
-	O
05	O
*	O
*	O
]	O
9	O
:	O
27	O
pm	O

(	O
end	O
of	O
report	O
)	O

19624	O
||||	O
5163	O
||||	O
5084	O
||||	O
discharge	O
_	O
summary	O
||||	O
2010	O
-	O
12	O
-	O
31	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2010	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2010	O
-	O
12	O
-	O
31	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1984	O
-	O
05	O
-	O
21	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
44	O
*	O
*	O
]	O

this	O
is	O
an	O
addendum	O
to	O
the	O
previous	O
dictation	O
covering	O
the	O
dates	O
[	O
*	O
*	O
2010	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
to	O
[	O
*	O
*	O
2010	O
-	O
12	O
-	O
26	O
*	O
*	O
]	O
.	O

hospital	O
course	O
:	O
1	O
.	O
pneumonia	B
-	O
the	O
patient	O
completed	O
a	O
21	O
day	O
course	O
of	O
azithromycin	O
.	O

the	O
patient	O
had	O
been	O
intubated	O
on	O
[	O
*	O
*	O
2010	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
.	O

initially	O
the	O
patient	O
was	O
difficult	O
to	O
wean	O
from	O
the	O
vent	O
secondary	O
to	O
issues	O
of	O
anxiety	B
and	O
agitation	B
.	O

originally	O
the	O
plan	O
was	O
made	O
for	O
tracheostomy	O
in	O
the	O
operating	O
room	O
by	O
the	O
interventional	O
pulmonary	O
staff	O
.	O

the	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
[	O
*	O
*	O
2010	O
-	O
12	O
-	O
29	O
*	O
*	O
]	O
for	O
rigid	O
bronchoscopy	O
and	O
laryngoscopy	O
.	O

at	O
that	O
time	O
tracheostomy	O
was	O
scheduled	O
to	O
be	O
performed	O
.	O

however	O
,	O
tracheostomy	O
was	O
not	O
performed	O
as	O
the	O
interventional	O
pulmonary	O
staff	O
felt	O
that	O
the	O
patient	O
did	O
not	O
have	O
evidence	O
of	O
severe	O
supraglottic	O
or	O
subglottic	B
stenosis	I
and	O
as	O
such	O
they	O
felt	O
that	O
he	O
was	O
a	O
good	O
candidate	O
to	O
be	O
safely	O
extubated	O
.	O

he	O
continued	O
to	O
improve	O
in	O
his	O
respiratory	B
status	I
and	O
was	O
able	O
to	O
be	O
weaned	O
from	O
the	O
ventilator	O
as	O
well	O
as	O
weaned	O
from	O
sedation	O
.	O

he	O
tolerated	O
extubation	O
on	O
[	O
*	O
*	O
2010	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
.	O

at	O
the	O
time	O
of	O
discharge	O
,	O
his	O
arterial	O
blood	O
gases	O
were	O
normalized	O
.	O

he	O
was	O
breathing	O
comfortably	O
as	O
well	O
as	O
saturating	O
in	O
the	O
high	O
90s	O
on	O
room	O
air	O
.	O

4	O
.	O
(	O
addendum	O
)	O
right	O
upper	O
extremity	O
deep	B
vein	I
thrombosis	I
and	O
pulmonary	B
embolus	I
-	O
the	O
patient	O
requires	O
a	O
total	O
of	O
six	O
months	O
of	O
anticoagulation	O
with	O
coumadin	O
for	O
his	O
right	O
upper	O
extremity	O
deep	B
vein	I
thrombosis	I
and	O
subsequent	O
small	O
pulmonary	B
embolus	I
at	O
the	O
left	O
lower	O
lung	O
base	O
.	O

he	O
was	O
initially	O
heparinized	O
during	O
his	O
hospital	O
course	O
but	O
was	O
changed	O
to	O

lovenox	O
and	O
coumadin	O
prior	O
to	O
discharge	O
.	O

he	O
will	O
require	O
daily	O
monitoring	O
of	O
his	O
inr	O
levels	O
as	O
subsequent	O
discontinuation	O
of	O
the	O
lovenox	O
when	O
his	O
inr	O
is	O
greater	O
than	O

2	O
.	O
0	O
.	O

8	O
.	O
(	O
addendum	O
)	O
ophthalmology	O
issues	O
-	O
the	O
patient	O
is	O
to	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
265	O
*	O
*	O
]	O
at	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
266	O
*	O
*	O
]	O
,	O
approximately	O
one	O
week	O
after	O
discharge	O
from	O
the	O
hospital	O
.	O

in	O
the	O
interim	O
,	O
he	O
is	O
to	O
continue	O
his	O
inpatient	O
regimen	O
of	O
ophthalmological	O
ointments	O
as	O
well	O
as	O
eyedrops	O
until	O
he	O
sees	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
265	O
*	O
*	O
]	O
in	O
follow	O
up	O
.	O

condition	O
on	O
discharge	O
:	O
stable	O
,	O
good	O
oxygen	O
saturation	O
on	O
room	O
air	O
.	O

per	O
physical	O
therapy	O
evaluation	O
,	O
the	O
patient	O
would	O
benefit	O
from	O
acute	O
rehabilitation	O
setting	O
.	O

discharge	O
status	O
:	O
the	O
patient	O
was	O
discharged	O
to	O
[	O
*	O
*	O
hospital	O
267	O
*	O
*	O
]	O
hospital	O
.	O

discharge	O
diagnosis	O
:	O

1	O
.	O
mycoplasma	B
pneumonia	I

2	O
.	O
acute	B
respiratory	I
failure	I
requiring	O
intubation	O

3	O
.	O
right	O
upper	O
extremity	O
deep	B
vein	I
thrombosis	I

4	O
.	O
pulmonary	B
embolus	I

5	O
.	O
[	O
*	O
*	O
lastname	O
268	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
10	O
*	O
*	O
]	O
syndrome	O

6	O
.	O
acute	O
respiratory	B
distress	I
syndrome	I

7	O
.	O
ileus	B

8	O
.	O
history	O
of	O
delirium	B

medications	O
on	O
discharge	O
:	O

1	O
.	O
colace	O
100	O
mg	O
one	O
tablet	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

2	O
.	O
tylenol	O
325	O
mg	O
one	O
to	O
two	O
tablets	O
p	O
.	O
o	O
.	O
q	O
.	O

6	O
hours	O
as	O
needed	O
for	O
pain	B
or	O
fever	B

3	O
.	O
reglan	O
10	O
mg	O
one	O
tablet	O
p	O
.	O
o	O
.	O
q	O
.	O
i	O
.	O
d	O
.	O
as	O
needed	O
for	O
nausea	B
or	O
gastrointestinal	B
upset	I

4	O
.	O
tobramycin	O
sulfate	O
/	O
dexamethasone	O
ointment	O
one	O
application	O
each	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
71	O
*	O
*	O
]	O
every	O
other	O
day	O

5	O
.	O
sodium	O
chloride	O
nasal	O
spray	O
,	O
one	O
to	O
two	O
sprays	O
each	O
nostril	O
t	O
.	O
i	O
.	O
d	O
.	O
as	O
needed	O
for	O
nasal	B
dryness	I

6	O
.	O
erythromycin	O
2%	O
solution	O
,	O
one	O
application	O
topically	O
b	O
.	O
i	O
.	O
d	O
.	O
as	O
needed	O
for	O
skin	B
lesion	I
secondary	O
to	O
[	O
*	O
*	O
lastname	O
268	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
10	O
*	O
*	O
]	O
syndrome	O
.	O

7	O
.	O
nystatin	O
100	O
units	O
/	O
ml	O
oral	O
suspension	O
5	O
ml	O
orally	O
four	O
times	O
a	O
day	O
as	O
needed	O
for	O
oral	B
thrush	I
.	O

8	O
.	O
polyvinyl	O
alcohol	O
1	O
.	O
4%	O
eyedrops	O
one	O
drop	O
each	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
71	O
*	O
*	O
]	O
q	O
.	O

6	O
hours	O

9	O
.	O
coumadin	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

10	O
.	O

lovenox	O
80	O
mg	O
one	O
injection	O
subcutaneously	O
q	O
.	O

12	O
hours	O
.	O

please	O
continue	O
until	O
the	O
patient	O
has	O
a	O
therapeutic	O
inr	O
greater	O
than	O
2	O
.	O
0	O
on	O
coumadin	O
,	O
at	O
that	O
time	O
lovenox	O
can	O
be	O
discontinued	O
.	O

11	O
.	O

senna	O
one	O
tablet	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
as	O
needed	O
for	O
constipation	B

12	O
.	O

lanolin	O
/	O
mineral	O
oil	O
/	O
petroleum	O
ointment	O
one	O
application	O
each	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
71	O
*	O
*	O
]	O
as	O
needed	O

13	O
.	O

bacitracin	O
polymyxin	O
sulfate	O
1	O
application	O
topically	O
q	O
.	O

6	O
hours	O
as	O
needed	O
for	O
the	O
next	O
seven	O
days	O
.	O

follow	O
up	O
plan	O
:	O
the	O
patient	O
is	O
to	O
follow	O
up	O
with	O
his	O
primary	O
care	O
physician	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
269	O
*	O
*	O
]	O
,	O
at	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
270	O
*	O
*	O
]	O
upon	O
discharge	O
from	O
the	O
rehabilitation	O
facility	O
.	O

additionally	O
he	O
should	O
call	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
265	O
*	O
*	O
]	O
from	O
ophthalmology	O
at	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
266	O
*	O
*	O
]	O
to	O
schedule	O
a	O
follow	O
up	O
appointment	O
.	O

ideally	O
he	O
should	O
be	O
seen	O
within	O
the	O
next	O
seven	O
to	O
ten	O
days	O
.	O

he	O
is	O
to	O
continue	O
all	O
of	O
his	O
ophthalmological	O
treatments	O
until	O
that	O
time	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
271	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
272	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
273	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
274	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2010	O
-	O
12	O
-	O
31	O
*	O
*	O
]	O
13	O
:	O
04	O

t	O
:	O
[	O
*	O
*	O
2010	O
-	O
12	O
-	O
31	O
*	O
*	O
]	O
12	O
:	O
11	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
275	O
*	O
*	O
]	O

cc	O
:	O
[	O
*	O
*	O
cc	O
contact	O
info	O
276	O
*	O
*	O
]	O

10331	O
||||	O
5382	O
||||	O
29506	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
06	O
-	O
23	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
06	O
-	O
16	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
06	O
-	O
23	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1964	O
-	O
08	O
-	O
19	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

roxicet	O
/	O
penicillins	O
/	O
aspirin	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
2352	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

lethargy	B
and	O
hypotension	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

trach	O
change	O

history	O
of	O
present	O
illness	O
:	O

50	O
y	O
/	O
o	O
male	O
with	O
a	O
h	O
/	O
o	O
squamous	B
cell	I
cancer	I
of	O
vallecula	O
s	O
/	O
p	O
xrt	O
and	O
tonsillar	B
cancer	I
w	O
/	O
recent	O
initiation	O
of	O
xrt	O
and	O
chemo	O
,	O
history	O
of	O
cirrohsis	B
,	O
history	O
of	O
seizure	B
disorder	I
on	O
meds	O
,	O
history	O
of	O
trach	O
and	O
peg	O
,	O
who	O
is	O
transferred	O
from	O
[	O
*	O
*	O
hospital	O
707	O
*	O
*	O
]	O
rehab	O
with	O
lethargy	B
and	O
hypotension	B
.	O

he	O
had	O
recent	O
admission	O
[	O
*	O
*	O
date	O
range	O
(	O
1	O
)	O
2353	O
*	O
*	O
]	O
for	O
2nd	O
cycle	O
of	O
chemo	O
/	O
xrt	O
which	O
involved	O
continued	O
treatment	O
of	O
a	O
pneumonia	B
that	O
had	O
been	O
diagnosed	O
at	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
rehab	O
.	O

his	O
sputum	O
grew	O
multidrug	O
resistant	O
klebsiella	O
so	O
abx	O
were	O
changed	O
to	O
meropenem	O
and	O
discharged	O
to	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
rehab	O
and	O
completed	O
course	O
on	O
[	O
*	O
*	O
2015	O
-	O
06	O
-	O
10	O
*	O
*	O
]	O
.	O

prior	O
to	O
this	O
admission	O
,	O
per	O
family	O
and	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
records	O
pt	O
has	O
been	O
noted	O
to	O
have	O
lethargy	B
and	O
over	O
the	O
past	O
few	O
days	O
with	O
sbp's	O
in	O
the	O
80's	O
.	O

this	O
time	O
she	O
states	O
he	O
finished	O
the	O
meropenem	O
on	O
[	O
*	O
*	O
06	O
-	O
10	O
*	O
*	O
]	O
and	O
on	O
[	O
*	O
*	O
06	O
-	O
12	O
*	O
*	O
]	O
he	O
became	O
more	O
lethargic	B
and	O
then	O
[	O
*	O
*	O
06	O
-	O
13	O
*	O
*	O
]	O
began	O
bringing	O
up	O
more	O
sputum	O
from	O
his	O
trach	O
.	O

she	O
states	O
he	O
has	O
not	O
been	O
tolerating	O
tube	O
feeds	O
for	O
the	O
few	O
days	O
pta	O
(	O
was	O
having	O
nausea	B
and	O
vomiting	B
)	O
and	O
so	O
these	O
have	O
been	O
held	O
for	O
most	O
of	O
the	O
weekend	O
.	O

ivf	O
were	O
also	O
held	O
over	O
the	O
past	O
few	O
days	O
.	O

she	O
states	O
at	O
baseline	O
(	O
when	O
he	O
is	O
on	O
abx	O
)	O
he	O
is	O
up	O
and	O
walking	O
around	O
and	O
able	O
to	O
care	O
for	O
his	O
g	O
tube	O
on	O
his	O
own	O
.	O

he	O
used	O
to	O
be	O
able	O
to	O
talk	O
with	O
a	O
passey	O
muir	O
valve	O
,	O
but	O
last	O
week	O
his	O
trach	O
was	O
downsized	O
to	O
a	O
smaller	O
one	O
that	O
does	O
not	O
allow	O
him	O
to	O
talk	O
.	O

this	O
has	O
been	O
very	O
frustrating	O
to	O
him	O
.	O

on	O
arrival	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
bp	O
was	O
90	O
/	O
58	O
but	O
then	O
dropped	O
to	O
74	O
/	O
41	O
.	O

4l	O
of	O
ns	O
were	O
hung	O
but	O
the	O
patient	O
only	O
received	O
approx	O
1l	O
ns	O
before	O
being	O
transferred	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
154	O
*	O
*	O
]	O
.	O

on	O
arrival	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
number	O
2354	O
*	O
*	O
]	O
was	O
135	O
/	O
75	O
.	O

in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
he	O
received	O
cefepime	O
1g	O
iv	O
,	O
vancomycin	O
1gm	O
iv	O
.	O

wife	O
states	O
pt	O
has	O
had	O
difficulty	O
with	O
edema	B
in	O
his	O
legs	O
in	O
the	O
past	O
,	O
and	O
thus	O
ns	O
boluses	O
were	O
stopped	O
and	O
pt	O
was	O
placed	O
on	O
d5ns	O
at	O
75	O
hour	O
x	O
1l	O
.	O

he	O
is	O
now	O
stabilized	O
in	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
154	O
*	O
*	O
]	O
and	O
transferred	O
to	O
the	O
floor	O
.	O

[	O
*	O
*	O
hospital	O
unit	O
name	O
154	O
*	O
*	O
]	O
course	O
:	O

-	O
id	O
-	O
his	O
was	O
found	O
to	O
have	O
mrsa	B
and	O
resistent	O
klebsiella	B
on	O
sputum	O
.	O

id	O
was	O
also	O
consulted	O
.	O

his	O
abx	O
was	O
changed	O
to	O
meropenem	O
and	O
vancomycin	O
.	O

this	O
was	O
c	O
/	O
b	O
leukopenia	B
likely	O
[	O
*	O
*	O
04	O
-	O
10	O
*	O
*	O
]	O
to	O
meropenem	O
.	O

his	O
wbc	O
has	O
been	O
decreasing	O
from	O
4k	O
to	O
1	O
.	O
6k	O
today	O
.	O
-	O
pulm	O
-	O
given	O
his	O
sputum	O
and	O
sig	O
sputum	O
and	O
infection	B
,	O
his	O
trach	O
was	O
upsized	O
to	O
facilitate	O
suction	O
.	O
-	O
heme	O
-	O
his	O
was	O
found	O
to	O
have	O
clot	B
in	O
left	O
subclavin	O
during	O
flouro	O
for	O
picc	O
.	O

this	O
was	O
c	O
/	O
b	O
low	B
plt	I
?	O

hit	B
.	O

this	O
returned	O
neg	O
and	O
was	O
started	O
lovenox	O
as	O
a	O
bridge	O
to	O
coumadin	O
.	O

past	O
medical	O
history	O
:	O

-	O
squamous	B
cell	I
cancer	I
of	O
the	O
vallecula	O
that	O
was	O
diagnosed	O
in	O
[	O
*	O
*	O
2008	O
*	O
*	O
]	O
(	O
t2n0m0	O
)	O
.	O

he	O
was	O
initially	O
treated	O
with	O
radiation	O
.	O

pt	O
later	O
presented	O
with	O
dysphagia	B
and	O
ct	O
of	O
his	O
neck	O
revealed	O
that	O
he	O
had	O

a	O
2	O
.	O
8	O
x2	O
.	O
1	O
x	O
4	O
.	O
5	O
cm	O
right	O
tonisillar	O
mass	B
,	O
unresectable	O
tonsil	B
cancer	I
,	O
which	O
could	O
be	O
palliated	O
with	O
systemic	O
chemotherapy	O
and	O
/	O
or	O
xrt	O
or	O
a	O
combination	O
of	O
both	O
.	O

xrt	O
and	O
chemo	O
(	O
taxol	O
/	O
cddp	O
)	O

initiated	O
in	O
2	O
/	O
07	O
.	O

-	O
alcoholic	B
cirrhosis	I

-	O
seizure	B
d	I
/	I
o	I
-	O
last	O
sz	B
>	O
2y	O
ago	O

-	O
psoriasis	B

-	O
g	O
tube	O
placed	O
[	O
*	O
*	O
01	O
-	O
12	O
*	O
*	O
]	O
[	O
*	O
*	O
04	O
-	O
10	O
*	O
*	O
]	O
failure	O
of	O
swallow	O
test	O
-	O
pancreatitis	B
secondary	O
to	O
etoh	O

-	O
hepatic	B
encephalopathy	I

-	O
bleeding	B
esophageal	I
varices	I

-	O
portal	B
vein	I
thrombosis	I

social	O
history	O
:	O

lives	O
with	O
his	O
wife	O
,	O
although	O
he	O
has	O
been	O
in	O
[	O
*	O
*	O
hospital1	O
707	O
*	O
*	O
]	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
and	O
more	O
recently	O
in	O
acute	O
rehab	O
at	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
rehab	O
for	O
the	O
past	O
[	O
*	O
*	O
04	O
-	O
11	O
*	O
*	O
]	O
months	O
.	O

former	O
etoh	O
.	O

former	O
smoking	O
.	O

family	O
history	O
:	O

brother	O
died	O
of	O
cad	B
at	O
age	O
34	O
.	O

physical	O
exam	O
:	O

vitals	O
:	O
99	O
.	O
3	O
,	O
80	O
,	O
135	O
/	O
75	O
,	O
18	O
,	O
93%	O
on	O
6l	O
trach	O
mask	O
,	O
increased	O
to	O
97%	O
s	O
/	O
p	O
suctioning	O
and	O
placement	O
on	O
35%	O
o2	O
via	O
trach	O
mask	O
.	O

general	O
:	O
50m	O
in	O
nad	B
,	O
appears	O
older	O
than	O
stated	O
age	O

heent	O
:	O
nc	O
/	O
at	O
.	O

perrla	O
.	O

eomi	O
.	O

mmm	O
.	O

neck	O
:	O
trach	O
collar	O
in	O
place	O
with	O
beige	O
secretions	O
.	O

cv	O
:	O
normal	O
s1	O
,	O
s2	O
without	O
m	B
/	O
r	B
/	O
g	B
.	O

pulm	O
:	O
coarse	B
breath	I
sounds	I
b	O
/	O
l	O
,	O
otw	O
ctab	O
.	O

abd	O
:	O
soft	O
,	O
nt	O
/	O
nd	O
with	O
normoactive	O
bs	O
.	O

peg	O
tube	O
in	O
place	O
,	O
c	O
/	O
d	O
/	O
i	O
.	O

ext	O
:	O
no	O
c	B
/	O
c	B
/	O
e	B
.	O
psoriasis	B
on	O
b	O
/	O
l	O
ue	O
and	O
le	O
.	O

neuro	O
:	O
pt	O
not	O
talking	O
,	O
but	O
nodding	O
head	O
appropriately	O
.	O

pertinent	O
results	O
:	O

head	O
ct	O
without	O
contrast	O
:	O
there	O
is	O
no	O
intra	O
-	O
or	O
extra	B
-	I
axial	I
hemorrhage	I
,	O
mass	B
effect	I
,	O
shift	O
of	O
normally	O
midline	O
structures	O
,	O
or	O
hydrocephalus	B
.	O

there	O
is	O
no	O
major	O
or	O
minor	O
vascular	O
territorial	O
infarction	B
.	O

the	O
differentiation	O
of	O
the	O
gray	O
-	O
white	O
matter	O
is	O
preserved	O
.	O

density	O
values	O
of	O
brain	O
parenchyma	O
are	O
within	O
normal	O
limits	O
.	O

the	O
surrounding	O
soft	O
tissues	O
and	O
osseous	O
structures	O
are	O
unremarkable	O
.	O

impression	O
:	O
no	O
evidence	O
of	O
acute	O
intra	O
-	O
or	O
extra	B
-	I
axial	I
hemorrhage	I
.	O

no	O
change	O
compared	O
to	O
[	O
*	O
*	O
2010	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O

portable	O
ap	O
chest	O
dated	O
[	O
*	O
*	O
2015	O
-	O
06	O
-	O
15	O
*	O
*	O
]	O
is	O
compared	O
to	O
the	O
prior	O
pa	O
and	O
lateral	O
from	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
25	O
*	O
*	O
]	O
.	O

tracheostomy	O
tube	O
is	O
seen	O
terminating	O
in	O
the	O
mid	O
trachea	O
,	O
good	O
and	O
stable	O
position	O
.	O

a	O
right	O
picc	O
line	O
terminates	O
in	O
the	O
mid	O
axillary	O
line	O
.	O

the	O
heart	O
size	O
is	O
normal	O
.	O

the	O
pulmonary	O
vasculature	O
is	O
normal	O
.	O

the	O
hilar	O
contours	O
are	O
stable	O
.	O

the	O
lungs	O
are	O
clear	O
.	O

there	O
is	O
no	O
pleural	B
effusion	I
or	O
pneumothorax	B

impression	O
:	O
no	O
evidence	O
for	O
infiltrate	B
.	O

brief	O
hospital	O
course	O
:	O

50	O
y	O
/	O
o	O
male	O
with	O
a	O
h	O
/	O
o	O
squamous	B
cell	I
cancer	I
of	O
vallecula	O
s	O
/	O
p	O
xrt	O
and	O
tonsillar	B
cancer	I
s	O
/	O
p	O
recent	O
chemo	O
/	O
xrt	O
and	O
recent	O
klebsiella	B
pna	I
admitted	O
with	O
recurrent	O
lethargy	B
and	O
increased	B
sputum	I
:	O

#	O
lethargy	B
and	O
increased	B
sputum	I
:	O
likely	O
[	O
*	O
*	O
04	O
-	O
10	O
*	O
*	O
]	O
recurrent	O
tracheo	B
-	I
bronchitis	I
,	O
treated	O
with	O
antibiotics	O
initially	O
given	O
poor	O
baseline	O
.	O

resp	O
therapist	O
noted	O
that	O
trach	O
plug	O
smelled	O
like	O
pseudomonas	O
.	O

pt	O
has	O
been	O
in	O
rehabs	O
/	O
hospitals	O
for	O
last	O
several	O
months	O
and	O
has	O
been	O
exposed	O
to	O
many	O
drug	O
-	O
resistant	O
organisms	O
.	O

however	O
,	O
positive	O
cultures	O
(	O
mrsa	O
,	O
esbl	O
klebsiella	O
)	O
may	O
represent	O
colonization	B
rather	O
than	O
true	O
infection	B
.	O

abx	O
stopped	O
on	O
[	O
*	O
*	O
06	O
-	O
20	O
*	O
*	O
]	O
and	O
clinically	O
well	O
-	O
appearing	O
,	O
with	O
no	O
fevers	B
.	O

-	O
wbc	O
continues	O
to	O
be	O
low	O
,	O
possibly	O
from	O
meropenem	O
;	O
trending	O
up	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
and	O
received	O
dose	O
of	O
neupogen	O
yesterday	O
-	O
trach	O
changed	O
[	O
*	O
*	O
06	O
-	O
17	O
*	O
*	O
]	O
,	O
still	O
with	O
thick	O
secretions	O
but	O
strong	O
cough	B
-	O
continue	O
airway	O
humidification	O
as	O
much	O
as	O
possible	O
to	O
help	O
break	O
up	O
secretions	O
-	O
pt	O
should	O
not	O
have	O
his	O
trach	O
downsized	O
in	O
the	O
near	O
future	O
,	O
even	O
at	O
rehab	O
due	O
to	O
problems	O
with	O
secretions	O
accumulating	O
and	O
infections	B

-	O
picc	O
changed	O
and	O
replaced	O
(	O
see	O
below	O
)	O

#	O
hypotension	B
:	O
likely	O
from	O
dehydration	B
given	O
that	O
wife	O
reports	O
tube	O
feeds	O
and	O
ivf	O
have	O
been	O
held	O
x	O
4	O
days	O
.	O

pt	O
responded	O
quickly	O
to	O
1l	O
ns	O
and	O
now	O
is	O
normotensive	B
.	O

initially	O
gave	O
d5ns	O
at	O
75	O
per	O
hour	O
until	O
tf	O
restarted	O
.	O
(	O
family	O
gives	O
history	O
of	O
extensive	O
le	B
edema	I
which	O
is	O
now	O
not	O
present	O
but	O
do	O
not	O
wish	O
to	O
overload	O
with	O
fluids	O
)	O
.	O

-	O
continues	O
to	O
be	O
normotensive	B
,	O
no	O
further	O
ivf	O
needed	O
for	O
now	O
-	O
should	O
have	O
airway	O
humidification	O
as	O
much	O
as	O
possible	O
to	O
avoid	O
dehydration	B
through	O
trach	O

#	O
left	O
subclavian	O
vein	O
dvt	B
:	O
detected	O
under	O
fluoro	O
for	O
picc	O
placement	O
;	O
not	O
started	O
on	O
heparin	O
overnight	O
due	O
to	O
concern	O
for	O
hit	B
;	O
however	O
,	O
on	O
discussion	O
with	O
heme	O
/	O
onc	O
,	O
pt	O
previously	O
worked	O
up	O
for	O
hit	B
and	O
has	O
intermittent	O
thrombocytopenia	B
-	O
bridge	O
to	O
coumadin	O
with	O
lovenox	O
(	O
coumadin	O
started	O
[	O
*	O
*	O
06	O
-	O
19	O
*	O
*	O
]	O
)	O

#	O
elevated	B
cr	I
:	O
only	O
slightly	O
elevated	O
to	O
1	O
.	O
2	O
(	O
baseline	O
0	O
.	O
7	O
)	O
on	O
admission	O
.	O

likely	O
from	O
dehydration	B
.	O

creat	O
down	O
with	O
hydration	O
.	O

#	O
onc	O
:	O
2	O
primary	O
head	O
and	O
neck	O
cancers	B
.	O

-	O
plan	O
per	O
oncology	O
team	O

#	O
psoriasis	B
-	O
cont	O
on	O
clobetasol	O
cream	O
.	O

#	O
cirrhosis	B
-	O
cont	O
lactulose	O
and	O
nadolol	O
.	O

lft's	O
at	O
baseline	O
.	O

#	O
seizure	B
disorder	I
-	O
cont	O
keppra	O
and	O
dilantin	O
.	O

dilantin	O
level	O
15	O
.	O
9	O
in	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
.	O
(	O
therapeutic	O
is	O
[	O
*	O
*	O
12	O
-	O
26	O
*	O
*	O
]	O
)	O
.	O

check	O
dilantin	O
level	O
as	O
may	O
be	O
interfering	O
with	O
wbc	O
.	O

#	O
fen	O
-	O
tube	O
feeds	O
,	O
will	O
change	O
to	O
bolus	O
.	O

cont	O
reglan	O
and	O
use	O
ativan	O
and	O
compazine	O
prn	O
nausea	B
.	O

#	O
access	O
:	O
has	O
picc	O
(	O
needs	O
tpa	O
)	O
and	O
peripherals	O
.	O

#	O
code	O
:	O
full	O
,	O
discussed	O
with	O
patient	O

medications	O
on	O
admission	O
:	O

-	O
dilantin	O
100mg	O
per	O
gt	O
q8am	O
and	O
qnoon	O
,	O
200mg	O
per	O
gt	O
q8pm	O
-	O
methadone	O
10mg	O
per	O
gt	O
tid	O

-	O
compazine	O
10mg	O
per	O
gt	O
q8	O

-	O
reglan	O
10mg	O
per	O
gt	O
q6	O

-	O
atrovent	O
nebs	O
q6	O

-	O
albuterol	O
nebs	O
q6	O

-	O
nadolol	O
20mg	O
daily	O

-	O
scopolamine	O
patch	O
1	O
.	O
5	O
td	O
q3	O
days	O

-	O
lactulose	O
30mg	O
tid	O

-	O
mucomyst	O
into	O
trach	O
bid	O

-	O
chlorhexidine	O
15ml	O
swish	O
and	O
spit	O
tid	O

-	O
clobetasol	O
0	O
.	O
05%	O
cream	O
bid	O
apply	O
to	O
upper	O
arms	O
-	O
clonidine	O
0	O
.	O
1mg	O
per	O
gt	O
qhs	O
-	O
gabapentin	O
300mg	O
po	O
q8am	O
and	O
q2pm	O
,	O
600mg	O
qhs	O
-	O
simethicone	O
80mg	O
qid	O

-	O
omeprazole	O
20mg	O
daily	O

-	O
tylenol	O
prn	O

-	O
dilaudid	O
4mg	O
q4	O
prn	O

-	O
ambien	O
5mg	O
qhs	O
prn	O

-	O
ativan	O
1mg	O
q6	O
prn	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

pneumonia	B

discharge	O
condition	O
:	O

stable	O

discharge	O
instructions	O
:	O

please	O
follow	O
up	O
with	O
the	O
doctor	O
at	O
your	O
facility	O
.	O

he	O
will	O
need	O
to	O
check	O
your	O
blood	O
to	O
determine	O
when	O
you	O
can	O
stop	O
the	O
lovenox	O
shots	O
.	O

please	O
continue	O
the	O
full	O
course	O
of	O
antibiotc	O
meropenem	O
as	O
prescribed	O
.	O

followup	O
instructions	O
:	O

provider	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2355	O
*	O
*	O
]	O
,	O
md	O
phone	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
115	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2015	O
-	O
06	O
-	O
30	O
*	O
*	O
]	O
2	O
:	O
00	O

provider	O
:	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2356	O
*	O
*	O
]	O
,	O
md	O
,	O
phd	O
phone	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
594	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2015	O
-	O
06	O
-	O
30	O
*	O
*	O
]	O
2	O
:	O
00	O

provider	O
:	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
1095	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2357	O
*	O
*	O
]	O
,	O
md	O
phone	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
25	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2015	O
-	O
07	O
-	O
30	O
*	O
*	O
]	O
11	O
:	O
45	O

[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2356	O
*	O
*	O
]	O
md	O
,	O
phd	O
12	O
-	O
arf	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
189	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1367	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1368	O
*	O
*	O
]	O
[	O
*	O
*	O
2015	O
-	O
06	O
-	O
30	O
*	O
*	O
]	O
@	O
1729	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
r	O
jain	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
75	O
*	O
*	O
]	O
[	O
*	O
*	O
2015	O
-	O
08	O
-	O
06	O
*	O
*	O
]	O
1	O
:	O
57	O
pm	O
(	O
end	O
of	O
report	O
)	O

274	O
||||	O
5837	O
||||	O
21754	O
||||	O
discharge	O
_	O
summary	O
||||	O
2009	O
-	O
08	O
-	O
17	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2009	O
-	O
08	O
-	O
16	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2009	O
-	O
08	O
-	O
17	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1984	O
-	O
07	O
-	O
31	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
tulles	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
a	O
25	O
year	O
old	O
male	O
without	O
significant	O
past	O
medical	O
history	O
who	O
was	O
found	O
unresponsive	B
outside	O
his	O
home	O
on	O
the	O
morning	O
of	O
admission	O
after	O
having	O
taken	O
gamma	O
-	O
hydroxybutyrate	O
in	O
the	O
context	O
of	O
mild	O
alcohol	B
use	I
the	O
night	O
prior	O
to	O
admission	O
while	O
at	O
a	O
club	O
.	O

his	O
friends	O
found	O
him	O
unresponsive	B
.	O

the	O
patient	O
reported	O
drinking	O
a	O
small	O
amount	O
of	O
gamma	O
-	O
hydroxybutyrate	O
,	O
being	O
in	O
a	O
club	O
drinking	O
several	O
alcoholic	O
drinks	O
,	O
left	O
the	O
club	O
feeling	B
tired	I
.	O

had	O
drank	O
one	O
red	O
bolt	O
drink	O
,	O
a	O
nonalcoholic	O
,	O
high	O
caffeine	O
beverage	O
and	O
then	O
left	O
.	O

he	O
was	O
driving	O
home	O
,	O
took	O
another	O
sip	O
of	O
gamma	O
-	O
hydroxybutyrate	O
and	O
immediately	O
felt	O
extremely	O
tired	O
and	O
unable	B
to	I
drive	I
further	O
.	O

he	O
got	O
into	O
the	O
passenger	O
seat	O
of	O
the	O
car	O
and	O
his	O
friend	O
took	O
over	O
driving	O
.	O

the	O
patient	O
has	O
no	O
further	O
recollection	B
after	O
this	O
.	O

his	O
friends	O
dropped	O
him	O
off	O
at	O
the	O
curb	O
outside	O
his	O
house	O
.	O

his	O
wife	O
heard	O
him	O
,	O
called	O
an	O
ambulance	O
and	O
he	O
was	O
brought	O
to	O
wood	O
[	O
*	O
*	O
hospital	O
428	O
*	O
*	O
]	O
hospital	O
.	O

vitals	O
showed	O
heart	O
rate	O
of	O
89	O
,	O
blood	O
pressure	O
172	O
/	O
86	O
,	O
o2	O
sat	O
77%	O
.	O

he	O
received	O
2	O
mg	O
of	O
versed	O
and	O
10	O
mg	O
of	O
pavulon	O
and	O
was	O
intubated	O
.	O

tox	O
screen	O
at	O
wood	O
was	O
negative	O
for	O
alcohol	O
,	O
positive	O
for	O
cocaine	O
.	O

the	O
patient	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
461	O
*	O
*	O
]	O
for	O
further	O
evaluation	O
and	O
management	O
.	O

of	O
note	O
,	O
the	O
patient	O
admits	O
to	O
trying	O
cocaine	O
on	O
friday	O
evening	O
,	O
the	O
25th	O
.	O

he	O
claims	O
this	O
was	O
his	O
first	O
episode	O
of	O
cocaine	O
use	O
ever	O
.	O

at	O
[	O
*	O
*	O
hospital	O
108	O
*	O
*	O
]	O
the	O
patient	O
was	O
agitated	B
with	O
blood	O
pressure	O
of	O
170	O
/	O
110	O
.	O

he	O
received	O
ativan	O
for	O
sedation	O
.	O

he	O
was	O
given	O
nitroglycerin	O
which	O
was	O
eventually	O
weaned	O
off	O
while	O
still	O
in	O
the	O
e	O
.	O
d	O
.	O
in	O
the	O
icu	O
the	O
patient	O
became	O
gradually	O
more	O
alert	B
without	O
agitation	B
.	O

he	O
was	O
following	O
commands	O
appropriately	O
and	O
demonstrating	O
spontaneous	O
respirations	O
.	O

he	O
was	O
changed	O
to	O
pressor	O
support	O
of	O
5	O
/	O
5	O
on	O
which	O
he	O
did	O
very	O
well	O
with	O
good	O
tidal	O
volumes	O
of	O
600	O
to	O
700	O
cc	O
.	O

he	O
was	O
extubated	O
at	O
11	O
:	O
15	O
a	O
.	O
m	O
.	O
on	O
the	O
26th	O
.	O

denied	O
any	O
chest	B
pain	I
.	O

past	O
medical	O
history	O
:	O
none	O
.	O

medications	O
:	O
none	O
.	O

in	O
discussion	O
with	O
the	O
family	O
he	O
was	O
using	O
insulin	O
as	O
part	O
of	O
his	O
body	O
building	O
regimen	O
.	O

has	O
a	O
history	O
of	O
cycling	B
anabolic	I
steroids	I
.	O

he	O
takes	O
creatinolfosfate	O
as	O
well	O
as	O
ibuprofen	O
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

family	O
history	O
:	O
not	O
significant	O
.	O

social	O
history	O
:	O
he	O
is	O
married	O
,	O
has	O
a	O
small	O
child	O
.	O

wife	O
denies	O
he	O
has	O
any	O
prior	O
history	O
of	O
drug	B
abuse	I
.	O

she	O
reports	O
he	O
does	O
not	O
consume	O
a	O
large	O
amount	O
of	O
alcohol	O
,	O
maybe	O
two	O
to	O
three	O
drinks	O
in	O
a	O
social	O
setting	O
.	O

anabolic	O
steroids	O
and	O
insulin	O
use	O
as	O
mentioned	O
above	O
.	O

the	O
patient	O
also	O
notes	O
he	O
had	O
used	O
gamma	O
-	O
hydroxybutyrate	O
several	O
times	O
after	O
working	O
out	O
to	O
help	O
him	O
sleep	O
,	O
but	O
he	O
claims	O
this	O
is	O
his	O
first	O
episode	O
using	O
it	O
in	O
a	O
party	O
setting	O
.	O

physical	O
examination	O
:	O
vitals	O
were	O
heart	O
rate	O
of	O
112	O
,	O
blood	O
pressure	O
124	O
/	O
56	O
,	O
temperature	O
96	O
.	O
9	O
.	O

in	O
general	O
,	O
he	O
was	O
well	O
developed	O
,	O
following	O
commands	O
,	O
moving	O
all	O
four	O
extremities	O
,	O
breathing	O
easily	O
.	O

sclerae	O
were	O
anicteric	B
.	O

pupils	O
were	O
minimally	O
reactive	O
.	O

moist	O
mucous	O
membranes	O
,	O
no	O
oral	O
lesions	B
.	O

neck	O
was	O
supple	O
,	O
no	O
lymphadenopathy	B
,	O
no	O
jvd	B
.	O

heart	O
was	O
tachy	B
,	O
regular	O
s1	O
,	O
s2	O
with	O
no	O
murmurs	B
,	O
rubs	B
or	O
gallops	B
.	O

lungs	O
showed	O
coarse	B
breath	I
sounds	I
throughout	O
.	O

abdomen	O
was	O
soft	O
,	O
nontender	O
,	O
nondistended	O
.	O

extremities	O
showed	O
no	O
clubbing	B
,	O
cyanosis	B
or	O
edema	B
,	O
2	O
+	O
distal	O
pulses	O
.	O

tattoo	B
over	O
right	O
deltoid	O
and	O
over	O
back	O
.	O

laboratory	O
data	O
:	O
labs	O
from	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
1131	O
*	O
*	O
]	O
showed	O
white	O
count	O
of	O
8	O
.	O
8	O
,	O
hematocrit	O
45	O
.	O
9	O
.	O

sodium	O
was	O
141	O
,	O
potassium	O
3	O
.	O
7	O
,	O
chloride	O
100	O
,	O
bicarb	O
24	O
,	O
bun	O
18	O
,	O
creatinine	O
1	O
.	O
1	O
,	O
glucose	O
117	O
,	O
calcium	O
8	O
.	O
8	O
.	O

pt	O
12	O
.	O
8	O
,	O
inr	O
1	O
.	O
0	O
,	O
ptt	O
27	O
.	O
6	O
.	O

ck	O
599	O
,	O
mb	O
3	O
.	O
2	O
.	O

total	O
cholesterol	O
193	O
.	O

ast	O
27	O
,	O
alt	O
30	O
,	O
ldh	O
27	O
.	O

tox	O
screen	O
was	O
positive	O
for	O
cocaine	O
.	O

negative	O
for	O
alcohol	O
,	O
opiates	O
.	O

ua	O
showed	O
15	O
ketones	O
,	O
3	O
to	O
4	O
red	O
cells	O
,	O
3	O
to	O
4	O
white	O
cells	O
,	O
10	O
to	O
15	O
bacteria	O
,	O
3	O
to	O
10	O
epithelials	O
.	O

initial	O
labs	O
at	O
[	O
*	O
*	O
hospital	O
288	O
*	O
*	O
]	O
showed	O
white	O
count	O
of	O
16	O
.	O
3	O
,	O
hematocrit	O
47	O
.	O
6	O
,	O
platelets	O
307	O
.	O

differential	O
showed	O
92%	O
polys	O
,	O
5	O
.	O
3%	O
lymphs	O
,	O
1	O
.	O
9%	O
monos	O
.	O

chem	O
-	O
7	O
showed	O
sodium	O
of	O
137	O
,	O
potassium	O
not	O
listed	O
,	O
chloride	O
95	O
,	O
bicarb	O
26	O
,	O
bun	O
17	O
,	O
creatinine	O
1	O
.	O
3	O
,	O
glucose	O
127	O
.	O

calcium	O
9	O
.	O
1	O
,	O
phos	O
4	O
.	O
3	O
,	O
mag	O
1	O
.	O
9	O
,	O
albumin	O
4	O
.	O
4	O
.	O

ck	O
was	O
603	O
with	O
mb	O
of	O
3	O
,	O
troponin	O
less	O
than	O

0	O
.	O
3	O
.	O

tox	O
screen	O
positive	O
for	O
cocaine	O
and	O
benzos	O
,	O
however	O
,	O
the	O
patient	O
had	O
received	O
ativan	O
at	O
wood	O
[	O
*	O
*	O
hospital	O
428	O
*	O
*	O
]	O
hospital	O
.	O

lfts	O
and	O
amylase	O
were	O
unremarkable	O
.	O

ua	O
showed	O
15	O
ketones	O
,	O
no	O
cells	O
,	O
few	O
bacteria	O
,	O
3	O
epithelials	O
.	O

ekg	O
at	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
1131	O
*	O
*	O
]	O
showed	O
normal	B
sinus	I
rhythm	I
at	O
80	O
,	O
normal	O
intervals	O
,	O
axis	O
70	O
,	O
t	B
wave	I
inversions	I
in	O
3	O
and	O
avf	O
,	O
t	B
flattening	I
2	O
.	O
at	O
[	O
*	O
*	O
hospital	O
57	O
*	O
*	O
]	O
3	O
1	O
/	O
2	O
hours	O
later	O
ekg	O
showed	O
sinus	B
tach	I
at	O
120	O
,	O
normal	O
intervals	O
,	O
[	O
*	O
*	O
street	O
address	O
726	O
*	O
*	O
]	O
depressions	O
in	O
2	O
,	O
3	O
and	O
avf	O
,	O
t	B
wave	I
inversions	I
in	O
3	O
and	O
avf	O
,	O
no	O
prior	O
study	O
from	O
this	O
hospital	O
available	O
for	O
comparison	O
.	O

chest	O
x	O
-	O
ray	O
showed	O
no	O
cardiomegaly	B
,	O
no	O
effusion	B
,	O
bilateral	B
perihilar	I
haziness	I
,	O
no	O
fractures	B
.	O

head	O
ct	O
showed	O
no	O
acute	O
intracranial	B
hemorrhage	I
,	O
no	O
fractures	B
,	O
small	B
air	I
fluid	I
levels	I
in	O
maxillary	O
and	O
sphenoid	O
sinuses	O
,	O
also	O
mucosal	B
thickening	I
of	O
the	O
ethmoids	O
.	O

echo	O
showed	O
left	O
atrium	O
normal	O
,	O
normal	O
left	O
ventricular	O
wall	O
thickness	O
.	O

cavity	O
size	O
and	O
systolic	O
function	O
were	O
normal	O
.	O

there	O
was	O
no	O
pericardial	B
effusion	I
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
74	O
*	O
*	O
]	O
from	O
wood	O
[	O
*	O
*	O
hospital	O
428	O
*	O
*	O
]	O
hospital	O
where	O
his	O
respiratory	B
status	I
continued	O
to	O
improve	O
.	O

he	O
was	O
extubated	O
without	O
difficulty	O
on	O
11	O
:	O
15	O
a	O
.	O
m	O
.	O
on	O
the	O
26th	O
and	O
the	O
patient	O
was	O
called	O
out	O
to	O
the	O
floor	O
.	O

given	O
his	O
elevated	B
ck	I
on	O
arrival	O
,	O
it	O
was	O
followed	O
during	O
this	O
admission	O
.	O

ckmb	O
and	O
troponin	O
on	O
arrival	O
were	O
603	O
,	O
3	O
,	O
less	O
than	O
0	O
.	O
3	O
.	O

ck	B
trended	I
down	I
from	O
603	O
,	O
429	O
,	O
325	O
,	O
280	O
at	O
6	O
:	O
00	O
a	O
.	O
m	O
.	O
on	O
the	O
27th	O
.	O

mb	O
fraction	O
remained	O
at	O
1	O
.	O

thus	O
the	O
patient	O
ruled	O
out	O
for	O
myocardial	B
infarction	I
.	O

given	O
this	O
patient's	O
history	O
of	O
anabolic	B
steroid	I
abuse	I
,	O
insulin	B
abuse	I
for	O
weight	O
lifting	O
purposes	O
as	O
well	O
as	O
indiscretion	O
with	O
recreational	O
drugs	O
,	O
several	O
conversations	O
were	O
held	O
with	O
the	O
patient	O
about	O
decision	O
making	O
in	O
terms	O
of	O
use	O
of	O
recreational	O
substances	O
and	O
the	O
potential	O
dangers	O
in	O
the	O
use	O
of	O
cocaine	O
and	O
gamma	O
-	O
hydroxybutyrate	O
as	O
well	O
as	O
an	O
attempt	O
to	O
communicate	O
to	O
the	O
patient	O
that	O
he	O
was	O
lucky	O
to	O
have	O
come	O
out	O
of	O
this	O
incident	O
without	O
further	O
deterioration	O
.	O

he	O
was	O
recommended	O
to	O
follow	O
up	O
with	O
a	O
substance	B
abuse	I
counselor	O
,	O
given	O
two	O
numbers	O
for	O
both	O
tri	O
-	O
city	O
substance	B
abuse	I
facility	O
in	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
1132	O
*	O
*	O
]	O
close	O
to	O
his	O
home	O
in	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
1133	O
*	O
*	O
]	O
as	O
well	O
as	O
given	O
the	O
name	O
of	O
[	O
*	O
*	O
doctor	O
first	O
name	O
1134	O
*	O
*	O
]	O
mclean	O
at	O
[	O
*	O
*	O
hospital	O
1135	O
*	O
*	O
]	O
clinic	O
.	O

the	O
patient	O
continued	O
to	O
do	O
well	O
and	O
on	O
the	O
afternoon	O
of	O
the	O
27th	O
felt	O
fine	O
.	O

other	O
than	O
persistent	O
tachycardia	B
felt	O
well	O
and	O
was	O
discharged	O
to	O
home	O
with	O
recommendations	O
that	O
he	O
follow	O
up	O
with	O
his	O
primary	O
care	O
physician	O
as	O
well	O
as	O
seek	O
out	O
counseling	O
for	O
his	O
poor	B
decision	I
making	I
and	O
substance	B
abuse	I
problems	O
.	O

discharge	O
diagnosis	O
:	O
polysubstance	B
overdose	I
.	O

discharge	O
status	O
:	O
to	O
home	O
.	O

condition	O
on	O
discharge	O
:	O
stable	O
.	O

discharge	O
instructions	O
:	O
follow	O
up	O
with	O
pcp	O
and	O
substance	B
abuse	I
counselor	O
.	O

discharge	O
medications	O
:	O
ilotycin	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
90	O
*	O
*	O
]	O
ointment	O
for	O
itchy	B
eyes	O
.	O

mark	O
[	O
*	O
*	O
doctor	O
last	O
name	O
1022	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
1023	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1136	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2009	O
-	O
08	O
-	O
19	O
*	O
*	O
]	O
11	O
:	O
28	O

t	O
:	O
[	O
*	O
*	O
2009	O
-	O
08	O
-	O
23	O
*	O
*	O
]	O
08	O
:	O
38	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
1137	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
48	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
1022	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
56	O
*	O
*	O
]	O
[	O
*	O
*	O
2009	O
-	O
08	O
-	O
27	O
*	O
*	O
]	O
5	O
:	O
32	O
pm	O
(	O
end	O
of	O
report	O
)	O

5003	O
||||	O
6134	O
||||	O
24066	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
07	O
-	O
23	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
20	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
23	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1948	O
-	O
09	O
-	O
10	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
201	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

chest	B
pain	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

cardiac	O
catheterization	O
with	O
rca	O
stent	O
x	O
2	O
placement	O
.	O

history	O
of	O
present	O
illness	O
:	O

64	O
y	O
/	O
o	O
male	O
with	O
h	O
/	O
o	O
cad	B
(	O
s	O
/	O
p	O
5vcabg	O
1996	O
)	O
,	O
htn	B
,	O
and	O
hyperlipidemia	B
who	O
presented	O
with	O
acute	O
onset	O
of	O
cp	B
.	O

patient	O
states	O
that	O
recently	O
he	O
has	O
noticed	O
increasing	O
exertional	B
cp	I
(	O
chest	B
pressure	I
)	O
over	O
the	O
past	O
year	O
.	O

today	O
,	O
around	O
1pm	O
,	O
he	O
developed	O
non	O
-	O
exertional	O
[	O
*	O
*	O
10	O
-	O
01	O
*	O
*	O
]	O
sscp	B
associated	O
with	O
sob	B
and	O
diaphoresis	B
.	O

pt	O
was	O
taken	O
to	O
osh	O
.	O

ekg	O
showed	O
ste	B
in	O
v2	O
,	O
v3	O
,	O
avf	O
and	O
std	B
in	O
v1	O
,	O
avl	O
.	O

pt	O
was	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
23	O
*	O
*	O
]	O
-	O
flighted	O
to	O
[	O
*	O
*	O
hospital1	O
2	O
*	O
*	O
]	O
for	O
cath	O
.	O

in	O
the	O
cath	O
lab	O
,	O
he	O
was	O
found	O
to	O
have	O
occluded	B
svg	I
to	O
d1	O
and	O
rca	O
;	O
patent	O
lima	O
to	O
lad	O
,	O
svg	O
to	O
om1	O
;	O
severe	O
3vd	B
.	O

90%	O
stenosed	B
rca	O
was	O
stented	O
with	O
2	O
overlapping	O
drug	O
eluting	O
stents	O
.	O

mildly	O
elevated	O
r	O
and	O
l	B
sided	I
pressure	I
.	O

normal	O
co	O
/	O
ci	O
.	O

the	O
patient	O
was	O
transferred	O
to	O
the	O
ccu	O
post	O
-	O
cath	O
for	O
further	O
monitoring	O
and	O
managment	O
.	O

in	O
the	O
ccu	O
,	O
pt	O
was	O
asymptomatic	B
without	O
any	O
cp	B
,	O
sob	B
,	O
diaphoresis	B
,	O
nausea	B
,	O
or	O
pain	B
.	O

past	O
medical	O
history	O
:	O

cad	B
(	O
s	O
/	O
p	O
5vcabg	O
[	O
*	O
*	O
2003	O
-	O
12	O
-	O
05	O
*	O
*	O
]	O
)	O

htn	B

hyperlipidemia	I

social	O
history	O
:	O

he	O
lives	O
with	O
his	O
wife	O
.	O
[	O
*	O
*	O
name	O
(	O
ni	O
)	O
*	O
*	O
]	O
denies	O
tobacco	O
,	O
etoh	O
,	O
or	O
ivdu	O
.	O

he	O
is	O
currently	O
unemployed	O
.	O

family	O
history	O
:	O

father	O
died	O
of	O
stroke	B
in	O
70s	O
.	O

sister	O
with	O
rheumatic	B
fever	I
.	O

physical	O
exam	O
:	O

vs	O
:	O
t97	O
.	O
2	O
p77	O
bp	O
141	O
/	O
70	O
rr	O
19	O
99%2l	O

gen	O
:	O
well	O
-	O
appearing	O
,	O
pleasant	O

neck	O
:	O
jvp	B
6cm	O
,	O
no	O
carotid	B
bruits	I

cvs	O
:	O
distant	B
hs	I
,	O
no	O
m	B
/	O
g	B
/	O
r	B

lungs	O
:	O
ctab	O
anteriorly	O

abd	O
:	O
soft	O
,	O
nt	O
,	O
nd	O
,	O
+	O
bs	O

ext	O
:	O
no	O
edema	B

groin	O
:	O
a	O
and	O
v	O
sheaths	O
in	O
place	O
.	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2013	O
-	O
07	O
-	O
20	O
*	O
*	O
]	O
wbc	O
-	O
15	O
.	O
8	O
hct	O
-	O
40	O
.	O
8	O
plt	O
ct	O
-	O
151	O
glucose	O
-	O
144	O
urean	O
-	O
21	O
creat	O
-	O
1	O
.	O
2	O
na	O
-	O
144	O
k	O
-	O
3	O
.	O
9	O
cl	O
-	O
109	O
hco3	O
-	O
21	O
blood	O
asa	O
-	O
neg	O
ethanol	O
-	O
neg	O
acetmnp	O
-	O
neg	O
bnzodzp	O
-	O
neg	O
barbitr	O
-	O
neg	O
tricycl	O
-	O
neg	O

[	O
*	O
*	O
2013	O
-	O
07	O
-	O
20	O
*	O
*	O
]	O
ck	O
1004	O
-	O
-	O
1425	O
-	O
-	O
1	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
5	O
)	O
7421	O
*	O
*	O
]	O
ck	O
-	O
mb	O
178	O
-	O
-	O
139	O
-	O
-	O
94	O
-	O
-	O
33	O
troponin	O
t	O
2	O
.	O
80	O
-	O
-	O
5	O
.	O
70	O
-	O
-	O
6	O
.	O
39	O

[	O
*	O
*	O
2013	O
-	O
07	O
-	O
23	O
*	O
*	O
]	O
wbc	O
-	O
8	O
.	O
8	O
rbc	O
-	O
4	O
.	O
83	O
hgb	O
-	O
15	O
.	O
1	O
hct	O
-	O
43	O
.	O
0	O
mcv	O
-	O
89	O
mch	O
-	O
31	O
.	O
3	O

mchc	O
-	O
35	O
.	O
1	O
*	O
rdw	O
-	O
12	O
.	O
9	O
plt	O
ct	O
-	O
122	O
*	O
glucose	O
-	O
238	O
*	O
urean	O
-	O
14	O
creat	O
-	O
1	O
.	O
1	O
na	O
-	O
139	O
k	O
-	O
3	O
.	O
9	O
cl	O
-	O
101	O
hco3	O
-	O
27	O
angap	O
-	O
15	O

[	O
*	O
*	O
2013	O
-	O
07	O
-	O
21	O
*	O
*	O
]	O
05	O
:	O
06am	O
blood	O
%hba1c	O
-	O
6	O
.	O
8	O
*	O

cardiac	O
cath	O
(	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
20	O
*	O
*	O
]	O
)	O
:	O
selective	O
coronary	O
angiography	O
of	O
this	O
right	O
dominant	O
system	O
revealed	O
severe	O
three	O
vessel	O
native	O
coronary	O
artery	O
disease	O
.	O

the	O
left	O
main	O
coronary	O
artery	O
had	O
diffuse	O
disease	O
up	O
to	O
30%	O
.	O

the	O
left	O
anterior	O
descending	O
coronary	O
artery	O
was	O
totally	O
occluded	B
in	O
the	O
mid	O
vessel	O
after	O
the	O
take	O
off	O
of	O
a	O
moderate	O
sized	O
d1	O
vessel	O
.	O

the	O
left	O
circumflex	O
coronary	O
artery	O
was	O
totally	O
occluded	B
proximally	O
.	O

the	O
right	O
coronary	O
artery	O
had	O
a	O
90%	O
ulcerated	O
proximal	O
stenosis	O
,	O
with	O
diffuse	O
40	O
-	O
50%	O

stenoses	B
in	O
the	O
mid	O
and	O
distal	O
rca	O
.	O

the	O
rca	O
was	O
a	O
large	O
vessel	O
with	O
a	O
pda	B
and	O
2	O
pl	O
branches	O
.	O

vein	O
graft	O
angiography	O
revealed	O
a	O
patent	O
svg	O
to	O
om1	O
.	O

the	O
svg	O
-	O
-	O
>	O
d1	O
and	O
svg	O
-	O
-	O
>	O
rca	O
(	O
with	O
possible	O
jump	O
graft	O
previously	O
)	O
were	O
totally	O
occluded	B
.	O

arterial	O
conduit	O
angiography	O
revealed	O
patent	O
lima	O
-	O
-	O
>	O
lad	O
.	O

resting	O
hemodynamics	O
revealed	O
mildly	O
elevated	O
right	O
and	O
left	O
sided	O
filling	O
pressures	O
,	O
with	O
rvedp	O
=	O
13	O
mmhg	O
and	O
mean	O
pcw	O
=	O
20	O
mmhg	O
.	O

there	O
was	O
no	O
evidence	O
of	O
pulmonary	B
hypertension	I
.	O

the	O
cardiac	O
output	O
and	O
index	O
were	O
preserved	O
at	O
5	O
.	O
5	O
and	O
3	O
.	O
0	O
respectively	O
.	O

there	O
was	O
no	O
evidence	O
of	O
systemic	B
hypertension	I
.	O

left	O
ventriculography	O
was	O
not	O
undertaken	O
.	O

echocardiogram	O
(	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
22	O
*	O
*	O
]	O
)	O
:	O

the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal	O
.	O

there	O
is	O
mild	O
regional	O
left	B
ventricular	I
systolic	I
dysfunction	I
with	O
focal	O
hypokinesis	B
of	O
the	O
distal	O
half	O
of	O
the	O
inferior	O
wall	O
and	O
mid	O
-	O
inferior	O
septum	O
.	O

the	O
remaining	O
left	O
ventricular	O
segments	O
contract	O
normally	O
and	O
overall	O
systolic	O
function	O
is	O
normal	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
ascending	O
aorta	O
is	O
mildly	O
dilated	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B
regurgitation	I
.	O

the	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	B
regurgitation	I
.	O

there	O
is	O
no	O
mitral	B
valve	I
prolapse	I
.	O

there	O
is	O
borderline	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

impression	O
:	O
mild	O
regional	O
left	B
ventricular	I
systolic	I
dysfunction	I
c	O
/	O
w	O
cad	B
.	O

ef	O
55%	O

brief	O
hospital	O
course	O
:	O

64	O
y	O
/	O
o	O
male	O
with	O
h	O
/	O
o	O
cad	B
s	O
/	O
p	O
5v	O
cabg	O
in	O
[	O
*	O
*	O
2002	O
*	O
*	O
]	O
,	O
htn	B
,	O
and	O
hyperlipidemia	B
who	O
presented	O
with	O
an	O
inferior	O
stemi	B
.	O

the	O
following	O
issues	O
were	O
addressed	O
during	O
this	O
hospitalization	O
.	O

1	O
.	O
cardiac	O

-	O
ischemia	B

the	O
patient	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
2	O
*	O
*	O
]	O
for	O
catheterization	O
after	O
he	O
was	O
found	O
to	O
have	O
had	O
an	O
inferior	O
stemi	B
.	O

see	O
above	O
for	O
ekg	O
results	O
.	O

he	O
is	O
s	O
/	O
p	O
rca	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
x2	O
.	O

he	O
was	O
transferred	O
to	O
the	O
ccu	O
for	O
post	O
-	O
cath	O
management	O
.	O

the	O
patient	O
was	O
hypotensive	B
on	O
night	O
of	O
admission	O
but	O
was	O
mentating	O
well	O
and	O
had	O
good	O
urine	O
output	O
.	O

he	O
did	O
not	O
require	O
pressors	O
.	O

he	O
was	O
started	O
on	O
aspirin	O
325	O
mg	O
po	O
daily	O
,	O
clopidogrel	O
75	O
mg	O
po	O
daily	O
,	O
and	O
atorvastatin	O
80	O
mg	O
po	O
daily	O
.	O

his	O
hba1c	O
was	O
checked	O
and	O
was	O
6	O
.	O
8	O
.	O

the	O
patient	O
will	O
need	O
further	O
workup	O
as	O
an	O
outpatient	O
with	O
his	O
pcp	O
regarding	O
possible	O
glucose	B
intolerance	I
.	O

his	O
bgs	O
during	O
this	O
hospital	O
admission	O
were	O
borderline	O
.	O

he	O
had	O
no	O
h	O
/	O
o	O
dm	B
upon	O
admission	O
but	O
may	O
have	O
had	O
impaired	B
glucose	I
tolerance	I
for	O
some	O
time	O
prior	O
to	O
admission	O
.	O

the	O
patient	O
was	O
transferred	O
to	O
the	O
floor	O
from	O
the	O
ccu	O
as	O
his	O
clinical	O
status	O
improved	O
.	O

pt	O
evaluated	O
the	O
patient	O
and	O
cleared	O
him	O
to	O
return	O
to	O
home	O
.	O

he	O
will	O
need	O
outpatient	O
cardiac	O
rehab	O
coordinated	O
by	O
his	O
pcp	O
after	O
discharge	O
.	O

the	O
patient	O
was	O
instructed	O
about	O
his	O
new	O
medications	O
and	O
the	O
importance	O
of	O
taking	O
plavix	O
due	O
to	O
the	O
placement	O
of	O
2	O
stents	O
.	O

his	O
medications	O
will	O
need	O
to	O
be	O
managed	O
by	O
his	O
pcp	O
and	O
follow	O
up	O
visit	O
with	O
cardiology	O
.	O

-	O
pump	O

the	O
patient	O
was	O
thought	O
to	O
be	O
volume	B
overloaded	I
given	O
elevated	B
l	I
sided	I
pressures	I
with	O
wedge	O
of	O
20	O
in	O
cath	O
lab	O
.	O

he	O
was	O
given	O
iv	O
lasix	O
x	O
1	O
but	O
required	O
volume	O
afterward	O
.	O

an	O
echocardiogram	O
was	O
done	O
after	O
his	O
catheterization	O
and	O
the	O
results	O
are	O
above	O
.	O

he	O
will	O
need	O
a	O
repeat	O
echo	O
in	O
approximately	O
6	O
months	O
to	O
re	O
-	O
evaluate	O
his	O
ef	O
and	O
any	O
changes	O
in	O
his	O
cardiac	O
function	O
.	O

2	O
.	O
htn	B

the	O
patient	O
was	O
initially	O
hypotensive	B
but	O
that	O
resolved	O
and	O
he	O
remained	O
normotensive	B
for	O
the	O
remainder	O
of	O
the	O
hospital	O
course	O
.	O

he	O
was	O
on	O
atenolol	O
25	O
mg	O
po	O
daily	O
at	O
home	O
.	O

he	O
was	O
changed	O
to	O
metoprolol	O
bid	O
in	O
house	O
in	O
order	O
to	O
titrate	O
.	O

he	O
was	O
discharged	O
home	O
on	O
his	O
home	O
dose	O
of	O
atenolol	O
.	O

3	O
.	O
hyperlipidemia	B

the	O
patient	O
was	O
on	O
atorvastatin	O
40	O
mg	O
po	O
qd	O
at	O
home	O
.	O

increased	O
to	O
80	O
mg	O
po	O
daily	O
for	O
acs	B
.	O

he	O
was	O
also	O
discharged	O
home	O
on	O
atorvastatin	O
80	O
mg	O
po	O
daily	O
.	O

medications	O
on	O
admission	O
:	O

aspirin	O
81	O
mg	O
daily	O

atenolol	O
25	O
mg	O
daily	O

atorvastatin	O
40	O
mg	O
daily	O

discharge	O
medications	O
:	O

1	O
.	O
clopidogrel	O
75	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
aspirin	O
325	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

3	O
.	O
atorvastatin	O
80	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

4	O
.	O
atenolol	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

primary	O
:	O
st	B
elevation	I
myocardial	I
infarction	I
with	O
rca	O
stent	O

secondary	O
:	O

coronary	B
artery	I
disease	I

discharge	O
condition	O
:	O

the	O
patient	O
was	O
discharged	O
hemodynamically	O
stable	O
,	O
afebrile	B
with	O
appropriate	O
follow	O
up	O
.	O

discharge	O
instructions	O
:	O

1	O
.	O
take	O
all	O
medications	O
as	O
prescribed	O
.	O

the	O
following	O
are	O
new	O
medications	O
:	O
plavix	O
75	O
mg	O
po	O
daily	O
,	O
atorvastatin	O
80	O
mg	O
po	O
each	O
night	O
,	O
and	O
metoprolol	O
25	O
mg	O
po	O
bid	O
,	O
aspirin	O
325	O
mg	O
po	O
daily	O
.	O

2	O
.	O
please	O
keep	O
all	O
follow	O
up	O
appointments	O
.	O

3	O
.	O
please	O
call	O
your	O
pcp	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
663	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
2408	O
*	O
*	O
]	O
at	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
7422	O
*	O
*	O
]	O
or	O
seek	O
medical	O
attention	O
in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
3	O
*	O
*	O
]	O
if	O
you	O
experience	O
worsening	O
chest	B
pain	I
,	O
shortness	B
of	I
breath	I
,	O
nausea	B
,	O
vomiting	B
,	O
diarrhea	B
,	O
abdominal	B
pain	I
,	O
or	O
any	O
other	O
concerning	O
symptom	B
.	O

followup	O
instructions	O
:	O

please	O
follow	O
up	O
with	O
your	O
pcp	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
663	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
2408	O
*	O
*	O
]	O
on	O
monday	O
,	O
[	O
*	O
*	O
07	O
-	O
29	O
*	O
*	O
]	O
at	O
3	O
:	O
30	O
.	O

please	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
2	O
weeks	O
by	O
calling	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
7423	O
*	O
*	O
]	O
for	O
an	O
appointment	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
204	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
205	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
name6	O
(	O
md	O
)	O
2260	O
*	O
*	O
]	O
peoples	O
md	O
[	O
*	O
*	O
md	O
number	O
2261	O
*	O
*	O
]	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
30	O
*	O
*	O
]	O
@	O
2044	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
pinto	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
67	O
*	O
*	O
]	O
[	O
*	O
*	O
2013	O
-	O
08	O
-	O
01	O
*	O
*	O
]	O
10	O
:	O
41	O
am	O
(	O
end	O
of	O
report	O
)	O

9968	O
||||	O
6557	O
||||	O
25986	O
||||	O
discharge	O
_	O
summary	O
||||	O
2016	O
-	O
07	O
-	O
06	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
06	O
-	O
27	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
07	O
-	O
06	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1935	O
-	O
02	O
-	O
18	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
236	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

fever	B
.	O

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O
.	O

history	O
of	O
present	O
illness	O
:	O

81	O
yo	O
m	O
with	O
h	O
/	O
o	O
copd	B
,	O
dementia	B
,	O
parkinson's	B
,	O
schizophrenia	B
,	O
who	O
was	O
biba	O
from	O
[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
393	O
*	O
*	O
]	O
ridge	O
nh	O
where	O
he	O
was	O
found	O
to	O
be	O
febrile	B
to	O
102	O
.	O
8	O
today	O
.	O

per	O
report	O
,	O
the	O
patient	O
had	O
t	O
102	O
.	O
8	O
,	O
p	O
100	O
,	O
bp	O
130	O
/	O
80	O
,	O
rr	O
24	O
,	O
o2	O
sat	O
90%	O
ra	O
.	O

the	O
patient	O
needs	O
assistance	O
with	O
adls	O
,	O
is	O
combative	B
and	O
non	B
-	I
verbal	I
at	O
baseline	O
.	O

in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
:	O
t	O
101	O
.	O
8	O
;	O
hr	O
130s	O
;	O
bp	O
120	O
/	O
92	O
;	O
rr	O
36	O
;	O
o2	O
sat	O
95%	O
on	O
5l	O
nc	O
.	O

lactate	O
2	O
.	O
8	O
.	O

wbc	O
9	O
.	O
9	O
.	O

ekg	O
wtih	O
afib	B
.	O

cxr	O
with	O
multifocal	O
opacities	B
.	O

received	O
vanco	O
,	O
levo	O
,	O
flagyl	O
.	O

blood	O
cx	O
drawn	O
.	O

patient	O
received	O
diltiazem	O
10	O
mg	O
iv	O
once	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
copd	B
/	O
emphysema	B

2	O
.	O
a	B
fib	I

3	O
.	O
parkinsons	B

4	O
.	O
osteomyelitis	B

5	O
.	O
schizophrenia	B

social	O
history	O
:	O

lives	O
in	O
the	O
nursing	O
home	O
.	O

at	O
baseline	O
,	O
needs	O
assistance	O
with	O
adl	O
.	O

the	O
rest	O
of	O
social	O
history	O
is	O
unknown	O
.	O

family	O
history	O
:	O

unknown	O
.	O

physical	O
exam	O
:	O

vs	O
:	O
100	O
.	O
2	O
rectal	O
;	O
hr	O
121	O
;	O
bp	O
95	O
/	O
71	O
;	O
rr	O
33	O
;	O
o2sat	O
95%	O
on	O
5l	O

general	O
:	O
cachectic	B
;	O
combative	B
;	O
non	B
-	I
verbal	I

heent	O
:	O
nc	O
,	O
at	O
,	O
poor	B
dentition	I

neck	O
:	O
no	O
jvp	B

cv	O
:	O
irregulary	B
irregular	I
;	O
no	O
m	B
/	O
r	B
/	O
g	B

pulm	O
:	O
cta	O
bilaterally	O

abd	O
:	O
+	O
bs	O
,	O
soft	O
,	O
nt	O
,	O
nd	O

extr	O
:	O
no	O
edema	B

pertinent	O
results	O
:	O

ekg	O
:	O
afib	B
rate	O
128	O
;	O
no	O
comparison	O
available	O

cxr	O
:	O
1	O
.	O
multifocal	O
airspace	O
opacities	B
,	O
likely	O
representing	O
aspiration	B
or	O
aspiration	B
pneumonia	I
,	O
given	O
mostly	O
dependent	O
distribution	O
.	O

followup	O
radiograph	O
recommended	O
in	O
six	O
weeks	O
to	O
document	O
resolution	O
.	O

2	O
.	O
9	O
-	O
mm	O
nodular	B
opacity	I
in	O
the	O
left	O
upper	O
lung	O
zone	O
,	O
which	O
may	O
represent	O
a	O
lung	B
nodule	I
.	O

this	O
can	O
be	O
further	O
evaluated	O
with	O
concomitant	O
pa	O
and	O
lateral	O
views	O
at	O
the	O
time	O
of	O
pneumonia	B
followup	O
.	O

brief	O
hospital	O
course	O
:	O

1	O
.	O
aspiration	B
pneumonia	I
:	O

initially	O
treated	O
for	O
an	O
aspiration	B
pneumonia	I
(	O
vanc	O
/	O
zosyn	O
)	O
.	O

his	O
saturations	O
improved	O
and	O
he	O
was	O
weaned	O
off	O
oxygen	O
.	O

when	O
the	O
patient	O
was	O
made	O
cmo	O
,	O
antibiotic	O
were	O
stopped	O
and	O
he	O
was	O
treated	O
supportively	O
.	O

2	O
.	O
failure	B
to	I
thrive	I
:	O

the	O
patient	O
was	O
43	O
kg	O
on	O
admission	O
and	O
dehydrated	B
.	O

he	O
had	O
an	O
ngt	O
placed	O
and	O
was	O
started	O
on	O
tube	O
feeds	O
given	O
an	O
inability	O
to	O
take	O
any	O
po	O
.	O

after	O
the	O
ng	O
was	O
pulled	O
,	O
an	O
attempt	O
was	O
made	O
to	O
replace	O
-	O
the	O
patient	O
did	O
not	O
tolerate	O
this	O
.	O

given	O
his	O
lack	O
of	O
quality	O
of	O
life	O
and	O
poor	O
long	O
-	O
term	O
prognosis	O
,	O
he	O
was	O
made	O
comfort	O
measures	O
only	O
.	O

3	O
.	O
atrial	B
fibrillation	I
:	O

initially	O
difficult	O
to	O
rate	O
control	O
,	O
however	O
,	O
improved	O
after	O
hydration	O
.	O

he	O
was	O
continued	O
on	O
outpatient	O
digoxin	O
and	O
low	O
dose	O
diltiazem	O
while	O
ng	O
was	O
in	O
place	O
.	O

iv	O
lopressor	O
was	O
used	O
after	O
ng	O
was	O
pulled	O
.	O

4	O
.	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
/	O
schizophrenia	B
:	O

continued	O
on	O
fluphenazine	O
and	O
benzotropine	O
while	O
ng	O
was	O
in	O
place	O
.	O

later	O
,	O
for	O
intermittent	O
agitation	B
,	O
the	O
patient	O
was	O
given	O
zyprexa	O
.	O

medications	O
on	O
admission	O
:	O

1	O
.	O
benztropine	O
mesylate	O
0	O
.	O
5	O
mg	O
po	O
bid	O

2	O
.	O
carbidopa	O
-	O
levodopa	O
(	O
10	O
-	O
100	O
)	O
2	O
tab	O
po	O
tid	O

3	O
.	O
prilosec	O
bid	O

4	O
.	O
multivitamins	O
1	O
cap	O
po	O
daily	O

5	O
.	O
digoxin	O
0	O
.	O
125	O
mg	O
po	O
daily	O

6	O
.	O
senna	O
2	O
tabs	O
qd	O

7	O
.	O
colace	O

8	O
.	O
fluphenazine	O
4	O
mg	O
po	O
qhs	O

9	O
.	O
compazine	O
prn	O

10	O
.	O

mom	O
prn	O

11	O
.	O

dulcolax	O
prn	O

12	O
.	O

tylenol	O

discharge	O
medications	O
:	O

1	O
.	O
olanzapine	O
5	O
mg	O
tablet	O
,	O
rapid	O
dissolve	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
rapid	O
dissolve	O
po	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
agitation	B
.	O

2	O
.	O
acetaminophen	O
325	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
q6h	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
for	O
fever	B
,	O
apparent	O
discomfort	B
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
393	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
394	O
*	O
*	O
]	O
rehabilitation	O
&	O
nursing	O
center	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
109	O
*	O
*	O
]	O

discharge	O
diagnosis	O
:	O

primary	O
diagnoses	O
:	O

1	O
.	O
multifocal	O
pneumonia	B
.	O

2	O
.	O
delirium	B
.	O

3	O
.	O
failure	B
to	I
thrive	I

secondary	O
:	O

1	O
.	O
dementia	B
.	O

2	O
.	O
schizophrenia	B

3	O
.	O
parkinson's	B
disease	I

4	O
.	O
copd	B

6	O
.	O
atrial	B
fibrillation	I

discharge	O
condition	O
:	O

stable	O
.	O

discharge	O
instructions	O
:	O

patient	O
was	O
hospitalized	O
in	O
the	O
icu	O
with	O
an	O
aspiration	B
pneumonia	I
which	O
was	O
treated	O
with	O
antibiotics	O
.	O

given	O
his	O
ongoing	O
risk	O
of	O
aspiration	B
,	O
we	O
attempted	O
to	O
place	O
an	O
ng	O
tube	O
.	O

the	O
patient	O
did	O
not	O
tolerate	O
this	O
intervention	O
.	O

we	O
then	O
had	O
a	O
discussion	O
with	O
his	O
health	O
care	O
proxy	O
and	O
[	O
*	O
*	O
name2	O
(	O
ni	O
)	O
395	O
*	O
*	O
]	O
that	O
given	O
his	O
end	O
-	O
stage	O
dementia	B
a	O
peg	O
tube	O
was	O
not	O
indicated	O
.	O

the	O
decision	O
was	O
made	O
to	O
transition	O
the	O
patient	O
to	O
comfort	O
care	O
.	O

followup	O
instructions	O
:	O

patient	O
will	O
be	O
discharged	O
to	O
long	O
-	O
term	O
care	O
facility	O
for	O
ongoing	O
comfort	O
care	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
242	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
243	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
244	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
245	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
246	O
*	O
*	O
]	O
[	O
*	O
*	O
2016	O
-	O
07	O
-	O
07	O
*	O
*	O
]	O
@	O
0829	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2016	O
-	O
07	O
-	O
08	O
*	O
*	O
]	O
2	O
:	O
48	O
pm	O

(	O
end	O
of	O
report	O
)	O

25053	O
||||	O
7214	O
||||	O
28581	O
||||	O
discharge	O
_	O
summary	O
||||	O
2016	O
-	O
03	O
-	O
02	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
02	O
-	O
26	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
01	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1935	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
blumgart	O
m	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
an	O
80	O
year	O
old	O
female	O
with	O
a	O
history	O
of	O
chronic	B
obstructive	I
pulmonary	I
disease	I
on	O
home	O
o2	O
and	O
a	O
cerebrovascular	B
accident	I
in	O
[	O
*	O
*	O
2015	O
-	O
11	O
-	O
21	O
*	O
*	O
]	O
,	O
with	O
a	O
residual	O
right	B
sided	I
weakness	I
,	O
who	O
presents	O
to	O
an	O
outside	O
hospital	O
on	O
[	O
*	O
*	O
2016	O
-	O
02	O
-	O
23	O
*	O
*	O
]	O
,	O
because	O
of	O
a	O
runny	B
nose	I
for	O
six	O
days	O
.	O

the	O
patient	O
complained	O
of	O
mild	O
shortness	B
of	I
breath	I
and	O
hoarseness	B
at	O
that	O
time	O
.	O

a	O
chest	O
x	O
-	O
ray	O
at	O
the	O
outside	O
hospital	O
showed	O
left	O
lower	O
lobe	O
infiltrate	B
,	O
then	O
levaquin	O
was	O
started	O
.	O

a	O
ct	O
angiogram	O
was	O
done	O
for	O
increasing	O
shortness	B
of	I
breath	I
and	O
showed	O
no	O
evidence	O
of	O
pulmonary	B
embolism	I
;	O
however	O
,	O
ct	O
scan	O
of	O
the	O
chest	O
did	O
show	O
a	O
right	O
hilar	O
mass	B
1	O
.	O
3	O
cm	O
nodule	B
in	O
the	O
superior	O
segment	O
of	O
the	O
right	O
lower	O
lobe	O
.	O

on	O
two	O
occasions	O
,	O
was	O
found	O
to	O
have	O
an	O
increasing	B
troponin	I
of	O
4	O
.	O
0	O
with	O
a	O
ck	O
of	O
around	O
100	O
.	O

cardiac	O
echocardiogram	O
showed	O
a	O
very	O
impaired	B
left	I
ventricular	I
ejection	I
fraction	I
.	O

she	O
was	O
then	O
transferred	O
to	O
[	O
*	O
*	O
hospital	O
137	O
*	O
*	O
]	O
for	O

cardiac	O
catheterization	O
.	O

the	O
cardiac	O
catheterization	O
showed	O
patent	O
coronary	O
arteries	O
with	O
an	O
increased	O
left	B
ventricular	I
end	I
diastolic	I
pressure	I
of	O
28	O
.	O

after	O
the	O
procedure	O
,	O
the	O
patient	O
became	O
tachypneic	B
and	O
hypoxemic	B
due	O
to	O
acute	B
heart	I
failure	I
with	O
fluid	B
overload	I
and	O
thus	O
she	O
was	O
transferred	O
to	O
the	O
intensive	O
care	O
unit	O
for	O
further	O
management	O
.	O

she	O
was	O
diuresed	O
over	O
two	O
liters	O
and	O
oxygen	B
demands	I
decreased	I
significantly	O
.	O

cardiology	O
considered	O
the	O
poor	B
left	I
ventricular	I
function	I
to	O
be	O
caused	O
by	O
viral	B
myocarditis	I
.	O

they	O
suggested	O
no	O
steroid	O
or	O
biopsy	O
of	O
the	O
myocardium	O
because	O
of	O
no	O
benefits	O
or	O
no	O
change	O
in	O
further	O
management	O
.	O

they	O
recommended	O
low	O
dose	O
beta	O
blockers	O
,	O
continuing	O
ace	O
inhibitor	O
and	O
digoxin	O
.	O

after	O
her	O
condition	O
was	O
stable	O
she	O
was	O
transferred	O
to	O
the	O
medical	O
floor	O
for	O
further	O
treatment	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
cerebrovascular	B
accident	I
in	O
[	O
*	O
*	O
2015	O
-	O
11	O
-	O
21	O
*	O
*	O
]	O
,	O
with	O
residual	O
right	B
sided	I
weakness	I
and	O
residual	O
word	B
finding	I
difficulties	I
.	O

2	O
.	O
chronic	B
obstructive	I
pulmonary	I
disease	I
with	O
home	O
o2	O
.	O

3	O
.	O
glaucoma	B
.	O

4	O
.	O
status	O
post	O
cholecystectomy	O
.	O

5	O
.	O
status	O
post	O
appendectomy	O
.	O

6	O
.	O
status	O
post	O
tonsillectomy	O
.	O

7	O
.	O
status	O
post	O
cataract	B
surgery	O
.	O

medications	O
as	O
outpatient	O
:	O

1	O
.	O
protonix	O
40	O
q	O
.	O
day	O
.	O

2	O
.	O
remeron	O
30	O
q	O
.	O
day	O
.	O

3	O
.	O
timolol	O
0	O
.	O
25%	O
twice	O
a	O
day	O
.	O

4	O
.	O
trusopt	O
2%	O
,	O
one	O
drop	O
twice	O
a	O
day	O
.	O

5	O
.	O
alphagan	O
0	O
.	O
15%	O
,	O
one	O
drop	O
left	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
three	O
times	O
a	O
day	O
.	O

6	O
.	O
pilocarpine	O
4%	O
,	O
one	O
drop	O
left	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
four	O
times	O
a	O
day	O
.	O

7	O
.	O
trazodone	O
25	O
mg	O
p	O
.	O
o	O
.	O
four	O
times	O
a	O
day	O
.	O

8	O
.	O
combivent	O
mdi	O
,	O
two	O
puffs	O
twice	O
a	O
day	O
.	O

family	O
history	O
:	O
one	O
sister	O
,	O
one	O
brother	O
and	O
two	O
sons	O
.	O

one	O
brother	O
and	O
father	O
with	O
asthma	B
.	O

social	O
history	O
:	O
the	O
patient	O
is	O
a	O
widow	O
.	O

husband	O
died	O
of	O
chronic	B
renal	I
failure	I
and	O
was	O
on	O
dialysis	O
.	O

the	O
patient	O
is	O
an	O
ex	O
-	O
smoker	O
that	O
quit	O
greater	O
than	O
15	O
years	O
ago	O
.	O

the	O
patient	O
started	O
smoking	O
at	O
age	O
18	O
.	O

the	O
patient	O
currently	O
lives	O
in	O
an	O
assisted	O
living	O
facility	O
.	O

the	O
patient	O
has	O
no	O
history	O
or	O
exposure	B
to	I
asbestos	I
or	O
chemicals	O
.	O

the	O
patient	O
denies	O
any	O
alcohol	O
use	O
.	O

physical	O
examination	O
:	O
on	O
admission	O
to	O
the	O
intensive	O
care	O

unit	O
per	O
notes	O
,	O
in	O
general	O
,	O
the	O
patient	O
is	O
an	O
anxious	B
appearing	O
female	O
in	O
respiratory	B
distress	I
.	O

vital	O
signs	O
with	O
temperature	O
of	O
95	O
.	O
2	O
f	O
.	O
;	O
blood	O
pressure	O
121	O
/	O
71	O
;	O
heart	O
rate	O
127	O
;	O
respiratory	O
rate	O
29	O
;	O
o2	O
sats	O
were	O
94%	O
on	O
100%	O
non	O
-	O
rebreather	O
.	O

heent	O
with	O
surgical	B
pupils	I
.	O

mucous	O
membranes	O
were	O
moist	O
.	O

oropharynx	O
clear	O
.	O

neck	O
supple	O
with	O
jugular	B
venous	I
pressure	I
approximately	O
8	O
to	O
9	O
cm	O
.	O

no	O
lymphadenopathy	B
.	O

cardiovascular	O
:	O
the	O
patient	O
is	O
tachycardic	B
with	O
a	O
ii	O
/	O
vi	O
systolic	B
ejection	I
murmur	I
at	O
the	O
apex	O
.	O

chest	O
:	O
the	O
patient	O
had	O
rhonchi	B
at	O
the	O
left	O
base	O
,	O
crackles	B
at	O
the	O
right	O
base	O
.	O

abdomen	O
is	O
soft	O
,	O
nontender	O
,	O
nondistended	O
,	O
positive	O
bowel	O
sounds	O
.	O

extremities	O
with	O
no	O
cyanosis	B
,	O
clubbing	B
or	O
edema	B
.	O

warm	O
with	O
plus	O
two	O
pulses	O
.	O

dorsalis	O
pedis	O
bilaterally	O
.	O

left	O
groin	O
sheath	O
was	O
in	O
place	O
at	O
that	O
time	O
.	O

neurologic	O
:	O
the	O
patient	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
,	O
moving	O
all	O
extremities	O
.	O

the	O
patient	O
had	O
some	O
word	B
finding	I
difficulties	I
.	O

laboratory	O
:	O
pertinent	O
labs	O
on	O
admission	O
were	O
the	O
patient's	O
troponin	O
of	O
0	O
.	O
47	O
.	O

bmp	O
was	O
367	O
.	O

ck	O
was	O
92	O
,	O
ck	O
mb	O
was	O
7	O
.	O
5	O
.	O

the	O
patient's	O
ekg	O
showed	O
normal	O
sinus	O
rhythm	O
.	O

the	O
patient's	O
chest	O
x	O
-	O
ray	O
showed	O
bilateral	O
short	O
pattern	O
with	O
a	O
right	O
lower	O
lobe	O
opacity	B
.	O

summary	O
of	O
hospitalization	O
course	O
:	O

1	O
.	O
congestive	B
heart	I
failure	I
:	O
as	O
stated	O
in	O
the	O
hpi	O
,	O
when	O
arriving	O
to	O
the	O
medical	O
floor	O
,	O
the	O
patient's	O
troponin	O
was	O
elevated	O
to	O
4	O
with	O
flat	O
cks	O
.	O

cardiac	O
echocardiogram	O
showed	O
an	O
impaired	B
left	I
ventricular	I
ejection	I
fraction	I
of	O
25	O
to	O
30%	O
.	O

cardiology	O
was	O
consulted	O
in	O
the	O
intensive	O
care	O
unit	O
at	O
which	O
time	O
the	O
patient's	O
poor	B
left	I
ventricular	I
function	I
was	O
seen	O
to	O
be	O
caused	O
by	O
viral	B
myocarditis	I
.	O

iron	O
studies	O
and	O
thyroid	O
studies	O
were	O
unrevealing	O
.	O

cardiology	O
suggested	O
that	O
no	O
steroids	O
or	O
biopsy	O
of	O
the	O
myocardium	O
was	O
warranted	O
because	O
of	O
no	O
change	O
in	O
further	O
management	O
.	O

she	O
was	O
started	O
on	O
a	O
low	O
dose	O
beta	O
blocker	O
,	O
ace	O
inhibitor	O
,	O
digoxin	O
and	O
lasix	O
upon	O
discharge	O
.	O

she	O
remained	O
stable	O
on	O
her	O
home	O
o2	O
,	O
however	O
,	O
she	O
required	O
this	O
throughout	O
the	O
day	O
and	O
night	O
.	O

the	O
patient	O
is	O
to	O
follow	O
-	O
up	O
with	O
either	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
688	O
*	O
*	O
]	O
or	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
91	O
*	O
*	O
]	O
in	O
congestive	B
heart	I
failure	I
clinic	O
as	O
this	O
is	O
a	O
new	O
onset	O
congestive	B
heart	I
failure	I
for	O
this	O
patient	O
.	O

2	O
.	O
history	O
of	O
pneumonia	B
:	O
the	O
patient	O
was	O
diagnosed	O
with	O
community	B
-	I
acquired	I
pneumonia	I
at	O
the	O
outside	O
hospital	O
.	O

she	O
was	O
continued	O
on	O
a	O
ten	O
day	O
course	O
of	O
levaquin	O
and	O
was	O
discharged	O
with	O
two	O
more	O
days	O
of	O
levaquin	O
left	O
.	O

the	O
patient	O
had	O
no	O
productive	B
cough	I
while	O
on	O
the	O
medical	O
floor	O
.	O

3	O
.	O
pulmonary	O
:	O
the	O
patient	O
has	O
a	O
right	O
hilar	B
mass	I
as	O
seen	O
on	O
outpatient	O
chest	O
ct	O
scan	O
.	O

the	O
patient	O
will	O
need	O
repeat	O
chest	O
ct	O
scan	O
to	O
follow	O
this	O
mass	B
.	O

the	O
patient's	O
family	O
was	O
not	O
interested	O
in	O
further	O
work	O
-	O
up	O
of	O
the	O
mass	B
during	O
this	O
hospitalization	O
.	O

4	O
.	O
chronic	B
obstructive	I
pulmonary	I
disease	I
:	O
the	O
patient	O
was	O
continued	O
on	O
albuterol	O
,	O
ipratropium	O
and	O
fluticasone	O
nebulizer	O
treatments	O
during	O
this	O
hospitalization	O
.	O

again	O
,	O
the	O
patient	O
required	O
oxygen	O
for	O
both	O
congestive	B
heart	I
failure	I
and	O
chronic	B
obstructive	I
pulmonary	I
disease	I
.	O

5	O
.	O
glaucoma	B
:	O
the	O
patient	O
was	O
continued	O
on	O
her	O
outpatient	O
glaucoma	B
medication	O
.	O

6	O
.	O
psychiatric	O
:	O
the	O
patient	O
was	O
continued	O
on	O
trazodone	O
and	O
mirtazapine	O
.	O

7	O
.	O
coronary	B
artery	I
disease	I
:	O
again	O
,	O
the	O
patient	O
was	O
not	O
found	O
to	O
have	O
any	O
coronary	B
artery	I
disease	I
on	O
catheterization	O
during	O
this	O
admission	O
.	O

the	O
patient	O
had	O
no	O
episodes	O
of	O
chest	B
pain	I
during	O
this	O
admission	O
.	O

condition	O
at	O
discharge	O
:	O
the	O
patient	O
was	O
discharged	O
on	O
home	O
oxygen	O
in	O
stable	O
condition	O
to	O
her	O
assisted	O
living	O
facility	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
congestive	B
heart	I
failure	I
with	O
an	O
ejection	O
fraction	O
of	O
15	O
to	O
30%	O
.	O

2	O
.	O
viral	B
myocarditis	I
.	O

3	O
.	O
glaucoma	B
.	O

4	O
.	O
community	B
-	I
acquired	I
pneumonia	I
.	O

5	O
.	O
chronic	B
obstructive	I
pulmonary	I
disease	I
on	O
home	O
oxygen	O
.	O

6	O
.	O
history	O
of	O
cerebrovascular	B
accident	I
with	O
residual	O
right	B
sided	I
weakness	I
and	O
word	B
finding	I
difficulties	I
.	O

discharge	O
medications	O
:	O

1	O
.	O
pantoprazole	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

2	O
.	O
mirtazapine	O
one	O
tablet	O
p	O
.	O
o	O
.	O
q	O
.	O
h	O
.	O
s	O
.	O

3	O
.	O
timolol	O
0	O
.	O
25%	O
drops	O
,	O
one	O
drop	O
twice	O
a	O
day	O
.	O

4	O
.	O
dorzolamide	O
2%	O
drops	O
,	O
one	O
drop	O
ophthalmologic	O
twice	O
a	O
day	O
.	O

5	O
.	O
pilocarpine	O
4%	O
drops	O
,	O
one	O
drop	O
ophthalmic	O
q	O
.	O
six	O
hours	O
.	O

6	O
.	O
brimonidine	O
tartrate	O
0	O
.	O
2%	O
drops	O
,	O
one	O
drop	O
ophthalmic	O
q	O
.	O
eight	O
hours	O
.	O

7	O
.	O
levofloxacin	O
250	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
times	O
three	O
days	O
.	O

8	O
.	O
ipratropium	O
two	O
puffs	O
four	O
times	O
a	O
day	O
.	O

9	O
.	O
digoxin	O
125	O
micrograms	O
,	O
one	O
tablet	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

10	O
.	O

fluticasone	O
two	O
puffs	O
inhaled	O
twice	O
a	O
day	O
.	O

11	O
.	O

albuterol	O
one	O
to	O
two	O
puffs	O
inhaled	O
twice	O
a	O
day	O
.	O

12	O
.	O

lisinopril	O
2	O
.	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
h	O
.	O
s	O
.	O

13	O
.	O

carvedilol	O
3	O
.	O
125	O
mg	O
p	O
.	O
o	O
.	O
twice	O
a	O
day	O
.	O

14	O
.	O

lasix	O
10	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

discharge	O
instructions	O
:	O

1	O
.	O
the	O
patient	O
is	O
to	O
follow	O
-	O
up	O
with	O
either	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
91	O
*	O
*	O
]	O
or	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
688	O
*	O
*	O
]	O
in	O
one	O
to	O
two	O
weeks	O
.	O

the	O
congestive	B
heart	I
failure	I
clinic	O
is	O
to	O
contact	O
her	O
with	O
an	O
appointment	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
4816	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
4801	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2016	O
-	O
02	O
-	O
29	O
*	O
*	O
]	O
17	O
:	O
36	O

t	O
:	O
[	O
*	O
*	O
2016	O
-	O
02	O
-	O
29	O
*	O
*	O
]	O
17	O
:	O
48	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
6401	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
23	O
*	O
*	O
]	O
10	O
:	O
36	O
am	O

(	O
end	O
of	O
report	O
)	O

40	O
||||	O
7546	O
||||	O
21965	O
||||	O
discharge	O
_	O
summary	O
||||	O
2009	O
-	O
10	O
-	O
08	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2009	O
-	O
10	O
-	O
03	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2009	O
-	O
10	O
-	O
08	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1933	O
-	O
11	O
-	O
26	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O

history	O
of	O
present	O
illness	O
:	O
mrs	O
.	O
[	O
*	O
*	O
lastname	O
225	O
*	O
*	O
]	O
is	O
a	O
75	O
year	O
old	O
woman	O
from	O
[	O
*	O
*	O
hospital	O
226	O
*	O
*	O
]	O
admitted	O
on	O
[	O
*	O
*	O
2009	O
-	O
10	O
-	O
03	O
*	O
*	O
]	O
for	O
evaluation	O
for	O
the	O
question	O
of	O
dialysis	O
.	O

the	O
patient	O
was	O
last	O
admitted	O
to	O
[	O
*	O
*	O
hospital	O
227	O
*	O
*	O
]	O
[	O
*	O
*	O
hospital	O
24	O
*	O
*	O
]	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
25	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
26	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2009	O
-	O
09	O
-	O
01	O
*	O
*	O
]	O
for	O
workup	O
of	O
new	O
onset	O
acute	B
renal	I
failure	I
,	O
urosepsis	B
,	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
228	O
*	O
*	O
]	O
syndrome	O
and	O
chronic	B
ventilatory	I
dependence	I
.	O

she	O
was	O
discharged	O
to	O
[	O
*	O
*	O
hospital	O
229	O
*	O
*	O
]	O
without	O
dialysis	O
as	O
there	O
was	O
no	O
indication	O
then	O
for	O
dialysis	O
.	O

the	O
patient's	O
acute	B
renal	I
failure	I
continued	O
to	O
worsen	O
and	O
she	O
had	O
a	O
question	O
of	O
altered	B
mental	I
status	I
,	O
leading	O
to	O
this	O
readmission	O
,	O
for	O
workup	O
of	O
uremic	B
encephalopathy	I
and	O
the	O
requirement	O
of	O
dialysis	O
.	O

the	O
patient	O
was	O
transferred	O
to	O
the	O
medical	O
intensive	O
care	O
unit	O
because	O
of	O
ventilator	B
dependence	I
at	O
night	O
.	O

active	O
issues	O
:	O

1	O
.	O
acute	B
renal	I
failure	I
:	O
the	O
patient	O
had	O
hyperkalemia	B
on	O
admission	O
,	O
which	O
resolved	O
with	O
a	O
kayexalate	O
enema	O
and	O
lasix	O
.	O

she	O
was	O
evaluated	O
by	O
the	O
renal	O
service	O
and	O
started	O
bedside	O
hemodialysis	O
through	O
a	O
femoral	O
line	O
on	O
[	O
*	O
*	O
2009	O
-	O
10	O
-	O
05	O
*	O
*	O
]	O
.	O

no	O
improvement	O
of	O
mental	B
status	I
was	O
noticed	O
after	O
two	O
days	O
of	O
dialysis	O
.	O

a	O
family	O
meeting	O
was	O
held	O
on	O
[	O
*	O
*	O
2009	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
with	O
the	O
patient's	O
sister	O
,	O
who	O
is	O
her	O
health	O
care	O
proxy	O
,	O
regarding	O
the	O
goals	O
of	O
our	O
care	O
for	O
the	O
patient	O
.	O

we	O
discussed	O
at	O
length	O
regarding	O
the	O
need	O
for	O
hemodialysis	O
,	O
the	O
need	O
for	O
a	O
permanent	O
catheter	O
to	O
be	O
placed	O
and	O
regarding	O
the	O
overall	O
prognosis	O
of	O
mrs	O
.	O
[	O
*	O
*	O
lastname	O
225	O
*	O
*	O
]	O
.	O

the	O
patient's	O
family	O
decided	O
to	O
give	O
her	O
a	O
trial	O
of	O
hemodialysis	O
from	O
her	O
femoral	O
line	O
and	O
observe	O
what	O
benefit	O
it	O
will	O
bring	O
,	O
then	O
they	O
will	O
decide	O
regarding	O
chronic	O
hemodialysis	O
.	O

mrs	O
.	O
[	O
*	O
*	O
lastname	O
225	O
*	O
*	O
]	O
had	O
minimal	O
mental	B
status	I
improvement	O
after	O
two	O
days	O
of	O
hemodialysis	O
.	O

the	O
patient's	O
family	O
decided	O
on	O
[	O
*	O
*	O
2009	O
-	O
10	O
-	O
06	O
*	O
*	O
]	O
that	O
they	O
would	O
not	O
consent	O
to	O
further	O
procedures	O
or	O
hemodialysis	O
and	O
would	O
want	O
only	O
comfort	B
measures	I
for	O
mrs	O
.	O
[	O
*	O
*	O
lastname	O
225	O
*	O
*	O
]	O
.	O

hemodialysis	O
was	O
stopped	O
on	O
[	O
*	O
*	O
2009	O
-	O
10	O
-	O
06	O
*	O
*	O
]	O
.	O

2	O
.	O
ventilatory	O
status	O
:	O
the	O
patient	O
was	O
placed	O
on	O
12	O
hours	O
off	O
ventilator	O
wean	O
on	O
her	O
first	O
day	O
,	O
and	O
was	O
noted	O
to	O
have	O
some	O
apneic	B
episodes	O
and	O
appear	O
labored	O
in	O
her	O
breathing	O
.	O

we	O
therefore	O
placed	O
her	O
on	O
24	O
hour	O
psv	O
then	O
switched	O
to	O
ac	O
in	O
order	O
to	O
better	O
ventilate	O
her	O
and	O
to	O
rule	O
out	O
any	O
hypoxia	B
,	O
hypercarbia	B
as	O
a	O
cause	O
of	O
her	O
altered	B
mental	I
status	I
.	O

the	O
patient's	O
family	O
had	O
decided	O
on	O
comfort	B
measures	I
only	O
on	O

[	O
*	O
*	O
2009	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
.	O

the	O
patient	O
was	O
then	O
taken	O
off	O
the	O
ventilator	O
that	O
afternoon	O
and	O
given	O
oxygen	O
over	O
her	O
tracheostomy	O
mask	O
.	O

she	O
was	O
not	O
to	O
be	O
put	O
on	O
ventilator	O
support	O
from	O
now	O
on	O
.	O

the	O
patient	O
is	O
to	O
receive	O
morphine	O
if	O
she	O
appears	O
distressed	O
from	O
breathing	O
.	O

3	O
.	O
urinary	B
tract	I
infection	I
:	O
on	O
admission	O
,	O
a	O
urinalysis	O
was	O
sent	O
and	O
the	O
patient	O
was	O
found	O
to	O
have	O
plenty	O
of	O
bacteria	O
and	O
yeast	O
in	O
her	O
urine	O
.	O

later	O
,	O
the	O
urine	O
culture	O
came	O
back	O
to	O
show	O
klebsiella	O
pneumoniae	O
,	O
sensitive	O
to	O
bactrim	O
.	O

the	O
patient	O
is	O
now	O
treated	O
,	O
day	O
number	O
five	O
of	O
bactrim	O
ds	O
on	O
discharge	O
.	O

4	O
.	O
diabetes	B
/	O
hyperglycemia	B
:	O
the	O
patient	O
had	O
been	O
hyperglycemic	B
during	O
this	O
admission	O
,	O
likely	O
secondary	O
to	O
her	O
urinary	B
tract	I
infection	I
.	O

as	O
the	O
patient	O
is	O
now	O
only	O
comfort	B
measures	I
,	O
she	O
is	O
getting	O
her	O
daily	O
nph	O
at	O
the	O
same	O
dose	O
as	O
on	O
transfer	O
,	O
but	O
no	O
more	O
daily	O
fingersticks	O
to	O
check	O
her	O
blood	O
sugar	O
level	O
.	O

5	O
.	O
nutrition	O
:	O
the	O
patient	O
is	O
to	O
receive	O
no	O
intravenous	O
fluids	O
.	O

she	O
received	O
35	O
cc	O
/	O
hour	O
of	O
nepro	O
tube	O
feeds	O
and	O
250	O
cc	O
of	O
free	O
water	O
bolus	O
through	O
her	O
nasogastric	O
tube	O
every	O
day	O
.	O

the	O
family	O
has	O
not	O
yet	O
decided	O
whether	O
to	O
stop	O
tube	O
feeding	O
her	O
and	O
to	O
remove	O
her	O
nasogastric	O
tube	O
.	O

6	O
.	O
altered	B
mental	I
status	I
:	O
a	O
ct	O
scan	O
was	O
performed	O
for	O
further	O
evaluation	O
of	O
possible	O
causes	O
of	O
the	O
patient's	O
mental	B
status	I
alteration	I
and	O
potential	O
prognostication	O
in	O
terms	O
of	O
neurological	O
status	O
.	O

a	O
ct	O
scan	O
of	O
the	O
head	O
showed	O
no	O
acute	O
infarction	B
or	O
hemorrhage	B
,	O
with	O
small	I
vessel	I
disease	I
in	O
the	O
periventricular	O
white	O
matter	O
and	O
an	O
old	O
putamen	O
infarction	B
.	O

7	O
.	O
cardiovascular	O
status	O
:	O
an	O
echocardiogram	O
was	O
performed	O
to	O
evaluate	O
the	O
cardiovascular	O
status	O
of	O
mrs	O
.	O
[	O
*	O
*	O
lastname	O
225	O
*	O
*	O
]	O
.	O

results	O
showed	O
a	O
mildly	O
dilated	B
left	I
atrium	I
and	O
right	O
atrium	O
,	O
otherwise	O
no	O
change	O
from	O
patient's	O
echocardiogram	O
on	O
[	O
*	O
*	O
2009	O
-	O
05	O
-	O
20	O
*	O
*	O
]	O
.	O

discharge	O
diagnoses	O
:	O

acute	B
renal	I
failure	I
.	O

diabetes	B
mellitus	I
.	O

urinary	B
tract	I
infection	I
.	O

tracheostomy	O
.	O

code	O
status	O
:	O
"do	O
not	B
resuscitate"	O
/	O
"do	O
not	B
intubate"	O
.	O

discharge	O
medications	O
:	O

nepro	O
tube	O
feeds	O
35	O
cc	O
/	O
hour	O
through	O
nasogastric	O
tube	O
.	O

synthroid	O
175	O
mcg	O
via	O
nasogastric	O
tube	O
q	O
.	O
d	O
.	O

lopressor	O
50	O
mg	O
via	O
nasogastric	O
tube	O
b	O
.	O
i	O
.	O
d	O
.	O

nystatin	O
powder	O
to	O
inguinal	O
rash	O
b	O
.	O
i	O
.	O
d	O
.	O

nph	O
45	O
units	O
s	O
.	O
c	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

bactrim	O
ds	O
one	O
per	O
nasogastric	O
tube	O
q	O
.	O
d	O
.	O

zantac	O
150	O
mg	O
per	O
nasogastric	O
tube	O
q	O
.	O
d	O
.	O

free	O
water	O
250	O
cc	O
per	O
nasogastric	O
tube	O
q	O
.	O
i	O
.	O
d	O
.	O

morphine	O
sulfate	O
1	O
to	O
5	O
mg	O
s	O
.	O
c	O
.	O
q	O
.	O
1h	O
.	O
p	O
.	O
r	O
.	O
n	O
.	O
discomfort	B
.	O

[	O
*	O
*	O
doctor	O
first	O
name	O
230	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
231	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
232	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
233	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2009	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
18	O
:	O
42	O

t	O
:	O
[	O
*	O
*	O
2009	O
-	O
12	O
-	O
08	O
*	O
*	O
]	O
10	O
:	O
54	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
234	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
230	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
231	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2009	O
-	O
12	O
-	O
14	O
*	O
*	O
]	O
12	O
:	O
03	O
pm	O

(	O
end	O
of	O
report	O
)	O

16743	O
||||	O
7683	O
||||	O
4543	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
07	O
-	O
19	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
26	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1936	O
-	O
09	O
-	O
11	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
neurology	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
a	O
75	O
year	O
-	O
old	O
man	O
with	O
a	O
past	O
medical	O
history	O
of	O
cerebrovascular	B
accident	I
with	O
residual	O
right	B
hemiparesis	I
in	O
[	O
*	O
*	O
1998	O
*	O
*	O
]	O
as	O
well	O
as	O
diabetes	B
type	I
2	I
,	O
coronary	B
artery	I
disease	I
,	O
status	O
post	O
catheterization	O
in	O

[	O
*	O
*	O
2011	O
*	O
*	O
]	O
with	O
three	B
vessel	I
disease	I
as	O
well	O
as	O
cataracts	B
,	O
hyperlipidemia	B
and	O
bipolar	B
disorder	I
who	O
is	O
admitted	O
to	O
[	O
*	O
*	O
hospital	O
20	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
26	O
*	O
*	O
]	O
after	O
he	O
was	O
found	B
down	I
in	O
his	O
home	O
.	O

he	O
was	O
diagnosed	O
with	O
a	O
left	O
basal	O
ganglia	O
intracranial	B
hemorrhage	I
likely	O
arising	O
from	O
the	O
caudate	O
with	O
large	O
intraventricular	O
extension	O
on	O
the	O
left	O
.	O

he	O
had	O
subsequent	O
hydrocephalus	B
as	O
well	O
as	O
an	O
acute	B
myocardial	I
infarction	I
with	O
troponins	O
going	O
greater	O
then	O
50	O
as	O
well	O
as	O
rhabdomyolysis	B
with	O
a	O
ck	O
in	O
the	O
10	O
,	O
000s	O
.	O

he	O
was	O
admitted	O
to	O
the	O
neurological	O
intensive	O
care	O
unit	O
for	O
closer	O
blood	O
pressure	O
and	O
neurologic	O
monitoring	O
.	O

it	O
was	O
felt	O
early	O
on	O
as	O
his	O
decreased	B
level	I
of	I
consciousness	I
was	O
profound	O
he	O
would	O
need	O
neurosurgical	O
intervention	O
with	O
a	O
right	O
ventricular	O
catheter	O
.	O

this	O
was	O
placed	O
on	O
[	O
*	O
*	O
06	O
-	O
27	O
*	O
*	O
]	O
the	O
day	O
after	O
admission	O
.	O

after	O
insertion	O
the	O
catheter	O
continued	O
to	O
have	O
200	O
to	O
300	O
cc	O
output	O
a	O
day	O
of	O
blood	O
tinged	O
fluid	O
and	O
his	O
mental	B
status	I
seemed	O
to	O
improve	O
.	O

on	O
admission	O
he	O
had	O
low	B
grade	I
fevers	I
100	O
to	O
101	O
range	O
with	O
an	O
increased	B
white	I
blood	I
cell	I
count	I
of	O
90	O
.	O
5	O
.	O

initial	O
workup	O
showed	O
pneumonia	B
with	O
right	O
upper	O
lobe	O
infiltrate	B
and	O
also	O
a	O
question	O
of	O
left	O
lower	O
lobe	O
infiltrate	B
.	O

he	O
was	O
given	O
ancef	O
initially	O
for	O
his	O
drain	O
on	O
the	O
first	O
day	O
,	O
however	O
,	O
it	O
was	O
then	O
changed	O
to	O
levaquin	O
as	O
well	O
as	O
flagyl	O
in	O
light	O
of	O
his	O
cultures	O
came	O
back	O
.	O

he	O
required	O
intubation	O
on	O
[	O
*	O
*	O
06	O
-	O
30	O
*	O
*	O
]	O
.	O

he	O
was	O
later	O
started	O
on	O
vancomycin	O
with	O
cultures	O
coming	O
back	O
as	O
heavy	O
growth	O
mrsa	B
.	O

he	O
was	O
followed	O
closely	O
in	O
the	O
neurosurgical	O
intensive	O
care	O

unit	O
,	O
the	O
neurology	O
,	O
neurosurgery	O
and	O
the	O
cicu	O
medical	O
team	O
.	O

he	O
continued	O
to	O
recover	O
from	O
his	O
myocardial	B
infarction	I
and	O
his	O
enzymes	O
trended	O
down	O
.	O

his	O
neurological	B
deficits	I
remained	O
significantly	O
unchanged	O
.	O

he	O
was	O
in	O
the	O
intensive	O
care	O
unit	O
with	O
cerebral	O
spinal	O
fluid	O
samples	O
taken	O
on	O
[	O
*	O
*	O
06	O
-	O
30	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
07	O
-	O
02	O
*	O
*	O
]	O
and	O

[	O
*	O
*	O
07	O
-	O
06	O
*	O
*	O
]	O
,	O
which	O
were	O
all	O
no	O
growth	O
and	O
the	O
patient	O
continued	O
to	O
have	O
fevers	B
even	O
on	O
broad	O
spectrum	O
antibiotics	O
with	O
a	O
white	O
blood	O
cell	O
count	O
of	O
12	O
to	O
16	O
.	O

he	O
was	O
briefly	O
extubated	O
,	O
but	O
then	O
needed	O
to	O
be	O
reintubated	O
the	O
same	O
night	O
.	O

his	O
sputum	O
continued	O
to	O
grow	O
large	O
amounts	O
of	O
mrsa	B
on	O
repeat	O
cultures	O
.	O

his	O
blood	O
and	O
urine	O
culture	O
were	O
negative	O
as	O
well	O
as	O
cerebral	O
spinal	O
fluid	O
.	O

vancomycin	O
was	O
held	O
briefly	O
from	O
[	O
*	O
*	O
07	O
-	O
09	O
*	O
*	O
]	O
to	O
[	O
*	O
*	O
07	O
-	O
10	O
*	O
*	O
]	O
,	O
however	O
,	O
the	O
patient's	O
temperature	B
again	O
increased	O
to	O
102	O
and	O
repeat	O
cerebral	O
spinal	O
fluid	O
from	O
ventricular	O
drain	O
at	O
this	O
point	O
showed	O
3	O
+	O
polys	O
,	O
3	O
+	O
gram	O
positive	O
cocci	O
in	O
pairs	O
and	O
clusters	O
within	O
the	O
fluid	O
with	O
4000	O
white	O
blood	O
cells	O
and	O
110	O
polys	O
and	O
a	O
glucose	O
of	O
1	O
.	O
ceftazidime	O
was	O
added	O
.	O

infectious	O
disease	O
was	O
consulted	O
at	O
that	O
time	O
.	O

his	O
neurological	O
examination	O
continued	O
to	O
wax	O
and	O
wane	O
.	O

his	O
vent	O
drain	O
was	O
raised	O
and	O
lowered	O
depending	O
on	O
his	O
arousal	O
.	O

he	O
was	O
noted	O
to	O
have	O
also	O
right	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
78	O
*	O
*	O
]	O
deviation	O
and	O
right	O
twitching	B
of	O
his	O
mouth	O
on	O
two	O
separate	O
occasions	O
,	O
which	O
is	O
suspicious	O
for	O
seizure	B
.	O

we	O
ordered	O
an	O
electroencephalogram	O
which	O
was	O
abnormal	O
due	O
to	O
low	O
voltage	O
slow	O
background	O
with	O
bursts	O
of	O
polymorphic	O
data	O
and	O
delta	O
frequency	O
slowing	O
.	O

this	O
indicated	O
a	O
wide	O
spread	O
cortical	B
dysfunction	I
as	O
well	O
as	O
dysfunction	B
of	O
the	O
deep	O
midline	O
structures	O
as	O
can	O
be	O
seen	O
with	O
severe	O
encephalopathy	B
.	O

there	O
were	O
no	O
focal	O
epileptiform	B
seizures	I
seen	O
.	O

at	O
that	O
point	O
we	O
decided	O
to	O
watch	O
him	O
.	O

later	O
on	O
in	O
his	O
course	O
he	O
had	O
another	O
episode	O
where	O
his	O
eyes	O
were	O
strongly	O
deviated	O
to	O
the	O
right	O
and	O
we	O
could	O
not	O
doll	O
him	O
pass	O
the	O
midline	O
.	O

at	O
that	O
point	O
it	O
was	O
felt	O
by	O
the	O
neuro	O
team	O
that	O
we	O
should	O
treat	O
him	O
for	O
seizures	B
.	O

we	O
loaded	O
him	O
on	O
phenytoin	O
and	O
gave	O
him	O
ativan	O
with	O
good	O
relief	O
of	O
his	O
seizures	B
.	O

there	O
was	O
no	O
need	O
at	O
that	O
time	O
to	O
repeat	O
an	O
electroencephalogram	O
as	O
his	O
clinical	O
suspicion	O
was	O
high	O
enough	O
for	O
epileptiform	B
events	I
.	O

we	O
decided	O
to	O
continue	O
with	O
our	O
management	O
and	O
watch	O
his	O
blood	O
pressure	O
,	O
heart	O
rate	O
and	O
temperature	O
.	O

he	O
continued	O
to	O
spike	O
.	O

we	O
involved	O
infectious	O
disease	O
who	O
felt	O
that	O
this	O
was	O
fever	B
meningismus	I
and	O
he	O
was	O
not	O
following	O
commands	O
.	O

there	O
was	O
concern	O
for	O
meningitis	B
and	O
this	O
should	O
be	O
treated	O
with	O
vancomycin	O
.	O

we	O
continued	O
that	O
per	O
their	O
recommendations	O
as	O
well	O
and	O
continued	O
rifampin	O
per	O
their	O
recommendations	O
also	O
.	O

he	O
continued	O
to	O
not	O
improve	O
clinically	O
and	O
his	O
neurological	O
examination	O
was	O
somewhat	O
limited	O
.	O

he	O
could	O
follow	O
simple	O
commands	O
intermittently	O
,	O
but	O
could	O
not	O
move	O
his	O
right	O
side	O
to	O
command	O
.	O

he	O
could	O
occasionally	O
squeeze	O
hand	O
,	O
but	O
not	O
consistently	O
.	O

he	O
could	O
not	O
also	O
consistently	O
follow	O
commands	O
,	O
but	O
he	O
would	O
open	O
his	O
eyes	O
to	O
voice	O
.	O

he	O
was	O
intubated	O
and	O
sedated	O
.	O

his	O
respiratory	O
coarse	B
breath	I
sounds	I
bilaterally	O
,	O
decreased	B
breath	I
sounds	I
.	O

his	O
cardiac	O
examination	O
was	O
regular	O
rate	O
and	O
rhythm	O
.	O

we	O
continued	O
to	O
watch	O
him	O
and	O
watch	O
his	O
laboratories	O
,	O
however	O
,	O
he	O
was	O
unable	O
to	O
improve	O
much	O
.	O

pulmonary	O
critical	O
care	O
team	O
felt	O
he	O
would	O
benefit	O
from	O
a	O
tracheostomy	O
and	O
this	O
was	O
planned	O
until	O
other	O
issues	O
medically	O
kept	O
him	O
from	O
this	O
procedure	O
.	O

it	O
was	O
felt	O
he	O
was	O
on	O
a	O
downhill	O
course	O
and	O
meningitis	B
,	O
which	O
was	O
being	O
treated	O
intrathecal	O
vancomycin	O
by	O
the	O
neurosurgical	O
service	O
and	O
that	O
his	O
hope	O
for	O
a	O
meaningful	O
recovery	O
was	O
somewhat	O
less	O
then	O
originally	O
due	O
to	O
many	O
additional	B
medical	I
issues	I
that	O
worsened	O
during	O
his	O
hospital	O
admission	O
.	O

it	O
was	O
felt	O
by	O
the	O
team	O
and	O
by	O
his	O
responsible	O
family	O
that	O
he	O
would	O
be	O
best	O
made	O
cmo	O
.	O

he	O
was	O
then	O
made	O
cmo	O
and	O
kept	O
in	O
the	O
intensive	O
care	O
unit	O
for	O
two	O
days	O
before	O
being	O
transferred	O
to	O
the	O
floor	O
.	O

he	O
was	O
given	O
morphine	O
for	O
comfort	O
as	O
well	O
as	O
ativan	O
for	O
respiratory	B
distress	I
.	O

on	O
[	O
*	O
*	O
07	O
-	O
19	O
*	O
*	O
]	O
,	O
he	O
was	O
found	O
to	O
be	O
pulseless	B
and	O
not	B
breathing	I
and	O
on	O
examination	O
he	O
was	O
pronounced	O
expired	O
at	O
7	O
:	O
00	O
p	O
.	O
m	O
.	O
on	O
[	O
*	O
*	O
07	O
-	O
19	O
*	O
*	O
]	O
.	O

his	O
nephew	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
was	O
called	O
at	O
his	O
home	O
and	O
arrangements	O
were	O
to	O
be	O
made	O
by	O
him	O
to	O
the	O
funeral	O
home	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
intraventricular	B
hemorrhage	I
secondary	O
to	O
likely	O
hypertensive	B
bleed	I
of	O
the	O
basal	O
ganglia	O
/	O
caudate	O
.	O

2	O
.	O
meningitis	B
.	O

3	O
.	O
respiratory	B
failure	I
.	O

4	O
.	O
coronary	B
artery	I
disease	I
status	O
post	O
myocardial	B
infarction	I
.	O

5	O
.	O
hyperlipidemia	B
.	O

6	O
.	O
diabetes	B
.	O

7	O
.	O
status	O
post	O
old	O
cerebrovascular	B
accident	I
with	O
right	B
hemiparesis	I
.	O

8	O
.	O
bipolar	B
disorder	I
.	O

discharge	O
status	O
:	O
to	O
funeral	O
home	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
3166	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
3167	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
25	O
*	O
*	O
]	O
02	O
:	O
46	O

t	O
:	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
25	O
*	O
*	O
]	O
09	O
:	O
05	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
3168	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
3169	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
25	O
*	O
*	O
]	O
12	O
:	O
10	O
pm	O

(	O
end	O
of	O
report	O
)	O

5646	O
||||	O
7797	O
||||	O
26151	O
||||	O
discharge	O
_	O
summary	O
||||	O
2019	O
-	O
09	O
-	O
10	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
09	O
-	O
10	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1959	O
-	O
01	O
-	O
26	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
neurosurgery	O

allergies	O
:	O

iodine	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
834	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

aphasia	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

left	O
sided	O
craniotomy	O

history	O
of	O
present	O
illness	O
:	O

pt	O
was	O
admitted	O
from	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2891	O
*	O
*	O
]	O
office	O
on	O
[	O
*	O
*	O
09	O
-	O
05	O
*	O
*	O
]	O
with	O
difficulty	B
speaking	I
.	O

patient	O
has	O
a	O
known	O
high	O
grade	O
large	O
b	O
-	O
cell	O

lymphoma	O
s	O
/	O
p	O
rchop	O
.	O

in	O
6	O
/	O
06	O
pt	O
had	O
a	O
pet	O
scan	O
for	O
staging	O
prior	O
to	O
bone	O
marrow	O
transplant	O
and	O
additional	O
chemo	O
when	O
she	O
was	O
found	O

to	O
have	O
incidental	O
temporal	O
lesion	B
.	O

as	O
of	O
7	O
/	O
7	O
(	O
patient	O
last	O
seen	O

in	O
clinic	O
)	O
she	O
was	O
at	O
baseline	O
.	O

pt	O
missed	O
her	O
appointment	O
on	O
[	O
*	O
*	O
09	O
-	O
04	O
*	O
*	O
]	O
and	O
after	O
multiple	O
phone	O
calls	O
was	O
seen	O
today	O
.	O

pt	O
unable	O
to	O

say	O
when	O
speech	B
difficulty	I
began	O
.	O

past	O
medical	O
history	O
:	O

large	O
b	O
-	O
cell	O
lymphoma	O
,	O
high	O
grade	O
dx	O
[	O
*	O
*	O
10	O
-	O
29	O
*	O
*	O
]	O
s	O
/	O
p	O
rchop	O

niddm	B

htn	I

hiatal	I
hernia	I

s	O
/	O
p	O
gastric	O
bypass	O

s	O
/	O
p	O
cholecystectomy	O

?b12	O
deficiency	B

social	O
history	O
:	O

lives	O
alone	O

works	O
as	O
secretary	O

(	O
+	O
)	O
tob	O
4ppd	O
x20yrs	O
(	O
quit	O
many	O
years	O
ago	O
)	O

not	O
married	O
;	O
no	O
children	O

family	O
history	O
:	O

her	O
mother	O
died	O
of	O
heart	B
problems	I
,	O
her	O
father	O
died	O
of	O
suicide	B
.	O

her	O
brother	O
is	O
alive	O
at	O
55	O
and	O
has	O
heart	B
problems	I

physical	O
exam	O
:	O

vitals	O
:	O
98	O
.	O
1	O
,	O
152	O
/	O
80	O
,	O
67	O
,	O
18	O
,	O
96%	O
ra	O

gen	O
:	O
obese	B
woman	O
in	O
nad	B

heent	O
:	O
nc	O
/	O
at	O
with	O
allopecia	B
,	O
anicteric	B
sclera	O
,	O
mmm	O

neck	O
:	O
supple	O
,	O
no	O
carotid	B
bruits	I

chest	O
:	O
normal	O
respiratory	O
pattern	O
,	O
cta	O
bilat	O

cv	O
:	O
regular	O
rate	O
and	O
rhythm	O
without	O
murmurs	B

abd	O
:	O
soft	O
,	O
nontender	O
,	O
nondistended	O
,	O
+	O
bs	O

extrem	O
:	O
gross	O
nonpitting	B
edema	I
to	O
the	O
knees	O
bilaterally	O

neuro	O
:	O

mental	O
status	O
:	O

patient	O
is	O
alert	O
,	O
awake	O
,	O
pleasant	O
affect	O
but	O
frustrated	O
at	O
her	O
language	B
dysfunction	I
.	O

oriented	O
to	O
person	O
,	O
place	O
"hospital"	O
"meth	O
[	O
*	O
*	O
country	O
*	O
*	O
]	O
"	O
,	O
time	O
(	O
"	O
[	O
*	O
*	O
2019	O
-	O
02	O
-	O
24	O
*	O
*	O
]	O
"	O
)	O
.	O

attention	O
appears	O
to	O
be	O
good	O
-	O
spells	O
world	O
forwards	O
and	O
backwards	O
well	O
,	O
dsf	O
of	O
2	O
(	O
poor	O
,	O
but	O
states	O
,	O
"i'm	O
always	O
bad	O
with	O

numbers	O
.	O
"	O

does	O
moyb	O
to	O
[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
439	O
*	O
*	O
]	O
,	O
then	O
can't	O
remember	O
the	O
month	O
prior	O
,	O
"oh	O
,	O
what's	O
it	O
called	O
,	O
i	O
know	O
what	O
it's	O
called	O
.	O
"	O

language	O
is	O
fluent	O
technically	O
but	O
with	O
great	O
word	O
finding	O
problems	O
,	O
stopping	O
mid	O
sentence	O
becoming	O
very	O
frustrated	O
,	O
with	O
frequent	O
paraphasic	B
errors	I
(	O
mostly	O
phenomic	O
but	O
some	O
semantic	O
like	O
"hear"	O
for	O
"feel"	O
)	O
.	O

she	O
follows	O
2	O
step	O
commands	O
(	O
good	O
comprehension	O
)	O
,	O
and	O
repitition	O
,	O
able	O
to	O
read	O
but	O
has	O
difficulty	B
writing	I
.	O

she	O
means	O
to	O
write	O
"i	O
love	O
cats"	O
,	O
and	O
instead	O
writes	O
"i	O

love	O
spacturs	O
.	O
"	O

very	O
bad	O
anomia	B
-	O
names	O
only	O
chair	O
on	O
the	O
nihss	O
card	O
.	O

no	O
dysarthria	B
.	O

no	O
apraxia	B
(	O
brushes	O
teeth	O
,	O
waves	O
goodbye	O
,	O
draws	O
a	O
decent	O
3	O
d	O
cube	O
)	O
,	O
no	O
neglect	B
.	O

able	O
to	O
calculate	O
,	O
no	O
left	O
/	O
right	O
mismatch	O
.	O

draws	O
a	O
clock	O
well	O
,	O
and	O
places	O
hands	O
appropriately	O
but	O
the	O
clock	O

is	O
not	O
perfect	O
(	O
hands	O
don't	O
meet	O
in	O
the	O
middle	O
)	O
.	O

cranial	O
nerves	O
:	O

i	O
:	O
deferred	O

ii	O
:	O
visual	O
fields	O
:	O
full	O
to	O
left	O
/	O
right	O
/	O
upper	O
/	O
lower	O
fields	O
.	O

fundoscopic	O
exam	O
:	O
discs	O
flat	O
,	O
fundi	O
clear	O
,	O
no	O
hemorrhages	B
or	O
exudates	B
.	O

pupils	O
:	O
3	O
-	O
>2	O
mm	O
,	O
consenual	O
constriction	O
to	O
light	O
.	O

iii	O
,	O
iv	O
,	O
vi	O
:	O
eoms	O
full	O
,	O
gaze	O
conjugate	O
.	O

no	O
nystagmus	B
or	O
ptosis	B
.	O

v	O
:	O
facial	O
sensation	O
intact	O
over	O
v1	O
/	O
2	O
/	O
3	O
to	O
light	O
touch	O
and	O
pin	O
prick	O
.	O

vii	O
:	O
asymmetric	B
face	I
(	O
mild	O
)	O
but	O
good	O
equal	O
strength	O
.	O

viii	O
:	O
hearing	B
decreased	I
on	O
the	O
right	O

ix	O
,	O
x	O
:	O
symmetric	O
elevation	O
of	O
palate	O
.	O

xi	O
:	O
scm	O
and	O
trapezius	O
[	O
*	O
*	O
06	O
-	O
28	O
*	O
*	O
]	O
bilaterally	O

xii	O
:	O
tongue	O
is	O
just	O
to	O
the	O
right	O
of	O
midline	O
but	O
with	O
good	O
quick	O
motions	O
.	O

sensory	O
:	O

decreased	B
touch	I
right>	O
left	O
legs	O
,	O
decreased	B
vibration	I
(	O
intact	O
at	O

ankles	O
)	O
,	O
decreased	B
pinprick	I
in	O
a	O
patchy	O
distribution	O
on	O
the	O
right	O

arm	O
and	O
leg	O
.	O

no	O
extinction	O
to	O
double	O
simultaneous	O
stimulation	O
.	O

motor	O
:	O

normal	O
bulk	O
,	O
tone	O
.	O

no	O
fasciculations	B
or	O
drift	B
.	O

no	O
adventitious	B
movements	I
.	O

no	O
asterixis	B
.	O

strength	O
:	O

delt	O
tri	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
we	O
wf	O
fe	O
ff	O
ip	O
qd	O
ham	O
df	O
pf	O
toe	O

rt	O
:	O
5	O
4	O
+	O
5	O
5	O
5	O
5	O
5	O
5	O
5	O
5	O
5	O
5	O
4	O

left	O
:	O
5	O
4	O
+	O
5	O
5	O
5	O
4	O
+	O
5	O
5	O
5	O
5	O
5	O
5	O
4	O

reflexes	O
:	O
absent	B
dtrs	I
,	O
toes	B
mute	I

coordination	O
:	O

normal	O
finger	O
-	O
to	O
-	O
nose	O
,	O
heel	O
-	O
to	O
-	O
shin	O
,	O
but	O
somewhat	O
clumbsy	O
rams	O
on	O

the	O
left	O
.	O

gait	O
:	O

normal	O
narrow	O
based	O
gait	O
.	O

patient	O
was	O
frustrated	O
,	O
did	O
not	O
push	O
further	O
.	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2019	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
06	O
:	O
40pm	O
plt	O
count	O
-	O
134	O
*	O

[	O
*	O
*	O
2019	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
06	O
:	O
40pm	O
hypochrom	O
-	O
1	O
+	O
anisocyt	O
-	O
1	O
+	O
poikilocy	O
-	O
2	O
+	O
microcyt	O
-	O
2	O
+	O

[	O
*	O
*	O
2019	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
06	O
:	O
40pm	O
neuts	O
-	O
54	O
.	O
3	O
lymphs	O
-	O
25	O
.	O
3	O
monos	O
-	O
14	O
.	O
2	O
*	O
eos	O
-	O
4	O
.	O
4	O
*	O
basos	O
-	O
1	O
.	O
7	O

[	O
*	O
*	O
2019	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
06	O
:	O
40pm	O
wbc	O
-	O
2	O
.	O
9	O
*	O
rbc	O
-	O
4	O
.	O
47	O
hgb	O
-	O
11	O
.	O
8	O
*	O
hct	O
-	O
34	O
.	O
6	O
*	O
mcv	O
-	O
77	O
*	O
mch	O
-	O
26	O
.	O
5	O
*	O
mchc	O
-	O
34	O
.	O
2	O
rdw	O
-	O
17	O
.	O
7	O
*	O

[	O
*	O
*	O
2019	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
06	O
:	O
40pm	O
vit	O
b12	O
-	O
784	O

[	O
*	O
*	O
2019	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
06	O
:	O
40pm	O
albumin	O
-	O
4	O
.	O
2	O
calcium	O
-	O
8	O
.	O
9	O
phosphate	O
-	O
3	O
.	O
7	O
magnesium	O
-	O
2	O
.	O
0	O

[	O
*	O
*	O
2019	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
06	O
:	O
40pm	O
ck	O
-	O
mb	O
-	O
notdone	O
ctropnt	O
-	O
<0	O
.	O
01	O

[	O
*	O
*	O
2019	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
06	O
:	O
40pm	O
lipase	O
-	O
21	O

[	O
*	O
*	O
2019	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
06	O
:	O
40pm	O
alt	O
(	O
sgpt	O
)	O
-	O
13	O
ast	O
(	O
sgot	O
)	O
-	O
27	O
ld	O
(	O
ldh	O
)	O
-	O
510	O
*	O
ck	O
(	O
cpk	O
)	O
-	O
36	O
alk	O
phos	O
-	O
94	O
amylase	O
-	O
30	O
tot	O
bili	O
-	O
0	O
.	O
5	O

[	O
*	O
*	O
2019	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
06	O
:	O
40pm	O
glucose	O
-	O
121	O
*	O
urea	O
n	O
-	O
10	O
creat	O
-	O
0	O
.	O
6	O
sodium	O
-	O
142	O
potassium	O
-	O
3	O
.	O
8	O
chloride	O
-	O
109	O
*	O
total	O
co2	O
-	O
22	O
anion	O
gap	O
-	O
15	O

[	O
*	O
*	O
2019	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
11	O
:	O
10pm	O
urine	O
mucous	O
-	O
rare	O

[	O
*	O
*	O
2019	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
11	O
:	O
10pm	O
urine	O
rbc	O
-	O
0	O
wbc	O
-	O
12	O
*	O
bacteria	O
-	O
occ	O
yeast	O
-	O
none	O
epi	O
-	O
<1	O
renal	O
epi	O
-	O
<1	O

[	O
*	O
*	O
2019	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
11	O
:	O
10pm	O
urine	O
blood	O
-	O
neg	O
nitrite	O
-	O
neg	O
protein	O
-	O
neg	O
glucose	O
-	O
neg	O
ketone	O
-	O
neg	O
bilirubin	O
-	O
neg	O
urobilngn	O
-	O
neg	O
ph	O
-	O
6	O
.	O
0	O
leuk	O
-	O
tr	O

brief	O
hospital	O
course	O
:	O

ms	O
[	O
*	O
*	O
lastname	O
2892	O
*	O
*	O
]	O
was	O
admitted	O
to	O
the	O
icu	O
with	O
q1	O
hour	O
neurochecks	O
,	O
started	O
on	O
mannitol	O
for	O
extreme	O
edema	B
.	O

she	O
was	O
also	O
started	O
on	O
dilantin	O
for	O
seizure	B
prophlaxis	O
.	O

she	O
underwent	O
resection	O
early	O
am	O
of	O
7	O
/	O
14	O
for	O
diagnosis	O
and	O
prevention	O
of	O
uncal	B
herniation	I
.	O

preliminary	O
biopsy	O
was	O
consistent	O
with	O
b	B
-	I
cell	I
lymphoma	I
.	O

the	O
case	O
went	O
without	O
complication	B
the	O
posteromedial	O
resection	O
,	O
it	O
was	O
quite	O
difficult	O
to	O
distinguish	O
between	O
brain	O
and	O
tumor	B
,	O
and	O
it	O
was	O
believed	O
that	O
some	O
small	O
residual	O
amount	O
of	O
tumor	B
was	O
left	O
behind	O
.	O

post	O
operatively	O
she	O
returned	O
to	O
the	O
icu	O
was	O
awake	O
,	O
alert	O
and	O
orientated	O
x3	O
.	O

her	O
speech	B
was	O
improving	O
slowly	O
she	O
was	O
neurologically	O
intact	O
.	O

her	O
bp	O
was	O
kept	O
less	O
than	O
120	O
overnight	O
.	O

mannitol	O
was	O
not	O
restarted	O
post	O
operatively	O
.	O

her	O
decadron	O
was	O
weaned	O
down	O
slowly	O
.	O

on	O
pod#2	O
she	O
was	O
tolerating	O
a	O
regular	O
diet	O
,	O
voiding	O
without	O
difficulty	O
.	O

she	O
was	O
transferred	O
out	O
of	O
the	O
unit	O
to	O
the	O
regular	O
floor	O
on	O
post	O
operative	O
day	O
3	O
.	O
she	O
was	O
seen	O
by	O
physical	O
therapy	O
and	O
felt	O
safe	O
to	O
go	O
home	O
with	O
speech	O
therapy	O
.	O

occupational	O
therapy	O
also	O
felt	O
she	O
was	O
safe	O
to	O
go	O
home	O
.	O

she	O
will	O
need	O
her	O
staples	O
out	O
on	O
arrival	O
to	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
2893	O
*	O
*	O
]	O
7	O
on	O
[	O
*	O
*	O
09	O
-	O
16	O
*	O
*	O
]	O

medications	O
on	O
admission	O
:	O

allopurinol	O
,	O
bupripion	O
,	O
propanolol	O
,	O
dilantin	O

discharge	O
medications	O
:	O

1	O
.	O
allopurinol	O
300	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

2	O
.	O
bupropion	O
75	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
am	O
(	O
)	O
.	O

3	O
.	O
bupropion	O
100	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
pm	O
(	O
)	O
.	O

4	O
.	O
propranolol	O
80	O
mg	O
capsule	O
,	O
sustained	O
action	O
24hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
,	O
sustained	O
action	O
24hr	O
po	O
daily	O
(	O
daily	O
)	O
.	O

5	O
.	O
pantoprazole	O
40	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
q24h	O
(	O
every	O
24	O
hours	O
)	O
.	O

6	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
:	O
use	O
while	O
taking	O
pain	B
medication	O
.	O

7	O
.	O
oxycodone	O
-	O
acetaminophen	O
5	O
-	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

8	O
.	O
dexamethasone	O
1	O
.	O
5	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
q8h	O
(	O
every	O
8	O
hours	O
)	O
.	O

disp	O
:	O
*	O
42	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

9	O
.	O
dilantin	O
100	O
mg	O
capsule	O
sig	O
:	O
take	O
2	O
bid	O
and	O
1	O
at	O
lunch	O
time	O
capsule	O
po	O
see	O
above	O
.	O

disp	O
:	O
*	O
30	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

b	B
-	I
cell	I
lymphoma	I
with	O
brain	B
involvement	I

discharge	O
condition	O
:	O

neurologically	O
stable	O

discharge	O
instructions	O
:	O

go	O
to	O
7	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
2894	O
*	O
*	O
]	O
on	O
east	O
campus	O
at	O
1000	O
for	O
methotrexate	O
therapy	O
on	O
[	O
*	O
*	O
09	O
-	O
16	O
*	O
*	O
]	O
dr	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1497	O
*	O
*	O
]	O
will	O
be	O
your	O
admitting	O
physician	O
[	O
*	O
*	O
name9	O
(	O
pre	O
)	O
2895	O
*	O
*	O
]	O
incision	O
clean	O
and	O
dry	O
watch	O
incision	O
for	O
redness	B
,	O
drainage	B
,	O
bleeding	B
,	O
swelling	B
,	O
fever	B
greater	O
than	O
101	O
.	O
5	O
call	O
dr	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2896	O
*	O
*	O
]	O
office	O
no	O
driving	O
have	O
staples	O
removed	O
on	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
2894	O
*	O
*	O
]	O
7	O
on	O
arrival	O

followup	O
instructions	O
:	O

follow	O
up	O
with	O
dr	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2897	O
*	O
*	O
]	O
and	O
brain	B
tumor	I
clinic	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
423	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
835	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
836	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2223	O
*	O
*	O
]	O
np	O
80	O
-	O
aky	O
[	O
*	O
*	O
2019	O
-	O
09	O
-	O
10	O
*	O
*	O
]	O
@	O
1324	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
423	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2019	O
-	O
10	O
-	O
18	O
*	O
*	O
]	O
2	O
:	O
19	O
pm	O

(	O
end	O
of	O
report	O
)	O

388895	O
||||	O
8216	O
||||	O
5989	O
||||	O
radiology	O
_	O
report	O
||||	O
2013	O
-	O
02	O
-	O
24	O
15	O
:	O
29	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
360	O
-	O
5168	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2013	O
-	O
02	O
-	O
24	O
*	O
*	O
]	O
3	O
:	O
29	O
pm	O

chest	O
(	O
portable	O
ap	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
6544	O
*	O
*	O
]	O
reason	O
:	O
post	O
ct	O
dc'd	O
admitting	O
diagnosis	O
:	O
atrial	B
defect\	O
repair	O
atrial	B
septal	I
defect	I
/	O
sda	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

40	O
year	O
old	O
woman	O
with	O
pfo	B
/	O
asd	B
s	O
/	O
p	O
minimal	O
invasive	O
asd	B
closure	O

reason	O
for	O
this	O
examination	O
:	O

post	O
ct	O
dc'd	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
chest	O
tube	O
removed	O
.	O

portable	O
chest	O
:	O
comparison	O
is	O
made	O
to	O
film	O
from	O
one	O
day	O
earlier	O
.	O

the	O
right	O
chest	O
tube	O
has	O
been	O
removed	O
.	O

the	O
tip	O
of	O
the	O
central	O
line	O
remains	O
in	O
the	O
distal	O
svc	O
.	O

the	O
cardiac	O
and	O
mediastinal	O
contours	O
are	O
stable	O
.	O

there	O
is	O
improved	B
aeration	I
in	O
the	O
right	O
lung	O
base	O
,	O
which	O
now	O
appears	O
largely	O
clear	O
.	O

there	O
is	O
however	O
progression	O
of	O
abnormal	B
density	I
in	O
the	O
left	O
retrocardiac	O
area	O
.	O

there	O
is	O
no	O
evidence	O
of	O
chf	B
or	O
pneumothorax	B
.	O

impression	O
:	O
1	O
.	O
no	O
evidence	O
of	O
pneumothorax	B
s	O
/	O
p	O
right	O
chest	O
tube	O
removal	O
.	O

2	O
.	O
improved	B
aeration	I
right	O
base	O
.	O

3	O
.	O
somewhat	O
worsened	B
aeration	I
left	O
base	O
.	O

97667	O
||||	O
8324	O
||||	O
10702	O
||||	O
echo	O
_	O
report	O
||||	O
2018	O
-	O
07	O
-	O
27	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
atrial	B
fibrillation	I
/	O
flutter	O
.	O

congestive	B
heart	I
failure	I
.	O

coronary	B
artery	I
disease	I
.	O

mitral	B
regurgitation	I
.	O

left	B
ventricular	I
function	I
.	O

height	O
:	O
(	O
in	O
)	O
73	O

weight	O
(	O
lb	O
)	O
:	O
126	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
77	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
118	O
/	O
64	O

hr	O
(	O
bpm	O
)	O
:	O
70	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2018	O
-	O
07	O
-	O
27	O
*	O
*	O
]	O
at	O
15	O
:	O
09	O

test	O
:	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
moderate	O
la	B
enlargement	I
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
moderately	O
dilated	B
ra	I
.	O

a	O
catheter	O
or	O
pacing	O
wire	O
is	O
seen	O
in	O
the	O
ra	O
and	O
extending	O
into	O
the	O
rv	O
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thickness	O
.	O

moderately	O
dilated	B
lv	I
cavity	O
.	O

severe	O
global	O
lv	O
hypokinesis	B
.	O

no	O
resting	B
lvot	I
gradient	I
.	O

no	O
lv	O
mass	B
/	O
thrombus	B
.	O

no	O
vsd	B
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aortic	O
valve	O
:	O
mildly	O
thickened	B
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

no	O
mvp	B
.	O

mild	O
mitral	B
annular	I
calcification	I
.	O

mild	O
thickening	B
of	O
mitral	O
valve	O
chordae	O
.	O

calcified	B
tips	I
of	O
papillary	O
muscles	O
.	O

no	O
ms	B
.	O

moderate	O
to	O
severe	O
(	O
3	O
+	O
)	O
mr	B
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
normal	O
pulmonic	O
valve	O
leaflets	O
with	O
physiologic	O
pr	B
.	O

normal	O
main	O
pa	O
.	O

no	O
doppler	O
evidence	O
for	O
pda	B

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

the	O
right	O
atrium	O
is	O
moderately	O
dilated	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
is	O
moderately	O
dilated	O
.	O

there	O
is	O
severe	O
global	O
left	O
ventricular	O
hypokinesis	B
(	O
ejection	O
fraction	O
20	O
-	O
30	O
percent	O
)	O
.	O

no	O
masses	B
or	O
thrombi	B
are	O
seen	O
in	O
the	O
left	O
ventricle	O
.	O

there	O
is	O
no	O
ventricular	B
septal	I
defect	I
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
but	O
aortic	B
stenosis	I
is	O
not	O
present	O
.	O

no	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
no	O
mitral	B
valve	I
prolapse	I
.	O

moderate	O
to	O
severe	O
(	O
3	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

compared	O
with	O
the	O
findings	O
of	O
the	O
prior	O
study	O
(	O
images	O
reviewed	O
)	O
of	O
[	O
*	O
*	O
35	O
-	O
06	O
-	O
12	O
*	O
*	O
]	O
,	O
no	O
major	O
change	O
is	O
evident	O
.	O

16301	O
||||	O
8415	O
||||	O
13277	O
||||	O
discharge	O
_	O
summary	O
||||	O
2011	O
-	O
05	O
-	O
04	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
04	O
-	O
29	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
04	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1985	O
-	O
10	O
-	O
27	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O

this	O
is	O
from	O
the	O
medical	O
intensive	O
care	O
unit	O
admission	O
intern	O
admission	O
note	O
.	O

chief	O
complaint	O
:	O
respiratory	B
distress	I
.	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
a	O
25	O
-	O
year	O
-	O
old	O
female	O
with	O
crohn's	B
disease	I
on	O
6mp	O
and	O
chronic	O
prednisone	O
times	O
six	O
weeks	O
,	O
who	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
[	O
*	O
*	O
2011	O
-	O
04	O
-	O
21	O
*	O
*	O
]	O
when	O
she	O
began	O
to	O
feel	O
nasal	B
congestion	I
,	O
spiking	B
temperatures	I
as	O
high	O
at	O
106	O
.	O
7	O
degrees	O
fahrenheit	O
,	O
accompanied	O
by	O
fevers	B
and	O
shaking	B
chills	I
.	O

the	O
symptoms	O
were	O
accompanied	O
by	O
lower	O
extremity	O
myalgias	B
,	O
diarrhea	B
,	O
that	O
was	O
without	O
blood	O
or	O
mucous	O
and	O
a	O
non	B
-	I
productive	I
cough	I
.	O

the	O
following	O
day	O
,	O
the	O
patient	O
presented	O
to	O
[	O
*	O
*	O
hospital	O
2002	O
*	O
*	O
]	O
and	O
had	O
a	O
lumbar	O
puncture	O
and	O
a	O
chest	O
x	O
-	O
ray	O
,	O
both	O
of	O
which	O
were	O
negative	O
for	O
any	O
signs	O
of	O
infection	B
.	O

she	O
had	O
a	O
normal	O
white	O
blood	O
cell	O
count	O
at	O
the	O
time	O
with	O
a	O
differential	O
that	O
later	O
came	O
back	O
as	O
27%	O
bands	O
.	O

the	O
patient	O
was	O
treated	O
with	O

tylenol	O
and	O
her	O
symptoms	B
persisted	I
.	O

the	O
patient	O
then	O
presented	O
two	O
days	O
later	O
to	O
her	O
primary	O
care	O
physician	O
who	O
placed	O
her	O
on	O
a	O
course	O
of	O
azithromycin	O
for	O
a	O
presumed	O
atypical	B
pneumonia	I
.	O

on	O
the	O
day	O
of	O
admission	O
,	O
the	O
primary	O
care	O
physician	O
reviewed	O
the	O
results	O
of	O
her	O
bandemia	B
from	O
the	O
outside	O
hospital	O
and	O
asked	O
her	O
to	O
come	O
to	O
the	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
emergency	O
department	O
for	O
further	O
evaluation	O
.	O

the	O
patient	O
presented	O
to	O
the	O
emergency	O
room	O
with	O
low	B
grade	I
temperatures	I
and	O
then	O
spiked	O
to	O
105	O
and	O
became	O
tachycardic	B
and	O
tachypneic	B
into	O
the	O
40s	O
.	O

she	O
then	O
developed	O
an	O
oxygen	O
requirement	O
up	O
to	O
15	O
liters	O
nasal	O
cannula	O
.	O

in	O
the	O
emergency	O
department	O
,	O
the	O
patient	O
had	O
a	O
chest	O
x	O
-	O
ray	O
which	O
revealed	O
a	O
right	O
hilar	O
infiltrate	B
and	O
left	O
lower	O
lobe	O
infiltrate	B
.	O

an	O
abdominal	O
ct	O
was	O
performed	O
to	O
check	O
for	O
occult	O
abscess	B
which	O
was	O
negative	O
,	O
however	O
,	O
this	O
showed	O
bibasilar	O
pneumonia	B
in	O
consolidations	B
.	O

ct	O
of	O
the	O
head	O
revealed	O
some	O
minor	O
sinus	B
thickening	I
and	O
no	O
other	O
abnormalities	B
.	O

in	O
the	O
emergency	O
department	O
,	O
the	O
patient	O
was	O
given	O
a	O
dose	O
of	O
intravenous	O
levaquin	O
and	O
transferred	O
to	O
the	O
medical	O
intensive	O
care	O
unit	O
for	O
impending	O
respiratory	B
failure	I
.	O

patient	O
gives	O
a	O
history	O
of	O
recent	O
travel	O
to	O
[	O
*	O
*	O
state	O
549	O
*	O
*	O
]	O
in	O
march	O
in	O
which	O
she	O
swam	O
in	O
a	O
pool	O
but	O
no	O
sick	O
contacts	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
crohn's	B
disease	I
diagnosed	O
in	O
[	O
*	O
*	O
2010	O
-	O
10	O
-	O
19	O
*	O
*	O
]	O
,	O
currently	O
with	O
a	O
course	O
of	O
6mp	O
and	O
prednisone	O
started	O
in	O
[	O
*	O
*	O
2011	O
-	O
02	O
-	O
19	O
*	O
*	O
]	O
.	O

the	O
prednisone	O
had	O
been	O
started	O
at	O
40	O
and	O
tapered	O
down	O
to	O
5	O
mg	O
by	O
the	O
time	O
of	O
admission	O
.	O

2	O
.	O
status	O
post	O
appendectomy	O
.	O

3	O
.	O
status	O
post	O
mononucleosis	B
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

medications	O
on	O
admission	O
:	O

1	O
.	O
6mp	O
50	O
mg	O
po	O
q	O
.	O
d	O
.	O

2	O
.	O
prednisone	O
5	O
mg	O
po	O
q	O
.	O
d	O
.	O

3	O
.	O
asacol	O
800	O
mg	O
po	O
t	O
.	O
i	O
.	O
d	O
.	O

recent	O
finishing	O
of	O
a	O
z	O
pack	O
and	O
an	O
oral	O
contraceptive	O
.	O

social	O
history	O
:	O
the	O
patient	O
is	O
a	O
financial	O
manager	O
at	O

fleet's	O
.	O

married	O
.	O

no	O
tobacco	O
,	O
no	O
alcohol	O
or	O
intravenous	O
drug	O
use	O
.	O

family	O
history	O
:	O
hypertension	B
,	O
hypercholesterolemia	B
,	O
and	O
a	O
grandmother	O
with	O
rheumatoid	B
arthritis	I
.	O

physical	O
examination	O
on	O
admission	O
:	O
blood	O
pressure	O
130	O
/	O
80	O
.	O

pulse	O
104	O
.	O

respiratory	O
rate	O
of	O
50	O
,	O
oxygenation	O
74%	O
on	O
room	O
air	O
up	O
to	O
90%	O
on	O
a	O
nonrebreather	O
.	O

head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
:	O
mucous	B
membranes	I
dry	I
.	O

general	O
:	O
diaphoretic	B
and	O
tachypneic	B
.	O

cardiovascular	O
:	O
tachycardic	B
,	O
no	O
murmurs	B
,	O
rubs	B
or	O
gallops	B
.	O

lungs	O
:	O
right	O
lower	O
lobe	O
crackles	B
,	O
good	O
air	O
movement	O
.	O

abdomen	O
:	O
positive	O
bowel	O
sounds	O
,	O
soft	O
,	O
nontender	O
,	O
nondistended	O
,	O
no	O
organomegaly	B
.	O

extremities	O
without	O
edema	B
.	O

laboratories	O
on	O
admission	O
:	O
white	O
blood	O
cell	O
count	O
8	O
,	O
hematocrit	O
35	O
.	O
2	O
,	O
platelet	O
count	O
242	O
,	O
000	O
.	O

differential	O
of	O
80	O
,	O
7%	O
polys	O
,	O
9%	O
lymphocytes	O
,	O
3%	O
monocytes	O
.	O

sodium	O
130	O
,	O
potassium	O
3	O
.	O
6	O
,	O
chloride	O
96	O
,	O
bicarbonate	O
23	O
,	O
bun	O
9	O
,	O
creatinine	O
0	O
.	O
7	O
,	O
glucose	O
154	O
.	O

chest	O
x	O
-	O
ray	O
with	O
mild	O
right	O
hilar	O
infiltrate	B
and	O
left	O
lower	O
lobe	O
infiltrate	B
.	O

ct	O
of	O
the	O
head	O
with	O
sinus	B
thickening	I
.	O

ct	O
of	O
the	O
abdomen	O
:	O
no	O
abscess	B
,	O
but	O
bibasilar	O
pneumonia	B
with	O
small	O
effusions	B
.	O

electrocardiogram	O
:	O
sinus	B
tachycardia	I
at	O
158	O
,	O
normal	O
axis	O
,	O
no	O
st	B
changes	I
.	O

hospital	O
course	O
:	O

1	O
.	O
pneumonia	B
:	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
medical	O

intensive	O
care	O
unit	O
for	O
impending	O
respiratory	B
failure	I
and	O
maintained	O
on	O
a	O
100%	O
nonrebreather	O
mask	O
.	O

her	O
initial	O
arterial	O
blood	O
gas	O
showed	O
a	O
ph	O
of	O
7	O
.	O
45	O
,	O
a	O
pco2	O
of	O
26	O
and	O
a	O
po2	O
of	O
82	O
on	O
the	O
100%	O
nonrebreather	O
.	O

the	O
patient	O
was	O
started	O
on	O
prednisone	O
40	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O
and	O
bactrim	O
for	O
suspected	O
pcp	B
pneumonia	I
given	O
her	O
immunosuppression	O
,	O
as	O
well	O
as	O
levaquin	O
500	O
mg	O
po	O
q	O
.	O
d	O
.	O
for	O
question	O
of	O
community	B
acquired	I
pneumonia	I
or	O
atypical	B
pneumonia	I
.	O

the	O
patient	O
spent	O
one	O
night	O
in	O
the	O
intensive	O
care	O
unit	O
and	O
was	O
weaned	O
off	O
of	O
her	O
100%	O
nonrebreather	O
down	O
to	O
two	O
liter	O
nasal	O
cannula	O
.	O

she	O
was	O
then	O
called	O
out	O
to	O
the	O
floor	O
.	O

her	O
bactrim	O
was	O
discontinued	O
as	O
she	O
did	O
have	O
a	O
rash	B
develop	O
to	O
this	O
that	O
did	O
go	O
away	O
after	O
the	O
bactrim	O
was	O
discontinued	O
with	O
a	O
lower	O
suspicion	O
of	O
pcp	B
given	O
her	O
ct	O
finding	O
of	O
dense	O
consolidations	B
,	O
a	O
negative	O
ldh	O
.	O

her	O
bactrim	O
was	O
discontinued	O
and	O
another	O
anti	O
-	O
pcp	B
medication	O
was	O
not	O
continued	O
.	O

her	O
sputum	O
did	O
return	O
negative	O
for	O
pcp	B
times	O
one	O
.	O

her	O
sputum	O
also	O
was	O
negative	O
for	O
legionella	B
antigen	I
,	O
as	O
well	O
as	O
her	O
urine	O
negative	O
for	O
legionella	B
.	O

her	O
sputum	O
did	O
not	O
grow	O
out	O
any	O
pathogenic	O
organisms	O
and	O
was	O
shown	O
to	O
have	O
oropharyngeal	O
flora	O
,	O
however	O
,	O
the	O
patient	O
did	O
not	O
have	O
a	O
large	O
sputum	O
production	O
and	O
this	O
was	O
a	O
small	O
induced	O
sample	O
.	O

it	O
is	O
likely	O
that	O
the	O
patient	O
had	O
a	O
bacterial	B
pneumonia	I
given	O
her	O
radiologic	O
picture	O
,	O
although	O
,	O
legionella	B
is	O
still	O
a	O
possibility	O
and	O
her	O
negative	O
urine	O
antigen	O
might	O
have	O
been	O
because	O
she	O
had	O
already	O
been	O
treated	O
with	O
antibiotics	O
.	O

the	O
patient	O
did	O
improve	O
and	O
was	O
on	O
room	O
air	O
with	O
a	O
trending	O
oxygen	O
saturation	O
of	O
97%	O
upon	O
discharge	O
.	O

2	O
.	O
anemia	B
:	O
the	O
patient	O
had	O
a	O
microcytic	B
anemia	I
with	O
a	O
hematocrit	O
that	O
came	O
down	O
to	O
25	O
after	O
fluids	O
.	O

the	O
anemia	O
was	O
microcytic	O
with	O
an	O
mcv	O
of	O
73	O
.	O

iron	O
studies	O
showed	O
an	O
iron	O
of	O
38	O
,	O
a	O
tibc	O
of	O
251	O
,	O
a	O
ferritin	O
of	O
69	O
,	O
transferrin	O
of	O
193	O
.	O

these	O
were	O
thought	O
to	O
be	O
consistent	O
with	O
a	O
mild	O
iron	B
deficiency	I
anemia	I
and	O
she	O
was	O
started	O
on	O
iron	O
.	O

her	O
reticulocyte	O
count	O
,	O
however	O
,	O
was	O
0	O
.	O
3	O
and	O
this	O
may	O
have	O
been	O
suppressed	O
in	O
the	O
setting	O
of	O
acute	O
illness	B
.	O

3	O
.	O
crohn's	B
disease	I
:	O
her	O
abdominal	O
ct	O
was	O
not	O
consistent	O
with	O
a	O
crohn's	B
flare	I
and	O
her	O
mild	O
loose	B
stools	I
were	O
thought	O
to	O
be	O
secondary	O
to	O
her	O
illness	B
rather	O
than	O
her	O
crohn's	B
disease	I
.	O

she	O
was	O
weaned	O
back	O
down	O
from	O
the	O
initial	O
40	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O

bactrim	O
she	O
had	O
been	O
put	O
on	O
for	O
pcp	B
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
5	O
mg	O
per	O
day	O
that	O
she	O
was	O
taking	O
for	O
her	O
crohn's	B
.	O

she	O
was	O
continued	O
on	O
her	O
asacol	O
as	O
per	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2003	O
*	O
*	O
]	O
recommendations	O
.	O

4	O
.	O
increased	B
lfts	I
:	O
the	O
patient's	O
alt	O
did	O
go	O
up	O
to	O
234	O
and	O

ast	O
to	O
93	O
.	O

this	O
was	O
thought	O
to	O
be	O
either	O
secondary	O
to	O
her	O
reaction	B
to	I
bactrim	I
versus	O
her	O
pneumonia	B
.	O

these	O
did	O
trend	O
down	O
after	O
her	O
bactrim	O
was	O
stopped	O
.	O

they	O
can	O
be	O
followed	O
out	O
for	O
continued	O
downtrending	O
to	O
normal	O
as	O
an	O
outpatient	O
.	O

the	O
patient	O
had	O
no	O
other	O
associated	O
findings	O
of	O
liver	B
disease	I
,	O
including	O
no	O
abdominal	B
pain	I
,	O
no	O
elevated	B
alkaline	I
phosphatase	I
and	O
a	O
normal	O
total	O
bilirubin	O
.	O

disposition	O
:	O
the	O
patient	O
was	O
discharged	O
home	O
.	O

follow	O
-	O
up	O
:	O
she	O
will	O
follow	O
-	O
up	O
with	O
her	O
primary	O
care	O
physician	O
,	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2004	O
*	O
*	O
]	O
,	O
tomorrow	O
and	O
follow	O
-	O
up	O
with	O
her	O
gastroenterologist	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
next	O
week	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
pneumonia	O
,	O
likely	O
bacterial	O
.	O

2	O
.	O
small	O
bilateral	B
pleural	I
effusions	I
likely	O
secondary	O
to	O
pneumonia	B
.	O

3	O
.	O
microcytic	B
anemia	I
,	O
likely	O
iron	B
deficiency	I
.	O

4	O
.	O
increased	B
lfts	I
,	O
now	O
trending	O
down	O
,	O
likely	O
secondary	O
to	O

bactrim	B
reaction	I
.	O

medications	O
on	O
discharge	O
:	O

1	O
.	O
levofloxacin	O
500	O
mg	O
per	O
tablet	O
,	O
1	O
po	O
q	O
.	O
d	O
.	O
for	O
eight	O
more	O
days	O
to	O
complete	O
a	O
14	O
day	O
course	O
.	O

2	O
.	O
pantoprazole	O
40	O
mg	O
po	O
q	O
.	O
d	O
.	O
for	O
gastrointestinal	O
prophylaxis	O
on	O
steroids	O
.	O

3	O
.	O
calcium	O
carbonate	O
500	O
mg	O
po	O
t	O
.	O
i	O
.	O
d	O
.	O

4	O
.	O
vitamin	O
d	O
400	O
units	O
q	O
.	O
d	O
.	O
for	O
bone	O
prophylaxis	O
on	O
steroids	O
.	O

5	O
.	O
ibuprofen	O
800	O
mg	O
po	O
t	O
.	O
i	O
.	O
d	O
.	O

6	O
.	O
prednisone	O
5	O
mg	O
po	O
q	O
.	O
d	O
.	O

7	O
.	O
iron	O
sulfate	O
325	O
mg	O
po	O
q	O
.	O
d	O
.	O

mark	O
[	O
*	O
*	O
doctor	O
last	O
name	O
377	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
378	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
05	O
*	O
*	O
]	O
02	O
:	O
23	O

t	O
:	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
04	O
*	O
*	O
]	O
18	O
:	O
48	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
2005	O
*	O
*	O
]	O

rp	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
09	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
377	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
10	O
*	O
*	O
]	O
8	O
:	O
11	O
am	O

(	O
end	O
of	O
report	O
)	O

3318	O
||||	O
8786	O
||||	O
9155	O
||||	O
discharge	O
_	O
summary	O
||||	O
2019	O
-	O
10	O
-	O
31	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
10	O
-	O
31	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1973	O
-	O
11	O
-	O
12	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
1655	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

"i'm	O
having	O
withdrawal"	O

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

cc	O
:	O
[	O
*	O
*	O
cc	O
contact	O
info	O
3114	O
*	O
*	O
]	O
.	O

hpi	O
:	O
45	O
yo	O
m	O
with	O
h	O
/	O
o	O
polysubstance	B
abuse	I
and	O
?	O
h	O
/	O
o	O
alcohol	B
withdrawal	I
seizures	I
who	O
was	O
found	O
in	O
his	O
hotel	O
room	O
drunk	B
and	O
naked	O
sitting	O
in	O
stool	O
after	O
calling	O
911	O
.	O

he	O
stated	O
he	O
was	O
using	B
heroin	I
.	O

initial	O
blood	O
sugar	O
123	O
,	O
bp	O
140	O
/	O
p	O
,	O
hr	O
106	O
,	O
97%	O
nrb	O
.	O

per	O
report	O
he	O
had	O
a	O
sz	B
in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
3	O
*	O
*	O
]	O
lobby	O
.	O

in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
3	O
*	O
*	O
]	O
he	O
received	O
ativan	O
2	O
mg	O
x2	O
.	O

head	O
ct	O
and	O
cxr	O
unremarkable	O
.	O

currently	O
he	O
is	O
sedated	O
but	O
arousable	O
to	O
sternal	O
rub	O
.	O

o2	O
sat	O
decreased	O
to	O
87%	O
on	O
2l	O
nc	O
while	O
asleep	O
,	O
increased	O
to	O
95%	O
on	O
4l	O
nc	O
.	O

he	O
reports	O
he	O
is	O
uncomfortable	B
secondary	O
to	O
withdrawel	B
symptoms	I
.	O

he	O
admits	O
to	O
drinking	B
2	O
liters	O
of	O
vodka	O
today	O
and	O
using	B
morphine	I
and	O
dilaudid	O
.	O

urine	O
and	O
serum	O
tox	O
screen	O
in	O
[	O
*	O
*	O
doctor	O
first	O
name	O
3	O
*	O
*	O
]	O
revealed	O
etoh	O
level	O
of	O
317	O
,	O
otherwise	O
negative	O
.	O

he	O
reports	O
being	O
sober	B
for	O
3	O
yrs	O
[	O
*	O
*	O
lastname	O
3115	O
*	O
*	O
]	O
to	O
recent	B
binge	I
.	O

pt	O
was	O
last	O
seen	O
at	O
[	O
*	O
*	O
hospital1	O
2	O
*	O
*	O
]	O
in	O
[	O
*	O
*	O
2016	O
-	O
10	O
-	O
12	O
*	O
*	O
]	O
.	O

at	O
that	O
time	O
he	O
was	O
evaluated	O
by	O
neuro	O
and	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
44	O
*	O
*	O
]	O
;	O
he	O
had	O
several	O
episodes	O
of	O
arm	O
and	O
leg	O
shaking	B
which	O
were	O
not	O
thought	O
to	O
be	O
seizures	B
.	O

he	O
reports	O
he	O
started	O
drinking	B
again	O
secondary	O
to	O
depression	B
.	O

he	O
admits	O
to	O
suicidal	B
ideation	I
with	O
a	O
plan	O
to	O
"drink	O
himself	O
to	O
death"	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
etoh	B
abuse	I

2	O
.	O
cocaine	B
abuse	I

3	O
.	O
heroin	B
abuse	I

4	O
.	O
?h	O
/	O
o	O
hepatitis	B
c	I
(	O
negative	O
hcv	O
ab	O
in	O
5	O
/	O
03	O
)	O

5	O
.	O
+	O
ppd	O
s	O
/	O
p	O
inh	O
x6	O
months	O

6	O
.	O
depression	B
treated	O
at	O
[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
85	O
*	O
*	O
]	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
304	O
*	O
*	O
]	O
va	O

social	O
history	O
:	O

reports	O
drinking	B
2	O
liters	O
of	O
vodka	O
today	O
.	O

he	O
was	O
incarcerated	O
for	O
vehicular	O
homicide	O
(	O
dui	O
)	O
in	O
[	O
*	O
*	O
2007	O
*	O
*	O
]	O
-	O
2002	O
.	O

started	O
drinking	B
age	O

13	O
.	O

enlisted	O
in	O
army	O
age	O
17	O
.	O

joined	O
army	O
rangers	O
.	O

6	O
children	O
in	O
his	O
family	O
.	O

living	O
with	O
mother	O
at	O
home	O
;	O
in	O
and	O
out	O
of	O
most	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
304	O
*	O
*	O
]	O
hospitals	O
.	O

recently	O
admitted	O
in	O
[	O
*	O
*	O
07	O
-	O
18	O
*	O
*	O
]	O
to	O
icu	O
at	O
[	O
*	O
*	O
hospital1	O
569	O
*	O
*	O
]	O
va	O
for	O
multiple	O
seizures	B
.	O

then	O
inpt	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
44	O
*	O
*	O
]	O
stay	O
,	O
completed	O
6	O
wk	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
85	O
*	O
*	O
]	O
detox	O
program	O
at	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
304	O
*	O
*	O
]	O
va	O
(	O
completed	O
labor	O
day	O
)	O
.	O

in	O
[	O
*	O
*	O
2016	O
*	O
*	O
]	O
committed	O
to	O
[	O
*	O
*	O
hospital	O
3116	O
*	O
*	O
]	O
for	O
30	O
days	O
.	O

family	O
reports	O
he	O
was	O
missing	O
since	O
5	O
days	O
[	O
*	O
*	O
lastname	O
3115	O
*	O
*	O
]	O
to	O
admission	O
.	O

was	O
living	O
with	O
his	O
mother	O
since	O
completed	O
va	O
program	O
.	O

family	O
history	O
:	O

unknown	O

physical	O
exam	O
:	O

upon	O
arrival	O
to	O
icu	O
:	O

tc	O
98	O
.	O
7	O
bp	O
130	O
/	O
69	O
hr	O
101	O
rr	O
9	O
-	O
18	O
sat	O
89	O
-	O
96%	O
4l	O
nc	O

gen	O
:	O
initially	O
sleeping	O
,	O
then	O
awakes	O
with	O
arm	O
shaking	B
,	O
refusing	O
to	O
open	O
eyes	O
or	O
mouth	O

hennt	O
:	O
anicteric	B

cv	O
:	O
rrr	O
,	O
nl	O
s1s2	O
,	O
no	O
m	B
/	O
r	B
/	O
g	B

lungs	O
:	O
anteriorly	O
ctab	O

abd	O
:	O
soft	O
,	O
nt	O
/	O
nd	O
,	O
+	O
bs	O
,	O
no	O
hsm	B

ext	O
:	O
no	O
edema	B
,	O
strong	O
dp	O
/	O
pt	O
pulses	O
bilaterally	O

neuro	O
:	O
spontaneously	O
moving	O
ue's	O
x	O
10	O
seconds	O
while	O
awake	O

skin	O
:	O
no	O
rash	B

pertinent	O
results	O
:	O

labs	O
on	O
admission	O
:	O

[	O
*	O
*	O
2019	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
09	O
:	O
13pm	O
glucose	O
-	O
86	O
urea	O
n	O
-	O
20	O
creat	O
-	O
0	O
.	O
9	O
sodium	O
-	O
136	O
potassium	O
-	O
3	O
.	O
6	O
chloride	O
-	O
96	O
total	O
co2	O
-	O
20	O
*	O
anion	O
gap	O
-	O
24	O
*	O
calcium	O
-	O
8	O
.	O
5	O
phosphate	O
-	O
1	O
.	O
9	O
*	O
#	O
magnesium	O
-	O
2	O
.	O
5	O
alt	O
(	O
sgpt	O
)	O
-	O
100	O
*	O
ast	O
(	O
sgot	O
)	O
-	O
67	O
*	O
ld	O
(	O
ldh	O
)	O
-	O
184	O
alk	O
phos	O
-	O
66	O
amylase	O
-	O
72	O
tot	O
bili	O
-	O
0	O
.	O
6	O
[	O
*	O
*	O
2019	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
:	O
serum	O
tox	O
:	O
asa	O
-	O
neg	O
ethanol	O
-	O
317	O
*	O
acetmnphn	O
-	O
neg	O
bnzodzpn	O
-	O
neg	O
barbitrt	O
-	O
neg	O
tricyclic	O
-	O
neg	O

[	O
*	O
*	O
2019	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
:	O
urine	O
tox	O
:	O
urine	O
bnzodzpn	O
-	O
neg	O
barbitrt	O
-	O
neg	O
opiates	O
-	O
neg	O
cocaine	O
-	O
neg	O
amphetmn	O
-	O
neg	O
mthdone	O
-	O
neg	O

10	O
/	O
18	O
-	O
19	O
/	O
06	O
:	O
cardiac	O
enzymes	O
tnt	O
<	O
0	O
.	O
01	O
x	O
3	O
sets	O

studies	O
:	O

cxr	O
[	O
*	O
*	O
10	O
-	O
29	O
*	O
*	O
]	O
:	O
no	O
evidence	O
for	O
acute	O
cardiopulmonary	B
abnormality	I
.	O

head	O
ct	O
[	O
*	O
*	O
10	O
-	O
29	O
*	O
*	O
]	O
:	O
no	O
evidence	O
of	O
intracranial	B
hemorrhage	I
,	O
injury	O
or	O
other	B
acute	I
process	I
.	O

[	O
*	O
*	O
2019	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
09	O
:	O
13pm	O
glucose	O
-	O
86	O
urea	O
n	O
-	O
20	O
creat	O
-	O
0	O
.	O
9	O
sodium	O
-	O
136	O

potassium	O
-	O
3	O
.	O
6	O
chloride	O
-	O
96	O
total	O
co2	O
-	O
20	O
*	O
anion	O
gap	O
-	O
24	O
*	O

[	O
*	O
*	O
2019	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
09	O
:	O
13pm	O
calcium	O
-	O
8	O
.	O
5	O
phosphate	O
-	O
1	O
.	O
9	O
*	O
#	O
magnesium	O
-	O
2	O
.	O
5	O

[	O
*	O
*	O
2019	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
02	O
:	O
56pm	O
urine	O
bnzodzpn	O
-	O
neg	O
barbitrt	O
-	O
neg	O
opiates	O
-	O
neg	O
cocaine	O
-	O
neg	O
amphetmn	O
-	O
neg	O
mthdone	O
-	O
neg	O

[	O
*	O
*	O
2019	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
02	O
:	O
40pm	O
asa	O
-	O
neg	O
ethanol	O
-	O
317	O
*	O
acetmnphn	O
-	O
neg	O
bnzodzpn	O
-	O
neg	O
barbitrt	O
-	O
neg	O
tricyclic	O
-	O
neg	O

[	O
*	O
*	O
2019	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
09	O
:	O
13pm	O
glucose	O
-	O
86	O
urea	O
n	O
-	O
20	O
creat	O
-	O
0	O
.	O
9	O
sodium	O
-	O
136	O
potassium	O
-	O
3	O
.	O
6	O
chloride	O
-	O
96	O
total	O
co2	O
-	O
20	O
*	O
anion	O
gap	O
-	O
24	O
*	O

[	O
*	O
*	O
2019	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
09	O
:	O
13pm	O
glucose	O
-	O
86	O
urea	O
n	O
-	O
20	O
creat	O
-	O
0	O
.	O
9	O
sodium	O
-	O
136	O
potassium	O
-	O
3	O
.	O
6	O
chloride	O
-	O
96	O
total	O
co2	O
-	O
20	O
*	O
anion	O
gap	O
-	O
24	O
*	O

[	O
*	O
*	O
2019	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
02	O
:	O
40pm	O
alt	O
(	O
sgpt	O
)	O
-	O
100	O
*	O
ast	O
(	O
sgot	O
)	O
-	O
67	O
*	O
ld	O
(	O
ldh	O
)	O
-	O
184	O
alk	O
phos	O
-	O
66	O
amylase	O
-	O
72	O
tot	O
bili	O
-	O
0	O
.	O
6	O

brief	O
hospital	O
course	O
:	O

a	O
/	O
p	O
:	O
45	O
yo	O
m	O
with	O
h	O
/	O
o	O
polysubstance	B
abuse	I
admitted	O
with	O
etoh	B
intoxication	I
.	O

1	O
.	O
)	O

etoh	B
intoxication	I
with	O
etoh	O
level	O
of	O
317	O
:	O
the	O
patient	O
presented	O
acutely	B
intoxicated	I
and	O
was	O
showing	O
early	O
evidence	O
of	O
tremulousness	B
suspicious	O
for	O
alcohol	B
withdrawal	I
.	O

as	O
the	O
patient	O
has	O
a	O
history	O
consistent	O
with	O
very	O
high	O
risk	O
for	O
severe	O
delerium	B
tremens	I
,	O
he	O
received	O
a	O
benzodiazepine	O
load	O
with	O
valium	O
and	O
ativan	O
.	O

he	O
received	O
a	O
total	O
of	O
350	O
mg	O
of	O
valium	O
and	O
24	O
mg	O
of	O
ativan	O
while	O
in	O
the	O
icu	O
.	O

his	O
vital	O
signs	O
remained	O
stable	O
without	O
evidence	O
of	O
autonomic	B
instability	I
.	O

he	O
received	O
ivf	O
with	O
folate	O
/	O
thiamin	O
/	O
multivitamins	O
.	O

in	O
collaboration	O
with	O
the	O
psychiatry	O
consult	O
service	O
,	O
he	O
was	O
started	O
on	O
a	O
low	O
dose	O
methadone	O
taper	O
to	O
manage	O
symptoms	O
of	O
opiate	B
withdrawal	I
as	O
his	O
dilated	B
pupils	I
were	O
more	O
consistent	O
with	O
this	O
withdrawal	B
syndrome	I
as	O
well	O
.	O

he	O
was	O
recommended	O
to	O
be	O
transferred	O
directly	O
to	O
an	O
inpatient	O
detox	O
program	O
at	O
the	O
[	O
*	O
*	O
hospital1	O
569	O
*	O
*	O
]	O
va	O
.	O

however	O
,	O
he	O
decided	O
that	O
he	O
would	O
leave	B
against	I
medical	I
advice	I
and	O
pursue	O
a	O
detox	O
program	O
on	O
his	O
own	O
.	O

it	O
was	O
explained	O
to	O
him	O
multiple	O
times	O
by	O
icu	O
staff	O
,	O
psychiatry	O
staff	O
,	O
and	O
social	O
work	O
staff	O
that	O
this	O
was	O
not	O
in	O
keeping	O
with	O
sound	O
medical	O
care	O
as	O
the	O
health	O
care	O
staff	O
was	O
concerned	O
that	O
he	O
would	O
simply	O
resume	O
drinking	O
upon	O
leaving	O
the	O
hospital	O
.	O

furthermore	O
,	O
he	O
was	O
reminded	O
that	O
if	O
he	O
left	O
,	O
he	O
would	O
be	O
homeless	O
as	O
there	O
was	O
no	O
time	O
to	O
arrange	O
housing	O
.	O

he	O
proceeded	O
with	O
leaving	B
ama	I
.	O

2	O
.	O
)	O

depression	B
with	O
si	B
.	O

he	O
initially	O
stated	O
that	O
he	O
was	O
trying	O
to	O
kill	O
himself	O
.	O

he	O
was	O
placed	O
on	O
a	O
1	O
:	O
1	O
supervision	O
while	O
he	O
was	O
intoxicated	B
.	O

upon	O
becoming	O
sober	B
,	O
he	O
denied	O
suicidal	B
ideation	I
.	O

the	O
psychiatry	O
consult	O
evaluated	O
him	O
and	O
confirmed	O
that	O
the	O
patient	O
was	O
not	O
actively	B
suicidal	I
.	O

he	O
continued	O
to	O
receive	O
lexapro	O
at	O
low	O
dose	O
.	O

3	O
.	O
)	O

atypical	O
muscular	O
skeletal	O
movements	B
:	O
the	O
patient	O
had	O
periodic	O
episodes	O
of	O
arm	O
and	O
leg	B
moving	I
.	O

these	O
were	O
evaluated	O
by	O
the	O
neurology	O
consult	O
and	O
thought	O
to	O
be	O
not	O
consistent	O
with	O
seizure	B
and	O
a	O
low	O
probability	O
for	O
a	O
positive	O
eeg	O
.	O

no	O
anti	O
-	O
convulsants	O
were	O
indicated	O
.	O

4	O
.	O
)	O

chest	B
pain	I
:	O
the	O
patient	O
had	O
a	O
brief	O
episode	O
of	O
chest	B
pain	I
in	O
the	O
left	O
side	O
of	O
his	O
chest	O
.	O

this	O
was	O
not	O
associated	O
with	O
diaphoresis	B
or	O
shortness	B
of	I
breath	I
.	O

an	O
ekg	O
showed	O
no	O
evidence	O
of	O
myocardial	B
ischemia	I
and	O
he	O
had	O
3	O
sets	O
of	O
negative	O
cardiac	O
enzymes	O
.	O

upon	O
discharge	O
,	O
it	O
was	O
recommended	O
that	O
he	O
take	O
a	O
baby	O
aspirin	O
daily	O
for	O
primary	O
cardiac	O
prevention	O
.	O

5	O
.	O
)	O

leukocytosis	B
(	O
wbc	O
14	O
)	O
likely	O
stress	B
response	I
.	O

no	O
evidence	O
of	O
infection	B
.	O

the	O
white	B
count	I
resolved	O
on	O
follow	O
-	O
up	O
.	O

6	O
.	O
)	O

anemia	B
:	O
the	O
patient	O
had	O
a	O
normocytic	B
anemia	I
.	O

this	O
developed	O
after	O
fluid	O
resusistation	O
.	O

there	O
was	O
no	O
evidence	O
of	O
acute	B
blood	I
loss	I
.	O

iron	O
studies	O
were	O
consistent	O
with	O
anemia	B
of	I
chronic	I
disease	I
.	O

the	O
anemia	B
could	O
not	O
be	O
completely	O
evaluated	O
as	O
the	O
patient	O
left	B
ama	I
.	O

the	O
anemia	B
should	O
be	O
further	O
evaluated	O
as	O
an	O
outpatient	O
.	O

7	O
.	O
)	O

fen	O
.	O

the	O
patient	O
received	O
ivf	O
with	O
thiamine	O
,	O
folate	O
,	O
mvi	O
in	O
1l	O
of	O
normal	O
saline	O
daily	O
for	O
2	O
days	O
.	O

replete	O
lytes	O
prn	O
.	O

once	O
he	O
was	O
sober	O
,	O
he	O
tolerated	O
a	O
regular	O
diet	O
.	O

8	O
.	O
)	O

heme	B
positive	I
stool	I
.	O

iron	O
studies	O
were	O
not	O
consistent	O
with	O
iron	B
deficiency	I
.	O

will	O
need	O
[	O
*	O
*	O
hospital1	O
85	O
*	O
*	O
]	O
workup	O
for	O
occult	O
blood	B
loss	I
.	O

9	O
.	O
)	O

ppx	O
.	O

sc	O
heparin	O
,	O
h2	O
blocker	O
while	O
not	O
taking	O
po's	O

10	O
.	O
)	O

code	O
:	O
full	O

11	O
.	O
)	O

access	O
:	O
piv	O

12	O
.	O
)	O

dispo	O
:	O
patient	O
left	B
against	I
medical	I
advice	I
.	O
psychiatry	O
consult	O
confirmed	O
that	O
patient	O
had	O
capacity	O
to	O
make	O
medical	O
decisions	O
once	O
he	O
was	O
sober	O
.	O

13	O
.	O
)	O

communication	O
:	O
sister	O
-	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
is	O
health	O
care	O
proxy	O
.	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
3117	O
*	O
*	O
]	O
(	O
h	O
)	O
;	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
3118	O
*	O
*	O
]	O
(	O
c	O
)	O

medications	O
on	O
admission	O
:	O

lexapro	O
(	O
unknown	O
dose	O
)	O

discharge	O
medications	O
:	O

1	O
.	O
escitalopram	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

2	O
.	O
aspirin	O
81	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

veterans	O
hospital	O

discharge	O
diagnosis	O
:	O

primary	O
:	O

ethanol	B
intoxication	I
and	O
withdrawal	O

secondary	O
:	O

polysubstance	B
abuse	I

atypical	O
musculoskeletal	B
jerking	I

non	I
-	I
cardiac	I
chest	I
pain	I

discharge	O
condition	O
:	O

stable	O
vital	O
signs	O
.	O
no	O
evidence	O
of	O
alcohol	B
withdrawal	I
.	O
ambulating	O
.	O
tolerating	O
oral	O
nutrition	O
and	O
medication	O
.	O

you	O
are	O
leaving	B
against	I
medical	I
advice	I
.	O

you	O
were	O
evaluated	O
by	O
psychiatry	O
and	O
and	O
felt	O
to	O
have	O
the	O
capacity	O
to	O
make	O
medical	O
decisions	O
.	O

discharge	O
instructions	O
:	O

you	O
have	O
been	O
evaluated	O
and	O
treated	O
for	O
your	O
alcohol	B
intoxication	I
and	O
withdrawal	B
symptoms	I
.	O

the	O
episodes	O
of	O
shaking	B
were	O
not	O
related	O
to	O
seizure	B
activity	O
.	O

the	O
brief	O
episode	O
of	O
chest	B
pain	I
was	O
evaluated	O
as	O
well	O
and	O
there	O
was	O
no	O
evidence	O
of	O
heart	B
damage	I
.	O

it	O
is	O
essential	O
that	O
you	O
attend	O
the	O
recommended	O
alcohol	O
detox	O
program	O
.	O

your	O
drinking	O
is	O
very	O
detrimental	O
to	O
your	O
health	O
and	O
persistant	O
drinking	O
will	O
very	O
likely	O
ultimately	O
kill	O
you	O
.	O

you	O
were	O
given	O
medications	O
to	O
manage	O
the	O
alcohol	B
withdrawal	I
symptoms	I
and	O
a	O
short	O
course	O
of	O
methadone	O
to	O
manage	O
opiate	B
withdrawal	I
.	O

these	O
medications	O
were	O
not	O
continued	O
once	O
you	O
left	O
the	O
hospital	O
.	O

if	O
you	O
experience	O
any	O
concerning	O
symptoms	B
,	O
particularly	O
chest	B
pain	I
,	O
persistant	O
nausea	B
/	O
vomiting	O
or	O
worsening	O
withdrawal	B
symptoms	I
contact	O
your	O
primary	O
doctor	O
.	O

followup	O
instructions	O
:	O

please	O
call	O
your	O
primary	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
clinic	O
at	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
3119	O
*	O
*	O
]	O
to	O
set	O
up	O
a	O
detox	O
program	O
.	O

contact	O
your	O
primary	O
doctor	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
2585	O
*	O
*	O
]	O
a	O
follow	O
-	O
up	O
appointment	O
for	O
as	O
soon	O
as	O
possible	O
.	O

(	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
3120	O
*	O
*	O
]	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
3119	O
*	O
*	O
]	O
)	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
618	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
1659	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1660	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
black	O
md	O
[	O
*	O
*	O
md	O
number	O
2356	O
*	O
*	O
]	O
[	O
*	O
*	O
2019	O
-	O
10	O
-	O
31	O
*	O
*	O
]	O
@	O
1437	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
618	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2019	O
-	O
11	O
-	O
04	O
*	O
*	O
]	O
9	O
:	O
40	O
am	O

(	O
end	O
of	O
report	O
)	O

2227	O
||||	O
8990	O
||||	O
25077	O
||||	O
discharge	O
_	O
summary	O
||||	O
2014	O
-	O
12	O
-	O
14	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
12	O
-	O
04	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
12	O
-	O
14	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1967	O
-	O
07	O
-	O
31	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
surgery	O

allergies	O
:	O

penicillins	O
/	O
acetaminophen	O
/	O
ultram	O
/	O
oxycontin	O
/	O
zantac	O
/	O
levofloxacin	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
2957	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

abdominal	B
pain	I
.	O

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

exploratory	O
laparotomy	O
,	O
lysis	O
of	O
adhesions	B
,	O

small	O
bowel	O
resection	O
,	O
primary	O
repair	O
of	O
recurrent	B
ventral	I
hernia	I
,	O
placement	O
of	O
left	O
femoral	O
vein	O
triple	O
lumen	O
central	O
venous	O
line	O
,	O
placement	O
of	O
picc	O
.	O

history	O
of	O
present	O
illness	O
:	O

the	O
patient	O
is	O
a	O
47	O
-	O
year	O
-	O
old	O
female	O
with	O
end	B

stage	I
renal	I
disease	I
on	O
hemodialysis	O
,	O
status	O
post	O
epigastric	B
ventral	I
hernia	I
repair	O
in	O
the	O
distant	O
past	O
,	O
who	O
was	O
noted	O
recurrence	O
of	O
the	O
ventral	O
hernia	O
but	O
without	O
any	O
symptoms	B
.	O

the	O
day	O
pta	O
,	O
during	O
hemodialysis	O
,	O
she	O
developed	O
abdominal	B
discomfort	I
and	O
nausea	B
,	O
and	O
thereafter	O
,	O
severe	B
pain	I
at	O
the	O
side	O
of	O
the	O
recurrent	O
epigastric	B
ventral	I
hernia	I
.	O

she	O
came	O
to	O
the	O
emergency	O
room	O
where	O
a	O
ct	O
scan	O
of	O
the	O
abdomen	O
revealed	O
a	O
small	O
omental	O
fat	O
-	O
containing	O
ventral	B
hernia	I
above	O
the	O
umbilicus	O
with	O
mild	O
adjacent	O
inflammatory	B
fat	I
stranding	I
.	O

adjacent	O
to	O
this	O
region	O
,	O
there	O
were	O
multiple	O
prominent	B
loops	I
of	I
small	I
bowel	I
with	O
fecalization	B
of	I
bowel	I
contents	O
and	O
surrounding	O
inflammatory	B
fat	I
stranding	I
and	O
fluid	O
locally	O
.	O

the	O
loops	B
of	I
bowel	I
distal	I
to	O
these	O
prominent	B
loops	I
appeared	O
decompressed	B
and	O
the	O
findings	O
were	O
suggestive	O
of	O
a	O
recent	O
reduction	O
of	O
an	O
incarcerated	B
hernia	I
with	O
high	O
grade	O
obstruction	B
.	O

she	O
now	O
presents	O
for	O
exploratory	O
laparotomy	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
significant	O
for	O
end	B
-	I
stage	I
renal	I
disease	I
secondary	O
to	O
glomerulonephritis	B
possibly	O
secondary	O
to	O
iga	B
diagnosed	I
in	O

[	O
*	O
*	O
1996	O
*	O
*	O
]	O
,	O
and	O
the	O
patient	O
has	O
been	O
on	O
hemodialysis	O
since	O
[	O
*	O
*	O
2001	O
*	O
*	O
]	O
.	O

she	O
is	O
anuric	B
and	O
is	O
on	O
monday	O
,	O
wednesday	O
,	O
and	O
friday	O
dialysis	O
schedule	O
.	O

2	O
.	O
the	O
patient	O
has	O
had	O
bilateral	O
below	O
-	O
the	O
-	O
knee	O
amputations	O
secondary	O
to	O
calciphylaxis	B
in	O
[	O
*	O
*	O
2011	O
-	O
04	O
-	O
15	O
*	O
*	O
]	O
as	O
well	O
as	O
multiple	O
finger	O
amputations	O
during	O
the	O
same	O
year	O
.	O

3	O
.	O
she	O
is	O
status	O
post	O
a	O
parathyroidectomy	O
for	O
previous	O
admissions	O
for	O
hypercalcemia	B
.	O

4	O
.	O
the	O
patient	O
is	O
status	O
post	O
a	O
left	O
arteriovenous	B
fistula	I
on	O
her	O
left	O
upper	O
extremity	O
placed	O
in	O
[	O
*	O
*	O
2010	O
*	O
*	O
]	O
,	O
which	O
became	O
injured	O
during	O
a	O
fistulogram	O
in	O
[	O
*	O
*	O
2013	O
-	O
06	O
-	O
15	O
*	O
*	O
]	O
.	O

5	O
.	O
she	O
has	O
chronic	B
pain	I
.	O

6	O
.	O
she	O
is	O
status	O
post	O
a	O
mitral	O
valve	O
replacement	O
in	O
[	O
*	O
*	O
2010	O
-	O
04	O
-	O
15	O
*	O
*	O
]	O
with	O
a	O
mechanical	O
carbomedics	O
29	O
-	O
mm	O
valve	O
for	O
rheumatic	B
heart	I
disease	I
;	O
and	O
she	O
is	O
on	O
coumadin	O
for	O
this	O
valve	O
.	O

she	O
also	O
has	O
a	O
history	O
of	O
endocarditis	B
.	O

7	O
.	O
history	O
of	O
hypertension	B
.	O

8	O
.	O
anxiety	B
.	O

social	O
history	O
:	O

the	O
patient	O
smokes	O
one	O
-	O
third	O
of	O
a	O
pack	O
per	O

day	O
.	O

she	O
denies	O
any	O
etoh	O
and	O
is	O
disabled	O
.	O

family	O
history	O
:	O

non	O
-	O
contributory	O

physical	O
exam	O
:	O

on	O
admission	O
:	O

99	O
.	O
8	O
100	O
90	O
/	O
49	O
19	O

a&ox3	O
in	O
obvious	O
pain	B

mmm	O
,	O
w	O
/	O
o	O
jvd	B

rrr	O
,	O
tachy	B
,	O
no	O
murmur	B

ctab	O

soft	O
+	O
bs	O
,	O
epigastric	O
ttp	B
,	O
voluntary	O
gaurding	B
,	O
non	B
-	I
distended	I
,	O
no	O
rebound	B

guaiac	O
negative	O

s	O
/	O
p	O
bilat	O
bka	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
12	O
*	O
*	O
]	O
01	O
:	O
10pm	O
blood	O
wbc	O
-	O
4	O
.	O
6	O
rbc	O
-	O
3	O
.	O
30	O
*	O
hgb	O
-	O
9	O
.	O
9	O
*	O
#	O
hct	O
-	O
28	O
.	O
9	O
*	O
mcv	O
-	O
88	O
mch	O
-	O
30	O
.	O
0#	O
mchc	O
-	O
34	O
.	O
2#	O
rdw	O
-	O
18	O
.	O
4	O
*	O
plt	O
ct	O
-	O
176	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
10	O
*	O
*	O
]	O
06	O
:	O
05am	O
blood	O
wbc	O
-	O
6	O
.	O
3	O
rbc	O
-	O
2	O
.	O
66	O
*	O
hgb	O
-	O
7	O
.	O
2	O
*	O
hct	O
-	O
23	O
.	O
1	O
*	O
mcv	O
-	O
87	O
mch	O
-	O
26	O
.	O
9	O
*	O
mchc	O
-	O
31	O
.	O
0	O
rdw	O
-	O
18	O
.	O
5	O
*	O
plt	O
ct	O
-	O
148	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
09	O
*	O
*	O
]	O
06	O
:	O
48am	O
blood	O
wbc	O
-	O
5	O
.	O
6	O
rbc	O
-	O
2	O
.	O
72	O
*	O
hgb	O
-	O
7	O
.	O
4	O
*	O
hct	O
-	O
23	O
.	O
9	O
*	O
mcv	O
-	O
88	O
mch	O
-	O
27	O
.	O
1	O
mchc	O
-	O
30	O
.	O
8	O
*	O
rdw	O
-	O
18	O
.	O
0	O
*	O
plt	O
ct	O
-	O
142	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
08	O
*	O
*	O
]	O
08	O
:	O
10am	O
blood	O
wbc	O
-	O
6	O
.	O
2	O
rbc	O
-	O
2	O
.	O
69	O
*	O
hgb	O
-	O
7	O
.	O
5	O
*	O
hct	O
-	O
23	O
.	O
8	O
*	O
mcv	O
-	O
89	O
mch	O
-	O
27	O
.	O
8	O
mchc	O
-	O
31	O
.	O
3	O
rdw	O
-	O
18	O
.	O
3	O
*	O
plt	O
ct	O
-	O
146	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
08	O
*	O
*	O
]	O
05	O
:	O
39am	O
blood	O
wbc	O
-	O
5	O
.	O
9	O
rbc	O
-	O
2	O
.	O
73	O
*	O
hgb	O
-	O
7	O
.	O
5	O
*	O
hct	O
-	O
24	O
.	O
5	O
*	O
mcv	O
-	O
90	O
mch	O
-	O
27	O
.	O
4	O
mchc	O
-	O
30	O
.	O
6	O
*	O
rdw	O
-	O
18	O
.	O
1	O
*	O
plt	O
ct	O
-	O
135	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
07	O
*	O
*	O
]	O
06	O
:	O
15am	O
blood	O
wbc	O
-	O
6	O
.	O
9	O
rbc	O
-	O
2	O
.	O
99	O
*	O
hgb	O
-	O
8	O
.	O
5	O
*	O
hct	O
-	O
26	O
.	O
8	O
*	O
mcv	O
-	O
90	O
mch	O
-	O
28	O
.	O
6	O
mchc	O
-	O
31	O
.	O
9	O
rdw	O
-	O
17	O
.	O
9	O
*	O
plt	O
ct	O
-	O
127	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
03	O
:	O
03am	O
blood	O
wbc	O
-	O
7	O
.	O
2	O
rbc	O
-	O
3	O
.	O
17	O
*	O
hgb	O
-	O
8	O
.	O
9	O
*	O
hct	O
-	O
27	O
.	O
5	O
*	O
mcv	O
-	O
87	O
mch	O
-	O
28	O
.	O
2	O
mchc	O
-	O
32	O
.	O
4	O
rdw	O
-	O
17	O
.	O
9	O
*	O
plt	O
ct	O
-	O
120	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
05	O
*	O
*	O
]	O
07	O
:	O
43pm	O
blood	O
hct	O
-	O
30	O
.	O
2	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
05	O
*	O
*	O
]	O
03	O
:	O
08am	O
blood	O
wbc	O
-	O
12	O
.	O
5	O
*	O
rbc	O
-	O
3	O
.	O
66	O
*	O
hgb	O
-	O
10	O
.	O
1	O
*	O
hct	O
-	O
31	O
.	O
1	O
*	O
mcv	O
-	O
85	O
mch	O
-	O
27	O
.	O
6	O
mchc	O
-	O
32	O
.	O
6	O
rdw	O
-	O
18	O
.	O
1	O
*	O
plt	O
ct	O
-	O
118	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
04	O
*	O
*	O
]	O
02	O
:	O
15pm	O
blood	O
wbc	O
-	O
16	O
.	O
1	O
*	O
rbc	O
-	O
3	O
.	O
51	O
*	O
hgb	O
-	O
9	O
.	O
7	O
*	O
hct	O
-	O
29	O
.	O
0	O
*	O
mcv	O
-	O
83	O
mch	O
-	O
27	O
.	O
7	O
mchc	O
-	O
33	O
.	O
6	O
rdw	O
-	O
18	O
.	O
2	O
*	O
plt	O
ct	O
-	O
114	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
04	O
*	O
*	O
]	O
08	O
:	O
00am	O
blood	O
wbc	O
-	O
15	O
.	O
9	O
*	O
rbc	O
-	O
3	O
.	O
61	O
*	O
#	O
hgb	O
-	O
10	O
.	O
0	O
*	O
#	O
hct	O
-	O
31	O
.	O
1	O
*	O
#	O
mcv	O
-	O
86	O
mch	O
-	O
27	O
.	O
7	O
mchc	O
-	O
32	O
.	O
2	O
rdw	O
-	O
18	O
.	O
6	O
*	O
plt	O
ct	O
-	O
107	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
03	O
*	O
*	O
]	O
09	O
:	O
40pm	O
blood	O
wbc	O
-	O
11	O
.	O
5	O
*	O
#	O
rbc	O
-	O
5	O
.	O
47	O
*	O
hgb	O
-	O
15	O
.	O
5	O
hct	O
-	O
46	O
.	O
2	O
mcv	O
-	O
84	O
mch	O
-	O
28	O
.	O
3	O
mchc	O
-	O
33	O
.	O
5	O
rdw	O
-	O
17	O
.	O
9	O
*	O
plt	O
ct	O
-	O
138	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
12	O
*	O
*	O
]	O
09	O
:	O
30am	O
blood	O
pt	O
-	O
23	O
.	O
8	O
*	O
ptt	O
-	O
49	O
.	O
4	O
*	O
inr	O
(	O
pt	O
)	O
-	O
4	O
.	O
1	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
11	O
*	O
*	O
]	O
05	O
:	O
40am	O
blood	O
pt	O
-	O
24	O
.	O
5	O
*	O
ptt	O
-	O
59	O
.	O
0	O
*	O
inr	O
(	O
pt	O
)	O
-	O
4	O
.	O
4	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
10	O
*	O
*	O
]	O
09	O
:	O
12pm	O
blood	O
pt	O
-	O
23	O
.	O
6	O
*	O
ptt	O
-	O
48	O
.	O
0	O
*	O
inr	O
(	O
pt	O
)	O
-	O
4	O
.	O
0	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
10	O
*	O
*	O
]	O
06	O
:	O
05am	O
blood	O
pt	O
-	O
27	O
.	O
4	O
*	O
ptt	O
-	O
56	O
.	O
0	O
*	O
inr	O
(	O
pt	O
)	O
-	O
5	O
.	O
5	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
09	O
*	O
*	O
]	O
06	O
:	O
48am	O
blood	O
pt	O
-	O
24	O
.	O
3	O
*	O
ptt	O
-	O
54	O
.	O
4	O
*	O
inr	O
(	O
pt	O
)	O
-	O
4	O
.	O
3	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
08	O
*	O
*	O
]	O
08	O
:	O
55pm	O
blood	O
pt	O
-	O
23	O
.	O
1	O
*	O
ptt	O
-	O
50	O
.	O
8	O
*	O
inr	O
(	O
pt	O
)	O
-	O
3	O
.	O
9	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
08	O
*	O
*	O
]	O
05	O
:	O
39am	O
blood	O
pt	O
-	O
22	O
.	O
9	O
*	O
ptt	O
-	O
104	O
.	O
3	O
*	O
inr	O
(	O
pt	O
)	O
-	O
3	O
.	O
8	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
07	O
*	O
*	O
]	O
06	O
:	O
15am	O
blood	O
pt	O
-	O
18	O
.	O
0	O
*	O
ptt	O
-	O
58	O
.	O
2	O
*	O
inr	O
(	O
pt	O
)	O
-	O
2	O
.	O
3	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
03	O
:	O
03am	O
blood	O
pt	O
-	O
16	O
.	O
8	O
*	O
ptt	O
-	O
56	O
.	O
5	O
*	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
9	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
03	O
*	O
*	O
]	O
07	O
:	O
00am	O
blood	O
pt	O
-	O
18	O
.	O
9	O
*	O
inr	O
(	O
pt	O
)	O
-	O
2	O
.	O
5	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
11	O
*	O
*	O
]	O
05	O
:	O
40am	O
blood	O
glucose	O
-	O
68	O
*	O
urean	O
-	O
22	O
*	O
creat	O
-	O
5	O
.	O
0	O
*	O
#	O
na	O
-	O
141	O
k	O
-	O
3	O
.	O
4	O
cl	O
-	O
96	O
hco3	O
-	O
28	O
angap	O
-	O
20	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
10	O
*	O
*	O
]	O
06	O
:	O
05am	O
blood	O
glucose	O
-	O
68	O
*	O
urean	O
-	O
43	O
*	O
creat	O
-	O
7	O
.	O
3	O
*	O
#	O
na	O
-	O
141	O
k	O
-	O
3	O
.	O
7	O
cl	O
-	O
102	O
hco3	O
-	O
23	O
angap	O
-	O
20	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
09	O
*	O
*	O
]	O
06	O
:	O
48am	O
blood	O
glucose	O
-	O
86	O
urean	O
-	O
35	O
*	O
creat	O
-	O
6	O
.	O
0	O
*	O
#	O
na	O
-	O
144	O
k	O
-	O
4	O
.	O
0	O
cl	O
-	O
102	O
hco3	O
-	O
25	O
angap	O
-	O
21	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
07	O
*	O
*	O
]	O
06	O
:	O
15am	O
blood	O
glucose	O
-	O
70	O
urean	O
-	O
45	O
*	O
creat	O
-	O
6	O
.	O
6	O
*	O
#	O
na	O
-	O
144	O
k	O
-	O
4	O
.	O
3	O
cl	O
-	O
100	O
hco3	O
-	O
24	O
angap	O
-	O
24	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
03	O
:	O
03am	O
blood	O
glucose	O
-	O
92	O
urean	O
-	O
32	O
*	O
creat	O
-	O
5	O
.	O
3	O
*	O
#	O
na	O
-	O
143	O
k	O
-	O
4	O
.	O
4	O
cl	O
-	O
102	O
hco3	O
-	O
24	O
angap	O
-	O
21	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
05	O
*	O
*	O
]	O
03	O
:	O
08am	O
blood	O
glucose	O
-	O
74	O
urean	O
-	O
46	O
*	O
creat	O
-	O
6	O
.	O
7	O
*	O
na	O
-	O
139	O
k	O
-	O
4	O
.	O
5	O
cl	O
-	O
98	O
hco3	O
-	O
22	O
angap	O
-	O
24	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
04	O
*	O
*	O
]	O
02	O
:	O
15pm	O
blood	O
glucose	O
-	O
89	O
urean	O
-	O
37	O
*	O
creat	O
-	O
5	O
.	O
9	O
*	O
na	O
-	O
140	O
k	O
-	O
4	O
.	O
6	O
cl	O
-	O
99	O
hco3	O
-	O
25	O
angap	O
-	O
21	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
04	O
*	O
*	O
]	O
08	O
:	O
00am	O
blood	O
glucose	O
-	O
141	O
*	O
urean	O
-	O
33	O
*	O
creat	O
-	O
5	O
.	O
5	O
*	O
na	O
-	O
141	O
k	O
-	O
4	O
.	O
2	O
cl	O
-	O
100	O
hco3	O
-	O
25	O
angap	O
-	O
20	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
03	O
*	O
*	O
]	O
11	O
:	O
20pm	O
blood	O
glucose	O
-	O
142	O
*	O
urean	O
-	O
28	O
*	O
creat	O
-	O
5	O
.	O
7	O
*	O
na	O
-	O
141	O
k	O
-	O
4	O
.	O
5	O
cl	O
-	O
94	O
*	O
hco3	O
-	O
27	O
angap	O
-	O
25	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
03	O
*	O
*	O
]	O
09	O
:	O
40pm	O
blood	O
glucose	O
-	O
119	O
*	O
urean	O
-	O
25	O
*	O
creat	O
-	O
5	O
.	O
7	O
*	O
#	O
na	O
-	O
139	O
k	O
-	O
4	O
.	O
7	O
cl	O
-	O
90	O
*	O
hco3	O
-	O
30	O
angap	O
-	O
24	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
03	O
*	O
*	O
]	O
09	O
:	O
40pm	O
blood	O
alt	O
-	O
66	O
*	O
ast	O
-	O
41	O
*	O
alkphos	O
-	O
468	O
*	O
amylase	O
-	O
415	O
*	O
totbili	O
-	O
0	O
.	O
5	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
11	O
*	O
*	O
]	O
05	O
:	O
40am	O
blood	O
calcium	O
-	O
8	O
.	O
6	O
phos	O
-	O
3	O
.	O
8	O
mg	O
-	O
1	O
.	O
4	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
10	O
*	O
*	O
]	O
06	O
:	O
05am	O
blood	O
calcium	O
-	O
8	O
.	O
3	O
*	O
phos	O
-	O
4	O
.	O
4	O
mg	O
-	O
1	O
.	O
5	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
09	O
*	O
*	O
]	O
06	O
:	O
48am	O
blood	O
calcium	O
-	O
8	O
.	O
8	O
phos	O
-	O
4	O
.	O
6	O
*	O
mg	O
-	O
1	O
.	O
7	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
08	O
*	O
*	O
]	O
08	O
:	O
10am	O
blood	O
albumin	O
-	O
3	O
.	O
0	O
*	O
calcium	O
-	O
8	O
.	O
7	O
phos	O
-	O
5	O
.	O
8	O
*	O
mg	O
-	O
1	O
.	O
7	O
uricacd	O
-	O
6	O
.	O
7	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
07	O
*	O
*	O
]	O
06	O
:	O
15am	O
blood	O
calcium	O
-	O
8	O
.	O
9	O
phos	O
-	O
5	O
.	O
2	O
*	O
mg	O
-	O
1	O
.	O
7	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
03	O
:	O
03am	O
blood	O
calcium	O
-	O
9	O
.	O
3	O
phos	O
-	O
5	O
.	O
1	O
*	O
mg	O
-	O
1	O
.	O
9	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
05	O
*	O
*	O
]	O
03	O
:	O
08am	O
blood	O
calcium	O
-	O
8	O
.	O
4	O
phos	O
-	O
5	O
.	O
2	O
*	O
mg	O
-	O
1	O
.	O
5	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
04	O
*	O
*	O
]	O
02	O
:	O
15pm	O
blood	O
calcium	O
-	O
8	O
.	O
3	O
*	O
phos	O
-	O
4	O
.	O
5	O
mg	O
-	O
1	O
.	O
5	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
04	O
*	O
*	O
]	O
08	O
:	O
00am	O
blood	O
calcium	O
-	O
8	O
.	O
3	O
*	O
phos	O
-	O
4	O
.	O
3	O
mg	O
-	O
1	O
.	O
5	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
03	O
*	O
*	O
]	O
09	O
:	O
40pm	O
blood	O
albumin	O
-	O
4	O
.	O
9	O
*	O
calcium	O
-	O
10	O
.	O
0	O
phos	O
-	O
4	O
.	O
8	O
*	O
mg	O
-	O
1	O
.	O
8	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
05	O
*	O
*	O
]	O
11	O
:	O
25am	O
blood	O
freeca	O
-	O
1	O
.	O
14	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
04	O
*	O
*	O
]	O
02	O
:	O
22pm	O
blood	O
freeca	O
-	O
1	O
.	O
15	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
04	O
*	O
*	O
]	O
06	O
:	O
33am	O
blood	O
freeca	O
-	O
1	O
.	O
04	O
*	O

[	O
*	O
*	O
2014	O
-	O
12	O
-	O
04	O
*	O
*	O
]	O
05	O
:	O
23am	O
blood	O
freeca	O
-	O
1	O
.	O
04	O
*	O

brief	O
hospital	O
course	O
:	O

pt	O
admitted	O
to	O
surgery	O
from	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
.	O

ct	O
showed	O
:	O

1	O
.	O
prominent	B
loops	I
of	O
proximal	O
small	O
bowel	O
adjacent	O
to	O
an	O
omental	O
fat	O
containing	O
ventral	B
hernia	I
with	O
fecalization	B
of	I
bowel	I
contents	I
,	O
adjacent	O
inflammatory	B
fat	I
stranding	I
,	O
and	O
small	O
amount	O
of	O
fluid	O
and	O
extraluminal	O
air	O
consistent	O
with	O
bowel	B
ischemia	I
and	O
contained	O
perforation	B
.	O

there	O
also	O
is	O
apparent	O
caliber	O
change	O
just	O
below	O
the	O
level	O
of	O
the	O
ventral	B
hernia	I
within	O
the	O
small	O
bowel	O
loops	O
,	O
as	O
the	O
distal	O
loops	O
of	O
small	O
bowel	O
are	O
markedly	O
collapsed	B
.	O

all	O
these	O
findings	O
are	O
suggestive	O
of	O
interval	O
reduction	O
of	O
an	O
incarcerated	B
hernia	I
with	O
high	O
-	O
grade	O
bowel	B
obstruction	I
.	O

at	O
this	O
time	O
,	O
no	O
bowel	B
loops	I
are	O
demonstrated	O
within	O
the	O
ventral	B
hernia	I
.	O

2	O
.	O
patent	O
mesenteric	O
vessels	O
.	O

3	O
.	O
2	O
,	O
low	O
-	O
density	O
lesions	B
within	O
the	O
spleen	O
,	O
likely	O
representing	O
hemangiomas	B
.	O

4	O
.	O
stable	O
appearance	O
of	O
simple	O
hepatic	B
cyst	I
within	O
the	O
dome	O
of	O
the	O
liver	O
.	O

5	O
.	O
diffuse	O
increase	O
in	O
density	O
of	O
the	O
osseous	O
structures	O
consistent	O
with	O
renal	B
osteodystrophy	I
.	O

6	O
.	O
collateral	O
vessels	O
within	O
the	O
right	O
lateral	O
chest	O
wall	O
.	O

these	O
findings	O
are	O
suggestive	O
of	O
a	O
right	O
subclavian	B
vein	I
stenosis	I
.	O

clinical	O
correlation	O
is	O
recommended	O
.	O

pt	O
taken	O
to	O
the	O
or	O
for	O
operation	O
.	O

taken	O
to	O
the	O
icu	O
intubated	O
.	O

renal	O
consulted	O
for	O
hd	O
and	O
recs	O
.	O

pt	O
extubated	O
on	O
pod1	O
.	O

renal	O
was	O
consulted	O
for	O
continuation	O
of	O
her	O
hemodialysis	O
,	O
which	O
went	O
on	O
with	O
out	O
complication	B
.	O

she	O
was	O
kept	O
npo	O
until	O
bowel	O
function	O
resumed	O
on	O
pod	O
3	O
,	O
she	O
transferred	O
out	O
of	O
the	O
icu	O
once	O
extubated	O
on	O
pod	O
1	O
.	O
she	O
was	O
kept	O
on	O
heparin	O
gtt	O
due	O
to	O
her	O
need	O
for	O
anti	O
-	O
coagulation	O
.	O

once	O
she	O
had	O
resumed	O
pos	O
,	O
coumadin	O
was	O
started	O
,	O
and	O
she	O
was	O
brought	O
up	O
to	O
her	O
normal	O
coagulation	O
level	O
of	O
2	O
.	O
5	O
-	O
3	O
.	O

she	O
will	O
follow	O
up	O
in	O
the	O
coumadin	O
clinic	O
and	O
hemodialysis	O
for	O
follwing	O
her	O
inr	O
.	O

through	O
the	O
remained	O
of	O
her	O
postoperative	O
course	O
,	O
she	O
was	O
advnced	O
through	O
sips	O
,	O
to	O
clears	O
,	O
fulls	O
,	O
then	O
to	O
a	O
regular	O
diet	O
which	O
she	O
tolerated	O
well	O
.	O

by	O
pod	O
10	O
,	O
she	O
was	O
tolerating	O
regular	O
diet	O
,	O
having	O
bowel	O
movements	O
and	O
her	O
coumadin	O
was	O
theraputic	O
.	O

she	O
was	O
d	O
/	O
c'ed	O
home	O
.	O

medications	O
on	O
admission	O
:	O

xanax	O

ms	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
*	O
*	O
]	O

[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
6985	O
*	O
*	O
]	O

protonix	O

fentanyl	O

levoxyl	O

dilaudid	O

coumadin	O

discharge	O
medications	O
:	O

1	O
.	O
metoprolol	O
tartrate	O
25	O
mg	O
tablet	O
sig	O
:	O
0	O
.	O
5	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
lorazepam	O
0	O
.	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
qid	O
(	O
4	O
times	O
a	O
day	O
)	O
.	O

3	O
.	O
b	O
complex	O
-	O
vitamin	O
c	O
-	O
folic	O
acid	O
1	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
cap	O
po	O
daily	O
(	O
daily	O
)	O
.	O

4	O
.	O
levothyroxine	O
sodium	O
25	O
mcg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

5	O
.	O
cinacalcet	O
30	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
)	O
.	O

6	O
.	O
calcium	O
carbonate	O
500	O
mg	O
tablet	O
,	O
chewable	O
sig	O
:	O
one	O
(	O
1	O
)	O

tablet	O
,	O
chewable	O
po	O
tid	O
w	O
/	O
meals	O
(	O
3	O
times	O
a	O
day	O
with	O
meals	O
)	O
.	O

7	O
.	O
fentanyl	O
75	O
mcg	O
/	O
hr	O
patch	O
72hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
patch	O
72hr	O

transdermal	O
q72h	O
(	O
every	O
72	O
hours	O
)	O
.	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

recurrent	B
ventral	I
hernia	I
with	O
small	B

bowel	I
obstruction	I
and	O
compromised	B
bowel	I
.	O

chronic	B
renal	I
failure	I

discharge	O
condition	O
:	O

good	O

discharge	O
instructions	O
:	O

you	O
may	O
resume	O
your	O
home	O
medications	O
,	O
please	O
take	O
all	O
new	O
medications	O
as	O
prescribed	O
.	O

you	O
may	O
resume	O
your	O
regular	O
activities	O
.	O

you	O
may	O
shower	O
,	O
pat	O
the	O
wound	B
dry	O
.	O

do	O
not	O
soak	O
the	O
wound	B
for	O
one	O
week	O
.	O

the	O
staples	O
will	O
be	O
removed	O
at	O
your	O
follow	O
up	O
appointment	O
.	O

please	O
refrain	O
from	O
driving	O
while	O
taking	O
narcotic	O
pain	B
medication	O
.	O

please	O
call	O
your	O
physician	O
or	O
return	O
to	O
the	O
hoptial	O
if	O
you	O
experience	O
:	O

-	O
increasing	O
pain	B

-	O
fever	B
(	O
>101	O
.	O
5	O
)	O

-	O
inability	B
to	I
eat	I
/	O
persistant	B
vomiting	I

-	O
other	O
symptoms	B
concerning	O
to	O
you	O

followup	O
instructions	O
:	O

please	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
.	O

call	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
6450	O
*	O
*	O
]	O
to	O
make	O
an	O
appointment	O
.	O

[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
410	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
archer	O
md	O
[	O
*	O
*	O
md	O
number	O
411	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
6670	O
*	O
*	O
]	O
[	O
*	O
*	O
2014	O
-	O
12	O
-	O
14	O
*	O
*	O
]	O
@	O
1128	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
410	O
*	O
*	O
]	O
[	O
*	O
*	O
name2	O
(	O
ni	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
2015	O
-	O
02	O
-	O
24	O
*	O
*	O
]	O
5	O
:	O
27	O
pm	O
(	O
end	O
of	O
report	O
)	O

26497	O
||||	O
9248	O
||||	O
23239	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
07	O
-	O
05	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
22	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
05	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1931	O
-	O
05	O
-	O
11	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
1461	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

hypoxic	B
respiratory	I
failure	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

intubation	O
.	O

history	O
of	O
present	O
illness	O
:	O

81	O
yo	O
man	O
w	O
/	O
ho	O
cad	B
,	O
cop	B
,	O
pvd	B
,	O
aaa	B
xfered	O
from	O
osh	O
for	O
mngmt	O
resp	B
failure	I
.	O

pt	O
was	O
found	O
@	O
home	O
by	O
ems	O
followign	O
c	O
/	O
o	O
[	O
*	O
*	O
05	O
-	O
29	O
*	O
*	O
]	O
"crushing"	O
,	O
nonradiating	O
sscp	B
.	O

pt	O
diaphoretic	B
during	O
transport	O
.	O

sat	O
84	O
-	O
-	O
>94%	O
on	O
nrb	O
.	O

given	O
asa	O
,	O
nt	O
,	O
nebs	O
en	O
route	O
to	O
osh	O
where	O
started	O
on	O
bipap	O
and	O
eventually	O
intubated	O
.	O

bp	O
on	O
arrival	O
240	O
/	O
140	O
so	O
started	O
on	O
ntg	O
drip	O
titrated	O
up	O
until	O
bp	B
fell	I
to	O
90	O
/	O
58	O
resulting	O
in	O
ivf	O
,	O
dopamine	O
.	O

given	O
80	O
iv	O
lasix	O
.	O

first	O
set	O
enzymes	O
negative	O
and	O
bnp	O
1700	O
.	O

pt	O
xferred	O
for	O
further	O
management	O
.	O

on	O
arrival	O
,	O
pt	O
intubated	O
but	O
responsive	O
to	O
y	O
/	O
n	O
questions	O
.	O

indicated	O
cp	B
similar	O
to	O
what	O
he	O
had	O
in	O
past	O
when	O
he	O
was	O
cathed	O
.	O

started	O
on	O
hep	O
gtt	O
in	O
[	O
*	O
*	O
doctor	O
first	O
name	O
45	O
*	O
*	O
]	O
.	O

past	O
medical	O
history	O
:	O

pvd	B
,	O
aaa	B
-	O
5	O
x	O
5	O
cm	O
,	O
paf	B
,	O
cva	B
,	O
copd	B
,	O
depression	B
,	O
symptomatic	O
bradycardia	B
(	O
dig	O
and	O
b	O
-	O
b	O
held	O
during	O
[	O
*	O
*	O
01	O
-	O
25	O
*	O
*	O
]	O
admit	O
w	O
/	O
resolution	O
of	O
brady	B
)	O

social	O
history	O
:	O

tob	O
:	O
quit	O
,	O
reports	O
2ppd	O
x	O
52	O
years	O

etoh	O
:	O
"quite	O
a	O
bit"	O
in	O
past	O
but	O
denies	O
any	O
use	O
x	O
several	O
mos	O
lives	O
alone	O
.	O

2	O
children	O
in	O
area	O
.	O

family	O
history	O
:	O

m	O
died	O
when	O
he	O
was	O
a	O
child	O

physical	O
exam	O
:	O

[	O
*	O
*	O
2012	O
-	O
06	O
-	O
28	O
*	O
*	O
]	O

96	O
.	O
8	O
126	O
/	O
72	O
(	O
117	O
-	O
153	O
/	O
60	O
-	O
78	O
)	O
18	O
94ra	O
1700	O
/	O
2300	O
&	O
100	O
/	O
950	O

mmm	O

jvd	B
@9cm	O
,	O
nl	O
s1	O
/	O
s2	O

ctab	O
;	O
cont	O
dtp	O
bil	O
bases	O
,	O
r	O
higher	O
than	O
l	O

abd	B
soft	I
,	O
nt	O
,	O
nd	O

ext	B
warm	I
x	O
4	O

a&o	O
x	O
3	O

cont	O
bipedal	O
pitting	B
edema	I
to	O
knees	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
06	O
-	O
22	O
*	O
*	O
]	O
echo	O
:	O

1	O
.	O
there	O
is	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
difficult	O
to	O
assess	O
but	O
is	O
probably	O
normal	O
(	O
lvef>55%	O
)	O
.	O

2	O
.	O
the	O
aortic	O
valve	O
leaflets	O
are	O
moderately	O
thickened	B
.	O

there	O
is	O
mild	O
aortic	B
valve	I
stenosis	I
.	O

3	O
.	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

4	O
.	O
there	O
is	O
a	O
small	O
pericardial	B
effusion	I
.	O

.	O
.	O
.	O

[	O
*	O
*	O
06	O
-	O
27	O
*	O
*	O
]	O
pa	O
/	O
lat	O
cxr	O

cardiomegaly	B
,	O
tortuous	B
aorta	I
,	O
and	O
improving	O
chf	B
and	O
atelectasis	B
,	O

with	O
persistent	O
bilateral	B
pleural	I
effusion	I
.	O

discrete	O
nodular	B
opacities	I
in	O

bilateral	O
lungs	O
,	O
which	O
are	O
probably	O
unchanged	O
and	O
represent	O
granulomas	B
,	O
however	O
,	O
please	O
repeat	O
the	O
pa	O
and	O
lat	O
study	O
after	O
chf	B
has	O
been	O
resolved	O
.	O

.	O
.	O
.	O

renal	O
artery	O
us	O
with	O
doppler	O
:	O
no	O
findings	O
to	O
suggest	O
renal	B
artery	I
stenosis	I
.	O

echogenic	O
kidneys	O
consistent	O
with	O
the	O
known	O
chronic	B
parenchymal	I
disease	I
.	O

if	O
clinically	O
[	O
*	O
*	O
last	O
name	O
(	O
lf	O
)	O
1462	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name3	O
(	O
lf	O
)	O
*	O
*	O
]	O
mr	O
could	O
be	O
performed	O
.	O

.	O
.	O
.	O

[	O
*	O
*	O
01	O
-	O
22	O
*	O
*	O
]	O
sputum	O
cx	O
+	O
for	O
hafnia	O
alvei	O
;	O
no	O
other	O
growth	O

brief	O
hospital	O
course	O
:	O

this	O
81	O
yo	O
man	O
w	O
/	O
ho	O
cad	B
,	O
cop	B
,	O
pvd	B
,	O
aaa	B
was	O
xfered	O
from	O
mvh	O
for	O
mngmt	O
resp	B
failure	I
.	O

resp	B
failure	I
-	O
etiology	O
likely	O
volume	B
overload	I
[	O
*	O
*	O
02	O
-	O
22	O
*	O
*	O
]	O
diastolic	B
chf	I
,	O
renal	B
failure	I
.	O

pt	O
was	O
diuresed	O
in	O
the	O
ccu	O
then	O
extubated	O
and	O
subsequently	O
oxygenated	O
well	O
and	O
was	O
called	O
out	O
to	O
the	O
stepdown	O
unit	O
.	O

the	O
patient	O
initially	O
failed	O
diuresis	O
with	O
lasix	O
alone	O
,	O
then	O
with	O
lasix	O
100	O
iv	O
/	O
diuril	O
500	O
.	O

thus	O
,	O
despite	O
lack	O
of	O
systolic	B
hf	I
,	O
nesiritide	O
was	O
used	O
in	O
the	O
urgent	O
situation	O
of	O
hypoxic	B
respiratory	I
failure	I
w	O
/	O
good	O
diuresisi	O
,	O
allowing	O
extubation	O
.	O

following	O
this	O
,	O
the	O
patient	O
did	O
respond	O
to	O
lasix	O
100	O
iv	O
w	O
/	O
500	O
diuril	O
.	O

following	O
recommendation	O
of	O
renal	O
consultation	O
,	O
60	O
po	O
lasix	O
with	O
5	O
metolazone	O
was	O
attempted	O
with	O
good	O
results	O
.	O

no	O
diuretics	O
given	O
after	O
[	O
*	O
*	O
06	O
-	O
30	O
*	O
*	O
]	O
and	O
patient	O
continued	O
to	O
autodiurese	O
about	O
1	O
l	O
/	O
day	O
.	O

will	O
d	O
/	O
c	O
patient	O
on	O
po	O
lasix	O
,	O
20	O
mg	O
/	O
day	O
.	O

he	O
was	O
instructed	O
to	O
call	O
his	O
cariologist	O
or	O
pcp	O
if	O
he	O
gains	O
>3	O
pounds	O
to	O
adjust	O
doses	O
of	O
this	O
medication	O
.	O

pt	O
reports	O
dry	O
weight	O
is	O
about	O
200lbs	O
(	O
91kg	O
)	O
.	O

chf	B
:	O
the	O
likely	O
contributors	O
to	O
decompensated	O
acute	B
pulmonary	I
edema	I
was	O
acute	O
htn	B
,	O
diastolic	B
htn	I
and	O
renal	B
dysfunction	I
.	O

bnp	O
at	O
mvh	O
was	O
7000	O
and	O
pro	O
-	O
bnp	O
was	O
17	O
,	O
700	O
here	O
.	O

stat	O
echocardiography	O
performed	O
on	O
admission	O
demonstrated	O
no	O
wall	B
motion	I
abnormalities	I
and	O
good	O
lv	O
function	O
.	O

the	O
patient	O
was	O
diuresed	O
as	O
above	O
.	O

htn	B
-	O
ccb	O
changed	O
to	O
clonidine	O
.	O

hydral	O
/	O
nitro	O
were	O
added	O
for	O
afterload	O
reduction	O
.	O

final	O
regimen	O
as	O
listed	O
under	O
dc	O
meds	O
.	O

pt	O
developed	O
chest	B
pain	I
while	O
in	O
the	O
mri	O
suite	O
when	O
getting	O
study	O
for	O
transient	O
aphasia	B
.	O

recieved	O
2	O
sl	O
nitro	O
and	O
sbp	O
remained	O
145	O
.	O

pt	O
was	O
briefly	O
transfered	O
to	O
neurology	O
service	O
on	O
[	O
*	O
*	O
06	O
-	O
30	O
*	O
*	O
]	O
for	O
further	O
work	O
up	O
/	O
evaluation	O
of	O
aphasia	B
at	O
which	O
time	O
all	O
bp	O
meds	O
were	O
stopped	O
.	O

on	O
transfer	O
back	O
to	O
cardiology	O
service	O
on	O
[	O
*	O
*	O
07	O
-	O
02	O
*	O
*	O
]	O
patient	O
was	O
restarted	O
on	O
metoprolol	O
24mg	O
bid	O
which	O
was	O
increased	O
to	O
50mg	O
bid	O
on	O
[	O
*	O
*	O
07	O
-	O
03	O
*	O
*	O
]	O
.	O

he	O
was	O
d	O
/	O
c'ed	O
on	O
this	O
dose	O
.	O

imdur	O
(	O
30mg	O
daily	O
)	O
was	O
added	O
back	O
on	O
[	O
*	O
*	O
07	O
-	O
03	O
*	O
*	O
]	O
.	O

neuro	O
-	O
?cva	O
/	O
tia	B
:	O
pt	O
appreared	O
to	O
have	O
tia	B
.	O

had	O
acute	O
episode	O
of	O
confusion	B
and	O
aphasia	B
.	O

completely	O
resolved	O
with	O
no	O
further	O
episodes	O
.	O

neuro	O
followed	O
pt	O
during	O
admission	O
,	O
and	O
he	O
was	O
transfered	O
to	O
neurology	O
service	O
briefly	O
for	O
further	O
eval	O
and	O
treatment	O
of	O
transient	O
aphasia	B
.	O

mra	O
with	O
unchanged	O
evidence	O
of	O
small	B
vessel	I
dz	I
but	O
no	O
acute	B
infarct	I
;	O
evidence	O
of	O
to	B
of	O
ica	O
but	O
there	O
is	O
reconstitution	O
of	O
the	O
right	O
anterior	O
cerebral	O
artery	O
and	O
right	O
middle	O
cerebral	O
artery	O
branches	O
from	O
the	O
left	O
side	O
via	O
anterior	O
communicating	O
artery	O
-	O
unchanged	O
from	O
prior	O
exam	O
.	O

it	O
was	O
thought	O
that	O
his	O
transient	O
aphagia	B
was	O
likely	O
tia	B
[	O
*	O
*	O
02	O
-	O
22	O
*	O
*	O
]	O
cardioembolic	B
event	I
.	O

he	O
was	O
restarted	O
on	O
coumadin	O
and	O
plavix	O
was	O
discontinued	O
.	O

keep	O
sbp	O
130	O
-	O
160	O
.	O
pt	O
has	O
been	O
on	O
coumadin	O
in	O
the	O
past	O
for	O
h	O
/	O
o	O
afib	B
.	O
wil	O
lrestart	O
coumadin	O
[	O
*	O
*	O
07	O
-	O
02	O
*	O
*	O
]	O
10mg	O
x2	O
nights	O
followed	O
by	O
5mg	O
qhs	O
.	O
cont	O
heparin	O
ggt	O
until	O
therapeutic	O
at	O
inr	O
of	O
2	O
-	O
3	O
.	O

his	O
inr	O
was	O
2	O
.	O
6	O
on	O
[	O
*	O
*	O
07	O
-	O
04	O
*	O
*	O
]	O
and	O
he	O
was	O
discharged	O
on	O
5mg	O
coumadin	O
qhs	O
.	O

he	O
is	O
to	O
follow	O
up	O
with	O
his	O
pcp	O
on	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
1463	O
*	O
*	O
]	O
for	O
inr	O
and	O
coumadin	O
adjustments	O
.	O

ischemia	B
-	O
?acs	O
,	O
but	O
no	O
sig	B
ekg	I
changes	I
and	O
enzymes	O
flat	O
,	O
no	O
wall	B
motion	I
abnormalities	I
.	O

there	O
was	O
thus	O
no	O
ischemia	B
.	O

arf	B
:	O
on	O
admission	O
,	O
creatinine	B
bumped	I
from	O
baseline	O
1	O
.	O
5	O
-	O
2	O
.	O
0	O
to	O
4	O
.	O
fena	O
of	O
.	O
06	O
indicates	O
effect	O
intravascular	B
depletion	I
or	O
renal	B
inability	I
to	I
excrete	I
na	I
.	O

may	O
be	O
poor	B
renal	I
perfusion	I
from	O
being	O
off	O
starling	O
curve	O
but	O
this	O
is	O
less	O
like	O
as	O
it	O
did	O
not	O
improve	O
with	O
diuresis	O
.	O

24	O
hour	O
urine	O
demonstrated	O
protein	O
of	O
14896	O
and	O
creatinine	O
of	O
1444	O
demonstrated	O
nephrotic	B
range	I
proteinuria	I
.	O

dopplers	O
ok	O
.	O

op	O
renal	O
bx	O
strongly	O
suggested	O
to	O
patient	O
,	O
but	O
he	O
refused	O
as	O
he	O
does	O
not	O
wish	O
this	O
intense	O
of	O
a	O
level	O
of	O
care	O
.	O

the	O
patient	O
was	O
full	O
code	O
throughout	O
his	O
stay	O
.	O

dispo	O
:	O
pt	O
was	O
consulted	O
but	O
reported	O
that	O
the	O
patient	O
has	O
no	O
pt	O
needs	O
.	O

he	O
was	O
dischareged	O
with	O
vna	O
services	O
for	O
bp	O
control	O
and	O
inr	O
follow	O
ups	O
.	O

medications	O
on	O
admission	O
:	O

vit	O
e	O
400	O
[	O
*	O
*	O
last	O
name	O
(	O
lf	O
)	O
1464	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name3	O
(	O
lf	O
)	O
*	O
*	O
]	O
325	O
qd	O
,	O
sertraline	O
50	O
qd	O
,	O
plavix	O
75	O
qd	O
,	O
folic	O
acid	O
1	O
qd	O
,	O
lipitor	O
40	O
qd	O
,	O
buspirone	O
15	O
mg	O
tid	O
,	O
amlodopine	O
10	O
mg	O
qd	O

discharge	O
medications	O
:	O

1	O
.	O
furosemide	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
atorvastatin	O
calcium	O
40	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

3	O
.	O
lansoprazole	O
30	O
mg	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

4	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
chewable	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
chewable	O
po	O
daily	O
(	O
daily	O
)	O
.	O

5	O
.	O
metoprolol	O
tartrate	O
50	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

6	O
.	O
isosorbide	O
mononitrate	O
30	O
mg	O
tablet	O
sustained	O
release	O
24hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
sustained	O
release	O
24hr	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
sustained	O
release	O
24hr	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

7	O
.	O
warfarin	O
sodium	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
:	O
please	O
have	O
your	O
pcp	O
follow	O
your	O
coumadin	O
levels	O
and	O
adjust	O
dose	O
of	O
this	O
medications	O
as	O
recommended	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

primary	O
diagnosis	O
:	O

congestive	B
heart	I
failure	I

secondary	O
diagnosis	O
:	O

1	O
.	O
pvd	B

2	O
.	O
aaa	B
-	O
5	O
x	O
5	O
cm	O

3	O
.	O
paf	B

4	O
.	O
cva	B

5	O
.	O
copd	B

6	O
.	O
depression	B

discharge	O
condition	O
:	O

fair	O

discharge	O
instructions	O
:	O

weigh	O
yourself	O
every	O
morning	O
,	O
call	O
md	O
if	O
weight	O
>	O
3	O
lbs	O
.	O

adhere	O
to	O
2	O
gm	O
sodium	O
diet	O

fluid	O
restriction	O
:	O
1	O
.	O
5l	O

please	O
take	O
all	O
medications	O
as	O
directed	O
.	O

followup	O
instructions	O
:	O

provider	O
[	O
*	O
*	O
name9	O
(	O
pre	O
)	O
1465	O
*	O
*	O
]	O
west	O
interventional	O
/	O
prostate	O
us	O
radiology	O
where	O
:	O
[	O
*	O
*	O
hospital	O
1466	O
*	O
*	O
]	O
radiology	O
phone	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1141	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
05	O
*	O
*	O
]	O
9	O
:	O
30	O

please	O
call	O
your	O
cardiologist	O
for	O
a	O
followup	O
appointment	O
within	O
one	O
week	O
of	O
your	O
discharge	O
.	O

you	O
have	O
an	O
appointment	O
with	O
your	O
primary	O
care	O
physician	O
,	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
1467	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name3	O
(	O
lf	O
)	O
1468	O
*	O
*	O
]	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1469	O
*	O
*	O
]	O
to	O
follow	O
up	O
on	O
your	O
chf	B
,	O
blood	O
pressure	O
,	O
to	O
arrange	O
neuropsych	O
evaluation	O
,	O
to	O
check	O
your	O
inr	O
and	O
to	O
further	O
evaluate	O
nodular	B
opacities	I
visualized	O
during	O
this	O
hospitalization	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
1470	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1471	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
311	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
728	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
729	O
*	O
*	O
]	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
05	O
*	O
*	O
]	O
@	O
1003	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
dow	O
on	O
:	O
mon	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
30	O
*	O
*	O
]	O
1	O
:	O
09	O
pm	O

(	O
end	O
of	O
report	O
)	O

28983	O
||||	O
9339	O
||||	O
6299	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
04	O
-	O
07	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
30	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
06	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1939	O
-	O
06	O
-	O
28	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
csu	O

history	O
of	O
present	O
illness	O
:	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
430	O
*	O
*	O
]	O
is	O
a	O
72	O
year	O
old	O
man	O
who	O
underwent	O
coronary	O
artery	O
bypass	O
grafting	O
times	O
three	O
as	O
well	O
as	O
a	O
maze	O
procedure	O
on	O
the	O
[	O
*	O
*	O
03	O
-	O
21	O
*	O
*	O
]	O
with	O
an	O
unremarkable	O
postoperative	O
course	O
.	O

he	O
was	O
discharged	O
to	O
rehabilitation	O
on	O
[	O
*	O
*	O
03	O
-	O
27	O
*	O
*	O
]	O
and	O
presented	O
to	O
the	O
emergency	O
room	O
at	O
[	O
*	O
*	O
hospital	O
431	O
*	O
*	O
]	O
hospital	O
on	O
[	O
*	O
*	O
03	O
-	O
30	O
*	O
*	O
]	O
with	O
serosanguineous	B
drainage	I
from	O
the	O
lower	O
aspect	O
of	O
his	O
sternal	O
wound	B
.	O

the	O
drainage	B
began	O
suddenly	O
following	O
an	O
episode	O
of	O
coughing	B
not	O
associated	O
with	O
any	O
chest	B
pain	I
,	O
increasing	O
shortness	B
of	I
breath	I
,	O
fever	B
,	O
chills	B
,	O
redness	O
or	O
erythema	O
of	O
the	O
wound	O
.	O

he	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital	O
193	O
*	O
*	O
]	O
from	O
[	O
*	O
*	O
hospital	O
431	O
*	O
*	O
]	O
hospital	O
following	O
initial	O
evaluation	O
at	O
the	O
emergency	O
room	O
at	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
431	O
*	O
*	O
]	O
.	O

past	O
medical	O
history	O
:	O
is	O
significant	O
for	O
coronary	B
artery	I
disease	I
,	O
status	O
post	O
coronary	O
artery	O
bypass	O
grafting	O
,	O
congestive	B
heart	I
failure	I
,	O
paroxysmal	B
atrial	I

fibrillation	I
/	O
flutter	O
,	O
status	O
post	O
maze	O
procedure	O
,	O
hypercholesterolemia	B
,	O
noninsulin	B
dependent	I
diabetes	I
mellitus	I
,	O
history	O
of	O
urosepsis	B
,	O
history	O
of	O
colon	B
carcinoma	I
,	O
status	O
post	O
colonic	O
resection	O
,	O
hypertension	B
,	O
degenerative	B
joint	I
disease	I
,	O
status	O
post	O
bilateral	O
total	O
knee	O
replacement	O
,	O
abdominal	B
aortic	I
aneurysm	I
and	O
bilateral	O
cataract	B
surgery	O
.	O

social	O
history	O
:	O
patient	O
lives	O
alone	O
.	O

he	O
has	O
a	O
remote	O
tobacco	O
history	O
,	O
quit	O
over	O
18	O
years	O
ago	O
alcohol	O
use	O
limited	O
to	O
one	O
drink	O
per	O
day	O
.	O

family	O
history	O
:	O
father	O
died	O
of	O
prostate	B
carcinoma	I
.	O

allergies	O
:	O
patient	O
states	O
no	O
known	O
drug	O
allergies	O
.	O

medications	O
on	O
admission	O
:	O
include	O
aspirin	O
81	O
mg	O
daily	O
,	O
lasix	O
20	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
colace	O
100	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
potassium	O
chloride	O
20	O
meq	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
percocet	O
prn	O
,	O
glipizide	O
2	O
.	O
5	O
mg	O
daily	O
,	O
amiodarone	O
400	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
lipitor	O
40	O
mg	O
daily	O
,	O
lopressor	O
50	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O

coumadin	O
7	O
.	O
5	O
mg	O
daily	O

physical	O
examination	O
:	O
temperature	O
98	O
.	O
9	O
,	O
heart	O
rate	O
67	O
,	O
blood	O
pressure	O
138	O
/	O
62	O
,	O
respiratory	O
rate	O
24	O
,	O
o2	O
saturation	O
94	O
percent	O
on	O
3	O
liters	O
.	O

neurologic	O
:	O
alert	O
and	O
oriented	O
times	O
three	O
,	O
nonfocal	O
examination	O
.	O

cardiovascular	O
:	O
regular	O
rhythm	O
with	O
no	O
murmurs	B
,	O
rubs	B
or	O
gallops	B
,	O
no	O
jugular	B
venous	I
distension	I
.	O

respiratory	O
:	O
coarse	B
breath	I
sounds	I
diminished	O
at	O
the	O
bases	O
.	O

sternal	O
wound	B
dehiscence	I
with	O
serosanguineous	B
drainage	I
,	O
no	O
surrounding	O
erythema	B
,	O
fluctuance	B
or	O
tenderness	B
.	O

abdomen	O
is	O
soft	O
,	O
nontender	O
,	O
nondistended	O
with	O
normal	O
active	O
bowel	O
sounds	O
.	O

extremities	O
are	O
warm	O
and	O
well	O
perfused	O
with	O
trace	O
edema	B
and	O
no	O
cyanosis	B
.	O

hospital	O
course	O
:	O
patient	O
was	O
admitted	O
to	O
cardiothoracic	O
surgery	O
.	O

chest	O
x	O
-	O
ray	O
showed	O
misaligned	B
sternal	I
wires	I
.	O

his	O

coumadin	O
was	O
discontinued	O
and	O
he	O
was	O
scheduled	O
to	O
go	O
to	O
the	O
operating	O
room	O
upon	O
correction	O
of	O
his	O
inr	O
.	O

on	O
the	O
[	O
*	O
*	O
04	O
-	O
01	O
*	O
*	O
]	O
the	O
patient	O
was	O
brought	O
to	O
the	O
operating	O
room	O
where	O
he	O
underwent	O
sternal	O
debridement	O
and	O
reclosure	O
.	O

the	O
patient	O
tolerated	O
the	O
operation	O
well	O
and	O
was	O
transferred	O
from	O
the	O
operating	O
room	O
to	O
the	O
cardiothoracic	O
intensive	O
care	O
unit	O
.	O

he	O
did	O
well	O
in	O
the	O
immediate	O
postoperative	O
area	O
.	O

his	O
anesthesia	O
was	O
reversed	O
and	O
he	O
weaned	O
from	O
the	O
ventilator	O
and	O
successfully	O
extubated	O
.	O

the	O
following	O
morning	O
the	O
patient	O
remained	O
hemodynamically	O
stable	O
.	O

his	O
chest	O
tubes	O
were	O
removed	O
and	O
he	O
was	O
transferred	O
to	O
424	O
for	O
continuous	O
postoperative	O
management	O
.	O

over	O
the	O
next	O
several	O
days	O
the	O
patient	O
had	O
an	O
uneventful	O
postoperative	O
course	O
.	O

his	O
activity	O
level	O
was	O
increased	O
with	O
the	O
assistance	O
of	O
the	O
nursing	O
staff	O
as	O
well	O
as	O
the	O
physical	O
therapy	O
staff	O
on	O
[	O
*	O
*	O
04	O
-	O
05	O
*	O
*	O
]	O
.	O

a	O
picc	O
line	O
was	O
placed	O
for	O
administration	O
of	O
long	O
term	O
antibiotics	O
.	O

at	O
that	O
time	O
the	O
patient's	O
culture	O
data	O
from	O
the	O
operating	O
room	O
came	O
back	O
as	O
rare	O
coag	O
negative	O
staph	O
as	O
well	O
as	O
sparse	O
enterococcus	O
from	O
broth	O
culture	O
only	O
resistant	O
to	O
vancomycin	O
,	O
sensitive	O
to	O
linezolid	O
.	O

at	O
that	O
time	O
it	O
was	O
decided	O
that	O
the	O
patient	O
was	O
stable	O
and	O
ready	O
to	O
be	O
transferred	O
to	O
rehabilitation	O
for	O
continuing	O
postoperative	O
care	O
as	O
well	O
as	O
antibiotic	O
administration	O
.	O

the	O
patient's	O
physical	O
examination	O
at	O
the	O
time	O
of	O
discharge	O
:	O
temperature	O
99	O
,	O
heart	O
rate	O
90	O
,	O
blood	O
pressure	O
152	O
/	O
75	O
,	O
respiratory	O
rate	O
24	O
,	O
o2	O
saturation	O
95	O
percent	O
on	O
room	O
air	O
.	O

weight	O
99	O
.	O
4	O
kilos	O
.	O

laboratory	O
data	O
:	O
pt	O
/	O
inr	O
13	O
.	O
4	O
,	O
inr	O
1	O
.	O
1	O
.	O

physical	O
examination	O
neurologic	O
:	O
alert	O
and	O
oriented	O
times	O
three	O
,	O
moves	O
all	O
extremities	O
,	O
follows	O
commands	O
,	O
nonfocal	O
examination	O
.	O

pulmonary	O
:	O
upper	O
airway	O
wheezes	B
,	O
otherwise	O
clear	O
to	O
auscultation	O
.	O

cardiac	O
:	O
irregular	B
rate	I
and	O
rhythm	O
.	O

sternum	O
is	O
stable	O
.	O

incision	O
with	O
staples	O
without	O
erythema	B
or	O
drainage	B
.	O

abdomen	O
is	O
soft	O
,	O
nontender	O
,	O
nondistended	O
,	O
normal	O
active	O
bowel	O
sounds	O
.	O

extremities	O
are	O
warm	O
with	O
no	O
edema	B
.	O

bilateral	O
leg	O
incision	O
open	O
to	O
air	O
with	O
no	O
erythema	B
.	O

picc	O
line	O
in	O
the	O
right	O
antecubital	O
space	O
,	O
a	O
4	O
[	O
*	O
*	O
ethnicity	O
432	O
*	O
*	O
]	O
single	O
lumen	O
catheter	O
.	O

condition	O
on	O
discharge	O
:	O
good	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
coronary	B
artery	I
disease	I
,	O
status	O
post	O
coronary	O
artery	O
bypass	O
grafting	O
times	O
three	O
complicated	O
by	O
sternal	B
drainage	I
requiring	O
sternal	O
rewiring	O
on	O
[	O
*	O
*	O
04	O
-	O
01	O
*	O
*	O
]	O
.	O

2	O
.	O
atrial	B
fibrillation	I
status	O
post	O
maze	O
.	O

3	O
.	O
hypertension	B
.	O

4	O
.	O
hypercholesterolemia	B
.	O

5	O
.	O
noninsulin	B
dependent	I
diabetes	I
mellitus	I
.	O

6	O
.	O
degenerative	B
joint	I
disease	I
,	O
status	O
post	O
bilateral	O
total	O
knee	O
replacement	O
.	O

7	O
.	O
abdominal	B
aortic	I
aneurysm	I
.	O

8	O
.	O
colon	B
carcinoma	I
,	O
status	O
post	O
colonic	O
resection	O
.	O

9	O
.	O
status	O
post	O
bilateral	O
cataract	B
surgery	O
.	O

follow	O
up	O
:	O
the	O
patient	O
is	O
have	O
follow	O
up	O
in	O
the	O
wound	B
clinic	O
one	O
week	O
following	O
his	O
discharge	O
from	O
[	O
*	O
*	O
hospital	O
193	O
*	O
*	O
]	O
,	O
that	O
would	O
be	O
on	O
[	O
*	O
*	O
06	O
-	O
25	O
*	O
*	O
]	O
with	O
one	O
of	O
the	O
mid	O
level	O
practitioners	O
,	O
and	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
433	O
*	O
*	O
]	O
in	O
three	O
to	O
four	O
weeks	O
.	O

medications	O
at	O
time	O
of	O
discharge	O
:	O
include	O
metoprolol	O
75	O
mg	O

b	O
.	O
i	O
.	O
d	O
.	O
,	O
atorvastatin	O
40	O
mg	O
daily	O
,	O
percocet	O
5	O
/	O
325	O
one	O
to	O
two	O
tablets	O
q	O
4	O
to	O
6	O
hours	O
prn	O
,	O
amiodarone	O
200	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O
times	O
seven	O
days	O
,	O
then	O
daily	O
,	O
lorazepam	O
0	O
.	O
5	O
mg	O
to	O
1	O
mg	O
q	O
6	O
hours	O

prn	O
,	O
combivent	O
2	O
puffs	O
q	O
6	O
hours	O
,	O
flovent	O
2	O
puffs	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O

lasix	O
40	O
mg	O
daily	O
,	O
warfarin	O
as	O
directed	O
to	O
maintain	O
a	O
goal	O

inr	O
of	O
2	O
to	O
2	O
.	O
5	O
.	O

the	O
patient	O
received	O
5	O
mg	O
on	O
[	O
*	O
*	O
04	O
-	O
04	O
*	O
*	O
]	O
as	O
well	O
as	O

[	O
*	O
*	O
04	O
-	O
05	O
*	O
*	O
]	O
.	O

his	O
warfarin	O
dose	O
prior	O
to	O
admission	O
was	O
7	O
.	O
5	O
mg	O
.	O

colace	O
100	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O
and	O
linezolid	O
600	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O
times	O
four	O
weeks	O
.	O

it	O
should	O
be	O
noted	O
that	O
the	O
patient	O
will	O
require	O
cbc	O
as	O
well	O
as	O
liver	O
function	O
tests	O
q	O
week	O
while	O
he	O
is	O
on	O
linezolid	O
.	O

his	O
staples	O
can	O
be	O
removed	O
on	O
or	O
about	O
[	O
*	O
*	O
04	O
-	O
22	O
*	O
*	O
]	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
434	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
state	O
/	O
zipcode	O
435	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
35	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
05	O
*	O
*	O
]	O
16	O
:	O
25	O
:	O
26	O

t	O
:	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
05	O
*	O
*	O
]	O
17	O
:	O
21	O
:	O
18	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
436	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
sat	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
07	O
*	O
*	O
]	O
1	O
:	O
06	O
pm	O

(	O
end	O
of	O
report	O
)	O

108127	O
||||	O
9531	O
||||	O
19759	O
||||	O
echo	O
_	O
report	O
||||	O
2009	O
-	O
10	O
-	O
26	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
?endocarditis	O

height	O
:	O
(	O
in	O
)	O
66	O

weight	O
(	O
lb	O
)	O
:	O
117	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
59	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
93	O
/	O
51	O

hr	O
(	O
bpm	O
)	O
:	O
103	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2009	O
-	O
10	O
-	O
26	O
*	O
*	O
]	O
at	O
16	O
:	O
17	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
complete	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
the	O
right	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

left	O
ventricle	O
:	O
left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

aorta	O
:	O
the	O
aortic	O
root	O
is	O
normal	O
in	O
diameter	O
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B
regurgitation	I
.	O

no	O
masses	B
or	O
vegetations	B
are	O
seen	O
on	O
the	O
aortic	O
valve	O
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal	O
.	O

no	O
mass	B
or	O
vegetation	B
is	O
seen	O
on	O
the	O
mitral	O
valve	O
.	O

physiologic	O
mitral	B
regurgitation	I
is	O
seen	O
(	O
within	O
normal	O
limits	O
)	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
the	O
pulmonic	O
valve	O
leaflets	O
appear	O
structurally	O
normal	O
with	O
physiologic	O
pulmonic	B
regurgitation	I
.	O

pericardium	O
:	O
there	O
is	O
no	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B
regurgitation	I
.	O

no	O
masses	B
or	O
vegetations	B
are	O
seen	O
on	O
the	O
aortic	O
valve	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal	O
.	O

no	O
mass	B
or	O
vegetation	B
is	O
seen	O
on	O
the	O
mitral	O
valve	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

no	O
echocardiographic	O
evidence	O
of	O
endocarditis	B
.	O

compared	O
with	O
the	O
prior	O
report	O
(	O
tape	O
unavailable	O
)	O
of	O
[	O
*	O
*	O
2009	O
-	O
10	O
-	O
06	O
*	O
*	O
]	O
,	O
no	O
significant	O
change	O
.	O
,	O

963	O
||||	O
9602	O
||||	O
20303	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
12	O
-	O
21	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
18	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
21	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1959	O
-	O
05	O
-	O
23	O
*	O
*	O
]	O
sex	O
:	O
m	O

chief	O
complaint	O
:	O
chest	B
pain	I
.	O

history	O
of	O
present	O
illness	O
:	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
2915	O
*	O
*	O
]	O
is	O
54	O
-	O
year	O
-	O
old	O
gentleman	O
with	O
a	O
history	O
of	O
hypertension	B
,	O
coronary	O
artery	O
in	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
08	O
*	O
*	O
]	O
.	O

he	O
is	O
status	O
post	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
and	O
stent	O
of	O
his	O
middle	O
left	O
anterior	O
descending	O
artery	O
and	O
diagonal	O
who	O
presents	O
from	O
an	O
outside	O
hospital	O
with	O
45	O
minutes	O
of	O
crushing	B
chest	I
pain	I
at	O
rest	O
which	O
began	O
in	O
his	O
left	O
arm	O
then	O
to	O
his	O
right	O
arm	O
associated	O
with	O
diaphoresis	B
.	O

an	O
electrocardiogram	O
revealed	O
2	O
-	O
mm	O
to	O
3	O
-	O
mm	O
st	B
elevations	I
in	O
v1	O
through	O
v3	O
with	O
which	O
was	O
improved	O
with	O
aspirin	O
and	O
sublingual	O
nitroglycerin	O
.	O

the	O
patient	O
was	O
given	O
morphine	O
,	O
lopressor	O
,	O
and	O
started	O
on	O
heparin	O
in	O
the	O
emergency	O
room	O
at	O
the	O
outside	O
hospital	O
.	O

he	O
was	O
sent	O
to	O
[	O
*	O
*	O
hospital	O
43	O
*	O
*	O
]	O
for	O
cardiac	O

catheterization	O
.	O

cardiac	O
catheterization	O
revealed	O
the	O
patient	O
had	O
2	B
-	I
vessel	I
coronary	I
artery	I
disease	I
,	O
right	B
-	I
dominant	I
system	I
,	O
left	O
anterior	O
descending	O
artery	O
occluded	B
distal	O
to	O
the	O
origin	O
,	O
proximal	O
left	O
anterior	O
descending	O
artery	O
underwent	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
with	O
stent	O
placement	O
,	O
left	O
main	O
coronary	O
artery	O
was	O
patent	O
,	O
his	O
left	O
circumflex	O
showed	O
minimal	O
luminal	B
irregularities	I
,	O
80%	O
stenosis	B
of	O
distal	O
vessel	O
,	O
right	O
coronary	O
artery	O
showed	O
minimal	O
luminal	B
irregularities	I
throughout	O
with	O
60%	O
proximal	O
stenosis	B
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
hypertension	B
.	O

2	O
.	O
coronary	B
artery	I
disease	I
,	O
status	O
post	O
catheterization	O
on	O

[	O
*	O
*	O
2012	O
-	O
05	O
-	O
08	O
*	O
*	O
]	O
,	O
where	O
he	O
received	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
with	O
stent	O
placement	O
to	O
his	O
middle	O
left	O
anterior	O
descending	O
artery	O
and	O
second	O
diagonal	O
.	O

social	O
history	O
:	O
he	O
does	O
not	O
smoke	O
.	O

no	O
history	O
of	O
intravenous	O
drug	O
use	O
.	O

occasional	O
alcohol	O
use	O
.	O

he	O
is	O
a	O
computer	O
programmer	O
.	O

he	O
is	O
married	O
with	O
three	O
children	O
.	O

family	O
history	O
:	O
family	O
history	O
is	O
negative	O
for	O
coronary	B
artery	I
disease	I
.	O

medications	O
on	O
admission	O
:	O
he	O
is	O
on	O
lipitor	O
10	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
h	O
.	O
s	O
.	O
and	O
aspirin	O
325	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

physical	O
examination	O
on	O
presentation	O
:	O
vital	O
signs	O
on	O
admission	O
were	O
temperature	O
of	O
98	O
.	O
5	O
,	O
pulse	O
80	O
to	O
82	O
,	O
blood	O
pressure	O
127	O
/	O
73	O
,	O
satting	O
95%	O
on	O
2	O
liters	O
.	O

he	O
was	O
a	O
well	O
-	O
developed	O
white	O
male	O
in	O
no	O
apparent	B
distress	I
.	O

heent	O
revealed	O
he	O
had	O
no	O
jugular	B
venous	I
distention	I
.	O

sclerae	O
were	O
anicteric	B
.	O

cardiovascular	O
had	O
a	O
regular	O
rate	O
and	O
rhythm	O
.	O

fourth	O
heart	O
sound	O
was	O
present	O
.	O

no	O
murmurs	B
,	O
rubs	B
or	O
gallops	B
.	O

respiratory	O
revealed	O
lungs	O
were	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

abdomen	O
revealed	O
good	O
bowel	O
sounds	O
,	O
nontender	O
,	O
and	O
nondistended	O
.	O

extremities	O
revealed	O
right	O
groin	O
area	O
revealed	O
no	O
hematoma	B
.	O

pulses	O
were	O
2	O
+	O
.	O

no	O
femoral	B
bruits	I
auscultated	O
.	O

no	O
lower	B
extremity	I
edema	I
.	O

laboratory	O
data	O
on	O
presentation	O
:	O
hematocrit	O
36	O
.	O
4	O
,	O
white	O
blood	O
cell	O
count	O
12	O
.	O
7	O
,	O
platelets	O
of	O
119	O
.	O

creatine	O
kinases	O
were	O
5928	O
.	O

inr	O
1	O
.	O
1	O
,	O
pt	O
12	O
.	O
4	O
,	O
ptt	O
23	O
.	O
2	O
.	O

bun	O
12	O
,	O
creatinine	O
0	O
.	O
8	O
,	O
potassium	O
4	O
.	O
1	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
had	O
no	O
post	O
catheterization	O
complications	B
.	O

the	O
patient's	O
right	O
groin	O
area	O
was	O
stable	O
post	O
catheterization	O
.	O

there	O
was	O
no	O
hematoma	B
palpated	O
or	O
femoral	B
bruit	I
auscultated	O
.	O

his	O
femoral	O
,	O
dorsalis	O
pedis	O
and	O
posterior	O
tibialis	O
pulses	O
were	O
2	O
+	O
.	O

his	O
hematocrit	O
and	O
creatinine	O
remained	O
stable	O
throughout	O
his	O
hospital	O
stay	O
.	O

he	O
denied	O
any	O
chest	B
pain	I
,	O
flank	O
,	O
or	O
leg	B
pain	I
.	O

after	O
catheterization	O
,	O
his	O
creatine	O
kinases	O
were	O
5928	O
and	O
fell	O
to	O
638	O
at	O
the	O
time	O
of	O
discharge	O
.	O

an	O
echocardiogram	O
showed	O
the	O
left	O
atrium	O
was	O
mildly	O
dilated	O
.	O

he	O
had	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

his	O
left	O
ventricle	O
was	O
mildly	O
dilated	O
.	O

his	O
left	O
ventricular	O
systolic	O
function	O
was	O
mildly	O
depressed	O
with	O
middle	O
,	O
distal	O
,	O
septal	O
,	O
and	O
anterior	O
akinesis	B
with	O
apical	O
dyskinesis	B
.	O

his	O
left	O
ventricular	O
systolic	O
function	O
was	O
within	O
normal	O
limits	O
.	O

he	O
had	O
1	O
+	O
mitral	B
regurgitation	I
and	O
1	O
+	O
aortic	B
regurgitation	I
.	O

as	O
a	O
result	O
of	O
the	O
echocardiogram	O
findings	O
,	O
he	O
was	O
started	O
on	O
coumadin	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
h	O
.	O
s	O
.	O
and	O
will	O
need	O
to	O
have	O
his	O
inr	O
checked	O
by	O
his	O
cardiologist	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
,	O
in	O
five	O
days	O
.	O

he	O
was	O
started	O
on	O
zocor	O
for	O
an	O
ldl	O
of	O
140	O
.	O

condition	O
at	O
discharge	O
:	O
condition	O
on	O
discharge	O
at	O
the	O
time	O
of	O
discharge	O
was	O
stable	O
.	O

discharge	O
status	O
:	O
discharged	O
to	O
home	O
.	O

discharge	O
instructions	O
:	O
return	O
to	O
the	O
emergency	O
room	O
if	O
he	O
developed	O
chest	B
pain	I
,	O
flank	B
pain	I
,	O
back	B
pain	I
,	O
or	O
leg	B
pain	I
.	O

discharge	O
followup	O
:	O
follow	O
up	O
with	O
his	O
cardiologist	O
,	O

dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
,	O
to	O
have	O
your	O
inr	B
checked	O
in	O
five	O
days	O
.	O

medications	O
on	O
discharge	O
:	O

1	O
.	O
aspirin	O
325	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

2	O
.	O
captopril	O
12	O
.	O
5	O
mg	O
p	O
.	O
o	O
.	O
t	O
.	O
i	O
.	O
d	O
.	O

3	O
.	O
plavix	O
75	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O
for	O
a	O
total	O
of	O
30	O
days	O
.	O

4	O
.	O
toprol	O
-	O
xl	O
25	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

5	O
.	O
zocor	O
20	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

6	O
.	O
coumadin	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
h	O
.	O
s	O
.	O

7	O
.	O
sublingual	O
nitroglycerin	O
0	O
.	O
4	O
mg	O
q	O
.	O
5min	O
.	O
p	O
.	O
r	O
.	O
n	O
.	O
for	O
chest	B
pain	I
.	O

[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
2758	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
2759	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1087	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
23	O
*	O
*	O
]	O
13	O
:	O
55	O

t	O
:	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
26	O
*	O
*	O
]	O
14	O
:	O
38	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
2916	O
*	O
*	O
]	O

(	O
cclist	O
)	O

dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
2758	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
27	O
*	O
*	O
]	O
8	O
:	O
38	O
pm	O

(	O
end	O
of	O
report	O
)	O

109051	O
||||	O
9703	O
||||	O
6078	O
||||	O
echo	O
_	O
report	O
||||	O
2012	O
-	O
02	O
-	O
16	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
cerebrovascular	B
event	I
/	O
tia	B
.	O

source	O
of	O
embolism	B
.	O

height	O
:	O
(	O
in	O
)	O
69	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
138	O
/	O
57	O

hr	O
(	O
bpm	O
)	O
:	O
60	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2012	O
-	O
02	O
-	O
16	O
*	O
*	O
]	O
at	O
10	O
:	O
20	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
saline	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
normal	O
la	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

no	O
asd	B
or	O
pfo	B
by	O
2d	O
,	O
color	O
doppler	O
or	O
saline	O
contrast	O
with	O
maneuvers	O
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
.	O

overall	O
normal	O
lvef	O
(	O
>55%	O
)	O
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
normal	O
ascending	O
,	O
transverse	O
and	O
descending	O
thoracic	O
aorta	O
with	O
no	O
atherosclerotic	B
plaque	I
.	O

mildly	O
dilated	B
aortic	I
root	I
.	O

focal	O
calcifications	B
in	O
aortic	O
root	O
.	O

normal	O
ascending	O
aorta	O
diameter	O
.	O

focal	O
calcifications	B
in	O
ascending	O
aorta	O
.	O

aortic	O
valve	O
:	O
mildly	O
thickened	B
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

no	O
mvp	B
.	O

mild	O
mitral	B
annular	I
calcification	I
.	O

mild	O
thickening	B
of	O
mitral	O
valve	O
chordae	O
.	O

calcified	B
tips	I
of	O
papillary	O
muscles	O
.	O

no	O
ms	B
.	O

mild	O
(	O
1	O
+	O
)	O
mr	B
.	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
36	O
*	O
*	O
]	O
lv	O
inflow	O
pattern	O
for	O
age	O
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
with	O
trivial	O
tr	B
.	O

normal	O
tricuspid	O
valve	O
supporting	O
structures	O
.	O

normal	O
pa	O
systolic	O
pressure	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
normal	O
pulmonic	O
valve	O
leaflets	O
with	O
physiologic	O
pr	B
.	O

normal	O
main	O
pa	O
.	O

no	O
doppler	O
evidence	O
for	O
pda	B

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
contrast	O
study	O
was	O
performed	O
with	O
2	O
iv	O
injections	O
of	O
8	O
ccs	O
of	O
agitated	O
normal	O
saline	O
,	O
at	O
rest	O
,	O
and	O
with	O
cough	O
.	O

patient	O
was	O
unable	O
to	O
cooperate	O
with	O
maneuvers	O
.	O

frequent	O
atrial	B
premature	I
beats	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

no	O
atrial	B
septal	I
defect	I
or	O
patent	B
foramen	I
ovale	I
is	O
seen	O
by	O
2d	O
,	O
color	O
doppler	O
or	O
saline	O
contrast	O
with	O
maneuvers	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef	O
60%	O
)	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
ascending	O
,	O
transverse	O
and	O
descending	O
thoracic	O
aorta	O
are	O
normal	O
in	O
diameter	O
and	O
free	O
of	O
atherosclerotic	B
plaque	I
.	O

the	O
aortic	O
root	O
is	O
mildly	O
dilated	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
but	O
aortic	B
stenosis	I
is	O
not	O
present	O
.	O

no	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
no	O
mitral	B
valve	I
prolapse	I
.	O

mild	O
(	O
1	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
normal	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

169426	O
||||	O
10434	O
||||	O
28605	O
||||	O
radiology	O
_	O
report	O
||||	O
2016	O
-	O
03	O
-	O
08	O
13	O
:	O
39	O
:	O
00	O
.	O
0	O
||||	O
d51	O
n	O
-	O
g	O
tube	O
placement	O
(	O
w	O
/	O
fluoro	O
)	O
||||	O
||||	O
clip	O
#	O
335	O
-	O
5425	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
08	O
*	O
*	O
]	O
1	O
:	O
39	O
pm	O

n	O
-	O
g	O
tube	O
placement	O
(	O
w	O
/	O
fluoro	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
1379	O
*	O
*	O
]	O
reason	O
:	O
please	O
place	O
distal	O
tube	O
post	O
-	O
pyloric	O
junction	O
admitting	O
diagnosis	O
:	O
failure	B
to	I
thrive	I

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

60	O
year	O
old	O
woman	O
with	O
hep	B
c	I
cirrhosis	I
s	O
/	O
p	O
transplant	O
with	O
repeat	O
bx	O
with	O
ng	O
tube	O
that	O
is	O
curled	O
in	O
the	O
stomach	O
.	O

reason	O
for	O
this	O
examination	O
:	O

please	O
place	O
distal	O
tube	O
post	O
-	O
pyloric	O
junction	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

history	O
:	O
s	O
/	O
p	O
liver	O
transplant	O
.	O

post	O
-	O
pyloric	O
tube	O
placement	O
:	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
9	O
*	O
*	O
]	O
wire	O
was	O
advanced	O
through	O
the	O
existing	O
feeding	O
tube	O
and	O
the	O
feeding	O
tube	O
is	O
advanced	O
toward	O
the	O
pylorus	O
.	O

however	O
,	O
it	O
is	O
technically	O
difficult	O
for	O
the	O
feeding	O
tube	O
to	O
pass	O
through	O
the	O
pylorus	O
.	O

the	O
patient	O
tolerated	O
the	O
procedure	O
without	O
complication	B
.	O

impression	O
:	O
the	O
tip	O
of	O
the	O
feeding	O
tube	O
is	O
at	O
the	O
pylorus	O
,	O
and	O
a	O
follow	O
up	O
chest	O
x	O
-	O
ray	O
would	O
be	O
helpful	O
to	O
assess	O
the	O
position	O
of	O
the	O
feeding	O
tube	O
.	O

discussed	O
with	O
the	O
surgical	O
resident	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1380	O
*	O
*	O
]	O
.	O

22213	O
||||	O
10539	O
||||	O
4075	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
10	O
-	O
14	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
14	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1932	O
-	O
05	O
-	O
01	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O

allergies	O
:	O

amoxicillin	O
/	O
aldomet	O
/	O
procardia	O
/	O
ampicillin	O
/	O
percocet	O
/	O
adhesive	O
tape	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
3178	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

left	O
sided	O
psoas	B
abscess	I
and	O
left	O
sided	O
nonfunctional	B
kidney	I
with	O
renal	B
calculi	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

left	O
nephrectomy	O
,	O
drainage	O
of	O
psoas	B
abscess	I

history	O
of	O
present	O
illness	O
:	O

81f	O
with	O
hyperparathyroidism	B
leading	O
to	O
20	O
years	O
of	O
urinary	B
calculi	I
.	O

recent	O
diagnosis	O
of	O
parathyroid	B
adenoma	I
resected	O
.	O

left	O
kidney	O
with	O
multiple	O
large	O
obstructing	O
calculi	O
,	O
found	O
to	O
be	O
non	O
functional	O
with	O
a	O
psoas	B
abscess	I
.	O

she	O
underwent	O
bilateral	O
percutaneous	O
nephrostomy	O
tube	O
placement	O
,	O
antibiotic	O
therapy	O
and	O
returned	O
on	O
this	O
admission	O
for	O
left	O
nephrectomy	O
and	O
drainage	O
of	O
abscess	B
.	O

past	O
medical	O
history	O
:	O

cad	B
s	O
/	O
p	O
mi	B
at	O
53	O

htn	B

chf	I
s	O
/	O
p	O
avr	O

nephrolithiasis	B

paf	I

l	O
cea	O

retroperitoneal	B
hematoma	I

social	O
history	O
:	O

pt	O
retired	O
and	O
currently	O
live	O
in	O
[	O
*	O
*	O
state	O
*	O
*	O
]	O
.	O

she	O
ambulates	O
and	O
still	O
drivestob	O
:	O
stopped	O
30	O
yrs	O
agoalc	O
:	O
none	O
pt	O
retired	O
and	O
currently	O
live	O
in	O
[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
islandshe	O
ambulates	O
and	O
still	O
drivestob	O
:	O
stopped	O
30	O
yrs	O
agoalc	O
:	O
none	O

family	O
history	O
:	O

non	O
-	O
contributory	O

physical	O
exam	O
:	O

physical	O
exam	O
:	O

t	O
:	O
97	O
.	O
5	O
bp	O
:	O
160	O
/	O
74	O
p	O
:	O
74	O
rr	O
:	O
18	O
o2	O
:	O
98%	O
ra	O

gen	O
:	O
pt	O
agitated	B
,	O
sitting	O
up	O
in	O
bed	O
,	O
aox2	O
.	O
5	O

heent	O
:	O
atnc	O
,	O
anicteric	O

neck	O
:	O
supple	O
no	O
jvd	B

cardiac	O
:	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
,	O
sem	B
heard	O
best	O
at	O
r	O
sternal	O
edge	O
and	O
throughout	O
precordium	O

lungs	O
:	O
cta	O
-	O
b	O

abd	O
:	O
soft	O
,	O
nt	O
/	O
nd	O
,	O
+	O
bs	O
r	O
nephrostomy	O
c	O
/	O
d	O
/	O
i	O
,	O
l	O
incision	O
c	O
/	O
d	O
/	O
i	O
non	O
-	O
erythematous	B

ext	O
:	O
trace	O
edema	I
in	O
le	O
b	O
/	O
l	O
,	O
5	O
/	O
5	O
strength	O
in	O
grip	O
/	O
bicpes	O
/	O
quads	O
.	O

from	O
throughout	O
.	O

pertinent	O
results	O
:	O

vre	O
screen	O
negative	O
(	O
historical	O
+	O
)	O

mrsa	O
screen	O
negative	O

at	O
admit	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
01	O
:	O
50pm	O
blood	O
wbc	O
-	O
11	O
.	O
2	O
*	O
rbc	O
-	O
4	O
.	O
03	O
*	O
hgb	O
-	O
10	O
.	O
9	O
*	O
hct	O
-	O
33	O
.	O
5	O
*	O
mcv	O
-	O
83	O
mch	O
-	O
27	O
.	O
2	O
mchc	O
-	O
32	O
.	O
7	O
rdw	O
-	O
15	O
.	O
7	O
*	O
plt	O
ct	O
-	O
268	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
07	O
:	O
00am	O
blood	O
pt	O
-	O
13	O
.	O
7	O
*	O
ptt	O
-	O
26	O
.	O
9	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
2	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
01	O
:	O
50pm	O
blood	O
plt	O
ct	O
-	O
268	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
01	O
:	O
50pm	O
blood	O
glucose	O
-	O
184	O
*	O
urean	O
-	O
14	O
creat	O
-	O
1	O
.	O
0	O
na	O
-	O
140	O
k	O
-	O
4	O
.	O
0	O
cl	O
-	O
107	O
hco3	O
-	O
24	O
angap	O
-	O
13	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
07	O
:	O
39pm	O
blood	O
calcium	O
-	O
7	O
.	O
6	O
*	O
phos	O
-	O
4	O
.	O
5	O
mg	O
-	O
1	O
.	O
8	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
11	O
:	O
52am	O
blood	O
type	O
-	O
art	O
rates	O
-	O
7	O
/	O
tidal	O
v	O
-	O
510	O
o2	O
-	O
44	O
po2	O
-	O
165	O
*	O
pco2	O
-	O
43	O
ph	O
-	O
7	O
.	O
40	O
calhco3	O
-	O
28	O
base	O
xs	O
-	O
1	O
intubat	O
-	O
intubated	O
vent	O
-	O
controlled	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
08	O
:	O
13am	O
blood	O
hgb	O
-	O
9	O
.	O
3	O
*	O
calchct	O
-	O
28	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
10	O
:	O
17am	O
blood	O
freeca	O
-	O
1	O
.	O
10	O
*	O

s	O
/	O
p	O
d	O
/	O
c	O
from	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
572	O
*	O
*	O
]	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
08	O
*	O
*	O
]	O
09	O
:	O
00pm	O
blood	O
wbc	O
-	O
10	O
.	O
2	O
rbc	O
-	O
4	O
.	O
29	O
hgb	O
-	O
11	O
.	O
5	O
*	O
hct	O
-	O
36	O
.	O
6	O
mcv	O
-	O
85	O
mch	O
-	O
26	O
.	O
7	O
*	O
mchc	O
-	O
31	O
.	O
3	O
rdw	O
-	O
16	O
.	O
4	O
*	O
plt	O
ct	O
-	O
313	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
09	O
*	O
*	O
]	O
06	O
:	O
20am	O
blood	O
pt	O
-	O
13	O
.	O
8	O
*	O
ptt	O
-	O
27	O
.	O
1	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
2	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
08	O
*	O
*	O
]	O
09	O
:	O
00pm	O
blood	O
glucose	O
-	O
86	O
urean	O
-	O
21	O
*	O
creat	O
-	O
1	O
.	O
2	O
*	O
na	O
-	O
143	O
k	O
-	O
4	O
.	O
0	O
cl	O
-	O
107	O
hco3	O
-	O
23	O
angap	O
-	O
17	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
08	O
*	O
*	O
]	O
09	O
:	O
00pm	O
blood	O
calcium	O
-	O
8	O
.	O
3	O
*	O
phos	O
-	O
3	O
.	O
5	O
mg	O
-	O
2	O
.	O
1	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
11	O
*	O
*	O
]	O
05	O
:	O
30am	O
blood	O
digoxin	O
-	O
0	O
.	O
9	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
06	O
*	O
*	O
]	O
01	O
:	O
38pm	O
blood	O
type	O
-	O
art	O
po2	O
-	O
91	O
pco2	O
-	O
35	O
ph	O
-	O
7	O
.	O
43	O
calhco3	O
-	O
24	O
base	O
xs	O
-	O
0	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
05	O
*	O
*	O
]	O
02	O
:	O
22am	O
blood	O
glucose	O
-	O
137	O
*	O
lactate	O
-	O
2	O
.	O
9	O
*	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
09	O
*	O
*	O
]	O
08	O
:	O
14am	O
blood	O
freeca	O
-	O
1	O
.	O
14	O

cxr	O
(	O
[	O
*	O
*	O
10	O
-	O
05	O
*	O
*	O
]	O
)	O
-	O
-	O
1	O
)	O
right	O
internal	O
jugular	O
central	O
venous	O
line	O
with	O
tip	O
at	O
the	O
superior	O
vena	O
cava	O
/	O
right	O
atrial	O
border	O
.	O

no	O
pneumothorax	B
.	O

2	O
)	O
mild	O
congestive	B
heart	I
failure	I
.	O

ct	O
(	O
[	O
*	O
*	O
10	O
-	O
09	O
*	O
*	O
]	O
)	O
-	O
-	O
impression	O
:	O

1	O
)	O
stable	O
right	O
upj	O
and	O
left	O
distal	O
ureter	B
stones	I
.	O

right	O
nephrostomy	O
tube	O
and	O
no	O
right	O
hydronephrosis	B
.	O

2	O
)	O
extensive	O
diverticulosis	B
without	O
evidence	O
of	O
diverticulitis	B
.	O

3	O
)	O
cholelithiasis	B
.	O

4	O
)	O
cardiomegaly	B
.	O

5	O
)	O
bilateral	B
pleural	I
effusions	I
.	O

6	O
)	O
probable	O
hepatic	B
cysts	I
.	O

brief	O
hospital	O
course	O
:	O

pt	O
was	O
admitted	O
on	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
for	O
the	O
purpose	O
of	O
definitive	O
surgical	O
management	O
of	O
a	O
chronic	O
l	O
kidney	O
failure	O
2nd	O
to	O
ureteral	B
calculi	I
and	O
l	O
purulent	O
perinephric	O
psoas	I
abcess	I
.	O

the	O
planned	O
l	O
radical	O
nephrectomy	O
/	O
ureterectomy	O
was	O
without	O
complication	B
or	O
finding	O
necessitating	O
a	O
change	O
in	O
the	O
pre	O
-	O
operative	O
diagnosis	O
,	O
but	O
given	O
her	O
fragile	O
health	O
,	O
large	O
fluid	O
shift	O
and	O
the	O
800cc	O
of	O
ebl	O
(	O
addressed	O
with	O
3u	O
prbc	O
)	O
she	O
was	O
maintained	O
in	O
the	O
pacu	O
overnight	O
.	O

r	O
nephrostomy	O
tube	O
remained	O
in	O
place	O
and	O
general	O
surgery	O
was	O
present	O
during	O
the	O
case	O
to	O
assist	O
with	O
the	O
lysis	O
of	O
extensive	O
adheions	O
of	O
the	O
abcess	B
to	O
surrounding	O
structures	O
.	O

on	O
pod#1	O
,	O
it	O
was	O
decided	O
to	O
wean	O
her	O
off	O
the	O
vent	O
(	O
simv	O
)	O
,	O
and	O
she	O
was	O
taken	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
572	O
*	O
*	O
]	O
for	O
immediate	O
post	O
-	O
operative	O
period	O
.	O

she	O
was	O
given	O
a	O
24	O
hour	O
course	O
of	O
vanco	O
,	O
and	O
started	O
on	O
7	O
days	O
of	O
ceftazidine	O
.	O

she	O
was	O
sucessfully	O
extubated	O
on	O
pod#2	O
.	O
however	O
at	O
this	O
same	O
time	O
,	O
she	O
was	O
noted	O
to	O
be	O
in	O
a	B
-	I
fib	I
with	O
an	O
inappropriate	B
pacemaker	I
response	I
and	O
ep	O
was	O
consulted	O
for	O
a	O
question	O
of	O
the	O
pm	B
failure	I
to	I
capture	I
.	O

the	O
pacemaker	O
was	O
interrogated	O
on	O
[	O
*	O
*	O
10	O
-	O
06	O
*	O
*	O
]	O
and	O
its	O
setting	O
reprogrammed	O
to	O
vv1	O
60	O
.	O

wide	B
complex	I
v	I
-	I
tach	I
was	O
noted	O
on	O
[	O
*	O
*	O
10	O
-	O
07	O
*	O
*	O
]	O
and	O
runs	O
of	O
nsvt	B
were	O
noted	O
on	O
[	O
*	O
*	O
10	O
-	O
09	O
*	O
*	O
]	O
.	O

ep	O
again	O
interrogated	O
the	O
pm	O
and	O
considered	O
it	O
functioning	O
well	O
,	O
but	O
her	O
digoxin	O
level	O
was	O
1	O
.	O
2	O
-	O
1	O
.	O
4	O
,	O
above	O
the	O
optimum	O
0	O
.	O
8	O
which	O
they	O
felt	O
could	O
have	O
been	O
contributing	O
to	O
ventricular	B
irritability	I
.	O

thus	O
her	O
out	O
-	O
pt	O
digoxin	O
dose	O
was	O
halves	O
in	O
compensate	O
for	O
her	O
change	O
in	O
renal	O
fxn	O
.	O

similarly	O
,	O
lisinopril	O
was	O
also	O
stopped	O
post	O
-	O
operatively	O
.	O

on	O
pod#3	O
,	O
pt	O
was	O
cleared	O
by	O
a	O
speech	O
and	O
swallow	O
eval	O
.	O

pt	O
was	O
transferred	O
to	O
12reisman	O
and	O
out	O
of	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
572	O
*	O
*	O
]	O
on	O
pod#4	O
,	O
with	O
telemetry	O
and	O
a	O
sitter	O
.	O

chest	O
tube	O
was	O
removed	O
on	O
pod#3	O
,	O
which	O
was	O
place	O
as	O
per	O
standard	O
procedure	O
for	O
a	O
thoracoabdominal	O
incision	O
.	O

she	O
was	O
advance	O
to	O
a	O
regular	O
diet	O
on	O
pod#5	O
,	O
and	O
restarted	O
on	O
her	O
home	O
dose	O
of	O
warfarin	O
.	O

throughout	O
the	O
post	O
-	O
operative	O
period	O
until	O
they	O
were	O
removed	O
on	O
pod#7	O
,	O
her	O
2	O
jp	O
drains	O
put	O
out	O
>100cc	O
of	O
serosanguinous	O
fluid	O
each	O
.	O

sitter	O
was	O
d	O
/	O
c'ed	O
on	O
pod#8	O
without	O
incident	O
;	O
pt	O
remained	O
agitated	B
but	O
cooperative	O
.	O

pt	O
was	O
ready	O
for	O
discharge	O
on	O
pod#7	O
,	O
but	O
could	O
not	O
be	O
discharged	O
due	O
to	O
a	O
sitter	O
being	O
involved	O
in	O
the	O
pt's	O
care	O
.	O

on	O
pod#10	O
,	O
pt	O
had	O
been	O
without	O
sitter	O
for	O
>24	O
hours	O
without	O
incident	O
,	O
and	O
had	O
notably	O
come	O
back	O
negative	O
for	O
both	O
vre	O
and	O
mrsa	O
.	O

medications	O
on	O
admission	O
:	O

same	O
as	O
below	O
with	O
the	O
addition	O
of	O
lisinopril	O

discharge	O
medications	O
:	O

1	O
.	O
acetaminophen	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

2	O
.	O
furosemide	O
40	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O

3	O
.	O
atorvastatin	O
calcium	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O

4	O
.	O
pantoprazole	O
sodium	O
40	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
q24h	O
(	O
every	O
24	O
hours	O
)	O
.	O

5	O
.	O
digoxin	O
125	O
mcg	O
tablet	O
sig	O
:	O
0	O
.	O
5	O
tablet	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O

6	O
.	O
colace	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
twice	O
a	O
day	O
for	O
21	O
days	O
.	O

disp	O
:	O
*	O
42	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

7	O
.	O
ativan	O
1	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
twice	O
a	O
day	O
as	O
needed	O
for	O
insomnia	B
:	O
as	O
needed	O
for	O
sleep	B
/	O
agitation	B
prn	O
,	O
not	O
to	O
exceed	O
3mg	O
/	O
24hrs	O
.	O

8	O
.	O
seroquel	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
twice	O
a	O
day	O
.	O

9	O
.	O
metoprolol	O
succinate	O
100	O
mg	O
tablet	O
sustained	O
release	O
24hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
sustained	O
release	O
24hr	O
po	O
once	O
a	O
day	O
.	O

10	O
.	O

warfarin	O
sodium	O
1	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
:	O
monday	O
,	O
wednesday	O
,	O
friday	O
,	O
alt	O
with	O
2mg	O
dose	O
.	O

11	O
.	O

warfarin	O
sodium	O
2	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
:	O
tuesday	O
,	O
thursday	O
,	O
saturday	O
,	O
sunday	O
.	O

12	O
.	O

ferrous	O
sulfate	O
325	O
(	O
65	O
)	O
mg	O
capsule	O
,	O
sustained	O
release	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
,	O
sustained	O
release	O
po	O
once	O
a	O
day	O
.	O

13	O
.	O

calcium	O
500	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
twice	O
a	O
day	O
.	O

14	O
.	O

cholecalciferol	O
(	O
vitamin	O
d3	O
)	O
400	O
unit	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

clipper	O
house	O

discharge	O
diagnosis	O
:	O

non	B
functional	I
left	I
kidney	I
with	O
psoas	B
abscess	I

discharge	O
condition	O
:	O

stable	O

discharge	O
instructions	O
:	O

follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1892	O
*	O
*	O
]	O
in	O
2	O
-	O
3	O
weeks	O
.	O

staples	O
to	O
be	O
removed	O
2	O
weeks	O
after	O
surgery	O
on	O
or	O
about	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
18	O
*	O
*	O
]	O
discharge	O
to	O
rehab	O
/	O
[	O
*	O
*	O
hospital1	O
7438	O
*	O
*	O
]	O
facility	O
.	O

keep	O
nephrostomy	O
tube	O
in	O
place	O
until	O
follow	O
up	O
visit	O
.	O

please	O
call	O
to	O
schedule	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1892	O
*	O
*	O
]	O
in	O
2	O
-	O
3	O
weeks	O
.	O

followup	O
instructions	O
:	O

as	O
above	O

schedule	O
f	O
/	O
u	O
as	O
noted	O
above	O
.	O

provider	O
:	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name3	O
(	O
lf	O
)	O
1896	O
*	O
*	O
]	O
f	O
.	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
2199	O
*	O
*	O
]	O
follow	O
-	O
up	O
appointment	O
should	O
be	O
in	O
2	O
weeks	O

aria	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
3180	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
3181	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
6411	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
6412	O
*	O
*	O
]	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
14	O
*	O
*	O
]	O
@	O
1127	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
1896	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
28	O
*	O
*	O
]	O
5	O
:	O
11	O
pm	O

(	O
end	O
of	O
report	O
)	O

110055	O
||||	O
10689	O
||||	O
436	O
||||	O
echo	O
_	O
report	O
||||	O
2013	O
-	O
10	O
-	O
04	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
aortic	B
valve	I
disease	I
.	O

left	B
ventricular	I
function	I
.	O

murmur	B
.	O

history	O
of	O
cabg	O
[	O
*	O
*	O
2008	O
*	O
*	O
]	O
.	O

height	O
:	O
(	O
in	O
)	O
61	O

weight	O
(	O
lb	O
)	O
:	O
180	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
81	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
168	O
/	O
44	O

hr	O
(	O
bpm	O
)	O
:	O
62	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
at	O
09	O
:	O
40	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
complete	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

the	O
left	O
atrium	O
is	O
elongated	B
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
the	O
right	O
atrium	O
is	O
mildly	O
dilated	O
.	O

left	O
ventricle	O
:	O
left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

right	O
ventricle	O
:	O
the	O
right	O
ventricular	O
wall	O
thickness	O
is	O
normal	O
.	O

right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
.	O

right	O
ventricular	O
systolic	O
function	O
is	O
normal	O
.	O

aorta	O
:	O
the	O
aortic	O
root	O
is	O
normal	O
in	O
diameter	O
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	B
.	O

there	O
is	O
mild	O
aortic	B
valve	I
stenosis	I
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
moderate	O
mitral	B
annular	I
calcification	I
.	O

trivial	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
physiologic	O
(	O
normal	O
)	O
pulmonic	B
regurgitation	I
is	O
seen	O
.	O

pericardium	O
:	O
there	O
is	O
no	O
pericardial	B
effusion	I
.	O

there	O
is	O
an	O
anterior	O
space	O
which	O
most	O
likely	O
represents	O
a	O
fat	O
pad	O
,	O
though	O
a	O
loculated	O
anterior	O
pericardial	B
effusion	I
cannot	O
be	O
excluded	O
.	O

general	O
comments	O
:	O
image	O
quality	O
was	O
suboptimal	O
.	O

conclusions	O
:	O

1	O
.	O
the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

the	O
left	O
atrium	O
is	O
elongated	B
.	O

2	O
.	O
left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

3	O
.	O
right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
.	O

right	O
ventricular	O
systolic	O
function	O
is	O
normal	O
.	O

4	O
.	O
the	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	B
.	O

there	O
is	O
mild	O
aortic	B
valve	I
stenosis	I
.	O

5	O
.	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

trivial	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

6	O
.	O
there	O
is	O
no	O
pericardial	B
effusion	I
.	O

there	O
is	O
an	O
anterior	O
space	O
which	O
most	O
likely	O
represents	O
a	O
fat	O
pad	O
,	O
though	O
a	O
loculated	O
anterior	O
pericardial	B
effusion	I
cannot	O
be	O
excluded	O
.	O

27033	O
||||	O
10773	O
||||	O
15558	O
||||	O
discharge	O
_	O
summary	O
||||	O
2018	O
-	O
06	O
-	O
14	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
05	O
-	O
31	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
14	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1933	O
-	O
07	O
-	O
13	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
csu	O

history	O
of	O
present	O
illness	O
:	O
ms	O
.	O
[	O
*	O
*	O
lastname	O
3528	O
*	O
*	O
]	O
is	O
an	O
84	O
-	O
year	O
-	O
old	O
woman	O
who	O
presented	O
to	O
the	O
[	O
*	O
*	O
hospital	O
1719	O
*	O
*	O
]	O
emergency	O

room	O
on	O
the	O
day	O
prior	O
to	O
admission	O
to	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
complaining	O
of	O
chest	B
pain	I
while	O
gardening	O
.	O

the	O
chest	B
pain	I
radiated	I
to	O
her	O
neck	O
and	O
jaw	O
.	O

it	O
was	O
associated	O
with	O
shortness	B
of	I
breath	I
and	O
diaphoresis	B
.	O

a	O
chest	O
x	O
-	O
ray	O
showed	O
congestive	B
heart	I
failure	I
.	O

one	O
sublingual	O
nitroglycerin	O
was	O
given	O
,	O
and	O
she	O
became	O
hypotensive	B
.	O

she	O
ruled	O
out	O
for	O
a	O
mi	B
by	O
enzymes	O
.	O

however	O
,	O
a	O
chest	O
ct	O
done	O
at	O
that	O
time	O
revealed	O
an	O
ascending	O
aortic	B
dissection	I
originating	O
at	O
the	O
level	O
of	O
the	O
rca	O
,	O
and	O
she	O
was	O
emergently	O
transferred	O
to	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
*	O
*	O
]	O
for	O
definitive	O
treatment	O
.	O

past	O
medical	O
history	O
:	O
significant	O
for	O
a	O
non	B
-	I
q	I
-	I
wave	I
mi	I
,	O
afib	B
,	O
hypertension	B
,	O
status	O
post	O
cholecystectomy	O
,	O
status	O
post	O
hemorrhoidectomy	O
,	O
tia	B
about	O
10	O
years	O
ago	O
,	O
and	O
question	O
of	O
cardiomyopathy	B
.	O

allergies	O
:	O
the	O
patient	O
states	O
no	O
known	O
drug	O
allergies	O
.	O

medications	O
on	O
admission	O
:	O
include	O
lisinopril	O
(	O
no	O
dose	O
available	O
)	O
,	O
atenolol	O
50	O
daily	O
,	O
lipitor	O
(	O
no	O
dose	O
available	O
)	O
,	O
potassium	O
chloride	O
20	O
meq	O
daily	O
,	O
aspirin	O
325	O
daily	O
,	O
vitamin	O
e	O
(	O
no	O
dose	O
available	O
)	O
,	O
and	O
hydrochlorothiazide	O
(	O
questionable	O
)	O
.	O

physical	O
examination	O
on	O
admission	O
:	O
neurologically	O
,	O
alert	O
and	O
oriented	O
.	O

moves	O
all	O
extremities	O
.	O

follows	O
commands	O
.	O

a	O
nonfocal	O
exam	O
.	O

pulmonary	O
reveals	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

cardiac	O
reveals	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	O
[	O
*	O
*	O
03	O
-	O
21	O
*	O
*	O
]	O
holosystolic	B
murmur	I
.	O

the	O
abdomen	O
is	O
benign	O
.	O

the	O
extremities	O
are	O
warm	O
and	O
well	O
perfused	O
with	O
no	O
edema	B
and	O
palpable	O
dorsalis	O
pedis	O
pulses	O
bilateral	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
evaluated	O
in	O
the	O
emergency	O
room	O
and	O
brought	O
emergently	O
to	O
the	O
operating	O
room	O
for	O
an	O
aortic	B
dissection	I
repair	O
.	O

please	O
see	O
the	O
or	O
report	O
for	O
full	O
details	O
.	O

in	O
summary	O
,	O
the	O
patient	O
had	O
an	O
ascending	O
aortic	O
replacement	O
with	O
a	O
#28	O
gelweave	O
graft	O
and	O
an	O
aortic	O
valve	O
resuspension	O
.	O

her	O
bypass	O
time	O
was	O
137	O
minutes	O
with	O
a	O
cross	O
-	O
clamp	O
time	O
of	O
90	O
minutes	O
and	O
a	O
shock	O
arrest	O
of	O
27	O
minutes	O
.	O

she	O
tolerated	O
the	O
operation	O
well	O
and	O
was	O
transferred	O
from	O
to	O
the	O
operating	O
room	O
to	O
the	O
cardiothoracic	O
intensive	O
care	O
unit	O
.	O

at	O
the	O
time	O
of	O
transfer	O
the	O
patient	O
was	O
a	O
paced	O
at	O
88	O
beats	O
per	O
minute	O
with	O
a	O
mean	O
arterial	O
pressure	O
of	O
74	O
.	O

the	O
patient	O
did	O
well	O
in	O
the	O
immediate	O
postoperative	O
period	O
.	O

following	O
an	O
initial	O
period	O
of	O
recovery	O
the	O
patient's	O
sedation	O
was	O
discontinued	O
;	O
following	O
which	O
she	O
did	O
open	O
her	O
eyes	O
and	O
move	O
both	O
arms	O
and	O
legs	O
;	O
however	O
not	O
to	O
command	O
.	O

with	O
this	O
,	O
the	O
patient	O
became	O
extremely	O
hypertensive	B
and	O
therefore	O
was	O
re	O
-	O
sedated	O
.	O

following	O
this	O
,	O
the	O
patient's	O
oxygen	O
demand	O
increased	O
and	O
therefore	O
it	O
was	O
decided	O
to	O
keep	O
the	O
patient	O
sedated	O
for	O
an	O
additional	O
day	O
.	O

on	O
postoperative	O
day	O
2	O
,	O
the	O
patient	O
removed	O
hemodynamically	O
stable	O
;	O
on	O
and	O
off	O
of	O
neo	O
-	O
synephrine	O
and	O
nitroglycerin	O
drips	O
to	O
maintain	O
a	O
mean	O
arterial	O
pressure	O
of	O
60	O
to	O
70	O
.	O

additionally	O
,	O
the	O
patient's	O
diuresis	O
was	O
begun	O
.	O

it	O
should	O
be	O
noted	O
throughout	O
this	O
period	O
that	O
the	O
patient	O
had	O
intermittent	O
periods	O
of	O
atrial	B
fibrillation	I
,	O
for	O
which	O
she	O
was	O
treated	O
with	O
amiodarone	O
.	O

on	O
postoperative	O
day	O
3	O
,	O
the	O
patient	O
continued	O
to	O
have	O
periods	O
of	O
atrial	B
fibrillation	I
with	O
a	O
ventricular	B
response	I
rate	I
up	I
to	O
150	O
;	O
for	O
which	O
she	O
was	O
cardioverted	O
on	O
numerous	O
occasions	O
.	O

she	O
removed	O
on	O
an	O
amiodarone	O
drip	O
and	O
was	O
also	O
treated	O
with	O
small	O
beta	O
blockade	O
.	O

on	O
postoperative	O
day	O
4	O
,	O
the	O
patient	O
was	O
more	O
hemodynamically	O
stable	O
.	O

her	O
sedation	O
was	O
again	O
discontinued	O
.	O

again	O
,	O
she	O
was	O
awake	O
.	O

however	O
did	O
not	O
follow	B
commands	I
,	O
but	O
we	O
were	O
able	O
to	O
successfully	O
wean	O
her	O
ventilation	O
.	O

by	O
postoperative	O
day	O
5	O
,	O
the	O
patient	O
was	O
having	O
less	O
frequent	O
periods	O
of	O
atrial	B
fibrillation	I
.	O

she	O
remained	O
on	O
amiodarone	O
and	O
beta	O
blockade	O
as	O
well	O
.	O

she	O
was	O
fully	O
anticoagulated	O
.	O

the	O
patient	O
was	O
again	O
on	O
and	O
off	O
of	O
neo	O
-	O
synephrine	O
infusion	O
to	O
maintain	O
an	O
adequate	O
blood	O
pressure	O
.	O

neurologically	O
she	O
was	O
awake	O
,	O
moving	O
all	O
extremities	O
,	O
and	O
intermittently	O
following	O
commands	O
.	O

she	O
was	O
weaned	O
to	O
cpap	O
on	O
the	O
ventilator	O
;	O
however	O
did	O
not	O
have	O
the	O
strength	O
to	O
be	O
successfully	O
extubated	O
.	O

on	O
postoperative	O
days	O
6	O
and	O
7	O
,	O
the	O
patient	O
was	O
awake	O
but	O
still	O
without	B
strength	I
to	O
be	O
successfully	O
extubated	O
.	O

therefore	O
,	O
she	O
remained	O
intubated	O
during	O
that	O
period	O
.	O

she	O
was	O
intermittently	O
on	O
neo	O
-	O
synephrine	O
while	O
she	O
was	O
having	O
her	O
episodes	O
of	O
rapid	B
atrial	I
fibrillation	I
.	O

during	O
the	O
opposing	O
times	O
she	O
required	O
nipride	O
and	O
/	O
or	O
nitroglycerin	O
to	O
control	O
her	O
hypertensive	B
episodes	O
.	O

on	O
postoperative	O
day	O
7	O
,	O
the	O
patient	O
had	O
a	O
flow	O
-	O
by	O
trial	O
and	O
was	O
successfully	O
extubated	O
.	O

by	O
postoperative	O
day	O
8	O
,	O
the	O
patient	O
was	O
successfully	O
weaned	O
from	O
all	O
vasoactive	O
iv	O
medications	O
and	O
converted	O
on	O
to	O
oral	O
medications	O
.	O

she	O
remained	O
in	O
the	O
icu	O
during	O
that	O
period	O
because	O
she	O
continued	O
to	O
have	O
some	O
periods	O
of	O
atrial	B
fibrillation	I
.	O

additionally	O
,	O
she	O
required	O
vigorous	O
pulmonary	O
toilet	O
.	O

for	O
2	O
additional	O
days	O
the	O
patient	O
remained	O
in	O
the	O
icu	O
for	O
pulmonary	O
toilet	O
.	O

she	O
had	O
no	O
further	O
episodes	O
of	O
atrial	B
fibrillation	I
.	O

additionally	O
,	O
on	O
postoperative	O
day	O
11	O
,	O
the	O
patient	O
had	O
a	O
left	O
-	O
sided	O
thoracentesis	O
for	O
approximately	O
600	O
cc	O
of	O
serosanguineous	O
fluid	O
.	O

ultimately	O
,	O
the	O
patient	O
was	O
transferred	O
from	O
the	O
icu	O
to	O
[	O
*	O
*	O
wardname	O
3529	O
*	O
*	O
]	O
two	O
on	O
postoperative	O
day	O
11	O
.	O

once	O
on	O
the	O
floor	O
,	O
the	O
patient	O
had	O
a	O
relatively	O
uneventful	O
postoperative	O
course	O
.	O

ultimately	O
,	O
on	O
postoperative	O
day	O
13	O
,	O
it	O
was	O
decided	O
that	O
the	O
patient	O
would	O
be	O
stable	O
and	O
ready	O
for	O
transfer	O
to	O
rehabilitation	O
on	O
the	O
following	O
day	O
.	O

at	O
the	O
time	O
of	O
this	O
dictation	O
the	O
patient's	O
physical	O
exam	O
is	O
as	O
follows	O
:	O
temperature	O
of	O
98	O
,	O
heart	O
rate	O
of	O
81	O
(	O
sinus	B
rhythm	I
)	O
,	O
blood	O
pressure	O
of	O
128	O
/	O
64	O
,	O
respiratory	O
rate	O
of	O
24	O
,	O
and	O
o2	O
saturation	O
of	O
93%	O
on	O
2	O
liters	O
.	O

weight	O
at	O
discharge	O
was	O
79	O
kilograms	O
;	O
preoperatively	O
was	O
78	O
kilograms	O
.	O

on	O
physical	O
exam	O
,	O
neurologically	O
alert	O
and	O
oriented	O
.	O

moves	O
all	O
extremities	O
.	O

follows	O
commands	O
,	O
although	O
somewhat	O
weak	B
and	O
lethargic	B
.	O

pulmonary	O
reveals	O
breath	O
sounds	O
are	O
diminished	O
bilaterally	O
.	O

clear	O
to	O
auscultation	O
in	O
the	O
upper	O
zones	O
.	O

cardiac	O
reveals	O
a	O
regular	O
rate	O
and	O
rhythm	O
.	O

s1	O
and	O
s2	O
.	O

the	O
sternum	O
is	O
stable	O
.	O

incision	O
is	O
clean	O
and	O
dry	O
without	O
erythema	B
or	O
drainage	B
.	O

the	O
abdomen	O
is	O
soft	O
,	O
nontender	O
,	O
and	O
nondistended	O
with	O
normal	O
active	O
bowel	O
sounds	O
.	O

the	O
extremities	O
are	O
warm	O
and	O
well	O
perfused	O
with	O
trace	O
edema	B
.	O

lab	O
data	O
with	O
a	O
sodium	O
of	O
138	O
,	O
potassium	O
of	O
4	O
.	O
3	O
,	O
chloride	O
of	O
105	O
,	O
co2	O
of	O
23	O
,	O
bun	O
of	O
26	O
,	O
creatinine	O
of	O
0	O
.	O
8	O
,	O
glucose	O
of	O
131	O
.	O

white	O
count	O
of	O
12	O
.	O
3	O
,	O
hematocrit	O
of	O
31	O
.	O
5	O
,	O
and	O
platelets	O
of	O

298	O
.	O

discharge	O
disposition	O
:	O
the	O
patient	O
is	O
to	O
be	O
discharged	O
to	O
rehabilitation	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
status	O
post	O
aortic	B
dissection	I
repair	O
with	O
#28	O
gelweave	O
graft	O
and	O
an	O
aortic	O
valve	O
resuspension	O
.	O

2	O
.	O
atrial	B
fibrillation	I
.	O

3	O
.	O
hypertension	B
.	O

4	O
.	O
cholecystectomy	O
.	O

5	O
.	O
hemorrhoidectomy	O
.	O

6	O
.	O
transient	B
ischemic	I
attacks	I
.	O

discharge	O
followup	O
:	O
the	O
patient	O
is	O
to	O
have	O
followup	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
3530	O
*	O
*	O
]	O
in	O
2	O
to	O
3	O
weeks	O
and	O
to	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
4	O
weeks	O
.	O

medications	O
on	O
discharge	O
:	O
include	O
lasix	O
20	O
mg	O
daily	O
,	O
potassium	O
chloride	O
20	O
meq	O
daily	O
,	O
colace	O
100	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O

tylenol	O
650	O
mg	O
q	O
.	O
4	O
.	O
h	O
.	O
as	O
needed	O
,	O
bisacodyl	O
10	O
mg	O
daily	O
as	O
needed	O
,	O
percocet	O
5	O
/	O
325	O
1	O
to	O
2	O
tablets	O
q	O
.	O
4	O
-	O
6h	O
.	O
as	O
needed	O
,	O
milk	O
of	O
magnesia	O
30	O
cc	O
daily	O
as	O
needed	O
,	O
aspirin	O
81	O
mg	O
daily	O
,	O
amiodarone	O
400	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O
x	O
7	O
days	O
and	O
then	O
400	O
mg	O
daily	O
x	O
7	O
days	O
and	O
then	O
200	O
mg	O
daily	O
,	O
combivent	O
2	O
puffs	O
q	O
.	O
6h	O
.	O
as	O
needed	O
,	O
pantoprazole	O
40	O
mg	O
daily	O
,	O
flovent	O
2	O
puffs	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
albuterol	O
2	O
puffs	O
q	O
.	O
6h	O
.	O
as	O
needed	O
,	O
atrovent	O
2	O
puffs	O
q	O
.	O
6h	O
.	O
as	O
needed	O
,	O
miconazole	O
powder	O
1	O
application	O
q	O
.	O
i	O
.	O
d	O
.	O
as	O
needed	O
,	O
labetalol	O
300	O
mg	O
t	O
.	O
i	O
.	O
d	O
.	O
,	O
and	O
lisinopril	O
2	O
.	O
5	O
mg	O
daily	O
.	O

[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
02aao	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1658	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
13	O
*	O
*	O
]	O
16	O
:	O
04	O
:	O
18	O

t	O
:	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
13	O
*	O
*	O
]	O
16	O
:	O
57	O
:	O
40	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
3531	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2018	O
-	O
07	O
-	O
04	O
*	O
*	O
]	O
10	O
:	O
53	O
am	O

(	O
end	O
of	O
report	O
)	O

4672	O
||||	O
11098	O
||||	O
26352	O
||||	O
discharge	O
_	O
summary	O
||||	O
2017	O
-	O
10	O
-	O
16	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
10	O
-	O
10	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
10	O
-	O
16	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1957	O
-	O
01	O
-	O
18	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
orthopaedics	O

allergies	O
:	O

hydrocodone	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
2117	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

60	O
yo	O
female	O
s	O
/	O
p	O
lumbar	O
fusion	O
[	O
*	O
*	O
04	O
-	O
29	O
*	O
*	O
]	O
.	O

patient	O
with	O
continued	O
back	B
pain	I
and	O
development	O
of	O
junctional	O
kyphosis	B
.	O

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

s	O
/	O
p	O
revision	O
posterior	O
thoracolumbar	O
fusion	O
with	O
instrumentation	O
and	O
iliac	O
crest	O
bone	O
graft	O
(	O
[	O
*	O
*	O
2017	O
-	O
10	O
-	O
10	O
*	O
*	O
]	O
)	O
.	O

history	O
of	O
present	O
illness	O
:	O

60	O
yo	O
female	O
s	O
/	O
p	O
lumbar	O
fusion	O
[	O
*	O
*	O
04	O
-	O
29	O
*	O
*	O
]	O
.	O

patient	O
developed	O
junctional	O
kyphosis	B
and	O
disc	B
degeneration	I
above	O
previous	O
fusion	O
construct	O
.	O

patient	O
developed	O
significant	O
low	B
back	I
pain	I
recalcitrant	O
to	O
nonoperative	O
modalities	O
of	O
management	O
.	O

patient	O
opted	O
to	O
pursue	O
surgical	O
intervention	O
for	O
revision	O
of	O
lumbar	O
fusion	O
with	O
extension	O
above	O
thoracolumbar	O
junction	O
.	O

past	O
medical	O
history	O
:	O

gastric	O
bypass	O

bilateral	O
hip	O
replacements	O

social	O
history	O
:	O

denies	O

family	O
history	O
:	O

n	O
/	O
c	O

physical	O
exam	O
:	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
14	O
*	O
*	O
]	O
:	O

ao	O
x	O
3	O
,	O
nad	O

afebrile	B
,	O
vss	O

incsion	O
clean	O
,	O
dry	O
,	O
intact	O
.	O

ble	O
:	O
from	O

[	O
*	O
*	O
04	O
-	O
28	O
*	O
*	O
]	O
quadriceps	O
/	O
adf	O
/	O
apf	O
/	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
150	O
*	O
*	O
]	O
/	O
fhl	O
/	O
eversion	O
l2	O
-	O
s1	O
sensation	O
intact	O
distal	O
pulses	O
intact	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
14	O
*	O
*	O
]	O
08	O
:	O
50am	O
blood	O
wbc	O
-	O
5	O
.	O
6	O
rbc	O
-	O
3	O
.	O
18	O
*	O
hgb	O
-	O
9	O
.	O
6	O
*	O
hct	O
-	O
27	O
.	O
8	O
*	O
mcv	O
-	O
88	O
mch	O
-	O
30	O
.	O
3	O
mchc	O
-	O
34	O
.	O
6	O
rdw	O
-	O
14	O
.	O
7	O
plt	O
ct	O
-	O
86	O
*	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
13	O
*	O
*	O
]	O
12	O
:	O
40pm	O
blood	O
wbc	O
-	O
6	O
.	O
6	O
rbc	O
-	O
3	O
.	O
15	O
*	O
hgb	O
-	O
9	O
.	O
5	O
*	O
hct	O
-	O
27	O
.	O
5	O
*	O
mcv	O
-	O
87	O
mch	O
-	O
30	O
.	O
3	O
mchc	O
-	O
34	O
.	O
7	O
rdw	O
-	O
14	O
.	O
8	O
plt	O
ct	O
-	O
68	O
*	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
12	O
*	O
*	O
]	O
08	O
:	O
14am	O
blood	O
wbc	O
-	O
5	O
.	O
4	O
rbc	O
-	O
2	O
.	O
99	O
*	O
hgb	O
-	O
9	O
.	O
1	O
*	O
hct	O
-	O
25	O
.	O
8	O
*	O
mcv	O
-	O
86	O
mch	O
-	O
30	O
.	O
3	O
mchc	O
-	O
35	O
.	O
1	O
*	O
rdw	O
-	O
15	O
.	O
6	O
*	O
plt	O
ct	O
-	O
71	O
*	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
11	O
*	O
*	O
]	O
06	O
:	O
46am	O
blood	O
wbc	O
-	O
5	O
.	O
8	O
rbc	O
-	O
3	O
.	O
17	O
*	O
hgb	O
-	O
9	O
.	O
5	O
*	O
hct	O
-	O
27	O
.	O
3	O
*	O
mcv	O
-	O
86	O
mch	O
-	O
30	O
.	O
1	O
mchc	O
-	O
35	O
.	O
0	O
rdw	O
-	O
16	O
.	O
0	O
*	O
plt	O
ct	O
-	O
77	O
*	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
10	O
*	O
*	O
]	O
08	O
:	O
08pm	O
blood	O
wbc	O
-	O
4	O
.	O
6	O
rbc	O
-	O
2	O
.	O
79	O
*	O
hgb	O
-	O
8	O
.	O
7	O
*	O
hct	O
-	O
24	O
.	O
2	O
*	O
mcv	O
-	O
87	O
mch	O
-	O
31	O
.	O
2	O
mchc	O
-	O
35	O
.	O
9	O
*	O
rdw	O
-	O
15	O
.	O
5	O
plt	O
ct	O
-	O
90	O
*	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
14	O
*	O
*	O
]	O
08	O
:	O
50am	O
blood	O
plt	O
ct	O
-	O
86	O
*	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
13	O
*	O
*	O
]	O
12	O
:	O
40pm	O
blood	O
plt	O
ct	O
-	O
68	O
*	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
13	O
*	O
*	O
]	O
12	O
:	O
40pm	O
blood	O
pt	O
-	O
12	O
.	O
1	O
ptt	O
-	O
26	O
.	O
7	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
0	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
10	O
*	O
*	O
]	O
08	O
:	O
08pm	O
blood	O
plt	O
ct	O
-	O
90	O
*	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
10	O
*	O
*	O
]	O
08	O
:	O
08pm	O
blood	O
pt	O
-	O
12	O
.	O
8	O
ptt	O
-	O
29	O
.	O
4	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
1	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
10	O
*	O
*	O
]	O
04	O
:	O
55pm	O
blood	O
pt	O
-	O
13	O
.	O
6	O
*	O
ptt	O
-	O
30	O
.	O
5	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
2	O
*	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
13	O
*	O
*	O
]	O
06	O
:	O
40am	O
blood	O
glucose	O
-	O
124	O
*	O
urean	O
-	O
10	O
creat	O
-	O
1	O
.	O
0	O
na	O
-	O
137	O
k	O
-	O
4	O
.	O
1	O
cl	O
-	O
104	O
hco3	O
-	O
28	O
angap	O
-	O
9	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
12	O
*	O
*	O
]	O
08	O
:	O
14am	O
blood	O
glucose	O
-	O
130	O
*	O
urean	O
-	O
11	O
creat	O
-	O
1	O
.	O
0	O
na	O
-	O
143	O
k	O
-	O
3	O
.	O
9	O
cl	O
-	O
109	O
*	O
hco3	O
-	O
31	O
angap	O
-	O
7	O
*	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
11	O
*	O
*	O
]	O
06	O
:	O
46am	O
blood	O
glucose	O
-	O
163	O
*	O
urean	O
-	O
14	O
creat	O
-	O
1	O
.	O
1	O
na	O
-	O
141	O
k	O
-	O
4	O
.	O
7	O
cl	O
-	O
109	O
*	O
hco3	O
-	O
26	O
angap	O
-	O
11	O

[	O
*	O
*	O
2017	O
-	O
10	O
-	O
11	O
*	O
*	O
]	O
01	O
:	O
32am	O
blood	O
glucose	O
-	O
177	O
*	O
urean	O
-	O
16	O
creat	O
-	O
1	O
.	O
1	O
na	O
-	O
142	O
k	O
-	O
4	O
.	O
5	O
cl	O
-	O
112	O
*	O
hco3	O
-	O
24	O
angap	O
-	O
11	O

brief	O
hospital	O
course	O
:	O

patient	O
underwent	O
revision	O
lumbar	O
fusion	O
and	O
extension	O
to	O
thoracolumbar	O
junction	O
on	O
[	O
*	O
*	O
2017	O
-	O
10	O
-	O
10	O
*	O
*	O
]	O
.	O

patient	O
tolerated	O
procedure	O
well	O
,	O
but	O
sustained	O
significant	O
blood	B
loss	I
.	O

she	O
was	O
monitored	O
in	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
8	O
*	O
*	O
]	O
overnight	O
without	O
complications	B
.	O

patient	O
did	O
receive	O
transfusion	O
of	O
prbc's	O
for	O
low	B
hematocrit	I
.	O

patient	O
was	O
transferred	O
to	O
orthopaedic	O
floor	O
.	O

she	O
was	O
able	O
to	O
resume	O
regular	O
diet	O
with	O
return	O
of	O
bowel	O
function	O
.	O

she	O
was	O
able	O
to	O
manage	O
pain	B
with	O
oral	O
meds	O
.	O

incision	O
was	O
noted	O
to	O
be	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
;	O
wound	O
drain	O
was	O
removed	O
.	O

heme	O
/	O
oncology	O
c	O
/	O
s	O
was	O
obtained	O
because	O
of	O
intraoperative	B
bleeding	I
and	O
concern	O
for	O
possible	O
occult	O
coagulopathy	B
.	O

heme	O
/	O
onc	O
to	O
complete	O
workup	O
on	O
outpatient	O
basis	O
.	O

patient	O
demonstrated	O
slow	O
progress	O
with	O
pt	O
and	O
was	O
deemed	O
suitable	O
for	O
extend	O
rehab	O
stay	O
.	O

after	O
evaluation	O
by	O
orthopaedic	O
spine	O
team	O
on	O
[	O
*	O
*	O
10	O
-	O
14	O
*	O
*	O
]	O
,	O
patient	O
was	O
judged	O
ready	O
for	O
transfer	O
to	O
rehab	O
bed	O
.	O

medications	O
on	O
admission	O
:	O

paroxetine	O

fluticasone	O

gabapentin	O

discharge	O
medications	O
:	O

1	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

2	O
.	O
paroxetine	O
hcl	O
20	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

3	O
.	O
gabapentin	O
300	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
.	O

4	O
.	O
fluticasone	O
50	O
mcg	O
/	O
actuation	O
aerosol	O
,	O
spray	O
sig	O
:	O
one	O
(	O
1	O
)	O
spray	O
nasal	O
daily	O
(	O
daily	O
)	O
.	O

5	O
.	O
oxycodone	O
20	O
mg	O
tablet	O
sustained	O
release	O
12hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
sustained	O
release	O
12hr	O
po	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
.	O

6	O
.	O
oxycodone	O
5	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

7	O
.	O
acetaminophen	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

8	O
.	O
bisacodyl	O
5	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
as	O
needed	O
.	O

9	O
.	O
pantoprazole	O
40	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
q24h	O
(	O
every	O
24	O
hours	O
)	O
.	O

10	O
.	O

cyanocobalamin	O
1	O
,	O
000	O
mcg	O
/	O
ml	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
1000mcg	O
/	O
ml	O
injection	O
daily	O
(	O
daily	O
)	O
for	O
7	O
days	O
:	O
started	O
[	O
*	O
*	O
10	O
-	O
15	O
*	O
*	O
]	O
.	O

11	O
.	O

cyanocobalamin	O
1	O
,	O
000	O
mcg	O
/	O
ml	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
1	O
,	O
000	O
mcg	O
/	O
ml	O
injection	O
once	O
a	O
week	O
for	O
4	O
weeks	O
:	O
please	O
begin	O
after	O
daily	O
dosing	O
has	O
completed	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

discharge	O
diagnosis	O
:	O

junctional	O
kyphosis	B
s	O
/	O
p	O
lumbar	O
fusion	O
.	O

discharge	O
condition	O
:	O

good	O
.	O

discharge	O
instructions	O
:	O

keep	O
incision	O
clean	O
,	O
dry	O
.	O

may	O
shower	O
with	O
wound	B
covered	O
.	O

use	O
brace	O
when	O
oob	O
.	O

take	O
pain	B
medication	O
as	O
directed	O
when	O
needed	O
.	O

resume	O
home	O
medications	O
.	O

physical	O
therapy	O
:	O

ambulate	O
as	O
tolerated	O
.	O

patient	O
to	O
wear	O
tlso	O
brace	O
when	O
oob	O
.	O

treatments	O
frequency	O
:	O

all	O
sutures	O
are	O
soluble	O
.	O

no	O
need	O
for	O
removal	O
.	O

keep	O
incision	O
clean	O
,	O
dry	O
.	O

may	O
leave	O
wound	B
open	O
to	O
air	O
when	O
dry	O
.	O

followup	O
instructions	O
:	O

f	O
/	O
u	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
per	O
previously	O
scheduled	O
appt	O
.	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
523	O
*	O
*	O
]	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2119	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
2120	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
2121	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
2122	O
*	O
*	O
]	O
pa	O
80	O
-	O
blu	O
[	O
*	O
*	O
2017	O
-	O
10	O
-	O
16	O
*	O
*	O
]	O
@	O
0947	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2017	O
-	O
10	O
-	O
17	O
*	O
*	O
]	O
8	O
:	O
25	O
am	O

(	O
end	O
of	O
report	O
)	O

103592	O
||||	O
11378	O
||||	O
27913	O
||||	O
echo	O
_	O
report	O
||||	O
2014	O
-	O
12	O
-	O
31	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
left	B
ventricular	I
function	I
.	O

weight	O
(	O
lb	O
)	O
:	O
144	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
111	O
/	O
74	O

hr	O
(	O
bpm	O
)	O
:	O
91	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2014	O
-	O
12	O
-	O
31	O
*	O
*	O
]	O
at	O
15	O
:	O
09	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
normal	O
la	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thickness	O
.	O

normal	O
lv	O
cavity	O
size	O
.	O

moderate	O
-	O
severe	O
global	O
left	O
ventricular	O
hypokinesis	B
.	O

moderately	O
depressed	B
lvef	I
.	O

tvi	O
e	O
/	O
e'	O
<	O
8	O
,	O
suggesting	O
normal	O
pcwp	O
(	O
<12mmhg	O
)	O
.	O

lv	O
wall	O
motion	O
:	O
regional	O
lv	B
wall	I
motion	I
abnormalities	I
include	O
:	O
basal	O
inferoseptal	O
-	O
hypo	B
;	O
mid	O
inferoseptal	O
-	O
hypo	B
;	O
basal	O
inferior	O
-	O
hypo	B
;	O
mid	O
inferior	O
-	O
hypo	B
;	O
basal	O
inferolateral	O
-	O
hypo	B
;	O
mid	O
inferolateral	O
-	O
hypo	B
;	O
inferior	O
apex	O
-	O
hypo	B
;	O
lateral	O
apex	O
-	O
hypo	B
;	O

right	O
ventricle	O
:	O
normal	O
rv	O
wall	O
thickness	O
.	O

normal	O
rv	O
chamber	O
size	O
.	O

rv	B
function	I
depressed	I
.	O

aorta	O
:	O
normal	O
aortic	O
root	O
diameter	O
.	O

normal	O
ascending	O
aorta	O
diameter	O
.	O

aortic	O
valve	O
:	O
mildly	O
thickened	B
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

mild	O
mitral	B
annular	I
calcification	I
.	O

no	O
mr	B
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
-	O
poor	O
echo	O
windows	O
.	O

suboptimal	O
image	O
quality	O
.	O

conclusions	O
:	O

1	O
.	O
the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

2	O
.	O
left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

while	O
the	O
lv	O
function	O
is	O
hard	O
to	O
assess	O
because	O
of	O
the	O
technical	O
difficulty	O
of	O
the	O
study	O
,	O
it	O
does	O
appear	O
that	O
there	O
is	O
mild	O
to	O
moderate	O
global	O
left	O
ventricular	O
hypokinesis	B
with	O
more	O
marked	O
hypokinesis	B
of	O
the	O
inferior	O
,	O
inferolateral	O
and	O
septal	O
walls	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
mildly	O
depressed	O
.	O

tissue	O
velocity	O
imaging	O
demonstrates	O
an	O
e	O
/	O
e'	O
<8	O
suggesting	O
a	O
normal	O
left	O
ventricular	O
filling	O
pressure	O
(	O
pcwp<12mmhg	O
)	O
.	O

3	O
.	O
right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
.	O

right	B
ventricular	I
systolic	I
function	I
appears	O
depressed	O
.	O

4	O
.	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

no	O
aortic	B
regurgitation	I
seen	O
.	O

5	O
.	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

no	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

6	O
.	O
there	O
is	O
no	O
pericardial	B
effusion	I
.	O

10791	O
||||	O
11392	O
||||	O
27321	O
||||	O
discharge	O
_	O
summary	O
||||	O
2016	O
-	O
06	O
-	O
01	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
06	O
-	O
01	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1964	O
-	O
01	O
-	O
25	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
surgery	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
2661	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

s	O
/	O
p	O
assault	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

52	O
yo	O
male	O
s	O
/	O
p	O
assault	B
;	O
he	O
was	O
taken	O
to	O
an	O
area	O
hospital	O
where	O
he	O
was	O
found	O
to	O
have	O
an	O
orbital	B
fracture	I
.	O

he	O
was	O
then	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
16	O
*	O
*	O
]	O
for	O
further	O
care	O
.	O

past	O
medical	O
history	O
:	O

aids	B

hcv	O

gerd	B

depression	I

ptsd	I

substance	I
abuse	I

social	O
history	O
:	O

resides	O
in	O
a	O
group	O
home	O
on	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
2338	O
*	O
*	O
]	O

family	O
history	O
:	O

noncontributory	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2016	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
10	O
:	O
14pm	O
glucose	O
-	O
98	O
lactate	O
-	O
2	O
.	O
9	O
*	O
na	O
+	O
-	O
142	O
k	O
+	O
-	O
3	O
.	O
9	O
cl	O
-	O
-	O
108	O

[	O
*	O
*	O
2016	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
09	O
:	O
50pm	O
urea	O
n	O
-	O
13	O
creat	O
-	O
1	O
.	O
0	O

[	O
*	O
*	O
2016	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
09	O
:	O
50pm	O
amylase	O
-	O
169	O
*	O

[	O
*	O
*	O
2016	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
09	O
:	O
50pm	O
alt	O
(	O
sgpt	O
)	O
-	O
301	O
*	O
ast	O
(	O
sgot	O
)	O
-	O
188	O
*	O
alk	O
phos	O
-	O
139	O
*	O
tot	O
bili	O
-	O
2	O
.	O
6	O
*	O

[	O
*	O
*	O
2016	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
09	O
:	O
50pm	O
ctropnt	O
-	O
<0	O
.	O
01	O

[	O
*	O
*	O
2016	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
09	O
:	O
50pm	O
asa	O
-	O
neg	O
ethanol	O
-	O
175	O
*	O
acetmnphn	O
-	O
neg	O
bnzodzpn	O
-	O
neg	O
barbitrt	O
-	O
neg	O
tricyclic	O
-	O
neg	O

[	O
*	O
*	O
2016	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
09	O
:	O
50pm	O
wbc	O
-	O
5	O
.	O
9	O
rbc	O
-	O
4	O
.	O
29	O
*	O
hgb	O
-	O
14	O
.	O
9	O
hct	O
-	O
42	O
.	O
0	O
mcv	O
-	O
98	O
mch	O
-	O
34	O
.	O
8	O
*	O
mchc	O
-	O
35	O
.	O
6	O
*	O
rdw	O
-	O
13	O
.	O
4	O

[	O
*	O
*	O
2016	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
09	O
:	O
50pm	O
pt	O
-	O
12	O
.	O
4	O
ptt	O
-	O
27	O
.	O
9	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
1	O

[	O
*	O
*	O
2016	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
09	O
:	O
50pm	O
plt	O
count	O
-	O
145	O
*	O

ct	O
head	O
w	O
/	O
o	O
contrast	O

reason	O
:	O
s	O
/	O
p	O
assault	B
.	O
?	O

bleed	B
.	O

underlying	O
medical	O
condition	O
:	O

52	O
year	O
old	O
man	O
s	O
/	O
p	O
assault	B
gcs	I
7	O

reason	O
for	O
this	O
examination	O
:	O

r	O
/	O
o	O
bleed	B

contraindications	O
for	O
iv	O
contrast	O
:	O
none	O
.	O

indication	O
:	O
52	O
-	O
year	O
-	O
old	O
man	O
status	O
post	O
assault	B
,	O
left	O
intracranial	B
hemorrhage	I
.	O

comparison	O
:	O
none	O
.	O

technique	O
:	O
non	O
-	O
contrast	O
head	O
ct	O
.	O

ct	O
head	O
without	O
iv	O
contrast	O
:	O
no	O
intracranial	B
hemorrhage	I
or	O
mass	B
effect	I
is	O
identified	O
.	O

the	O
ventricles	O
are	O
symmetric	O
,	O
and	O
there	O
is	O
no	O
shift	O
of	O
normally	O
midline	O
structures	O
.	O

the	O
gray	O
-	O
white	O
matter	O
differentiation	O
is	O
preserved	O
.	O

there	O
is	O
extensive	O
soft	B
tissue	I
swelling	I
overlying	O
the	O
left	O
orbit	O
in	O
the	O
area	O
of	O
known	O
trauma	B
.	O

additionally	O
,	O
there	O
are	O
fractures	B
involving	O
the	O
lateral	O
aspect	O
of	O
the	O
left	O
orbit	O
and	O
left	O
maxillary	O
sinus	O
,	O
and	O
fluid	B
can	O
be	O
seen	O
within	O
the	O
left	O
maxillary	O
sinus	O
.	O

there	O
is	O
also	O
opacification	B
of	O
several	O
anterior	O
ethmoid	O
air	O
cells	O
along	O
the	O
medial	O
wall	O
of	O
the	O
orbit	O
.	O

this	O
area	O
is	O
better	O
evaluated	O
on	O
the	O
dedicated	O
ct	O
scan	O
of	O
the	O
sinuses	O
performed	O
the	O
day	O
.	O

a	O
small	O
amount	O
of	O
fluid	B
is	O
seen	O
within	O
the	O
sphenoid	O
sinus	O
.	O

the	O
middle	O
ear	O
cavities	O
and	O
mastoid	O
air	O
cells	O
are	O
well	O
aerated	O
.	O

impression	O
:	O

1	O
.	O
no	O
intracranial	B
hemorrhage	I
or	O
mass	B
effect	I
.	O

2	O
.	O
soft	B
tissue	I
swelling	I
overlying	O
the	O
left	O
orbit	O
,	O
along	O
with	O
fracture	B
involving	O
the	O
left	O
lateral	O
orbital	O
wall	O
are	O
better	O
evaluated	O
on	O
the	O
dedicated	O
ct	O
scan	O
of	O
the	O
facial	O
bones	O
performed	O
at	O
the	O
same	O
time	O
.	O

ct	O
c	O
-	O
spine	O
w	O
/	O
o	O
contrast	O

reason	O
:	O
s	O
/	O
p	O
assault	B
.	O
?	O

fx	B

underlying	O
medical	O
condition	O
:	O

52	O
year	O
old	O
man	O
s	O
/	O
p	O
assault	B
gcs	I
7	O

reason	O
for	O
this	O
examination	O
:	O

r	O
/	O
o	O
fx	B

contraindications	O
for	O
iv	O
contrast	O
:	O
none	O
.	O

indication	O
:	O
52	O
-	O
year	O
-	O
old	O
man	O
status	O
post	O
assault	B
with	O
a	O
gcs	B
of	O
7	O
,	O
evaluate	O
for	O
fracture	B
.	O

comparison	O
:	O
none	O
.	O

technique	O
:	O
contiguous	O
axial	O
images	O
of	O
the	O
cervical	O
spinal	O
canal	O
.	O

coronal	O
and	O
sagittal	O
reformatted	O
images	O
.	O

ct	O
c	O
-	O
spine	O
:	O
patient	O
is	O
intubated	O
and	O
has	O
an	O
ng	O
tube	O
in	O
place	O
.	O

there	O
is	O
no	O
malalignment	B
.	O

no	O
definite	O
fractures	B
are	O
identified	O
.	O

there	O
are	O
degenerative	B
changes	O
at	O
c3	O
-	O
4	O
with	O
osteophytes	B
narrowing	I
the	O
spinal	O
canal	O
and	O
potential	O
mildly	O
indenting	B
the	O
spinal	O
cord	O
.	O

at	O
c4	O
-	O
5	O
a	O
large	O
osteophyte	B
narrows	I
the	O
canal	O
and	O
the	O
left	O
neural	O
foramen	O
.	O

it	O
likely	O
compresses	O
the	O
left	O
side	O
of	O
the	O
spinal	O
cord	O
.	O

at	O
c5	O
-	O
6	O
a	O
large	O
osteophyte	B
narrows	I
the	O
spinal	O
canal	O
and	O
likely	O
compresses	O
the	O
cord	O
.	O

there	O
is	O
bilateral	O
neural	O
foraminal	O
narrowing	B
.	O

an	O
uncovertebral	O
osteophyte	B
narrows	I
the	O
left	O
foramen	O
at	O
c6	O
-	O
7	O
.	O

there	O
is	O
no	O
significant	O
prevertebral	O
soft	B
tissue	I
swelling	I
.	O

ct	O
is	O
limited	O
evaluation	O
of	O
intrathecal	O
contents	O
.	O

impression	O
:	O
no	O
fracture	B
or	O
malalignment	B
.	O

degenerative	B
changes	O
are	O
seen	O
which	O
result	O
in	O
narrowing	B
of	O
the	O
spinal	O
canal	O
and	O
neural	O
foramina	O
at	O
multiple	O
levels	O
.	O

ct	O
sinus	O
/	O
mandible	O
/	O
maxillofacia	O

reason	O
:	O
s	O
/	O
p	O
assault	B
.	O
?	O

fx	B

underlying	O
medical	O
condition	O
:	O

52	O
year	O
old	O
man	O
s	O
/	O
p	O
assault	B
from	O
the	O
field	O
.	O

reason	O
for	O
this	O
examination	O
:	O

r	O
/	O
o	O
fracture	B

contraindications	O
for	O
iv	O
contrast	O
:	O
none	O
.	O

indication	O
:	O
52	O
-	O
year	O
-	O
old	O
man	O
with	O
history	O
of	O
assault	B
.	O

technique	O
:	O
axial	O
non	O
-	O
contrast	O
images	O
of	O
paranasal	O
sinuses	O
were	O
obtained	O
.	O

coronal	O
reformatted	O
images	O
were	O
prepared	O
on	O
a	O
separate	O
workstation	O
.	O

sinus	O
ct	O
:	O
there	O
are	O
fractures	B
of	O
the	O
medial	O
,	O
inferior	O
,	O
and	O
lateral	O
walls	O
of	O
the	O
left	O
orbit	O
.	O

there	O
is	O
fluid	B
accumulation	I
within	O
the	O
left	O
maxillary	O
sinus	O
,	O
frontal	O
,	O
sphenoid	O
and	O
ethmoid	O
sinuses	O
,	O
with	O
no	O
other	O
evidence	O
of	O
fracture	B
within	O
the	O
bony	O
walls	O
of	O
the	O
sinus	O
.	O

the	O
right	O
maxillary	O
sinus	O
,	O
right	O
ethmoid	O
sinus	O
,	O
and	O
right	O
frontal	O
sinus	O
have	O
normal	O
appearance	O
.	O

the	O
cribriform	O
plates	O
are	O
not	O
equal	B
in	I
height	I
.	O

the	O
anterior	O
clinoid	O
processes	O
are	O
not	O
pneumatized	B
.	O

the	O
nasal	O
septum	O
is	O
in	O
midline	O
.	O

impression	O
:	O

1	O
.	O
fracture	B
of	O
the	O
medial	O
,	O
inferior	O
,	O
and	O
lateral	O
walls	O
of	O
left	O
orbit	O
.	O

2	O
.	O
fluid	B
accumulation	I
within	O
the	O
sphenoid	O
sinus	O
,	O
left	O
maxillary	O
sinus	O
,	O
left	O
ethmoid	O
sinus	O
,	O
and	O
left	O
frontal	O
sinus	O
with	O
no	O
other	O
evidence	O
of	O
fractures	B
within	O
the	O
bony	O
plates	O
of	O
these	O
sinuses	O
.	O

brief	O
hospital	O
course	O
:	O

he	O
was	O
admitted	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
4002	O
*	O
*	O
]	O
service	O
.	O

plastic	O
surgery	O
was	O
consulted	O
given	O
his	O
orbital	B
fracture	I
;	O
this	O
injury	B
was	O
nonoperative	O
.	O

he	O
will	O
follow	O
up	O
in	O
2	O
weeks	O
with	O
plastics	O
clinic	O
for	O
further	O
treatment	O
of	O
this	O
injury	B
.	O

ophthalmology	O
was	O
also	O
consulted	O
to	O
rule	O
out	O
any	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
107	O
*	O
*	O
]	O
injuries	B
;	O
no	O
acute	O
injuries	B
were	O
identified	O
.	O
it	O
is	O
being	O
recommended	O
that	O
he	O
follow	O
up	O
as	O
outpatient	O
for	O
a	O
full	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
107	O
*	O
*	O
]	O
examination	O
.	O

psychiatry	O
was	O
also	O
consulted	O
for	O
concerns	O
over	O
possible	O
suicidality	B
and	O
also	O
given	O
his	O
history	O
of	O
depression	B
and	O
substance	O
/	O
etoh	B
use	I
.	O

he	O
was	O
placed	O
on	O
1	O
:	O
1	O
sitters	O
.	O

it	O
was	O
initially	O
thought	O
that	O
he	O
may	O
require	O
an	O
inpatient	O
psychiatric	O
stay	O
.	O

the	O
psychiatrist	O
following	O
him	O
here	O
was	O
able	O
to	O
obtain	O
the	O
name	O
of	O
his	O
mental	O
health	O
providers	O
outpatient	O
and	O
these	O
individuals	O
were	O
contacted	O
.	O

it	O
is	O
being	O
recommended	O
that	O
he	O
transfer	O
to	O
an	O
inpatient	O
psychiatric	O
facility	O
upon	O
discharge	O
once	O
medically	O
stable	O
.	O

on	O
[	O
*	O
*	O
2016	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
he	O
was	O
medically	O
cleared	O
by	O
the	O
surgery	O
attending	O
of	O
record	O
for	O
discharge	O
to	O
inpatient	O
psychiatric	O
facility	O
.	O

his	O
home	O
medications	O
were	O
restarted	O
.	O

psychiatric	O
nurse	O
case	O
manager	O
was	O
notified	O
to	O
initiate	O
transfer	O
to	O
inpatient	O
facility	O
.	O

physical	O
therapy	O
was	O
also	O
consulted	O
because	O
of	O
balance	B
issues	I
.	O

he	O
was	O
cleared	O
on	O
[	O
*	O
*	O
2016	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
.	O

medications	O
on	O
admission	O
:	O

antiretroviral	O
medications	O

seroquel	O

discharge	O
medications	O
:	O

1	O
.	O
emtricitabine	O
-	O
tenofovir	O
200	O
-	O
300	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

2	O
.	O
atazanavir	O
150	O
mg	O
capsule	O
sig	O
:	O
two	O
(	O
2	O
)	O
capsule	O
po	O
daily	O
(	O
daily	O
)	O
.	O

3	O
.	O
ritonavir	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
daily	O
(	O
daily	O
)	O
.	O

4	O
.	O
quetiapine	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
:	O
may	O
repeat	O
x1	O
if	O
not	O
asleep	O
within	O
1	O
hour	O
.	O

5	O
.	O
oxycodone	O
5	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
every	O
4	O
-	O
6	O
hours	O
as	O
needed	O
for	O
pain	B
.	O

6	O
.	O
colace	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
twice	O
a	O
day	O
as	O
needed	O
for	O
constipation	B
.	O

7	O
.	O
milk	O
of	O
magnesia	O
800	O
mg	O
/	O
5	O
ml	O
suspension	O
sig	O
:	O
[	O
*	O
*	O
11	O
-	O
07	O
*	O
*	O
]	O
ml's	O
po	O
at	O
bedtime	O
as	O
needed	O
for	O
constipation	B
.	O

8	O
.	O
nicotine	O
7	O
mg	O
/	O
24	O
hr	O
patch	O
24	O
hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
patch	O
24	O
hr	O
transdermal	O
daily	O
(	O
daily	O
)	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

discharge	O
diagnosis	O
:	O

s	O
/	O
p	O
assault	B

left	O
orbital	B
fracture	I

discharge	O
condition	O
:	O

stable	O

discharge	O
instructions	O
:	O

return	O
to	O
the	O
emergency	O
room	O
if	O
you	O
develop	O
any	O
fevers	B
,	O
headache	B
,	O
visual	B
disturbances	I
,	O
dizziness	B
,	O
chest	B
pain	I
,	O
increased	O
shortness	B
of	I
breath	I
,	O
abdominal	B
pain	I
and	O
/	O
or	O
any	O
other	O
symptoms	B
that	O
are	O
concerning	O
to	O
you	O
.	O

followup	O
instructions	O
:	O

follow	O
up	O
with	O
your	O
primary	O
psychotherapists	O
after	O
discharge	O
;	O
you	O
will	O
need	O
to	O
calll	O
for	O
an	O
appointment	O
.	O

follow	O
up	O
in	O
plastics	O
clinic	O
in	O
1	O
-	O
2	O
weeks	O
,	O
call	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
4003	O
*	O
*	O
]	O
for	O
an	O
appointment	O
.	O

follow	O
up	O
in	O
[	O
*	O
*	O
hospital	O
4004	O
*	O
*	O
]	O
clinic	O
in	O
2	O
-	O
3	O
weeks	O
,	O
call	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
2236	O
*	O
*	O
]	O
for	O
a	O
appointment	O
to	O
have	O
a	O
follow	O
up	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
107	O
*	O
*	O
]	O
examination	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
451	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2663	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
2664	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
488	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
489	O
*	O
*	O
]	O
np	O
80	O
-	O
byl	O
[	O
*	O
*	O
2016	O
-	O
05	O
-	O
31	O
*	O
*	O
]	O
@	O
1449	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
451	O
*	O
*	O
]	O
schneider	O
on	O
:	O
wed	O
[	O
*	O
*	O
2016	O
-	O
06	O
-	O
01	O
*	O
*	O
]	O
1	O
:	O
11	O
pm	O

(	O
end	O
of	O
report	O
)	O

26221	O
||||	O
11552	O
||||	O
29263	O
||||	O
discharge	O
_	O
summary	O
||||	O
2017	O
-	O
09	O
-	O
04	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
04	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1961	O
-	O
03	O
-	O
28	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
375	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

post	O
anoxic	B
brain	I
injury	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

56f	O
with	O
history	O
of	O
pneumococcal	B
sepsis	I
w	O
/	O
multiple	O
complications	B
in	O
[	O
*	O
*	O
2012	O
*	O
*	O
]	O
,	O
hypercholesterolemia	B
,	O
depression	B
awoke	O
from	O
sleeping	O
at	O
1am	O
this	O
morning	O
saying	O
she	O
could	B
not	I
breathe	I
.	O

she	O
became	O
unresponsive	B
and	O
ems	O
arrived	O
where	O
she	O
was	O
found	O
to	O
be	O
bradycardic	B
in	O
the	O
20s	O
and	O
in	O
pea	B
arrest	I
.	O

she	O
was	O
intubated	O
in	O
the	O
field	O
and	O
given	O
epi	O
and	O
atropine	O
.	O

the	O
rhythm	O
changed	O
to	O
vf	B
and	O
she	O
converted	O
to	O
sinus	B
tach	I
.	O

estimated	O
time	O
of	O
low	O
perfusion	O
was	O
~40	O
minutes	O
.	O

she	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
18	O
*	O
*	O
]	O
intubated	O
,	O
sedated	O
.	O

past	O
medical	O
history	O
:	O

pneumococcl	B
sepsis	I
in	O
[	O
*	O
*	O
2012	O
*	O
*	O
]	O
,	O
c	O
/	O
b	O
ards	B
,	O
arf	B
depression	I

hypercholesterolemia	I

multinodular	I
goiter	I

social	O
history	O
:	O

lives	O
at	O
home	O
with	O
boyfriend	O
and	O
uncle	O
,	O
2	O
children	O
,	O
divorced	O
,	O
60	O
pack	O
-	O
year	O
h	O
/	O
o	O
smoking	O
,	O
social	O
etoh	O
,	O
no	O
ivda	B
.	O

works	O
in	O
patient	O
information	O
at	O
[	O
*	O
*	O
hospital1	O
18	O
*	O
*	O
]	O
.	O

family	O
history	O
:	O

dm	B
in	O
parents	O
,	O
prostate	B
ca	I
in	O
family	O
,	O
mother	O
with	O
ovarian	B
cancer	I
,	O
no	O
cva	B
or	O
seizures	B

physical	O
exam	O
:	O

vs	O
:	O
93	O
,	O
79	O
,	O
120	O
/	O
85	O
,	O
ac	O
500	O
x	O
20	O
,	O
1	O
.	O
0	O
/	O
5	O

gen	O
:	O
intubated	O
woman	O
,	O
laying	O
in	O
bed	O
,	O
covered	O
with	O
warming	O
blanket	O
,	O
generalized	O
myoclonus	B
of	O
face	O
,	O
arms	O
,	O
axial	O
muscles	O

heent	O
:	O
nc	O
/	O
at	O
,	O
anicteric	B
sclera	O
,	O
mmm	O

neck	O
:	O
supple	O
,	O
no	O
carotid	B
bruits	I
,	O
+	O
multinodular	B
goiter	I

chest	O
:	O
course	B
bs	I
bilterally	O

cv	O
:	O
rrr	O
without	O
murmurs	B

abd	O
:	O
soft	O
,	O
nt	O
/	O
nd	O
,	O
+	O
bs	O
,	O
no	O
hsm	B
,	O
obese	O

ext	O
:	O
no	O
edema	B
,	O
wwp	O
,	O
radial	O
and	O
dp	O
pulses	O
2	O
+	O

neuro	O
:	O

ms	O
:	O
does	O
not	O
open	O
eyes	O
to	O
voice	O
or	O
stimulation	O

cn	O
:	O

-	O
pupils	O
4	O
-	O
>2mm	O
bilaterally	O
and	O
reactive	O

-	O
fundi	O
with	O
crisp	O
disc	O
margins	O
,	O
no	O
hemorrhages	B
,	O
discs	O
with	O
rim	O
of	O
hyperpigmentation	B
surrounding	O
disc	O
laterally	O
-	O
eom	O
exam	O
:	O
no	O
dolls	B
,	O
no	O
spontaneous	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
movements	O
-	O
corneal	O
reflex	O
:	O
present	O
b	O
/	O
l	O
-	O
facial	O
symmetry	O
:	O
appers	O
symmetric	O
but	O
ett	O
limits	O
exam	O
-	O
gag	B
reflex	I
:	O
not	O
present	O

motor	O
:	O
+	O
myoclonus	B
of	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
lids	O
/	O
face	O
/	O
chest	O
/	O
arms	O
,	O
nonrhythmic	O
.	O

no	O
spontaneous	B
movement	I
of	O
any	O
limbs	O
.	O

hypotonic	B
extremities	O
.	O

sensory	O
:	O
withdraws	O
arms	O
to	O
painful	O
stimuli	O
,	O
triple	O
flexion	O
legs	O
bilaterally	O
to	O
painful	O
stim	O
.	O

reflexes	O
:	O
2	O
+	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
/	O
br	O
/	O
tri	O
/	O
pat	O
/	O
ach	O
,	O
toes	O
upgoing	B
b	O
/	O
l	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
27am	O
urine	O
color	O
-	O
straw	O
appear	O
-	O
hazy	O
sp	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
7	O
*	O
*	O
]	O
-	O
1	O
.	O
013	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
27am	O
urine	O
blood	O
-	O
sm	O
nitrite	O
-	O
neg	O
protein	O
-	O
500	O
glucose	O
-	O
1000	O
ketone	O
-	O
tr	O
bilirubin	O
-	O
neg	O
urobilngn	O
-	O
neg	O
ph	O
-	O
6	O
.	O
5	O
leuk	O
-	O
neg	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
27am	O
urine	O
rbc	O
-	O
[	O
*	O
*	O
01	O
-	O
14	O
*	O
*	O
]	O
*	O
wbc	O
-	O
<1	O
bacteria	O
-	O
mod	O
yeast	O
-	O
rare	O
epi	O
-	O
0	O
-	O
2	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
27am	O
fibrinoge	O
-	O
357	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
27am	O
pt	O
-	O
11	O
.	O
5	O
ptt	O
-	O
23	O
.	O
3	O
inr	O
(	O
pt	O
)	O
-	O
0	O
.	O
9	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
27am	O
wbc	O
-	O
6	O
.	O
2	O
rbc	O
-	O
4	O
.	O
43	O
hgb	O
-	O
12	O
.	O
2	O
hct	O
-	O
36	O
.	O
3	O
mcv	O
-	O
82	O
mch	O
-	O
27	O
.	O
6	O
mchc	O
-	O
33	O
.	O
7	O
rdw	O
-	O
13	O
.	O
7	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
27am	O
plt	O
count	O
-	O
244	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
27am	O
urine	O
bnzodzpn	O
-	O
neg	O
barbitrt	O
-	O
neg	O
opiates	O
-	O
neg	O
cocaine	O
-	O
neg	O
amphetmn	O
-	O
neg	O
mthdone	O
-	O
neg	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
27am	O
asa	O
-	O
neg	O
ethanol	O
-	O
neg	O
acetmnphn	O
-	O
neg	O
bnzodzpn	O
-	O
neg	O
barbitrt	O
-	O
neg	O
tricyclic	O
-	O
neg	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
27am	O
ck	O
-	O
mb	O
-	O
2	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
27am	O
ck	O
(	O
cpk	O
)	O
-	O
125	O
amylase	O
-	O
91	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
27am	O
urea	O
n	O
-	O
26	O
*	O
creat	O
-	O
1	O
.	O
3	O
*	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
31am	O
freeca	O
-	O
1	O
.	O
10	O
*	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
31am	O
hgb	O
-	O
12	O
.	O
3	O
calchct	O
-	O
37	O
o2	O
sat	O
-	O
92	O
carboxyhb	O
-	O
7	O
.	O
6	O
*	O
met	O
hgb	O
-	O
0	O
.	O
3	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
31am	O
glucose	O
-	O
242	O
*	O
lactate	O
-	O
6	O
.	O
0	O
*	O
na	O
+	O
-	O
142	O
k	O
+	O
-	O
4	O
.	O
0	O
cl	O
-	O
-	O
107	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
31am	O
ph	O
-	O
7	O
.	O
32	O
*	O
comments	O
-	O
green	O
top	O

[	O
*	O
*	O
2017	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
02	O
:	O
34am	O
ctropnt	O
-	O
<0	O
.	O
01	O

brief	O
hospital	O
course	O
:	O

the	O
patient	O
was	O
transferred	O
to	O
the	O
ccu	O
because	O
the	O
cause	O
of	O
the	O
patient's	O
cardiac	B
arrest	I
was	O
unclear	O
.	O

a	O
tte	O
showed	O
normal	O
ef	O
and	O
a	O
very	O
small	O
pericardial	B
effusion	I
with	O
no	O
signs	O
of	O
tamponade	B
.	O

a	O
cta	O
was	O
negative	O
for	O
pe	B
and	O
only	O
showed	O
small	O
bilateral	O
atelectasis	B
and	O
the	O
known	O
goiter	B
.	O

tox	O
screens	O
were	O
negative	O
.	O

a	O
head	O
ct	O
showed	O
global	O
loss	B
of	I
gray	I
-	I
white	I
differentiation	I
,	O
which	O
was	O
concerning	O
for	O
edema	B
related	O
to	O
ischemia	B
.	O

the	O
patient	O
was	O
started	O
on	O
mannitol	O
.	O

eeg	O
showed	O
frequent	B
discharges	I
c	O
/	O
w	O
either	O
non	B
-	I
convlusive	I
status	I
or	O
periodic	B
epileptiform	I
discharges	I
with	O
suppression	O
pattern	O
.	O

a	O
pentobarb	O
coma	O
was	O
initiated	O
because	O
of	O
failure	O
of	O
dilantin	O
and	O
phenobarbitol	O
to	O
suppress	O
this	O
activity	O
.	O

her	O
care	O
was	O
transferred	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
32	O
*	O
*	O
]	O
team	O
given	O
her	O
normal	O
cv	O
status	O
.	O

in	O
consultation	O
with	O
neurology	O
,	O
the	O
patient's	O
prognosis	O
for	O
any	O
meaningful	O
recovery	O
was	O
deemed	O
to	O
be	O
very	O
poor	O
.	O

after	O
several	O
family	O
meetings	O
with	O
members	O
of	O
the	O
icu	O
team	O
,	O
her	O
pcp	O
,	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
8995	O
*	O
*	O
]	O
,	O
nurses	O
,	O
and	O
social	O
worker	O
/	O
case	O
management	O
,	O
the	O
decision	O
was	O
made	O
by	O
the	O
family	O
to	O
withdraw	O
care	O
.	O

given	O
the	O
patient's	O
wishes	O
to	O
be	O
an	O
organ	O
donor	O
,	O
the	O
patient	O
received	O
30	O
,	O
000u	O
of	O
heparin	O
iv	O
at	O
the	O
time	O
of	O
extubation	O
on	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
04	O
*	O
*	O
]	O
.	O

the	O
patient	O
expired	O
at	O
1356	O
on	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
04	O
*	O
*	O
]	O
.	O

medications	O
on	O
admission	O
:	O

lipitor	O
10mg	O
qd	O

risperdal	O
1mg	O
qhs	O
for	O
sleep	O

discharge	O
medications	O
:	O

n	O
/	O
a	O

discharge	O
disposition	O
:	O

expired	O

discharge	O
diagnosis	O
:	O

pea	B
arrest	I
of	O
unclear	O
etiology	O

discharge	O
condition	O
:	O

expired	O

discharge	O
instructions	O
:	O

n	O
/	O
a	O

followup	O
instructions	O
:	O

n	O
/	O
a	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
385	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
386	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name8	O
(	O
md	O
)	O
8996	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
8997	O
*	O
*	O
]	O
[	O
*	O
*	O
2017	O
-	O
12	O
-	O
31	O
*	O
*	O
]	O
@	O
1321	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
01	O
*	O
*	O
]	O
8	O
:	O
17	O
am	O

(	O
end	O
of	O
report	O
)	O

22505	O
||||	O
11681	O
||||	O
5595	O
||||	O
discharge	O
_	O
summary	O
||||	O
2016	O
-	O
10	O
-	O
11	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
10	O
-	O
11	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1929	O
-	O
08	O
-	O
25	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
1962	O
*	O
*	O
]	O

allergies	O
:	O

percocet	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
3030	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

right	B
hemiparesis	I
,	O
dysarthria	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

patient	O
is	O
an	O
87	O
year	O
old	O
right	O
-	O
handed	O
female	O
with	O
past	O
medical	O
history	O
of	O
hypertension	B
who	O
presented	O
as	O
a	O
transfer	O
to	O
our	O
hospital	O
for	O
right	B
-	I
sided	I
weakness	I
after	O
left	O
pontine	O
stroke	B
.	O

patient	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
tuesday	O
[	O
*	O
*	O
2016	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
.	O

she	O
awoke	O
that	O
morning	O
and	O
found	O
that	O
her	O
right	O
side	O
was	O
weak	B
when	O
she	O
was	O
attempting	O
to	O
walk	O
to	O
the	O
bathroom	O
.	O

she	O
fell	B
onto	O
the	O
bathroom	O
floor	O
and	O
laid	O
there	O
for	O
~1	O
hour	O
.	O

no	O
head	B
injury	I
or	O
loss	B
of	I
consciousness	I
status	O
post	O
fall	B
.	O

she	O
made	O
it	O
back	O
to	O
her	O
bed	O
and	O
went	O
back	O
to	O
sleep	O
.	O

later	O
that	O
morning	O
,	O
she	O
called	O
her	O
daughter	O
,	O
who	O
noted	O
that	O
her	O
speech	O
was	O
slurred	O
.	O

at	O
that	O
point	O
,	O
she	O
was	O
taken	O
to	O
[	O
*	O
*	O
hospital	O
4647	O
*	O
*	O
]	O
in	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
8190	O
*	O
*	O
]	O
.	O

while	O
at	O
[	O
*	O
*	O
hospital	O
4647	O
*	O
*	O
]	O
,	O
mri	O
reportedly	O
showed	O
a	O
left	O
pontine	O
infarct	B
and	O
2	O
small	O
occipital	O
lesions	B
.	O

she	O
was	O
started	O
on	O

plavix	O
.	O

carotid	O
ultrasound	O
showed	O
no	O
stenosis	O
.	O

echocardiogram	O
showed	O
an	O
ejection	O
fraction	O
of	O
55%	O
,	O
trace	O
mitral	B
regurgitation	I
and	O
trace	O
pulmonic	B
insufficiency	I
.	O

as	O
mra	O
showed	O
a	O
tight	O
mid	O
-	O
portion	O
basilar	B
stenosis	I
,	O
she	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
189	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2016	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
for	O
further	O

care	O
.	O

she	O
denies	O
recent	O
fevers	B
,	O
chills	B
,	O
headaches	B
,	O
visual	B
changes	I
like	O
blurry	O
or	O
double	B
vision	I
,	O
chest	B
pain	I
,	O
palpitations	B
,	O
shortness	B
of	I
breath	I
,	O
nausea	B
,	O
vomiting	B
,	O
urinary	B
frequency	I
or	O
incontinence	O
.	O

she	O
denies	O
parasthesias	B
,	O
incoordination	B
,	O
dizziness	B
or	O
vertigo	B
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
hypertension	B
since	O
[	O
*	O
*	O
1985	O
*	O
*	O
]	O

2	O
.	O
left	O
-	O
sided	O
hip	O
surgery	O
x	O
2	O
in	O
[	O
*	O
*	O
1950	O
*	O
*	O
]	O
and	O
1948	O
after	O
fracture	B

3	O
.	O
osteoarthritis	B

4	O
.	O
status	O
post	O
cholecystectomy	O

5	O
.	O
right	O
cataract	B
surgery	O

social	O
history	O
:	O

widowed	O
.	O

has	O
11	O
children	O
.	O

was	O
a	O
homemaker	O
.	O

was	O
living	O
alone	O
and	O
independent	O
in	O
activities	O
of	O
daily	O
living	O
prior	O
to	O
this	O
admission	O
.	O

walks	O
with	O
a	O
walker	O
.	O

family	O
history	O
:	O

father	O
and	O
sister	O
with	O
strokes	B
,	O
at	O
age	O
60s	O
and	O
47	O
respectively	O
.	O

oldest	O
son	O
died	O
of	O
mi	B
at	O
age	O
70	O
.	O

one	O
son	O
deceased	O
from	O
muscular	B
dystrophy	I
.	O

physical	O
exam	O
:	O

on	O
admission	O
:	O

tc	O
:	O
98	O
.	O
1	O
tm	O
:	O
100	O
.	O
1	O
bp	O
:	O
160	O
/	O
76	O
hr	O
:	O
70	O
(	O
59	O
-	O
70	O
)	O

rr	O
:	O
18	O
o2sat	O
.	O
:	O
98%	O
/	O
2	O
.	O
5	O
-	O
3l	O
fsbg	O
:	O
95	O
,	O
82	O

gen	O
:	O
wd	O
/	O
wn	O
,	O
female	O
,	O
comfortable	O
,	O
pleasant	O
,	O
nad	B
.	O

heent	O
:	O
nc	O
/	O
at	O
.	O

anicteric	B
.	O

mmm	O
.	O

neck	O
:	O
supple	O
.	O

no	O
masses	B
or	O
lad	B
.	O

no	O
jvd	B
.	O

no	O
thyromegaly	B
.	O

no	O
carotid	B
bruits	I
.	O

lungs	O
:	O
cta	O
bilaterally	O
.	O

no	O
r	B
/	O
r	B
/	O
w	B
.	O

cardiac	O
:	O
rrr	O
.	O

s1	O
/	O
s2	O
.	O

no	O
m	B
/	O
r	B
/	O
g	B
.	O

abd	O
:	O
soft	O
,	O
nt	O
,	O
nd	O
,	O
+	O
nabs	O
.	O

no	O
rebound	B
or	O
guarding	B
.	O

no	O
hsm	B
.	O

extrem	O
:	O
warm	O
and	O
well	O
-	O
perfused	O
.	O

no	O
c	B
/	O
c	B
/	O
e	B
.	O

neuro	O
:	O

mental	O
status	O
:	O
awake	O
and	O
alert	O
,	O
cooperative	O
with	O
exam	O
,	O
normal	O
affect	O
.	O

oriented	O
to	O
person	O
,	O
place	O
,	O
and	O
date	O
.	O

able	O
to	O
recite	O
[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
forwards	O
and	O
backwards	O
.	O

registration	O
intact	O
.	O

recalled	O
[	O
*	O
*	O
03	O
-	O
16	O
*	O
*	O
]	O
objects	O
at	O
5	O
minutes	O
.	O

speech	O
fluent	O
with	O
good	O
comprehension	O
and	O
repetition	O
.	O

naming	O
intact	O
.	O

moderate	O
dysarthria	B
.	O

no	O
paraphasic	B
errors	I
.	O

no	O
apraxia	B
,	O
no	O
neglect	B
.	O

no	O
right	B
/	I
left	I
confusion	I
.	O

cranial	O
nerves	O
:	O

i	O
:	O
not	O
tested	O

ii	O
:	O
right	O
pupil	O
surgical	O
left	O
pupils	O
round	O
and	O
reactive	O
to	O
light	O
,	O
3	O
to	O
2	O
mm	O
bilaterally	O
.	O

visual	O
fields	O
are	O
full	O
to	O
confrontation	O
.	O

unable	O
to	O
assess	O
optic	O
disks	O
.	O

iii	O
,	O
iv	O
,	O
vi	O
:	O
extraocular	O
movements	O
intact	O
bilaterally	O
without	O
nystagmus	B
.	O

v	O
,	O
vii	O
:	O
right	O
facial	B
droop	I
.	O

left	O
facial	O
strength	O
within	O
normal	O
limits	O
.	O

facial	O
sensation	O
intact	O
and	O
symmetric	O
.	O

viii	O
:	O
hearing	O
intact	O
to	O
finger	O
rub	O
bilaterally	O
.	O

ix	O
,	O
x	O
:	O
palatal	O
elevation	O
symmetrical	O
.	O

xi	O
:	O
sternocleidomastoid	O
and	O
trapezius	O
normal	O
bilaterally	O
.	O

xii	O
:	O
tongue	O
midline	O
without	O
fasciculations	O
.	O

motor	O
:	O
normal	O
bulk	O
.	O

tone	B
decreased	I
right	O
upper	O
and	O
lower	O
extremities	O
.	O

no	O
abnormal	B
movements	I
,	O
tremors	B
.	O
+	O
right	B
drift	I
.	O

strength	O
:	O

d	O
t	O
b	O
wrf	O
wre	O
fif	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
io	O
ip	O
q	O
h	O
ta	O
gas	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
1722	O
*	O
*	O
]	O
r	O
3	O
4	O
-	O
4	O
-	O
4	O
-	O
4	O
-	O
3	O
1	O
1	O
3	O
5	O
-	O
4	O
4	O
+	O
4	O
+	O
4	O
+	O

l	O
5	O
-	O
5	O
-	O
5	O
5	O
5	O
5	O
5	O
-	O
5	O
-	O
5	O
5	O
5	O
5	O
5	O
5	O
-	O

sensation	O
:	O
intact	B
to	I
light	I
touch	I
,	O
propioception	B
,	O
pinprick	O
and	O
vibration	O
bilaterally	O
.	O

reflexes	O
:	O
b	O
t	O
br	O
pa	O
ac	O

right	O
2	O
2	O
2	O
2	O
1	O

left	O
2	O
2	O
2	O
2	O
1	O

with	O
upper	O
extremity	O
brisker	O
than	O
lower	O
bilaterally	O
.	O

grasp	B
reflex	I
absent	O
.	O

toes	B
upgoing	I
bilaterally	O
.	O

coordination	O
:	O
normal	O
on	O
finger	O
-	O
nose	O
-	O
finger	O
,	O
rapid	O
alternatingmovements	O
on	O
left	O
.	O

right	O
side	O
limited	O
by	O
motor	B
weakness	I
.	O

gait	O
:	O
did	O
not	O
assess	O
.	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2016	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
06	O
:	O
05am	O
%hba1c	O
-	O
6	O
.	O
1	O
*	O

[	O
*	O
*	O
2016	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
04	O
:	O
37am	O
glucose	O
-	O
137	O
*	O
urea	O
n	O
-	O
15	O
creat	O
-	O
0	O
.	O
7	O
sodium	O
-	O
143	O
potassium	O
-	O
3	O
.	O
1	O
*	O
chloride	O
-	O
108	O
total	O
co2	O
-	O
25	O
anion	O
gap	O
-	O
13	O

[	O
*	O
*	O
2016	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
04	O
:	O
37am	O
alt	O
(	O
sgpt	O
)	O
-	O
18	O
ast	O
(	O
sgot	O
)	O
-	O
21	O
ck	O
(	O
cpk	O
)	O
-	O
118	O
alk	O
phos	O
-	O
75	O
tot	O
bili	O
-	O
0	O
.	O
7	O

[	O
*	O
*	O
2016	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
04	O
:	O
37am	O
ck	O
-	O
mb	O
-	O
4	O
ctropnt	O
-	O
<0	O
.	O
01	O

[	O
*	O
*	O
2016	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
04	O
:	O
37am	O
calcium	O
-	O
8	O
.	O
5	O
phosphate	O
-	O
2	O
.	O
7	O
magnesium	O
-	O
1	O
.	O
9	O
cholest	O
-	O
162	O

[	O
*	O
*	O
2016	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
04	O
:	O
37am	O
triglycer	O
-	O
125	O
hdl	O
chol	O
-	O
39	O
chol	O
/	O
hdl	O
-	O
4	O
.	O
2	O
ldl	O
(	O
calc	O
)	O
-	O
98	O

[	O
*	O
*	O
2016	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
04	O
:	O
37am	O
wbc	O
-	O
11	O
.	O
5	O
*	O
rbc	O
-	O
3	O
.	O
67	O
*	O
hgb	O
-	O
12	O
.	O
2	O
hct	O
-	O
34	O
.	O
1	O
*	O
mcv	O
-	O
93	O
mch	O
-	O
33	O
.	O
2	O
*	O
mchc	O
-	O
35	O
.	O
7	O
*	O
rdw	O
-	O
12	O
.	O
7	O

[	O
*	O
*	O
2016	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
04	O
:	O
37am	O
plt	O
count	O
-	O
189	O

[	O
*	O
*	O
2016	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
04	O
:	O
37am	O
pt	O
-	O
13	O
.	O
3	O
ptt	O
-	O
25	O
.	O
4	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
1	O

brief	O
hospital	O
course	O
:	O

ms	O
.	O
[	O
*	O
*	O
lastname	O
8191	O
*	O
*	O
]	O
was	O
admitted	O
to	O
the	O
neurology	O
service	O
with	O
right	B
hemiparesis	I
and	O
dysarthria	B
.	O

mri	O
/	O
mra	O
revealed	O
acute	O
left	O
pontine	O
infarct	B
,	O
nonvisualization	O
of	O
right	O
vertebral	O
artery	O
indicating	O
occlusion	B
,	O
and	O
high	O
grade	O
stenosis	B
in	O
the	O
mid	O
basilar	O
artery	O
.	O

echocardiogram	O
provided	O
no	O
evidence	O
for	O
patent	B
foramen	I
ovale	I
or	O
a	O
source	O
of	O
embolus	B
.	O

as	O
her	O
stroke	B
was	O
likely	O
embolic	B
in	O
origin	O
,	O
she	O
was	O
started	O
on	O
coumadin	O
and	O
iv	O
heparin	O
.	O

she	O
continued	O
to	O
receive	O
treatment	O
for	O
hypercholesterolemia	B
.	O

her	O
blood	O
pressue	O
during	O
hospitalization	O
was	O
usually	O
in	O
the	O
range	O
of	O
140	O
-	O
160	O
systolic	O
,	O
60	O
-	O
70	O
diastolic	O
.	O

goal	O
sbp	O
as	O
an	O
putpatient	O
was	O
to	O
be	O
sbp	O
:	O
120	O
-	O
130s	O
,	O
given	O
her	O
intracranial	O
stenosis	B
.	O

she	O
was	O
seen	O
by	O
physical	O
therapy	O
,	O
occupational	O
therapy	O
,	O
and	O
the	O
speech	O
consult	O
services	O
who	O
all	O
felt	O
she	O
would	O
benefit	O
from	O
acute	O
inpatient	O
rehabilitation	O
.	O

clinically	O
,	O
ms	O
.	O
[	O
*	O
*	O
lastname	O
8191	O
*	O
*	O
]	O
improved	O
during	O
hospitalization	O
.	O

she	O
regained	B
some	I
strength	I
in	O
her	O
right	O
upper	O
extremity	O
and	O
her	O
speech	B
improved	I
.	O

she	O
was	O
determined	O
to	O
to	O
be	O
at	O
high	O
risk	O
for	O
aspiration	B
and	O
was	O
started	O
on	O
a	O
soft	O
solid	O
diet	O
with	O
nectar	O
thick	O
liquids	O
.	O

in	O
the	O
future	O
,	O
stroke	B
neurology	O
clearance	O
will	O
be	O
necessary	O
to	O
optimize	O
care	O
,	O
in	O
the	O
event	O
that	O
she	O
ever	O
needs	O
to	O
undergo	O
surgery	O
or	O
stop	B
anticoagulation	I
.	O

medications	O
on	O
admission	O
:	O

home	O
medications	O
prior	O
to	O
admission	O
to	O
[	O
*	O
*	O
hospital	O
4647	O
*	O
*	O
]	O
:	O

1	O
.	O
prinvil	O
20	O
mg	O
po	O
qd	O

2	O
.	O
atenolol	O
100	O
mg	O
po	O
qd	O

3	O
.	O
norvasc	O
10	O
mg	O
po	O
qd	O

medications	O
at	O
[	O
*	O
*	O
hospital	O
4647	O
*	O
*	O
]	O
prior	O
to	O
transfer	O
to	O
[	O
*	O
*	O
hospital1	O
189	O
*	O
*	O
]	O
:	O
1	O
.	O
heparin	O
sc	O

2	O
.	O
plavix	O
75	O
mg	O
po	O
qd	O

3	O
.	O
protonix	O
40	O
mg	O
po	O
qd	O

discharge	O
medications	O
:	O

1	O
.	O
atorvastatin	O
calcium	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
warfarin	O
sodium	O
2	O
.	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

3	O
.	O
insulin	O
regular	O
human	O
100	O
unit	O
/	O
ml	O
solution	O
sig	O
:	O
variable	O
units	O
injection	O
asdir	O
(	O
as	O
directed	O
)	O
:	O
dispense	O
qid	O
per	O
regular	O
insulin	O
sliding	O
scale	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

[	O
*	O
*	O
hospital	O
3406	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
3248	O
*	O
*	O
]	O

discharge	O
diagnosis	O
:	O

1	O
.	O
stroke	B

2	O
.	O
hypertension	B

3	O
.	O
left	O
sided	O
hip	O
surgery	O
x	O
2	O

4	O
.	O
osteoarthritis	B

5	O
.	O
status	O
post	O
cholecystectomy	O

6	O
.	O
right	O
cataract	B
surgery	O

discharge	O
condition	O
:	O

fair	O
;	O
residual	O
dysarthira	B
,	O
right	O
upper	O
and	O
lower	B
extremity	I
weakness	I
.	O

discharge	O
instructions	O
:	O

please	O
seek	O
medical	O
attention	O
if	O
you	O
experience	O
weakness	B
,	O
numbness	B
,	O
difficulty	B
speaking	I
,	O
chest	B
pain	I
or	O
any	O
other	O
concerning	O
symptoms	B
.	O

followup	O
instructions	O
:	O

follow	O
up	O
with	O
drs	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
6278	O
*	O
*	O
]	O
and	O
[	O
*	O
*	O
name5	O
(	O
ptitle	O
)	O
*	O
*	O
]	O
in	O
the	O
stroke	B
clinic	O
in	O
3	O
months	O
.	O

please	O
call	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
8192	O
*	O
*	O
]	O
for	O
an	O
appointment	O
.	O

follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
8193	O
*	O
*	O
]	O
(	O
pcp	O
)	O
in	O
2	O
weeks	O
.	O

please	O
call	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
8194	O
*	O
*	O
]	O
for	O
appt	O
.	O

dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
8193	O
*	O
*	O
]	O
may	O
want	O
to	O
restart	O
therapy	O
for	O
hypertension	B
.	O

additionally	O
,	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
8193	O
*	O
*	O
]	O
will	O
be	O
responsible	O
for	O
following	O
your	O
coumadin	O
level	O
via	O
blood	O
testing	O
after	O
your	O
discharge	O
from	O
rehab	O
.	O

goal	O
inr	O
is	O
2	O
.	O
0	O
-	O
3	O
.	O
0	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
65	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
7184	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
7185	O
*	O
*	O
]	O
[	O
*	O
*	O
2016	O
-	O
10	O
-	O
11	O
*	O
*	O
]	O
@	O
1116	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2016	O
-	O
10	O
-	O
17	O
*	O
*	O
]	O
7	O
:	O
16	O
am	O

(	O
end	O
of	O
report	O
)	O

22364	O
||||	O
12125	O
||||	O
17352	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
10	O
-	O
10	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
10	O
-	O
10	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1951	O
-	O
05	O
-	O
03	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
865	O
*	O
*	O
]	O

allergies	O
:	O

lidocaine	O
/	O
wheat	O
starch	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
5852	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

sscp	B

doe	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

cardiac	O
catheterization	O
with	O
stent	O
placement	O

history	O
of	O
present	O
illness	O
:	O

64yo	O
man	O
with	O
h	O
/	O
o	O
cad	B
s	O
/	O
p	O
multiple	O
percutaneous	O
interventions	O
,	O
htn	B
,	O
hypercholesterolemia	B
,	O
who	O
had	O
sscp	B
2wks	O
pta	O
,	O
was	O
scheduled	O
for	O
ett	O
,	O
had	O
pnd	B
and	O
palpitations	B
on	O
pm	O
pta	O
,	O
then	O
nsvt	B
on	O
doa	O
during	O
his	O
ett	O
and	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
189	O
*	O
*	O
]	O
for	O
cath	O
.	O

pt's	O
cad	B
history	O
consists	O
of	O
angioplasty	O
of	O
om1	O
,	O
om2	O
in	O
[	O
*	O
*	O
2002	O
*	O
*	O
]	O
,	O
a	O
crown	O
stent	O
placed	O
in	O
his	O
lad	O
in	O
[	O
*	O
*	O
2009	O
*	O
*	O
]	O
,	O
a	O
relook	O
in	O
[	O
*	O
*	O
2010	O
*	O
*	O
]	O
,	O
and	O
a	O
cath	O
in	O

[	O
*	O
*	O
2011	O
-	O
07	O
-	O
23	O
*	O
*	O
]	O
that	O
showed	O
ef	O
42%	O
,	O
om1	O
99%	O
stenosis	B
,	O
om2	O
100%	O
stenosis	B
,	O
rca	O
20	O
-	O
30%	O
stenosis	B
,	O
lvedp	O
12	O
mmhg	O
,	O
moderate	O
global	O
hypokinesis	B
with	O
lvef	O
42%	O
.	O

no	O
intervention	O
done	O
at	O
that	O
time	O
.	O

patient	O
was	O
in	O
his	O
usoh	O
until	O
2	O
weeks	O
pta	O
,	O
when	O
he	O
had	O
sscp	B
while	O
jogging	O
on	O
a	O
treadmill	O
that	O
ended	O
on	O
its	O
own	O
,	O
no	O
associated	B
symptoms	I
,	O
no	O
n	B
/	O
v	B
,	O
radiations	B
,	O
no	O
diaphoresis	B
,	O
[	O
*	O
*	O
05	O
-	O
02	O
*	O
*	O
]	O
pain	B
at	O
worst	O
.	O

he	O
went	O
in	O
to	O
his	O
ett	O
on	O
am	O
of	O
admit	O
,	O
started	O
exercising	O
and	O
was	O
stopped	O
by	O
the	O
tech	O
for	O
nsvt	B
of	O
3	O
beats	O
.	O

pcp	O
transfer	O
to	O
[	O
*	O
*	O
hospital1	O
189	O
*	O
*	O
]	O
for	O
cath	O
.	O

in	O
cath	O
,	O
pt	O
was	O
found	O
to	O
have	O
right	B
dominant	I
system	I
,	O
single	B
vessel	I
coronary	I
artery	I
disease	I
,	O
lmca	O
clear	O
,	O
lad	O
patent	O
stent	O
,	O
lcx	O
with	O
to	B
of	O
om2	O
branch	O
,	O
filling	O
via	O
collaterals	O
,	O
rca	B
tortuous	I
mid	O
vessel	O
50	O
to	O
60%	O
stenoses	B
,	O
lvedp	O
14	O
mm	O
hg	O
,	O
lvef	O
53%	O
,	O
no	O
mr	B
.	O

pressure	O
wire	O
was	O
placed	O
in	O
mid	O
-	O
rca	O
with	O
ffr	O
0	O
.	O
6	O
(	O
>0	O
.	O
75	O
indicating	O
restricted	O
flow	O
)	O
;	O
during	O
attempts	O
at	O
stent	O
placement	O
dissection	B
occurred	O
,	O
pt	O
had	O
[	O
*	O
*	O
09	O
-	O
01	O
*	O
*	O
]	O
"elephant	O
sitting	O
on	O
my	O
chest"	O
pain	B
;	O
one	O
stent	O
was	O
placed	O
proximal	O
to	O
the	O
lesion	B
,	O
fentanyl	O
given	O
,	O
iabp	O
started	O
,	O
pain	B
relieved	O
,	O
pt	O
sent	O
to	O
ccu	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
hypercholesterolemia	B

2	O
.	O
htn	B

3	O
.	O
cad	B
as	O
in	O
hpi	O

4	O
.	O
gerd	B

social	O
history	O
:	O

etoh	O
:	O
social	O

tob	O
:	O
quit	O
1990	O

drugs	O
:	O
none	O

family	O
history	O
:	O

noncontributory	O

physical	O
exam	O
:	O

on	O
admit	O
:	O

vitals	O
:	O
hr	O
72	O
rr	O
18	O
bp	O
150	O
/	O
69	O
o2	O
sat	O
96%ra	O

gen	O
:	O
middle	O
-	O
aged	O
man	O
,	O
pleasant	O
,	O
lying	O
flat	O
on	O
bed	O
with	O
iabp	O

skin	O
:	O
warm	O
and	O
dry	B
skin	I
,	O
no	O
rash	B

heent	O
:	O
nc	O
/	O
at	O
,	O
perrl	O
,	O
eomi	O
,	O
op	O
clear	O
,	O
mmm	O

cv	O
:	O
rrr	O
,	O
[	O
*	O
*	O
02	O
-	O
27	O
*	O
*	O
]	O
syst	B
murmur	I
at	O
apex	O
,	O
jvp	B
flat	I

lungs	O
:	O
trace	O
rales	B
lower	O
[	O
*	O
*	O
01	O
-	O
24	O
*	O
*	O
]	O
bilaterally	O

abd	O
:	O
soft	O
,	O
nt	O
,	O
nd	O
,	O
no	O
hsm	B

groin	O
:	O
r	O
-	O
-	O
a	O
+	O
v	O
sheaths	O
in	O
place	O
;	O
ecchymosis	B
,	O
tender	B
;	O
l	O
-	O
-	O
a	O
sheath	O
with	O
iabp	O
in	O
place	O
;	O
ecchymosis	B
,	O
tender	B
;	O
no	O
bruits	B
on	O
either	O
side	O

ext	O
:	O
no	O
lower	B
extremity	I
edema	I
,	O
2	O
+	O
dp	O
and	O
pt	O
pulses	O
b	O
/	O
l	O
,	O
no	O
clubbing	B
,	O
cyanosis	B
or	O
erythema	B

neuro	O
:	O
nonfocal	O
exam	O
,	O
sensation	O
intact	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
08	O
:	O
47pm	O
blood	O
hct	O
-	O
36	O
.	O
7	O
*	O
plt	O
ct	O
-	O
169	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
08	O
*	O
*	O
]	O
05	O
:	O
01am	O
blood	O
wbc	O
-	O
7	O
.	O
5	O
rbc	O
-	O
4	O
.	O
18	O
*	O
hgb	O
-	O
13	O
.	O
1	O
*	O
hct	O
-	O
37	O
.	O
1	O
*	O
mcv	O
-	O
89	O
mch	O
-	O
31	O
.	O
3	O
mchc	O
-	O
35	O
.	O
3	O
*	O
rdw	O
-	O
12	O
.	O
9	O
plt	O
ct	O
-	O
180	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
09	O
*	O
*	O
]	O
05	O
:	O
04am	O
blood	O
wbc	O
-	O
8	O
.	O
0	O
rbc	O
-	O
4	O
.	O
06	O
*	O
hgb	O
-	O
12	O
.	O
6	O
*	O
hct	O
-	O
36	O
.	O
6	O
*	O
mcv	O
-	O
90	O
mch	O
-	O
31	O
.	O
1	O
mchc	O
-	O
34	O
.	O
4	O
rdw	O
-	O
12	O
.	O
9	O
plt	O
ct	O
-	O
164	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
08	O
:	O
47pm	O
blood	O
plt	O
ct	O
-	O
169	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
08	O
*	O
*	O
]	O
05	O
:	O
01am	O
blood	O
pt	O
-	O
13	O
.	O
3	O
ptt	O
-	O
48	O
.	O
8	O
*	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
1	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
09	O
*	O
*	O
]	O
05	O
:	O
04am	O
blood	O
pt	O
-	O
13	O
.	O
0	O
ptt	O
-	O
28	O
.	O
4	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
1	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
09	O
*	O
*	O
]	O
05	O
:	O
04am	O
blood	O
plt	O
ct	O
-	O
164	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
09	O
*	O
*	O
]	O
05	O
:	O
04am	O
blood	O
ret	O
aut	O
-	O
2	O
.	O
5	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
08	O
:	O
47pm	O
blood	O
urean	O
-	O
13	O
creat	O
-	O
0	O
.	O
7	O
k	O
-	O
3	O
.	O
2	O
*	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
08	O
*	O
*	O
]	O
05	O
:	O
01am	O
blood	O
glucose	O
-	O
105	O
urean	O
-	O
15	O
creat	O
-	O
0	O
.	O
7	O
na	O
-	O
138	O
k	O
-	O
3	O
.	O
7	O
cl	O
-	O
105	O
hco3	O
-	O
21	O
*	O
angap	O
-	O
16	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
09	O
*	O
*	O
]	O
05	O
:	O
04am	O
blood	O
glucose	O
-	O
114	O
*	O
urean	O
-	O
16	O
creat	O
-	O
1	O
.	O
1	O
na	O
-	O
141	O
k	O
-	O
4	O
.	O
8	O
cl	O
-	O
106	O
hco3	O
-	O
28	O
angap	O
-	O
12	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
02	O
:	O
30pm	O
blood	O
ck	O
(	O
cpk	O
)	O
-	O
121	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
08	O
:	O
47pm	O
blood	O
ck	O
(	O
cpk	O
)	O
-	O
88	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
08	O
*	O
*	O
]	O
05	O
:	O
01am	O
blood	O
alt	O
-	O
33	O
ast	O
-	O
24	O
ld	O
(	O
ldh	O
)	O
-	O
219	O
ck	O
(	O
cpk	O
)	O
-	O
97	O
alkphos	O
-	O
72	O
totbili	O
-	O
1	O
.	O
1	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
09	O
*	O
*	O
]	O
05	O
:	O
04am	O
blood	O
alt	O
-	O
27	O
ast	O
-	O
18	O
ld	O
(	O
ldh	O
)	O
-	O
201	O
ck	O
(	O
cpk	O
)	O
-	O
68	O
alkphos	O
-	O
71	O
totbili	O
-	O
0	O
.	O
8	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
02	O
:	O
30pm	O
blood	O
ck	O
-	O
mb	O
-	O
3	O
ctropnt	O
-	O
<0	O
.	O
01	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
08	O
*	O
*	O
]	O
05	O
:	O
01am	O
blood	O
ck	O
-	O
mb	O
-	O
notdone	O
ctropnt	O
-	O
<0	O
.	O
01	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
09	O
*	O
*	O
]	O
05	O
:	O
04am	O
blood	O
ck	O
-	O
mb	O
-	O
notdone	O
ctropnt	O
-	O
<0	O
.	O
01	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
08	O
:	O
47pm	O
blood	O
mg	O
-	O
1	O
.	O
8	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
08	O
*	O
*	O
]	O
05	O
:	O
01am	O
blood	O
albumin	O
-	O
3	O
.	O
9	O
calcium	O
-	O
7	O
.	O
9	O
*	O
phos	O
-	O
2	O
.	O
6	O
*	O
mg	O
-	O
2	O
.	O
3	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
09	O
*	O
*	O
]	O
05	O
:	O
04am	O
blood	O
albumin	O
-	O
4	O
.	O
0	O
calcium	O
-	O
9	O
.	O
2	O
phos	O
-	O
3	O
.	O
6	O
mg	O
-	O
1	O
.	O
8	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
08	O
*	O
*	O
]	O
05	O
:	O
01am	O
blood	O
hapto	O
-	O
<20	O
*	O

[	O
*	O
*	O
2015	O
-	O
10	O
-	O
09	O
*	O
*	O
]	O
05	O
:	O
04am	O
blood	O
hapto	O
-	O
42	O

brief	O
hospital	O
course	O
:	O

64yo	O
man	O
with	O
h	O
/	O
o	O
cad	B
s	O
/	O
p	O
multiple	O
pcis	O
,	O
htn	B
,	O
hyperchol	B
,	O
who	O
had	O
sscp	B
2wks	O
pta	O
,	O
was	O
scheduled	O
for	O
ett	O
,	O
had	O
pnd	B
and	O
palpitations	B
on	O
pm	O
prior	O
to	O
study	O
and	O
nsvt	B
during	O
study	O
,	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
189	O
*	O
*	O
]	O
for	O
cath	O
.	O

1	O
.	O
cardio	O

a	O
.	O

coronaries	O
:	O

during	O
pt's	O
cath	O
procedure	O
,	O
mid	O
rca	O
50	O
-	O
60%	O
stenosis	B
was	O
encountered	O
.	O

a	O
pressure	O
wire	O
read	O
an	O
ffr	O
of	O
0	O
.	O
69	O
after	O
adenosine	O
,	O
0	O
.	O
83	O
at	O
rest	O
.	O

an	O
attempt	O
was	O
made	O
to	O
stent	O
the	O
lesion	B
,	O
but	O
given	O
the	O
tortuous	B
nature	O
of	O
the	O
rca	O
a	O
dissection	O
of	O
the	O
artery	O
occurred	O
.	O

the	O
patient	O
then	O
had	O
[	O
*	O
*	O
09	O
-	O
01	O
*	O
*	O
]	O
pain	B
"like	O
an	O
elephant	O
was	O
sitting	O
on	O
[	O
his	O
]	O
chest	O
.	O
"	O

he	O
was	O
given	O
fentanyl	O
and	O
a	O
iabp	O
for	O
pain	B
control	O
and	O
for	O
increased	O
flow	O
to	O
his	O
coronaries	O
.	O

he	O
was	O
admitted	O
to	O
the	O
ccu	O
,	O
and	O
had	O
a	O
largely	O
uneventful	O
ccu	O
course	O
.	O

he	O
was	O
maintained	O
on	O
asa	O
325mg	O
qd	O
,	O
lipitor	O
80mg	O
qd	O
(	O
for	O
antiinflammatory	O
properities	O
the	O
higher	O
dose	O
was	O
used	O
)	O
,	O
iabp	O
for	O
two	O
days	O
.	O

ct	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
was	O
emailed	O
and	O
made	O
aware	O
,	O
though	O
pt's	O
dissection	B
was	O
managed	O
medically	O
without	O
further	O
evidence	O
of	O
cp	B
,	O
sob	B
,	O
doe	B
,	O
or	O
pnd	B
.	O

cardiac	B
enzymes	I
peaked	O
on	O
the	O
doa	O
and	O
trended	O
down	O
thereafter	O
,	O
without	O
nstemi	B
.	O

b	O
.	O

pump	O
:	O

pt	O
was	O
on	O
an	O
iabp	O
initially	O
for	O
pain	B
relief	O
and	O
to	O
increase	O
flow	O
to	O
the	O
stented	O
rca	O
in	O
the	O
tortuous	B
artery	I
.	O

an	O
attempt	O
was	O
made	O
to	O
wean	O
the	O
pump	O
1d	O
post	O
cath	O
that	O
failed	O
secondary	O
to	O
hypotension	B
.	O

another	O
attempt	O
to	O
wean	O
on	O
day	O
2	O
post	O
cath	O
was	O
successful	O
.	O

he	O
started	O
on	O
metoprolol	O
25mg	O
po	O
bid	O
on	O
day	O
3	O
,	O
but	O
did	O
not	O
tolerate	O
with	O
hr	O
in	O
40s	O
,	O
so	O
was	O
switched	O
over	O
to	O
metoprolol	O
12	O
.	O
5mg	O
po	O
qd	O
.	O

he	O
was	O
also	O
started	O
on	O
lisinopril	O
2	O
.	O
5mg	O
po	O
qd	O
.	O

c	O
.	O

rhythm	O
:	O
nsr	B
,	O
intially	O
with	O
multiple	O
pvcs	B
c	O
/	O
w	O
reperfusion	B
of	O
myocardial	O
tissue	O
but	O
then	O
stabilizing	O
in	O
nsr	B
without	O
ectopy	B
.	O

2	O
.	O
renal	O
:	O
creatinine	O
immediately	O
post	O
-	O
procedure	O
0	O
.	O
7	O
,	O
bumped	O
to	O

1	O
.	O
1	O
,	O
likely	O
[	O
*	O
*	O
02	O
-	O
23	O
*	O
*	O
]	O
dye	O
load	O

3	O
.	O
gi	O
:	O
gerd	B
;	O
was	O
on	O
protonix	O
as	O
outpatient	O
,	O
which	O
was	O
continued	O
in	O
the	O
hospital	O

4	O
.	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
:	O
hematuria	B
noted	O
after	O
anticoagulation	O
and	O
foley	O
placement	O
;	O
after	O
the	O
foley	O
and	O
the	O
anticoag	O
were	O
d	O
/	O
c'd	O
this	O
issue	O
resolved	O
.	O

5	O
.	O
heme	O
:	O
hct	B
drop	I
on	O
admit	O
but	O
then	O
stable	O
around	O
37	O
and	O
trending	O
up	O
,	O
thought	O
possibly	O
from	O
procedure	O
and	O
urinary	B
loss	I

medications	O
on	O
admission	O
:	O

lipitor	O
10mg	O
qd	O

asa	O
81mg	O
qd	O

atenolol	O
25mg	O
qd	O

diltiazem	O
60mg	O
bid	O

protonix	O

discharge	O
medications	O
:	O

1	O
.	O
aspirin	O
325	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
clopidogrel	O
bisulfate	O
75	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
for	O
30	O
days	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
5	O
*	O

3	O
.	O
atorvastatin	O
calcium	O
80	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

4	O
.	O
metoprolol	O
tartrate	O
25	O
mg	O
tablet	O
sig	O
:	O
0	O
.	O
5	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

5	O
.	O
lisinopril	O
5	O
mg	O
tablet	O
sig	O
:	O
0	O
.	O
5	O
tablet	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
15	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

6	O
.	O
protonix	O
as	O
per	O
outpatient	O
regimen	O
,	O
qd	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

unstable	B
angina	I

rca	I
dissection	I

discharge	O
condition	O
:	O

stable	O

discharge	O
instructions	O
:	O

please	O
take	O
all	O
medications	O
as	O
prescribed	O
and	O
arrange	O
appointments	O
with	O
your	O
primary	O
care	O
doctor	O
in	O
the	O
next	O
week	O
to	O
have	O
your	O
electrolytes	O
checked	O
now	O
that	O
we	O
have	O
started	O
you	O
on	O
new	O
medications	O
.	O

you	O
should	O
also	O
set	O
up	O
an	O
appointment	O
with	O
the	O
cardiologist	O
who	O
performed	O
your	O
procedure	O
in	O
the	O
next	O
month	O
or	O
so	O
.	O

followup	O
instructions	O
:	O

please	O
call	O
your	O
primary	O
care	O
doctor	O
to	O
set	O
up	O
an	O
appointment	O
within	O
the	O
next	O
week	O
if	O
possible	O
to	O
have	O
your	O
blood	O
electrolytes	O
checked	O
now	O
that	O
you	O
have	O
been	O
started	O
on	O
new	O
medications	O
.	O

your	O
primary	O
care	O
doctor	O
should	O
also	O
check	O
your	O
blood	O
pressure	O
and	O
heart	O
rate	O
during	O
this	O
visit	O
to	O
see	O
if	O
any	O
medications	O
need	O
to	O
be	O
changed	O
.	O

you	O
will	O
also	O
need	O
to	O
call	O
your	O
cardiologist	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1706	O
*	O
*	O
]	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
7835	O
*	O
*	O
]	O
to	O
set	O
up	O
a	O
follow	O
up	O
appointment	O
for	O
within	O
the	O
next	O
month	O
or	O
two	O
if	O
possible	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
796	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
1714	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
5856	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2595	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
2596	O
*	O
*	O
]	O
[	O
*	O
*	O
2015	O
-	O
10	O
-	O
10	O
*	O
*	O
]	O
@	O
1435	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2015	O
-	O
10	O
-	O
23	O
*	O
*	O
]	O
1	O
:	O
33	O
pm	O

(	O
end	O
of	O
report	O
)	O

4020	O
||||	O
12530	O
||||	O
19614	O
||||	O
discharge	O
_	O
summary	O
||||	O
2019	O
-	O
12	O
-	O
06	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
12	O
-	O
03	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1947	O
-	O
11	O
-	O
04	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
4153	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

loss	B
of	I
consciousness	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

hemodialysis	O
.	O

intubation	O
.	O

history	O
of	O
present	O
illness	O
:	O

72	O
year	O
old	O
man	O
with	O
stage	B
4	I
ckd	I
on	O
hd	O
,	O
cad	B
,	O
htn	B
,	O
asthma	B
who	O
presented	O
with	O
multiple	B
falls	I
and	O
was	O
found	O
by	O
ems	O
to	O
be	O
in	O
a	O
wide	O
complex	O
brady	B
to	O
20	O
bpm	O
with	O
bp	O
of	O
50	O
systolic	O
.	O

per	O
wife	O
and	O
friend	O
,	O
pt	O
was	O
in	O
usoh	O
until	O
day	O
prior	O
to	O
admission	O
,	O
when	O
he	O
started	O
to	O
feel	O
shaky	B
&	O
tremulous	B
hands	O
.	O

gait	O
somewhat	O
unsteady	O
w	O
/	O
generalized	B
weakness	I
.	O

has	O
not	O
had	O
any	O
fevers	B
/	O
chills	B
/	O
sweats	B
,	O
no	O
diarrhea	B
,	O
no	O
cp	B
/	O
palpitations	B
/	O
sob	B
.	O

on	O
morning	O
of	O
admission	O
,	O
pt	O
went	O
shopping	O
w	O
/	O
friend	O
,	O
upon	O
leaving	O
store	O
pt	O
was	O
very	O
nauseated	B
,	O
+	O
emesis	B
,	O
friend	O
took	O
pt	O
home	O
.	O

at	O
home	O
,	O
pt	O
became	O
unresponsive	B
,	O
&	O
wife	O
[	O
*	O
*	O
name	O
(	O
ni	O
)	O
5219	O
*	O
*	O
]	O
ems	O
.	O
[	O
*	O
*	O
doctor	O
first	O
name	O
3	O
*	O
*	O
]	O
course	O
:	O
pt	O
found	O
to	O
be	O
bradycardic	B
hr	O
20s	O
,	O
sbp	O
50s	O
-	O
received	O
atropine	O
x1	O
which	O
precipitated	O
to	O
wide	B
complex	I
tachycardia	I
hr	O
100s	O
,	O
sbp	O
200s	O
.	O

immediately	O
thereafter	O
sbp	O
back	O
down	O
to	O
50s	O
,	O
started	O
levophed	O
.	O

initial	O
k	O
8	O
.	O
9	O
,	O
transcutaneous	O
pacing	O
at	O
60amp	O
attempted	O
was	O
unsuccessful	O
.	O

continued	O
w	O
/	O
calcium	O
chloride	O
,	O
atropine	O
x2	O
,	O
epi	O
x2	O
,	O
bicarb	O
x1amp	O
,	O
insulin	O
,	O
d50	O
,	O
kayexalate	O
x1	O
.	O

renal	O
to	O
intiate	O
hd	O
when	O
arrives	O
to	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
221	O
*	O
*	O
]	O
.	O

ep	O
consulted	O
which	O
concluded	O
significant	O
hyperkalemia	B
resulted	O
in	O
bradycardia	B
,	O
followed	O
by	O
wide	B
complex	I
tachycardia	I
and	O
hypotension	B
.	O

past	O
medical	O
history	O
:	O

-	O
cad	B

-	O
asthma	B

-	O
ckd	B
on	O
hd	O
(	O
polycystic	B
kidney	I
disease	I
)	O
,	O
hd	O
-	O
t	O
,	O
th	O
,	O
sat	O
at	O
[	O
*	O
*	O
hospital	O
5220	O
*	O
*	O
]	O
-	O
htn	B

-	O
prostate	B
ca	I

social	O
history	O
:	O

pt	O
lives	O
w	O
/	O
wife	O
,	O
retired	O
.	O
[	O
*	O
*	O
name2	O
(	O
ni	O
)	O
1741	O
*	O
*	O
]	O
speaking	O
only	O
.	O

family	O
history	O
:	O

noncontributory	O

physical	O
exam	O
:	O

vs	O
95	O
.	O
7	O
bp	O
149	O
/	O
73	O
hr	O
107	O

gen	O
:	O
intubated	O
,	O
sedated	O

heent	O
:	O
ett	O
in	O
place	O
,	O
perrl	O

resp	O
:	O
cta	O
bl	O

cv	O
:	O
reg	O
,	O
nml	O
s1	O
,	O
s2	O
,	O
no	O
m	B
/	O
r	B
/	O
g	B

abd	O
:	O
soft	O
nd	O
/	O
nt	O
,	O
+	O
bs	O

ext	O
:	O
no	O
c	B
/	O
c	B
/	O
e	B
,	O
warm	O
,	O
1	O
+	O
dp	O
pulses	O
b	O
/	O
l	O

neuro	O
:	O
hyporeflexia	B
,	O
sedated	O
,	O
responds	O
to	O
painful	O
stimuli	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
03	O
*	O
*	O
]	O
12	O
:	O
30pm	O
glucose	O
-	O
180	O
*	O
urea	O
n	O
-	O
90	O
*	O
creat	O
-	O
9	O
.	O
8	O
*	O
#	O
sodium	O
-	O
144	O
potassium	O
-	O
7	O
.	O
3	O
*	O
chloride	O
-	O
104	O
total	O
co2	O
-	O
21	O
*	O
anion	O
gap	O
-	O
26	O
*	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
03	O
*	O
*	O
]	O
12	O
:	O
30pm	O
calcium	O
-	O
11	O
.	O
9	O
*	O
phosphate	O
-	O
5	O
.	O
6	O
*	O
magnesium	O
-	O
1	O
.	O
7	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
03	O
*	O
*	O
]	O
12	O
:	O
30pm	O
wbc	O
-	O
16	O
.	O
7	O
*	O
#	O
rbc	O
-	O
3	O
.	O
56	O
*	O
hgb	O
-	O
11	O
.	O
9	O
*	O
hct	O
-	O
35	O
.	O
9	O
*	O
mcv	O
-	O
101	O
*	O
#	O
mch	O
-	O
33	O
.	O
4	O
*	O
#	O
mchc	O
-	O
33	O
.	O
1	O
rdw	O
-	O
16	O
.	O
0	O
*	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
03	O
*	O
*	O
]	O
12	O
:	O
23pm	O
glucose	O
-	O
160	O
*	O
na	O
+	O
-	O
143	O
k	O
+	O
-	O
8	O
.	O
4	O
*	O
cl	O
-	O
-	O
107	O
tco2	O
-	O
19	O
*	O

brief	O
hospital	O
course	O
:	O

ap	O
:	O
72	O
yo	O
w	O
/	O
esrd	B
on	O
hd	O
,	O
cad	B
,	O
htn	B
,	O
asthma	B
p	O
/	O
w	O
significant	O
hyperkalemia	B
&	O
associated	O
arrythmias	B
.	O

#	O
hyperkalemia	B
:	O
pt	O
arrived	O
in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
3	O
*	O
*	O
]	O
with	O
potassium	O
of	O
8	O
.	O
4	O
(	O
arterial	O
)	O
.	O

pt	O
admitted	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
221	O
*	O
*	O
]	O
,	O
underwent	O
hd	O
with	O
resolution	O
of	O
hyperkalemia	B
.	O

the	O
cause	O
of	O
the	O
hyperkalemia	B
was	O
most	O
likely	O
due	O
to	O
inadequate	O
/	O
incomplete	B
hd	I
two	O
days	O
pta	O
.	O

pt	O
reportedly	O
received	O
abbreviated	O
hd	O
session	O
two	O
days	O
pta	O
-	O
-	O
his	O
regularly	O
scheduled	O
hd	O
day	O
.	O

he	O
reported	O
no	O
increased	O
ingestion	O
of	O
k	O
,	O
nor	O
any	O
changes	O
in	O
his	O
medications	O
.	O

no	O
clear	O
evidence	O
of	O
hyperaldo	B
.	O

the	O
pt's	O
k	O
level	O
remained	O
stable	O
after	O
admission	O
.	O

#	O
dysrythmias	B
:	O
pt	O
has	O
baseline	O
conduction	B
disease	I
(	O
rbb	O
+	O
/	O
-	O
fascicular	B
blocks	I
)	O
.	O

on	O
admission	O
,	O
he	O
reportedly	O
had	O
bradycardic	B
(	O
junctional	B
rhythm	I
)	O
to	O
20's	O
.	O

became	O
hypotensive	B
to	O
sbp	O
of	O
50	O
/	O
pulse	O
.	O

he	O
received	O
atropine	O
&	O
epi	O
.	O

found	O
to	O
be	O
hyperkalemic	B
(	O
8	O
.	O
4	O
)	O
,	O
which	O
was	O
likely	O
the	O
cause	O
of	O
his	O
dysrythmias	B
.	O

in	O
[	O
*	O
*	O
doctor	O
first	O
name	O
3	O
*	O
*	O
]	O
,	O
transcutaneous	O
pacing	O
attempted	O
,	O
but	O
unsuccessful	O
.	O

went	O
into	O
wide	B
-	I
complex	I
tachycardia	I
w	O
/	O
possible	O
sine	O
wave	O
on	O
ekg	O
.	O

pt	O
intubated	O
&	O
put	O
on	O
pressors	O
.	O

received	O
emergent	O
hd	O
.	O

pt	O
extubated	O
&	O
weaned	O
off	O
pressors	O
after	O
1	O
day	O
.	O

no	O
further	O
dysrythmias	B
(	O
aside	O
from	O
pt's	O
baseline	O
)	O
after	O
his	O
hyperkalemia	B
was	O
treated	O
.	O

#	O
cad	B
:	O
not	O
active	O
at	O
present	O
.	O

continued	O
asa	O
and	O
statin	O
.	O

#	O
esrd	B
:	O
history	O
of	O
polycystic	B
kidney	I
disease	I
.	O

on	O
hd	O
on	O
t	O
,	O
th	O
,	O
sat	O
@	O
[	O
*	O
*	O
hospital	O
5221	O
*	O
*	O
]	O
.	O

renal	O
consulted	O
.	O

pt	O
to	O
resume	O
outpatient	O
dialysis	O
.	O

#	O
hypoxia	B
:	O
patient	O
was	O
hypoxic	B
on	O
admission	O
.	O

patient	O
was	O
intubated	O
while	O
in	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
221	O
*	O
*	O
]	O
.	O

cause	O
of	O
hypoxia	B
unclear	O
:	O
possibly	O
asthma	B
exacerbation	I
,	O
question	O
of	O
copd	B
exacerbation	I
(	O
however	O
,	O
the	O
pt	O
does	O
not	O
have	O
documented	O
copd	B
,	O
though	O
he	O
does	O
have	O
long	O
smoking	O
history	O
)	O
.	O

no	O
evidence	O
of	O
pna	B
.	O

prior	O
to	O
discharge	O
,	O
pt	O
was	O
tolerating	O
room	O
air	O
,	O
and	O
was	O
discharged	O
on	O
inhalers	O
.	O

#	O
htn	B
:	O
not	O
an	O
active	O
issue	O
during	O
hospitalization	O

#	O
anemia	B
:	O
chronic	B
anemia	I
.	O

baseline	O
thought	O
to	O
be	O
in	O
low	O
30's	O
.	O

mildly	O
macrocytic	B
.	O

hct	O
in	O
low	O
30's	O
during	O
stay	O
.	O

likely	O
component	O
of	O
both	O
anemia	B
of	I
chronic	I
kidney	I
disease	I
&	O
anemia	B
of	I
chronic	I
disease	I
.	O

iron	O
slightly	O
low	O
,	O
ferritin	B
elevated	I
,	O
tibc	B
low	I
.	O

vitamin	O
b12	O
&	O
folate	O
normal	O
.	O

#	O
thrombocytopenia	B
:	O
pt's	O
plts	O
nearly	O
[	O
*	O
*	O
01	O
-	O
07	O
*	O
*	O
]	O
of	O
that	O
on	O
admission	O
.	O

hit	B
antibody	O
negative	O
.	O

possible	O
component	O
of	O
splenic	B
sequestration	I
w	O
/	O
enlarged	B
liver	I
.	O

#	O
elevated	B
ck	I
:	O
may	O
have	O
been	O
due	O
to	O
falls	B
prior	O
to	O
admission	O
.	O

#	O
elevated	B
aminotransferases	I
:	O
trending	O
down	O
.	O

likely	O
due	O
to	O
polycystic	B
liver	I
disease	I
.	O

#	O
fen	O
:	O
cardiac	O
diet	O

#	O
.	O

ppx	O
:	O
pneumoboots	O

#	O
.	O

code	O
:	O
full	O

medications	O
on	O
admission	O
:	O

-	O
lotpel	O

-	O
asa	O
81mg	O

-	O
phoslo	O

-	O
nephrocaps	O

-	O
doxazosin	O

-	O
calcium	O
+	O
vitamin	O
d	O
500	O
/	O
20	O

-	O
urosit	O
10mg	O

-	O
nexium	O
40mg	O

-	O
simvastatin	O
10mg	O

-	O
ambien	O
10mg	O

-	O
lasix	O
80mg	O

-	O
singulair	O
10mg	O

-	O
catapres	O

-	O
lyrica	O
75mg	O

-	O
bisacodyl	O

-	O
megestrol	O
40mg	O

discharge	O
medications	O
:	O

1	O
.	O
ipratropium	O
bromide	O
17	O
mcg	O
/	O
actuation	O
aerosol	O
sig	O
:	O
six	O
(	O
6	O
)	O
puff	O
inhalation	O
qid	O
(	O
4	O
times	O
a	O
day	O
)	O
.	O

2	O
.	O
simvastatin	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

3	O
.	O
bisacodyl	O
5	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
as	O
needed	O
.	O

4	O
.	O
albuterol	O
-	O
ipratropium	O
103	O
-	O
18	O
mcg	O
/	O
actuation	O
aerosol	O
sig	O
:	O
[	O
*	O
*	O
01	O
-	O
07	O
*	O
*	O
]	O
puffs	O
inhalation	O
q6h	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

5	O
.	O
aspirin	O
325	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

6	O
.	O
phoslo	O
667	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
three	O
times	O
a	O
day	O
.	O

disp	O
:	O
*	O
90	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

7	O
.	O
nephrocaps	O
1	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
once	O
a	O
day	O
.	O

8	O
.	O
norvasc	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

9	O
.	O
doxazosin	O
4	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
at	O
bedtime	O
.	O

10	O
.	O

lyrica	O
75	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
once	O
a	O
day	O
.	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

hyperkalemia	B

discharge	O
condition	O
:	O

stable	O
.	O

discharge	O
instructions	O
:	O

you	O
were	O
admitted	O
to	O
the	O
hospital	O
with	O
a	O
change	O
in	O
your	O
heart	O
functioning	O
related	O
to	O
your	O
electrolytes	O
.	O

the	O
elevated	B
potassium	I
was	O
treated	O
with	O
several	O
medications	O
and	O
your	O
heart	B
rhythm	I
abnormality	I
resolved	O
.	O

we	O
stopped	O
one	O
medication	O
that	O
you	O
were	O
taking	O
-	O
catapres	O
.	O

please	O
do	O
not	O
continue	O
taking	O
this	O
medication	O
.	O

it	O
is	O
essential	O
that	O
you	O
take	O
all	O
of	O
your	O
medications	O
as	O
prescribed	O
.	O

call	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
5222	O
*	O
*	O
]	O
or	O
911	O
if	O
you	O
experience	O
any	O
chest	B
pains	I
,	O
palpitations	B
,	O
dizziness	B
,	O
lightheadedness	B
,	O
shortness	B
of	I
breath	I
,	O
fevers	B
,	O
nausea	B
or	O
vomiting	B
,	O
severe	O
muscle	B
pain	I
or	O
any	O
other	O
concerning	O
symptoms	B
.	O

followup	O
instructions	O
:	O

continue	O
with	O
your	O
regularly	O
scheduled	O
dialysis	O
treatments	O
and	O
follow	O
up	O
with	O
your	O
kidney	O
doctors	O
.	O

you	O
will	O
need	O
hd	O
tomorrow	O
.	O

provider	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
phone	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
445	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2020	O
-	O
01	O
-	O
23	O
*	O
*	O
]	O
1	O
:	O
00	O

please	O
call	O
your	O
pcp	O
for	O
[	O
*	O
*	O
name	O
initial	O
(	O
pre	O
)	O
*	O
*	O
]	O
follow	O
up	O
appt	O
next	O
week	O
.	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
5223	O
*	O
*	O
]	O
.	O

please	O
call	O
your	O
cardiologist	O
dr	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
5224	O
*	O
*	O
]	O
,	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
5225	O
*	O
*	O
]	O
for	O
a	O
f	O
/	O
u	O
in	O
1	O
-	O
2	O
weeks	O
.	O

you	O
will	O
need	O
an	O
echocardiogram	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
4157	O
*	O
*	O
]	O
md	O
,	O
mph	O
12	O
-	O
aoq	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
1953	O
*	O
*	O
]	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1954	O
*	O
*	O
]	O
[	O
*	O
*	O
2020	O
-	O
01	O
-	O
20	O
*	O
*	O
]	O
@	O
2000	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1737	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2020	O
-	O
02	O
-	O
18	O
*	O
*	O
]	O
9	O
:	O
24	O
am	O

(	O
end	O
of	O
report	O
)	O

11060	O
||||	O
12582	O
||||	O
29587	O
||||	O
discharge	O
_	O
summary	O
||||	O
2020	O
-	O
06	O
-	O
02	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2020	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2020	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1934	O
-	O
03	O
-	O
03	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
4744	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

food	B
impaction	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

egd	O

manommetry	O

history	O
of	O
present	O
illness	O
:	O

86	O
yo	O
m	O
with	O
pmhx	O
signifiacnt	O
for	O
achalasia	B
,	O
hiatal	B
hernia	I
and	O
history	O
of	O
food	B
impaction	I
x	O
2	O
p	O
/	O
w	O
initially	O
yesterday	O
to	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
154	O
*	O
*	O
]	O
for	O
another	O
episode	O
of	O
food	B
impaction	I
after	O
having	O
some	O
cornmeal	O
.	O

per	O
pt	O
,	O
shortly	O
afterwards	O
takin	O
the	O
cornmeal	O
,	O
he	O
felt	O
that	O
food	B
got	I
stuck	I
in	O
his	O
throat	O
to	O
the	O
point	O
where	O
he	O
was	O
unable	O
to	O
keep	O
food	O
down	O
or	O
even	O
saliva	O
.	O

no	O
other	O
compalints	B
at	O
the	O
time	O
.	O

in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
,	O
afebrile	B
,	O
vss	O
,	O
pt	O
reported	O
some	O
cp	B
w	O
/	O
associated	O
sob	B
.	O

ekg	O
which	O
showed	O
rbbb	B
(	O
old	O
)	O
and	O
cxr	O
done	O
which	O
was	O
unremarkable	O
.	O

he	O
was	O
transferred	O
to	O
the	O
icu	O
from	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
so	O
egd	O
could	O
be	O
performed	O
.	O

in	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
154	O
*	O
*	O
]	O
,	O
egd	O
showed	O
food	B
compaction	I
in	O
the	O
lower	O
third	O
of	O
the	O
esophagus	O
and	O
gastroesophageal	O
junction	O
,	O
which	O
was	O
pushed	O
through	O
and	O
removed	O
.	O

pale	O
and	O
friable	B
mucosa	I
at	O
the	O
ge	O
junction	O
and	O
large	O
paraesophageal	B
hernia	I
with	O
possible	O
torsion	B
.	O

otherwise	O
normal	O
egd	O
to	O
second	O
part	O
of	O
the	O
duodenum	O
.	O

he	O
was	O
successfuly	O
extubated	O
this	O
am	O
and	O
vs	O
remained	O
stable	O
.	O

he	O
was	O
called	O
out	O
to	O
the	O
floor	O
for	O
further	O
evaluation	O
of	O
his	O
paraesophageal	B
hernia	I
.	O

past	O
medical	O
history	O
:	O

(	O
1	O
)	O
hypertension	B
.	O

(	O
2	O
)	O
hypercholesterolemia	B
.	O

(	O
3	O
)	O
kidney	B
stone	I
.	O

(	O
4	O
)	O
right	O
hydrocele	B
.	O

(	O
5	O
)	O
spinal	B
stenosis	I
.	O

(	O
6	O
)	O
right	B
inguinal	I
hernia	I
status	O
post	O
repair	O
.	O

(	O
7	O
)	O
hiatal	B
hernia	I
.	O

(	O
8	O
)	O
food	B
impaction	I
x	O
2	O
.	O

social	O
history	O
:	O

he	O
does	O
not	O
smoke	O
or	O
drink	O
.	O

he	O
is	O
retired	O
.	O

family	O
history	O
:	O

a	O
cousin	O
has	O
gastric	B
cancer	I
.	O

physical	O
exam	O
:	O

t	O
96	O
.	O
5	O
hr	O
64	O
bp	O
173	O
/	O
81	O
rr	O
18	O
o2sat	O
99%ra	O

gen	O
:	O
nad	B

heent	O
:	O
perrla	O
,	O
eomi	O

lungs	O
:	O
cta	O
b	O
/	O
l	O

heart	O
:	O
rrr	O
s1	O
/	O
s2	O
no	O
murmurs	B

abdomen	O
:	O
soft	O
,	O
nt	O

ext	O
:	O
no	O
edema	B

neuro	O
:	O
aaox3	O

pertinent	O
results	O
:	O

admission	O
labs	O
:	O

[	O
*	O
*	O
2020	O
-	O
05	O
-	O
31	O
*	O
*	O
]	O
04	O
:	O
28am	O
blood	O
wbc	O
-	O
6	O
.	O
4	O
rbc	O
-	O
4	O
.	O
48	O
*	O
hgb	O
-	O
13	O
.	O
2	O
*	O
hct	O
-	O
37	O
.	O
8	O
*	O

mcv	O
-	O
85	O
mch	O
-	O
29	O
.	O
5	O
mchc	O
-	O
34	O
.	O
9	O
rdw	O
-	O
13	O
.	O
8	O
plt	O
ct	O
-	O
137	O
*	O

[	O
*	O
*	O
2020	O
-	O
05	O
-	O
31	O
*	O
*	O
]	O
04	O
:	O
28am	O
blood	O
pt	O
-	O
12	O
.	O
9	O
ptt	O
-	O
31	O
.	O
8	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
1	O

[	O
*	O
*	O
2020	O
-	O
05	O
-	O
31	O
*	O
*	O
]	O
04	O
:	O
28am	O
blood	O
glucose	O
-	O
92	O
urean	O
-	O
14	O
creat	O
-	O
1	O
.	O
1	O
na	O
-	O
143	O
k	O
-	O
3	O
.	O
8	O
cl	O
-	O
107	O
hco3	O
-	O
30	O
angap	O
-	O
10	O

discharge	O
labs	O
:	O

[	O
*	O
*	O
2020	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O
04	O
:	O
20am	O
blood	O
wbc	O
-	O
4	O
.	O
4	O
rbc	O
-	O
4	O
.	O
79	O
hgb	O
-	O
13	O
.	O
9	O
*	O
hct	O
-	O
39	O
.	O
6	O
*	O

mcv	O
-	O
83	O
mch	O
-	O
29	O
.	O
0	O
mchc	O
-	O
35	O
.	O
0	O
rdw	O
-	O
13	O
.	O
7	O
plt	O
ct	O
-	O
141	O
*	O

[	O
*	O
*	O
2020	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O
04	O
:	O
20am	O
blood	O
pt	O
-	O
12	O
.	O
7	O
ptt	O
-	O
30	O
.	O
9	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
1	O

[	O
*	O
*	O
2020	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O
04	O
:	O
20am	O
blood	O
glucose	O
-	O
112	O
*	O
urean	O
-	O
8	O
creat	O
-	O
1	O
.	O
1	O
na	O
-	O
142	O
k	O
-	O
3	O
.	O
6	O
cl	O
-	O
105	O
hco3	O
-	O
32	O
angap	O
-	O
9	O

[	O
*	O
*	O
2020	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O
04	O
:	O
20am	O
blood	O
calcium	O
-	O
8	O
.	O
6	O
phos	O
-	O
3	O
.	O
8	O
mg	O
-	O
2	O
.	O
2	O

cxr	O
(	O
[	O
*	O
*	O
2020	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
)	O

impression	O
:	O
stable	O
appearance	O
of	O
chest	O
with	O
no	O
evidence	O
of	O
radiopaque	O
foreign	B
body	I
or	O
pneumomediastinum	B
.	O

egd	O
(	O
[	O
*	O
*	O
2020	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
)	O

findings	O
:	O
esophagus	O
:	O

contents	O
:	O
solid	O
food	O
mixed	O
with	O
fluid	O
was	O
seen	O
impacted	B
in	O
the	O
lower	O
third	O
of	O
the	O
esophagus	O
and	O
gastroesophageal	O
junction	O
.	O

due	O
to	O
risk	O
of	O
aspiration	B
the	O
endoscope	O
was	O
withdrawn	O
and	O
patient	O
was	O
intubated	O
for	O
airway	O
protection	O
.	O

repeat	O
endoscopy	O
showed	O
large	O
pieces	O
of	O
solid	O
food	O
in	O
the	O
distal	O
esophagus	O
.	O

several	O
pieces	O
of	O
food	O
material	O
were	O
successfully	O
removed	O
using	O
a	O
snare	O
and	O
[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
net	O
.	O

subsequently	O
the	O
ge	O
junction	O
was	O
clearly	O
visualized	O
.	O

the	O
remiander	O
of	O
the	O
food	O
particles	O
were	O
gently	O
pushed	O
into	O
the	O
stomach	O
lumen	O
under	O
direct	O
endoscopic	O
visualization	O
.	O

the	O
stomach	O
and	O
duodenum	O
appeared	O
normal	O
.	O

retroflexion	O
in	O
the	O
antrum	O
showed	O
a	O
large	O
paraesophageal	B
hernia	I
with	O
food	O
material	O
in	O
the	O
hernia	O
sac	O
.	O

some	O
of	O
this	O
material	O
was	O
suctioned	O
successfully	O
.	O

the	O
mucosa	O
in	O
the	O
distal	O
esophagus	O
appeared	O
pale	O
and	O
friable	O
suggestive	O
of	O
possible	O
ischemic	B
changes	O
.	O

additionally	O
a	O
torsion	B
of	O
the	O
hernia	O
sac	O
could	O
not	O
be	O
ruled	O
out	O
.	O

stomach	O
:	O
normal	O
stomach	O
.	O

duodenum	O
:	O
normal	O
duodenum	O
.	O

impression	O
:	O
food	O
in	O
the	O
lower	O
third	O
of	O
the	O
esophagus	O
and	O
gastroesophageal	O
junction	O
.	O
(	O
foreign	B
body	I
removal	O
)	O
pale	O
and	O
friable	B
mucosa	I
at	O
the	O
ge	O
junction	O
.	O
large	O
paraesophageal	B
hernia	I
with	O
possible	O
torsion	B
.	O

otherwise	O
normal	O
egd	O
to	O
second	O
part	O
of	O
the	O
duodenum	O

cxr	O
(	O
[	O
*	O
*	O
2020	O
-	O
05	O
-	O
31	O
*	O
*	O
]	O
)	O

impression	O
:	O
scarring	B
versus	O
atelectasis	B
in	O
right	O
lung	O
base	O
.	O

no	O
acute	B
process	I
.	O

barium	O
swallow	O
(	O
[	O
*	O
*	O
2020	O
-	O
06	O
-	O
01	O
*	O
*	O
]	O
)	O

barium	O
esophagram	O
:	O
esophagus	O
demonstrates	O
nonpropulsive	B
tertiary	I
contraction	I
.	O

a	O
moderate	O
axial	O
hiatal	B
hernia	I
is	O
present	O
.	O

lower	O
esophageal	O
sphincter	O
opens	O
normally	O
without	O
evidence	O
of	O
achalasia	B
.	O

a	O
13	O
-	O
mm	O
barium	O
tablet	O
passes	O
freely	O
through	O
the	O
esophagus	O
without	O
holdup	O
.	O

small	O
amount	O
of	O
gastroesophageal	B
reflux	I
was	O
demonstrated	O
during	O
the	O
exam	O
.	O

impression	O
:	O
findings	O
consistent	O
with	O
presbyesophagus	B
.	O

moderate	O
axial	O
hiatal	B
hernia	I
.	O

esophageal	O
manometry	O
(	O
[	O
*	O
*	O
2020	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O
)	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
478	O
*	O
*	O
]	O
pending	O

brief	O
hospital	O
course	O
:	O

the	O
patient	O
is	O
a	O
86	O
y	O
/	O
o	O
male	O
with	O
pmhx	O
of	O
achalasia	B
,	O
hiatal	B
hernia	I
food	I
impaction	I
p	O
/	O
w	O
other	O
episode	O
of	O
food	B
impacted	I
in	O
esophagus	O
after	O
eating	O
a	O
meal	O
s	O
/	O
p	O
egd	O
evacuation	O
.	O

his	O
hopsital	O
course	O
during	O
this	O
admission	O
is	O
as	O
follow	O
:	O

1	O
food	B
impaction	I
s	O
/	O
p	O
egd	O
evacuation	O
:	O
his	O
typical	O
presentation	O
of	O
food	B
impaction	I
symptoms	O
.	O
risk	O
factors	O
?achalasia	O
(	O
or	O
other	O
gi	B
motility	I
disorder	I
)	O
and	O
hh	B
hernia	I
.	O

egd	O
yesterday	O
again	O
revealed	O
food	B
impaction	I
and	O
was	O
pushed	O
through	O
into	O
the	O
stomachand	O
evacuated	O
,	O
also	O
with	O
type	O
iii	O
paraesophageal	B
hernia	I
with	O
?	O
torsion	B
.	O

pt	O
tolerated	O
the	O
procedure	O
very	O
well	O
,	O
and	O
remained	O
asymtomatic	O
post	O
procedure	O
.	O

he	O
was	O
started	O
on	O
ppi	O
post	O
egd	O
.	O

surgery	O
was	O
consulted	O
given	O
concerns	O
of	O
infarction	B
vs	O
tortion	B
of	O
hernia	B
,	O
he	O
underwent	O
a	O
ugi	O
series	O
and	O
esophageal	O
manometry	O
test	O
prior	O
to	O
discharge	O
in	O
preparation	O
for	O
potential	O
surgery	O
and	O
will	O
be	O
evaluated	O
this	O
thursday	O
after	O
discharge	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
for	O
possible	O
surgery	O
late	O
this	O
week	O
.	O

he	O
was	O
started	O
on	O
clear	O
liquid	O
diet	O
which	O
he	O
tolerated	O
well	O
,	O
and	O
he	O
was	O
to	O
continue	O
soft	O
diet	O
post	O
discharge	O
until	O
he	O
sees	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
this	O
thursday	O
for	O
surgical	O
evaluation	O
.	O

2	O
htn	B
:	O
no	O
current	O
issues	O
,	O
continued	O
bb	O
,	O
acei	O
,	O
and	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
(	O
home	O
meds	O
)	O
;	O
hold	O
lasix	O
while	O
given	O
ivfs	O
or	O
on	O
clear	O
liquid	O
diet	O
.	O

3	O
hypercholesterolemia	B
:	O
continued	O
statin	O

4	O
ppx	O
:	O
ppi	O
,	O
sc	O
hep	O
,	O
bowel	O
regimen	O

5	O
fen	O
:	O
initially	O
npo	O
with	O
ivf	O
,	O
then	O
started	O
clear	O
/	O
soft	O
diet	O
which	O
he	O
tolerated	O
well	O
;	O
replete	O
lytes	O
prn	O

6	O
full	O
code	O

7	O
communication	O
:	O
hcp	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
4745	O
*	O
*	O
]	O
(	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
4746	O
*	O
*	O
]	O
shillinford	O
)	O

medications	O
on	O
admission	O
:	O

1	O
.	O
asa	O
81	O
mg	O
daily	O

2	O
.	O
atorvastatin	O
5	O
mg	O
po	O
daily	O
start	O
:	O
in	O
am	O

3	O
.	O
avapro	O
*	O
nf	O
*	O
300	O
mg	O
oral	O
daily	O
start	O
:	O
[	O
*	O
*	O
2020	O
-	O
05	O
-	O
31	O
*	O
*	O
]	O

4	O
.	O
lasix	O
20mg	O
daily	O

5	O
.	O
lisinopril	O
10	O
mg	O
po	O
bid	O
hold	O
for	O
sbp	O
<	O
100	O

6	O
.	O
metoprolol	O
xl	O
(	O
toprol	O
xl	O
)	O
25	O
mg	O
po	O
daily	O
start	O
:	O
in	O
am	O
hold	O
for	O
sbp	O
<	O
100	O
and	O
hr	O
<	O
55	O

discharge	O
medications	O
:	O

1	O
.	O
atorvastatin	O
10	O
mg	O
tablet	O
sig	O
:	O
0	O
.	O
5	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

2	O
.	O
irbesartan	O
300	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

3	O
.	O
docusate	O
sodium	O
50	O
mg	O
/	O
5	O
ml	O
liquid	O
sig	O
:	O
one	O
(	O
1	O
)	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

4	O
.	O
lisinopril	O
5	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

5	O
.	O
metoprolol	O
succinate	O
25	O
mg	O
tablet	O
sustained	O
release	O
24	O
hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
sustained	O
release	O
24	O
hr	O
po	O
daily	O
(	O
daily	O
)	O
.	O

6	O
.	O
senna	O
8	O
.	O
6	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

7	O
.	O
protonix	O
40	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
once	O
a	O
day	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

food	B
impaction	I

paraesophageal	I
hernia	I

discharge	O
condition	O
:	O

stable	O
,	O
tolerating	O
clears	O
,	O
ambulating	O

discharge	O
instructions	O
:	O

you	O
were	O
admitted	O
for	O
food	B
impaction	I
and	O
you	O
underwent	O
endoscopy	O
which	O
was	O
removed	O
.	O

you	O
need	O
to	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
this	O
thursday	O
regarding	O
potentially	O
scheduling	O
for	O
outpatient	O
surgery	O
for	O
your	O
hiatal	B
hernia	I
.	O

you	O
also	O
had	O
a	O
manommetry	O
study	O
of	O
your	O
esophagus	O
prior	O
to	O
discharge	O
inpreparatoin	O
for	O
potential	O
surgery	O
this	O
week	O
,	O
and	O
you	O
need	O
to	O
follow	O
up	O
the	O
results	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
(	O
see	O
appointment	O
time	O
below	O
)	O
.	O

you	O
need	O
to	O
continue	O
a	O
soft	O
diet	O
(	O
no	O
solid	O
food	O
)	O
until	O
you	O
see	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
4747	O
*	O
*	O
]	O
,	O
and	O
you	O
should	O
hold	O
off	O
aspirin	O
until	O
you	O
see	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
4747	O
*	O
*	O
]	O
as	O
well	O
in	O
case	O
of	O
surgery	O
later	O
this	O
week	O
.	O

please	O
take	O
all	O
of	O
your	O
medications	O
(	O
please	O
crush	O
them	O
)	O
.	O

we	O
held	O
you	O
aspirin	O
in	O
preparation	O
for	O
surgery	O
,	O
and	O
your	O
lasix	O
while	O
you	O
are	O
only	O
on	O
clear	O
liquid	O
diet	O
.	O

please	O
follow	O
up	O
all	O
of	O
your	O
appointments	O
.	O

please	O
call	O
911	O
or	O
go	O
to	O
the	O
neareast	O
emergency	O
room	O
if	O
you	O
have	O
fever>101	O
,	O
chills	B
,	O
chest	B
pain	I
,	O
shortness	B
of	I
breath	I
,	O
nausea	B
,	O
vomiting	B
,	O
diarrhea	B
,	O
pain	O
or	O
difficulty	O
w	O
/	O
swallowing	O
or	O
any	O
other	O
symptoms	B
that	O
are	O
concerning	O
to	O
you	O
.	O

followup	O
instructions	O
:	O

please	O
follow	O
up	O
w	O
/	O
provider	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
977	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2220	O
*	O
*	O
]	O
,	O
md	O
phone	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
2323	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2020	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O
11	O
:	O
15	O
(	O
call	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1487	O
*	O
*	O
]	O
for	O
directions	O

please	O
also	O
follow	O
up	O
with	O
your	O
pcp	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
112	O
*	O
*	O
]	O
within	O
2	O
weeks	O
after	O
discharge	O
.	O

[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
888	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
889	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
2948	O
*	O
*	O
]	O
[	O
*	O
*	O
name8	O
(	O
md	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
2949	O
*	O
*	O
]	O
[	O
*	O
*	O
2020	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O
@	O
1541	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
888	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2020	O
-	O
08	O
-	O
17	O
*	O
*	O
]	O
8	O
:	O
39	O
am	O

(	O
end	O
of	O
report	O
)	O

27862	O
||||	O
12618	O
||||	O
28777	O
||||	O
discharge	O
_	O
summary	O
||||	O
2014	O
-	O
04	O
-	O
11	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
04	O
-	O
08	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
04	O
-	O
11	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1991	O
-	O
06	O
-	O
19	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
19	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

somnolence	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

22	O
yo	O
male	O
,	O
h	O
/	O
o	O
primitive	B
neuroectodermal	I
tumor	I
with	O
mets	B
to	O
brain	O
and	O
spine	O
,	O
transferred	O
from	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
,	O
initially	O
in	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
25	O
*	O
*	O
]	O
and	O
then	O
transferred	O
to	O
the	O
floor	O
.	O

he	O
was	O
initially	O
diagnosed	O
with	O
a	O
thoracic	O
gangliogliom	B
/	O
resected	O
in	O
[	O
*	O
*	O
2012	O
*	O
*	O
]	O
.	O

he	O
had	O
back	B
pain	I
in	O
2	O
/	O
04	O
,	O
seen	O
at	O
[	O
*	O
*	O
company	O
1119	O
*	O
*	O
]	O
,	O
and	O
was	O
found	O
to	O
have	O
mets	B
to	O
brain	O
and	O
spine	O
.	O

biopsy	O
at	O
that	O
time	O
confirmed	O
diagnosis	O
of	O
net	B
.	O

at	O
this	O
time	O
,	O
he	O
had	O
radiation	O
to	O
his	O
spine	O
(	O
3600	O
cgy	O
)	O
with	O
carboplatin	O
as	O
sensitizer	O
.	O

he	O
then	O
had	O
6	O
cycles	O
of	O
cytoxan	O
/	O
vincristine	O
as	O
maintenance	O
,	O
followed	O
by	O
high	O
dose	O
chemo	O
and	O
stem	O
cell	O
tx	O
3	O
months	O
ago	O
.	O

mri	O
3	O
months	O
after	O
this	O
(	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
04	O
*	O
*	O
]	O
)	O
showed	O
some	O
enhancement	B
along	O
spine	O
at	O
c2	O
,	O
mid	O
thoracic	O
,	O
and	O
sacral	O
lesion	B
,	O
consistent	O
with	O
metastatic	B
disease	I
.	O

mri	O
brain	O
was	O
neg	O
for	O
disease	B
,	O
and	O
cytology	O
on	O
lp	O
was	O
negative	O
.	O

he	O
started	O
temozolomide	O
/	O
oral	O
etoposided	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
24	O
*	O
*	O
]	O
.	O

most	O
recent	O
mri	O
showed	O
new	O
left	O
frontal	O
lobe	O
lesion	B
among	O
other	O
mets	B
.	O

most	O
recently	O
,	O
he	O
has	O
been	O
on	O
multiple	O
meds	O
for	O
pain	B
,	O
including	O
dilaudid	O
,	O
methadone	O
,	O
and	O
he	O
had	O
recently	O
had	O
an	O
increase	O
in	O
his	O
decadron	O
.	O

thalidomide	O
had	O
also	O
recently	O
been	O
started	O
.	O

the	O
weekend	O
prior	O
to	O
admission	O
,	O
he	O
had	O
intermittent	O
episodes	O
of	O
somnolence	B
interrupted	O
by	O
completely	O
lucid	O
/	O
alert	B
moments	I
.	O

on	O
morning	O
of	O
admission	O
,	O
he	O
was	O
slurring	B
speech	I
,	O
making	B
grammatical	I
errors	I
.	O

he	O
had	O
a	O
ct	O
at	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
(	O
thought	O
to	O
have	O
stable	O
appearance	O
)	O
.	O

his	O
mental	B
status	I
partially	O
improved	O
after	O
administration	O
of	O
narcan	O
.	O

he	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
79	O
*	O
*	O
]	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
25	O
*	O
*	O
]	O
for	O
an	O
icu	O
bed	O
.	O

in	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
25	O
*	O
*	O
]	O
,	O
his	O
mental	B
status	I
continued	O
to	O
improve	O
.	O

he	O
was	O
followed	O
by	O
neurology	O
/	O
neurosurgery	O
.	O

antibiotics	O
were	O
initially	O
administered	O
for	O
?meningitis	O
(	O
lp	O
not	O
performed	O
)	O
,	O
and	O
it	O
was	O
felt	O
that	O
no	O
emergent	O
treatment	O
was	O
needed	O
at	O
this	O
time	O
.	O

upon	O
transfer	O
to	O
the	O
floor	O
,	O
his	O
mental	B
status	I
was	O
improved	O
but	O
still	O
not	O
at	O
baseline	O
;	O
he	O
was	O
still	O
somnolent	B
,	O
drowsy	B
,	O
but	O
with	O
no	O
new	O
weakness	B
,	O
tingling	B
,	O
neurologic	B
deficits	I
.	O

he	O
denies	O
fevers	B
/	O
chills	B
/	O
stiff	B
neck	I
/	O
photophobia	B
/	O
new	O
urinary	O
or	O
bowel	B
symptoms	I
.	O

plan	O
is	O
for	O
transfer	O
to	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
if	O
icu	O
bed	O
is	O
available	O
vs	O
.	O
discharge	O
home	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
thoracic	O
spine	O
ganglioma	B
resected	O
2003	O

2	O
.	O
primitive	B
neuroectodermal	I
tumor	I
with	O
mets	B
to	O
brain	O
and	O
spine	O
,	O
dx	O
[	O
*	O
*	O
03	O
-	O
07	O
*	O
*	O
]	O
,	O
s	O
/	O
p	O
radiation	O
,	O
chemo	O
;	O
currently	O
was	O
on	O
thalidomide	O
;	O
most	O
recently	O
on	O
temozolomide	O
/	O
oral	O
etoposide	O
.	O

social	O
history	O
:	O

lives	O
with	O
parents	O

denies	O
smoking	O
,	O
etoh	O
,	O
drugs	O

family	O
history	O
:	O

nc	O

physical	O
exam	O
:	O

vs	O
:	O
afeb	O
,	O
98	O
/	O
56	O
70	O
18	O

gen	O
:	O
thin	O
male	O
,	O
ill	B
-	I
appearing	I
,	O
lying	O
in	O
bed	O
,	O
very	O
pleasant	O

heent	O
:	O
pupils	O
reactive	O
,	O
right	O
larger	O
than	O
left	O
,	O
op	O
clear	O
,	O
no	O
rashes	B
/	O
sores	B

neck	O
:	O
no	O
lad	B
,	O
no	O
bruits	B
appreciated	O
,	O
no	O
jvd	B

cv	O
:	O
2	O
/	O
6	O
sem	B
llsb	O
,	O
no	O
r	B
/	O
g	B
;	O
with	O
port	O
in	O
left	O
sc	O
;	O
no	O
erythema	B
/	O
tenderness	B

lungs	O
:	O
cta	O
bilaterally	O
,	O
no	O
w	B
/	O
r	B
/	O
r	B

abd	O
:	O
soft	O
,	O
nt	O
/	O
nd	O
,	O
nabs	O
,	O
no	O
masses	B
appreciated	O

extr	O
:	O
no	O
c	B
/	O
c	B
/	O
e	B
,	O
pt	O
1	O
+	O
bilaterally	O

neuro	O
:	O
slight	O
abduction	O
of	O
right	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
82	O
*	O
*	O
]	O
,	O
with	O
some	O
facial	B
asymmetry	I
with	O
droop	O
on	O
right	O
;	O
ue	O
strenght	O
[	O
*	O
*	O
06	O
-	O
05	O
*	O
*	O
]	O
bilaterally	O
and	O
symmetrically	O
,	O
le	O
3	O
/	O
5	O
strength	O
,	O
decreased	B
sensation	I
to	I
light	I
touch	I
in	O
le	O
bilaterally	O
;	O
no	O
pronator	B
drift	I

pertinent	O
results	O
:	O

labs	O
:	O

blood	O
wbc	O
-	O
1	O
.	O
4	O
*	O
rbc	O
-	O
2	O
.	O
33	O
*	O
#	O
hgb	O
-	O
7	O
.	O
7	O
*	O
hct	O
-	O
21	O
.	O
2	O
*	O
mcv	O
-	O
91	O
plt	O
ct	O
-	O
35	O
*	O

anc=850	O
*	O

glucose	O
-	O
248	O
*	O
urean	O
-	O
8	O
creat	O
-	O
0	O
.	O
6	O
na	O
-	O
135	O
k	O
-	O
3	O
.	O
4	O
cl	O
-	O
97	O
hco3	O
-	O
34	O
*	O

angap	O
-	O
7	O
*	O

calcium	O
-	O
8	O
.	O
7	O
phos	O
-	O
2	O
.	O
9	O
mg	O
-	O
1	O
.	O
8	O

mri	O
brain	O
:	O

largest	O
lesion	B
in	O
left	O
frontal	O
lobe	O
abutting	O
frontal	O
[	O
*	O
*	O
doctor	O
last	O
name	O
85	O
*	O
*	O
]	O
,	O
small	O
amount	O
intraventricular	B
blood	I
in	O
horns	O
of	O
lateral	O
ventricls	O
,	O
small	O
lesions	B
in	O
right	O
frontal	O
and	O
left	O
cerebellar	O

brief	O
hospital	O
course	O
:	O

1	O
.	O
delta	B
ms	I
:	O
was	O
likely	O
in	O
setting	O
of	O
oversedation	B
from	O
medications	O
.	O

he	O
was	O
on	O
dilaudid	O
,	O
methadone	O
,	O
and	O
had	O
recently	O
been	O
started	O
on	O
thalidomide	O
(	O
which	O
can	O
cause	O
somnolence	B
)	O
.	O

his	O
mental	B
status	I
improved	O
after	O
narcan	O
,	O
was	O
started	O
empirically	O
on	O
broad	O
spectrum	O
antibiotics	O
for	O
?meningitis	O
;	O
these	O
were	O
stopped	O
,	O
however	O
,	O
as	O
he	O
has	O
no	O
obvious	O
signs	O
of	O
meningitis	B
.	O

lp	O
was	O
deferred	O
given	O
thrombocytopenia	B
.	O

his	O
mental	B
status	I
remained	O
stable	O
(	O
although	O
not	O
at	O
baseline	O
according	O
to	O
family	O
)	O
.	O

all	O
sedating	O
meds	O
continued	O
to	O
be	O
held	O
,	O
and	O
he	O
was	O
discharged	O
just	O
on	O
dilaudid	O
for	O
pain	B
control	O
.	O

he	O
will	O
follow	O
up	O
with	O
his	O
primary	O
oncologist	O
at	O
[	O
*	O
*	O
hospital	O
5753	O
*	O
*	O
]	O
who	O
will	O
arrange	O
for	O
further	O
pain	B
management	O
and	O
treatment	O
.	O

2	O
.	O
neuroectodermal	B
tumor	I
:	O
seen	O
by	O
neuro	O
,	O
neuroonc	O
in	O
-	O
house	O
;	O
no	O
treatment	O
at	O
this	O
time	O
.	O

as	O
per	O
his	O
primary	O
oncologist	O
,	O
will	O
either	O
be	O
transferred	O
back	O
to	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
or	O
home	O
tomorrow	O
.	O

no	O
worsening	O
on	O
mri	O
,	O
no	O
herniation	B
or	O
midline	B
shift	I
.	O

he	O
had	O
visual	B
field	I
cuts	I
that	O
were	O
possibly	O
new	O
,	O
but	O
his	O
neurologic	O
exam	O
remained	O
stable	O
while	O
in	O
-	O
house	O
.	O

decadron	O
was	O
continued	O
for	O
possible	O
cerebral	B
edema	I
.	O

his	O
oncologist	O
at	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
(	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
)	O
will	O
follow	O
up	O
with	O
him	O
after	O
discharge	O
for	O
further	O
management	O
.	O

he	O
will	O
have	O
also	O
have	O
ophthalmology	O
follow	O
up	O
for	O
formal	O
visual	O
field	O
testing	O
and	O
management	O
.	O

3	O
.	O
pancytopenia	B
:	O
likely	O
related	B
to	I
chemotherapy	I
,	O
received	O
1	O
u	O
prbc	O
in	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
25	O
*	O
*	O
]	O
,	O
no	O
signs	O
of	O
active	O
bleeding	B
.	O

his	O
anc	O
was	O
540	O
at	O
time	O
of	O
discharge	O
,	O
and	O
platelets	O
/	O
hematocrit	O
were	O
stably	O
low	O
.	O

he	O
was	O
kept	O
on	O
neutropenic	B
precautions	O
while	O
in	O
-	O
house	O
.	O

4	O
.	O
pain	B
:	O
dilaudid	O
as	O
needed	O
for	O
pain	B
,	O
and	O
he	O
was	O
discharged	O
on	O
this	O
medication	O
.	O

he	O
will	O
follow	O
up	O
in	O
the	O
pain	B
clinic	O
at	O
[	O
*	O
*	O
hospital	O
267	O
*	O
*	O
]	O
so	O
that	O
a	O
better	O
pain	B
regimen	O
can	O
be	O
determined	O
(	O
and	O
oversedation	B
can	O
be	O
avoided	O
)	O
.	O

5	O
.	O
constipation	B
:	O
his	O
aggressive	O
outpatient	O
bowel	O
regimen	O
was	O
continued	O
.	O

6	O
.	O
bladder	O
function	O
:	O
detrol	O
was	O
continued	O
in	O
-	O
house	O
.	O

7	O
.	O
dispo	O
:	O
he	O
was	O
discharged	O
to	O
home	O
,	O
to	O
continue	O
on	O
dilaudid	O
for	O
pain	B
control	O
.	O

he	O
will	O
follow	O
up	O
in	O
2	O
days	O
at	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
for	O
further	O
management	O
.	O

medications	O
on	O
admission	O
:	O

methadone	O
10	O
mg	O
daily	O

dilaudid	O
4	O
mg	O
prn	O

xanaflex	O
4	O
mg	O

decadron	O
2	O
mg	O
tid	O

amitryptilline	O
25	O
-	O
50	O
mg	O
qhs	O

protonix	O
40	O
mg	O
daily	O

detrol	O
1	O
mg	O
bid	O

senna	O

zofran	O

thalidomide	O
50	O
mg	O
qhs	O

fiber	O
laxative	O

all	O
:	O
nkda	O

discharge	O
medications	O
:	O

1	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

2	O
.	O
bisacodyl	O
5	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
as	O
needed	O
.	O

3	O
.	O
pantoprazole	O
sodium	O
40	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
q24h	O
(	O
every	O
24	O
hours	O
)	O
.	O

4	O
.	O
senna	O
8	O
.	O
6	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

5	O
.	O
dexamethasone	O
2	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

6	O
.	O
hydromorphone	O
hcl	O
2	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
every	O
[	O
*	O
*	O
05	O
-	O
07	O
*	O
*	O
]	O
hours	O
as	O
needed	O
for	O
4	O
days	O
:	O
please	O
do	O
not	O
take	O
if	O
somnolent	B
or	O
oversedated	B
.	O

disp	O
:	O
*	O
32	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

7	O
.	O
polyethylene	O
glycol	O
3350	O
17	O
g	O
(	O
100%	O
)	O
packet	O
sig	O
:	O
one	O
(	O
1	O
)	O
packet	O
po	O
qhs	O
(	O
)	O
as	O
needed	O
for	O
constipation	B
.	O

8	O
.	O
tolterodine	O
tartrate	O
1	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

primary	O
diagnoses	O
:	O

1	O
.	O
primitive	B
neuroectodermal	I
tumor	I

2	O
.	O
somnolence	B
/	O
oversedation	B

discharge	O
condition	O
:	O

stable	O

discharge	O
instructions	O
:	O

1	O
.	O
please	O
take	O
all	O
your	O
medications	O
exactly	O
as	O
described	O
in	O
this	O
discharge	O
paperwork	O
.	O

2	O
.	O
please	O
follow	O
up	O
with	O
your	O
neuro	O
-	O
oncologist	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
,	O
as	O
described	O
below	O
.	O

3	O
.	O
please	O
call	O
your	O
doctor	O
if	O
you	O
are	O
experiencing	O
fever	B
,	O
chills	B
,	O
chest	B
pain	I
,	O
shortness	B
of	I
breath	I
,	O
increased	O
weakness	B
,	O
or	O
with	O
any	O
other	O
concerns	O
.	O

followup	O
instructions	O
:	O

1	O
.	O
please	O
follow	O
up	O
on	O
monday	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
at	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
.	O

she	O
will	O
arrange	O
for	O
you	O
to	O
follow	O
up	O
in	O
the	O
pain	B
clinic	O
at	O
[	O
*	O
*	O
hospital	O
267	O
*	O
*	O
]	O
.	O

she	O
will	O
also	O
arrange	O
for	O
you	O
to	O
follow	O
up	O
in	O
the	O
ophthalmology	O
clinic	O
for	O
evaluation	O
and	O
formal	O
visual	O
field	O
testing	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
39	O
*	O
*	O
]	O
md	O
,	O
phd	O
12	O
-	O
944	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
1044	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
1045	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1046	O
*	O
*	O
]	O
[	O
*	O
*	O
2014	O
-	O
04	O
-	O
14	O
*	O
*	O
]	O
@	O
0903	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
43	O
*	O
*	O
]	O
yang	O
on	O
:	O
mon	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
07	O
*	O
*	O
]	O
8	O
:	O
28	O
pm	O

(	O
end	O
of	O
report	O
)	O

109059	O
||||	O
12627	O
||||	O
23718	O
||||	O
echo	O
_	O
report	O
||||	O
2019	O
-	O
07	O
-	O
16	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
left	B
ventricular	I
function	I
.	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
147	O
/	O
81	O

hr	O
(	O
bpm	O
)	O
:	O
62	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2019	O
-	O
07	O
-	O
16	O
*	O
*	O
]	O
at	O
15	O
:	O
47	O

test	O
:	O
tte	O
(	O
focused	O
views	O
)	O

doppler	O
:	O
limited	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
ventricle	O
:	O
mild	O
symmetric	O
lvh	B
.	O

normal	O
lv	O
cavity	O
size	O
.	O

overall	O
normal	O
lvef	O
(	O
>55%	O
)	O
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aortic	O
valve	O
:	O
mildly	O
thickened	B
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

no	O
mvp	B
.	O

mild	O
mitral	B
annular	I
calcification	I
.	O

mild	O
thickening	B
of	O
mitral	O
valve	O
chordae	O
.	O

calcified	B
tips	I
of	O
papillary	O
muscles	O
.	O

no	O
ms	B
.	O

mild	O
(	O
1	O
+	O
)	O
mr	B
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
.	O

normal	O
tricuspid	O
valve	O
supporting	O
structures	O
.	O

mild	O
to	O
moderate	O
[	O
[	O
*	O
*	O
02	O
-	O
11	O
*	O
*	O
]	O
+	O
]	O
tr	B
.	O

normal	O
pa	O
systolic	O
pressure	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
normal	O
pulmonic	O
valve	O
leaflets	O
with	O
physiologic	O
pr	B
.	O

normal	O
main	O
pa	O
.	O

no	O
doppler	O
evidence	O
for	O
pda	B

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef	O
70%	O
)	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
but	O
aortic	B
stenosis	I
is	O
not	O
present	O
.	O

no	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
no	O
mitral	B
valve	I
prolapse	I
.	O

mild	O
(	O
1	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
normal	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

compared	O
with	O
the	O
findings	O
of	O
the	O
prior	O
study	O
(	O
images	O
reviewed	O
)	O
of	O
[	O
*	O
*	O
47	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
,	O
no	O
major	O
change	O
is	O
evident	O
.	O

101915	O
||||	O
13990	O
||||	O
25542	O
||||	O
echo	O
_	O
report	O
||||	O
2019	O
-	O
12	O
-	O
12	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
left	B
ventricular	I
function	I
.	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
117	O
/	O
67	O

hr	O
(	O
bpm	O
)	O
:	O
72	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2019	O
-	O
12	O
-	O
12	O
*	O
*	O
]	O
at	O
09	O
:	O
50	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
elongated	B
la	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
moderately	O
dilated	B
ra	I
.	O

left	O
ventricle	O
:	O
mild	O
symmetric	O
lvh	B
.	O

normal	O
lv	O
cavity	O
size	O
.	O

mild	O
global	O
lv	O
hypokinesis	B
.	O

no	O
resting	B
lvot	I
gradient	I
.	O

right	O
ventricle	O
:	O
dilated	B
rv	I
cavity	O
.	O

borderline	O
normal	B
rv	I
systolic	I
function	I
.	O

[	O
intrinsic	O
rv	B
systolic	I
function	I
likely	O
more	O
depressed	O
given	O
the	O
severity	O
of	O
tr	B
]	O
.	O

abnormal	B
septal	I
motion	I
/	O
position	O
consistent	O
with	O
rv	O
pressure	O
/	O
volume	O
overload	O
.	O

aorta	O
:	O
normal	O
aortic	O
root	O
diameter	O
.	O

normal	O
ascending	O
aorta	O
diameter	O
.	O

mildly	O
dilated	B
aortic	O
arch	O
.	O

aortic	O
valve	O
:	O
mildly	O
thickened	B
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

mild	O
(	O
1	O
+	O
)	O
ar	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

mild	O
(	O
1	O
+	O
)	O
mr	B
.	O

lv	O
inflow	O
pattern	O
c	O
/	O
w	O
impaired	B
relaxation	I
.	O

tricuspid	O
valve	O
:	O
mildly	O
thickened	O
tricuspid	O
valve	O
leaflets	O
.	O

moderate	O
[	O
2	O
+	O
]	O
tr	B
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
significant	O
pr	B
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
elongated	B
.	O

the	O
right	O
atrium	O
is	O
moderately	O
dilated	O
.	O

there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

there	O
is	O
mild	O
global	O
left	O
ventricular	O
hypokinesis	B
.	O

the	O
right	O
ventricular	O
cavity	O
is	O
dilated	O
.	O

right	O
ventricular	O
systolic	O
function	O
is	O
borderline	O
normal	O
.	O

[	O
intrinsic	O
right	B
ventricular	I
systolic	I
function	I
is	O
likely	O
more	O
depressed	O
given	O
the	O
severity	O
of	O
tricuspid	B
regurgitation	I
.	O
]	O

there	O
is	O
abnormal	B
septal	I
motion	I
/	O
position	O
consistent	O
with	O
right	O
ventricular	O
pressure	O
/	O
volume	O
overload	O
.	O

the	O
aortic	O
arch	O
is	O
mildly	O
dilated	B
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

there	O
is	O
no	O
aortic	B
valve	I
stenosis	I
.	O

mild	O
(	O
1	O
+	O
)	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

mild	O
(	O
1	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
left	O
ventricular	O
inflow	O
pattern	O
suggests	O
impaired	B
relaxation	I
.	O

the	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

moderate	O
[	O
2	O
+	O
]	O
tricuspid	B
regurgitation	I
is	O
seen	O
.	O

significant	O
pulmonic	B
regurgitation	I
is	O
seen	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

22846	O
||||	O
14285	O
||||	O
972	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
12	O
-	O
09	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
12	O
-	O
09	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1970	O
-	O
07	O
-	O
29	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
6368	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

respiratory	B
depression	I
and	O
cyanosis	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

endotracheal	O
tube	O

og	O
tube	O
placement	O

history	O
of	O
present	O
illness	O
:	O

42	O
yo	O
male	O
found	B
down	I
unresponsive	I
and	O
cyanotic	B
by	O
ems	O
.	O

someone	O
called	O
ems	O
however	O
no	O
other	O
person	O
on	O
site	O
when	O
ems	O
arrived	O
.	O

pt	O
was	O
unresponsive	B
with	O
rr4	O
.	O

rr	O
increased	O
to	O
10	O
with	O
1mg	O
of	O
narcan	O
x2	O
.	O

at	O
that	O
point	O
,	O
pt	O
withdraw	B
from	I
pain	I
and	O
had	O
slightly	O
opened	B
eyes	I
with	O
pin	B
point	I
pupils	I
.	O

he	O
received	O
an	O
additional	O
1	O
mg	O
of	O
narcan	O
intra	O
-	O
nasally	O
.	O

upon	O
arrival	O
at	O
[	O
*	O
*	O
hospital1	O
189	O
*	O
*	O
]	O
,	O
rr=20	O
,	O
hr120's	O
,	O
bp	O
170's	O
/	O
100	O
.	O

95%	O
on	O
nrb	O
but	O
still	O
unresponsive	B
.	O

he	O
then	O
received	O
an	O
additional	O
1mg	O
of	O
narcan	O
,	O
pupils	O
became	O
reactive	O
to	O
light	O
.	O

he	O
vomited	B
and	O
required	O
intubation	O
for	O
airway	O
protection	O
.	O

as	O
per	O
ems	O
report	O
,	O
the	O
police	O
found	O
a	O
brown	O
substance	O
on	O
the	O
patient	O
that	O
may	O
have	O
represented	O
heroine	O
and	O
smell	O
of	O
alcohol	O
.	O

per	O
pt	O
wife	O
,	O
he	O
was	O
last	O
seen	O
by	O
her	O
at	O
7pm	O
last	O
night	O
,	O
pt	O
recently	O
was	O
d	O
/	O
cd	O
of	O
all	O
his	O
pain	B
meds	O
and	O
had	O
an	O
argument	O
with	O
her	O
yesterday	O
due	O
to	O
pain	B
issue	O
.	O

in	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
,	O
urine	O
tox	O
screen	O
positive	O
for	O
benzos	O
,	O
cocaine	O
and	O
opiates	O
.	O

serum	O
tox	O
pos	O
for	O
benzos	O
,	O
neg	O
for	O
etoh	O
,	O
asa	O
,	O

acetominophen	O
,	O
barb	O
.	O

pt	O
has	O
increased	B
cr	I
to	O
1	O
.	O
5	O
,	O
hyperglycemia	B
to	O
163	O
,	O
hyperkalemia	B
6	O
.	O
2	O
and	O
thrombocytosis	B
(	O
wbc	O
20	O
.	O
1	O
)	O
.	O

cxr	O
showing	O
opacity	B
of	O
bil	O
upper	O
lobes	O
?aspiration	O
,	O
also	O
w	O
apparent	O
mediastinal	O
upper	O
widening	O
and	O
this	O
is	O
likely	O
due	O
to	O
the	O
patient's	O
positioning	O
and	O
technique	O
.	O

head	O
ct	O
pending	O
.	O

no	O
agap	O
.	O

abg	O
:	O
7	O
.	O
35	O
/	O
42	O
/	O
356	O
/	O
24	O
/	O
-	O
2	O
,	O
toxicology	O
consulted	O
.	O

past	O
medical	O
history	O
:	O

pmh	O
:	O
htn	B
,	O
dm	B
,	O
hepc	B
dx	O
in	O
[	O
*	O
*	O
2004	O
*	O
*	O
]	O
,	O
depression	B
,	O
ivda	B
x	O
5	O
yrs	O
1980's	O
,	O
back	B
injury	I
with	O
chronic	B
pain	I
meds	O
use	O
,	O
recently	O
d	O
/	O
cd	O
all	O
pain	B
meds	O
.	O

asthma	B
,	O
bronchitis	B
,	O
osa	B
(	O
use	O
a	O
machine	O
when	O
sleep	O
at	O
home	O
)	O
,	O
?cad	O
.	O

social	O
history	O
:	O

shx	O
:	O
married	O
with	O
2	O
kids	O
,	O
lives	O
with	O
his	O
wife	O
.	O
[	O
*	O
*	O
name	O
(	O
ni	O
)	O
*	O
*	O
]	O
worker	O
out	O
of	O
hob	O
for	O
2	O
yrs	O
,	O
chronic	O
back	B
injury	I
from	O
work	O
.	O
hx	O
of	O
ivda	B
(	O
[	O
*	O
*	O
1990	O
-	O
08	O
-	O
16	O
*	O
*	O
]	O
)	O
,	O
marijuana	O
,	O
cocaine	O
(	O
1979	O
-	O
87	O
)	O
,	O
etoh	O
(	O
clean	O
from	O
etoh	O
for	O
2	O
yrs	O
;	O
3	O
detoxes	O
since	O
[	O
*	O
*	O
1995	O
*	O
*	O
]	O
)	O
.	O

family	O
history	O
:	O

non	O
contributory	O

physical	O
exam	O
:	O

temp	O
101	O
8	O
rectal	O
in	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O

bp	O
127	O
/	O
87	O

pulse	O
91	O
reg	O
.	O

resp	O
on	O
ac	O
,	O
100%	O
fio2	O
,	O
peep	O
5	O
:	O
100%	O
sat	O

gen	O
-	O
intubated	O
sedated	O
,	O
non	B
-	I
responsive	I

heent	O
-	O
perrl	O

neck	O
-	O
thick	B
neck	I

chest	O
-	O
bronchial	B
bs	I
anterirorly	O
with	O
coarse	B
sounds	I

cv	O
-	O
distant	O
,	O
normal	O
s1	O
/	O
s2	O
,	O
rrr	O
,	O
no	O
murmurs	B
,	O
rubs	B
,	O
or	O
gallops	B
abd	O
-	O
soft	O
,	O
distended	O
/	O
obese	O
,	O
with	O
normoactive	O
bowel	O
sounds	O
extr	O
-	O
no	O
clubbing	B
,	O
cyanosis	B
,	O
or	O
edema	B
.	O

2	O
+	O
dp	O
pulses	O
bilaterally	O
neuro	O
-	O
sedated	O
on	O
propofol	O
,	O
no	O
limb	B
movements	I
,	O
equivocal	O

bainksi	O
,	O
no	O
dtrs	B

skin	O
-	O
freckles	B
,	O
left	O
shin	O
psoriatic	B
lesion	O

pertinent	O
results	O
:	O

head	O
ct	O
:	O
no	O
bleed	B
or	O
evidence	O
of	O
mass	B

cxr	O
:	O
ett	O
tube	O
in	O
place	O
,	O
bilateral	O
upper	O
lobe	O
opacities	B

ekg	O
:	O
sinus	B
tachy	I
about	O
110	O
bpm	O
,	O
nl	O
axis	O
,	O
nl	O
intervals	O
,	O
peaked	O
ts	O
in	O
v3	O
-	O
v6	O
.	O

pt	O
received	O
insulin	O
10u	O
,	O
d50	O
and	O
nahco3	O
,	O
also	O
received	O
charcoal	O
50g	O
via	O
og	O
tube	O
.	O

brief	O
hospital	O
course	O
:	O

1	O
.	O
mental	B
status	I
:	O
hypoperfusion	B
vs	O
.	O
drugs	B
vs	O
seizure	B
.	O

head	O
ct	O
was	O
negative	O
for	O
bleed	B
or	O
mass	B
.	O

neuro	B
status	I
improved	O
with	O
improved	O
resp	B
failure	I
.	O

2	O
.	O
respiratory	B
status	I
:	O
dec	B
resp	I
.	I
drive	I
secondary	O
to	O
rep	B
depression	I
from	O
cocaine	O
.	O

intubated	O
in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
and	O
place	O
on	O
ac	O
.	O

over	O
the	O
next	O
24	O
hours	O
,	O
he	O
was	O
weaned	O
to	O
40%	O
fio2	O
and	O
ps	O
.	O

he	O
was	O
extubated	O
24	O
hours	O
after	O
admission	O
and	O
eventually	O
able	O
to	O
tolerated	O
good	O
sats	O
on	O
ra	O
.	O

pt	O
remained	O
afebril	B
after	O
admission	O
and	O
did	O
not	O
need	O
any	O
treatment	O
for	O
quesiton	O
of	O
aspiration	B
during	O
intubation	O
.	O

3	O
.	O
hyper	B
k	I
:	O
due	O
to	O
succinylcholine	O
used	O
in	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
.	O

transiently	O
elevated	O
with	O
no	O
ekg	B
changes	I
,	O
resolved	O
in	O
24	O
hours	O
without	O
intervention	O
.	O

4	O
.	O
elevated	B
ck	I
:	O
elevated	B
ck	I
on	O
admission	O
with	O
negative	O
cardiac	B
enzyme	I
fractions	I
.	O

trended	O
down	O
during	O
stay	O
.	O

5	O
.	O
htn	B
:	O
stable	O
,	O
on	O
labetaolol	O
since	O
this	O
is	O
better	O
in	O
cocaine	B
o	I
/	I
d	I
patients	O
.	O

d	O
/	O
c	O
on	O
metorprolol	O
with	O
f	O
/	O
u	O
with	O
pcp	O
.	O

6	O
.	O
elevated	B
lfts	I
:	O
question	O
of	O
shock	B
liver	I
vs	O
.	O
toxic	B
metabolic	I
injury	I
.	O

also	O
chronic	B
hep	I
c	I
.	O

trending	O
down	O
.	O

will	O
give	O
pt	O
follow	O
up	O
for	O
liver	O
clinic	O
.	O

7	O
.	O
elevated	B
cr	I
:	O
prerenal	B
resolved	O
with	O
fluids	O

8	O
.	O
polysubstance	B
abuse	I
:	O
ogt	O
placed	O
for	O
ng	O
charcol	O
lavage	O
.	O

pt	O
recovered	O
from	O
overdose	B
.	O

he	O
wil	O
reconnect	O
with	O
sponser	O
for	O
aa	O
/	O
na	O
.	O

since	O
he	O
is	O
from	O
nh	O
,	O
it	O
is	O
difficult	O
for	O
him	O
to	O
use	O
any	O
resources	O
from	O
here	O
in	O
ma	O
.	O

comm	O
:	O
was	O
with	O
wife	O

[	O
*	O
*	O
name	O
(	O
ni	O
)	O
1752	O
*	O
*	O
]	O
:	O
full	O

pt	O
was	O
d	O
/	O
c'd	O
home	O
with	O
one	O
day	O
vicodin	O
script	O
to	O
f	O
/	O
u	O
with	O
pcp	O
.	O

medications	O
on	O
admission	O
:	O

wellbutrin	O
300	O
mg	O
sr	O

discharge	O
medications	O
:	O

1	O
.	O
metoprolol	O
tartrate	O
50	O
mg	O
tablet	O
sig	O
:	O
0	O
.	O
5	O
tablet	O
po	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
45	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
hydrocodone	O
-	O
acetaminophen	O
5	O
-	O
500	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
:	O
dispense	O
10	O
tablets	O
.	O

disp	O
:	O
*	O
10	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

1	O
.	O
polysubstance	B
abuse	I

2	O
.	O
hypertension	B

discharge	O
condition	O
:	O

stable	O
.	O

discharge	O
instructions	O
:	O

if	O
you	O
have	O
chest	B
pain	I
,	O
shortness	B
of	I
breath	I
,	O
nausea	B
or	O
vomiting	B
,	O
please	O
call	O
your	O
pcp	O
or	O
come	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
.	O

followup	O
instructions	O
:	O

provider	O
:	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
name11	O
(	O
nameis	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
*	O
*	O
]	O
call	O
to	O
schedule	O
appointment	O
for	O
the	O
next	O
two	O
days	O
.	O

call	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
at	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1370	O
*	O
*	O
]	O

[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
6373	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
6374	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
name6	O
(	O
md	O
)	O
6649	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
6650	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
6651	O
*	O
*	O
]	O
[	O
*	O
*	O
2012	O
-	O
12	O
-	O
09	O
*	O
*	O
]	O
@	O
1311	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2013	O
-	O
01	O
-	O
15	O
*	O
*	O
]	O
2	O
:	O
51	O
pm	O

(	O
end	O
of	O
report	O
)	O

16750	O
||||	O
15021	O
||||	O
15806	O
||||	O
discharge	O
_	O
summary	O
||||	O
2011	O
-	O
05	O
-	O
26	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
19	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1937	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
a	O
73	O
-	O
year	O
-	O
old	O
female	O
who	O
has	O
been	O
experiencing	O
exertional	B
chest	I
discomfort	I
since	O
last	O
fall	O
.	O

she	O
has	O
chest	B
discomfort	I
after	O
climbing	O
one	O
flight	O
of	O
stairs	O
or	O
walking	O
up	O
an	O
incline	O
.	O

she	O
denies	O
any	O
rest	B
symptoms	I
.	O

she	O
deferred	O
medical	O
treatment	O
until	O
january	O
because	O
her	O
husband	O
was	O
terminally	B
ill	I
and	O
passed	O
away	O
this	O

fall	O
.	O

she	O
went	O
to	O
her	O
primary	O
care	O
physician	O
in	O
[	O
*	O
*	O
name9	O
(	O
pre	O
)	O
3181	O
*	O
*	O
]	O
and	O
was	O
sent	O
for	O
a	O
routine	O
stress	O
test	O
which	O
revealed	O
1	O
-	O
mm	O
to	O
1	O
.	O
5	O
-	O
mm	O
st	B
depressions	I
in	O
the	O
inferior	O
and	O
anterolateral	O
leads	O
at	O
peak	O
exercise	O
.	O

she	O
was	O
subsequently	O
referred	O
for	O
a	O
stress	O
echocardiogram	O
and	O
had	O
3	O
-	O
mm	O
st	B
depressions	I
in	O
leads	O
ii	O
,	O
iii	O
,	O
avf	O
,	O
and	O
in	O
v4	O
,	O
v5	O
,	O
and	O
v6	O
;	O
that	O
normalized	O
by	O
10	O
minutes	O
of	O
recovery	O
.	O

the	O
pre	O
-	O
stress	O
echocardiogram	O
showed	O
basilar	O
inferior	O
hypokinesis	B
and	O
an	O
ejection	O
fraction	O
of	O
60%	O
.	O

the	O
post	O
stress	O
echocardiogram	O
showed	O
appropriate	O
augmentation	O
with	O
a	O
question	O
of	O
inferobasilar	O
hypokinesis	B
.	O

she	O
underwent	O
cardiac	O
catheterization	O
at	O
[	O
*	O
*	O
hospital	O
22	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
11	O
*	O
*	O
]	O
which	O
revealed	O
severe	O
aortic	B
stenosis	I
.	O

no	O
mitral	B
regurgitation	I
.	O

an	O
ejection	O
fraction	O
of	O
66%	O
.	O

clean	O
coronary	O
arteries	O
except	O
for	O
less	O
than	O
20%	O
ostial	O
left	O
main	O
stenosis	O
.	O

past	O
medical	O
history	O
:	O
(	O
her	O
past	O
medical	O
history	O
is	O
significant	O
for	O
)	O

1	O
.	O
history	O
of	O
hypertension	B
.	O

2	O
.	O
history	O
of	O
hyperlipidemia	B
.	O

3	O
.	O
history	O
of	O
osteoporosis	B
.	O

4	O
.	O
history	O
of	O
basal	B
cell	I
carcinoma	I
of	I
the	I
face	I
.	O

5	O
.	O
status	O
post	O
left	O
oophorectomy	O
.	O

medications	O
on	O
admission	O
:	O
(	O
her	O
medications	O
on	O
admission	O
were	O
)	O

1	O
.	O
fosamax	O
70	O
mg	O
p	O
.	O
o	O
.	O
ever	O
week	O
.	O

2	O
.	O
evista	O
60	O
mg	O
p	O
.	O
o	O
.	O
once	O
per	O
day	O
.	O

3	O
.	O
cholestyramine	O
two	O
scoops	O
once	O
per	O
day	O
.	O

4	O
.	O
gemfibrozil	O
600	O
mg	O
p	O
.	O
o	O
.	O
twice	O
per	O
day	O
.	O

5	O
.	O
spironolactone	O
25	O
mg	O
p	O
.	O
o	O
.	O
once	O
per	O
day	O
.	O

6	O
.	O
aspirin	O
81	O
mg	O
p	O
.	O
o	O
.	O
once	O
per	O
day	O
.	O

allergies	O
:	O
she	O
has	O
no	O
known	O
drug	O
allergies	O
.	O

social	O
history	O
:	O
her	O
social	O
history	O
is	O
significant	O
in	O
that	O
she	O
does	O
not	O
smoke	O
cigarettes	O
.	O

family	O
history	O
:	O
family	O
history	O
is	O
significant	O
for	O
cerebrovascular	B
accident	I
.	O

physical	O
examination	O
on	O
presentation	O
:	O
on	O
physical	O
examination	O
,	O
she	O
was	O
a	O
well	O
-	O
developed	O
elderly	O
white	O
female	O
in	O
no	O
apparent	B
distress	I
.	O

vital	O
signs	O
were	O
stable	O
.	O

the	O
patient	O
was	O
afebrile	B
.	O

head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
and	O
throat	O
examination	O
revealed	O
normocephalic	O
and	O
atraumatic	O
.	O

extraocular	O
movements	O
were	O
intact	O
.	O

the	O
oropharynx	O
was	O
benign	O
.	O

the	O
neck	O
was	O
supple	O
with	O
full	O
range	O
of	O
motion	O
.	O

no	O
lymphadenopathy	B
or	O
thyromegaly	B
.	O

carotids	O
were	O
2	O
+	O
and	O
equal	O
bilaterally	O
and	O
without	O
bruits	B
.	O

the	O
lungs	O
were	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

cardiovascular	O
examination	O
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
.	O

normal	O
first	O
heart	O
sounds	O
and	O
second	O
heart	O
sounds	O
.	O

a	O
[	O
*	O
*	O
03	O
-	O
31	O
*	O
*	O
]	O
murmur	B
was	O
heard	O
best	O
at	O
the	O
second	O
intercostal	O
space	O
,	O
left	O
sternal	O
border	O
,	O
and	O
right	O
sternal	O
border	O
.	O

she	O
had	O
no	O
rubs	B
.	O

her	O
murmur	B
radiated	I
to	O
both	O
carotids	O
.	O

her	O
abdomen	O
was	O
soft	O
and	O
nontender	O
with	O
positive	O
bowel	O
sounds	O
.	O

no	O
masses	B
or	O
hepatosplenomegaly	B
.	O

extremity	O
examination	O
revealed	O
no	O
clubbing	B
,	O
cyanosis	B
,	O
or	O
edema	B
.	O

pulses	O
were	O
2	O
+	O
and	O
equal	O
bilaterally	O
throughout	O
except	O
for	O
the	O
posterior	O
tibialis	O
which	O
was	O
1	O
+	O
and	O
equal	O
bilaterally	O
.	O

neurologic	O
examination	O
was	O
nonfocal	O
.	O

hospital	O
course	O
:	O
on	O
[	O
*	O
*	O
05	O
-	O
19	O
*	O
*	O
]	O
,	O
the	O
patient	O
underwent	O
an	O
aortic	O
valve	O
replacement	O
with	O
a	O
21	O
-	O
mm	O
mosaic	O
porcine	O
valve	O
.	O

cross	O
-	O
clamp	O
times	O
65	O
minutes	O
.	O

total	O
bypass	O
times	O
was	O
91	O
minutes	O
.	O

she	O
tolerated	O
the	O
procedure	O
well	O
and	O
was	O
transferred	O
to	O
the	O

cardiothoracic	O
surgery	O
recovery	O
unit	O
in	O
stable	O
condition	O
.	O

she	O
was	O
extubated	O
postoperative	O
night	O
and	O
was	O
on	O
some	O

neo	O
-	O
synephrine	O
on	O
postoperative	O
day	O
one	O
.	O

on	O
postoperative	O
day	O
two	O
,	O
she	O
was	O
off	O
her	O
drips	O
.	O

on	O
postoperative	O
day	O
three	O
,	O
she	O
was	O
transferred	O
to	O
the	O
floor	O
in	O
stable	O
condition	O
.	O

her	O
wires	O
were	O
discontinued	O
.	O

her	O
chest	O
tube	O
were	O
discontinued	O
on	O
postoperative	O
day	O
two	O
.	O

she	O
continued	O
to	O
progress	O
.	O

she	O
did	O
go	O
into	O
postoperative	O
atrial	B
fibrillation	I
and	O
was	O
treated	O
with	O
lopressor	O
,	O
and	O
she	O
converted	O
to	O
a	O
sinus	B
rhythm	I
but	O
did	O
have	O
intermittent	O
runs	O
atrial	B
fibrillation	I
and	O
was	O
anticoagulated	O
.	O

discharge	O
status	O
:	O
on	O
postoperative	O
day	O
seven	O
,	O
she	O
was	O
discharged	O
to	O
home	O
.	O

condition	O
at	O
discharge	O
:	O
condition	O
on	O
discharge	O
was	O
stable	O
.	O

medications	O
on	O
discharge	O
:	O

1	O
.	O
colace	O
100	O
mg	O
p	O
.	O
o	O
.	O
twice	O
per	O
day	O
.	O

2	O
.	O
percocet	O
one	O
to	O
two	O
tablets	O
p	O
.	O
o	O
.	O
q	O
.	O
4	O
-	O
6h	O
.	O
as	O
needed	O
(	O
for	O
pain	B
)	O
.	O

3	O
.	O
potassium	O
20	O
meq	O
p	O
.	O
o	O
.	O
twice	O
per	O
day	O
(	O
times	O
seven	O
days	O
)	O
.	O

4	O
.	O
lasix	O
20	O
mg	O
p	O
.	O
o	O
.	O
twice	O
per	O
day	O
(	O
times	O
seven	O
days	O
)	O
.	O

5	O
.	O
aspirin	O
81	O
mg	O
p	O
.	O
o	O
.	O
once	O
per	O
day	O
.	O

6	O
.	O
lopressor	O
75	O
mg	O
p	O
.	O
o	O
.	O
twice	O
per	O
day	O
.	O

7	O
.	O
coumadin	O
1	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
h	O
.	O
s	O
.	O

8	O
.	O
evista	O
60	O
mg	O
p	O
.	O
o	O
.	O
once	O
per	O
day	O
.	O

9	O
.	O
fosamax	O
70	O
mg	O
p	O
.	O
o	O
.	O
every	O
week	O
.	O

10	O
.	O

gemfibrozil	O
600	O
mg	O
p	O
.	O
o	O
.	O
twice	O
per	O
day	O
.	O

11	O
.	O

cholestyramine	O
two	O
scoops	O
once	O
per	O
day	O
.	O

pertinent	O
laboratory	O
data	O
on	O
discharge	O
:	O
her	O
laboratories	O
on	O
discharge	O
revealed	O
hematocrit	O
was	O
30	O
.	O
6	O
,	O
white	O
blood	O
cell	O
count	O
was	O
9	O
,	O
400	O
,	O
and	O
platelets	O
were	O
500	O
,	O
000	O
.	O

sodium	O
was	O
131	O
,	O
potassium	O
was	O
4	O
.	O
1	O
,	O
chloride	O
was	O
103	O
,	O
bicarbonate	O
was	O
25	O
,	O
blood	O
urea	O
nitrogen	O
was	O
9	O
,	O
creatinine	O
was	O
0	O
.	O
7	O
,	O
and	O
blood	O
glucose	O
was	O
87	O
.	O

prothrombin	O
time	O
was	O
16	O
.	O
8	O
with	O
an	O
inr	O
of	O

1	O
.	O
9	O
.	O

discharge	O
instructions	O
/	O
followup	O
:	O

1	O
.	O
she	O
was	O
to	O
be	O
followed	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3182	O
*	O
*	O
]	O
for	O
an	O
appointment	O
in	O
one	O
to	O
two	O
weeks	O
and	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
339	O
*	O
*	O
]	O
for	O
an	O
appointment	O
in	O
six	O
weeks	O
.	O

2	O
.	O
she	O
was	O
to	O
have	O
her	O
coagulations	O
drawn	O
and	O
called	O
in	O
to	O

dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3183	O
*	O
*	O
]	O
office	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
340	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1046	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
14	O
:	O
59	O

t	O
:	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
17	O
:	O
21	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
3184	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
32	O
*	O
*	O
]	O
[	O
*	O
*	O
2011	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O
12	O
:	O
44	O
pm	O
(	O
end	O
of	O
report	O
)	O

12950	O
||||	O
15230	O
||||	O
19482	O
||||	O
discharge	O
_	O
summary	O
||||	O
2014	O
-	O
10	O
-	O
29	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
18	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1959	O
-	O
04	O
-	O
25	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
ccu	O

addendum	O
:	O

this	O
is	O
an	O
addendum	O
to	O
the	O
previously	O
described	O
interim	O
discharge	O
summary	O
.	O

please	O
see	O
admission	O
history	O
,	O
physical	O
and	O
hospital	O
course	O
through	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
13	O
*	O
*	O
]	O
accordingly	O
.	O

hospital	O
course	O
continued	O
:	O

1	O
.	O
cardiovascular	O
:	O
as	O
of	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
13	O
*	O
*	O
]	O
blood	O
pressures	O
continued	O
to	O
remain	O
labile	O
.	O

metoprolol	O
150	O
mg	O
t	O
.	O
i	O
.	O
d	O
.	O
,	O

diltiazem	O
90	O
mg	O
q	O
.	O
i	O
.	O
d	O
.	O
,	O
hydralazine	O
100	O
mg	O
q	O
.	O
i	O
.	O
d	O
.	O
and	O

clonidine	O
0	O
.	O
2	O
mg	O
t	O
.	O
i	O
.	O
d	O
.	O
and	O
labetalol	O
drip	O
.	O

on	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
14	O
*	O
*	O
]	O
,	O
the	O
patient	O
was	O
weaned	O
off	O
the	O
labetalol	O
drip	O
and	O

clonidine	O
dosing	O
was	O
gradually	O
increased	O
to	O
maximum	O
dose	O
of	O

0	O
.	O
8	O
mg	O
t	O
.	O
i	O
.	O
d	O
.	O

the	O
patient	O
was	O
also	O
started	O
on	O

hydrochlorothiazide	O
50	O
mg	O
q	O
.	O
d	O
.	O
with	O
little	O
improvement	O
of	O
blood	O
pressure	O
control	O
.	O

with	O
improvement	O
of	O
renal	B
function	I
,	O
an	O
angiotensin	O
converting	O
enzyme	O
inhibitor	O
was	O
also	O
added	O
to	O
the	O
regimen	O
on	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
17	O
*	O
*	O
]	O
.	O

at	O
this	O
time	O
the	O
patient's	O
systolic	O
blood	O
pressure	O
was	O
staying	O
at	O
approximately	O
140	O
mmhg	O
and	O
a	O
heart	O
rate	O
between	O
75	O
to	O
85	O
and	O
a	O
ccu	O
team	O
decided	O
this	O
patient	O
was	O
stable	O
enough	O
to	O
be	O
transferred	O
to	O
the	O
floor	O
.	O

within	O
48	O
hours	O
of	O
transfer	O
,	O
the	O
patient	O
began	O
to	O
experience	O
chest	B
pain	I
with	O
radiation	O
to	O
the	O
back	O
.	O

sublingual	O

nitroglycerin	O
was	O
given	O
three	O
times	O
and	O
0	O
.	O
5	O
mg	O
of	O
iv	O
morphine	O
with	O
mild	O
relief	B
.	O

the	O
patient	O
was	O
taken	O
for	O
emergent	O
ct	O
scan	O
angiogram	O
of	O
the	O
chest	O
that	O
revealed	O
further	O
increase	O
of	O
thoracic	B
luminal	I
diameter	I
from	O
3	O
.	O
5	O
to	O
3	O
.	O
8	O
cm	O
,	O
increase	O
in	O
size	O
of	O
the	O
luminal	O
thrombosis	B
and	O
increase	B
in	I
size	I
of	I
the	I
lumen	I
at	O
the	O
left	O
pulmonary	O
artery	O
to	O
4	O
.	O
5	O
cm	O
.	O

cardiothoracic	O
surgery	O
was	O
consulted	O
at	O
this	O
time	O
and	O
stated	O
that	O
there	O
was	O
no	O
indication	O
for	O
surgery	O
at	O
this	O
time	O
.	O

the	O
patient	O
was	O
then	O
transferred	O
back	O
to	O
the	O
ccu	O
for	O
more	O
aggressive	O
control	O
of	O
his	O
blood	O
pressure	O
and	O
the	O
patient	O
was	O
restarted	O
on	O
nitroglycerin	O
drip	O
for	O
48	O
hours	O
.	O

the	O
patient	O
was	O
then	O
started	O
on	O
norvasc	O
5	O
mg	O
.	O

the	O
following	O
evening	O
,	O
the	O
patient	O
again	O
experienced	O
an	O
episode	O
of	O
chest	B
pain	I
,	O
but	O
this	O
time	O
without	O
back	B
pain	I
and	O
showed	O
no	O
clinical	O
signs	O
of	O
extension	O
or	O
dissection	B
nor	O
changes	B
on	I
ekg	I
.	O

later	O
on	O
that	O
evening	O
,	O
the	O
patient	O
experienced	O
a	O
drop	B
in	I
blood	I
pressure	I
to	O
systolic	O
blood	O
pressure	O
of	O
70	O
,	O
30	O
minutes	O
after	O
receiving	O
night	O
time	O
dosages	O
of	O
clonidine	O
and	O
captopril	O
.	O

the	O
patient	O
responded	O
to	O
500	O
cc	O
bolus	O
of	O
normal	O
saline	O
and	O
maintained	O
him	O
at	O
greater	O
than	O
60	O
.	O

within	O
the	O
next	O
24	O
hours	O
,	O
the	O
patient	O
had	O
another	O
episode	O
of	O
substernal	B
chest	I
pain	I
with	O
stable	O
vital	O
signs	O
and	O
no	O
ekg	B
changes	I
.	O

the	O
patient	O
had	O
moderate	O
relief	B
with	O
nitroglycerin	O
times	O
two	O
.	O

there	O
are	O
no	O
ekg	B
changes	I
at	O
this	O
time	O
.	O

repeat	O
ct	O
scan	O
angiogram	O
revealed	O
no	O
progression	O
of	O
dissection	B
.	O

again	O
,	O
blood	O
pressure	O
remained	O
stable	O
in	O
both	O
arms	O
.	O

there	O
are	O
no	O
clinical	O
signs	O
for	O
evidence	O
of	O
progression	O
of	O
dissection	B
.	O

given	O
the	O
episode	O
of	O
substernal	B
chest	I
pain	I
,	O
the	O
patient	O
was	O
started	O
on	O
aspirin	O
.	O

the	O
patient's	O
blood	O
pressure	O
remained	O
well	O
controlled	O
in	O
the	O
unit	O
.	O

the	O
patient	O
was	O
,	O
again	O
,	O
transferred	O
to	O
the	O
floor	O
on	O

[	O
*	O
*	O
2014	O
-	O
10	O
-	O
25	O
*	O
*	O
]	O
.	O

between	O
the	O
time	O
of	O
transfer	O
and	O
patient's	O
date	O
of	O
discharge	O
on	O
[	O
*	O
*	O
10	O
-	O
29	O
*	O
*	O
]	O
,	O
patient's	O
blood	O
pressure	O
was	O
controlled	O
on	O
blood	O
pressure	O
medication	O
.	O

blood	O
pressure	O
medication	O
regimen	O
was	O
adjusted	O
as	O
necessary	O
.	O

please	O
see	O
discharge	O
medications	O
for	O
discharge	O
antihypertensive	O
medications	O
.	O

2	O
.	O
infectious	O
disease	O
:	O
the	O
patient	O
completed	O
a	O
14	O
out	O
of	O
14	O
day	O
course	O
of	O
linezolid	O
and	O
aztreonam	O
for	O
mrsa	B
and	O
potential	O
gram	B
negative	I
pneumonia	I
as	O
per	O
infectious	O
disease	O
.	O

patient	O
remained	O
afebrile	B
with	O
a	O
stable	O
white	O
blood	O
cell	O
count	O
for	O
the	O
remainder	O
of	O
the	O
hospital	O
stay	O
.	O

3	O
.	O
neurology	O
:	O
given	O
patient's	O
somnolence	B
,	O
confusion	B
,	O
mental	B
status	I
changes	I
status	O
post	O
extubation	O
,	O
neurology	O
was	O
consulted	O
given	O
these	O
findings	O
on	O
exam	O
.	O

on	O
exam	O
it	O
was	O
noted	O
that	O
the	O
patient	O
also	O
had	O
a	O
left	B
gazed	I
deviation	I
,	O
right	O
field	O
,	O
right	B
hemiparesis	I
.	O

a	O
mri	O
on	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
23	O
*	O
*	O
]	O
revealed	O
:	O

1	O
.	O
laminar	B
necrosis	I
with	O
hemorrhage	B
in	O
media	O
left	O
occipital	O
lobe	O
and	O
left	O
thalamus	O
.	O

2	O
.	O
sinus	B
disease	I
.	O

neurology	O
recommendations	O
including	O
maintaining	O
systolic	O
blood	O
pressure	O
less	O
than	O
140	O
,	O
keep	O
head	O
of	O
bed	O
elevated	O
greater	O
than	O
30	O
degrees	O
,	O
and	O
patient	O
was	O
followed	O
by	O
the	O

neurology	O
for	O
the	O
remainder	O
of	O
the	O
hospital	O
course	O
.	O

the	O
patient	O
improved	O
mental	B
status	I
throughout	O
the	O
remainder	O
of	O
the	O
hospital	O
stay	O
with	O
increased	B
speech	I
and	O
movement	B
of	O
all	O
extremities	O
.	O

the	O
stroke	B
service	O
was	O
also	O
consulted	O
to	O
evaluate	O
the	O
patient	O
for	O
possible	O
cardiac	O
catheterization	O
given	O
patient's	O
history	O
of	O
substernal	B
chest	I
pain	I
and	O
possible	O
future	O
need	O
of	O
cardiothoracic	O
surgery	O
for	O
aortic	B
dissection	I
.	O

a	O
mri	O
showed	O
a	O
left	O
pca	O
involving	O
infarct	B
and	O
thus	O
it	O
was	O
concluded	O
it	O
was	O
best	O
to	O
wait	O
two	O
to	O
three	O
weeks	O
for	O
anticoagulation	O
.	O

patient	O
is	O
to	O
follow	O
with	O
neurology	O
clinic	O
as	O
an	O
outpatient	O
.	O

condition	O
on	O
discharge	O
:	O
good	O
.	O

discharge	O
status	O
:	O
to	O
rehab	O
facility	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
aortic	B
dissection	I
,	I
type	I
b	I
.	O

2	O
.	O
cerebrovascular	B
accident	I
.	O

3	O
.	O
hypertension	B
.	O

4	O
.	O
aspiration	B
pneumonia	I
.	O

5	O
.	O
ards	B
.	O

6	O
.	O
acute	B
renal	I
failure	I
.	O

7	O
.	O
methicillin	B
-	I
resistant	I
staphylococcus	I
aureus	I
bacteremia	I
.	O

discharge	O
medications	O
:	O

1	O
.	O
atenolol	O
100	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

2	O
.	O
lisinopril	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

3	O
.	O
norvasc	O
10	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

4	O
.	O
clonidine	O
0	O
.	O
2	O
mg	O
p	O
.	O
o	O
.	O
t	O
.	O
i	O
.	O
d	O
.	O
times	O
one	O
week	O
.	O

5	O
.	O
nitroglycerin	O
sublingual	O
p	O
.	O
r	O
.	O
n	O
.	O
chest	B
pain	I

6	O
.	O
aspirin	O
325	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

7	O
.	O
vitamin	O
c	O
250	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

8	O
.	O
zinc	O
sulfate	O
220	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

follow	O
up	O
plans	O
:	O

1	O
.	O
follow	O
up	O
with	O
cardiothoracic	O
surgery	O
in	O
one	O
month	O
.	O

2	O
.	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1604	O
*	O
*	O
]	O
in	O
one	O
to	O
two	O
weeks	O
for	O
blood	O
pressure	O
management	O
,	O
this	O
is	O
the	O
patient's	O
primary	O
care	O
physician	O
.	O

3	O
.	O
follow	O
up	O
with	O
cardiology	O
in	O
one	O
month	O
including	O
outpatient	O
stress	O
test	O
.	O

4	O
.	O
follow	O
up	O
in	O
neurology	O
clinic	O
in	O
two	O
to	O
three	O
weeks	O
.	O

5	O
.	O
occupational	O
therapy	O
and	O
physical	O
therapy	O
.	O

dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name3	O
(	O
lf	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
md	O
number	O
3609	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
3610	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2014	O
-	O
11	O
-	O
24	O
*	O
*	O
]	O
14	O
:	O
08	O

t	O
:	O
[	O
*	O
*	O
2014	O
-	O
11	O
-	O
24	O
*	O
*	O
]	O
14	O
:	O
31	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
3611	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2014	O
-	O
12	O
-	O
16	O
*	O
*	O
]	O
8	O
:	O
25	O
am	O

(	O
end	O
of	O
report	O
)	O

14779	O
||||	O
15664	O
||||	O
2620	O
||||	O
discharge	O
_	O
summary	O
||||	O
2011	O
-	O
07	O
-	O
01	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
06	O
-	O
14	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
07	O
-	O
01	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1940	O
-	O
07	O
-	O
15	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O

addendum	O
:	O

this	O
addendum	O
summarizes	O
the	O
patient's	O
final	O
hospital	O
day	O
:	O

1	O
.	O
gastrointestinal	O
:	O
the	O
patient	O
is	O
doing	O
well	O
on	O

erythromycin	O
250	O
mg	O
p	O
.	O
o	O
.	O
three	O
times	O
a	O
day	O
,	O
colace	O
100	O
mg	O
p	O
.	O
o	O
.	O
twice	O
a	O
day	O
;	O
myralact	O
one	O
teaspoon	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

she	O
is	O
tolerating	O
a	O
full	O
soft	O
solid	O
diet	O
.	O

she	O
has	O
daily	O
bowel	O
movements	O
.	O

should	O
the	O
constipation	B
recur	O
,	O
cathartic	O
laxatives	O
can	O
be	O
used	O
on	O
a	O
p	O
.	O
r	O
.	O
n	O
.	O
basis	O
.	O

the	O
patient	O
will	O
also	O
benefit	O
from	O
manual	O
rectal	O
stimulation	O
.	O

2	O
.	O
neurological	O
:	O
the	O
patient	O
was	O
evaluated	O
by	O
the	O
movement	O
disorder	O
service	O
,	O
who	O
felt	O
that	O
it	O
would	O
be	O
appropriate	O
to	O
continue	O
on	O
sinemet	O
25	O
/	O
100	O
,	O
one	O
tablet	O
p	O
.	O
o	O
.	O
four	O
times	O
a	O
day	O
.	O

they	O
recommended	O
crushing	O
the	O
tablets	O
and	O
dissolving	O
them	O
in	O
carbonated	O
liquid	O
for	O
better	O
absorption	O
.	O

they	O
also	O
recommended	O
seroquel	O
12	O
.	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
h	O
.	O
s	O
.	O
as	O
an	O
adjunct	O
.	O

she	O
will	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
3017	O
*	O
*	O
]	O
of	O
the	O
movement	O
disorder	O
service	O
.	O

his	O
office	O
will	O
call	O
with	O
an	O
appointment	O
or	O
can	O
be	O
reached	O
at	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
3018	O
*	O
*	O
]	O
.	O

condition	O
at	O
discharge	O
:	O
the	O
patient	O
is	O
discharged	O
to	O
[	O
*	O
*	O
hospital	O
561	O
*	O
*	O
]	O
rehabilitation	O
hospital	O
in	O
good	O
condition	O
.	O

discharge	O
instructions	O
:	O

1	O
.	O
she	O
will	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
3017	O
*	O
*	O
]	O
at	O
the	O
[	O
*	O
*	O
hospital	O
3400	O
*	O
*	O
]	O
movement	O
disorder	O
clinic	O
as	O
scheduled	O
.	O

2	O
.	O
she	O
will	O
also	O
follow	O
-	O
up	O
with	O
her	O
primary	O
care	O
provider	O
,	O

dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
or	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
7501	O
*	O
*	O
]	O
,	O
nurse	O
practitioner	O
,	O
on	O
[	O
*	O
*	O
2011	O
-	O
07	O
-	O
05	O
*	O
*	O
]	O
,	O
at	O
03	O
:	O
40	O
p	O
.	O
m	O
.	O
at	O
the	O
[	O
*	O
*	O
hospital	O
1195	O
*	O
*	O
]	O
clinic	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
parkinson's	B
disease	I
.	O

2	O
.	O
obstipation	B
.	O

3	O
.	O
hypertension	B
.	O

discharge	O
medications	O
:	O

1	O
.	O
sinemet	O
25	O
/	O
100	O
,	O
one	O
tablet	O
p	O
.	O
o	O
.	O
four	O
times	O
a	O
day	O
,	O
crushed	O
and	O
dissolved	O
in	O
carbonated	O
liquid	O
.	O

2	O
.	O
colace	O
100	O
mg	O
p	O
.	O
o	O
.	O
twice	O
a	O
day	O
.	O

3	O
.	O
captopril	O
25	O
mg	O
p	O
.	O
o	O
.	O
three	O
times	O
a	O
day	O
.	O

4	O
.	O
lopressor	O
100	O
mg	O
p	O
.	O
o	O
.	O
three	O
times	O
a	O
day	O
.	O

5	O
.	O
erythromycin	O
250	O
mg	O
p	O
.	O
o	O
.	O
three	O
times	O
a	O
day	O
.	O

6	O
.	O
miralax	O
one	O
teaspoon	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
dissolved	O
in	O
liquid	O
.	O

7	O
.	O
heparin	O
5000	O
units	O
subcutaneously	O
twice	O
a	O
day	O
until	O
ambulatory	O
.	O

8	O
.	O
lactulose	O
30	O
cc	O
.	O
,	O
p	O
.	O
o	O
.	O
three	O
times	O
a	O
day	O
,	O
p	O
.	O
r	O
.	O
n	O
.	O
constipation	B
.	O

9	O
.	O
soft	O
/	O
solid	O
heart	O
low	O
sodium	O
diet	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
255	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
3596	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
6094	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2011	O
-	O
07	O
-	O
01	O
*	O
*	O
]	O
13	O
:	O
55	O

t	O
:	O
[	O
*	O
*	O
2011	O
-	O
07	O
-	O
01	O
*	O
*	O
]	O
16	O
:	O
36	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
7502	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
255	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2011	O
-	O
08	O
-	O
01	O
*	O
*	O
]	O
10	O
:	O
40	O
am	O

(	O
end	O
of	O
report	O
)	O

26988	O
||||	O
15751	O
||||	O
23389	O
||||	O
discharge	O
_	O
summary	O
||||	O
2018	O
-	O
06	O
-	O
13	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
07	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
13	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1937	O
-	O
08	O
-	O
09	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
cardiothoracic	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
565	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

doe	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

avr	O
(	O
21mm	O
ce	O
)	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
07	O
*	O
*	O
]	O

history	O
of	O
present	O
illness	O
:	O

80	O
y	O
/	O
o	O
male	O
with	O
2	O
yr	O
h	O
/	O
o	O
sob	B
.	O

had	O
echo	O
that	O
revealed	O
as	B
.	O

has	O
had	O
serial	O
echo's	O
since	O
,	O
with	O
the	O
last	O
done	O
on	O
[	O
*	O
*	O
04	O
-	O
17	O
*	O
*	O
]	O
which	O
showed	O
worsening	O
as	B
.	O

past	O
medical	O
history	O
:	O

aortic	B
stenosis	I

hypertension	I

hypercholesterolemia	I

diabetes	I
mellitus	I
type	I
2	I

left	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
glaucoma	B

severe	O
le	O
varicosities	B

h	O
/	O
o	O
bilat	O
.	O

renal	B
calculi	I

s	O
/	O
p	O
bilat	O
.	O
cataract	B
surgery	O

s	O
/	O
p	O
appendectomy	O

s	O
/	O
p	O
tonsillectomy	O

s	O
/	O
p	O
lithotripsy	O

social	O
history	O
:	O

lives	O
with	O
wife	O
,	O
retired	O
.	O

quit	O
smoking	O
20yrs	O
ago	O
(	O
40	O
-	O
50	O
pk	O
yrs	O
)	O
.	O

etoh	O
:	O
1	O
glass	O
wine	O
/	O
day	O
.	O

family	O
history	O
:	O

sister	O
with	O
rhf	B
/	O
valve	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
1711	O
*	O
*	O
]	O
.	O

physical	O
exam	O
:	O

vs	O
:	O
76	O
14	O
154	O
/	O
78	O
5'10"	O
165#	O

general	O
:	O
well	O
-	O
appearing	O
,	O
well	O
-	O
nourished	O
elderly	O
man	O

skin	O
:	O
unremarkable	O
,	O
-	O
lesions	B

heent	O
:	O
perrla	O
,	O
eomi	O
,	O
nc	O
/	O
at	O

neck	O
:	O
supple	O
,	O
from	O
,	O
-	O
jvd	B
,	O
murmur	B
radiating	O
to	O
carotids	O

chest	O
:	O
ctab	O
,	O
-	O
w	B
/	O
r	B
/	O
r	B

heart	O
:	O
rrr	O
,	O
+	O
s1s2	O
,	O
2	O
/	O
6	O
sem	B

abd	O
:	O
soft	O
,	O
nt	O
/	O
nd	O
+	O
bs	O

ext	O
:	O
warm	O
,	O
well	O
-	O
perfused	O
,	O
-	O
c	B
/	O
c	B
/	O
e	B
,	O
+	O
severe	O
bilat	O
varicosities	B
(	O
l>r	O
)	O
2	O
+	O
pulses	O
bilat	O
.	O

fem	O
,	O
pt	O
,	O
and	O
l	O
dp	O
.	O

no	O
pulse	O
on	O
r	O
dp	O
.	O

neuro	O
:	O
cn	O
[	O
*	O
*	O
02	O
-	O
24	O
*	O
*	O
]	O
intact	O
,	O
non	O
-	O
focal	O
,	O
mae	O
[	O
*	O
*	O
04	O
-	O
17	O
*	O
*	O
]	O
strengths	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
07	O
*	O
*	O
]	O
10	O
:	O
16am	O
blood	O
wbc	O
-	O
15	O
.	O
2	O
*	O
#	O
rbc	O
-	O
2	O
.	O
89	O
*	O
#	O
hgb	O
-	O
9	O
.	O
6	O
*	O
#	O
hct	O
-	O
26	O
.	O
3	O
*	O
#	O
mcv	O
-	O
91	O
mch	O
-	O
33	O
.	O
3	O
*	O
mchc	O
-	O
36	O
.	O
5	O
*	O
rdw	O
-	O
13	O
.	O
8	O
plt	O
ct	O
-	O
175	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
12	O
*	O
*	O
]	O
06	O
:	O
25am	O
blood	O
wbc	O
-	O
8	O
.	O
5	O
rbc	O
-	O
3	O
.	O
44	O
*	O
hgb	O
-	O
11	O
.	O
0	O
*	O
hct	O
-	O
31	O
.	O
5	O
*	O
mcv	O
-	O
92	O
mch	O
-	O
32	O
.	O
0	O
mchc	O
-	O
34	O
.	O
9	O
rdw	O
-	O
14	O
.	O
2	O
plt	O
ct	O
-	O
228	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
07	O
*	O
*	O
]	O
10	O
:	O
16am	O
blood	O
pt	O
-	O
16	O
.	O
1	O
*	O
ptt	O
-	O
40	O
.	O
3	O
*	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
7	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
11	O
*	O
*	O
]	O
02	O
:	O
40am	O
blood	O
pt	O
-	O
13	O
.	O
3	O
ptt	O
-	O
26	O
.	O
3	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
2	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
07	O
*	O
*	O
]	O
11	O
:	O
25am	O
blood	O
urean	O
-	O
15	O
creat	O
-	O
0	O
.	O
8	O
cl	O
-	O
105	O
hco3	O
-	O
27	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
07	O
*	O
*	O
]	O
07	O
:	O
55pm	O
blood	O
glucose	O
-	O
111	O
*	O
k	O
-	O
3	O
.	O
3	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
12	O
*	O
*	O
]	O
06	O
:	O
25am	O
blood	O
glucose	O
-	O
167	O
*	O
urean	O
-	O
34	O
*	O
creat	O
-	O
0	O
.	O
9	O
na	O
-	O
140	O
k	O
-	O
3	O
.	O
4	O
cl	O
-	O
101	O
hco3	O
-	O
28	O
angap	O
-	O
14	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
13	O
*	O
*	O
]	O
06	O
:	O
25am	O
blood	O
k	O
-	O
3	O
.	O
9	O

brief	O
hospital	O
course	O
:	O

as	O
stated	O
in	O
the	O
hpi	O
,	O
he	O
is	O
a	O
80	O
y	O
/	O
o	O
male	O
with	O
a	O
h	O
/	O
o	O
as	B
who	O
was	O
initially	O
seen	O
as	O
an	O
outpt	O
.	O

he	O
was	O
a	O
same	O
day	O
admit	O
and	O
brought	O
to	O
the	O
operating	O
room	O
,	O
where	O
he	O
underwent	O
an	O
aortic	O
valve	O
replacement	O
.	O

please	O
see	O
op	O
note	O
for	O
full	O
surgical	O
details	O
.	O

he	O
tolerated	O
the	O
procedure	O
well	O
with	O
a	O
total	O
bypass	O
time	O
of	O
71	O
minutes	O
and	O
cross	O
clamp	O
time	O
of	O
58	O
minutes	O
.	O

he	O
was	O
transferred	O
to	O
csru	O
in	O
stable	O
condition	O
with	O
a	O
map	O
of	O
60	O
,	O
cvp	O
7	O
,	O
pad	O
13	O
,	O
[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
18	O
,	O
hr	O
87	O
nsr	O
and	O
being	O
titrated	O
on	O
neo	O
,	O
propofol	O
,	O
and	O
insulin	O
.	O

pt	O
was	O
weaned	O
from	O
propofol	O
and	O
mechanical	O
ventilation	O
and	O
was	O
extubated	O
later	O
on	O
op	O
day	O
.	O

he	O
was	O
awake	O
,	O
alert	O
,	O
mae	O
,	O
and	O
following	O
commands	O
.	O

on	O
pod	O
#1	O
he	O
was	O
recovering	O
well	O
.	O

swan	O
ganz	O
catheter	O
was	O
removed	O
.	O

diuretics	O
and	O
b	O
-	O
blockers	O
were	O
started	O
per	O
protocol	O
.	O

his	O
chest	O
x	O
-	O
ray	O
showed	O
bibasilar	O
atelectasis	B
and	O
small	O
r	O
.	O
pleural	B
effusion	I
which	O
was	O
matched	O
with	O
bibasilar	O
rales	B
and	O
dimished	B
bs	I
on	O
exam	O
.	O

pod	O
#2	O
his	O
chest	O
tubes	O
were	O
removed	O
,	O
but	O
cont	O
.	O
to	O
have	O
decreased	B
breath	I
sounds	I
with	O
cxr	O
showing	O
cont	O
.	O
atelectasis	B
and	O
effusion	B
.	O

he	O
was	O
cont	O
.	O
to	O
be	O
aggressively	O
diuresed	O
along	O
with	O
aggressive	O
cpt	O
w	O
/	O
postural	O
drainage	O
.	O

also	O
received	O
flovent	O
and	O
combivent	O
and	O
levaquin	O
was	O
started	O
for	O
poss	O
.	O
pneumonia	B
.	O

pod	O
#3	O
his	O
epicaridal	O
pacing	O
wires	O
and	O
foley	O
were	O
removed	O
.	O

he	O
remained	O
in	O
the	O
csru	O
and	O
repeat	O
cxr	O
showed	O
cont	O
.	O
r	O
.	O
effusion	B
and	O
atelectasis	B
w	O
/	O
poss	O
.	O
superimposed	O
pnuemonia	B
.	O

pod	O
#4	O
he	O
appeared	O
to	O
be	O
improved	O
,	O
but	O
had	O
cont	O
.	O
decreased	B
bs	I
right	O
base	O
.	O

he	O
was	O
transferred	O
to	O
telemetry	O
floor	O
.	O

cxr	O
showed	O
decreased	O
atelectasis	B
.	O

by	O
pod	O
#5	O
he	O
appeared	O
to	O
be	O
doing	O
quite	O
well	O
.	O

cont	O
.	O
to	O
ambulate	O
and	O
get	O
oob	O
.	O

o2	O
sats	O
remained	O
alittle	O
low	O
depsite	O
o2	O
via	O
nc	O
.	O

exam	O
unremarkable	O
.	O

he	O
was	O
d	O
/	O
c'd	O
on	O
pod	O
#6	O
.	O
exam	O
was	O
unremarkable	O
,	O
incisions	O
stable	O
,	O
breath	O
sounds	O
clear	O
.	O

labs	O
were	O
stable	O
and	O
he	O
would	O
follow	O
-	O
up	O
as	O
directed	O
.	O

medications	O
on	O
admission	O
:	O

1	O
.	O
hctz	O
50mg	O
qd	O

2	O
.	O
atenolol	O
50mg	O
qd	O

3	O
.	O
glucophage	O
500mg	O
qd	O

4	O
.	O
kcl	O
er	O
600mg	O
qd	O

5	O
.	O
gemfibrozil	O
600mg	O
qd	O

6	O
.	O
omeprazole	O
20mg	O
qd	O

7	O
.	O
vit	O
.	O

e	O
qd	O

8	O
.	O
omega	O
5	O
oils	O

9	O
.	O
allphagan	O
[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
299	O
*	O
*	O
]	O
10	O
.	O

b	O
-	O
complex	O

discharge	O
medications	O
:	O

1	O
.	O
oxycodone	O
-	O
acetaminophen	O
5	O
-	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4h	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B
.	O

disp	O
:	O
*	O
50	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

2	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

3	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

4	O
.	O
brimonidine	O
tartrate	O
0	O
.	O
15	O
%	O
drops	O
sig	O
:	O
one	O
(	O
1	O
)	O
drop	O

ophthalmic	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
1	O
bottle	O
*	O
refills	O
:	O
*	O
2	O
*	O

5	O
.	O
fluticasone	O
propionate	O
110	O
mcg	O
/	O
actuation	O
aerosol	O
sig	O
:	O
two	O
(	O
2	O
)	O
puff	O
inhalation	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
1	O
inhaler	O
*	O
refills	O
:	O
*	O
2	O
*	O

6	O
.	O
albuterol	O
-	O
ipratropium	O
103	O
-	O
18	O
mcg	O
/	O
actuation	O
aerosol	O
sig	O
:	O
[	O
*	O
*	O
01	O
-	O
14	O
*	O
*	O
]	O

puffs	O
inhalation	O
q4h	O
(	O
every	O
4	O
hours	O
)	O
.	O

disp	O
:	O
*	O
1	O
inhaler	O
*	O
refills	O
:	O
*	O
2	O
*	O

7	O
.	O
metformin	O
hcl	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

8	O
.	O
levofloxacin	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q24h	O
(	O
every	O
24	O
hours	O
)	O
for	O
3	O
days	O
.	O

disp	O
:	O
*	O
3	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

9	O
.	O
latanoprost	O
0	O
.	O
005	O
%	O
drops	O
sig	O
:	O
one	O
(	O
1	O
)	O
drop	O
ophthalmic	O
hs	O
(	O
at	O
bedtime	O
)	O
.	O

disp	O
:	O
*	O
1	O
bottle	O
*	O
refills	O
:	O
*	O
2	O
*	O

10	O
.	O

potassium	O
chloride	O
10	O
meq	O
capsule	O
,	O
sustained	O
release	O
sig	O
:	O
two	O
(	O
2	O
)	O
capsule	O
,	O
sustained	O
release	O
po	O
daily	O
(	O
daily	O
)	O
for	O
7	O
days	O
.	O

disp	O
:	O
*	O
14	O
capsule	O
,	O
sustained	O
release	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

11	O
.	O

lopressor	O
50	O
mg	O
tablet	O
sig	O
:	O
1	O
.	O
5	O
tablets	O
po	O
three	O
times	O
a	O
day	O
.	O

disp	O
:	O
*	O
135	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

12	O
.	O

lasix	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
twice	O
a	O
day	O
for	O
7	O
days	O
.	O

disp	O
:	O
*	O
14	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

13	O
.	O

omeprazole	O
20	O
mg	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
once	O
a	O
day	O
.	O

disp	O
:	O
*	O
30	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

14	O
.	O

zocor	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

aortic	B
stenosis	I
s	O
/	O
p	O
aortic	O
valve	O
replacement	O

hypertension	B

hypercholesterolemia	I

diabetes	I
mellitus	I
type	I
2	I

left	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
glaucoma	B

severe	O
le	O
varicosities	B

h	O
/	O
o	O
bilat	O
.	O

renal	B
calculi	I

discharge	O
condition	O
:	O

good	O

discharge	O
instructions	O
:	O

follow	O
medications	O
on	O
discharge	O
instructions	O
.	O

you	O
may	O
not	O
drive	O
for	O
4	O
weeks	O
.	O

you	O
may	O
not	O
lift	O
more	O
than	O
10	O
lbs	O
.	O
for	O
3	O
months	O
.	O

you	O
should	O
shower	O
,	O
let	O
water	O
flow	O
over	O
wounds	B
,	O
pat	O
dry	O
with	O
a	O
towel	O

do	O
not	O
put	O
lotions	O
or	O
creams	O
on	O
incisions	O
.	O

followup	O
instructions	O
:	O

make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3378	O
*	O
*	O
]	O
for	O
1	O
-	O
2	O
weeks	O
.	O

make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
776	O
*	O
*	O
]	O
for	O
2	O
-	O
3	O
weeks	O
.	O

make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
for	O
4	O
weeks	O
.	O

[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
574	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
575	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
388	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
389	O
*	O
*	O
]	O
pa	O
80	O
-	O
bmd	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
14	O
*	O
*	O
]	O
@	O
0906	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
20	O
*	O
*	O
]	O
12	O
:	O
16	O
pm	O

(	O
end	O
of	O
report	O
)	O

7213	O
||||	O
15789	O
||||	O
4552	O
||||	O
discharge	O
_	O
summary	O
||||	O
2011	O
-	O
05	O
-	O
25	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
23	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
25	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1970	O
-	O
03	O
-	O
27	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
cardiothoracic	O

history	O
of	O
present	O
illness	O
:	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
7380	O
*	O
*	O
]	O
is	O
a	O
41	O
-	O
year	O
-	O
old	O
man	O
with	O
known	O
history	O
of	O
mitral	B
valve	I
prolapse	I
x	O
15	O
years	O
.	O

a	O
recent	O
echocardiogram	O
revealed	O
severe	O
mitral	B
regurgitation	I
with	O
moderate	O
to	O
severe	O
tricuspid	B
regurgitation	I
and	O
partial	O
flail	B
mitral	I
valve	I
leaflet	I
with	O
a	O
mildly	O
dilated	B
left	I
atrium	I
.	O

he	O
has	O
had	O
rare	O
episodes	O
of	O
dyspnea	B
on	I
exertion	I
and	O
palpitations	B
,	O
otherwise	O
he	O
is	O
asymptomatic	B
.	O

he	O
was	O
referred	O
by	O
his	O
cardiologist	O
for	O
catheterization	O
today	O
in	O
anticipation	O
of	O
mitral	O
valve	O
surgery	O
in	O
the	O
future	O
.	O

please	O
see	O
the	O
catheterization	O
report	O
for	O
full	O
details	O
.	O

in	O
summary	O
,	O
the	O
catheterization	O
showed	O
an	O
ejection	O
fraction	O
of	O
54%	O
with	O
4	O
+	O
mitral	B
regurgitation	I
and	O
normal	O
coronaries	O
.	O

past	O
medical	O
history	O
:	O
1	O
.	O
known	O
mitral	B
valve	I
prolapse	I
.	O

2	O
.	O

hypertension	B
.	O

3	O
.	O
right	O
shoulder	O
surgery	O
.	O

4	O
.	O
tonsillectomy	O
and	O
adenoidectomy	O
.	O

5	O
.	O
dental	O
surgery	O
.	O

allergies	O
:	O
the	O
patient	O
has	O
no	O
known	O
drug	O
allergies	O
.	O

medications	O
on	O
admission	O
:	O
1	O
.	O
aspirin	O
81	O
mg	O
q	O
.	O
d	O
.	O

2	O
.	O
atenolol	O
50	O
mg	O
q	O
.	O
d	O
.	O

3	O
.	O
verapamil	O
240	O
mg	O
q	O
.	O
d	O
.	O

4	O
.	O
vitamin	O
e	O
400	O
mg	O
q	O
.	O
d	O
.	O

laboratory	O
data	O
:	O
white	O
count	O
8	O
.	O
8	O
,	O
hematocrit	O
38	O
.	O
5	O
,	O
platelet	O
count	O
240	O
,	O
inr	O
1	O
.	O
1	O
,	O
sodium	O
137	O
,	O
potassium	O
4	O
.	O
0	O
,	O
chloride	O
104	O
,	O
co2	O
25	O
,	O
bun	O
20	O
,	O
creatinine	O
1	O
.	O
1	O
,	O
glucose	O
96	O
.	O

ekg	O
was	O
normal	O
sinus	O
rhythm	O
.	O

liver	O
function	O
tests	O
were	O
normal	O
.	O

review	O
of	O
systems	O
:	O
the	O
patient	O
denies	O
any	O
seizures	B
,	O
any	O
transient	B
ischemic	I
attacks	I
or	O
headaches	B
.	O

pulmonary	O
:	O
denies	O
cough	B
,	O
wheezes	B
or	O
sputum	B
.	O

cardiac	O
:	O
as	O
per	O
history	O
.	O

gi	O
:	O

denies	O
any	O
gastroesophageal	B
reflux	I
disease	I
,	O
nausea	B
or	O
diarrhea	B
.	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
:	O
no	O
problems	O
.	O

hematology	O
,	O
infectious	O
disease	O
and	O
endocrine	O
:	O
denies	O
any	O
significant	O
problems	O
.	O

musculoskeletal	O
:	O
status	O
post	O
right	O
shoulder	O
surgery	O
with	O
decreased	B
range	I
of	I
motion	I
of	O
the	O
right	O
shoulder	O
.	O

physical	O
examination	O
:	O
general	O
:	O
no	O
acute	B
distress	I
.	O

neurological	O
:	O
grossly	O
intact	O
.	O

pulmonary	O
:	O
lung	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

heart	O
:	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	O
4	O
/	O
6	O
systolic	B
ejection	I
murmur	I
.	O

abdomen	O
:	O
soft	O
,	O
nontender	O
,	O
nondistended	O
with	O
positive	O
bowel	O
sounds	O
.	O

extremities	O
:	O
warm	O
and	O
well	O
perfused	O
with	O
no	O
edema	B
.	O

hospital	O
course	O
:	O
on	O
[	O
*	O
*	O
05	O
-	O
23	O
*	O
*	O
]	O
the	O
patient	O
was	O
brought	O
to	O
the	O
operating	O
room	O
.	O

please	O
see	O
the	O
operative	O
report	O
for	O
full	O
details	O
.	O

in	O
summary	O
,	O
he	O
had	O
a	O
minimally	O
invasive	O
mitral	O
valve	O
repair	O
with	O
quadrangular	O
resection	O
of	O
the	O
posterior	O
leaflet	O
with	O
a	O
28	O
mm	O
[	O
*	O
*	O
doctor	O
last	O
name	O
1660	O
*	O
*	O
]	O
annuloplasty	O
ring	O
placed	O
.	O

his	O
bypass	O
time	O
was	O
108	O
minutes	O
with	O
a	O
cross	O
-	O
clamp	O
time	O
of	O
80	O
minutes	O
.	O

he	O
tolerated	O
the	O
operation	O
well	O
and	O
was	O
transferred	O
from	O
the	O
operating	O
room	O
to	O
the	O
cardiothoracic	O
intensive	O
care	O
unit	O
.	O

the	O
did	O
well	O
in	O
the	O
immediate	O
postoperative	O
period	O
.	O

his	O
anesthesia	O
was	O
reversed	O
.	O

sedation	O
was	O
discontinued	O
.	O

he	O
was	O
weaned	O
from	O
the	O
ventilator	O
and	O
successfully	O
extubated	O
.	O

on	O
the	O
morning	O
of	O
postoperative	O
day	O
one	O
the	O
patient	O
continued	O
to	O
do	O
well	O
.	O

he	O
was	O
hemodynamically	O
stable	O
.	O

he	O
was	O
off	O
all	O
cardioactive	O
iv	O
medications	O
.	O

his	O
chest	O
tubes	O
were	O
removed	O
as	O
well	O
as	O
his	O
central	O
access	O
lines	O
and	O
he	O
was	O
transferred	O
to	O
the	O
floor	O
for	O
continuing	O
postoperative	O
care	O
and	O
cardiac	O
rehabilitation	O
.	O

on	O
the	O
floor	O
with	O
the	O
assistance	O
of	O
the	O
nursing	O
staff	O
and	O
physical	O
therapy	O
the	O
patient's	O
activity	O
level	O
was	O
increased	O
and	O
at	O
the	O
end	O
of	O
postoperative	O
day	O
two	O
it	O
was	O
decided	O
that	O
the	O
patient	O
was	O
stable	O
and	O
ready	O
to	O
be	O
discharged	O
to	O
home	O
.	O

at	O
the	O
time	O
of	O
discharge	O
the	O
patient's	O
physical	O
examination	O
was	O
as	O
follows	O
:	O
vital	O
signs	O
were	O
stable	O
and	O
he	O
was	O
afebrile	B
.	O

neurologically	O
he	O
was	O
alert	O
and	O
oriented	O
x	O
3	O
,	O
moved	O
all	O
extremities	O
,	O
followed	O
commands	O
.	O

respiratory	O
was	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

cardiovascular	O
was	O
regular	O
rate	O
and	O
rhythm	O
,	O
s1	O
and	O
s2	O
with	O
no	O
murmur	B
.	O

abdomen	O
was	O
soft	O
and	O
nontender	O
,	O
nondistended	O
,	O
with	O
normal	O
active	O
bowel	O
sounds	O
.	O

extremities	O
were	O
warm	O
and	O
well	O
perfused	O
with	O
no	O
clubbing	B
,	O
cyanosis	B
or	O
edema	B
.	O

right	O
thoracotomy	O
incision	O
was	O
clean	O
and	O
dry	O
with	O
no	O
erythema	B
.	O

laboratory	O
data	O
showed	O
a	O
white	O
count	O
of	O
13	O
.	O
2	O
,	O
hematocrit	O

23	O
.	O
7	O
,	O
platelet	O
count	O
135	O
,	O
pt	O
12	O
.	O
7	O
,	O
ptt	O
27	O
.	O
6	O
,	O
inr	O
1	O
.	O
1	O
,	O
sodium	O
137	O
,	O
potassium	O
3	O
.	O
6	O
,	O
chloride	O
102	O
,	O
co2	O
28	O
,	O
bun	O
12	O
,	O
creatinine	O
0	O
.	O
9	O
,	O
glucose	O
87	O
.	O

chest	O
x	O
-	O
ray	O
showed	O
minimal	O
apical	O
pneumothorax	B
on	O
the	O
right	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
aspirin	O
325	O
q	O
.	O
d	O
.	O

2	O
.	O
colace	O
100	O
b	O
.	O
i	O
.	O
d	O
.	O

3	O
.	O
tylenol	O
#3	O
,	O
1	O
-	O
2	O
tablets	O
p	O
.	O
o	O
.	O
q	O
.	O

4	O
hours	O
p	O
.	O
r	O
.	O
n	O
.	O

4	O
.	O
niferex	O
150	O
mg	O
q	O
.	O
d	O
.	O

5	O
.	O
vitamin	O
c	O
500	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O

6	O
.	O
atenolol	O
25	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
status	O
post	O
mitral	O
valve	O
repair	O
.	O

2	O
.	O
hypertension	B
.	O

3	O
.	O
status	O
post	O
right	O
shoulder	O
surgery	O
.	O

4	O
.	O
status	O
post	O
tonsillectomy	O
and	O
adenoidectomy	O
.	O

condition	O
on	O
discharge	O
:	O
good	O
.	O

follow	O
up	O
:	O
he	O
is	O
to	O
have	O
follow	O
up	O
with	O
his	O
primary	O
care	O
physician	O
in	O
two	O
weeks	O
.	O

he	O
is	O
to	O
have	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
four	O
weeks	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
7066	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
7067	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
7381	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
09	O
:	O
34	O

t	O
:	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
09	O
:	O
47	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
7382	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
7066	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2011	O
-	O
07	O
-	O
06	O
*	O
*	O
]	O
4	O
:	O
42	O
pm	O

(	O
end	O
of	O
report	O
)	O

152402	O
||||	O
16055	O
||||	O
1984	O
||||	O
radiology	O
_	O
report	O
||||	O
2016	O
-	O
04	O
-	O
02	O
05	O
:	O
35	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
335	O
-	O
8675	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2016	O
-	O
04	O
-	O
02	O
*	O
*	O
]	O
5	O
:	O
35	O
am	O

chest	O
(	O
portable	O
ap	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
104	O
*	O
*	O
]	O
reason	O
:	O
chest	O
tube	O

admitting	O
diagnosis	O
:	O
wound	B
infection	I

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

83	O
year	O
old	O
woman	O
s	O
/	O
p	O
bronchoscopy	O
to	O
clear	O
out	O
secretions	O
.	O

r	O
chest	O
tube	O
placed	O
this	O
morning	O
for	O
large	O
r	O
pleural	B
effusion	I
,	O
lung	O
noted	O
to	O
be	O
collapsed	O
on	O
f	O
/	O
u	O
cxr	O
,	O
?	O
plugged	B
with	I
secretions	I
.	O

reason	O
for	O
this	O
examination	O
:	O

compare	O
to	O
prior	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

compared	O
to	O
previous	O
study	O
of	O
one	O
day	O
earlier	O
.	O

clinical	O
indication	O
:	O
chest	O
tube	O
placement	O
for	O
large	O
pleural	B
effusion	I
.	O

pre	O
-	O
evaluate	O
lung	B
collapse	I
.	O

an	O
endotracheal	O
tube	O
remains	O
in	O
place	O
.	O

the	O
tip	O
is	O
in	O
a	O
relatively	O
low	O
position	O
,	O
within	O
1	O
.	O
5	O
cm	O
of	O
the	O
carina	O
,	O
but	O
this	O
is	O
likely	O
accenuated	O
by	O
the	O
flexed	O
position	O
of	O
the	O
patient's	O
neck	O
.	O

a	O
left	O
sided	O
chest	O
tube	O
remains	O
in	O
place	O
,	O
with	O
no	O
evidence	O
of	O
pneumothorax	B
,	O
and	O
right	O
internal	O
jugular	O
vascular	O
catheter	O
remains	O
in	O
satisfactory	O
position	O
.	O

cardiac	O
and	O
mediastinal	O
contours	O
are	O
within	O
normal	O
limits	O
.	O

there	O
has	O
been	O
interval	O
improved	O
aeration	O
in	O
the	O
left	O
retrocardiac	O
region	O
.	O

there	O
remains	O
a	O
small	O
left	O
pleural	B
effusion	I
and	O
a	O
moderate	O
layering	O
right	O
pleural	B
effusion	I
.	O

impression	O
:	O
improving	O
left	O
retrocardiac	O
opacity	B
,	O
likely	O
due	O
to	O
atelectasis	B
.	O

persistent	O
small	O
left	O
and	O
moderate	O
right	O
pleural	I
effusions	I
.	O

relatively	O
low	O
position	O
of	O
the	O
endotracheal	O
tube	O
.	O

170823	O
||||	O
16072	O
||||	O
26057	O
||||	O
radiology	O
_	O
report	O
||||	O
2018	O
-	O
05	O
-	O
24	O
17	O
:	O
56	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
435	O
-	O
6530	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2018	O
-	O
05	O
-	O
24	O
*	O
*	O
]	O
5	O
:	O
56	O
pm	O

chest	O
(	O
portable	O
ap	O
)	O
;	O
-	O
77	O
by	O
different	O
physician	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
255	O
*	O
*	O
]	O
reason	O
:	O
please	O
assess	O
for	O
trach	O
placement	O
/	O
etc	O
admitting	O
diagnosis	O
:	O
chest	B
pain	I

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

40	O
year	O
old	O
woman	O
with	O
severe	O
resp	B
failure	I
now	O
s	O
/	O
p	O
trach	O
and	O
peg	O
reason	O
for	O
this	O
examination	O
:	O
please	O
assess	O
for	O
trach	O
placement	O
/	O
etc	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
severe	O
respiratory	B
failure	I
status	O
post	O
trach	O
and	O
peg	O
.	O

assess	O
for	O
trach	O
placement	O
.	O

comparison	O
:	O
chest	O
x	O
-	O
ray	O
from	O
14	O
hours	O
prior	O
.	O

single	O
ap	O
semi	O
-	O
upright	O
bedside	O
chest	O
radiograph	O
:	O
there	O
has	O
been	O
interval	O
placement	O
of	O
a	O
tracheostomy	O
tube	O
with	O
tip	O
approximately	O
5	O
.	O
6	O
cm	O
above	O
the	O
carina	O
.	O

right	O
subclavian	O
line	O
terminates	O
at	O
the	O
mid	O
svc	O
.	O

there	O
is	O
no	O
pneumothorax	B
.	O

there	O
has	O
been	O
slight	O
decrease	O
to	O
small	O
bilateral	B
pleural	I
effusions	I
and	O
pulmonary	B
edema	I
with	O
some	O
residual	O
cephalization	B
and	O
perivascular	B
haziness	I
.	O

retrocardiac	O
opacity	B
with	O
clustered	B
bronchial	I
markings	I
is	O
likely	O
due	O
to	O
atelectasis	B
.	O

impression	O
:	O
interval	O
placement	O
of	O
tracheostomy	O
tube	O
,	O
in	O
satisfactory	O
position	O
.	O

mild	O
improvement	O
in	O
chf	B
.	O

left	O
basilar	O
atelectasis	B
persists	O
.	O

204168	O
||||	O
16134	O
||||	O
8271	O
||||	O
radiology	O
_	O
report	O
||||	O
2016	O
-	O
11	O
-	O
10	O
16	O
:	O
39	O
:	O
00	O
.	O
0	O
||||	O
t9112	O
mr	O
head	O
w	O
&	O
w	O
/	O
o	O
contrast	O
||||	O
||||	O
clip	O
#	O
327	O
-	O
5899	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2016	O
-	O
11	O
-	O
10	O
*	O
*	O
]	O
4	O
:	O
39	O
pm	O

mr	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
146	O
*	O
*	O
]	O
w	O
&	O
w	O
/	O
o	O
contrast	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
1033	O
*	O
*	O
]	O
reason	O
:	O
question	O
bony	B
erosions	I
of	O
sinuses	O
secondary	O
to	O
long	O
-	O
term	O
asp	B
admitting	O
diagnosis	O
:	O
aspergillosis\bronchoscopy	O
rigid	O
;	O
flexible	O
contrast	O
:	O
magnevist	O
amt	O
:	O
10	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

37	O
year	O
old	O
woman	O
with	O
?invasive	O
aspergillosis	B
.	O

please	O
eval	O
.	O
for	O
sinus	B
involvement	I
.	O

reason	O
for	O
this	O
examination	O
:	O

question	O
bony	B
erosions	I
of	O
sinuses	O
secondary	O
to	O
long	O
-	O
term	O
aspergillosis	B
infection	O
.	O
recommended	O
by	O
id	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

mri	O
head	O
w	O
/	O
o&w	O
contrast	O

clinical	O
history	O
:	O
aspergillosis	B
.	O

technique	O
:	O
multiplanar	O
thin	O
section	O
pre	O
and	O
post	O
contrast	O
t1	O
weighted	O
images	O
,	O
and	O
coronal	O
stir	O
images	O
were	O
obtained	O
.	O

some	O
of	O
the	O
images	O
are	O
limited	O
by	O
patient	O
motion	O
.	O

findings	O
:	O

there	O
is	O
soft	O
tissue	O
thickening	B
in	O
the	O
maxillary	O
sinuses	O
,	O
worse	O
on	O
the	O
left	O
than	O
the	O
right	O
,	O
as	O
seen	O
on	O
the	O
preceding	O
day's	O
ct	O
.	O

as	O
noted	O
on	O
that	O
ct	O
,	O
the	O
right	O
inferior	O
and	O
middle	O
nasal	O
turbinates	O
are	O
not	O
seen	O
and	O
there	O
is	O
a	O
defect	B
in	O
the	O
nasal	O
septum	O
.	O

on	O
the	O
mri	O
,	O
there	O
is	O
mild	O
soft	O
tissue	O
thickening	B
in	O
some	O
of	O
the	O
anterior	O
ethmoid	O
air	O
cells	O
.	O

the	O
sphenoid	O
sinus	O
is	O
well	O
aerated	O
.	O

no	O
edema	B
is	O
seen	O
in	O
the	O
orbits	O
or	O
inferior	O
to	O
the	O
skull	O
base	O
and	O
the	O
visualized	O
portions	O
of	O
the	O
brain	O
parenchyma	O
are	O
normal	O
.	O

as	O
noted	O
,	O
previously	O
,	O
there	O
is	O
opacification	B
of	O
the	O
right	O
mastoid	O
air	O
cells	O
,	O
visible	O
on	O
the	O
axial	O
images	O
.	O

impression	O
:	O

1	O
)	O
there	O
are	O
defects	B
in	O
the	O
nasal	O
turbinates	O
and	O
the	O
nasal	O
septum	O
as	O
described	O
on	O
the	O
ct	O
.	O

2	O
)	O
there	O
is	O
nonspecific	O
soft	O
tissue	O
thickening	B
in	O
the	O
maxillary	O
sinuses	O
and	O
to	O
a	O
much	O
lesser	O
extent	O
in	O
the	O
anterior	O
ethmoid	O
air	O
cells	O
without	O
evidence	O
of	O
bone	B
destruction	I
or	O
soft	O
tissue	O
edema	B
surrounding	O
the	O
sinuses	O
.	O

3	O
)	O
the	O
sphenoid	O
sinus	O
and	O
frontal	O
sinuses	O
are	O
well	O
aerated	O
.	O

4	O
)	O
there	O
is	O
opacification	B
of	O
the	O
right	O
mastoid	O
air	O
cells	O
,	O
visualized	O
on	O
two	O
sets	O
of	O
axial	O
t1	O
weighted	O
images	O
.	O

the	O
tympanic	O
cavity	O
appears	O
to	O
be	O
well	O
aerated	O
.	O

28319	O
||||	O
16247	O
||||	O
28159	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
03	O
-	O
19	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
13	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
19	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1946	O
-	O
12	O
-	O
21	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
cardiothoracic	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
565	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

witnessed	O
cardiac	B
arrest	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

cabgx2	O
(	O
lima	O
-	O
>lad	O
,	O
svg	O
-	O
>om1	O
)	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
13	O
*	O
*	O
]	O

cardiac	O
catheterization	O
with	O
placement	O
of	O
an	O
iabp	O
.	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
13	O
*	O
*	O
]	O

history	O
of	O
present	O
illness	O
:	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
is	O
a	O
66	O
year	O
old	O
gentleman	O
who	O
awoke	O
at	O
4am	O
on	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
13	O
*	O
*	O
]	O
with	O
10	O
/	O
10	O
chest	B
pain	I
.	O

paramedics	O
were	O
called	O
and	O
he	O
subsequently	O
sustained	O
a	O
cardiac	B
arrest	I
.	O

he	O
was	O
cardioverted	O
for	O
ventricular	B
tachycardia	I
,	O
sedated	O
and	O
intubated	O
and	O
taken	O
to	O
the	O
[	O
*	O
*	O
hospital	O
6801	O
*	O
*	O
]	O
[	O
*	O
*	O
hospital3	O
*	O
*	O
]	O
.	O

he	O
was	O
treated	O
with	O
aspirin	O
,	O
betablockade	O
,	O
aggrestat	O
and	O
heparin	O
.	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
was	O
urgently	O
transferred	O
to	O
the	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
346	O
*	O
*	O
]	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
*	O
*	O
]	O
for	O
a	O
cardiac	O
catheterization	O
which	O
revealed	O
an	O
80%	O
stenosed	B
left	O
main	O
and	O
a	O
50%	O
stenosed	B
left	O
anterior	O
descending	O
artery	O
.	O

an	O
intra	O
-	O
aortic	O
balloon	O
pump	O
was	O
placed	O
for	O
coronary	O
perfusion	O
and	O
the	O
cardiac	O
surgical	O
service	O
was	O
consulted	O
for	O
surgical	O
revascularization	O
.	O

past	O
medical	O
history	O
:	O

hypercholesterolemia	B

hypothyroidism	I

social	O
history	O
:	O

retired	O
engineer	O
.	O

lives	O
with	O
wife	O
in	O
[	O
*	O
*	O
name2	O
(	O
ni	O
)	O
391	O
*	O
*	O
]	O
,	O
ma	O
.	O

denies	O
smoking	O
history	O
or	O
excessive	O
alcohol	O
use	O
.	O

family	O
history	O
:	O

unavailable	O

physical	O
exam	O
:	O

gen	O
:	O
pt	O
in	O
cath	O
lab	O
bed	O
,	O
intubated	O
and	O
sedated	O
.	O

iabp	O
in	O
place	O
.	O

vitals	O
:	O
132	O
/	O
80	O
91	O
sr	O
pa	O
36	O
/	O
20	O

heent	O
:	O
jvd	B
6cm	O
,	O
oropharynx	O
benign	O
,	O
no	O
audible	O
carotid	B
bruits	I
bilaterally	O
,	O
anicteric	B
sclera	O
.	O

cardiac	O
:	O
rrr	O
,	O
no	O
murmur	B

lungs	O
:	O
clear	O

abdomen	O
:	O
soft	O
,	O
nontender	O
,	O
nondistended	O
,	O
no	O
hepatosplenomegally	B
.	O

extremities	O
:	O
no	O
clubbing	B
,	O
cyanosis	B
or	O
edema	B
.	O

neuro	O
:	O
intubated	O
and	O
sedated	O
.	O

pupils	O
equal	O
.	O

pulses	O
:	O
2	O
+	O
femoral	O
,	O
radial	O
dorsalis	O
pedis	O
and	O
posterior	O
tibial	O
bilaterally	O
.	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2012	O
-	O
03	O
-	O
13	O
*	O
*	O
]	O
08	O
:	O
30am	O
wbc	O
-	O
13	O
.	O
4	O
*	O
rbc	O
-	O
3	O
.	O
75	O
*	O
hgb	O
-	O
11	O
.	O
9	O
*	O
hct	O
-	O
32	O
.	O
8	O
*	O
mcv	O
-	O
87	O
mch	O
-	O
31	O
.	O
7	O
mchc	O
-	O
36	O
.	O
3	O
*	O
rdw	O
-	O
12	O
.	O
9	O

[	O
*	O
*	O
2012	O
-	O
03	O
-	O
13	O
*	O
*	O
]	O
08	O
:	O
30am	O
alt	O
(	O
sgpt	O
)	O
-	O
59	O
*	O
ast	O
(	O
sgot	O
)	O
-	O
51	O
*	O
alk	O
phos	O
-	O
62	O
tot	O
bili	O
-	O
0	O
.	O
6	O

[	O
*	O
*	O
2012	O
-	O
03	O
-	O
13	O
*	O
*	O
]	O
08	O
:	O
30am	O
glucose	O
-	O
160	O
*	O
urea	O
n	O
-	O
12	O
creat	O
-	O
0	O
.	O
7	O
sodium	O
-	O
136	O
potassium	O
-	O
3	O
.	O
9	O
chloride	O
-	O
106	O
total	O
co2	O
-	O
25	O
anion	O
gap	O
-	O
9	O

[	O
*	O
*	O
2012	O
-	O
03	O
-	O
13	O
*	O
*	O
]	O
08	O
:	O
58am	O
type	O
-	O
art	O
rates	O
-	O
0	O
/	O
16	O
tidal	O
vol	O
-	O
600	O
peep	O
-	O
5	O
po2	O
-	O
290	O
*	O
pco2	O
-	O
42	O
ph	O
-	O
7	O
.	O
35	O
total	O
co2	O
-	O
24	O
base	O
xs	O
-	O
-	O
2	O
intubated	O
-	O
intubated	O

electrocardiogram	O
performed	O
on	O
:	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
13	O
*	O
*	O
]	O

atrial	O
activity	O
is	O
not	O
clearly	O
discernible	O
.	O

the	O
rhythm	O
appears	O
to	O
be	O
atrial	B
flutter	I
with	O
3	O
:	O
1	O
a	B
-	I
v	I
conduction	I
at	O
90	O
.	O

intraventricular	B
conduction	I
delay	I
.	O

prior	O
anteroseptal	O
and	O
lateral	B
myocardial	I
infarction	I
.	O

there	O
is	O
much	O
baseline	O
artifact	O
.	O

st	B
segment	I
elevations	I
in	O
leads	O
i	O
,	O
avl	O
and	O
v4	O
-	O
v6	O
consistent	O
with	O
active	O
anterolateral	O
ischemia	B
.	O

followup	O
and	O
clinical	O
correlation	O
are	O
suggested	O
.	O

no	O
previous	O
tracing	O
available	O
for	O
comparison	O
.	O

[	O
*	O
*	O
2012	O
-	O
03	O
-	O
13	O
*	O
*	O
]	O
echocardiogram	O

impression	O
:	O
severely	O
depressed	B
lv	I
systolic	I
function	I
(	O
lvef	O
20	O
-	O
25%	O
)	O
with	O
regional	O
wall	B
motion	I
abnormalities	I
c	O
/	O
w	O
cad	B
.	O

normal	O
rv	O
systolic	O
function	O
.	O

at	O
least	O
mild	O
mitral	O
and	O
aortic	B
regurgitation	I
.	O

[	O
*	O
*	O
2012	O
-	O
03	O
-	O
19	O
*	O
*	O
]	O
echocardiogram	O

mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
with	O
mild	O
regional	O
systolic	B
dysfunction	I
c	O
/	O
w	O
cad	B
.	O

mild	O
aortic	B
regurgitation	I
.	O

compared	O
with	O
the	O
prior	O
study	O
(	O
tape	O
reviewed	O
)	O
of	O
[	O
*	O
*	O
2011	O
-	O
03	O
-	O
13	O
*	O
*	O
]	O
,	O
global	O
left	B
ventricular	I
systolic	I
function	I
is	O
improved	O
.	O

mild	O
aortic	B
regurgitation	I
is	O
also	O
now	O
seen	O
.	O

[	O
*	O
*	O
2012	O
-	O
03	O
-	O
13	O
*	O
*	O
]	O
cardiac	O
catheterization	O

1	O
.	O
selective	O
coronary	O
arteriography	O
of	O
this	O
right	O
-	O
dominant	O
system	O
revealed	O
severe	O
lmca	B
disease	I
demonstrating	O
an	O
80%	O
distal	O
stenosis	B
.	O

the	O
lad	O
had	O
a	O
long	O
50%	O
lesion	B
involving	O
the	O
proximal	O
and	O
mid	O
vessel	O
as	O
well	O
as	O
the	O
d1	O
branch	O
.	O

the	O
lcx	O
and	O
rca	O
were	O
free	O
of	O
flow	O
-	O
limiting	O
stenoses	B
.	O

2	O
.	O
hemodynamic	O
evaluation	O
after	O
angiography	O
revealed	O
normal	O
right	O
-	O
sided	O
pressures	O
(	O
mean	O
ra	O
was	O
8	O
and	O
rvedp	O
was	O
10	O
mmhg	O
)	O
,	O
moderately	O
elevated	B
left	I
-	I
sided	I
pressures	I
(	O
mean	O
pcw	O
was	O
21	O
mmhg	O
)	O
,	O
and	O
moderately	O
elevated	B
pulmonary	I
pressures	I
(	O
pa	O
was	O
43	O
/	O
18	O
mmhg	O
)	O
.	O

the	O
cardiac	O
index	O
was	O
supranormal	O
at	O
6	O
.	O
9	O
l	O
/	O
min	O
/	O
m2	O
(	O
on	O
dopamine	O
infusion	O
,	O
during	O
1	O
:	O
1	O
intra	O
-	O
aortic	O
balloon	O
counterpulsations	O
,	O
and	O
using	O
an	O
assumed	O
oxygen	O
consumption	O
)	O
.	O

3	O
.	O
an	O
intra	O
-	O
aortic	O
balloon	O
pump	O
was	O
placed	O
via	O
the	O
right	O
femoral	O
arteriotomy	O
site	O
with	O
appropriate	O
diastolic	O
augmentation	O
and	O
systolic	O
unloading	O
.	O

[	O
*	O
*	O
2012	O
-	O
03	O
-	O
13	O
*	O
*	O
]	O
cxr	O

1	O
)	O
.	O

an	O
endotracheal	O
tube	O
terminates	O
is	O
slightly	O
proximal	O
in	O
location	O
.	O

2	O
)	O
.	O

pulmonary	O
parenchymal	O
opacity	B
is	O
present	O
within	O
the	O
left	O
lung	O
base	O
obscuring	O
the	O
left	O
hemidiaphragm	O
with	O
an	O
associated	O
small	O
left	O
-	O
sided	O
pleural	B
effusion	I
.	O

brief	O
hospital	O
course	O
:	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
was	O
admitted	O
to	O
the	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
346	O
*	O
*	O
]	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
medical	O
center	O
on	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
13	O
*	O
*	O
]	O
for	O
a	O
cardiac	O
catheterization	O
.	O

he	O
was	O
found	O
to	O
have	O
an	O
80%	O
stenosed	B
left	O
main	O
and	O
a	O
50%	O
stenosed	B
left	O
anterior	O
descending	O
artery	O
.	O

an	O
intra	O
-	O
aortic	O
balloon	O
pump	O
(	O
iabp	O
)	O
was	O
placed	O
for	O
coronary	O
perfusion	O
and	O
the	O
cardiac	O
surgical	O
service	O
was	O
consulted	O
for	O
surgical	O
evaluation	O
.	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
was	O
worked	O
-	O
up	O
in	O
the	O
usual	O
preoperative	O
manner	O
and	O
taken	O
urgently	O
to	O
the	O
operating	O
room	O
where	O
he	O
underwent	O
coronary	O
artery	O
bypass	O
grafting	O
to	O
two	O
vessels	O
.	O

postoperatively	O
he	O
was	O
taken	O
to	O
the	O
cardiac	O
surgical	O
intensive	O
care	O
unit	O
for	O
monitoring	O
.	O

his	O
iabp	O
was	O
weaned	O
and	O
removed	O
on	O
postoperative	O
day	O
one	O
without	O
complication	B
.	O

on	O
postoperative	O
day	O
two	O
,	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
740	O
*	O
*	O
]	O
neurologically	O
intact	O
and	O
was	O
extubated	O
.	O

amiodarone	O
was	O
continued	O
for	O
prevention	O
of	O
ventricular	B
arrythmias	I
.	O

he	O
was	O
placed	O
on	O
a	O
course	O
of	O
zosyn	O
for	O
thick	O
,	O
yellow	O
bronchial	B
secretions	I
.	O

on	O
postoperative	O
day	O
three	O
,	O
he	O
was	O
transferred	O
to	O
the	O
cardiac	O
surgical	O
step	O
down	O
unit	O
for	O
further	O
recovery	O
.	O

he	O
was	O
gently	O
diuresed	O
towards	O
his	O
preoperative	O
weight	O
.	O

his	O
epicardial	O
pacing	O
wires	O
and	O
drains	O
were	O
removed	O
per	O
protocol	O
.	O

the	O
physical	O
therapy	O
service	O
was	O
consulted	O
for	O
assistance	O
with	O
his	O
postoperative	O
strength	O
and	O
mobility	O
.	O

given	O
his	O
history	O
of	O
a	O
ventricular	B
tachycardia	I
arrest	I
and	O
low	B
ejection	I
fraction	I
,	O
the	O
electrophysiology	O
service	O
was	O
consulted	O
.	O

a	O
repeat	O
echocardiogram	O
revealed	O
improvement	O
in	O
his	O
left	B
ventricular	I
ejection	I
fraction	I
from	O
20%	O
to	O
roughly	O
35%	O
.	O

it	O
was	O
recommended	O
to	O
add	O
betablockade	O
and	O
follow	O
-	O
up	O
in	O
4	O
-	O
6	O
weeks	O
with	O
his	O
cardiologist	O
for	O
a	O
repeat	O
echocardiogram	O
with	O
possible	O
referral	O
to	O
the	O
electrophysiology	O
service	O
for	O
further	O
testing	O
.	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
continued	O
to	O
make	O
steady	O
progress	O
and	O
was	O
discharged	O
home	O
on	O
postoperative	O
day	O
six	O
.	O

he	O
will	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
,	O
his	O
cardiologist	O
and	O
his	O
primary	O
care	O
physician	O
as	O
an	O
outpatient	O
.	O

medications	O
on	O
admission	O
:	O

aspirin	O
325mg	O
once	O
daily	O

synthroid	O
100mcg	O
once	O
daily	O

lipitor	O
20mg	O
once	O
daily	O

discharge	O
medications	O
:	O

1	O
.	O
furosemide	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
for	O
7	O
days	O
.	O

disp	O
:	O
*	O
14	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

2	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

3	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

4	O
.	O
levothyroxine	O
sodium	O
100	O
mcg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

5	O
.	O
amiodarone	O
hcl	O
200	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
7	O
days	O
:	O
then	O
decrease	O
to	O
400	O
mg	O
po	O
daily	O
for	O
7	O
days	O
,	O
then	O
decrease	O
to	O
200	O
mg	O
po	O
daily	O
.	O

disp	O
:	O
*	O
50	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

6	O
.	O
potassium	O
chloride	O
10	O
meq	O
capsule	O
,	O
sustained	O
release	O
sig	O
:	O
two	O
(	O
2	O
)	O
capsule	O
,	O
sustained	O
release	O
po	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
for	O
7	O
days	O
.	O

disp	O
:	O
*	O
28	O
capsule	O
,	O
sustained	O
release	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

7	O
.	O
atorvastatin	O
calcium	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

coronary	B
artery	I
disease	I
.	O

discharge	O
condition	O
:	O

good	O
.	O

discharge	O
instructions	O
:	O

follow	O
medications	O
on	O
discharge	O
instructions	O
.	O

you	O
may	O
not	O
drive	O
for	O
4	O
weeks	O
.	O

you	O
may	O
not	O
lift	O
more	O
than	O
10	O
lbs	O
.	O
for	O
3	O
months	O
.	O

you	O
should	O
shower	O
,	O
let	O
water	O
flow	O
over	O
wounds	O
,	O
pat	O
dry	O
with	O
a	O
towel	O
.	O

followup	O
instructions	O
:	O

make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
for	O
1	O
-	O
2	O
weeks	O
.	O

make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
725	O
*	O
*	O
]	O
for	O
2	O
-	O
3	O
weeks	O
.	O

make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
for	O
4	O
weeks	O
.	O

[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
574	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
575	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
745	O
*	O
*	O
]	O
pa	O
80	O
-	O
bye	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
12	O
*	O
*	O
]	O
@	O
1017	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
13	O
*	O
*	O
]	O
3	O
:	O
26	O
pm	O

(	O
end	O
of	O
report	O
)	O

4075	O
||||	O
16660	O
||||	O
19936	O
||||	O
discharge	O
_	O
summary	O
||||	O
2019	O
-	O
12	O
-	O
15	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
12	O
-	O
15	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1949	O
-	O
03	O
-	O
14	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
cardiothoracic	O

allergies	O
:	O

lipitor	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
98	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

chest	B
pain	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

[	O
*	O
*	O
12	O
-	O
06	O
*	O
*	O
]	O
cardiac	O
catherization	O

[	O
*	O
*	O
12	O
-	O
11	O
*	O
*	O
]	O
coronary	O
artery	O
bypass	O
graft	O
(	O
left	O
internal	O
mammary	O
artery	O
-	O
>	O
left	O
anterior	O
descending	O
artery	O
,	O
saphenous	O
vein	O
graft	O
-	O
>	O
diagonal	O
,	O
saphenous	O
vein	O
graft	O
-	O
>	O
obtuse	O
marginal	O
)	O
and	O
aortic	O
valve	O
replacement	O
(	O
21mm	O
pericardial	O
)	O
and	O
septal	O
myomectomy	O

history	O
of	O
present	O
illness	O
:	O

70	O
yo	O
m	O
with	O
mild	O
as	B
,	O
hyperlipidemia	B
who	O
presents	O
with	O
chest	B
pain	I
on	I
exersion	I
.	O

he	O
reports	O
minimal	O
chest	B
discomfort	I
with	I
exertion	I
x1	O
year	O
,	O
improved	O
with	O
belching	B
,	O
no	O
improved	O
with	O
ppi	O
.	O

he	O
had	O
a	O
stress	O
mibi	O
which	O
per	O
report	O
showed	O
significant	O
ischemia	B
at	O
apex	O
and	O
septum	O
.	O

tte	O
showed	O
ef	O
60%	O
with	O
mild	O
as	B
but	O
valve	O
gradient	O
0	O
.	O
8	O
.	O

now	O
referred	O
for	O
cardiac	O
catherization	O

past	O
medical	O
history	O
:	O

coronary	B
artery	I
disease	I

aortic	I
stenosis	I

hyperlipidemia	I

hiatal	I
hernia	I

gilberts	I
disease	I

h	O
/	O
o	O
tonsillectomy	O

social	O
history	O
:	O

retired	O
fire	O
fighter	O
captain	O
.	O

denies	O
tobacco	O
use	O
,	O
2	O
beers	O
[	O
*	O
*	O
03	O
-	O
09	O
*	O
*	O
]	O
times	O
per	O
week	O
.	O

lives	O
with	O
spouse	O

family	O
history	O
:	O

nc	O

physical	O
exam	O
:	O

t	O
:	O
nr	O
bp	O
:	O
139	O
/	O
69	O
p	O
:	O
70	O
rr	O
:	O
16	O
o2	O
sats	O
:	O
100%	O

gen	O
:	O
nad	B

heent	O
:	O
nc	O
,	O
at	O
,	O
perrl	O
,	O
eomi	O
,	O
mmm	O

neck	O
:	O
no	O
lad	B
,	O
systolic	B
ejection	I
murmur	I
radiating	O
to	O
carotid	O
arteries	O
b	O
/	O
l	O

cv	O
:	O
rrr	O
,	O
nl	O
s1	O
,	O
s2	O
,	O
3	O
/	O
6	O
systolic	B
ejection	I
murmur	I
at	O
lusb	O
radiating	O
to	O
carotids	O

resp	O
:	O
cta	O
anteriorly	O

abd	O
:	O
soft	O
,	O
nontender	O
,	O
nondistended	O
,	O
bowel	O
sounds	O
present	O

ext	O
:	O
no	O
edema	B
,	O
pedal	O
pulses	O
2	O
+	O
bilaterally	O
.	O

r	O
grion	O
dressing	O
dry	O
and	O
intact	O
,	O
no	O
hematoma	B
,	O
no	O
carotid	B
bruits	I

neuro	O
:	O
cn	O
ii	O
-	O
xii	O
intact	O
,	O
sensation	O
intact	O

discharge	O

99	O
.	O
6	O
,	O
90	O
,	O
120	O
/	O
70	O
,	O
18	O
96%	O
ra	O

gen	O
:	O
nad	B
a	O
/	O
o	O
x3	O

card	O
rrr	O

lungs	O
cta	O

abd	B
nt	I
,	O
nd	O
+	O
bs	O
,	O
soft	O

ext	O
trace	O
edema	B

pertinent	O
results	O
:	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
15	O
*	O
*	O
]	O
04	O
:	O
35am	O
blood	O
wbc	O
-	O
7	O
.	O
1	O
rbc	O
-	O
2	O
.	O
81	O
*	O
hgb	O
-	O
9	O
.	O
1	O
*	O
hct	O
-	O
25	O
.	O
3	O
*	O
mcv	O
-	O
90	O
mch	O
-	O
32	O
.	O
5	O
*	O
mchc	O
-	O
36	O
.	O
2	O
*	O
rdw	O
-	O
14	O
.	O
3	O
plt	O
ct	O
-	O
119	O
*	O
#	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
02	O
:	O
10pm	O
blood	O
wbc	O
-	O
4	O
.	O
8	O
rbc	O
-	O
4	O
.	O
05	O
*	O
hgb	O
-	O
13	O
.	O
2	O
*	O
hct	O
-	O
36	O
.	O
1	O
*	O
mcv	O
-	O
89	O
mch	O
-	O
32	O
.	O
6	O
*	O
mchc	O
-	O
36	O
.	O
6	O
*	O
rdw	O
-	O
13	O
.	O
7	O
plt	O
ct	O
-	O
253	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
15	O
*	O
*	O
]	O
04	O
:	O
35am	O
blood	O
plt	O
ct	O
-	O
119	O
*	O
#	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
13	O
*	O
*	O
]	O
02	O
:	O
46am	O
blood	O
pt	O
-	O
14	O
.	O
7	O
*	O
ptt	O
-	O
28	O
.	O
2	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
3	O
*	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
02	O
:	O
10pm	O
blood	O
pt	O
-	O
13	O
.	O
5	O
*	O
ptt	O
-	O
101	O
.	O
9	O
*	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
2	O
*	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
02	O
:	O
10pm	O
blood	O
plt	O
ct	O
-	O
253	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
15	O
*	O
*	O
]	O
04	O
:	O
35am	O
blood	O
glucose	O
-	O
107	O
*	O
urean	O
-	O
18	O
creat	O
-	O
0	O
.	O
9	O
na	O
-	O
139	O
k	O
-	O
3	O
.	O
8	O
cl	O
-	O
102	O
hco3	O
-	O
29	O
angap	O
-	O
12	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
02	O
:	O
10pm	O
blood	O
glucose	O
-	O
141	O
*	O
urean	O
-	O
11	O
creat	O
-	O
1	O
.	O
0	O
na	O
-	O
141	O
k	O
-	O
3	O
.	O
5	O
cl	O
-	O
105	O
hco3	O
-	O
28	O
angap	O
-	O
12	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
02	O
:	O
10pm	O
blood	O
alt	O
-	O
14	O
ast	O
-	O
17	O
alkphos	O
-	O
40	O
totbili	O
-	O
0	O
.	O
4	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
14	O
*	O
*	O
]	O
04	O
:	O
20am	O
blood	O
mg	O
-	O
2	O
.	O
0	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
02	O
:	O
10pm	O
blood	O
%hba1c	O
-	O
5	O
.	O
1	O
[	O
hgb	O
]	O
-	O
done	O
[	O
a1c	O
]	O
-	O
done	O

[	O
*	O
*	O
2019	O
-	O
12	O
-	O
07	O
*	O
*	O
]	O
06	O
:	O
57am	O
blood	O
triglyc	O
-	O
73	O
hdl	O
-	O
51	O
chol	O
/	O
hd	O
-	O
3	O
.	O
9	O
ldlcalc	O
-	O
133	O
*	O

cxr	O
[	O
*	O
*	O
12	O
-	O
14	O
*	O
*	O
]	O

median	O
sternotomy	O
and	O
aortic	O
valve	O
prosthesis	O
is	O
identified	O
and	O
unchanged	O
.	O

there	O
is	O
again	O
seen	O
a	O
left	O
apical	O
pneumothorax	B
which	O
is	O
small	O
and	O
unchanged	O
since	O
the	O
previous	O
study	O
.	O

there	O
is	O
a	O
small	O
amount	O
of	O
free	B
air	I
underneath	O
the	O
right	O
hemidiaphragm	O
.	O

no	O
focal	O
consolidation	B
,	O
signs	O
of	O
pulmonary	B
edema	I
,	O
or	O
pleural	B
effusions	I
are	O
noted	O
.	O

impression	O
:	O

1	O
.	O
persistent	O
left	O
apical	O
pneumothorax	B
and	O
free	B
air	I
underneath	O
the	O
hemidiaphragm	O
not	O
significantly	O
changed	O
.	O

2	O
.	O
small	O
bilateral	B
pleural	I
effusions	I
are	O
also	O
stable	O
.	O

[	O
*	O
*	O
12	O
-	O
11	O
*	O
*	O
]	O
tee	O

conclusions	O
:	O

pre	O
-	O
cpb	O
:	O
no	O
mass	B
/	O
thrombus	B
is	O
seen	O
in	O
the	O
left	O
atrium	O
or	O
left	O
atrial	O
appendage	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

there	O
are	O
simple	O
atheroma	B
in	O
the	O
aortic	O
root	O
.	O

the	O
ascending	O
aorta	O
is	O
mildly	O
dilated	O
.	O

there	O
are	O
simple	O
atheroma	B
in	O
the	O
ascending	O
aorta	O
.	O

the	O
descending	O
thoracic	O
aorta	O
is	O
mildly	O
dilated	O
.	O

there	O
are	O
simple	O
atheroma	B
in	O
the	O
descending	O
thoracic	O
aorta	O
.	O

the	O
number	O
of	O
aortic	O
valve	O
leaflets	O
cannot	O
be	O
determined	O
.	O

there	O
is	O
moderate	O
aortic	B
valve	I
stenosis	I
(	O
area	O
0	O
.	O
8	O
-	O
1	O
.	O
19cm2	O
)	O
mild	O
to	O
moderate	O
(	O
[	O
*	O
*	O
01	O
-	O
07	O
*	O
*	O
]	O
+	O
)	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

trivial	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

the	O
inter	O
-	O
ventricular	O
septum	O
is	O
hypertrophied	B
near	O
the	O
lvot	O
,	O
but	O
does	O
not	O
cause	O

obstruction	B
or	O
a	O
gradient	B
.	O

post	O
-	O
cpb	O
:	O
preserved	O
biventricular	O
systolic	O
fxn	O
.	O

a	O
prosthetic	O
aortic	O
valve	O
is	O
seen	O
with	O
good	O
leaflet	O
excursion	O
,	O
trace	O
regurgitation	O
and	O
a	O
residual	O
peak	O
gradient	O
of	O
19	O
mmhg	O
.	O

ascending	O
and	O
descending	O
aorta	O
intact	O
.	O

a	O
small	O
septal	O
myotomy	O
has	O
been	O
done	O
at	O
the	O
lvot	O
.	O

other	O
parameters	O
as	O
pre	O
-	O
bypass	O
.	O

brief	O
hospital	O
course	O
:	O

70	O
year	O
old	O
male	O
admitted	O
for	O
workup	O
of	O
angina	B
which	O
cardiac	O
catherization	O
revealed	O
lm	O
and	O
lad	O
disease	B
with	O
aortic	B
stenosis	I
.	O

underwent	O
cardiac	O
surgery	O
pre	O
operative	O
work	O
up	O
and	O
was	O
transfered	O
to	O
the	O
operating	O
room	O
on	O
[	O
*	O
*	O
12	O
-	O
11	O
*	O
*	O
]	O
and	O
underwent	O
coronary	O
artery	O
bypass	O
graft	O
,	O
aortic	O
valve	O
replacement	O
,	O
and	O
septal	O
myomectomy	O
.	O

please	O
see	O
operative	O
report	O
for	O
further	O
details	O
.	O

he	O
was	O
transferred	O
to	O
cardiac	O
surgery	O
recovery	O
unit	O
for	O
continued	O
hemodynamic	O
monitoring	O
on	O
neosynephrine	O
and	O
propofol	O
.	O

with	O
in	O
the	O
first	O
24	O
hours	O
he	O
awoke	O
neurologically	O
intact	O
,	O
extubated	O
without	O
difficulty	O
,	O
and	O
weaned	O
from	O
vasoactive	O
medications	O
.	O

he	O
continued	O
to	O
progress	O
,	O
was	O
started	O
on	O
beta	O
blockers	O
and	O
on	O
post	O
operative	O
day	O
2	O
he	O
was	O
transferred	O
to	O
[	O
*	O
*	O
wardname	O
*	O
*	O
]	O
2	O
.	O
he	O
continued	O
to	O
progress	O
and	O
worked	O
with	O
physical	O
therapy	O
.	O

on	O
post	O
operative	O
day	O
4	O
he	O
was	O
ready	O
for	O
discharge	O
home	O
with	O
vna	O
services	O
.	O

medications	O
on	O
admission	O
:	O

asa	O
81	O

zocor	O
40	O

zetia	O
10	O

prilosec	O
20	O

mvi	O

glucosamine	O

discharge	O
medications	O
:	O

1	O
.	O
furosemide	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
for	O
5	O
days	O
:	O
for	O
5	O
days	O
.	O

disp	O
:	O
*	O
5	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

2	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

3	O
.	O
simvastatin	O
40	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

4	O
.	O
ezetimibe	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

5	O
.	O
metoprolol	O
tartrate	O
25	O
mg	O
tablet	O
sig	O
:	O
three	O
(	O
3	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
180	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

prilosec	O
20mg	O
once	O
a	O
day	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

coronary	B
artery	I
disease	I
s	O
/	O
p	O
cabg	O

aortic	B
stenosis	I
s	O
/	O
p	O
avr	O

hyperlipidemia	B

hiatal	I
hernia	I

gilberts	I
disease	I

discharge	O
condition	O
:	O

good	O
.	O

discharge	O
instructions	O
:	O

may	O
shower	O
,	O
no	O
baths	O
or	O
swimming	O

monitor	O
wounds	O
for	O
infection	O
-	O
redness	O
,	O
drainage	O
or	O
increased	O
pain	B

report	O
any	O
fever	B
greater	O
than	O
101	O

report	O
any	O
weight	B
gain	I
of	O
greater	O
than	O
2	O
pounds	O
in	O
24	O
hours	O
or	O
5	O
pounds	O
in	O
one	O
week	O

no	O
creams	O
or	O
lotions	O
or	O
ointments	O
to	O
incisions	O

no	O
driving	O
for	O
one	O
month	O

no	O
lifting	O
more	O
than	O
10	O
pounds	O
for	O
10	O
weeks	O

please	O
call	O
with	O
questions	O
or	O
concerns	O

followup	O
instructions	O
:	O

dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
ct	O
surgery	O
clinic	O
in	O
4	O
weeks	O
.	O

please	O
call	O
for	O
an	O
appointment	O
at	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
101	O
*	O
*	O
]	O
dr	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
5356	O
*	O
*	O
]	O
in	O
1	O
week	O
-	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
5357	O
*	O
*	O
]	O
please	O
call	O
for	O
appointment	O
wound	B
check	O
appointment	O
[	O
*	O
*	O
wardname	O
*	O
*	O
]	O
as	O
instructed	O
by	O
nurse	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
1	O
)	O
*	O
*	O
]	O

[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
103	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
104	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
378	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
379	O
*	O
*	O
]	O
np	O
80	O
-	O
cdh	O
[	O
*	O
*	O
2019	O
-	O
12	O
-	O
16	O
*	O
*	O
]	O
@	O
0959	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
2020	O
-	O
01	O
-	O
17	O
*	O
*	O
]	O
5	O
:	O
25	O
pm	O
(	O
end	O
of	O
report	O
)	O

10128	O
||||	O
16677	O
||||	O
19369	O
||||	O
discharge	O
_	O
summary	O
||||	O
2010	O
-	O
11	O
-	O
18	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
16	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
18	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1964	O
-	O
06	O
-	O
16	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
neurosurgical	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
a	O
46	O
year	O
-	O
old	O
woman	O
with	O
a	O
history	O
of	O
a	O
cerebral	B
aneurysm	I
that	O
was	O
clipped	O
in	O
[	O
*	O
*	O
2001	O
*	O
*	O
]	O
,	O
also	O
history	O
of	O
headaches	B
,	O
hypertension	B
,	O
diabetes	B
,	O
hepatitis	B
c	I
,	O
depression	B
.	O

she	O
was	O
admitted	O
to	O
the	O
neurosurgical	O
service	O
for	O
a	O
four	O
vessel	O
angiogram	O
and	O
possible	O
coiling	O
of	O
her	O

past	O
medical	O
history	O
:	O
as	O
stated	O
,	O
history	O
of	O
headaches	B
,	O
hypertension	B
,	O
diabetes	B
,	O
hepatitis	B
c	I
,	O
depression	B
.	O

medications	O
:	O
mavic	O
2	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
zoloft	O
100	O
mg	O
q	O
.	O
d	O
.	O
,	O

neurontin	O
300	O
mg	O
in	O
the	O
morning	O
and	O
900	O
mg	O
at	O
night	O
,	O
percocet	O
prn	O
,	O
verapamil	O
240	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O

allergies	O
:	O
imitrex	O
and	O
compazine	O
.	O

social	O
history	O
:	O
the	O
patient	O
occasionally	O
drinks	O
alcohol	O
.	O

has	O
a	O
history	O
of	O
crack	O
abuse	O
and	O
smokes	O
an	O
unknown	O
amount	O
of	O
cigarettes	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
underwent	O
four	O
vessel	O
angiogram	O
demonstrating	O
aneurysm	B
of	O
the	O
right	O
posterior	O
cerebral	O
artery	O
/	O
basilar	O
artery	O
junction	O
.	O

coiling	O
was	O
attempted	O
,	O
but	O
due	O
to	O
the	O
tortuous	B
course	O
of	O
the	O
vertebral	O
artery	O
the	O
risks	O
of	O
attempting	O
coiling	O
were	O
greater	O
then	O
the	O
benefits	O
of	O
protection	O
from	O
hemorrhage	B
.	O

the	O
patient	O
was	O
therefore	O
taken	O
back	O
to	O
the	O
intensive	O
care	O
unit	O
where	O
she	O
was	O
monitored	O
overnight	O
given	O
the	O
manipulation	O
using	O
the	O
microcatheter	O
.	O

she	O
remains	O
neurologically	O
stable	O
.	O

headache	B
was	O
treated	O
with	O
percocet	O
.	O

she	O
was	O
transferred	O
to	O
the	O
neurosurgical	O
floor	O
on	O
[	O
*	O
*	O
11	O
-	O
17	O
*	O
*	O
]	O
and	O
discharged	O
on	O
[	O
*	O
*	O
11	O
-	O
18	O
*	O
*	O
]	O
.	O

the	O
patient	O
will	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1120	O
*	O
*	O
]	O
in	O
two	O
weeks	O
.	O

[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
1121	O
*	O
*	O
]	O
[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
1122	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1248	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
18	O
*	O
*	O
]	O
10	O
:	O
28	O

t	O
:	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
22	O
*	O
*	O
]	O
07	O
:	O
49	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
1249	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
1121	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
22	O
*	O
*	O
]	O
7	O
:	O
24	O
pm	O

(	O
end	O
of	O
report	O
)	O

13010	O
||||	O
16743	O
||||	O
17174	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
09	O
-	O
02	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
08	O
-	O
28	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1959	O
-	O
03	O
-	O
05	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O

th	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3796	O
*	O
*	O
]	O
a	O
54	O
-	O
year	O
-	O
old	O
male	O
with	O
a	O
known	O
mitral	B
valve	I
prolapse	I
since	O
adolescence	O
who	O
developed	O
significant	O
regurgitation	O
.	O

he	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
[	O
*	O
*	O
2013	O
-	O
08	O
-	O
28	O
*	O
*	O
]	O
where	O
a	O
mitral	O
valve	O
repair	O
was	O
done	O
.	O

the	O
patient	O
did	O
well	O
postoperatively	O
and	O
was	O
transferred	O
to	O
the	O
csru	O
.	O

he	O
was	O
fully	O
weaned	O
from	O
his	O
ventilator	O
and	O
extubated	O
.	O

he	O
continued	O
to	O
improve	O
.	O

physical	O
therapy	O
was	O
consulted	O
for	O
ambulation	O
and	O
he	O
did	O
well	O
postoperatively	O
.	O

the	O
chest	O
tube	O
was	O
removed	O
.	O

his	O
foley	O
was	O
pulled	O
and	O
he	O
was	O
kept	O
on	O
a	O
-	O
pacing	O
due	O
to	O
slow	O
return	O
of	O
sinus	O
rhythm	O
.	O

he	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
postoperative	O
day	O
#2	O
.	O
he	O
continued	O
to	O
improve	O
.	O

his	O
chest	O
tube	O
was	O
pulled	O
.	O

his	O
foley	O
had	O
been	O
removed	O
at	O
midnight	O
.	O

he	O
improved	O
and	O
physical	O
therapy	O
came	O
to	O
see	O
him	O
.	O

they	O
suggested	O
for	O
him	O
to	O
go	O
home	O
with	O
full	O
ambulation	O
.	O

his	O
wires	O
were	O
removed	O
on	O
postoperative	O
day	O
#2	O
and	O
on	O
postoperative	O
day	O
#3	O
,	O
the	O
patient	O
was	O
discharged	O
home	O
on	O
stable	O
condition	O
.	O

he	O
was	O
given	O
prescriptions	O
for	O
percocet	O
1	O
to	O
2	O
tablets	O
po	O
q4h	O
,	O
zantac	O
150	O
po	O
bid	O
,	O
colace	O
100	O
po	O
bid	O
,	O
kcl	O
20	O
milliequivalents	O
po	O
bid	O
,	O
lasix	O
20	O
mg	O
po	O
bid	O
,	O
motrin	O
400	O
po	O
q6h	O
prn	O
.	O

the	O
patient	O
is	O
instructed	O
to	O
follow	O
up	O
in	O
one	O
to	O
two	O
weeks	O
with	O
is	O
primary	O
care	O
physician	O
and	O
four	O
to	O
six	O
weeks	O
with	O
dr	O
.	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
3797	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
.	O

the	O
patient	O
is	O
discharged	O
in	O
stable	O
condition	O
.	O

[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
473	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
3798	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2013	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
10	O
:	O
36	O

t	O
:	O
[	O
*	O
*	O
2013	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
10	O
:	O
45	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
3799	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2013	O
-	O
09	O
-	O
24	O
*	O
*	O
]	O
1	O
:	O
58	O
pm	O

(	O
end	O
of	O
report	O
)	O

825	O
||||	O
16997	O
||||	O
20375	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
01	O
-	O
19	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
01	O
-	O
02	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
01	O
-	O
19	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1937	O
-	O
01	O
-	O
18	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
cardiothoracic	O

addendum	O
:	O
on	O
the	O
day	O
of	O
discharge	O
[	O
*	O
*	O
01	O
-	O
13	O
*	O
*	O
]	O
the	O
plan	O
was	O
to	O
discharge	O
the	O
patient	O
to	O
rehab	O
when	O
his	O
sternal	B
drainage	I
decreased	O
.	O

on	O
examination	O
on	O
the	O
morning	O
of	O
the	O
18th	O
he	O
had	O
continued	O
drainage	B
and	O
his	O
rehab	O
bed	O
was	O
canceled	O
.	O

he	O
was	O
continued	O
on	O
antibiotics	O
and	O
he	O
continued	O
his	O
physical	O
therapy	O
while	O
he	O
remained	O
under	O
observation	O
.	O

on	O
the	O
19th	O
he	O
was	O
comfortable	O
with	O
no	O
complaints	B
.	O

he	O
was	O
hemodynamically	O
stable	O
and	O
afebrile	B
sating	O
95%	O
on	O
room	O
air	O
.	O

his	O
sternal	O
dressing	O
had	O
2	O
cm	O
spot	O
of	O
serosanguinous	B
staining	I
again	O
.	O

his	O
lungs	O
were	O
clear	O
.	O

his	O
heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
.	O

he	O
had	O
trace	O
to	O
1	O
+	O
edema	B
in	O
his	O
bilateral	O
lower	O
extremities	O
.	O

additional	O
laboratory	O
work	O
was	O
done	O
with	O
a	O
chest	O
x	O
-	O
ray	O
to	O
follow	O
on	O
his	O
postoperative	O
twelfth	O
day	O
.	O

on	O
the	O
evening	O
of	O
the	O
19th	O
the	O
resident	O
was	O
called	O
to	O
see	O
the	O
patient	O
for	O
a	O
temperature	B
max	O
of	O
101	O
.	O
6	O
with	O
no	O
complaints	B
.	O

he	O
was	O
sating	O
well	O
.	O

he	O
was	O
generally	O
comfortable	O
.	O

his	O
sternum	O
had	O
no	O
drainage	O
that	O
evening	O
or	O
no	O
erythema	B
,	O
but	O
his	O
right	O
lower	O
extremity	O
was	O
warm	B
and	O
erythematous	B
around	O
the	O
saphenectomy	O
site	O
.	O

he	O
appeared	O
to	O
have	O
some	O
dried	O
blood	O
at	O
the	O
wound	B
without	O
any	O
exudate	O
and	O
no	O
drainage	O
from	O
the	O
wound	B
.	O

no	O
fluid	B
collection	I
was	O
appreciated	O
and	O
the	O
[	O
*	O
*	O
doctor	O
last	O
name	O
2567	O
*	O
*	O
]	O
for	O
a	O
source	O
of	O
his	O
fever	B
continued	O
.	O

he	O
was	O
noted	O
to	O
have	O
pleural	B
effusion	I
to	O
be	O
aspirated	O
under	O
ultrasound	O
guidance	O
in	O
the	O
morning	O
.	O

a	O
sputum	O
culture	O
was	O
sent	O
.	O

urinalysis	O
and	O
cns	O
was	O
sent	O
.	O

his	O
examination	O
was	O
consistent	O
with	O
some	O
cellulitis	B
of	O
his	O
right	O
lower	O
extremity	O
.	O

the	O
patient	O
was	O
on	O
vancomycin	O
and	O
peaks	O
and	O
troughs	O
were	O
to	O
be	O
checked	O
.	O

he	O
had	O
blood	O
cultures	O
sent	O
off	O
.	O

he	O
did	O
not	O
have	O
any	O
pain	B
or	O
discomfort	B
with	O
that	O
.	O

on	O
the	O
20th	O
he	O
was	O
afebrile	B
overnight	O
.	O

his	O
right	O
lower	O
extremity	O
dressing	O
became	O
soaked	O
with	O
increased	O
amount	O
of	O
dark	B
blood	I
after	O
steri	O
-	O
strips	O
was	O
removed	O
from	O
his	O
incision	O
.	O

his	O
extremities	O
did	O
not	O
have	O
any	O
drainage	B
.	O

his	O
temperature	O
max	O
was	O
101	O
.	O
6	O
down	O
to	O
101	O
.	O
2	O
at	O
the	O
time	O
of	O
examination	O
.	O

he	O
was	O
sating	O
well	O
on	O
room	O
air	O
and	O
was	O
hemodynamically	O
stable	O
.	O

he	O
continued	O
on	O
vancomycin	O
and	O
levofloxacin	O
for	O
his	O
wound	B
coverage	O
.	O

his	O
other	O
continuing	O
issue	O
was	O
a	O
little	O
bit	O
of	O
dysphagia	B
and	O
was	O
seen	O
by	O
the	O
speech	O
and	O
orl	O
service	O
.	O

he	O
was	O
also	O
continued	O
to	O
be	O
followed	O
by	O
physical	O
therapy	O
and	O
case	O
management	O
who	O
was	O
reviewing	O
his	O
need	O
for	O
a	O
bed	O
.	O

he	O
also	O
received	O
a	O
podiatry	O
consult	O
who	O
noted	O
his	O
signs	O
of	O
peripheral	B
neuropathy	I
.	O

his	O
swallowing	O
trial	O
was	O
deferred	O
on	O
the	O
21st	O
as	O
the	O
patient	O
had	O
been	O
up	O
all	O
evening	O
and	O
was	O
exhausted	B
.	O

on	O
the	O
21st	O
he	O
was	O
ambulating	O
a	O
level	O
three	O
/	O
four	O
with	O
no	O
complaints	B
with	O
a	O
temperature	O
max	O
of	O
100	O
.	O
4	O
remaining	O
febrile	B
to	O
100	O
.	O
1	O
at	O
the	O
time	O
of	O
examination	O
.	O

he	O
was	O
comfortable	O
.	O

he	O
was	O
hemodynamically	O
stable	O
.	O

his	O
sternum	O
had	O
no	O
drainage	O
.	O

his	O
right	O
lower	O
extremity	O
,	O
his	O
groin	O
wound	O
had	O
no	O
drainage	O
.	O

he	O
had	O
decreased	O
induration	O
of	O
his	O
distal	O
wound	O
.	O

the	O
culture	O
of	O
the	O
hematoma	B
aspirate	O
was	O
still	O
pending	O
.	O

his	O
white	O
count	O
was	O
15	O
.	O
4	O
with	O
a	O
hematocrit	O
of	O
31	O
.	O
7	O
with	O
a	O
k	O
of	O
4	O
.	O
9	O
and	O
a	O
bun	O
of	O
40	O
and	O
creatinine	O
2	O
.	O
0	O
,	O
which	O
was	O
a	O
slight	O
increase	O
.	O

he	O
was	O
to	O
continue	O
on	O
his	O
levofloxacin	O
and	O
vancomycin	O
for	O
thirteen	O
more	O
days	O
.	O

his	O
lasix	O
was	O
discontinued	O
.	O

he	O
had	O
some	O
crackles	I
on	O
the	O
right	O
side	O
of	O
his	O
lungs	O
greater	O
then	O
left	O
.	O

he	O
did	O
have	O
a	O
grade	O
2	O
over	O
6	O
systolic	B
murmur	I
,	O
but	O
his	O
heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
.	O

after	O
his	O
examination	O
on	O
the	O
21st	O
on	O
postoperative	O
day	O
thirteen	O
with	O
decreased	O
induration	O
of	O
his	O
distal	O
wound	O
his	O
white	O
count	O
was	O
15	O
.	O
4	O
,	O
hematocrit	O

31	O
.	O
7	O
,	O
bun	O
36	O
,	O
creatinine	O
1	O
.	O
6	O
with	O
a	O
k	O
of	O
4	O
.	O
5	O
.	O

the	O
aspirate	O
results	O
were	O
pending	O
.	O

he	O
continued	O
on	O
vancomycin	O
day	O
seven	O
and	O
levofloxacin	O
day	O
two	O
.	O

he	O
was	O
followed	O
by	O
physical	O
therapy	O
.	O

on	O
postoperative	O
day	O
fifteen	O
[	O
*	O
*	O
01	O
-	O
17	O
*	O
*	O
]	O
he	O
was	O
ambulating	O
approximately	O
100	O
feet	O
,	O
but	O
needed	O
a	O
wheel	O
chair	O
to	O
return	O
to	O
the	O
room	O
.	O

he	O
had	O
no	O
new	O
complaints	B
.	O

his	O
temperature	O
max	O
was	O
101	O
.	O
1	O
with	O
98	O
.	O
2	O
at	O
the	O
time	O
of	O
examination	O
.	O

his	O
lungs	O
were	O
clear	O
bilaterally	O
.	O

his	O
heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
.	O

his	O
right	O
lower	O
extremity	O
groin	O
wound	B
was	O
clean	O
,	O
dry	O
and	O
intact	O
.	O

his	O
distal	O
wound	B
was	O
unchanged	O
.	O

his	O
wound	B
aspirate	O
from	O
the	O
proximal	O
leg	O
showed	O
no	O
pmns	O
and	O
no	O
growth	O
to	O
date	O
.	O

he	O
continued	O
on	O
levofloxacin	O
and	O
vancomycin	O
with	O
a	O
possibility	O
of	O
a	O
picc	O
line	O
placement	O
on	O
friday	O
.	O

on	O
postoperative	O
day	O
sixteen	O
his	O
temperature	O
max	O
was	O
100	O
.	O
8	O
.	O

he	O
had	O
some	O
crackles	B
on	O
the	O
right	O
side	O
greater	O
then	O
the	O
left	O
with	O
a	O
systolic	B
ejection	I
murmur	I
of	O
grade	O
2	O
over	O
6	O
.	O
his	O
extremities	O
were	O
intact	O
with	O
no	O
edema	B
bilaterally	O
.	O

his	O
sternum	O
had	O
no	O
drainage	O
.	O

his	O
white	O
count	O
dropped	O
to	O
11	O
.	O
0	O
with	O
a	O
hematocrit	O
of	O
30	O
.	O
7	O
,	O
but	O
his	O
creatinine	O
rose	O
to	O
2	O
.	O
0	O
from	O
the	O
day	O
prior	O
.	O

his	O
lasix	O
was	O
discontinued	O
and	O
he	O
continued	O
on	O
his	O
double	O
antibiotic	O
therapy	O
.	O

he	O
appeared	O
to	O
be	O
somewhat	O
fatigued	B
,	O
but	O
continued	O
having	O
encouragement	O
to	O
participate	O
in	O
physical	O
therapy	O
as	O
his	O
need	O
for	O
rehab	O
increased	O
.	O

on	O
[	O
*	O
*	O
01	O
-	O
18	O
*	O
*	O
]	O
case	O
management	O
updated	O
to	O
report	O
that	O
they	O
had	O
done	O
multiple	O
screens	O
for	O
him	O
for	O
discharge	O
on	O
the	O
following	O
day	O
to	O
rehab	O
at	O
brandin	O
woods	O
.	O

the	O
swallowing	O
trial	O
was	O
deferred	O
by	O
the	O
patient	O
on	O
the	O
23rd	O
.	O

he	O
was	O
saying	O
he	O
had	O
no	O
complaints	B
and	O
no	O
signs	O
or	O
symptoms	B
of	I
aspiration	I
.	O

on	O
the	O
23rd	O
also	O
a	O
picc	O
line	O
was	O
placed	O
by	O
intravenous	O
therapy	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2568	O
*	O
*	O
]	O
of	O
radiology	O
.	O

he	O
also	O
was	O
seen	O
by	O
infectious	O
disease	O
on	O
the	O
23rd	O
.	O

at	O
the	O
time	O
he	O
had	O
a	O
white	O
count	O
of	O
9	O
.	O
9	O
,	O
hematocrit	O
31	O
.	O
0	O
,	O
bun	O
39	O
,	O
creatinine	O
1	O
.	O
8	O
with	O
a	O
k	O
of	O
4	O
.	O
1	O
.	O

his	O
hematoma	B
from	O
the	O
leg	O
wound	B
on	O
the	O
20th	O
had	O
negative	O
organisms	O
or	O
pmns	O
and	O
the	O
culture	O
was	O
negative	O
.	O

the	O
blood	O
cultures	O
from	O
[	O
*	O
*	O
01	O
-	O
15	O
*	O
*	O
]	O
were	O
pending	O
.	O

the	O
urine	O
culture	O
from	O
the	O
19th	O
showed	O
less	O
then	O
10	O
,	O
000	O
organisms	O
.	O

the	O
urinalysis	O
from	O
the	O
19th	O
showed	O
microscopic	O
red	O
blood	O
cells	O
and	O
no	O
white	O
blood	O
cells	O
.	O

please	O
refer	O
to	O
he	O
urinalysis	O
report	O
from	O
the	O
19th	O
.	O

the	O
chest	O
x	O
-	O
ray	O
on	O
the	O
19th	O
also	O
showed	O
a	O
stable	O
mediastinal	O
appearance	O
with	O
bilateral	B
pleural	I
effusions	I
with	O
loculated	B
component	I
in	O
the	O
left	O
upper	O
hemithorax	O
.	O

he	O
also	O
was	O
noted	O
to	O
have	O
a	O
sort	O
of	O
gouty	B
tophus	I
erythematous	I
nodule	I
on	O
his	O
right	O
index	O
finger	O
.	O

according	O
to	O
the	O
id	O
fellow	O
his	O
right	O
lower	O
extremity	O
also	O
showed	O
two	O
areas	O
of	O
minimal	O
drainage	O
with	O
no	O
erythema	B
.	O

id	O
fellow	O
recommended	O
x	O
-	O
ray	O
of	O
the	O
digit	O
with	O
gouty	B
nodule	I
,	O
checking	O
a	O
uric	O
acid	O
level	O
and	O
getting	O
rheumatology	O
evaluation	O
either	O
in	O
house	O
or	O
as	O
an	O
outpatient	O
.	O

there	O
appeared	O
to	O
be	O
no	O
evidence	O
of	O
septic	B
arthritis	I
and	O
recommended	O
follow	O
up	O
with	O
rheumatology	O
.	O

on	O
the	O
24th	O
the	O
patient	O
continued	O
to	O
have	O
now	O
a	O
papular	B
erythematous	I
lesion	I
over	O
his	O
right	O
index	O
finger	O
.	O

he	O
was	O
ambulating	O
a	O
level	O
four	O
with	O
no	O
complaints	B
.	O

his	O
temperature	O
max	O
was	O
100	O
.	O
3	O
,	O
which	O
is	O
what	O
it	O
was	O
at	O
the	O
time	O
of	O
examination	O
.	O

he	O
was	O
comfortable	O
.	O

his	O
chest	O
was	O
clear	O
bilaterally	O
.	O

he	O
continued	O
to	O
have	O
a	O
faint	O
systolic	B
murmur	I
.	O

his	O
sternum	O
had	O
no	O
dressing	O
.	O

his	O
abdomen	O
was	O
soft	O
,	O
nontender	O
,	O
nondistended	O
.	O

he	O
was	O
discharged	O
to	O
rehab	O
on	O

[	O
*	O
*	O
01	O
-	O
19	O
*	O
*	O
]	O
on	O
postoperative	O
day	O
seventeen	O
with	O
recommendations	O
for	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
40	O
*	O
*	O
]	O
,	O
having	O
an	O
outpatient	O
rheumatology	O
consult	O
and	O
follow	O
up	O
also	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2569	O
*	O
*	O
]	O
in	O
three	O
weeks	O
his	O
primary	O
care	O
physician	O
.	O

please	O
refer	O
to	O
the	O
discharge	O
summary	O
that	O
was	O
done	O
on	O

[	O
*	O
*	O
01	O
-	O
13	O
*	O
*	O
]	O
at	O
the	O
time	O
of	O
his	O
original	O
planned	O
discharge	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
status	O
post	O
coronary	O
artery	O
bypass	O
grafting	O
.	O

2	O
.	O
insulin	B
dependent	I
diabetes	I
mellitus	I
.	O

3	O
.	O
hyperlipidemia	B
.	O

4	O
.	O
recurrent	O
transient	B
ischemic	I
attacks	I
.	O

5	O
.	O
chronic	O
mild	O
azotemia	B
.	O

6	O
.	O
depression	B
.	O

7	O
.	O
question	O
gouty	B
nodule	I
right	O
index	O
finger	O
.	O

discharge	O
medications	O
:	O
protonix	O
40	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
nph	O
insulin	O
36	O
units	O
subq	O
every	O
morning	O
,	O
6	O
units	O
subq	O
every	O
evening	O
,	O

colace	O
100	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
sliding	O
scale	O
regular	O
insulin	O
per	O
rehab	O
protocol	O
.	O

celexa	O
20	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
zocor	O
10	O
mg	O
po	O
q	O
.	O
h	O
.	O
s	O
.	O
,	O
percocet	O
one	O
to	O
two	O
tabs	O
po	O
q	O
4	O
hours	O
to	O
6	O
hours	O
prn	O
.	O

lopresor	O
75	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O

persantine	O
100	O
mg	O
po	O
q	O
.	O
i	O
.	O
d	O
.	O
,	O

levofloxacin	O
250	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
vancomycin	O
1	O
gram	O
intravenous	O
q	O
24	O
hours	O
,	O
enteric	O
coated	O
aspirin	O
81	O
mg	O
po	O
q	O
.	O
d	O
.	O

again	O
,	O
the	O
patient	O
was	O
discharged	O
to	O
rehab	O
on	O
[	O
*	O
*	O
2013	O
-	O
01	O
-	O
19	O
*	O
*	O
]	O
in	O
stable	O
condition	O
.	O

the	O
period	O
dictated	O
is	O
[	O
*	O
*	O
01	O
-	O
13	O
*	O
*	O
]	O
through	O
[	O
*	O
*	O
2013	O
-	O
01	O
-	O
19	O
*	O
*	O
]	O
date	O
of	O
discharge	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
42	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
275	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
649	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2013	O
-	O
02	O
-	O
27	O
*	O
*	O
]	O
10	O
:	O
07	O

t	O
:	O
[	O
*	O
*	O
2013	O
-	O
03	O
-	O
05	O
*	O
*	O
]	O
11	O
:	O
05	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
2570	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
42	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
2013	O
-	O
03	O
-	O
08	O
*	O
*	O
]	O
12	O
:	O
30	O
pm	O
(	O
end	O
of	O
report	O
)	O

16976	O
||||	O
17054	O
||||	O
13966	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
03	O
-	O
29	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
24	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
29	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1939	O
-	O
01	O
-	O
22	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
[	O
*	O
*	O
hospital1	O
1	O
*	O
*	O
]	O

chief	O
complaint	O
:	O
one	O
week	O
abdominal	B
distention	I
,	O
weakness	B
and	O
shortness	B
of	I
breath	I
.	O

of	O
note	O
,	O
the	O
patient	O
was	O
initially	O
admitted	O
to	O
the	O
coronary	O

care	O
unit	O
and	O
then	O
transferred	O
to	O
the	O
medical	O
floor	O
.	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
a	O
73	O
year	O
-	O
old	O
woman	O
with	O
a	O
history	O
of	O
type	B
b	I
aortic	I
dissection	I
,	O
abdominal	B
aortic	I
aneurysm	I
,	O
rcia	B
and	O
[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
,	O
aneurysm	B
,	O
renal	B
artery	I
stenosis	I
and	O
hepatitis	B
b	I
,	O
cirrhosis	B
who	O
presents	O
to	O
[	O
*	O
*	O
hospital	O
20	O
*	O
*	O
]	O
from	O
an	O
emergency	O
room	O
in	O
[	O
*	O
*	O
hospital1	O
18	O
*	O
*	O
]	O
.	O

the	O
patient	O
initially	O
presented	O
with	O
a	O
history	O
of	O
increasing	O
shortness	B
of	I
breath	I
,	O
abdominal	B
distention	I
and	O
fatigue	B
at	O
[	O
*	O
*	O
hospital1	O
18	O
*	O
*	O
]	O
.	O

the	O
patient	O
had	O
a	O
ct	O
angio	O
and	O
her	O
systolic	O
blood	O
pressure	O
was	O
in	O
the	O
200s	O
.	O

the	O
patient	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital	O
9	O
*	O
*	O
]	O
whose	O
ct	O

was	O
read	O
as	O
not	O
being	O
appreciably	O
different	O
from	O
the	O
last	O
ct	O
performed	O
on	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
14	O
*	O
*	O
]	O
.	O

the	O
patient	O
was	O
seen	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3666	O
*	O
*	O
]	O
last	O
year	O
.	O

the	O
patient	O
was	O
placed	O
on	O
nitroprusside	O
drip	O
,	O
po	O
labetalol	O
200	O
mg	O
a	O
day	O
and	O
was	O
seen	O
by	O
the	O
liver	O
service	O
who	O
performed	O
an	O
esophagogastroduodenoscopy	O
to	O
evaluate	O
for	O
guaiac	B
positive	I
stools	I
and	O
hematocrit	O
of	O
22	O
.	O
8	O
on	O
presentation	O
.	O

the	O
esophagogastroduodenoscopy	O
showed	O
varices	B
in	O
the	O
lower	O
third	O
of	O
the	O
esophagus	O
with	O
the	O
middle	O
grade	O
one	O
.	O

the	O
esophagogastroduodenoscopy	O
also	O
showed	O
erosions	B
consistent	O
with	O
portal	B
hypertension	I
.	O

a	O
sigmoidoscopy	O
was	O
performed	O
,	O
which	O
showed	O
spotting	O
from	O
the	O
hemorrhoids	B
.	O

the	O
patient	O
status	O
post	O
esophagogastroduodenoscopy	O
required	O
2	O
.	O
5	O
mcg	O
per	O
minute	O
of	O
nitroprusside	O
and	O
norvasc	O
5	O
mg	O
po	O
q	O
.	O
d	O
.	O
was	O
started	O
with	O
a	O
goal	O
blood	O
pressure	O
of	O
decreased	O
blood	O
pressure	O
given	O
the	O
dissection	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
type	B
b	I
aortic	I
dissection	I
.	O

2	O
.	O
cirrhosis	B
.	O

3	O
.	O
hepatitis	B
b	I
.	O

4	O
.	O
abdominal	B
aortic	I
aneurysm	I
5	O
.	O
5	O
cm	O
.	O

5	O
.	O
history	O
of	O
varices	B
.	O

6	O
.	O
history	O
of	O
ascites	B
.	O

7	O
.	O
rc	B
one	I
aneurysm	I
,	O
[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
aneurysm	B
.	O

8	O
.	O
severe	O
left	O
renal	B
stenosis	I
.	O

10	O
.	O

question	O
cri	B
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

medications	O
:	O
triamterene	O
/	O
hctz	O
37	O
.	O
5	O
/	O
25	O
.	O

social	O
history	O
:	O
the	O
patient	O
has	O
no	O
current	O
alcohol	O
or	O
tobacco	O
use	O
.	O

she	O
is	O
[	O
*	O
*	O
ethnicity	O
3667	O
*	O
*	O
]	O
and	O
does	O
not	O
speak	O
english	O
.	O

physical	O
examination	O
on	O
presentation	O
:	O
her	O
vital	O
signs	O
were	O
temperature	O
97	O
.	O

heart	O
rate	O
of	O
56	O
to	O
60	O
.	O

blood	O
pressure	O
139	O
/	O
60	O
.	O

is	O
and	O
os	O
840	O
in	O
and	O
280	O
out	O
.	O

she	O
was	O
100%	O
on	O
nasal	O
cannula	O
.	O

in	O
general	O
,	O
no	O
acute	B
distress	I
,	O
lying	O
in	O
bed	O
.	O

heent	O
pupils	O
are	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
.	O

lungs	O
clear	O
to	O
auscultation	O
anteriorly	O
.	O

cardiovascular	O
no	O
jvd	B
,	O
regular	O
rate	O
and	O
rhythm	O
.	O

s1	O
and	O
s2	O
.	O
+	O
s4	O
2	O
out	O
of	O
6	O
systolic	B
ejection	I
murmur	I
at	O
the	O
right	O
upper	O
sternal	O
border	O
.	O

abdomen	B
shifting	I
dullness	I
,	O
small	O
liver	O
,	O
guaiac	O
positive	O
,	O
positive	O
bowel	O
sounds	O
,	O
positive	O
distention	B
.	O

extremities	O
1	O
+	O
pedal	B
edema	I
,	O
2	O
+	O
sacral	B
edema	I
.	O

imaging	O
:	O
chest	O
x	O
-	O
ray	O
showed	O
no	O
infiltrate	B
or	O
congestive	B
heart	I
failure	I
.	O

right	O
upper	O
lobe	O
opacity	B
.	O

ct	O
of	O
the	O
pelvis	O
from	O
[	O
*	O
*	O
03	O
-	O
14	O
*	O
*	O
]	O
showed	O
dissection	O
of	O
lower	O
thoracic	O
abdominal	O
aorta	O
and	O
right	O
common	O
iliac	O
,	O
infrarenal	B
abdominal	I
aortic	I
aneurysm	I
maximum	O
diameter	O
5	O
.	O
5	O
by	O
5	O
cm	O
.	O

right	O
common	B
iliac	I
aneurysm	I
,	O
left	O
internal	B
iliac	I
aneurysm	I
,	O
severe	O
left	O
renal	B
artery	I
cirrhosis	I
,	O
cirrhosis	B
of	I
the	I
liver	I
,	O
portal	B
hypertension	I
,	O
varices	B
.	O

laboratories	O
at	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
:	O
white	O

blood	O
cell	O
count	O
5	O
.	O
2	O
,	O
hematocrit	O
22	O
.	O
8	O
,	O
platelets	O
63	O
.	O

diff	O

72	O
.	O
6	O
,	O
lymphocytes	O
11	O
.	O
1	O
,	O
106	O
,	O
2	O
.	O
8	O
.	O

electrolytes	O
sodium	O
135	O
,	O
k	O

3	O
.	O
3	O
,	O
chloride	O
103	O
,	O
bicarb	O
25	O
,	O
bun	O
40	O
,	O
creatinine	O
1	O
.	O
5	O
,	O
glucose	O
143	O
,	O
inr	O
1	O
.	O
3	O
,	O
albumin	O
2	O
.	O
1	O
.	O

white	O
blood	O
cell	O
250	O
,	O
red	O
blood	O
cell	O
500	O
,	O
polys	O
6	O
,	O
lymphocytes	O
28	O
,	O
monocytes	O
46	O
,	O
eosinophils	O
1	O
,	O
mesothelial	O
cells	O
14	O
,	O
macro	O
15	O
.	O

chest	O
x	O
-	O
ray	O
of	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
24	O
*	O
*	O
]	O
showed	O
a	O
1	O
.	O
1	O
cm	O
pulmonary	B
nodule	I
right	O
upper	O
lobe	O
,	O
prominent	O
tortuous	B
aorta	I
.	O

medications	O
from	O
transfer	O
from	O
ccc	O
included	O
tylenol	O
,	O

trazodone	O
,	O
docusate	O
sodium	O
,	O
pantoprazole	O
,	O
lactulose	O
,	O
ferrous	O
,	O
amlodipine	O
10	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
labetalol500	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O

albuterol	O
nebulizers	O
.	O

hospital	O
course	O
:	O
1	O
.	O
patient	O
with	O
a	O
history	O
of	O
aortic	B
dissection	I
initially	O
placed	O
on	O
nitroprusside	O
drip	O
for	O
blood	O
pressure	O
control	O
.	O

the	O
patient's	O
blood	O
pressure	O
medications	O
were	O
weaned	O
during	O
the	O
course	O
of	O
her	O
hospitalization	O
.	O

it	O
was	O
necessary	O
to	O
maintain	O
a	O
blood	O
pressure	O
so	O
that	O
her	O
aortic	B
dissection	I
would	O
not	O
progress	O
.	O

vascular	O
surgery	O
was	O
consulted	O
and	O
no	O
intervention	O
was	O
considered	O
an	O
option	O
during	O
the	O
hospitalization	O
.	O

2	O
.	O
shortness	B
of	I
breath	I
:	O
patient	O
with	O
no	O
pneumonia	B
on	O
x	O
-	O
ray	O
.	O

it	O
was	O
possible	O
that	O
her	O
shortness	B
of	I
breath	I
might	O
be	O
consistent	O
to	O
volume	B
overload	I
.	O

on	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
26	O
*	O
*	O
]	O
a	O
repeat	O
chest	O
x	O
-	O
ray	O
was	O
performed	O
.	O

the	O
impression	O
was	O
a	O
right	O
upper	O
lobe	O
lung	B
nodule	I
.	O

further	O
evaluation	O
with	O
a	O
ct	O
was	O
suggested	O
.	O

there	O
was	O
also	O
an	O
increase	O
in	O
patchy	O
opacity	B
at	O
the	O
right	O
lung	O
base	O
.	O

the	O
differential	O
included	O
atelectasis	B
versus	O
an	O
evolving	O
pneumonia	B
.	O

there	O
was	O
also	O
a	O
small	O
persistent	O
,	O
small	O
right	O
pleural	B
effusion	I
.	O

as	O
a	O
result	O
the	O
patient	O
was	O
discharged	O
on	O
levofloxacin	O
for	O
possible	O
pneumonia	B
,	O
which	O
attributed	O
to	O
her	O
hypoxia	B
.	O

3	O
.	O
hematology	O
:	O
patient	O
with	O
iron	B
deficiency	I
anemia	I
,	O
decreased	O
iron	O
.	O

patient	O
was	O
transfused	O
2	O
units	O
of	O
packed	O
red	O
blood	O
cells	O
.	O

the	O
patient's	O
hematocrit	O
was	O
felt	O
to	O
require	O
an	O
outpatient	O
colonoscopy	O
.	O

of	O
note	O
,	O
the	O
patient	O
was	O
status	O
post	O
an	O
esophagogastroduodenoscopy	O
with	O
bleeding	B
varices	I
,	O
status	O
post	O
sigmoidoscopy	O
with	O
bleeding	O
source	O
hemorrhoids	O
.	O

4	O
.	O
gastrointestinal	O
:	O
patient	O
with	O
a	O
history	O
of	O
hepatitis	B
b	I
cirrhosis	I
and	O
increasing	B
abdominal	I
girth	I
.	O

the	O
patient	O
had	O
an	O
ultrasound	O
guided	O
abdominal	O
paracentesis	O
to	O
evaluate	O
for	O
sbp	B
.	O

these	O
showed	O
transudative	O
.	O

the	O
etiology	O
of	O
cirrhosis	B
with	O

vna	O
/	O
igga	O
were	O
sent	O
.	O

on	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
25	O
*	O
*	O
]	O
an	O
abdominal	O
ultrasound	O
and	O
diagnostic	O
paracentesis	O
was	O
performed	O
,	O
which	O
showed	O
a	O
small	O
3	O
cm	O
pocket	O
of	O
ascites	B
located	O
within	O
the	O
right	O
lower	O
quadrant	O
the	O
patient	O
in	O
the	O
sitting	O
position	O
.	O

an	O
abdominal	O
ultrasound	O
on	O
[	O
*	O
*	O
03	O
-	O
26	O
*	O
*	O
]	O
was	O
performed	O
.	O

the	O
impression	O
was	O
a	O
nodular	B
liver	I
consistent	O
with	O
the	O
patient's	O
known	O
cirrhosis	B
,	O
patent	O
flow	O
to	O
the	O
liver	O
,	O
borderline	O
enlarged	B
spleen	I
,	O
mild	O
ascites	B
and	O
abdominal	O
portion	O
of	O
the	O
aortic	B
dissection	I
seen	O
in	O
the	O
dissection	B
consistent	O
with	O
both	O
ct	O
and	O
mr	O
recently	O
with	O
correlation	O
of	O
the	O
studies	O
was	O
suggested	O
.	O

5	O
.	O
kidney	O
:	O
the	O
patient	O
developed	O
acute	O
renal	B
dysfunction	I
during	O
her	O
hospitalization	O
.	O

the	O
differential	O
included	O
drug	O
induced	O
atn	B
versus	O
hypotension	B
versus	O
secondary	O
to	O
aortic	B
dissection	I
.	O

it	O
was	O
felt	O
that	O
it	O
was	O
likely	O
due	O
to	O
hypotension	B
.	O

the	O
patient	O
was	O
rehydrated	O
in	O
house	O
.	O

a	O
renal	O
ultrasound	O
was	O
performed	O
on	O
[	O
*	O
*	O
04	O
-	O
26	O
*	O
*	O
]	O
.	O

the	O
ultrasound	O
showed	O
color	O
flow	O
seen	O
to	O
both	O
kidneys	O
,	O
but	O
the	O
wave	O
form	O
is	O
parvus	O
sitarist	O
suggesting	O
more	O
proximal	O
stenosis	B
in	I
both	I
renal	I
arteries	I
.	O

there	O
was	O
no	O
evidence	O
of	O
echogenic	B
kidney	I
seen	O
with	O
medical	O
renal	B
disease	I
.	O

the	O
patient's	O
creatinine	O
on	O
presentation	O
was	O
1	O
.	O
5	O
.	O

the	O
patient	O
,	O
however	O
,	O
was	O
not	O
felt	O
to	O
be	O
a	O
hemodialysis	O
candidate	O
at	O
this	O
time	O
.	O

6	O
.	O
prophylaxis	O
:	O
the	O
patient	O
was	O
placed	O
on	O
pneumoboots	O
.	O

7	O
.	O
nutrition	O
:	O
nutrition	O
was	O
provided	O
with	O
boost	O
and	O
a	O
cardiac	O
healthy	O
low	O
protein	O
diet	O
.	O

final	O
diagnoses	O
:	O

1	O
.	O
liver	B
cirrhosis	I

2	O
.	O
renal	B
failure	I
.	O

3	O
.	O
aortic	B
aneurysm	I
.	O

the	O
patient	O
was	O
recommended	O
to	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
within	O
one	O
week	O
.	O

major	O
surgical	O
invasive	O
procedures	O
were	O
none	O
.	O

discharge	O
condition	O
:	O
fair	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
pantoprazole	O
40	O
mg	O
po	O
q	O
.	O
d	O
.	O

2	O
.	O
amlodipine	O
5	O
mg	O
tablets	O
two	O
tabs	O
po	O
q	O
.	O
d	O
.	O

3	O
.	O
levofloxacin	O
250	O
mg	O
po	O
q	O
.	O
d	O
.	O

4	O
.	O
labetalol	O
hcl	O
100	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O

5	O
.	O
lactulose	O
15	O
ml	O
oral	O
t	O
.	O
i	O
.	O
d	O
.	O

[	O
*	O
*	O
doctor	O
first	O
name	O
1040	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
1041	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
300	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
25	O
*	O
*	O
]	O
09	O
:	O
37	O

t	O
:	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
25	O
*	O
*	O
]	O
13	O
:	O
10	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
3668	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
1040	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
sat	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
16	O
*	O
*	O
]	O
10	O
:	O
37	O
am	O

(	O
end	O
of	O
report	O
)	O

368450	O
||||	O
17097	O
||||	O
28577	O
||||	O
radiology	O
_	O
report	O
||||	O
2015	O
-	O
03	O
-	O
11	O
19	O
:	O
09	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
335	O
-	O
6754	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
11	O
*	O
*	O
]	O
7	O
:	O
09	O
pm	O

chest	O
(	O
portable	O
ap	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
709	O
*	O
*	O
]	O
reason	O
:	O
s	O
/	O
p	O
trach	O
,	O
ng	O
placement	O
admitting	O
diagnosis	O
:	O
myocardial	B
infarction\cath	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

77	O
year	O
old	O
woman	O
with	O
triple	B
vessel	I
cad	I
s	O
/	O
p	O
rca	O
stent	O
x	O
2	O
for	O
rv	O
infarct	B
and	O
coronary	O
pacer	O
for	O
junctional	B
rhythm	I
reason	O
for	O
this	O
examination	O
:	O
s	O
/	O
p	O
trach	O
,	O
eval	O
position	B
of	I
trach	I
,	O
eval	O
for	O
pneumothorax	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
77	O
year	O
old	O
female	O
status	O
post	O
stent	O
placement	O
.	O

check	O
position	B
of	I
tracheostomy	I
.	O

rule	O
out	O
pneumothorax	B
.	O

comparison	O
:	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
11	O
*	O
*	O
]	O
and	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
10	O
*	O
*	O
]	O
.	O

ap	O
supine	O
single	O
view	O
of	O
the	O
chest	O
:	O

there	O
is	O
interval	O
change	O
of	O
an	O
et	O
tube	O
for	O
an	O
endotracheal	O
tube	O
.	O

there	O
is	O
no	O
evidence	O
of	O
pneumothorax	B
.	O

there	O
is	O
pleural	B
thickening	I
in	O
the	O
left	O
apex	O
.	O

the	O
cardiac	O
size	O
,	O
mediastinum	O
and	O
hilum	O
are	O
unchanged	O
when	O
compared	O
to	O
the	O
previous	O
study	O
earlier	O
today	O
.	O

the	O
pulmonary	O
vascularity	O
is	O
unchanged	O
when	O
compared	O
to	O
the	O
previous	O
study	O
earlier	O
today	O
.	O

the	O
appearance	O
of	O
the	O
lungs	O
is	O
not	O
significantly	O
changed	O
.	O

there	O
is	O
a	O
nasogastric	O
tube	O
with	O
the	O
tip	O
in	O
the	O
stomach	O
.	O

10718	O
||||	O
17467	O
||||	O
28030	O
||||	O
discharge	O
_	O
summary	O
||||	O
2016	O
-	O
07	O
-	O
07	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
07	O
-	O
04	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
07	O
-	O
07	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1955	O
-	O
07	O
-	O
15	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
247	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

elective	O
evaluation	O
of	O
hypoglycemia	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

60	O
year	O
-	O
old	O
female	O
with	O
past	O
medical	O
history	O
of	O
diabetes	B
mellitus	I
type	I
ii	I
previously	O
on	O
insulin	O
,	O
hypertension	B
,	O
and	O
s	O
/	O
p	O
right	O
hip	O
arthroplasty	O
recently	O
admitted	O
to	O
[	O
*	O
*	O
hospital	O
3800	O
*	O
*	O
]	O
s	O
/	O
p	O
mechanical	B
fall	I
,	O
diagnosed	O
with	O
hairline	O
fracture	B
of	O
the	O
right	O
hip	O
and	O
eventually	O
discharged	O
home	O
after	O
insulin	O
regimen	O
changed	O
from	O
baseline	O
of	O
nph	O
20	O
units	O
each	O
morning	O
to	O
lantus	O
10	O
units	O
at	O
night	O
after	O
she	O
had	O
a	O
bg	O
of	O
12	O
with	O
loss	B
of	I
consiousness	I
in	O
the	O
hospital	O
.	O

subsequently	O
,	O
she	O
had	O
episode	O
of	O
malaise	B
and	O
confusion	B
at	O
home	O
in	O
the	O
setting	O
of	O
poor	B
pos	I
.	O

called	O
ems	O
,	O
who	O
measured	O
fbs	O
39	O
,	O
treated	O
with	O
glucagon	O
.	O

she	O
was	O
then	O
admitted	O
to	O
[	O
*	O
*	O
hospital1	O
16	O
*	O
*	O
]	O
(	O
[	O
*	O
*	O
2016	O
-	O
05	O
-	O
01	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
2016	O
-	O
05	O
-	O
04	O
*	O
*	O
]	O
)	O
for	O
hypoglycemia	B
.	O

during	O
that	O
hospitalization	O
,	O
a	O
4x5cm	O
anterior	O
llq	O
mass	B
was	O
found	O
.	O

during	O
that	O
hospitalization	O
,	O
insulin	O
was	O
stopped	O
and	O
pt	O
started	O
on	O
metformin	O
500	O
bid	O
and	O
prandin	O
0	O
.	O
5	O
qac	O
.	O

pt	O
states	O
that	O
when	O
her	O
glucose	O
was	O
low	O
,	O
she	O
felt	O
nausea	B
and	O
then	O
passed	B
out	I
;	O
does	O
not	O
recall	O
feeling	O
diaphoretic	B
.	O

she	O
was	O
seen	O
by	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
519	O
*	O
*	O
]	O
,	O
who	O
is	O
concerned	O
that	O
this	O
tumor	B
is	O
igf	O
-	O
2	O
secreting	O
based	O
on	O
her	O
lack	O
of	O
need	O
for	O
insulin	O
now	O
(	O
when	O
she	O
had	O
required	O
insulin	O
in	O
the	O
past	O
)	O
and	O
morning	O
hypoglycemia	B
.	O

the	O
pt	O
states	O
that	O
since	O
her	O
last	O
admission	O
she	O
has	O
only	O
been	O
on	O
metformin	O
,	O
and	O
her	O
fingersticks	O
have	O
been	O
ranging	O
in	O
the	O
100s	O
-	O
200s	O
without	O
any	O
episodes	O
of	O
hypoglycemia	B

ros	O
:	O
the	O
pt	O
denies	O
diarrhea	B
,	O
constipation	B
,	O
abdominal	B
pain	I
,	O
dysuria	B
,	O
hematuria	B
,	O
brbpr	B
,	O
ha	B
,	O
f	B
/	O
c	B
/	O
s	B
,	O
weight	B
changes	I
,	O
diaphoresis	B
,	O
dizziness	B
,	O
cp	B
,	O
sob	B
,	O
palpitations	B
.	O

she	O
admits	O
to	O
occasional	O
emesis	B
post	O
-	O
prandial	O
,	O
with	O
last	O
episode	O
over	O
2	O
weeks	O
ago	O
.	O

she	O
also	O
admits	O
to	O
chronic	O
ankle	B
swelling	I
.	O

past	O
medical	O
history	O
:	O

type	B
2	I
diabetes	I
mellitus	I
since	O
[	O
*	O
*	O
2001	O
*	O
*	O
]	O

llq	O
mass	B
undiagnosed	O

s	O
/	O
p	O
r	O
hip	B
fracture	I
with	O
repair	O

hypertension	B

mild	O
lv	B
diastolic	I
dysfunction	I

social	O
history	O
:	O

lives	O
alone	O
.	O

son	O
recently	O
deceased	O
in	O
[	O
*	O
*	O
country	O
3801	O
*	O
*	O
]	O
war	O
.	O

smokes	O
cigarettes	O
for	O
15	O
-	O
20	O
yrs	O
,	O
but	O
quit	O
5	O
yrs	O
ago	O
.	O

drinks	O
1	O
beer	O
a	O
day	O
.	O

no	O
illicit	O
drug	O
use	O
.	O

on	O
disability	O
,	O
but	O
had	O
been	O
a	O
home	O
visiting	O
nurse	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
3802	O
*	O
*	O
]	O
.	O

family	O
history	O
:	O

no	O
fh	O
of	O
dm	B
or	O
malignancy	B
.	O

both	O
parents	O
died	O
of	O
mi	B

physical	O
exam	O
:	O

vitals	O
:	O
97	O
.	O
3	O
162	O
/	O
100	O
69	O
14	O
100%	O
ra	O

gen	O
:	O
well	O
appearing	O
woman	O
,	O
nad	B

heent	O
:	O
perrl	O
,	O
ncat	O
,	O
muddy	B
sclerae	I
,	O
poor	B
dentition	I
,	O
mmm	O

neck	O
:	O
supple	O
,	O
no	O
jvd	B
,	O
no	O
thyromegaly	B
or	O
nodules	B

cv	O
:	O
rrr	O
,	O
no	O
m	B
/	O
r	B
/	O
g	B
,	O
nl	O
s1	O
/	O
s2	O

lungs	O
:	O
ctab	O

ab	O
:	O
soft	O
,	O
nt	O
/	O
nd	O
,	O
fullness	B
in	O
llq	O
,	O
nabs	O

extrem	O
:	O
1	O
+	O
pitting	B
edema	I
in	O
bl	O
le	O
up	O
to	O
the	O
knees	O
,	O
warm	O
,	O
good	O
pulses	O
,	O
no	O
c	B
/	O
c	B
/	O
e	B

skin	O
:	O
flushed	B
,	O
warm	O

neuro	O
:	O
a	O
and	O
ox3	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2016	O
-	O
07	O
-	O
04	O
*	O
*	O
]	O
03	O
:	O
00pm	O
glucose	O
-	O
232	O
*	O
urea	O
n	O
-	O
6	O
creat	O
-	O
0	O
.	O
7	O
sodium	O
-	O
135	O
potassium	O
-	O
5	O
.	O
2	O
*	O
chloride	O
-	O
101	O
total	O
co2	O
-	O
25	O
anion	O
gap	O
-	O
14	O

[	O
*	O
*	O
2016	O
-	O
07	O
-	O
04	O
*	O
*	O
]	O
03	O
:	O
00pm	O
wbc	O
-	O
9	O
.	O
7	O
rbc	O
-	O
3	O
.	O
66	O
*	O
hgb	O
-	O
12	O
.	O
5	O
hct	O
-	O
36	O
.	O
9	O
mcv	O
-	O
101	O
*	O
mch	O
-	O
34	O
.	O
2	O
*	O
mchc	O
-	O
33	O
.	O
9	O
rdw	O
-	O
15	O
.	O
2	O

prior	O
imaging	O
studies	O
:	O

mri	O
abdomen	O
[	O
*	O
*	O
2016	O
-	O
05	O
-	O
02	O
*	O
*	O
]	O
:	O

impression	O
:	O

anteriorly	O
within	O
the	O
left	O
pelvis	O
is	O
a	O
mass	B
measuring	O
4	O
.	O
7	O
x	O
4	O
.	O
5	O
x	O
5	O
.	O
0	O
cm	O
,	O
which	O
is	O
hypointense	O
on	O
t2	O
weighted	O
images	O
.	O

no	O
internal	B
fat	I
is	O
identified	O
.	O

no	O
arterial	B
-	I
phase	I
enhancement	I
is	O
noted	O
;	O
mild	O
peripheral	B
enhancement	I
surrounds	O
a	O
central	O
nonenhancing	O
core	O
.	O

the	O
mass	B
is	O
well	O
circumscribed	O
and	O
adjacent	O
to	O
the	O
sigmoid	O
colon	O
.	O

there	O
is	O
no	O
parasitization	B
of	O
vessels	O
or	O
relationship	O
to	O
pelvic	O
arterial	O
vasculature	O
.	O

impression	O
:	O
1	O
.	O
signal	O
characteristics	O
and	O
morphology	O
are	O
suggestive	O
of	O
a	O
tumor	B
of	O
mesenchymal	O
origin	O
or	O
,	O
perhaps	O
,	O
a	O
broad	B
ligament	I
fibroid	I
.	O

similarly	O
,	O
the	O
morphology	O
and	O
enhancement	O
pattern	O
,	O
as	O
well	O
as	O
the	O
lack	O
of	O
regionally	O
enlarged	B
lymph	I
nodes	I
,	O
favors	O
a	O
non	B
aggressive	I
process	I
.	O

brief	O
hospital	O
course	O
:	O

this	O
is	O
a	O
60	O
yo	O
with	O
a	O
history	O
of	O
dmii	B
,	O
intermittent	O
hypoglycemia	B
,	O
and	O
a	O
llq	O
mass	B
who	O
presents	O
for	O
evaluation	O
of	O
her	O
hypoglycemia	B
.	O

#	O
intermittent	O
hypoglycemia	B
:	O
it	O
is	O
unclear	O
if	O
the	O
patient	O
has	O
an	O
igf	O
-	O
2	O
secreting	O
tumor	B
in	O
her	O
llq	O
to	O
account	O
for	O
her	O
symptoms	B
.	O

patient	O
admitted	O
for	O
a	O
fasting	O
study	O
for	O
formal	O
diagnosis	O
.	O

the	O
patient	O
had	O
fingersticks	O
q2h	O
while	O
glucose	O
>	O
150	O
,	O
then	O
q1	O
hour	O
when	O
glucose	O
<	O
150	O
.	O

the	O
plan	O
was	O
when	O
her	O
glucose	O
was	O
<	O
45	O
,	O
or	O
<	O
55	O
with	O
symptoms	O
,	O
she	O
would	O
have	O
blood	O
drawn	O
and	O
sent	O
for	O
glucose	O
,	O
insulin	O
,	O
pro	O
-	O
insulin	O
,	O
igf	O
-	O
1	O
,	O
igf	O
-	O
2	O
,	O
c	O
-	O
peptide	O
,	O
b	O
-	O
hydroxyacetate	O
,	O
and	O
sulfonylurea	O
screen	O
;	O
and	O
also	O
send	O
another	O
tube	O
to	O
the	O
lab	O
with	O
the	O
indication	O
"store	O
the	O
serum"	O
.	O

the	O
patient	O
never	O
had	O
hypoglycemia	B
during	O
her	O
course	O
and	O
she	O
refused	O
to	O
finish	O
the	O
study	O
.	O

endocrine	O
was	O
aware	O
and	O
advised	O
to	O
draw	O
the	O
labs	O
before	O
the	O
patient	O
left	O
(	O
as	O
she	O
had	O
completed	O
the	O
majority	O
of	O
the	O
fast	O
,	O
~	O
68	O
hours	O
)	O
.	O

all	O
of	O
the	O
above	O
labs	O
need	O
to	O
be	O
followed	O
as	O
an	O
outpatient	O
by	O
her	O
endocrinologist	O
and	O
the	O
patient	O
needs	O
close	O
follow	O
-	O
up	O
with	O
her	O
endocrinologist	O
as	O
an	O
outpatient	O
.	O

she	O
was	O
advised	O
to	O
resume	O
her	O
metformin	O
and	O
return	O
for	O
recurrence	O
of	O
symptoms	B
.	O

#	O
llq	O
mass	B
:	O
this	O
mass	B
appears	O
benign	B
on	O
mri	O
,	O
but	O
there	O
is	O
concern	O
for	O
it	O
being	O
igf	O
-	O
2	O
secreting	O
.	O

the	O
patient	O
was	O
seen	O
by	O
anesthesia	O
and	O
surgery	O
and	O
she	O
will	O
have	O
pre	O
-	O
op	O
testing	O
on	O
[	O
*	O
*	O
07	O
-	O
18	O
*	O
*	O
]	O
and	O
her	O
mass	B
will	O
be	O
removed	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
07	O
-	O
25	O
*	O
*	O
]	O
.	O

#	O
dm2	B
:	O
the	O
patient	O
had	O
her	O
metformin	O
held	O
while	O
performing	O
fasting	O
study	O
.	O

she	O
remained	O
asymptomatic	B
and	O
without	O
the	O
need	O
for	O
any	O
intervention	O
during	O
her	O
course	O
.	O

she	O
will	O
need	O
close	O
follow	O
-	O
up	O
of	O
her	O
sugars	O
as	O
an	O
outpatient	O
.	O

#	O
htn	B
:	O
the	O
patient	O
had	O
poorly	B
controlled	I
blood	I
pressure	I
as	O
an	O
inpatient	O
.	O

her	O
enalapril	O
was	O
increased	O
and	O
amlodopine	O
was	O
added	O
.	O

she	O
was	O
sent	O
home	O
on	O
the	O
increased	O
dose	O
of	O
enalapril	O
,	O
and	O
it	O
was	O
decided	O
to	O
hold	O
the	O
amlodopine	O
and	O
have	O
her	O
follow	O
-	O
up	O
with	O
her	O
primary	O
doctor	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
3803	O
*	O
*	O
]	O
of	O
her	O
medications	O
.	O

medications	O
on	O
admission	O
:	O

potassium	O
chloride	O

enalapril	O
maleate	O
20	O
mg	O
daily	O

oxycodone	O
-	O
acetaminophen	O
5	O
-	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q6h	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

metformin	O
500	O
mg	O
bid	O

discharge	O
medications	O
:	O

1	O
.	O
percocet	O
5	O
-	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
every	O
six	O
(	O
6	O
)	O
hours	O
as	O
needed	O
for	O
pain	B
.	O

2	O
.	O
metformin	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
twice	O
a	O
day	O
.	O

3	O
.	O
enalapril	O
maleate	O
10	O
mg	O
tablet	O
sig	O
:	O
three	O
(	O
3	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
90	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

primary	O
:	O

hypoglycemia	B

secondary	O
:	O

left	O
lower	O
quadrant	O
mass	B

diabetes	I

hypertension	I

discharge	O
condition	O
:	O

stable	O
,	O
tolerating	O
medications	O

discharge	O
instructions	O
:	O

you	O
were	O
hospitalized	O
for	O
a	O
fast	O
to	O
determine	O
the	O
cause	O
of	O
your	O
hypoglycemia	B
.	O

you	O
should	O
follow	O
-	O
up	O
with	O
endocrinology	O
.	O

please	O
contact	O
a	O
physician	O
if	O
you	O
experience	O
fevers	B
,	O
sweating	B
,	O
chills	B
,	O
chest	B
pain	I
,	O
shortness	B
of	I
breath	I
,	O
dizziness	B
,	O
nausea	B
,	O
fatigue	B
,	O
or	O
any	O
other	O
concerning	O
symptoms	B
.	O

please	O
take	O
your	O
medications	O
as	O
prescribed	O
.	O

-	O
your	O
enalapril	O
dose	O
was	O
increased	O
for	O
your	O
blood	O
pressure	O
,	O
and	O
otherwise	O
you	O
will	O
continue	O
all	O
home	O
medications	O
.	O

please	O
keep	O
your	O
follow	O
-	O
up	O
appointments	O
as	O
below	O
.	O

you	O
are	O
scheduled	O
for	O
removal	O
of	O
your	O
mass	B
on	O
[	O
*	O
*	O
07	O
-	O
25	O
*	O
*	O
]	O
and	O
will	O
have	O
testing	O
on	O
[	O
*	O
*	O
07	O
-	O
18	O
*	O
*	O
]	O
before	O
surgery	O
.	O

followup	O
instructions	O
:	O

1	O
.	O
follow	O
-	O
up	O
with	O
surgery	O
:	O
provider	O
:	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
*	O
*	O
]	O
rm	O
4	O
pat	O
-	O
preadmission	O
testing	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2016	O
-	O
07	O
-	O
18	O
*	O
*	O
]	O
2	O
:	O
00	O
.	O

they	O
are	O
on	O
the	O
3rd	O
floor	O
of	O
the	O
clinical	O
center	O
building	O
west	O
campus	O

2	O
.	O
surgery	O
[	O
*	O
*	O
07	O
-	O
25	O
*	O
*	O
]	O
at	O
7	O
:	O
30	O
am	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
,	O
call	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
3804	O
*	O
*	O
]	O
for	O
more	O
information	O
.	O

3	O
.	O
call	O
your	O
endocrinologist	O
or	O
the	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
clinic	O
at	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
3805	O
*	O
*	O
]	O
for	O
the	O
results	O
of	O
your	O
blood	O
work	O
and	O
adjustment	O
of	O
your	O
medications	O
.	O

make	O
an	O
appointment	O
within	O
1	O
week	O
.	O

4	O
.	O
please	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3806	O
*	O
*	O
]	O
,	O
jeralyn	O
c	O
call	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
3807	O
*	O
*	O
]	O
for	O
a	O
follow	O
-	O
up	O
in	O
1	O
week	O
.	O

you	O
should	O
have	O
your	O
blood	O
pressure	O
checked	O
and	O
medications	O
adjusted	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
259	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
260	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
1462	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
3576	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
3577	O
*	O
*	O
]	O
[	O
*	O
*	O
2016	O
-	O
07	O
-	O
07	O
*	O
*	O
]	O
@	O
1441	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
75	O
*	O
*	O
]	O
[	O
*	O
*	O
2016	O
-	O
07	O
-	O
07	O
*	O
*	O
]	O
3	O
:	O
44	O
pm	O
(	O
end	O
of	O
report	O
)	O

22047	O
||||	O
17583	O
||||	O
1254	O
||||	O
discharge	O
_	O
summary	O
||||	O
2017	O
-	O
07	O
-	O
19	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1931	O
-	O
06	O
-	O
23	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
cme	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
an	O
86	O
year	O
old	O

caucasian	O
female	O
with	O
a	O
history	O
of	O
hypercholesterolemia	B
,	O
right	B
bundle	I
branch	I
block	I
on	O
ekg	O
,	O
and	O
osteoporosis	B
,	O
who	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
two	O
days	O
prior	O
to	O
admission	O
when	O
she	O
had	O
intermittent	O
nausea	B
and	O
weakness	B
.	O

the	O
patient	O
states	O
that	O
she	O
has	O
been	O
unable	B
to	I
get	I
up	I
from	O
a	O
chair	O
secondary	O
to	O
weakness	B
.	O

she	O
denies	O
palpitations	B
,	O
pnd	B
,	O
orthopnea	B
.	O

she	O
has	O
stable	O
lower	I
extremity	I
edema	I
,	O
perhaps	O
slightly	O
worse	O
over	O
the	O
last	O
day	O
.	O

she	O
denies	O
chest	B
pain	I
or	O
pressure	O
.	O

she	O
reports	O
intermittent	O
dizziness	B
but	O
no	O
episodes	O
of	O
loss	B
of	I
consciousness	I
.	O

the	O
patient's	O
daughter	O
,	O
who	O
is	O
a	O
nurse	O
,	O
noted	O
the	O
patient	O
to	O
be	O
bradycardic	B
and	O
brought	O
the	O
patient	O
to	O
the	O
e	O
.	O
d	O
.	O
,	O
where	O
on	O
ekg	O
she	O
was	O
noted	O
to	O
have	O
a	O
new	O
left	B
bundle	I
branch	I
block	I
and	O
to	O
be	O
in	O
complete	B
heart	I
block	I
with	O
an	O
atrial	O
rate	O
of	O
110	O
and	O
a	O
ventricular	O
rate	O
of	O
40	O
.	O

the	O
patient's	O
daughter	O
reports	O
that	O
an	O
ekg	O
one	O
week	O
prior	O
to	O
admission	O
did	O
not	O
have	O
a	O
complete	B
heart	I
block	I
.	O

past	O
medical	O
history	O
:	O
hyperlipidemia	B
.	O

gastroesophageal	B
reflux	I
disease	I
.	O

hiatal	B
hernia	I
.	O

dementia	B
.	O

catatonic	B
depression	I
.	O

spinal	B
stenosis	I
,	O
status	O
post	O
surgery	O
.	O

urinary	B
retention	I
.	O

osteoporosis	B
.	O

cataracts	B
.	O

biceps	O
tendon	O
repair	O
.	O

chronic	B
constipation	I
.	O

sciatica	B
.	O

medications	O
:	O
fosamax	O
70	O
mg	O
q	O
.	O
week	O
.	O

protonix	O
40	O
mg	O
q	O
.	O
day	O
.	O

nortriptyline	O
50	O
mg	O
q	O
.	O
p	O
.	O
m	O
.	O

trilafon	O
4	O
mg	O
q	O
.	O
p	O
.	O
m	O
.	O

multivitamin	O
.	O

vitamin	O
e	O
.	O

calcium	O
.	O

vitamin	O
d	O
.	O

fibercon	O
.	O

flax	O
seed	O
oil	O
.	O

ocular	O
eyedrops	O
1	O
drop	O
o	O
.	O
u	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

advil	O
400	O
mg	O
t	O
.	O
i	O
.	O
d	O
.	O

social	O
history	O
:	O
the	O
patient	O
previously	O
lived	O
in	O
an	O
assisted	O
-	O
living	O
facility	O
for	O
many	O
years	O
until	O
her	O
husband	O
passed	O
away	O
;	O
now	O
she	O
lives	O
with	O
her	O
daughter	O
,	O
who	O
is	O
a	O
nurse	O
and	O
performs	O
all	O
of	O
her	O
adl	O
.	O

she	O
denies	O
a	O
history	O
of	O
tobacco	O
,	O
alcohol	O
,	O
or	O
drug	O
use	O
.	O

physical	O
examination	O
:	O
general	O
:	O
bp	O
120	O
/	O
70	O
,	O
heart	O
rate	O
41	O
,	O
respirations	O
12	O
,	O
99	O
percent	O
on	O
room	O
air	O
.	O

in	O
general	O
,	O
the	O
patient	O
is	O
an	O
elderly	O
woman	O
in	O
no	O
acute	B
distress	I
with	O
a	O
depressed	B
affect	I
.	O

heent	O
:	O
normocephalic	O
,	O
atraumatic	O
.	O

extraocular	O
movements	O
are	O
intact	O
.	O

oropharynx	O
is	O
clear	O
.	O

dry	B
mucous	I
membranes	I
.	O

chest	O
:	O
lungs	O
are	O
clear	O
to	O
auscultation	O
bilaterally	O
aside	O
from	O
mild	O
bibasilar	O
crackles	B
.	O

heart	O
:	O
bradycardic	B
.	O

no	O
murmurs	B
,	O
rubs	B
,	O
or	O
gallops	B
.	O

abdomen	O
:	O
soft	O
,	O
nondistended	O
,	O
with	O
mild	O
tenderness	O
on	O
palpation	O
in	O
the	O
suprapubic	O
region	O
with	O
normoactive	O
bowel	O
sounds	O
.	O

extremities	O
:	O
no	O
clubbing	B
or	O
cyanosis	B
.	O

there	O
is	O
2	O
+	O
bilateral	O
pitting	B
edema	I
.	O

dp	O
pulses	O
are	O
2	O
+	O
bilaterally	O
.	O

all	O
extremities	O
are	O
cool	O
.	O

laboratory	O
data	O
:	O
white	O
blood	O
cells	O
11	O
.	O
9	O
,	O
hematocrit	O
27	O
.	O
5	O
,	O
platelets	O
305	O
,	O
sodium	O
137	O
,	O
potassium	O
4	O
.	O
3	O
,	O
chloride	O
103	O
,	O
bicarb	O
27	O
,	O
bun	O
22	O
,	O
creatinine	O
1	O
.	O
0	O
,	O
glucose	O
93	O
,	O
iron	O
2	O
.	O
1	O
,	O
calcium	O
11	O
.	O
7	O
,	O
phosphorus	O
4	O
.	O
1	O
,	O
inr	O
1	O
.	O
1	O
.	O

hospital	O
course	O
:	O
complete	B
heart	I
block	I
:	O
the	O
patient	O
was	O
noted	O
to	O
be	O
in	O
complete	B
heart	I
block	I
on	O
admission	O
ekg	O
,	O
was	O
admitted	O
to	O
the	O
coronary	O
care	O
unit	O
for	O
temporary	O
pacer	O
wire	O
placement	O
.	O

she	O
received	O
a	O
temporary	O
pacer	O
wire	O
on	O
the	O
evening	O
of	O
admission	O
.	O

on	O
[	O
*	O
*	O
2017	O
-	O
07	O
-	O
18	O
*	O
*	O
]	O
,	O
the	O
patient	O
was	O
taken	O
for	O
a	O
pacemaker	O
.	O

the	O
patient	O
underwent	O
an	O
uncomplicated	O
placement	O
of	O
a	O
dual	O
-	O
chamber	O
pacemaker	O
.	O

upon	O
return	O
to	O
the	O
floor	O
,	O
the	O
patient	O
complained	O
of	O
6	O
out	O
of	O
10	O
chest	I
pressure	I
substernally	O
without	O
radiation	O
.	O

her	O
cardiac	B
enzymes	I
were	O
not	O
elevated	O
and	O
she	O
had	O
no	O
ekg	B
changes	I
.	O

her	O
cardiac	O
enzymes	O
were	O
cycled	O
and	O
were	O
noted	O
to	O
be	O
normal	O
.	O

the	O
patient's	O
chest	B
pressure	I
resolved	O
overnight	O
.	O

the	O
site	O
of	O
the	O
pacemaker	O
was	O
stable	O
and	O
nontender	O
without	O
evidence	O
of	O
hematoma	B
.	O

an	O
echocardiogram	O
performed	O
after	O
pacemaker	O
placement	O
revealed	O
a	O
very	O
small	O
anterior	O
pericardial	B
effusion	I
.	O

a	O
repeat	O
echocardiogram	O
done	O
the	O
following	O
morning	O
showed	O
no	O
change	O
in	O
the	O
small	O
effusion	B
.	O

the	O
patient's	O
nonsteroidal	O
anti	O
-	O
inflammatory	O
medications	O
were	O
held	O
.	O

coronary	B
artery	I
disease	I
:	O
the	O
patient	O
has	O
no	O
known	O
history	O
of	O
coronary	B
artery	I
disease	I
.	O

an	O
ldl	O
was	O
97	O
.	O

the	O
patient	O
was	O
given	O
aspirin	O
throughout	O
her	O
brief	O
hospitalization	O
.	O

as	O
noted	O
previously	O
,	O
she	O
had	O
complaints	O
of	O
mild	O
chest	B
pressure	I
after	O
her	O
pacemaker	O
placement	O
but	O
had	O
cycled	O
cardiac	O
enzymes	O
which	O
were	O
normal	O
and	O
no	O
ekg	B
changes	I
.	O

bone	B
lucency	I
:	O
noted	O
on	O
a	O
chest	O
x	O
-	O
ray	O
was	O
a	O
right	O
humerus	O
lucency	B
.	O

this	O
was	O
confirmed	O
with	O
a	O
right	O
shoulder	O
film	O
which	O
confirmed	O
a	O
focal	O
lucent	I
lesion	I
in	O
the	O
proximal	O
right	O
humerus	O
shaft	O
with	O
an	O
ill	O
-	O
defined	O
border	O
.	O

this	O
lucent	B
lesion	I
was	O
concerning	O
for	O
metastatic	B
disease	I
,	O
multiple	B
myeloma	I
,	O
or	O
a	O
benign	B
bony	I
lesion	I
.	O

the	O
patient	O
had	O
an	O
s	O
-	O
pep	O
and	O
a	O
u	O
-	O
pep	O
which	O
were	O
sent	O
and	O
were	O
negative	O
.	O

she	O
was	O
evaluated	O
with	O
a	O
breast	O
exam	O
that	O
was	O
normal	O
.	O

it	O
is	O
anticipated	O
that	O
a	O
further	O
workup	O
for	O
this	O
right	O
humerus	B
lucency	I
will	O
be	O
performed	O
as	O
an	O
outpatient	O
and	O
the	O
patient's	O
primary	O
care	O
physician	O
was	O
contacted	O
prior	O
to	O
discharge	O
.	O

osteoporosis	B
:	O
the	O
patient	O
was	O
continued	O
on	O
alendronate	O
,	O
vitamin	O
d	O
and	O
calcium	O
throughout	O
her	O
brief	O
hospitalization	O
.	O

gastroesophageal	B
reflux	I
disease	I
:	O
the	O
patient	O
was	O
continued	O
on	O
her	O
fibercon	O
,	O
flax	O
seed	O
oil	O
,	O
and	O
proton	O
pump	O
inhibitor	O
throughout	O
this	O
hospitalization	O
and	O
was	O
asymptomatic	O
.	O

psychiatric	O
:	O
the	O
patient	O
was	O
continued	O
on	O
her	O
outpatient	O
dose	O
of	O
nortriptyline	O
and	O
had	O
a	O
stable	O
,	O
somewhat	O
flat	B
affect	I
throughout	O
her	O
hospitalization	O
.	O

anemia	B
:	O
the	O
patient	O
was	O
noted	O
to	O
have	O
a	O
somewhat	O
low	O
hematocrit	O
throughout	O
her	O
hospitalization	O
that	O
was	O
stable	O
.	O

the	O
etiology	O
of	O
this	O
is	O
somewhat	O
unclear	O
.	O

the	O
patient	O
was	O
guaiac	O
negative	O
on	O
admission	O
.	O

it	O
is	O
anticipated	O
that	O
the	O
patient's	O
hematocrit	O
and	O
iron	O
studies	O
will	O
be	O
followed	O
by	O
her	O
primary	O
care	O
physician	O
as	O
an	O
outpatient	O
.	O

condition	O
on	O
discharge	O
:	O
good	O
.	O

discharge	O
status	O
:	O
the	O
patient	O
is	O
discharged	O
to	O
home	O
.	O

discharge	O
diagnoses	O
:	O
complete	B
heart	I
block	I
,	O
status	O
post	O
pacemaker	O
placement	O
.	O

hyperlipidemia	B
.	O

gastroesophageal	B
reflux	I
disease	I
/	O
hiatal	B
hernia	I
.	O

depression	B
.	O

anemia	B
.	O

osteoporosis	B
.	O

medications	O
:	O
alendronate	O
sodium	O
70	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
week	O
.	O

pantoprazole	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

nortriptyline	O
50	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
h	O
.	O
s	O
.	O

multivitamin	O
1	O
cap	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

vitamin	O
e	O
400	O
units	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

calcium	O
carbonate	O
500	O
mg	O
p	O
.	O
o	O
.	O
t	O
.	O
i	O
.	O
d	O
.	O

vitamin	O
d	O
400	O
units	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

ketorolac	O
0	O
.	O
5	O
percent	O
one	O
drop	O
o	O
.	O
u	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

perphenazine	O
4	O
mg	O
q	O
.	O
a	O
.	O
m	O
.	O

flax	O
seed	O
oil	O
.	O

fibercon	O
.	O

follow	O
up	O
:	O
the	O
patient	O
has	O
a	O
followup	O
appointment	O
with	O
her	O
primary	O
care	O
physician	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
2017	O
-	O
07	O
-	O
21	O
*	O
*	O
]	O
at	O
1	O
:	O
45	O
p	O
.	O
m	O
.	O

she	O
is	O
instructed	O
to	O
have	O
her	O
hematocrit	O
and	O
iron	O
studies	O
drawn	O
the	O
day	O
after	O
admission	O
to	O
be	O
followed	O
up	O
by	O
her	O
primary	O
care	O
physician	O
.	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
36	O
*	O
*	O
]	O
patient's	O
primary	O
care	O
physician	O
will	O
also	O
follow	O
up	O
on	O
the	O
right	O
shoulder	O
lucency	B
seen	O
on	O
x	O
-	O
ray	O
.	O

the	O
patient	O
also	O
has	O
a	O
followup	O
appointment	O
with	O
cardiology	O
on	O
[	O
*	O
*	O
2017	O
-	O
07	O
-	O
25	O
*	O
*	O
]	O
at	O
2	O
:	O
00	O
pm	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
state	O
/	O
zipcode	O
7018	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
7021	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2017	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O
20	O
:	O
55	O
:	O
35	O

t	O
:	O
[	O
*	O
*	O
2017	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O
22	O
:	O
33	O
:	O
44	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
7022	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
90	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2017	O
-	O
07	O
-	O
24	O
*	O
*	O
]	O
9	O
:	O
27	O
am	O

(	O
end	O
of	O
report	O
)	O

17974	O
||||	O
17644	O
||||	O
12326	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
12	O
-	O
18	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
08	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
18	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1952	O
-	O
01	O
-	O
06	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O

admission	O
diagnosis	O
:	O
rectal	B
cancer	I
.	O

discharge	O
diagnosis	O
:	O
rectal	B
cancer	I
,	O
status	O
post	O
abdominoperineal	O
resection	O
.	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
a	O
63	O
year	O
old	O
man	O
with	O
a	O
known	O
history	O
of	O
right	O
colon	B
adenocarcinoma	I
,	O
staging	O

t3	O
n0	O
,	O
rectal	B
adenocarcinoma	I
staging	O
t1	O
n0	O
,	O
status	O
post	O
chemotherapy	O
and	O
radiation	O
therapy	O
in	O
august	O
and	O
[	O
*	O
*	O
2015	O
-	O
09	O
-	O
27	O
*	O
*	O
]	O
.	O

the	O
patient	O
had	O
had	O
previous	O
resections	O
for	O
the	O
known	O
cancers	B
.	O

he	O
now	O
has	O
a	O
recurrence	O
of	O
a	O
rectal	B
cancer	I
at	O
the	O
suture	O
line	O
.	O

the	O
patient	O
comes	O
for	O
further	O
surgical	O
resection	O
of	O
the	O
recurrent	O
cancer	B
.	O

physical	O
examination	O
:	O
in	O
general	O
,	O
the	O
patient	O
is	O
in	O
no	O
acute	B
distress	I
.	O

chest	O
is	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

cardiovascular	O
is	O
regular	O
rate	O
and	O
rhythm	O
,	O
without	O
murmurs	B
,	O
rubs	B
or	O
gallops	B
.	O

the	O
abdomen	O
is	O
soft	O
,	O
nontender	O
,	O
nondistended	O
.	O

incisional	O
scars	B
consistent	O
with	O
previous	O
surgery	O
.	O

extremities	O
-	O
the	O
patient	O
does	O
have	O
some	O
mild	O
pitting	B
edema	I
of	O
the	O
bilateral	O
lower	O
extremities	O
.	O

otherwise	O
,	O
the	O
extremities	O
are	O
warm	O
,	O
noncyanotic	B
,	O
nonedematous	B
.	O

neurologically	O
,	O
the	O
patient	O
is	O
grossly	O
intact	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
right	O
colon	B
adenocarcinoma	I
,	O
t3	O
n0	O
.	O

2	O
.	O
rectal	B
adenocarcinoma	I
,	O
t1	O
n0	O
.	O

3	O
.	O
status	O
post	O
chemotherapy	O
and	O
radiation	O
treatment	O
in	O

august	O
and	O
[	O
*	O
*	O
2015	O
-	O
09	O
-	O
27	O
*	O
*	O
]	O
.	O

4	O
.	O
hypertension	B
.	O

5	O
.	O
history	O
of	O
atrial	B
fibrillation	I
.	O

6	O
.	O
history	O
of	O
clostridium	B
difficile	I
infection	I
.	O

7	O
.	O
status	O
post	O
right	O
colectomy	O
and	O
sigmoid	O
resection	O
in	O

[	O
*	O
*	O
2012	O
-	O
12	O
-	O
26	O
*	O
*	O
]	O
.	O

8	O
.	O
transurethral	O
resection	O
of	O
prostate	O
[	O
*	O
*	O
2015	O
-	O
10	O
-	O
27	O
*	O
*	O
]	O
.	O

9	O
.	O
port	O
-	O
a	O
-	O
cath	O
placement	O
[	O
*	O
*	O
2015	O
-	O
08	O
-	O
27	O
*	O
*	O
]	O
.	O

medications	O
on	O
admission	O
:	O

1	O
.	O
lasix	O
40	O
mg	O
once	O
daily	O
.	O

2	O
.	O
diltiazem	O
extended	O
release	O
120	O
mg	O
once	O
daily	O
.	O

3	O
.	O
accupril	O
10	O
mg	O
once	O
daily	O
.	O

4	O
.	O
potassium	O
chloride	O
10	O
meq	O
once	O
daily	O
.	O

5	O
.	O
albuterol	O
inhaler	O
two	O
puffs	O
four	O
times	O
a	O
day	O
.	O

6	O
.	O
atrovent	O
inhaler	O
two	O
puffs	O
four	O
times	O
a	O
day	O
.	O

7	O
.	O
digoxin	O
250	O
mcg	O
once	O
daily	O
.	O

8	O
.	O
warfarin	O
1	O
mg	O
once	O
daily	O
,	O
has	O
been	O
off	O
warfarin	O
preoperatively	O
.	O

9	O
.	O
azmacort	O
inhaler	O
p	O
.	O
r	O
.	O
n	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
for	O
further	O
surgical	O
therapy	O
of	O
his	O
recurrent	O
rectal	B
cancer	I
.	O

in	O
the	O
operating	O
room	O
,	O
the	O
decision	O
was	O
made	O
to	O
proceed	O
with	O
abdominoperineal	O
resection	O
.	O

the	O
patient	O
seemed	O
to	O
tolerate	O
the	O
procedure	O
well	O
without	O
complication	B
.	O

postoperatively	O
,	O
the	O
patient	O
was	O
recovering	O
nicely	O
on	O
bedrest	O
until	O
the	O
morning	O
of	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
10	O
*	O
*	O
]	O
,	O
postoperative	O
day	O
number	O
two	O
.	O

the	O
patient	O
on	O
postoperative	O
day	O
number	O
two	O
had	O
some	O
mental	B
status	I
changes	I
and	O
was	O
initially	O
somewhat	O
lethargic	B
and	O
became	O
agitated	B
and	O
intermittently	B
violent	I
.	O

the	O
patient	O
became	O
disoriented	B
although	O
he	O
was	O
alert	O
.	O

initial	O
workup	O
including	O
cardiac	O
and	O
metabolic	O
workups	O
proved	O
to	O
be	O
negative	O
.	O

the	O
patient	O
did	O
have	O
some	O
crackles	B
on	O
physical	O
examination	O
throughout	O
his	O
lung	O
fields	O
.	O

after	O
speaking	O
with	O
the	O
family	O
,	O
the	O
patient	O
had	O
a	O
history	O
of	O
some	O
altered	B
mental	I
status	I
changes	O
preceding	O
a	O
previous	O
episode	O
of	O
pneumonia	B
that	O
he	O
had	O
had	O
.	O

working	O
diagnosis	O
at	O
that	O
time	O
was	O
pneumonia	B
versus	O
hospital	O
psychosis	B
.	O

the	O
patient's	O
mental	B
status	I
did	O
not	O
improve	O
over	O
the	O
course	O
of	O
the	O
following	O
two	O
days	O
with	O
some	O
intermittent	O
agitation	B
.	O

the	O
patient	O
was	O
medicated	O
with	O
haldol	O
and	O
ativan	O
.	O

this	O
had	O
some	O
success	O
.	O

on	O
the	O
evening	O
of	O
postoperative	O
day	O
number	O
four	O
,	O
the	O
patient	O
had	O
an	O
acute	O
episode	O
of	O
respiratory	B
distress	I
and	O
required	O
intubation	O
on	O
the	O
floor	O
.	O

subsequent	O
to	O
this	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
intensive	O
care	O
unit	O
for	O
closer	O
monitoring	O
and	O
ventilatory	O
management	O
.	O

in	O
the	O
intensive	O
care	O
unit	O
,	O
the	O
patient	O
did	O
well	O
and	O
was	O
extubated	O
postoperative	O
day	O
number	O
six	O
.	O

the	O
patient	O
was	O
empirically	O
covered	O
for	O
a	O
probable	O
aspiration	B
pneumonia	I
with	O
levaquin	O
,	O
a	O
seven	O
day	O
course	O
.	O

the	O
patient	O
was	O
transferred	O
back	O
to	O
the	O
floor	O
on	O
postoperative	O
day	O
number	O
six	O
.	O

his	O
mental	O
status	O
was	O
normal	O
at	O
that	O
time	O
.	O

throughout	O
the	O
rest	O
of	O
his	O
hospital	O
course	O
,	O
the	O
patient	O
did	O
quite	O
well	O
.	O

his	O
diet	O
was	O
advanced	O
as	O
tolerated	O
.	O

the	O
patient	O
was	O
discharged	O
on	O
postoperative	O
day	O
number	O
ten	O
tolerating	O
a	O
regular	O
diet	O
and	O
having	O
regular	O
ostomy	O
output	O
,	O
good	O
pain	B
control	O
on	O
p	O
.	O
o	O
.	O
pain	B
medications	O
.	O

condition	O
on	O
discharge	O
:	O
good	O
.	O

disposition	O
:	O
to	O
home	O
.	O

diet	O
:	O
ad	O
lib	O
.	O

medications	O
on	O
discharge	O
:	O

1	O
.	O
lasix	O
40	O
mg	O
once	O
daily	O
.	O

2	O
.	O
diltiazem	O
extended	O
release	O
120	O
mg	O
once	O
daily	O
.	O

3	O
.	O
accupril	O
10	O
mg	O
once	O
daily	O
.	O

4	O
.	O
potassium	O
chloride	O
10	O
meq	O
once	O
daily	O
.	O

5	O
.	O
albuterol	O
inhaler	O
two	O
puffs	O
four	O
times	O
a	O
day	O
.	O

6	O
.	O
atrovent	O
inhaler	O
two	O
puffs	O
four	O
times	O
a	O
day	O
.	O

7	O
.	O
digoxin	O
250	O
mcg	O
once	O
daily	O
.	O

8	O
.	O
warfarin	O
1	O
mg	O
once	O
daily	O
,	O
has	O
been	O
off	O
warfarin	O
preoperatively	O
.	O

9	O
.	O
azmacort	O
inhaler	O
p	O
.	O
r	O
.	O
n	O
.	O

10	O
.	O

amiodarone	O
400	O
mg	O
twice	O
a	O
day	O
.	O

11	O
.	O

percocet	O
5	O
/	O
325	O
mg	O
one	O
to	O
two	O
tablets	O
q4hours	O
p	O
.	O
r	O
.	O
n	O
.	O

follow	O
-	O
up	O
:	O
the	O
patient	O
is	O
to	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
165	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
21	O
*	O
*	O
]	O
.	O

he	O
is	O
being	O
sent	O
home	O
with	O
vna	O
for	O
ostomy	O
care	O
and	O
[	O
*	O
*	O
lastname	O
198	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
200	O
*	O
*	O
]	O
teaching	O
.	O
[	O
*	O
*	O
lastname	O
198	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
200	O
*	O
*	O
]	O
will	O
likely	O
be	O
discontinued	O
at	O
subsequent	O
office	O
visit	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
165	O
*	O
*	O
]	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
167	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1248	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
18	O
*	O
*	O
]	O
08	O
:	O
21	O

t	O
:	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
20	O
*	O
*	O
]	O
09	O
:	O
18	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
5810	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
22	O
*	O
*	O
]	O
11	O
:	O
44	O
am	O

(	O
end	O
of	O
report	O
)	O

18982	O
||||	O
17652	O
||||	O
16576	O
||||	O
discharge	O
_	O
summary	O
||||	O
2016	O
-	O
01	O
-	O
18	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
31	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
18	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1941	O
-	O
04	O
-	O
23	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
a	O
75	O
-	O
year	O
-	O
old	O
gentleman	O
,	O
who	O
has	O
a	O
history	O
of	O
known	O
coronary	B
artery	I
disease	I
had	O
been	O
managed	O
medically	O
over	O
the	O
last	O
several	O
years	O
with	O
a	O
ptca	O
in	O
[	O
*	O
*	O
2001	O
*	O
*	O
]	O
.	O

recently	O
has	O
been	O
experiencing	O
increased	O
exertional	B
angina	I
.	O

had	O
a	O
positive	O
stress	O
test	O
in	O
[	O
*	O
*	O
2015	O
-	O
11	O
-	O
14	O
*	O
*	O
]	O
,	O
which	O
showed	O
a	O
large	O
reversible	O
inferolateral	O
wall	O
defect	B
with	O
a	O
fixed	O
component	O
of	O
inferior	O
apex	O
,	O
an	O
ejection	O
fraction	O
of	O
38%	O
.	O

an	O
echocardiogram	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
14	O
*	O
*	O
]	O
showed	O
mild	O
left	B
ventricular	I
hypertrophy	I
,	O
moderate	O
inferior	O
wall	O
hypokinesis	B
,	O
and	O
ejection	O
fraction	O
of	O
50%	O
.	O

patient	O
was	O
referred	O
to	O
[	O
*	O
*	O
hospital	O
20	O
*	O
*	O
]	O
for	O
cardiac	O
catheterization	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
coronary	B
artery	I
disease	I
.	O

2	O
.	O
hyperlipidemia	B
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

preoperative	O
medications	O
:	O

1	O
.	O
zocor	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

2	O
.	O
procardia	O
30	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

3	O
.	O
isosorbide	O
dinitrate	O
30	O
mg	O
p	O
.	O
o	O
.	O
t	O
.	O
i	O
.	O
d	O
.	O

4	O
.	O
inderal	O
30	O
mg	O
p	O
.	O
o	O
.	O
t	O
.	O
i	O
.	O
d	O
.	O

5	O
.	O
aspirin	O
325	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

patient	O
was	O
admitted	O
to	O
the	O
cardiac	O
catheterization	O

laboratory	O
on	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
01	O
*	O
*	O
]	O
.	O

cardiac	O
catheterization	O
showed	O
left	O
ventricular	O
end	O
diastolic	O
pressure	O
of	O
26	O
,	O
ejection	O
fraction	O
of	O
25%	O
,	O
95%	O
distal	O
left	O
main	O
involving	O
the	O
ostia	O
,	O
the	O
lad	O
,	O
and	O
circumflex	O
,	O
30%	O
mid	O
lad	O
,	O
95%	O
very	O
proximal	O
left	O
circumflex	O
,	O
and	O
95%	O
mid	O
left	O
circumflex	O
after	O
om	O
-	O
1	O
,	O
dominant	O
diffusely	O
diseased	B
rca	O
with	O
90%	O
mid	O
lesion	B
and	O
90%	O
distal	O
lesion	B
.	O

patient	O
was	O
referred	O
for	O
cardiac	O
surgery	O
.	O

patient	O
was	O
originally	O
scheduled	O
for	O
surgery	O
on	O
[	O
*	O
*	O
01	O
-	O
04	O
*	O
*	O
]	O
or	O
[	O
*	O
*	O
01	O
-	O
05	O
*	O
*	O
]	O
,	O
however	O
,	O
on	O
the	O
evening	O
of	O
[	O
*	O
*	O
01	O
-	O
02	O
*	O
*	O
]	O
,	O
patient	O
had	O
episode	O
of	O
ventricular	B
fibrillation	I
,	O
which	O
required	O
d	O
-	O
c	O
cardioversion	O
with	O
200	O
joules	O
.	O

patient	O
was	O
cardioverted	O
into	O
a	O
sinus	B
rhythm	I
.	O

patient	O
recovered	O
a	O
good	O
blood	O
pressure	O
.	O

patient	O
was	O
then	O
transported	O
to	O
the	O
cardiac	O
catheterization	O
laboratory	O
,	O
where	O
an	O
intra	O
-	O
aortic	O
balloon	O
pump	O
was	O
placed	O
,	O
and	O
cardiac	O
surgery	O
was	O
consulted	O
.	O

it	O
was	O
decided	O
at	O
that	O
time	O
to	O
take	O
the	O
patient	O
urgently	O
for	O
a	O
cabg	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
72	O
*	O
*	O
]	O
.	O

patient	O
underwent	O
a	O
cabg	O
x4	O
:	O
lima	O
to	O
lad	O
,	O
svg	O
to	O
om	O
-	O
1	O
,	O
svg	O
to	O
om	O
-	O
2	O
,	O
and	O
svg	O
to	O
pda	O
.	O

patient	O
tolerated	O
the	O
procedure	O
well	O
.	O

was	O
transported	O
to	O
the	O
intensive	O
care	O
unit	O
in	O
stable	O
condition	O
on	O
levophed	O
and	O
milrinone	O
as	O
well	O
as	O
intra	O
-	O
aortic	O
balloon	O
pump	O
.	O

patient	O
awoke	O
postoperatively	O
,	O
followed	O
commands	O
,	O
moved	O
all	O
extremities	O
,	O
and	O
was	O
nonfocal	O
neurologically	O
.	O

patient	O
was	O
weaned	O
and	O
extubated	O
from	O
mechanical	O
ventilation	O
on	O
postoperative	O
day	O
#1	O
.	O
the	O
milrinone	O
and	O
levophed	O
were	O
weaned	O
down	O
to	O
off	O
.	O

the	O
intra	O
-	O
aortic	O
balloon	O
pump	O
was	O
discontinued	O
on	O
postoperative	O
day	O
#1	O
.	O
liver	O
function	O
tests	O
were	O
drawn	O
as	O
it	O
was	O
felt	O
that	O
the	O
patient	O
had	O
some	O
jaundice	B
.	O

the	O
liver	B
function	I
tests	I
were	O
all	O
significantly	O
elevated	O
with	O
an	O
alt	O
of	O
1433	O
,	O
ast	O
1958	O
,	O
ldh	O
2408	O
,	O
alkaline	O
phosphatase	O
of	O
69	O
,	O
and	O
a	O
total	O
bilirubin	O
of	O
0	O
.	O
6	O
.	O

it	O
was	O
recommended	O
by	O
the	O
hepatology	O
service	O
that	O
a	O
right	O
upper	O
quadrant	O
ultrasound	O
be	O
obtained	O
to	O
check	O
flow	O
to	O
the	O
patient's	O
liver	O
.	O

however	O
,	O
it	O
was	O
felt	O
that	O
the	O
etiology	O
was	O
most	O
likely	O
ischemic	B
hepatitis	I
due	O
to	O
the	O
poor	O
forward	O
flow	O
during	O
the	O
arrest	B
and	O
subsequent	O
cabg	O
.	O

the	O
right	O
upper	O
quadrant	O
ultrasound	O
showed	O
no	O
obstruction	B
,	O
no	O
evidence	O
of	O
cholecystitis	B
,	O
and	O
good	O
blood	O
flow	O
to	O
the	O
liver	O
.	O

the	O
patient's	O
liver	O
function	O
tests	O
continued	O
to	O
rise	O
.	O

it	O
was	O
also	O
recommended	O
by	O
the	O
hepatology	O
service	O
that	O
a	O
hepatitis	B
panel	O
be	O
sent	O
which	O
is	O
pending	O
at	O
this	O
date	O
.	O

it	O
was	O
noted	O
by	O
the	O
nurses	O
on	O
postoperative	O
day	O
#2	O
,	O
that	O
this	O
patient's	O
right	O
upper	O
extremity	O
was	O
felt	O
to	O
be	O
weak	B
.	O

it	O
was	O
recommended	O
carotid	O
ultrasounds	O
be	O
obtained	O
and	O
patient	O
have	O
a	O
ct	O
scan	O
of	O
his	O
head	O
.	O

carotid	O
ultrasound	O
showed	O
that	O
the	O
patient	O
had	O
less	O
than	O
40%	O
narrowing	O
of	O
his	O
carotids	O
bilaterally	O
.	O

around	O
this	O
time	O
,	O
the	O
patient	O
also	O
had	O
episodes	O
of	O
rapid	B
atrial	I
fibrillation	I
which	O
causes	O
decrease	O
in	O
his	O
blood	O
pressure	O
requiring	O
cardioversion	O
.	O

patient	O
had	O
been	O
started	O
on	O
amiodarone	O
due	O
to	O
the	O
patient's	O
elevated	B
liver	I
function	I
tests	I
.	O

electrophysiology	O
service	O
was	O
consulted	O
for	O
alternative	O
to	O
amiodarone	O
.	O

it	O
was	O
recommended	O
by	O

electrophysiology	O
service	O
to	O
discontinue	O
the	O
amiodarone	O
due	O
to	O
the	O
patient's	O
elevated	B
liver	I
enzymes	I
.	O

start	O
the	O
patient	O
on	O
digoxin	O
for	O
rate	O
control	O
should	O
the	O
patient	O
go	O
into	O
atrial	B
fibrillation	I
,	O
and	O
it	O
was	O
also	O
recommended	O
to	O
switch	O
the	O
patient	O
from	O
lopressor	O
to	O
atenolol	O
.	O

on	O
postoperative	O
day	O
#3	O
,	O
patient	O
began	O
working	O
with	O
physical	O
therapy	O
.	O

was	O
able	O
to	O
ambulate	O
only	O
about	O
100	O
feet	O
,	O
still	O
in	O
the	O
intensive	O
care	O
unit	O
.	O

still	O
requiring	O
neo	O
-	O
synephrine	O
to	O
maintain	O
adequate	O
blood	O
pressure	O
.	O

on	O
the	O
early	O
morning	O
of	O
postoperative	O
day	O
three	O
,	O
patient	O
developed	O
periods	O
of	O
agitation	B
and	O
confusion	B
.	O

it	O
was	O
felt	O
that	O
this	O
was	O
due	O
to	O
percocet	O
.	O

percocet	O
was	O
discontinued	O
.	O

patient	O
was	O
given	O
low	O
dose	O
haldol	O
,	O
and	O
subsequently	O
cleared	O
.	O

patient	O
was	O
switched	O
to	O
dilaudid	O
for	O
pain	B
control	O
.	O

patient's	O
mediastinal	O
chest	O
tubes	O
were	O
removed	O
.	O

left	O
sided	O
watershed	B
stroke	I
:	O
neurology	O
thought	O
this	O
was	O
likely	O
due	O
to	O
hypoperfusion	B
.	O

patient's	O
right	O
upper	B
extremity	I
weakness	I
continued	O
to	O
improve	O
.	O

electrophysiology	O
service	O
was	O
again	O
reconsulted	O
for	O
patient's	O
atrial	B
fibrillation	I
as	O
well	O
as	O
patient's	O
preoperative	O
ventricular	B
fibrillation	I
,	O
and	O
the	O
need	O
for	O
electrophysiology	O
study	O
.	O

echocardiogram	O
per	O
the	O
ep	O
service	O
,	O
showed	O
ejection	O
fraction	O
of	O
25	O
-	O
30%	O
and	O
it	O
was	O
planned	O
to	O
take	O
the	O
patient	O
for	O
an	O
ep	O
study	O
and	O
question	O
of	O

aicd	O
implantation	O
.	O

the	O
day	O
the	O
patient	O
was	O
scheduled	O
to	O
go	O
for	O
his	O
study	O
,	O
it	O
was	O
noted	O
the	O
patient	O
had	O
elevated	B
white	I
blood	I
cell	I
count	I
of	O
21	O
,	O
000	O
.	O

the	O
case	O
was	O
cancelled	O
and	O
the	O
patient	O
was	O
brought	O
back	O
to	O
[	O
*	O
*	O
wardname	O
2947	O
*	O
*	O
]	O
.	O

patient	O
was	O
pancultured	O
and	O
it	O
was	O
found	O
that	O
patient	O
had	O
a	O
mild	O
pancreatitis	B
.	O

the	O
ep	O
service	O
felt	O
that	O
the	O
ventricular	B
fibrillation	I
was	O
likely	O
due	O
to	O
his	O
ischemic	B
state	I
preoperatively	O
.	O

they	O
felt	O
that	O
the	O
study	O
could	O
be	O
deferred	O
for	O
1	O
-	O
2	O
weeks	O
while	O
patient	O
recovered	O
from	O
his	O
surgery	O
.	O

a	O
general	O
surgery	O
consult	O
was	O
obtained	O
for	O
the	O
patient's	O
pancreatitis	B
.	O

patient's	O
lipase	O
was	O
502	O
with	O
an	O
amylase	O
of	O
183	O
and	O
mild	O
left	B
upper	I
quadrant	I
pain	I
.	O

patient	O
was	O
made	O
npo	O
.	O

ct	O
scan	O
of	O
the	O
abdomen	O
was	O
obtained	O
,	O
which	O
showed	O
no	O
evidence	O
of	O
significant	O
pancreatitis	B
.	O

the	O
patient	O
continued	O
to	O
be	O

npo	O
.	O

on	O
[	O
*	O
*	O
01	O
-	O
14	O
*	O
*	O
]	O
,	O
patient's	O
amylase	O
and	O
lipase	O
were	O
trending	O
downward	O
.	O

patient	O
had	O
no	O
abdominal	B
pain	I
.	O

was	O
started	O
on	O
clear	O
liquids	O
and	O
advanced	O
to	O
a	O
regular	O
diet	O
without	O
any	O
abdominal	B
pain	I
.	O

patient's	O
amylase	O
and	O
lipase	O
continued	O
to	O
trend	O
downward	O
.	O

it	O
was	O
decided	O
by	O
the	O
electrophysiology	O
service	O
that	O
patient	O
was	O
safe	O
to	O
be	O
discharged	O
to	O
home	O
and	O
will	O
return	O
for	O
his	O
study	O
.	O

by	O
postoperative	O
day	O
#15	O
,	O
patient	O
had	O
completed	O
a	O
level	O
five	O
with	O
physical	O
therapy	O
,	O
and	O
the	O
patient	O
was	O
cleared	O
for	O
discharge	O
to	O
home	O
.	O

condition	O
on	O
discharge	O
:	O
t	O
max	O
99	O
.	O
1	O
,	O
pulse	O
80	O
sinus	O
rhythm	O
,	O
blood	O
pressure	O
104	O
/	O
52	O
,	O
respiratory	O
rate	O
16	O
,	O
on	O
room	O
air	O
oxygen	O
saturation	O
97%	O
.	O

neurologically	O
,	O
the	O
patient	O
is	O
awake	O
,	O
alert	O
,	O
and	O
oriented	O
times	O
three	O
.	O

right	O
upper	O
extremity	O
has	O
significantly	O
improved	O
strength	B
with	O
barely	O
perceptible	O
weakness	B
.	O

right	O
lower	O
extremity	O
and	O
left	O
lower	O
extremity	O
have	O
equal	O
strength	O
bilaterally	O
.	O

heart	O
:	O
regular	O
rate	O
and	O
rhythm	O
without	O
rub	B
or	O
murmur	B
.	O

breath	O
sounds	O
are	O
clear	O
bilaterally	O
.	O

abdomen	O
is	O
soft	O
,	O
nontender	O
,	O
nondistended	O
,	O
positive	O
bowel	O
sounds	O
,	O
tolerating	O
regular	O
diet	O
.	O

sternal	O
incision	B
:	O
the	O
staples	O
are	O
intact	O
,	O
clean	O
,	O
and	O
dry	O
.	O

there	O
is	O
no	O
erythema	B
or	O
drainage	B
.	O

right	O
lower	O
extremity	O
vein	O
harvest	O
site	O
is	O
clean	O
and	O
dry	O
.	O

ste	O
[	O
*	O
*	O
md	O
number	O
6045	O
*	O
*	O
]	O
ips	O
were	O
intact	O
.	O

there	O
is	O
minimal	O
erythema	B
over	O
the	O
medial	O
portion	O
of	O
the	O
incision	O
.	O

extremities	O
have	O
1	O
+	O
edema	B
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
coronary	B
artery	I
disease	I
.	O

2	O
.	O
preoperative	O
ventricular	B
fibrillation	I
.	O

3	O
.	O
postoperative	O
atrial	B
fibrillation	I
.	O

4	O
.	O
postoperative	O
pancreatitis	B
.	O

5	O
.	O
postoperative	O
ischemic	B
hepatitis	I
.	O

discharge	O
medications	O
:	O

1	O
.	O
zocor	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

2	O
.	O
enteric	O
coated	O
aspirin	O
325	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

3	O
.	O
colace	O
100	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

4	O
.	O
dilaudid	O
2	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
4	O
-	O
6h	O
.	O
prn	O
.	O

5	O
.	O
atenolol	O
100	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

6	O
.	O
digoxin	O
0	O
.	O
125	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

discharge	O
instructions	O
:	O
the	O
patient	O
is	O
discharged	O
to	O
home	O
in	O
stable	O
condition	O
with	O
home	O
occupational	O
and	O
physical	O
therapy	O
.	O

patient	O
is	O
to	O
followup	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
7837	O
*	O
*	O
]	O
in	O
his	O
office	O
in	O
1	O
-	O
2	O
weeks	O
.	O

patient	O
has	O
an	O
appointment	O
for	O
an	O
electrophysiology	O
study	O
on	O
[	O
*	O
*	O
01	O
-	O
29	O
*	O
*	O
]	O
at	O
7	O
a	O
.	O
m	O
.	O

patient	O
will	O
be	O
contacted	O
by	O
the	O
electrophysiology	O
department	O
for	O
further	O
instructions	O
,	O
and	O
patient	O
should	O
see	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
72	O
*	O
*	O
]	O
in	O
one	O
month	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
58	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
73	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
7205	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
18	O
*	O
*	O
]	O
12	O
:	O
50	O

t	O
:	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
18	O
*	O
*	O
]	O
12	O
:	O
49	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
7838	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
58	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
216	O
*	O
*	O
]	O
[	O
*	O
*	O
2016	O
-	O
02	O
-	O
09	O
*	O
*	O
]	O
11	O
:	O
52	O
am	O
(	O
end	O
of	O
report	O
)	O

14129	O
||||	O
17774	O
||||	O
512	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
07	O
-	O
29	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
07	O
-	O
17	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
07	O
-	O
29	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1936	O
-	O
10	O
-	O
22	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
cardiac	O

chief	O
complaint	O
:	O
coronary	B
artery	I
disease	I
.	O

history	O
of	O
the	O
present	O
illness	O
:	O
mrs	O
.	O
[	O
*	O
*	O
lastname	O
6236	O
*	O
*	O
]	O
is	O
a	O
78	O
-	O
year	O
-	O
old	O
female	O
who	O
is	O
transferred	O
here	O
from	O
an	O
outside	O
hospital	O
following	O
an	O
positive	O
exercise	O
treadmill	O
test	O
and	O
positive	O
catheterization	O
.	O

she	O
is	O
to	O
be	O
evaluated	O
for	O
coronary	O
artery	O
bypass	O
graft	O
.	O

she	O
has	O
had	O
three	O
admissions	O
at	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
hospital	O
in	O
the	O
past	O
two	O
months	O
for	O
what	O
appears	O
to	O
be	O
ischemic	B
pulmonary	I
edema	I
.	O

she	O
now	O
appears	O
to	O
be	O
failing	O
outpatient	O
medical	O
management	O
.	O

this	O
included	O
increasing	O
her	O
beta	O
blockers	O
,	O
increasing	O
lasix	O
,	O
instituting	O
aldactone	O
,	O
and	O
increasing	O
her	O
norvasc	O
.	O

the	O
recent	O
echocardiogram	O
was	O
on	O

[	O
*	O
*	O
2015	O
-	O
06	O
-	O
09	O
*	O
*	O
]	O
,	O
demonstrated	O
apical	O
dyskinesis	B
with	O
an	O
ejection	O
fraction	O
of	O
45%	O
to	O
50%	O
.	O

past	O
medical	O
history	O
:	O
history	O
is	O
notable	O
for	O
the	O
following	O
:	O
1	O
.	O
coronary	B
artery	I
disease	I
with	O
early	O
cardiomegaly	B
.	O

2	O
.	O
severe	O
arthritis	B
.	O

3	O
.	O
lung	B
cancer	I
status	O
post	O
right	O
lower	O
lobe	O
excision	O
in	O

[	O
*	O
*	O
2006	O
*	O
*	O
]	O
.	O

4	O
.	O
hyperlipidemia	B
.	O

5	O
.	O
non	B
-	I
insulin	I
-	I
dependent	I
diabetes	I
mellitus	I
.	O

6	O
.	O
decreased	B
hearing	I
.	O

7	O
.	O
chronic	B
low	I
back	I
pain	I
.	O

8	O
.	O
gastritis	B
.	O

9	O
.	O
obesity	B
.	O

allergies	O
:	O
the	O
patient	O
is	O
not	O
allergic	O
to	O
any	O
medicines	O
.	O

medications	O
:	O

1	O
.	O
norvasc	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

2	O
.	O
lasix	O
80	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

3	O
.	O
lopressor	O
100	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

4	O
.	O
protonix	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

5	O
.	O
diovan	O
80	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

6	O
.	O
ecotrin	O
81	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

7	O
.	O
plavix	O
75	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

8	O
.	O
imdur	O
90	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

9	O
.	O
glyburide	O
2	O
.	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
a	O
.	O
m	O
.	O

10	O
.	O

nystatin	O
powder	O
to	O
the	O
right	O
groin	O
b	O
.	O
i	O
.	O
d	O
.	O

social	O
history	O
:	O
the	O
patient	O
does	O
not	O
drink	O
alcohol	O
or	O
use	O
tobacco	O
.	O

physical	O
examination	O
:	O
on	O
physical	O
examination	O
,	O
she	O
is	O
noted	O
to	O
be	O
a	O
pleasant	O
female	O
who	O
is	O
hard	B
of	I
hearing	I
,	O
but	O
otherwise	O
,	O
in	O
no	O
acute	B
distress	I
.	O

head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
throat	O
and	O
neck	O
:	O
she	O
is	O
without	O
jvd	B
.	O

chest	O
:	O
lungs	O
were	O
clear	O
to	O
auscultation	O
bilaterally	O
:	O
heart	O
:	O
regular	O
rate	O
and	O
rhythm	O
.	O

abdomen	O
:	O
soft	O
,	O
obese	O
,	O
nontender	O
.	O

the	O
right	O
groin	O
catheterization	O
site	O
on	O
arrival	O
had	O
no	O
hematoma	B
and	O
peripherally	O
the	O
extremities	O
are	O
without	O
clubbing	B
,	O
cyanosis	B
or	O
edema	B
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
to	O
cardiac	O
surgery	O
service	O
and	O
appropriate	O
preoperative	O
workup	O
was	O
obtained	O
.	O

pulmonary	O
consultation	O
was	O
obtained	O
for	O
this	O
patient's	O
underlying	O
pulmonary	B
hypertension	I
.	O

they	O
believe	O
that	O
this	O
was	O
in	O
fact	O
due	O
to	O
left	B
ventricular	I
failure	I
and	O
they	O
recommended	O
treating	O
her	O
failure	B
including	O
continued	O
diuresis	O
.	O

they	O
also	O
noted	O
that	O
she	O
had	O
no	O
pulmonary	O
contraindication	B
to	O
undergoing	O
cardiac	O
surgery	O
.	O

therefore	O
,	O
on	O
[	O
*	O
*	O
2015	O
-	O
07	O
-	O
21	O
*	O
*	O
]	O
,	O
the	O
patient	O
underwent	O
coronary	O
artery	O
bypass	O
grafting	O
times	O
three	O
.	O

she	O
had	O
saphenous	O
vein	O
graft	O
to	O
lad	O
,	O
saphenous	O
vein	O
graft	O
to	O
om	O
,	O
and	O
saphenous	O
vein	O
graft	O
to	O
rca	O
.	O

total	O
cardiopulmonary	O
bypass	O
time	O
was	O
75	O
minutes	O
.	O

cross	O
clamp	O
time	O
was	O
41	O
minutes	O
.	O

postoperatively	O
,	O
the	O
patient	O
was	O
taken	O
intubated	O
to	O
the	O
cardiac	O
surgery	O
intensive	O
care	O
unit	O
.	O

in	O
the	O
cardiac	O
surgery	O
intensive	O
care	O
unit	O
she	O
was	O
extubated	O
on	O
the	O
evening	O
of	O
her	O
operation	O
and	O
some	O
of	O
her	O
pressors	O
including	O
milrinone	O
were	O
weaned	O
off	O
.	O

the	O
chest	O
tubes	O
were	O
discontinued	O
on	O
the	O
first	O
postoperative	O
day	O
,	O
as	O
was	O
the	O
j	O
-	O
p	O
drain	O
left	O
in	O
her	O
leg	O
.	O

however	O
,	O
this	O
ultimately	O
required	O
a	O
total	O
of	O
six	O
postoperative	O
days	O
in	O
the	O
intensive	O
care	O
unit	O
.	O

this	O
was	O
primarily	O
for	O
aggressive	O
pulmonary	O
toilet	O
and	O
for	O
delirious	B
mental	I
status	I
changes	I
that	O
responded	O
well	O
to	O
haldol	O
p	O
.	O
r	O
.	O
n	O
.	O

during	O
this	O
time	O
she	O
was	O
continued	O
on	O
her	O
normal	O
perioperative	O
course	O
of	O
vancomycin	O
in	O
addition	O
,	O
possible	O
sources	O
of	O
her	O
delirium	B
were	O
aggressively	O
sought	O
and	O
non	O
appeared	O
to	O
have	O
been	O
found	O
.	O

during	O
all	O
of	O
the	O
time	O
the	O
white	O
count	O
remained	O
stable	O
in	O
the	O
10	O
to	O
12	O
region	O
and	O
the	O

bun	O
and	O
creatinine	O
were	O
also	O
stable	O
.	O

by	O
the	O
7th	O
postoperative	O
day	O
,	O
the	O
patient	O
was	O
transferred	O
our	O
of	O
intensive	O
care	O
onto	O
the	O
hospital	O
floor	O
.	O

on	O
the	O
floor	O
,	O
the	O
lopressor	O
was	O
sequentially	O
increased	O
to	O
a	O
final	O
dose	O
of	O
75	O
b	O
.	O
i	O
.	O
d	O
.	O

in	O
addition	O
,	O
the	O
lasix	O
was	O
converted	O
from	O
iv	O
to	O
a	O
p	O
.	O
o	O
.	O
form	O
as	O
she	O
continued	O
to	O
diurese	O
and	O
approached	O
her	O
preoperative	O
weight	O
.	O

in	O
addition	O
,	O
the	O
physical	O
therapy	O
team	O
assessed	O
her	O
and	O
noted	O
her	O
severe	O
impairment	B
and	O
mobility	B
.	O

they	O
recommended	O
rehabilitation	O
upon	O
discharge	O
and	O
felt	O
that	O
she	O
had	O
good	O
potential	O
for	O
return	O
to	O
her	O
prior	O
level	O
of	O
functioning	O
.	O

the	O
patient	O
had	O
no	O
other	O
acute	B
events	I
during	O
her	O
hospitalization	O
.	O

it	O
should	O
be	O
noted	O
that	O
the	O
white	O
blood	O
cell	O
count	O
on	O
the	O
day	O
prior	O
to	O
her	O
transfer	O
did	O
climb	O
from	O
11	O
to	O
15	O
.	O

however	O
,	O
on	O
the	O
day	O
of	O
her	O
transfer	O
it	O
went	O
back	O
down	O
to	O
12	O
.	O

during	O
all	O
this	O
time	O
,	O
she	O
remained	O
afebrile	B
.	O

on	O
[	O
*	O
*	O
2015	O
-	O
07	O
-	O
29	O
*	O
*	O
]	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O

tcu	O
for	O
further	O
care	O
.	O

it	O
should	O
be	O
noted	O
that	O
her	O
care	O
originated	O
at	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
.	O

she	O
is	O
asked	O
to	O
followup	O
with	O
her	O
primary	O
care	O
physician	O
in	O
approximately	O
two	O
weeks	O
and	O
to	O
see	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
in	O
approximately	O
four	O
weeks	O
.	O

the	O
patient	O
is	O
transferred	O
on	O
the	O
following	O
medications	O
:	O

1	O
.	O
lasix	O
20	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

2	O
.	O
potassium	O
chloride	O
20	O
meq	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

3	O
.	O
heparin	O
5000	O
subcutaneously	O
b	O
.	O
i	O
.	O
d	O
.	O

4	O
.	O
colace	O
100	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

5	O
.	O
enteric	O
coated	O
aspirin	O
325	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

6	O
.	O
protonix	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

7	O
.	O
glyburide	O
2	O
.	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

8	O
.	O
lopressor	O
75	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

9	O
.	O
ibuprofen	O
400	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
4h	O
.	O
to	O
6h	O
.	O
p	O
.	O
r	O
.	O
n	O
.	O

10	O
.	O

tylenol	O
650	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
4h	O
.	O
to	O
6h	O
.	O
p	O
.	O
r	O
.	O
n	O
.	O

11	O
.	O

sliding	O
scale	O
regular	O
insulin	O
.	O

of	O
note	O
:	O
regarding	O
the	O
preoperative	O
medications	O
,	O
we	O
could	O
not	O
find	O
a	O
definitive	O
indication	O
for	O
plavix	O
and	O
have	O
not	O
yet	O
restarted	O
that	O
,	O
in	O
addition	O
to	O
a	O
likely	O
need	O
to	O
have	O
her	O

norvasc	O
,	O
diovan	O
,	O
and	O
lipitor	O
restarted	O
in	O
the	O
future	O
,	O
it	O
is	O
unclear	O
whether	O
or	O
not	O
she	O
will	O
continue	O
to	O
need	O
the	O
higher	O
does	O
of	O
lopressor	O
or	O
the	O
higher	O
dose	O
of	O
lasix	O
following	O
her	O
operation	O
.	O

it	O
is	O
recommended	O
that	O
she	O
be	O
followed	O
clinically	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
coronary	B
artery	I
disease	I
,	O
status	O
post	O
coronary	O
artery	O
bypass	O
grafting	O
times	O
three	O
.	O

2	O
.	O
pulmonary	B
hypertension	I
.	O

3	O
.	O
hypertension	B
,	O
treated	O
.	O

4	O
.	O
non	B
-	I
insulin	I
-	I
dependent	I
diabetes	I
mellitus	I
treated	O
.	O

5	O
.	O
hyperlipidemia	B
,	O
treated	O
.	O

6	O
.	O
severe	O
arthritis	B
and	O
chronic	B
low	I
back	I
pain	I
.	O

[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
473	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
6176	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2015	O
-	O
07	O
-	O
29	O
*	O
*	O
]	O
13	O
:	O
22	O

t	O
:	O
[	O
*	O
*	O
2015	O
-	O
07	O
-	O
29	O
*	O
*	O
]	O
13	O
:	O
42	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
6237	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2015	O
-	O
08	O
-	O
03	O
*	O
*	O
]	O
5	O
:	O
18	O
pm	O

(	O
end	O
of	O
report	O
)	O

381702	O
||||	O
18108	O
||||	O
15997	O
||||	O
radiology	O
_	O
report	O
||||	O
2016	O
-	O
03	O
-	O
31	O
10	O
:	O
23	O
:	O
00	O
.	O
0	O
||||	O
c11	O
chest	O
(	O
pa	O
&	O
lat	O
)	O
||||	O
||||	O
clip	O
#	O
314	O
-	O
1246	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
31	O
*	O
*	O
]	O
10	O
:	O
23	O
am	O

chest	O
(	O
pa	O
&	O
lat	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
1513	O
*	O
*	O
]	O
reason	O
:	O
?	O
effusions	B
,	O
infiltrate	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

47	O
year	O
old	O
woman	O
with	O
sub	O
acute	O
onset	O
liver	B
failure	I
,	O
ascites	B
and	O
decreased	O
basilar	O
breath	O
sounds	O
,	O
increased	B
02	I
requirement	I

reason	O
for	O
this	O
examination	O
:	O

?	O
effusions	B
,	O
infiltrate	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indications	O
:	O
subacute	O
onset	O
of	O
liver	B
failure	I
,	O
ascites	B
,	O
decreased	O
basilar	O
breath	O
sounds	O
.	O

evaluate	O
for	O
effusions	B
or	O
infiltrate	B
.	O

comparisons	O
:	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
30	O
*	O
*	O
]	O
.	O

pa	O
and	O
lateral	O
chest	O
:	O
there	O
has	O
been	O
significant	O
interval	O
improvement	O
in	O
the	O
appearance	O
of	O
the	O
multifocal	O
pulmonary	O
opacities	B
in	O
the	O
one	O
day	O
interval	O
.	O

particularly	O
,	O
there	O
has	O
been	O
near	O
resolution	O
in	O
the	O
right	O
upper	O
lobe	O
opacity	B
.	O

this	O
appearance	O
could	O
be	O
consistent	O
with	O
interval	O
improvement	O
in	O
multifocal	O
pneumonia	B
.	O

however	O
,	O
given	O
the	O
repeatidy	O
of	O
improvement	O
,	O
this	O
may	O
be	O
consistent	O
with	O
improving	O
pulmonary	B
edema	I
in	O
the	O
appropriate	O
clinical	O
context	O
.	O

the	O
left	O
picc	O
is	O
unchanged	O
in	O
position	O
.	O

there	O
are	O
no	O
pleural	B
effusions	I
.	O

impression	O
:	O
significant	O
interval	O
improvement	O
in	O
the	O
multifocal	O
pulmonary	O
opacities	B
.	O

this	O
may	O
relate	O
to	O
improving	O
multifocal	O
pneumonia	B
.	O

however	O
,	O
given	O
the	O
repeatidy	O
of	O
improvement	O
,	O
this	O
may	O
indicate	O
improving	O
pulmonary	B
edema	I
.	O

360237	O
||||	O
18114	O
||||	O
10699	O
||||	O
radiology	O
_	O
report	O
||||	O
2019	O
-	O
07	O
-	O
29	O
04	O
:	O
48	O
:	O
00	O
.	O
0	O
||||	O
q111	O
ct	O
head	O
w	O
/	O
o	O
contrast	O
||||	O
||||	O
clip	O
#	O
407	O
-	O
6272	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2019	O
-	O
07	O
-	O
29	O
*	O
*	O
]	O
4	O
:	O
48	O
am	O

ct	O
head	O
w	O
/	O
o	O
contrast	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
1596	O
*	O
*	O
]	O
reason	O
:	O
?	O
progression	O
of	O
right	O
posterior	O
fossa	O
bleed	B
admitting	O
diagnosis	O
:	O
cerebeller	B
hemorrhage	I

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

69	O
year	O
old	O
man	O
with	O
reason	O
for	O
this	O
examination	O
:	O
?	O
progression	O
of	O
right	O
posterior	O
fossa	O
bleed	B
no	O
contraindications	O
for	O
iv	O
contrast	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
evaluate	O
for	O
progression	O
of	O
right	O
posterior	O
fossa	O
bleed	B
.	O

comparison	O
:	O
[	O
*	O
*	O
2019	O
-	O
07	O
-	O
28	O
*	O
*	O
]	O
.	O

non	O
-	O
contrast	O
head	O
ct	O
:	O
there	O
is	O
no	O
short	O
interval	O
change	O
in	O
appearance	O
of	O
the	O
brain	O
from	O
the	O
prior	O
study	O
.	O

the	O
patient	O
is	O
status	O
post	O
right	O
occipital	O
craniotomy	O
with	O
a	O
large	O
amount	O
of	O
residual	O
hemorrhage	B
seen	O
in	O
the	O
posterior	O
fossa	O
extending	O
into	O
the	O
third	O
,	O
fourth	O
and	O
lateral	O
ventricles	O
.	O

the	O
amount	O
of	O
hemorrhage	B
is	O
relatively	O
unchanged	O
compared	O
to	O
[	O
*	O
*	O
2019	O
-	O
07	O
-	O
28	O
*	O
*	O
]	O
.	O

there	O
has	O
been	O
almost	O
complete	O
resolution	O
of	O
the	O
previously	O
described	O
pneumocephalus	B
within	O
the	O
right	O
posterior	O
fossa	O
.	O

hyperdense	B
material	I
in	O
the	O
right	O
parietal	O
sulci	O
representing	O
subarachnoid	B
hemorrhage	I
is	O
unchanged	O
.	O

there	O
are	O
periventricular	O
white	O
matter	O
hypodensities	B
consistent	O
with	O
chronic	O
microvascular	O
infarction	B
.	O

there	O
is	O
no	O
significant	O
shift	B
of	I
midline	I
structures	I
.	O

the	O
basal	O
cisterns	O
are	O
not	O
effaced	B
.	O

mild	O
polypoid	B
mucosal	I
thickening	I
of	O
the	O
maxillary	O
sinuses	O
and	O
ethmoid	O
air	O
cells	O
is	O
again	O
noted	O
.	O

impression	O
:	O
no	O
significant	O
interval	O
change	O
.	O

status	O
post	O
right	O
occipital	O
craniotomy	O
with	O
expected	O
post	O
-	O
surgical	O
changes	O
as	O
well	O
as	O
a	O
large	O
amount	O
of	O
residual	O
hemorrhage	B
in	O
the	O
posterior	O
fossa	O
extending	O
into	O
the	O
third	O
,	O
fourth	O
and	O
lateral	O
ventricles	O
.	O

a	O
small	O
amount	O
of	O
right	O
parietal	O
lobe	O
subarachnoid	B
hemorrhage	I
is	O
stable	O
.	O

7698	O
||||	O
18317	O
||||	O
20898	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
03	O
-	O
30	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
25	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
30	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1961	O
-	O
06	O
-	O
19	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O

history	O
:	O
the	O
patient	O
is	O
a	O
53	O
-	O
year	O
-	O
old	O
male	O
with	O
a	O
history	O
of	O
diabetes	B
mellitus	I
,	O
endstage	B
renal	I
disease	I
,	O
who	O
is	O
status	O
post	O
hemodialysis	O
catheter	O
4	O
days	O
prior	O
to	O
his	O
death	O
.	O

initially	O
there	O
was	O
the	O
dialysis	O
catheter	O
at	O
one	O
point	O
placed	O
in	O
the	O
right	O
common	O
carotid	O
.	O

this	O
was	O
repaired	O
with	O
the	O
assistance	O
of	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
of	O
vascular	O
surgery	O
as	O
well	O
as	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
of	O
transplant	O
surgery	O
,	O
the	O
attending	O
surgeon	O
of	O
record	O
.	O

the	O
patient	O
had	O
been	O
doing	O
well	O
on	O
the	O
floor	O
postoperatively	O
with	O
the	O
exception	O
of	O
blood	O
sugars	O
that	O
had	O
been	O
difficult	O
to	O
manage	O
.	O

he	O
was	O
found	O
by	O
nursing	O
between	O
4	O
and	O
5	O
a	O
.	O
m	O
.	O
unresponsive	B
,	O
asystolic	B
without	O
a	O
blood	B
pressure	I
.	O

code	O
blue	O
was	O
called	O
.	O

acls	O
was	O
initiated	O
for	O
30	O
minutes	O
with	O
chest	O
compressions	O
,	O
epi	O
x2	O
,	O
atropine	O
x2	O
,	O
insulin	O
,	O
d50	O
shock	O
x1	O
.	O

pulse	O
,	O
blood	O
pressure	O
returned	O
.	O

the	O
patient	O
remained	O
unresponsive	B
following	O
event	O
.	O

ct	O
/	O
cta	O
were	O
done	O
of	O
the	O
head	O
and	O
neck	O
to	O
evaluate	O
for	O
dissection	B
.	O

cta	O
was	O
negative	O
for	O
dissection	B
,	O
however	O
ct	O
demonstrated	O
infarct	B
of	O
bilateral	O
occipital	O
lobes	O
and	O
subacute	O
thalamic	B
infarcts	I
bilaterally	O
.	O

neurology	O
was	O
called	O
.	O

no	O
significant	O
brain	B
stem	I
reflexes	I
were	O
found	O
.	O

the	O
patient	O
was	O
intubated	O
,	O
no	O
sedation	O
was	O
given	O
in	O
the	O
event	O
and	O
not	B
responsive	I
to	O
noxious	O
stimuli	O
and	O
had	O
bilateral	O
papilledema	B
and	O
poor	B
prognosis	I
.	O

the	O
patient	O
is	O
a	O
53	O
-	O
year	O
-	O
old	O
male	O
with	O
past	O
medial	O
history	O
significant	O
for	O
chf	B
with	O
an	O
ef	O
of	O
35%	O
,	O
insulin	B
dependent	I
diabetes	I
mellitus	I
x2	O
,	O
triopathy	B
,	O
chronic	B
renal	I
insufficiency	I
awaiting	O
transplant	O
.	O

he	O
is	O
on	O
hemodialysis	O
.	O

hepatitis	B
c	I
,	O
hypertension	B
,	O
high	B
cholesterol	I
,	O
hyperparathyroidism	B
.	O

medications	O
at	O
home	O
:	O

1	O
.	O
reglan	O
.	O

2	O
.	O
nexium	O
.	O

3	O
.	O
coreg	O
.	O

4	O
.	O
glargine	O
.	O

on	O
[	O
*	O
*	O
03	O
-	O
30	O
*	O
*	O
]	O
after	O
extensive	O
discussion	O
was	O
undertaken	O
with	O
the	O
family	O
with	O
both	O
the	O
doctor	O
attending	O
,	O
icu	O
attending	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
2110	O
*	O
*	O
]	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
,	O
a	O
decision	O
was	O
made	O
to	O
withdraw	O
all	O
care	O
as	O
the	O
patient	O
was	O
declared	O
brain	B
dead	I
after	O
brain	B
death	I
examination	O
.	O

the	O
ventilator	O
was	O
withdrawn	O
and	O
the	O
patient	O
expired	O
shortly	O
after	O
.	O

time	O
of	O
death	O
was	O
recorded	O
as	O
8	O
:	O
56	O
p	O
.	O
m	O
.	O
on	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
30	O
*	O
*	O
]	O
.	O

medical	O
examiner	O
was	O
notified	O
and	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2111	O
*	O
*	O
]	O
of	O
the	O
medical	O
examiner's	O
office	O
declined	O
the	O
case	O
,	O
however	O
autopsy	O
permission	O
was	O
granted	O
by	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
lastname	O
2112	O
*	O
*	O
]	O
and	O
autopsy	O
was	O
to	O
be	O
performed	O
expeditiously	O
as	O
there	O
were	O
still	O
no	O
clear	O
etiology	O
as	O
per	O
the	O
asystolic	B
event	O
that	O
lead	O
to	O
an	O
anoxic	B
brain	I
injury	I
and	O
eventual	O
brain	B
death	I
and	O
demise	O
in	O
this	O
patient	O
.	O

on	O
the	O
night	O
of	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
30	O
*	O
*	O
]	O
,	O
i	O
declared	O
the	O
patient	O
after	O
withdrawal	O
of	O
support	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
state	O
/	O
zipcode	O
2113	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
2114	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
30	O
*	O
*	O
]	O
21	O
:	O
34	O
:	O
53	O

t	O
:	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
30	O
*	O
*	O
]	O
22	O
:	O
42	O
:	O
26	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
2115	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
170	O
*	O
*	O
]	O
[	O
*	O
*	O
2015	O
-	O
04	O
-	O
30	O
*	O
*	O
]	O
4	O
:	O
40	O
pm	O
(	O
end	O
of	O
report	O
)	O

10240	O
||||	O
18531	O
||||	O
29482	O
||||	O
discharge	O
_	O
summary	O
||||	O
2014	O
-	O
06	O
-	O
17	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
06	O
-	O
08	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
06	O
-	O
17	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1957	O
-	O
04	O
-	O
21	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
1665	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

found	B
down	I
,	O
vfib	B
arrest	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

cardiac	O
catheterization	O

intubation	O

history	O
of	O
present	O
illness	O
:	O

57	O
y	O
/	O
o	O
m	O
unknown	O
pmh	O
,	O
presented	O
to	O
osh	O
after	O
cardiac	B
arrest	I
.	O

per	O
report	O
,	O
he	O
was	O
sitting	O
on	O
bench	O
at	O
bus	O
station	O
when	O
witnessed	O
to	O
become	O
unresponsive	B
after	O
seizure	B
like	O
activity	O
.	O

estimated	O
time	O
when	O
ems	O
was	O
contacted	O
was	O
13	O
:	O
07	O
.	O

ems	O
arrived	O
within	O
3	O
min	O
,	O
found	O
him	O
to	O
be	O
in	O
vfib	B
arrest	I
.	O

he	O
was	O
unresponsive	B
pulseless	I
,	O
apneic	B
,	O
pupils	O
fixed	O
and	O
dilated	O
w	O
/	O
gcs	B
of	O
3	O
.	O

he	O
was	O
intubated	O
,	O
shocked	O
x2	O
(	O
120j	O
,	O
150j	O
)	O
,	O
received	O
epi	O
1	O
mg	O
,	O
lido	O
100	O
mg	O
+	O
50	O
mg	O
ivp	O
and	O
started	O
on	O
lido	O
gtt	O
.	O

he	O
broke	O
out	O
of	O
vfib	B
at	O
around	O
13	O
:	O
17	O
with	O
a	O
pulse	O
of	O
90	O
and	O
pressure	O
of	O
140	O
/	O
palp	O
,	O
rr	O
of	O
4	O
.	O
he	O
also	O
received	O
100	O
mcg	O
of	O
fentanyl	O
,	O
1mg	O
versed	O
.	O

he	O
reached	O
lgh	O
at	O
around	O
13	O
:	O
30	O
when	O
he	O
continued	O
to	O
be	O
unresponsive	B
,	O
in	O
nsr	O
w	O
/	O
bp	O
98	O
/	O
74	O
,	O
hr	O
90	O
,	O
sat	O
100%	O
on	O
vent	O
,	O
gcs	B
7	O
.	O
ekg	O
showed	O
st	B
elevations	I
in	O
infero	O
-	O
lateral	O
leads	O
(	O
i	O
,	O
ii	O
,	O
iii	O
,	O
avf	O
,	O
v4	O
-	O
6	O
)	O
;	O
right	O
sided	O
ekg	O
was	O
showed	O
st	B
elevations	I
in	O
v4	O
.	O

he	O
was	O
placed	O
on	O
spinal	O
pracautions	O
,	O
given	O
asa	O
,	O
plavix	O
,	O
heparin	O
gtt	O
,	O
integrillin	O
gtt	O
,	O
cont	O
lido	O
gtt	O
and	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
16	O
*	O
*	O
]	O
for	O
emergent	O
cath	O
.	O

cath	O
at	O
[	O
*	O
*	O
hospital1	O
16	O
*	O
*	O
]	O
showed	O
:	O

right	O
dominant	O

lmca	O
:	O
normal	O

lad	O
:	O
mid	O
-	O
segment	O
50%	O
lesion	B

lcx	O
:	O
non	O
-	O
dominant	O
with	O
occlussion	B
of	O
om2	O
at	O
the	O
bifurcation	O
with	O
the	O
avg	O

lcx	O
:	O
distal	O
vessel	O
is	O
filled	O
from	O
i	O
-	O
i	O
collaterals	O

rca	O
:	O
dominant	O
vessel	O
with	O
occlussion	B
midsegment	O
.	O
bridging	O
collaterals	O
to	O
the	O
distal	O
rca	O
and	O
-	O
lr	O
collaterals	O
from	O
the	O
proximal	O
lad	O

attempts	O
to	O
cross	O
the	O
lcx	O
occlussion	B
failed	O
despite	O
aggressive	O
wire	O
manipulation	O
.	O
lesion	B
left	O
untreates	O
given	O
chronicity	O
of	O
the	O
lesion	B

wire	O
was	O
passed	O
through	O
the	O
rca	B
occlussion	I
but	O
attempts	O
to	O
deliver	O
balloon	O
in	O
the	O
rca	O
failed	O
.	O
there	O
was	O
no	O
return	O
of	O
distal	B
flow	I
.	O

despite	O
the	O
failure	O
of	O
crossing	O
hese	O
occlusions	B
,	O
he	O
remained	O
hemodynamically	O
stable	O
and	O
st	O
segments	O
were	O
normal	O
.	O

hemodynamics	O
:	O

co	O
-	O
4	O
.	O
69	O

ci	O
-	O
2	O
.	O
4	O

mean	O
pressures	O
:	O
ra	O
14	O
;	O
pcw	O
22	O
,	O
pa	O
24	O

post	O
-	O
cath	O
in	O
the	O
ccu	O
,	O
he	O
was	O
continued	O
on	O
integrillin	O
drip	O
,	O
his	O
dopamine	O
was	O
weanted	O
off	O
from	O
10	O
-	O
>5	O
-	O
>0	O
mcg	O
/	O
kg	O
/	O
min	O
,	O
lidocaine	O
drip	O
was	O
stopped	O
at	O
6pm	O
.	O

hypothermia	B
protocol	O
for	O
vfib	B
arrest	I
was	O
initiated	O
between	O
19	O
:	O
00	O
and	O
19	O
:	O
15	O
.	O

he	O
was	O
noted	O
to	O
have	O
a	O
episode	O
of	O
posturing	B
where	O
he	O
had	O
upward	O
deviation	B
of	I
eyes	I
with	O
extension	B
of	O
both	O
his	O
upper	O
extremities	O
and	O
lower	O
extremities	O
.	O

this	O
was	O
associated	O
with	O
hypertension	B
to	O
~200	O
and	O
tachycardia	B
.	O

this	O
spontaneously	O
resolved	O
;	O
however	O
he	O
got	O
ativan	O
,	O
lopressor	O
and	O
was	O
started	O
on	O
versed	O
,	O
fentanly	O
and	O
vecuronium	O
gtt	O
per	O

hypothermia	B
protocol	O
.	O

past	O
medical	O
history	O
:	O

no	O
known	O
past	O
medical	O
history	O
(	O
per	O
wife	O
)	O

cardiac	O
risk	O
factors	O
:	O
no	O
known	O
risk	O
factors	O

social	O
history	O
:	O

smoked	O
around	O
[	O
*	O
*	O
03	O
-	O
11	O
*	O
*	O
]	O
pack	O
a	O
day	O
for	O
40	O
yrs	O
,	O
quit	O
almost	O
5	O
yrs	O
back	O

drinks	O
around	O
[	O
*	O
*	O
05	O
-	O
11	O
*	O
*	O
]	O
glasses	O
of	O
beer	O
per	O
day	O

family	O
history	O
:	O

h	O
/	O
o	O
scd	B
-	O
>	O
father	O
died	O
of	O
scd	B
at	O
the	O
age	O
of	O
69	O

mother	O
-	O
>	O
hyperlipidemia	B

sister	O
-	O
>	O
diabetes	B

physical	O
exam	O
:	O

pe	O
:	O
97	O
.	O
5	O
,	O
87	O
,	O
157	O
/	O
95	O
,	O
100%	O
/	O
50%	O
fio2	O

vent	O
:	O
ac	O
0	O
.	O
5	O
/	O
600	O
/	O
14	O
/	O
5	O

gen	O
:	O
intubated	O
,	O
unresponsive	B

heent	O
:	O
bruise	B
on	I
forhead	I
,	O
ng	O
tube	O
,	O
tracheal	O
tube	O

neck	O
:	O
cervical	O
collar	O
in	O
place	O

cv	O
:	O
rr	O
,	O
nl	O
rate	O
.	O

nl	O
s1	O
,	O
s2	O
.	O

no	O
murmurs	B
appreciable	O

lungs	O
:	O
cta	O
anteriorly	O
,	O
occassional	O
exp	B
wheezing	I

abd	O
:	O
soft	O
,	O
nt	O
,	O
nd	O
.	O

nl	O
bs	O

ext	O
:	O
no	O
edema	B
.	O

dopplerable	O
dp	O
pulses	O
bilaterally	O

skin	O
:	O
no	O
lesions	O

neuro	O
:	O
unresponsive	B
,	O
pupils	O
intially	O
on	O
presentation	O
to	O
[	O
*	O
*	O
hospital1	O
16	O
*	O
*	O
]	O
were	O
around	O
4mm	O
sluggishly	O
reactive	O
to	O
light	O
,	O
later	O
were	O
pinpoint	O
[	O
*	O
*	O
04	O
-	O
11	O
*	O
*	O
]	O
fentanly	O
.	O
vestibulo	B
-	I
ocular	I
reflex	I
was	O
negative	O
.	O
rest	O
of	O
neurologic	O
exam	O
was	O
deferred	O
as	O
patient	O
was	O
sedated	B
and	O
paralyzed	O
.	O

gcs	B
score==3	O
(	O
before	O
paralysis	O
)	O

pertinent	O
results	O
:	O

lgh	O
ekg	O
showed	O
-	O
-	O
nsr	O
@	O
90	O
,	O
nml	O
axis	O
,	O
borderline	O
prolonged	B
qtc	I
,	O
q	O
in	O
2	O
3	O
avf	O
;	O
>1mm	O
st	B
elevations	I
in	O
2	O
,	O
3	O
,	O
avf	O
,	O
v4	O
-	O
6	O
w	O
/	O
st	B
dep	I
in	O
avr	O
,	O
v1	O
-	O
2	O
.	O

r	O
sided	O
ekg	O
showed	O
st	B
elevations	I
in	O
v4	O
.	O

[	O
*	O
*	O
hospital1	O
16	O
*	O
*	O
]	O
postcath	O
ekg	O
showed	O
:	O
resolved	O
st	B
elevations	I
w	O
/	O
lvh	B
like	O
pattern	O

cardiac	O
cath	O
:	O

final	O
diagnosis	O
:	O

1	O
.	O
3	B
vessel	I
coronary	I
artery	I
disease	I
.	O

2	O
.	O
elevated	O
left	O
and	O
right	O
sided	O
filling	O
pressures	O
.	O

3	O
.	O
mildly	O
depressed	B
cardiac	I
index	I
.	O

4	O
.	O
unsuccessful	O
attempts	O
to	O
cross	O
and	O
open	O
the	O
cx	O
and	O
rca	B
occlusions	I

echo	O
:	O
ef	O
40	O
-	O
45%	O

left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
mildly	O
depressed	O
with	O
akinesis	B
of	O
the	O
basal	O
to	O
mid	O
infero	O
-	O
lateral	O
wall	O
and	O
basal	O
inferior	O
wall	O
.	O

the	O
aortic	O
root	O
is	O
mildly	O
dilated	O
at	O
the	O
sinus	O
level	O
.	O

brief	O
hospital	O
course	O
:	O

57	O
m	O
w	O
/	O
vfib	B
arrest	I
,	O
stemi	B
s	O
/	O
p	O
cath	O
showing	O
3vd	B
,	O
none	O
intervened	O
,	O
w	O
/	O
likely	O
anoxic	B
brain	I
injury	I
.	O

active	O
issues	O
during	O
this	O
hospitalization	O
include	O
:	O

cardiac	O
problems	O
:	O

#	O
rhythm	O
/	O
vfib	B
arrest	I
:	O
patient	O
found	O
in	O
vifib	B
arrest	I
in	O
the	O
setting	O
of	O
stemi	B
;	O
was	O
shocked	O
x2	O
,	O
was	O
on	O
lido	O
gtt	O
,	O
and	O
by	O
time	O
arrived	O
at	O
[	O
*	O
*	O
hospital1	O
16	O
*	O
*	O
]	O
was	O
in	O
sinus	B
rhythm	I
.	O

cooling	B
/	O
hypothermia	B
protocol	O
started	O
within	O
6	O
hrs	O
of	O
cardiac	B
arrest	I
and	O
continued	O
for	O
24	O
hrs	O
.	O

after	O
rewarming	B
,	O
he	O
had	O
no	O
further	O
arrhythmias	B
.	O

#	O
stemi	B
:	O
he	O
was	O
noted	O
to	O
have	O
st	B
segment	I
elevations	I
in	O
inferolateral	O
leads	O
,	O
elevated	B
ce's	I
;	O
ste	B
resolved	O
during	O
pci	O
.	O

he	O
was	O
noted	O
to	O
have	O
evidence	O
of	O
chronic	O
3vd	B
but	O
none	O
intervened	O
.	O

it	O
was	O
unclear	O
whether	O
his	O
mi	B
was	O
acute	O
or	O
subacute	O
given	O
the	O
state	O
of	O
his	O
coronary	O
arteries	O
seen	O
in	O
cath	O
.	O

integrillin	O
was	O
stopped	O
around	O
90	O
min	O
after	O
cath	O
[	O
*	O
*	O
04	O
-	O
11	O
*	O
*	O
]	O
ugi	B
bleed	I
.	O

he	O
was	O
maintained	O
on	O
asa	O
(	O
dose	O
reduced	O
)	O
,	O
statin	O
,	O
bb	O
,	O
acei	O
,	O
iv	O
lopressor	O
prn	O
for	O
sbp>160	O
,	O
hr>80	O
,	O
and	O
plavix	O
.	O

echo	O
revealed	O
ef	O
40	O
-	O
45%	O
,	O
overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
mildly	O
depressed	O
with	O
akinesis	B
of	O
the	O
basal	O
to	O
mid	O
infero	O
-	O
lateral	O
wall	O
and	O
basal	O
inferior	O
wall	O
.	O

#	O
pump	O
:	O
he	O
mildly	O
depressed	B
ci	I
,	O
elevated	B
pcwp	I
;	O
however	O
maintaining	O
bp	O
well	O
off	O
the	O
dopamine	O
gtt	O
,	O
oxygenating	O
well	O
on	O
40%	O
fio2	O

#	O
neuro	O
/	O
anoxic	B
brain	I
injury	I
/	O
seizure	B
:	O
on	O
first	O
day	O
of	O
admission	O
,	O
patient	O
was	O
noted	O
to	O
have	O
myoclonic	B
jerking	I
and	O
posturing	B
from	O
cerebral	B
ischemia	I
and	O
seizure	B
activity	O
confirmed	O
on	O
eeg	O
.	O

ct	O
head	O
/	O
spine	O
revealed	O
no	O
bleed	B
/	O
stroke	B
and	O
c	O
-	O
spine	O
cleared	O
.	O

he	O
was	O
started	O
on	O
dilantin	O
and	O
keppra	O
for	O
presumed	O
status	B
epilepticus	I
.	O

at	O
family	O
meeting	O
with	O
neuro	O
,	O
family	O
decided	O
to	O
try	O
propofol	O
sedation	O
to	O
suppress	O
seizure	B
.	O

while	O
on	O
high	O
dose	O
propofol	O
,	O
dopamine	O
and	O
neosynephrine	O
were	O
used	O
to	O
maintain	O
bp	O
.	O

after	O
withdrawal	O
of	O
propofol	O
,	O
pt	O
continued	O
to	O
have	O
seizure	B
activity	O
.	O

#	O
respiratory	B
failure	I
:	O
pt	O
intubated	O
on	O
field	O
for	O
airway	O
prtection	O
.	O

on	O
second	O
day	O
of	O
admission	O
,	O
patient	O
developed	O
either	O
chf	B
/	O
flash	B
pulm	I
edema	I
or	O
ards	B
/	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
.	O

pao2	O
/	O
fio2	O
was	O
266	O
,	O
cvp	O
10	O
-	O
14	O
.	O

ultimately	O
,	O
patient	O
responded	O
well	O
to	O
diuresis	O
with	O
improved	O
oxygenation	O
.	O

#	O
hypotension	B
:	O
intermittently	O
require	O
dopamine	O
+	O
/	O
-	O
levophed	O
while	O
on	O
sedation	O
.	O

#	O
fever	B
:	O
lll	O
infiltrate	B
,	O
likelihood	O
of	O
aspiration	B
pneumonia	I
in	O
addition	O
to	O
other	O
respiratory	B
issues	I
.	O

he	O
started	O
levo	O
/	O
flagyl	O
.	O

all	O
cx	O
ngtd	O
.	O

#	O
loose	B
tooth	I
:	O
awaiting	O
extraction	O
from	O
oms	O

#	O
transaminitis	B
:	O
mildly	O
elevated	B
lactate	I
,	O
transaminases	O
;	O
likely	O
from	O
shock	B
liver	I
.	O

#	O
ugib	B
:	O
initially	O
had	O
op	O
bleeding	B
and	O
coffee	O
ground	O
ng	O
tube	O
output	O
in	O
the	O
setting	O
of	O
getting	O
asa	O
,	O
plavix	O
,	O
heparin	O
,	O

integrillin	O
.	O

he	O
remained	O
hemodynamically	O
stable	O
,	O
bid	O
ppi	O
,	O
bleeding	B
decreased	O
over	O
hospital	O
course	O
,	O
and	O
he	O
required	O
no	O
transfusions	O

#	O
leukocytosis	B
:	O
likely	O
from	O
mi	B
;	O
now	O
trending	O
down	O
.	O

#	O
fen	O
:	O
npo	O
,	O
ng	O
tube	O
lavage	O

#	O
ppx	O
:	O
ppi	O
iv	O
bid	O
,	O
heparin	O
sq	O
,	O
hob	O
elevation	O

#	O
access	O
:	O
2	O
piv	O
,	O
r	O
scl	O

#	O
comm	O
:	O
hcp	O
is	O
wife	O
(	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
1838	O
*	O
*	O
]	O
[	O
*	O
*	O
lastname	O
1372	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1839	O
*	O
*	O
]	O
)	O
;	O
however	O
she	O
does	O
not	O
speak	O
english	O
,	O
therefor	O
all	O
the	O
communication	O
will	O
be	O
through	O
her	O
niece	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1840	O
*	O
*	O
]	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1841	O
*	O
*	O
]	O
)	O
.	O

if	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
cannot	O
be	O
reached	O
,	O
then	O
her	O
other	O
[	O
*	O
*	O
last	O
name	O
(	O
lf	O
)	O
1842	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
1843	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1844	O
*	O
*	O
]	O
should	O
be	O
contacted	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1845	O
*	O
*	O
]	O
)	O

#	O
dispo	O
:	O
family	O
meeting	O
on	O
[	O
*	O
*	O
06	O
-	O
12	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
06	O
-	O
14	O
*	O
*	O
]	O
.	O

pts	O
wife	O
does	O
not	O
wish	O
to	O
make	O
any	O
decisions	O
regarding	O
goals	O
of	O
care	O
stating	O
that	O
"god	O
will	O
decide	O
.	O
"	O

family	O
aware	O
of	O
very	O
dire	O
prognosis	O
.	O

medications	O
on	O
admission	O
:	O

none	O

discharge	O
disposition	O
:	O

expired	O

discharge	O
diagnosis	O
:	O

expired	O

discharge	O
condition	O
:	O

expired	O

discharge	O
instructions	O
:	O

n	O
/	O
a	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
1666	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1667	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
1760	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1761	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1762	O
*	O
*	O
]	O
[	O
*	O
*	O
2015	O
-	O
02	O
-	O
13	O
*	O
*	O
]	O
@	O
1439	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2015	O
-	O
02	O
-	O
17	O
*	O
*	O
]	O
9	O
:	O
34	O
am	O

(	O
end	O
of	O
report	O
)	O

25729	O
||||	O
19138	O
||||	O
3406	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
02	O
-	O
21	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
02	O
-	O
02	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
02	O
-	O
21	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1950	O
-	O
12	O
-	O
15	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
a	O
62	O
-	O
year	O
-	O
old	O
female	O
with	O
a	O
history	O
of	O
chronic	B
obstructive	I
pulmonary	I
disease	I
,	O
coronary	B
artery	I
disease	I
,	O
mitral	O
valve	O
replacement	O
and	O
was	O
found	O
to	O
have	O
a	O
right	O
upper	O
lobe	O
mass	B
on	O
chest	O
x	O
-	O
ray	O
in	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
03	O
*	O
*	O
]	O
.	O

the	O
patient	O
had	O
a	O
follow	O
-	O
up	O
chest	O
ct	O
scan	O
which	O
confirmed	O
the	O
presence	O
of	O
a	O
mass	B
in	O
the	O
right	O
upper	O
lobe	O
and	O
collapse	B
of	O
that	O
lobe	O
in	O
[	O
*	O
*	O
2012	O
-	O
10	O
-	O
03	O
*	O
*	O
]	O
.	O

approximately	O
four	O
weeks	O
prior	O
to	O
admission	O
the	O
patient	O
is	O
noted	O
to	O
have	O
increased	O
dyspnea	B
on	I
exertion	I
and	O
two	O
weeks	O
prior	O
to	O
admission	O
the	O
patient	O
presented	O
to	O
the	O
emergency	O
department	O
with	O
dyspnea	B
on	I
exertion	I
and	O
lower	B
extremity	I
edema	I
.	O

however	O
,	O
at	O
that	O
time	O
she	O
left	B
against	I
medical	I
advise	I
because	O
she	O
did	O
not	O
want	O
to	O
have	O
a	O
bronchoscopy	O
or	O
a	O
thoracentesis	O
done	O
.	O

the	O
patient	O
returned	O
two	O
weeks	O
later	O
on	O
[	O
*	O
*	O
02	O
-	O
02	O
*	O
*	O
]	O
with	O
the	O
same	O
symptoms	O
of	O
shortness	B
of	I
breath	I
,	O
dyspnea	B
,	O
exertion	O
and	O
lower	B
extremity	I
edema	I
.	O

she	O
also	O
states	O
she	O
had	O
a	O
chronic	B
cough	I
and	O
a	O
20	O
pound	O
weight	B
loss	I
in	O
the	O
past	O
year	O
with	O
one	O
episode	O
of	O
hemoptysis	B
.	O

during	O
the	O
initial	O
part	O
of	O
the	O
hospitalization	O
the	O
patient's	O
coumadin	O
was	O
discontinued	O
.	O

she	O
had	O
lower	O
extremity	O
ultrasounds	O
which	O
were	O
negative	O
for	O
deep	B
vein	I
thrombosis	I
and	O
chest	O
x	O
-	O
ray	O
showed	O
right	O
pleural	B
effusion	I
and	O
cardiomegaly	B
.	O

when	O
the	O
patient's	O
inr	B
decreased	I
she	O
was	O
taken	O
for	O
a	O
bronchoscopy	O
which	O
showed	O
a	O
pulsatile	O
mass	B
in	O
the	O
right	O
middle	O
lobe	O
.	O

a	O
biopsy	O
and	O
washings	O
were	O
performed	O
.	O

after	O
the	O
procedure	O
the	O
patient	O
did	O
well	O
until	O
approximately	O
90	O
minutes	O
later	O
when	O
she	O
went	O
into	O
acute	B
respiratory	I
distress	I
and	O
respiratory	B
failure	I
.	O

she	O
was	O
intubated	O
and	O
brought	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
32	O
*	O
*	O
]	O
for	O
further	O
care	O
.	O

on	O
arrival	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
32	O
*	O
*	O
]	O
the	O
patient	O
was	O
awake	O
and	O
appeared	O
comfortable	O
not	O
in	O
any	O
distress	B
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
right	O
upper	O
lobe	O
mass	B
;	O
see	O
history	O
of	O
present	O
illness	O
.	O

2	O
.	O
atrial	B
fibrillation	I
.	O

3	O
.	O
chronic	B
obstructive	I
pulmonary	I
disease	I
.	O

4	O
.	O
rheumatic	B
heart	I
disease	I
with	O
mitral	O
valve	O
replacement	O
in	O
[	O
*	O
*	O
1995	O
*	O
*	O
]	O
.	O

5	O
.	O
coronary	B
artery	I
disease	I
status	O
post	O
coronary	O
artery	O
bypass	O
graft	O
.	O

6	O
.	O
pulmonary	B
artery	I
hypertension	I
.	O

7	O
.	O
biatrial	B
enlargement	I
.	O

8	O
.	O
hyperlipidemia	B
.	O

9	O
.	O
hypothyroidism	B
.	O

10	O
.	O

history	O
of	O
hepatitis	B
.	O

social	O
history	O
:	O
the	O
patient	O
is	O
a	O
35	O
-	O
pack	O
-	O
year	O
tobacco	O
smoker	O
who	O
quit	O
12	O
years	O
ago	O
.	O

no	O
alcohol	O
or	O
drug	O
use	O
.	O

physical	O
examination	O
:	O
on	O
admission	O
the	O
patient	O
was	O
intubated	O
but	O
following	O
commands	O
.	O

vital	O
signs	O
;	O
temperature	O
98	O
.	O
9	O
f	O
,	O
pulse	O
78	O
to	O
81	O
,	O
blood	O
pressure	O
89	O
to	O
97	O
over	O
36	O
to	O
69	O
.	O

the	O
patient	O
was	O
having	O
an	O
oxygen	O
saturation	O
of	O
95	O
to	O
100%	O
on	O
controlled	O
ventilation	O
.	O

chest	O
exam	O
significant	O
for	O
decreased	B
breath	I
sounds	I
on	O
the	O
right	O
with	O
coarse	B
breath	I
sounds	I
and	O
scattered	O
rales	B
anteriorly	O
bilaterally	O
.	O

heart	O
exam	O
significant	O
for	O
mechanical	B
heart	I
sounds	I
.	O

abdomen	O
is	O
benign	O
.	O

extremities	O
show	O
1	O
+	O
pitting	B
edema	I
bilaterally	O
with	O
no	O
calf	O
tenderness	B
.	O

laboratory	O
on	O
admission	O
to	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
32	O
*	O
*	O
]	O
:	O
complete	O
blood	O
count	O
;	O
white	O
blood	O
cell	O
count	O
9	O
.	O
8	O
,	O
hematocrit	O
20	O
.	O
6	O
,	O
platelet	O
count	O
343	O
,	O
000	O
.	O

coags	O
significant	O
for	O
an	O
inr	O
of	O
1	O
.	O
4	O
.	O

chemistry	O
significant	O
for	O
bicarbonate	O
of	O
38	O
,	O
chloride	O
of	O
91	O
.	O

calcium	O
was	O
elevated	O
at	O
11	O
.	O
6	O
.	O

chest	O
x	O
-	O
ray	O
showed	O
complete	O
opacification	B
of	O
the	O
right	O
hemothorax	B
and	O
a	O
large	B
right	I
atrium	I
.	O

electrocardiogram	O
showed	O
atrial	B
fibrillation	I
at	O
80	O
to	O
85	O
beats	O
per	O
minute	O
with	O
right	B
axis	I
deviation	I
and	O
t	B
-	I
wave	I
inversions	I
in	O
leads	O
2	O
,	O
3	O
and	O
avf	O
with	O
nonspecific	O
st	B
changes	I
.	O

hospital	O
course	O
:	O

1	O
.	O
right	O
upper	O
lobe	O
mass	B
.	O

due	O
to	O
the	O
size	O
and	O
nature	O
of	O
the	O
mass	B
seen	O
by	O
x	O
-	O
ray	O
and	O
ct	O
as	O
well	O
as	O
bronchoscopy	O
it	O
most	O
likely	O
represented	O
a	O
malignancy	B
.	O

however	O
,	O
the	O
biopsy	O
obtained	O
during	O
the	O
bronchoscopy	O
was	O
not	O
definitive	O
.	O

numerous	O
sputum	O
cytologies	O
were	O
sent	O
which	O
showed	O
highly	O
atypical	O
keratinized	O
squamous	O
cells	O
highly	O
suspicious	O
for	O
non	B
-	I
small	I
cell	I
lung	I
cancer	I
.	O

the	O
patient	O
was	O
offered	O
more	O
definitive	O
diagnostic	O
modality	O
such	O
as	O
a	O
transthoracic	O
ct	O
guided	O
needle	O
biopsy	O
;	O
however	O
,	O
she	O
did	O
decline	O
due	O
to	O
the	O
likelihood	O
that	O
this	O
was	O
malignancy	B
.	O

pth	O
related	O
peptide	O
was	O
also	O
sent	O
as	O
the	O
patient	O
was	O
hypercalcemic	B
and	O
this	O
showed	O
that	O
there	O
was	O
an	O
elevated	O
level	O
of	O
pthrp	O
which	O
again	O
made	O
lung	B
cancer	I
the	O
most	O
likely	O
and	O
very	O
likely	O
diagnosis	O
.	O

both	O
oncology	O
,	O
radiation	O
oncology	O
and	O
ct	O
surgery	O
were	O
consulted	O
for	O
recommendations	O
on	O
treatment	O
options	O
.	O

radiation	O
oncology	O
felt	O
that	O
the	O
mass	B
was	O
too	O
large	O
to	O
receive	O
radiation	O
for	O
treatment	O
,	O
however	O
the	O
patient	O
could	O
receive	O
radiation	O
for	O
palliative	O
reasons	O
,	O
perhaps	O
to	O
improve	O
compression	B
on	O
large	O
airways	O
which	O
may	O
improve	O
her	O
respiratory	B
function	I
.	O

therefore	O
,	O
the	O
patient	O
was	O
taken	O
for	O
two	O
doses	O
of	O
radiation	O
,	O
however	O
,	O
this	O
did	O
not	O
resolve	O
the	O
insignificant	O
improvement	O
in	O
any	O
of	O
her	O
symptoms	B
including	O
her	O
respiratory	B
function	I
.	O

neither	O
the	O
oncology	O
service	O
nor	O
the	O
cardiac	O
thoracic	O
surgery	O
service	O
felt	O
that	O
there	O
was	O
any	O
definitive	O
treatment	O
that	O
could	O
be	O
done	O
to	O
significantly	O
improve	O
the	O
patient's	O
mortality	O
.	O

2	O
.	O
respiratory	B
failure	I
.	O

the	O
patient's	O
respiratory	B
failure	I
was	O
thought	O
to	O
be	O
secondary	O
to	O
the	O
large	O
right	O
lung	B
mass	I
as	O
well	O
as	O
the	O
copious	B
amount	I
of	I
secretions	I
that	O
she	O
was	O
producing	O
possibly	O
secondary	O
to	O
the	O
lung	B
mass	I
and	O
combination	O
of	O
her	O
underlying	O
lung	B
disease	I
of	O
chronic	B
obstructive	I
pulmonary	I
disease	I
.	O

she	O
was	O
continued	O
on	O
mechanical	O
ventilation	O
for	O
her	O
entire	O
intensive	O
care	O
unit	O
stay	O
until	O
the	O
last	O
day	O
.	O

she	O
was	O
also	O
given	O
inhalers	O
for	O
bronchodilation	O
for	O
her	O
chronic	B
obstructive	I
pulmonary	I
disease	I
.	O

numerous	O
attempts	O
were	O
made	O
to	O
wean	O
the	O
patient	O
from	O
the	O
ventilator	O
.	O

finally	O
,	O
it	O
was	O
decided	O
since	O
the	O
patient	O
had	O
a	O
terminal	B
illness	I
that	O
the	O
patient	O
and	O
the	O
family	O
both	O
wanted	O
to	O
try	O
extubation	O
and	O
spontaneous	O
breathing	O
.	O

the	O
patient	O
was	O
therefore	O
extubated	O
per	O
her	O
wishes	O
.	O

initially	O
she	O
did	O
well	O
but	O
after	O
approximately	O
two	O
hours	O
the	O
patient	O
went	O
into	O
respiratory	B
arrest	I
and	O
passed	O
away	O
.	O

prior	O
to	O
her	O
extubation	O
it	O
was	O
decided	O
that	O
were	O
the	O
patient	O
go	O
into	O
respiratory	B
arrest	I
she	O
would	O
not	O
be	O
reintubated	O
or	O
resuscitated	O
.	O

3	O
.	O
cardiovascular	O
.	O

the	O
patient	O
had	O
a	O
rate	O
that	O
appeared	O
to	O
be	O
junctional	O
while	O
she	O
was	O
in	O
the	O
intensive	O
care	O
unit	O
.	O

she	O
was	O
initiated	O
on	O
digoxin	O
;	O
however	O
,	O
was	O
taken	O
off	O
of	O
this	O
and	O
her	O
rate	O
was	O
well	O
controlled	O
.	O

she	O
did	O
not	O
require	O
any	O
other	O
nodal	O
agents	O
for	O
rate	O
control	O
.	O

the	O
patient	O
was	O
maintained	O
on	O
anticoagulation	O
for	O
an	O
artifical	O
valve	O
.	O

shortly	O
after	O
extubation	O
the	O
patient	O
was	O
found	O
to	O
be	O
asystolic	B
on	O
telemetry	O
monitor	O
.	O

she	O
passed	O
away	O
at	O
1	O
:	O
44	O
p	O
.	O
m	O
.	O
on	O
[	O
*	O
*	O
2013	O
-	O
02	O
-	O
21	O
*	O
*	O
]	O
.	O

discharge	O
diagnosis	O
:	O

1	O
.	O
lung	B
cancer	I
.	O

2	O
.	O
intermittent	O
atrial	B
fibrillation	I
.	O

3	O
.	O
chronic	B
obstructive	I
pulmonary	I
disease	I
.	O

4	O
.	O
hypercalcemia	B
malignancy	I
.	O

5	O
.	O
coronary	B
artery	I
disease	I
.	O

postmortem	O
examination	O
was	O
declined	O
by	O
the	O
family	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initial	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
6499	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
5458	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2013	O
-	O
04	O
-	O
04	O
*	O
*	O
]	O
15	O
:	O
17	O

t	O
:	O
[	O
*	O
*	O
2013	O
-	O
04	O
-	O
05	O
*	O
*	O
]	O
09	O
:	O
57	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
7760	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2013	O
-	O
04	O
-	O
08	O
*	O
*	O
]	O
11	O
:	O
44	O
am	O

(	O
end	O
of	O
report	O
)	O

166217	O
||||	O
19154	O
||||	O
7888	O
||||	O
radiology	O
_	O
report	O
||||	O
2012	O
-	O
09	O
-	O
11	O
17	O
:	O
36	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
348	O
-	O
5236	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2012	O
-	O
09	O
-	O
11	O
*	O
*	O
]	O
5	O
:	O
36	O
pm	O

chest	O
(	O
portable	O
ap	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
1700	O
*	O
*	O
]	O
reason	O
:	O
new	O
hypoxia	B
,	O
fevers	B
,	O
please	O
r	O
/	O
o	O
pneumonia	B
admitting	O
diagnosis	O
:	O
skull	B
fracture	I
;	O
head	B
injury	I
;	O
sah	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

65	O
year	O
old	O
man	O
with	O

reason	O
for	O
this	O
examination	O
:	O

new	O
hypoxia	B
,	O
fevers	B
,	O
please	O
r	O
/	O
o	O
pneumonia	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

clinical	O
history	O
:	O
a	O
65	O
-	O
year	O
-	O
old	O
male	O
with	O
hypoxia	B
and	O
fevers	B
.	O

technique	O
:	O
portable	O
ap	O
chest	O
.	O

comparison	O
:	O
[	O
*	O
*	O
2012	O
-	O
09	O
-	O
09	O
*	O
*	O
]	O
.	O

findings	O
:	O
endotracheal	O
tube	O
,	O
enteric	O
tube	O
,	O
and	O
right	O
subclavian	O
central	O
venous	O
catheter	O
remain	O
in	O
stable	O
position	O
.	O

the	O
cardiac	O
and	O
mediastinal	O
contours	O
are	O
unchanged	O
.	O

there	O
has	O
been	O
interval	O
improvement	O
in	O
the	O
appearance	O
of	O
the	O
previously	O
evident	O
pulmonary	B
edema	I
.	O

however	O
,	O
there	O
is	O
now	O
a	O
dense	O
left	O
retrocardiac	O
density	B
compatible	O
with	O
consolidation	B
or	O
collapse	B
.	O

there	O
are	O
no	O
definite	O
pleural	B
effusions	I
,	O
although	O
the	O
extreme	O
left	O
costophrenic	O
angle	O
is	O
excluded	O
from	O
this	O
study	O
.	O

impression	O
:	O

1	O
.	O
improved	O
interstitial	B
edema	I
.	O

2	O
.	O
left	O
lower	O
lobe	O
collapse	B
versus	O
consolidation	B
.	O

7256	O
||||	O
19596	O
||||	O
14806	O
||||	O
discharge	O
_	O
summary	O
||||	O
2018	O
-	O
01	O
-	O
17	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
17	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1943	O
-	O
04	O
-	O
16	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
2121	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

change	B
in	I
mental	I
status	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

74f	O
with	O
mixed	B
dementia	I
,	O
esrd	B
on	O
hd	O
,	O
admitted	O
on	O
[	O
*	O
*	O
01	O
-	O
12	O
*	O
*	O
]	O
with	O
change	B
in	I
mental	I
status	I
/	O
seizures	B
at	O
hd	O
on	O
the	O
date	O
of	O
admission	O
.	O

in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
2	O
*	O
*	O
]	O
,	O
the	O
patient	O
was	O
afebrile	B
,	O
with	O
hr	O
61	O
bp	O
251	O
/	O
82	O
.	O

given	O
10mg	O
hydralazine	O
with	O
bp	O
noted	O
to	O
improve	O
to	O
sbps	O
170	O
.	O

patient	O
was	O
started	O
on	O
nipride	O
gtt	O
and	O
admitted	O
to	O
ficu	O
for	O
hypertensive	B
urgency	I
.	O

in	O
the	O
ficu	O
,	O
pt	O
.	O
was	O
treated	O
with	O
nipride	O
gtt	O
,	O
then	O
transitioned	O
to	O
labetalol	O
gtt	O
,	O
then	O
to	O
ccb	O
and	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
,	O
on	O
which	O
she	O
was	O
normotensive	O
.	O

ams	B
thought	O
to	O
be	O
multifactorial	B
,	O
secondary	O
to	O
worsening	O
dementia	B
,	O
hypertensive	B
encephalopathy	I
,	O
hypercalcemia	B
.	O

pt	O
.	O
also	O
noted	O
to	O
have	O
labile	B
blood	I
glucose	I
in	O
icu	O
.	O

per	O
renal	O
,	O
goal	O
sbp	O
140	O
-	O
150	O
.	O

upon	O
arrival	O
to	O
floor	O
,	O
pt	O
.	O
is	O
disoriented	B
and	O
refuses	O
to	O
answer	O
questions	O
.	O

she	O
reports	O
that	O
she	O
is	O
at	O
a	O
party	O
,	O
knows	O
it	O
is	O
"	O
[	O
*	O
*	O
holiday	O
*	O
*	O
]	O
month"	O
,	O
does	O
not	O
know	O
first	O
name	O
,	O
year	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
end	B
-	I
stage	I
renal	I
disease	I
.	O

2	O
.	O
diabetic	B
nephropathy	I
.	O

3	O
.	O
hemodialysis	O
for	O
years	O
.	O

4	O
.	O
right	O
av	B
fistula	I
.	O

5	O
.	O
noninsulin	B
-	I
dependent	I
diabetes	I
mellitus	I
.	O

6	O
.	O
hypertension	B
.	O

7	O
.	O
encephalopathy	B
.	O

8	O
.	O
cholecystectomy	O
.	O

9	O
.	O
nephrectomy	O
.	O

10	O
.	O

angioplasty	O
of	O
av	B
fistula	I
in	O
[	O
*	O
*	O
2014	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
.	O

11	O
.	O
s	O
/	O
p	O
recent	O
corn	B
removals	O
on	O
l	O
foot	O

12	O
.	O
mixed	O
vascular	O
and	O
alzheimer's	B
dementia	I

social	O
history	O
:	O

denies	O
alcohol	O
,	O
drug	O
use	O
,	O
smoking	O
.	O

lives	O
in	O
the	O
bottom	O
floor	O
of	O
an	O
apartment	O
-	O
family	O
lives	O
in	O
floors	O
above	O
her	O
.	O

says	O
she	O
is	O
independent	O
with	O
her	O
activities	O
of	O
daily	O
living	O
.	O

family	O
history	O
:	O

unable	O
to	O
obtain	O
.	O

physical	O
exam	O
:	O

pe	O
:	O
afebrile	B
,	O
241	O
/	O
88	O
73	O
20	O
99%ra	O

heent	O
:	O
perrl	O
,	O
eomi	O
,	O
op	O
clear	O
,	O
not	O
lad	B

cvs	O
:	O
nl	O
s1s2	O
,	O
rrr	O
,	O
no	O
m	B
/	O
r	B
/	O
g	B

chest	O
:	O
cta	O
b	O
/	O
l	O

abd	O
:	O
soft	O
,	O
nt	O
/	O
nd	O
,	O
+	O
bs	O
,	O
no	O
organomegaly	B

ext	O
:	O
no	O
c	B
/	O
c	B
/	O
edema	B
;	O
+	O
oa	B
in	O
knees	O
,	O
av	B
fistula	I
rue	O
.	O
neuro	O
:	O
awake	O
,	O
orientated	O
to	O
person	O
,	O
and	O
month	O
.	O

speech	O
coherent	O
,	O
though	O
tangential	O
;	O
mild	O
preservations	O
.	O

4	O
/	O
5	O
strength	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
769	O
*	O
*	O
]	O
/	O
ble	O
+	O
2	O
patella	O
and	O
biceps	O
tendon	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
06	O
:	O
15pm	O
urine	O
color	O
-	O
straw	O
appear	O
-	O
clear	O
sp	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
5	O
*	O
*	O
]	O
-	O
1	O
.	O
010	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
06	O
:	O
15pm	O
urine	O
blood	O
-	O
neg	O
nitrite	O
-	O
neg	O
protein	O
-	O
100	O
glucose	O
-	O
100	O
ketone	O
-	O
neg	O
bilirubin	O
-	O
neg	O
urobilngn	O
-	O
neg	O
ph	O
-	O
9	O
.	O
0	O
*	O
leuk	O
-	O
neg	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
06	O
:	O
15pm	O
urine	O
rbc	O
-	O
0	O
-	O
2	O
wbc	O
-	O
0	O
-	O
2	O
bacteria	O
-	O
mod	O
yeast	O
-	O
none	O
epi	O
-	O
0	O
-	O
2	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
12	O
:	O
24pm	O
lactate	O
-	O
1	O
.	O
3	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
12	O
:	O
12pm	O
glucose	O
-	O
120	O
*	O
urea	O
n	O
-	O
17	O
creat	O
-	O
5	O
.	O
0	O
*	O
#	O
sodium	O
-	O
144	O
potassium	O
-	O
3	O
.	O
9	O
chloride	O
-	O
95	O
*	O
total	O
co2	O
-	O
34	O
*	O
anion	O
gap	O
-	O
19	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
12	O
:	O
12pm	O
wbc	O
-	O
4	O
.	O
7	O
rbc	O
-	O
4	O
.	O
71	O
hgb	O
-	O
14	O
.	O
3	O
hct	O
-	O
44	O
.	O
6	O
mcv	O
-	O
95	O
mch	O
-	O
30	O
.	O
3	O
mchc	O
-	O
32	O
.	O
0	O
rdw	O
-	O
18	O
.	O
4	O
*	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
12	O
:	O
12pm	O
neuts	O
-	O
62	O
.	O
1	O
lymphs	O
-	O
30	O
.	O
1	O
monos	O
-	O
4	O
.	O
8	O
eos	O
-	O
1	O
.	O
8	O
basos	O
-	O
1	O
.	O
3	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
12	O
:	O
12pm	O
hypochrom	O
-	O
1	O
+	O
anisocyt	O
-	O
2	O
+	O
macrocyt	O
-	O
1	O
+	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
12	O
:	O
12pm	O
plt	O
count	O
-	O
132	O
*	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
12	O
:	O
12pm	O
pt	O
-	O
12	O
.	O
4	O
ptt	O
-	O
38	O
.	O
7	O
*	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
0	O

ecg	O
:	O
sinus	B
brady	I
with	O
prolonged	B
qtc	I
,	O
lad	O
,	O
lvh	B
,	O
with	O
ste	B
in	O
v2	O
/	O
v3	O
likely	O
representing	O
repolarization	B
abnormalities	I
;	O
no	O
other	O
acute	O
st	O
/	O
t	B
wave	I
changes	I

cxr	O
:	O
no	O
radiographic	O
evidence	O
of	O
pneumonia	B
.	O

ct	O
head	O
:	O
no	O
evidence	O
of	O
acute	O
intracranial	B
hemorrhage	I
.	O

brief	O
hospital	O
course	O
:	O

74f	O
with	O
mixed	B
dementia	I
,	O
presenting	O
with	O
a	O
one	O
week	O
history	O
of	O
mental	B
status	I
changes	I
/	O
increased	O
confusion	B
,	O
also	O
with	O
hypertensive	B
urgency	I
.	O

on	O
the	O
floor	O
,	O
the	O
pt	O
.	O
was	O
treated	O
with	O
hydralazine	O
prn	O
for	O
elevated	B
systolic	I
pressure	I
,	O
and	O
was	O
transitioned	O
back	O
to	O
amlodipine	O
and	O
losartan	O
,	O
with	O
goal	O
sbp	O
140	O
-	O
150	O
.	O

metoprolol	O
was	O
discontinued	O
.	O

pt	O
.	O
was	O
normotensive	B
at	O
the	O
time	O
of	O
discharge	O
.	O

pt's	O
change	B
in	I
mental	I
status	I
thought	O
to	O
be	O
multifactorial	B
:	O
ddx	O
included	O
worsening	O
dementia	B
with	O
possible	O
contribution	O
of	O
hypertensive	B
encephalopathy	I
and	O
hypercalcemia	B
.	O

with	O
continued	O
orientation	O
and	O
support	O
from	O
family	O
members	O
and	O
nursing	O
staff	O
,	O
pt	O
.	O
's	O
mentation	B
improved	O
.	O

her	O
donepezil	O
was	O
continued	O
.	O

per	O
records	O
,	O
pt	O
.	O
has	O
chronic	O
hypercalcemia	B
thought	O
to	O
be	O
related	O
to	O
her	O
chronic	B
renal	I
insufficiency	I
/	O
failure	O
and	O
secondary	O
hyperparathyroidism	B
.	O

tums	O
and	O
vit	O
.	O

d	O
were	O
held	O
.	O

sevelamer	O
was	O
continued	O
for	O
hyperphosphatemia	B
at	O
an	O
increased	O
dose	O
(	O
2400mg	O
tid	O
)	O
,	O
and	O
the	O
pt	O
.	O
was	O
started	O
on	O
sensipar	O
30mg	O
qd	O
.	O

the	O
pt	O
.	O
was	O
seen	O
and	O
evaluated	O
by	O
social	O
work	O
.	O

it	O
is	O
probable	O
that	O
pt	O
.	O
will	O
require	O
increased	O
amounts	O
of	O
support	O
at	O
home	O
over	O
the	O
coming	O
months	O
/	O
years	O
in	O
performing	O
her	O
adls	O
.	O

the	O
pt	O
.	O
will	O
continue	O
hemodialysis	O
on	O
m	O
,	O
w	O
,	O
f	O
.	O

an	O
spep	O
was	O
checked	O
just	O
before	O
discharge	O
,	O
at	O
the	O
request	O
of	O
the	O
renal	O
team	O
.	O

the	O
result	O
can	O
be	O
followed	O
up	O
at	O
the	O
pt's	O
next	O
appointment	O
.	O

medications	O
on	O
admission	O
:	O

norvasc	O
10	O

renal	O
caps	O

zantac	O
150	O
bid	O

glucotrol	O
xl	O
10	O

tums	O
tid	O

aricept	O

asa	O

cozaar	O

metoprolol	O
100	O

renagel	O
800	O
tiw	O

calcijex	O

epo	O

discharge	O
medications	O
:	O

1	O
.	O
b	O
complex	O
-	O
vitamin	O
c	O
-	O
folic	O
acid	O
1	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
cap	O
po	O
daily	O
(	O
daily	O
)	O
.	O

2	O
.	O
donepezil	O
5	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
.	O

3	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
chewable	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
chewable	O
po	O
daily	O
(	O
daily	O
)	O
.	O

4	O
.	O
losartan	O
50	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

5	O
.	O
amlodipine	O
5	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

6	O
.	O
sevelamer	O
800	O
mg	O
tablet	O
sig	O
:	O
three	O
(	O
3	O
)	O
tablet	O
po	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
:	O
please	O
take	O
with	O
food	O
/	O
drink	O
.	O

7	O
.	O
zantac	O
150	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
twice	O
a	O
day	O
.	O

8	O
.	O
renal	O
caps	O
1	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
once	O
a	O
day	O
.	O

9	O
.	O
humalog	O
insulin	O
sliding	O
scale	O

10	O
.	O

glucotrol	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
at	O
bedtime	O
.	O

11	O
.	O

sensipar	O
30	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
464	O
*	O
*	O
]	O

discharge	O
diagnosis	O
:	O

1	O
.	O
end	B
-	I
stage	I
renal	I
disease	I
,	O
on	O
hemodialysis	O

2	O
.	O
niddm	B

3	O
.	O
dementia	B
/	O
encephalopathy	B

discharge	O
condition	O
:	O

fair	O
,	O
stable	O
.	O

discharge	O
instructions	O
:	O

please	O
continue	O
to	O
take	O
all	O
your	O
medications	O
exactly	O
as	O
prescribed	O
.	O

if	O
you	O
experience	O
chest	B
pain	I
,	O
shortness	B
of	I
breath	I
,	O
fevers	B
,	O
or	O
abdominal	B
pain	I
,	O
plesae	O
call	O
your	O
pcp	O
or	O
return	O
to	O
the	O
hospital	O
.	O

followup	O
instructions	O
:	O

please	O
continue	O
to	O
follow	O
up	O
with	O
your	O
pcp	O
as	O
you	O
have	O
been	O
doing	O
.	O

provider	O
:	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
name11	O
(	O
nameis	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
initial	O
(	O
nameis	O
)	O
*	O
*	O
]	O
.	O
,	O
[	O
*	O
*	O
location	O
7493	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2018	O
-	O
03	O
-	O
01	O
*	O
*	O
]	O
8	O
:	O
00	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2122	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
2123	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
6999	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
7000	O
*	O
*	O
]	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
18	O
*	O
*	O
]	O
@	O
0712	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2018	O
-	O
02	O
-	O
26	O
*	O
*	O
]	O
8	O
:	O
26	O
am	O

(	O
end	O
of	O
report	O
)	O

1791	O
||||	O
19778	O
||||	O
12711	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
09	O
-	O
12	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
09	O
-	O
09	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
09	O
-	O
12	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1961	O
-	O
06	O
-	O
08	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

penicillins	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
2923	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

chest	B
pressure	I
and	O
arm	B
pain	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

cardiac	O
catheterization	O

percutaneous	O
coronary	O
transluminal	O
angioplasty	O
with	O
stenting	O

history	O
of	O
present	O
illness	O
:	O

51	O
y	O
/	O
o	O
male	O
with	O
history	O
of	O
htn	B
and	O
hypercholesterolemia	B
presented	O
with	O
new	O
onset	O
of	O
bilateral	O
arm	B
pain	I
associated	O
with	O
chest	B
tightness	I
.	O

received	O
four	O
baby	O
aspirin	O
from	O
ems	O
and	O
taken	O
to	O
[	O
*	O
*	O
location	O
5831	O
*	O
*	O
]	O
.	O

had	O
full	O
thrombolysis	O
with	O
tknase	O
as	O
he	O
would	O
not	O
be	O
able	O
to	O
make	O
it	O
to	O
[	O
*	O
*	O
hospital1	O
461	O
*	O
*	O
]	O
in	O
approproate	O
time	O
frame	O
.	O

once	O
thrombolysed	O
,	O
taken	O
to	O
[	O
*	O
*	O
hospital1	O
461	O
*	O
*	O
]	O
via	O
ambulance	O
and	O
upon	O
arival	O
,	O
still	O
with	O
chest	B
pain	I
so	O
taken	O
emergently	O
to	O
the	O
cath	O
lab	O
where	O
he	O
had	O
cath	O
and	O
pci	O
to	O
rca	O
.	O

past	O
medical	O
history	O
:	O

gerd	B

htn	I

hypercholesterolemia	I

retinal	I
detachments	I
s	O
/	O
p	O
multiple	O
retinal	O
surgeries	O

social	O
history	O
:	O

not	O
a	O
smoker	O
.	O

alcohol	O
use	O
-	O
one	O
drink	O
every	O
couple	O
of	O
weeks	O
.	O

no	O
drug	O
use	O
.	O

family	O
history	O
:	O

no	O
significant	O
history	O
of	O
familial	O
heart	B
disease	I
.	O

paternal	O

grandmother	O
had	O
mi	B
at	O
age	O
78	O
.	O

physical	O
exam	O
:	O

vitals	O
:	O
t	O
afebrile	O
hr	O
55	O
bp	O
118	O
/	O
78	O
rr	O
15	O
sat	O
98	O

general	O
:	O
well	O
developed	O
male	O
in	O
nad	B

skin	O
:	O
no	O
rashes	B

head	O
:	O
nc	O
/	O
at	O

eyes	O
:	O
eomi	O
,	O
anicteric	B
,	O
r	O
pupil	O
located	O
laterally	O
on	O
[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
3650	O
*	O
*	O
]	O
,	O
l	O
pupil	O
dyssymetric	B

throat	O
:	O
no	O
erythema	B
,	O
no	O
tonsillar	B
enlargement	I
,	O
tongue	B
midline	I
neck	O
:	O
no	O
stiffness	B
,	O
no	O
masses	B
,	O
no	O
lad	B
,	O
palpable	O
carotid	O
pulses	O
,	O
no	O
bruits	B
,	O
no	O
jvd	B

chest	O
:	O
no	O
supraclavicular	O
or	O
axillary	B
lad	I
,	O
lungs	O
clear	O
to	O

asculation	O
,	O
no	O
wheezes	B
/	O
rhonchi	B
/	O
crackles	B

heart	O
:	O
normal	O
pmi	O
,	O
rrr	O
,	O
no	O
murmurs	B
/	O
gallops	B
/	O
rubs	B

back	O
:	O
no	O
cva	B
tenderness	I
,	O
no	O
spinal	O
tenderness	B

abdomen	O
:	O
flat	O
,	O
nabs	O
,	O
soft	O
,	O
no	O
organomegaly	B
,	O
no	O
masses	B
,	O
no	O
guarding	B
,	O
no	O
rebound	B

ext	O
:	O
no	O
clubbing	B
/	O
cyanosis	B
/	O
edema	B
.	O

good	O
pulses	O
.	O

neuro	O
:	O
oriented	O
to	O
person	O
,	O
place	O
,	O
time	O

pertinent	O
results	O
:	O

admission	O
labs	O
:	O

[	O
*	O
*	O
2012	O
-	O
09	O
-	O
09	O
*	O
*	O
]	O
07	O
:	O
25pm	O
wbc	O
-	O
16	O
.	O
5	O
*	O
rbc	O
-	O
4	O
.	O
35	O
*	O
hgb	O
-	O
14	O
.	O
2	O
hct	O
-	O
40	O
.	O
8	O
mcv	O
-	O
94	O
mch	O
-	O
32	O
.	O
7	O
*	O
mchc	O
-	O
34	O
.	O
8	O
rdw	O
-	O
12	O
.	O
6	O

[	O
*	O
*	O
2012	O
-	O
09	O
-	O
09	O
*	O
*	O
]	O
07	O
:	O
25pm	O
plt	O
smr	O
-	O
normal	O
plt	O
count	O
-	O
232	O

[	O
*	O
*	O
2012	O
-	O
09	O
-	O
09	O
*	O
*	O
]	O
07	O
:	O
25pm	O
neuts	O
-	O
87	O
.	O
6	O
*	O
bands	O
-	O
0	O
lymphs	O
-	O
10	O
.	O
1	O
*	O
monos	O
-	O
1	O
.	O
8	O
*	O
eos	O
-	O
0	O
.	O
4	O
basos	O
-	O
0	O
.	O
2	O

[	O
*	O
*	O
2012	O
-	O
09	O
-	O
09	O
*	O
*	O
]	O
07	O
:	O
25pm	O
pt	O
-	O
15	O
.	O
1	O
*	O
ptt	O
-	O
134	O
.	O
8	O
*	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
6	O

[	O
*	O
*	O
2012	O
-	O
09	O
-	O
09	O
*	O
*	O
]	O
07	O
:	O
25pm	O
glucose	O
-	O
122	O
*	O
urea	O
n	O
-	O
12	O
creat	O
-	O
1	O
.	O
1	O
sodium	O
-	O
138	O
potassium	O
-	O
4	O
.	O
3	O
chloride	O
-	O
103	O
total	O
co2	O
-	O
21	O
*	O
anion	O
gap	O
-	O
18	O

[	O
*	O
*	O
2012	O
-	O
09	O
-	O
09	O
*	O
*	O
]	O
07	O
:	O
25pm	O
ck	O
(	O
cpk	O
)	O
-	O
192	O
*	O

[	O
*	O
*	O
2012	O
-	O
09	O
-	O
09	O
*	O
*	O
]	O
07	O
:	O
25pm	O
ck	O
-	O
mb	O
-	O
10	O
mb	O
indx	O
-	O
5	O
.	O
2	O
ctropnt	O
-	O
0	O
.	O
17	O
*	O

[	O
*	O
*	O
2012	O
-	O
09	O
-	O
10	O
*	O
*	O
]	O
01	O
:	O
28am	O
blood	O
ck	O
(	O
cpk	O
)	O
-	O
515	O
*	O

[	O
*	O
*	O
2012	O
-	O
09	O
-	O
10	O
*	O
*	O
]	O
10	O
:	O
30am	O
blood	O
ck	O
(	O
cpk	O
)	O
-	O
1016	O
*	O

[	O
*	O
*	O
2012	O
-	O
09	O
-	O
11	O
*	O
*	O
]	O
06	O
:	O
10am	O
blood	O
ck	O
(	O
cpk	O
)	O
-	O
743	O
*	O

[	O
*	O
*	O
2012	O
-	O
09	O
-	O
12	O
*	O
*	O
]	O
07	O
:	O
20am	O
blood	O
ck	O
(	O
cpk	O
)	O
-	O
336	O
*	O

[	O
*	O
*	O
2012	O
-	O
09	O
-	O
10	O
*	O
*	O
]	O
01	O
:	O
28am	O
blood	O
ck	O
-	O
mb	O
-	O
38	O
*	O
mb	O
indx	O
-	O
7	O
.	O
4	O
*	O
ctropnt	O
-	O
1	O
.	O
54	O
*	O

[	O
*	O
*	O
2012	O
-	O
09	O
-	O
10	O
*	O
*	O
]	O
10	O
:	O
30am	O
blood	O
ck	O
-	O
mb	O
-	O
110	O
*	O
mb	O
indx	O
-	O
10	O
.	O
8	O
*	O
ctropnt	O
-	O
2	O
.	O
19	O
*	O

[	O
*	O
*	O
2012	O
-	O
09	O
-	O
11	O
*	O
*	O
]	O
06	O
:	O
10am	O
blood	O
ck	O
-	O
mb	O
-	O
33	O
*	O
mb	O
indx	O
-	O
4	O
.	O
4	O
ctropnt	O
-	O
1	O
.	O
55	O
*	O

[	O
*	O
*	O
2012	O
-	O
09	O
-	O
12	O
*	O
*	O
]	O
07	O
:	O
20am	O
blood	O
ck	O
-	O
mb	O
-	O
10	O
mb	O
indx	O
-	O
3	O
.	O
0	O
ctropnt	O
-	O
1	O
.	O
39	O
*	O
.	O

cath	O
:	O

1	O
.	O
selective	O
coronary	O
angiography	O
of	O
this	O
right	B
dominant	I
sytem	I
revealed	O
single	B
vessel	I
cad	I
.	O

the	O
rca	O
was	O
a	O
dominant	O
vessel	O
and	O
was	O
95%	O
occluded	O
in	O
the	O
mid	O
vessel	O
with	O
thrombus	B
.	O

the	O
rca	O
gave	O
rise	O
to	O
a	O
large	O
pda	B
.	O

the	O
lmca	O
was	O
without	O
angiographic	O
evidence	O
of	O
flow	O
limiting	O
stenosis	B
.	O
teh	O
lad	O
had	O
no	O
angiographically	O
apparent	O
flow	O
limiting	O
stenosis	B
and	O
gave	O
rise	O
to	O
a	O
large	O
d1	O
.	O

the	O
lcx	O
had	O
no	O
angiographically	O
visible	O
flow	O
limiting	O
lesions	B
and	O
gave	O
rise	O
to	O
a	O
large	O
om	O
branch	O
.	O

2	O
.	O
limited	O
resting	O
hmeodynamics	O
revealed	O
mildy	O
elevated	B
systemic	I

pressures	I
.	O

3	O
.	O
left	O
ventriculography	O
was	O
deferred	O
.	O

4	O
.	O
successful	O
pci	O
of	O
the	O
proximal	O
and	O
mid	O
rca	O
with	O
two	O
cypher	O
des	O
(	O
non	O
-	O
overlapping	O
3	O
.	O
5	O
x	O
18	O
mm	O
)	O
,	O
both	O
post	O
-	O
dilated	O
with	O
a	O
4	O
.	O
5	O
mm	O
balloon	O
.	O

5	O
.	O
successful	O
closure	O
of	O
the	O
rfa	O
arteriotomy	O
site	O
with	O
a	O
6	O
[	O
*	O
*	O
ethnicity	O
203	O
*	O
*	O
]	O
angioseal	O
device	O
.	O

final	O
diagnosis	O
:	O

1	O
.	O
angiographic	O
evidence	O
of	O
single	B
vessel	I
coronary	I
artery	I
disease	I
.	O

2	O
.	O
mildly	O
elevated	B
systemic	I
pressures	I
.	O

3	O
.	O
successful	O
rescue	O
pci	O
with	O
stenting	O
of	O
the	O
proximal	O
and	O
mid	O
-	O
rca	O
for	O
failed	O
fibrinolytic	O
therapy	O
for	O
acute	B
inferior	I
myocardial	I
infarction	I
.	O

echo	O
:	O

.	O

selective	O
coronary	O
angiography	O
of	O
this	O
right	B
dominant	I
sytem	I
revealed	O
single	B
vessel	I
cad	I
.	O

the	O
rca	O
was	O
a	O
dominant	O
vessel	O
and	O
was	O
95%	O
occluded	O
in	O
the	O
mid	O
vessel	O
with	O
thrombus	B
.	O

the	O
rca	O
gave	O
rise	O
to	O
a	O
large	O
pda	B
.	O

the	O
lmca	O
was	O
without	O
angiographic	O
evidence	O
of	O
flow	O
limiting	O
stenosis	B
.	O
teh	O
lad	O
had	O
no	O
angiographically	O
apparent	O
flow	O
limiting	O
stenosis	B
and	O
gave	O
rise	O
to	O
a	O
large	O
d1	O
.	O

the	O
lcx	O
had	O
no	O
angiographically	O
visible	O
flow	O
limiting	O
lesions	B

and	O
gave	O
rise	O
to	O
a	O
large	O
om	O
branch	O
.	O

2	O
.	O
limited	O
resting	O
hmeodynamics	O
revealed	O
mildy	O
elevated	B
systemic	I

pressures	I
.	O

3	O
.	O
left	O
ventriculography	O
was	O
deferred	O
.	O

4	O
.	O
successful	O
pci	O
of	O
the	O
proximal	O
and	O
mid	O
rca	O
with	O
two	O
cypher	O
des	O
(	O
non	O
-	O
overlapping	O
3	O
.	O
5	O
x	O
18	O
mm	O
)	O
,	O
both	O
post	O
-	O
dilated	O
with	O
a	O
4	O
.	O
5	O
mm	O
balloon	O
.	O

5	O
.	O
successful	O
closure	O
of	O
the	O
rfa	O
arteriotomy	O
site	O
with	O
a	O
6	O
[	O
*	O
*	O
ethnicity	O
203	O
*	O
*	O
]	O
angioseal	O
device	O
.	O

final	O
diagnosis	O
:	O

1	O
.	O
angiographic	O
evidence	O
of	O
single	B
vessel	I
coronary	I
artery	I
disease	I
.	O

2	O
.	O
mildly	O
elevated	B
systemic	I
pressures	I
.	O

3	O
.	O
successful	O
rescue	O
pci	O
with	O
stenting	O
of	O
the	O
proximal	O
and	O
mid	O
-	O
rca	O
for	O
failed	O
fibrinolytic	O
therapy	O
for	O
acute	B
inferior	I
myocardial	I
infarction	I
.	O

ekg	O
on	O
admission	O
:	O

sinus	B
bradycardia	I
.	O

rsr'	O
pattern	O
in	O
leads	O
v1	O
-	O
v2	O
.	O

st	B
segment	I
elevations	I
in	O
leads	O
ii	O
,	O
iii	O
and	O
avf	O
consistent	O
with	O
possible	O
inferior	B
ischemia	I
/	O
infarction	O
.	O

follow	O
up	O
ekg	O
:	O

normal	O
sinus	O
rhythm	O
.	O

right	B
bundle	I
-	I
branch	I
block	I
.	O

left	B
anterior	I
fascicular	I
block	I
.	O

compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2012	O
-	O
09	O
-	O
10	O
*	O
*	O
]	O
the	O
right	B
bundle	I
-	I
branch	I
block	I
is	O
new	O
.	O

there	O
are	O
also	O
prominent	O
t	B
wave	I
inversions	I
in	O
leads	O
iii	O
and	O
avf	O
with	O
deep	B
q	I
waves	I
suggestive	O
of	O
inferior	B
infarction	I
/	O
ischemia	O

brief	O
hospital	O
course	O
:	O

51	O
yo	O
male	O
transferred	O
from	O
osh	O
with	O
imi	B
.	O

lysed	O
with	O
full	O
dose	O
tnk	O
,	O
incompletely	O
reperfused	O
and	O
still	O
with	O
pain	B
on	O
arrival	O
at	O
[	O
*	O
*	O
hospital1	O
461	O
*	O
*	O
]	O
,	O
taken	O
to	O
cath	O
lab	O
,	O
had	O
95%	O
rca	O
lesion	B
which	O
was	O
stented	O
with	O
cyphers	O
x	O
2	O
.	O
he	O
had	O
an	O
uncomplicated	O
recovery	O
and	O
was	O
discharged	O
pain	B
free	O
after	O
three	O
days	O
on	O
toprol	O
[	O
*	O
*	O
last	O
name	O
(	O
lf	O
)	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name3	O
(	O
lf	O
)	O
*	O
*	O
]	O
,	O
lisinopril	O
,	O
and	O
plavix	O
.	O

medications	O
on	O
admission	O
:	O

atenolol	O

niacin	O

prilosec	O

discharge	O
medications	O
:	O

1	O
.	O
aspirin	O
325	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
clopidogrel	O
75	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

3	O
.	O
atorvastatin	O
80	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

4	O
.	O
lisinopril	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

5	O
.	O
toprol	O
xl	O
25	O
mg	O
tablet	O
sustained	O
release	O
24hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
sustained	O
release	O
24hr	O
po	O
once	O
a	O
day	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
sustained	O
release	O
24hr	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

coronary	B
artery	I
disease	I

acute	I
st	I
segment	I
elevation	I
myocardial	I
infarction	I

discharge	O
condition	O
:	O

stable	O
,	O
without	O
chest	B
pain	I
.	O

discharge	O
instructions	O
:	O

please	O
call	O
your	O
doctor	O
or	O
go	O
to	O
the	O
emergency	O
room	O
if	O
you	O
experience	O
any	O
chest	B
pressure	I
/	O
pain	O
or	O
any	O
symptomes	B
concerning	O
for	O
a	O
heart	B
attack	I
.	O

please	O
make	O
an	O
appointment	O
with	O
your	O
primary	O
care	O
doctor	O
in	O
the	O
next	O
week	O
.	O

please	O
follow	O
up	O
with	O
your	O
cardiologist	O
.	O

followup	O
instructions	O
:	O

please	O
follow	O
up	O
with	O
your	O
primary	O
care	O
doctor	O
and	O
cardiologist	O
.	O

cardiac	O
rehabilitation	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2927	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
2928	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
3273	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
3274	O
*	O
*	O
]	O
[	O
*	O
*	O
2012	O
-	O
10	O
-	O
19	O
*	O
*	O
]	O
@	O
1653	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2012	O
-	O
12	O
-	O
04	O
*	O
*	O
]	O
11	O
:	O
40	O
am	O

(	O
end	O
of	O
report	O
)	O

175533	O
||||	O
19911	O
||||	O
10724	O
||||	O
radiology	O
_	O
report	O
||||	O
2019	O
-	O
08	O
-	O
27	O
04	O
:	O
20	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
411	O
-	O
9581	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2019	O
-	O
08	O
-	O
27	O
*	O
*	O
]	O
4	O
:	O
20	O
am	O

chest	O
(	O
portable	O
ap	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
8225	O
*	O
*	O
]	O
reason	O
:	O
please	O
assess	O
for	O
clinical	B
change	I
admitting	O
diagnosis	O
:	O
sepsis	B

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

66	O
year	O
old	O
woman	O
with	O
esrd	B
on	O
cvvh	O
,	O
resp	B
.	I
failure	I
.	O

reason	O
for	O
this	O
examination	O
:	O
please	O
assess	O
for	O
clinical	B
change	I
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

ap	O
chest	O
4	O
:	O
38	O
a	O
.	O
m	O
.	O
on	O
[	O
*	O
*	O
08	O
-	O
27	O
*	O
*	O
]	O
.	O

history	O
:	O
on	O
dialysis	O
.	O

respiratory	B
failure	I
.	O

impression	O
:	O
ap	O
chest	O
compared	O
to	O
[	O
*	O
*	O
08	O
-	O
02	O
*	O
*	O
]	O
and	O
24	O
:	O

moderate	O
right	O
pleural	B
effusion	I
has	O
increased	O
since	O
[	O
*	O
*	O
08	O
-	O
22	O
*	O
*	O
]	O
,	O
partially	O
obscuring	O
anatomic	O
detail	O
in	O
the	O
right	O
lung	O
but	O
mild	O
interstitial	B
edema	I
is	O
probably	O
present	O
.	O

leftward	B
mediastinal	I
shift	I
_	O
_	O
_	O
_	O
_	O
a	O
function	O
of	O
right	O
pleural	B
effusion	I
and	O
substantial	O
left	B
lower	I
lobe	I
collapse	I
,	O
even	O
though	O
the	O
latter	O
appears	O
to	O
have	O
improved	O
since	O
[	O
*	O
*	O
08	O
-	O
22	O
*	O
*	O
]	O
.	O

cardiac	O
silhouette	O
is	O
top	O
normal	O
size	O
.	O

no	O
pneumothorax	B
.	O

tracheostomy	O
tube	O
and	O
a	O
dual	O
channel	O
right	O
internal	O
jugular	O
dialysis	O
line	O
are	O
in	O
standard	O
placements	O
.	O

no	O
pneumothorax	B
.	O

103427	O
||||	O
20223	O
||||	O
5893	O
||||	O
echo	O
_	O
report	O
||||	O
2014	O
-	O
03	O
-	O
28	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
shortness	B
of	I
breath	I
.	O

height	O
:	O
(	O
in	O
)	O
67	O

weight	O
(	O
lb	O
)	O
:	O
165	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
87	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
160	O
/	O
80	O

hr	O
(	O
bpm	O
)	O
:	O
74	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
28	O
*	O
*	O
]	O
at	O
12	O
:	O
54	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
saline	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
moderate	O
la	B
enlargement	I
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thickness	O
.	O

normal	O
lv	O
cavity	O
size	O
.	O

suboptimal	O
technical	O
quality	O
,	O
a	O
focal	O
lv	B
wall	I
motion	I
abnormality	I
cannot	O
be	O
fully	O
excluded	O
.	O

overall	O
normal	O
lvef	O
(	O
>55%	O
)	O
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
wall	O
thickness	O
.	O

normal	O
rv	O
chamber	O
size	O
.	O

normal	O
rv	O
systolic	O
function	O
.	O

aorta	O
:	O
mildly	O
dilated	B
aortic	I
root	I
.	O

normal	O
ascending	O
aorta	O
diameter	O
.	O

normal	O
aortic	O
arch	O
diameter	O
.	O

aortic	O
valve	O
:	O
mildly	O
thickened	B
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

mitral	O
valve	O
:	O
mild	O
mitral	B
annular	I
calcification	I
.	O

mild	O
(	O
1	O
+	O
)	O
mr	B
.	O

tricuspid	O
valve	O
:	O
physiologic	O
tr	B
.	O

indeterminate	O
pa	B
systolic	I
pressure	I
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
.	O

conclusions	O
:	O

1	O
.	O
the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

2	O
.	O
left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

due	O
to	O
suboptimal	O
technical	O
quality	O
,	O
a	O
focal	O
wall	B
motion	I
abnormality	I
cannot	O
be	O
fully	O
excluded	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

3	O
.	O
right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
.	O

right	O
ventricular	O
systolic	O
function	O
is	O
normal	O
.	O

4	O
.	O
the	O
aortic	O
root	O
is	O
mildly	O
dilated	O
.	O

5	O
.	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

no	O
aortic	B
regurgitation	I
present	O
.	O

6	O
.	O
mild	O
mitral	O
valve	O
thickness	B
.	O

mild	O
(	O
1	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

7	O
.	O
the	O
pulmonary	B
artery	I
systolic	I
pressure	I
could	O
not	O
be	O
determined	O
.	O

8	O
.	O
there	O
is	O
no	O
pericardial	B
effusion	I
.	O

24150	O
||||	O
20389	O
||||	O
17922	O
||||	O
discharge	O
_	O
summary	O
||||	O
2016	O
-	O
08	O
-	O
07	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
08	O
-	O
02	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
08	O
-	O
07	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1942	O
-	O
11	O
-	O
18	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

penicillins	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
1593	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

x	O
-	O
fer	O
for	O
cath	O

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

cardiac	O
catheterization	O
:	O
severe	O
3vd	B
;	O
not	O
amendabel	O
to	O

percutaneous	O
intervention	O

egd	O
:	O
[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
esophagitis	B
;	O
gastric	B
ulcers	I

history	O
of	O
present	O
illness	O
:	O

73	O
yo	O
male	O
with	O
no	O
known	O
cad	B
,	O
but	O
multiple	O
risk	O
factors	O
including	O
htn	B
,	O
hyperlipidemia	B
,	O
niddm	B
and	O
smoking	O
,	O
has	O
been	O
experiencing	O
incteasing	O
doe	B
.	O
was	O
admitted	O
to	O
osh	O
on	O
[	O
*	O
*	O
2016	O
-	O
07	O
-	O
30	O
*	O
*	O
]	O
,	O
where	O
he	O
undewent	O
elective	O
radical	O
prostatectomy	O
,	O
post	O
-	O
operatively	O
,	O
developed	O
n	B
/	O
v	B
/	O
diaphoresis	B
and	O
ruled	O
in	O
for	O
inferior	O
stemi	B
with	O
peak	O
ck	O
of	O
770	O
and	O
tri	O
of	O
29	O
on	O
[	O
*	O
*	O
07	O
-	O
31	O
*	O
*	O
]	O
-	O
-	O
>	O
was	O
transferred	O
to	O
icu	O
(	O
osh	O
)	O
for	O
close	O
monitoring	O
,	O
where	O
he	O
develped	O
afib	B
with	O
rvr	B
,	O
experienced	O
episode	O
of	O
hypotension	B
after	O
iv	O
lopressor	O
and	O
was	O
subsequently	O
transferred	O
to	O
bodmc	O
for	O
further	O
management	O
on	O
heparin	O
gtt	O
;	O
dilt	O
gtt	O
,	O
and	O
asa	O
.	O

upon	O
arrival	O
to	O
[	O
*	O
*	O
hospital1	O
18	O
*	O
*	O
]	O
ccu	O
,	O
pt	O
was	O
in	O
nsr	O
and	O
was	O
sx	B
-	O
free	O
.	O

pt	O
denies	O
h	O
/	O
o	O
prior	O
af	B
.	O

he	O
never	O
had	O
a	O
prior	O
cardiac	O
evaluation	O
.	O

past	O
medical	O
history	O
:	O

htn	B

hyperchol	I

niddm	I

prostate	I
ca	I
-	O
>	O
s	O
/	O
p	O
radical	O
prostatectomy	O

gout	B

social	O
history	O
:	O

retired	O
;	O
long	O
standing	O
h	O
/	O
o	O
tobacco	O
use	O
(	O
quit	O
3	O
mos	O
ago	O
)	O
;	O
last	O
drink	O
3	O
mos	O
ago	O

family	O
history	O
:	O

n	O
/	O
c	O

physical	O
exam	O
:	O

hr	O
65	O
100	O
/	O
60	O

nad	B

no	O
jvd	B
;	O
no	O
bruits	B

cta	O
b	O

rrr	O
;	O
s1	O
/	O
2	O
;	O
no	O
m	B
/	O
r	B
/	O
g	B

obese	I
abd	I
;	O
positive	O
bs	O

no	O
c	B
/	O
c	B
/	O
e	B
;	O
peripheral	O
pulses	O
intact	O
by	O
doppler	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2016	O
-	O
08	O
-	O
02	O
*	O
*	O
]	O
10	O
:	O
39am	O
pt	O
-	O
14	O
.	O
0	O
*	O
ptt	O
-	O
52	O
.	O
4	O
*	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
3	O

[	O
*	O
*	O
2016	O
-	O
08	O
-	O
02	O
*	O
*	O
]	O
10	O
:	O
39am	O
plt	O
count	O
-	O
250	O

[	O
*	O
*	O
2016	O
-	O
08	O
-	O
02	O
*	O
*	O
]	O
10	O
:	O
39am	O
wbc	O
-	O
13	O
.	O
8	O
*	O
rbc	O
-	O
3	O
.	O
39	O
*	O
hgb	O
-	O
10	O
.	O
6	O
*	O
hct	O
-	O
30	O
.	O
5	O
*	O
mcv	O
-	O
90	O
mch	O
-	O
31	O
.	O
2	O
mchc	O
-	O
34	O
.	O
8	O
rdw	O
-	O
13	O
.	O
4	O

[	O
*	O
*	O
2016	O
-	O
08	O
-	O
02	O
*	O
*	O
]	O
10	O
:	O
39am	O
triglycer	O
-	O
119	O
hdl	O
chol	O
-	O
43	O
chol	O
/	O
hdl	O
-	O
3	O
.	O
7	O
ldl	O
(	O
calc	O
)	O
-	O
94	O

[	O
*	O
*	O
2016	O
-	O
08	O
-	O
02	O
*	O
*	O
]	O
10	O
:	O
39am	O
calcium	O
-	O
9	O
.	O
1	O
phosphate	O
-	O
2	O
.	O
2	O
*	O
magnesium	O
-	O
2	O
.	O
1	O
cholest	O
-	O
161	O

[	O
*	O
*	O
2016	O
-	O
08	O
-	O
02	O
*	O
*	O
]	O
10	O
:	O
39am	O
ck	O
-	O
mb	O
-	O
11	O
*	O
mb	O
indx	O
-	O
5	O
.	O
3	O
ctropnt	O
-	O
2	O
.	O
43	O
*	O

[	O
*	O
*	O
2016	O
-	O
08	O
-	O
02	O
*	O
*	O
]	O
10	O
:	O
39am	O
ck	O
(	O
cpk	O
)	O
-	O
208	O
*	O
tot	O
bili	O
-	O
0	O
.	O
8	O

[	O
*	O
*	O
2016	O
-	O
08	O
-	O
02	O
*	O
*	O
]	O
10	O
:	O
39am	O
glucose	O
-	O
232	O
*	O
urea	O
n	O
-	O
27	O
*	O
creat	O
-	O
1	O
.	O
6	O
*	O
sodium	O
-	O
135	O
potassium	O
-	O
3	O
.	O
5	O
chloride	O
-	O
101	O
total	O
co2	O
-	O
25	O
anion	O
gap	O
-	O
13	O

[	O
*	O
*	O
2016	O
-	O
08	O
-	O
02	O
*	O
*	O
]	O
03	O
:	O
00pm	O
pt	O
-	O
13	O
.	O
8	O
*	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
3	O

[	O
*	O
*	O
2016	O
-	O
08	O
-	O
02	O
*	O
*	O
]	O
03	O
:	O
00pm	O
alt	O
(	O
sgpt	O
)	O
-	O
19	O
ast	O
(	O
sgot	O
)	O
-	O
31	O
ck	O
(	O
cpk	O
)	O
-	O
154	O
alk	O
phos	O
-	O
58	O
amylase	O
-	O
14	O
tot	O
bili	O
-	O
0	O
.	O
9	O

brief	O
hospital	O
course	O
:	O

73	O
yo	O
male	O
with	O
multiple	O
cardiac	O
risk	O
factors	O
;	O
s	O
/	O
o	O
inferior	O
stemi	B
at	O
osh	O
and	O
one	O
episode	O
of	O
rapid	B
afib	I
.	O

1	O
.	O
s	O
/	O
p	O
inferior	O
stemi	B
:	O
sx	B
free	O
upom	O
arrival	O
on	O
asa	O
,	O
integrillin	O
,	O
heparin	O
gtt	O
.	O

started	O
lipitor	O
,	O
cont	O
lopressor	O
.	O
cardiac	O
cath	O
revealed	O
3vd	B
:	O
80%	O
prox	O
lad	O
and	O
70%	O
mid	O
lad	O
;	O
50	O
%	O
diffuse	O
om1	O
and	O
70%	O
om2	O
;	O
cronically	O
occluded	B
rca	I
with	O
timi	O
1	O
flow	O
via	O
l	O
-	O
r	O
collaterals	O
.	O

c	O
-	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
consult	O
was	O
obtained	O
for	O
evaluation	O
for	O
cabg	O
.	O

however	O
,	O
pt	O
had	O
an	O
episode	O
of	O
melena	B
and	O
egd	O
revelaed	O
severe	O
[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
esophagitis	B
and	O
esoph	B
ulcers	I
;	O
it	O
was	O
felt	O
that	O
pt	O
is	O
at	O
high	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
risk	O
and	O
cabg	O
was	O
postponed	O
with	O
outpt	O
followed	O
up	O
after	O
appropriate	O
h	O
.	O
pylori	O
therapy	O
.	O

2	O
.	O
pump	O
:	O
tte	O
revealed	O
ef	O
20	O
-	O
25%	O
;	O
2	O
+	O
mr	B
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
4276	O
*	O
*	O
]	O
pulm	B
htn	I
.	O

ace	O
-	O
i	O
was	O
started	O
and	O
tolerated	O
well	O
by	O
pt	O
.	O

it	O
was	O
decided	O
to	O
place	O
swan	O
-	O
[	O
*	O
*	O
doctor	O
last	O
name	O
4277	O
*	O
*	O
]	O
catheter	O
for	O
tailored	O
diuresis	O
prior	O
to	O
anticipated	O
cabg	O
later	O
on	O
same	O
week	O
.	O

s	O
-	O
g	O
catheter	O
was	O
successfully	O
placed	O
with	O
initial	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
1157	O
*	O
*	O
]	O
of	O
pa	O
45	O
/	O
19	O
(	O
28	O
)	O
;	O
pcwp	O
26	O
;	O
ci	O
4	O
.	O
5	O
;	O
co	O
21	O
.	O
;	O
svr	O
1262	O
;	O
mvo2	O
57%	O
,	O
with	O
improvement	O
after	O
diuresis	O
.	O

pt	O
toleareted	O
lopressor	O
and	O
ace	O
-	O
i	O
.	O

3	O
.	O
rhythm	O
:	O
afib	B
:	O
several	O
episodes	O
of	O
afib	B
while	O
in	O
the	O
hospital	O
.	O

amio	O
po	O
load	O
;	O
heparin	O
gtt	O
for	O
anticoagulation	O

4	O
.	O
gib	B
:	O
pt	O
had	O
an	O
episode	O
of	O
melena	B
.	O

hct	O
was	O
checked	O
and	O
was	O
stable	O
at	O
29	O
,	O
iron	O
studies	O
were	O
c	O
/	O
w	O
mixed	O
iron	B
deficiency	I
anemia	I
and	O
aocd	B
.	O
it	O
was	O
decided	O
to	O
proceed	O
with	O
egd	O
to	O
r	O
/	O
o	O
significant	O
ugib	B
prior	O
to	O
planed	O
cabg	O
.	O

egd	O
showed	O
severe	O
[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
esophagitis	B
and	O
multiple	B
ulcers	I
.	O

it	O
was	O
felt	O
that	O
pt	O
would	O
be	O
at	O
a	O
high	O
risk	O
for	O
cabg	O
and	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
was	O
postponed	O
.	O

fluconazole	O
was	O
started	O
as	O
well	O
as	O
h	O
/	O
pyloru	O
therapy	O

5	O
.	O
uti	B
:	O
treated	O
with	O
ciprofolacin	O
without	O
complications	B

6	O
.	O
dm	B
:	O
oral	O
hypoglycemics	O
in	O
addition	O
to	O
insulin	O
sliding	O
scale	O
.	O
diabetic	B
education	O
provided	O
to	O
pt	O
and	O
his	O
wife	O
with	O
[	O
*	O
*	O
name2	O
(	O
ni	O
)	O
4278	O
*	O
*	O
]	O
on	O
importance	O
of	O
toght	O
glycemic	B
control	I
.	O
toleratig	O
glargine	O
.	O

medications	O
on	O
admission	O
:	O

lipitor	O

paxil	O

discharge	O
medications	O
:	O

1	O
.	O
aspirin	O
325	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
atorvastatin	O
calcium	O
40	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

3	O
.	O
fluconazole	O
100	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q24h	O
(	O
every	O
24	O
hours	O
)	O
for	O
11	O
days	O
.	O

disp	O
:	O
*	O
21	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

4	O
.	O
lisinopril	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

5	O
.	O
imdur	O
30	O
mg	O
tablet	O
sustained	O
release	O
24hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
sustained	O
release	O
24hr	O
po	O
once	O
a	O
day	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
sustained	O
release	O
24hr	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

6	O
.	O
glimepiride	O
2	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
twice	O
a	O
day	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

7	O
.	O
clarithromycin	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
11	O
days	O
:	O
take	O
through	O
[	O
*	O
*	O
08	O
-	O
17	O
*	O
*	O
]	O
,	O
to	O
complete	O
your	O
2	O
-	O
week	O
course	O
.	O

disp	O
:	O
*	O
21	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

8	O
.	O
colchicine	O
0	O
.	O
6	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
for	O
3	O
days	O
.	O

disp	O
:	O
*	O
3	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

9	O
.	O
amiodarone	O
hcl	O
200	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
as	O
directed	O
.	O
:	O
take	O
every	O
12	O
hours	O
through	O
[	O
*	O
*	O
08	O
-	O
10	O
*	O
*	O
]	O
.	O

then	O
take	O
once	O
daily	O
thereafter	O
.	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

10	O
.	O

multivitamin	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
cap	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
30	O
cap	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

11	O
.	O

amoxicillin	O
500	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
for	O
11	O
days	O
:	O
take	O
through	O
[	O
*	O
*	O
08	O
-	O
17	O
*	O
*	O
]	O
.	O

disp	O
:	O
*	O
21	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

12	O
.	O

metoprolol	O
succinate	O
100	O
mg	O
tablet	O
sustained	O
release	O
24hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
sustained	O
release	O
24hr	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
sustained	O
release	O
24hr	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

13	O
.	O

pantoprazole	O
sodium	O
40	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
:	O
take	O
twice	O
daily	O
through	O
[	O
*	O
*	O
08	O
-	O
17	O
*	O
*	O
]	O
,	O
then	O
take	O
once	O
daily	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

14	O
.	O

nitroglycerin	O
0	O
.	O
3	O
mg	O
tablet	O
,	O
sublingual	O
sig	O
:	O
one	O
(	O
1	O
)	O

sublingual	O
prn	O
as	O
needed	O
for	O
chest	B
pain	I
:	O
take	O
for	O
episodes	O
of	O
chest	B
pain	I
.	O

contact	O
your	O
pcp	O
or	O
go	O
to	O
[	O
*	O
*	O
doctor	O
first	O
name	O
5	O
*	O
*	O
]	O
if	O
your	O
pain	B
is	O
not	O
relieved	O
by	O
2	O
-	O
3	O
tabs	O
.	O

disp	O
:	O
*	O
30	O
pills	O
*	O
refills	O
:	O
*	O
2	O
*	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

1	O
.	O
inferior	O
stemi	B

2	O
.	O
cad	B
:	O
3	B
vessel	I
disease	I

3	O
.	O
[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
esophagitis	B

4	O
.	O
gib	B
:	O
gastric	B
ulcers	I

5	O
.	O
diabetes	O
,	O
type	O
ii	O

6	O
.	O
chronic	B
renal	I
insufficiency	I

7	O
.	O
s	O
/	O
p	O
prostatectomy	O

8	O
.	O
paroxysmal	B
atrial	I
fibrillation	I

discharge	O
condition	O
:	O

stable	O

discharge	O
instructions	O
:	O

1	O
.	O
please	O
take	O
all	O
of	O
your	O
medications	O
as	O
directed	O
.	O

you	O
have	O
several	O
new	O
medications	O
.	O

2	O
.	O
please	O
return	O
to	O
the	O
emergency	O
room	O
if	O
you	O
experince	O
any	O
chest	B
pressure	I
or	O
tightness	O
,	O
chest	B
pain	I
or	O
shortness	B
of	I
breath	I
,	O
especially	O
if	O
your	O
symptoms	B
are	O
not	O
relieved	O
by	O
rest	O
.	O

followup	O
instructions	O
:	O

1	O
.	O
please	O
follow	O
up	O
with	O
your	O
primary	O
care	O
physician	O
[	O
*	O
*	O
name9	O
(	O
pre	O
)	O
*	O
*	O
]	O
1	O
week	O
.	O
-	O
you	O
should	O
have	O
your	O
kidney	O
function	O
(	O
creatinine	O
)	O
and	O
blood	O
count	O
(	O
hematocrit	O
)	O
checked	O
within	O
one	O
week	O
,	O
and	O
again	O
within	O
one	O
month	O
,	O
along	O
with	O
liver	O
and	O
muscle	O
tests	O
(	O
as	O
you	O
have	O
been	O
started	O
on	O
a	O
higher	O
dose	O
of	O
lipitor	O
)	O
.	O
-	O
you	O
should	O
also	O
discuss	O
referral	O
for	O
a	O
repeat	O
endosocopy	O
(	O
egd	O
)	O
one	O
month	O
from	O
hospital	O
discharge	O
(	O
prior	O
to	O
your	O
bypass	O
surgery	O
,	O
as	O
per	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
272	O
*	O
*	O
]	O
)	O
.	O
-	O
discuss	O
also	O
having	O
an	O
outpatint	O
colonoscopy	O
with	O
your	O
primary	O
care	O
physician	O
following	O
bypass	O
surgery	O
.	O
-	O
in	O
addition	O
,	O
since	O
you	O
have	O
been	O
started	O
on	O
a	O
new	O
medication	O
called	O
amiodarone	O
(	O
to	O
control	O
your	O
heart	B
rate	I
/	O
arrhythmia	B
)	O
,	O
you	O
will	O
need	O
to	O
have	O
pulmonary	O
function	O
tests	O
and	O
thyroid	O
tests	O
within	O
the	O
next	O
month	O
(	O
your	O
pcp	O
can	O
give	O
you	O
a	O
referral	O
for	O
this	O
)	O
.	O
-	O
discuss	O
also	O
referral	O
for	O
diabetic	B
education	O
on	O
lifestyle	O
modification	O
.	O

2	O
.	O
please	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
272	O
*	O
*	O
]	O
in	O
4	O
-	O
6	O
weeks	O
.	O

please	O
phone	O
to	O
schedule	O
appointment	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1030	O
*	O
*	O
]	O
.	O

3	O
.	O
please	O
follow	O
-	O
up	O
with	O
your	O
urologist	O
within	O
one	O
week	O
.	O

please	O
phone	O
to	O
schedule	O
your	O
appointment	O
.	O

4	O
.	O
please	O
also	O
schedule	O
a	O
follow	O
-	O
up	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
223	O
*	O
*	O
]	O
for	O
an	O
electrophysiology	O
consultation	O
(	O
following	O
your	O
bypass	O
surgery	O
)	O
.	O

his	O
office	O
phone	O
number	O
is	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
487	O
*	O
*	O
]	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1596	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
name6	O
(	O
md	O
)	O
1597	O
*	O
*	O
]	O
goldman	O
md	O
[	O
*	O
*	O
md	O
number	O
1598	O
*	O
*	O
]	O
[	O
*	O
*	O
2016	O
-	O
12	O
-	O
23	O
*	O
*	O
]	O
@	O
1636	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2016	O
-	O
12	O
-	O
27	O
*	O
*	O
]	O
5	O
:	O
21	O
pm	O

(	O
end	O
of	O
report	O
)	O

23289	O
||||	O
20442	O
||||	O
1075	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
07	O
-	O
15	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
08	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
15	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1937	O
-	O
09	O
-	O
12	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
csu	O

chief	O
complaint	O
:	O
this	O
is	O
a	O
75	O
-	O
year	O
-	O
old	O
male	O
patient	O
of	O
[	O
*	O
*	O
firstname	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
and	O
[	O
*	O
*	O
firstname	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
517	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
224	O
*	O
*	O
]	O
referred	O
for	O
an	O
outpatient	O
cardiac	O
catheterization	O
due	O
to	O
an	O
abnormal	B
stress	I
echocardiogram	I
.	O

history	O
of	O
present	O
illness	O
:	O
in	O
[	O
*	O
*	O
2011	O
-	O
12	O
-	O
02	O
*	O
*	O
]	O
,	O
pta	O
with	O
stenting	O
,	O

[	O
*	O
*	O
2012	O
-	O
12	O
-	O
07	O
*	O
*	O
]	O
diffuse	O
instent	O
restenosis	B
of	O
rsfa	O
stent	O
status	O
post	O
pta	O
of	O
entire	O
right	O
sfa	O
and	O
a	O
placement	O
of	O
a	O
new	O
stent	O
.	O

on	O

[	O
*	O
*	O
2013	O
-	O
04	O
-	O
10	O
*	O
*	O
]	O
status	O
post	O
left	O
sfa	O
stent	O
placement	O
and	O
right	O
sfa	O
stent	O
placement	O
.	O

patient	O
has	O
a	O
history	O
of	O
a	O
silent	B
mi	I
approximately	O
seven	O
years	O
.	O

for	O
4	O
-	O
6	O
weeks	O
prior	O
to	O
admission	O
,	O
he	O
had	O
been	O
experiencing	O
symptoms	O
of	O
heartburn	B
with	O
activity	O
and	O
anxiety	B
.	O

a	O
gi	O
workup	O
initially	O
revealed	O
a	O
stomach	B
polyp	I
and	O
an	O
esophageal	B
polyp	I
,	O
which	O
was	O
biopsied	O
and	O
found	O
negative	O
.	O

dobutamine	O
stress	O
echocardiogram	O
on	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
03	O
*	O
*	O
]	O
was	O
positive	O
for	O
chest	B
pain	I
and	O
ekg	B
changes	I
.	O

echocardiogram	O
revealed	O
an	O
ef	O
of	O
50	O
percent	O
,	O
posterior	O
basilar	O
akinesis	B
,	O
aortic	B
sclerosis	I
,	O
no	O
ai	B
,	O
thickened	B
mitral	O
valve	O
,	O
mild	O
mr	B
,	O
concentric	O
left	B
ventricular	I
hypertrophy	I
,	O
mild	O
-	O
to	O
-	O
moderate	O
tr	B
,	O
mild	O
pulmonary	B
hypertension	I
,	O
whose	O
exercise	O
imaging	O
revealed	O
mid	O
to	O
apical	O
and	O
inferior	O
apical	O
marked	O
hypokinesis	B
consistent	O
with	O
lad	O
stenosis	B
.	O

patient	O
was	O
then	O
referred	O
for	O
cardiac	O
catheterization	O
,	O
which	O
he	O
underwent	O
on	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
08	O
*	O
*	O
]	O
.	O

the	O
catheterization	O
revealed	O
normal	O
left	O
main	O
with	O
lad	O
80	O
percent	O
occlusion	B
at	O
the	O
origin	O
,	O
80	O
percent	O
mid	O
occlusion	B
,	O
left	O
circumflex	O
occluded	B
after	O
a	O
large	O
om	O
-	O
1	O
with	O
a	O
70	O
percent	O
.	O

om	O
-	O
2	O
fills	O
by	O
collaterals	O
and	O
rca	B
occluded	I
.	O

at	O
that	O
time	O
,	O
the	O
patient	O
was	O
referred	O
for	O
coronary	O
artery	O
bypass	O
grafting	O
by	O
[	O
*	O
*	O
firstname	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
458	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
457	O
*	O
*	O
]	O
.	O

past	O
medical	O
history	O
:	O
gerd	B
.	O

silent	B
mi	I
seven	O
years	O
.	O

status	O
post	O
prostate	B
cancer	I
treated	O
with	O
radiation	O
treatment	O
.	O

pvd	B
status	O
post	O
right	O
and	O
left	O
sfa	O
stenting	O
.	O

stomach	B
polyp	I
.	O

allergies	O
:	O
latex	O
.	O

medications	O
at	O
home	O
:	O

1	O
.	O
zestril	O
40	O
mg	O
q	O
.	O
d	O
.	O

2	O
.	O
plavix	O
70	O
mg	O
q	O
.	O
d	O
.	O

3	O
.	O
aspirin	O
325	O
mg	O
q	O
.	O
d	O
.	O

4	O
.	O
ranitidine	O
150	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O

5	O
.	O
lasix	O
5	O
mg	O
q	O
monday	O
and	O
thursday	O
.	O

6	O
.	O
prilosec	O
40	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O

7	O
.	O
folic	O
acid	O
1	O
.	O
6	O
mg	O
daily	O
.	O

8	O
.	O
multivitamin	O
daily	O
.	O

9	O
.	O
flomax	O
0	O
.	O
4	O
mg	O
daily	O
.	O

10	O
.	O

norvasc	O
2	O
.	O
5	O
mg	O
q	O
monday	O
,	O
wednesday	O
,	O
and	O
friday	O
,	O
and	O
5	O
mg	O
q	O
tuesdays	O
,	O
thursdays	O
,	O
and	O
saturdays	O
.	O

11	O
.	O

lipitor	O
5	O
mg	O
daily	O
.	O

12	O
.	O

fish	O
oil	O
1000	O
mg	O
daily	O
.	O

13	O
.	O

lorazepam	O
prn	O
for	O
anxiety	B
.	O

14	O
.	O

cranberry	O
capsules	O
405	O
mg	O
q	O
.	O
h	O
.	O
s	O
.	O

physical	O
examination	O
on	O
admission	O
:	O
heart	O
rate	O
88	O
,	O
blood	O
pressure	O
110	O
/	O
63	O
.	O

general	O
:	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

head	O
is	O
normocephalic	O
,	O
atraumatic	O
.	O

neck	O
is	O
supple	O
,	O
no	O
bruits	B
.	O

chest	O
was	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

cardiac	O
:	O
regular	O
,	O
rate	O
,	O
and	O
rhythm	O
,	O
normal	O
s1	O
,	O
s2	O
.	O

abdomen	O
is	O
soft	O
,	O
nontender	O
,	O
nondistended	O
.	O

neurologic	O
:	O
grossly	O
intact	O
.	O

pulses	O
:	O
2	O
plus	O
bilateral	O
radial	O
,	O
2	O
plus	O
left	O
femoral	O
,	O
and	O
1	O
plus	O
right	O
dorsalis	O
pedis	O
.	O

laboratory	O
data	O
at	O
discharge	O
:	O
wbc	O
4	O
.	O
9	O
,	O
hematocrit	O
30	O
.	O
0	O
,	O
platelets	O
184	O
,	O
bun	O
18	O
,	O
creatinine	O
1	O
.	O
3	O
.	O

chest	O
x	O
-	O
ray	O
from	O
day	O
of	O
discharge	O
pending	O
.	O

summary	O
of	O
hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
on	O

[	O
*	O
*	O
2013	O
-	O
07	O
-	O
08	O
*	O
*	O
]	O
for	O
cardiac	O
catheterization	O
,	O
and	O
was	O
subsequently	O
referred	O
for	O
coronary	O
artery	O
bypass	O
grafting	O
.	O

he	O
went	O
to	O
the	O
operating	O
room	O
under	O
the	O
care	O
of	O
[	O
*	O
*	O
firstname	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
458	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
457	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
09	O
*	O
*	O
]	O
.	O

he	O
underwent	O
a	O
cabg	O
x5	O
with	O
a	O
lima	O
to	O
the	O
lad	O
and	O
saphenous	O
vein	O
grafting	O
to	O
d1	O
,	O
om	O
,	O
ramus	O
,	O
and	O
pda	O
.	O

his	O
or	O
course	O
was	O
uneventful	O
with	O
a	O
cross	O
-	O
clamp	O
time	O
of	O
89	O
minutes	O
and	O
a	O
bypass	O
time	O
of	O
106	O
minutes	O
.	O

he	O
left	O
the	O
operating	O
room	O
,	O
and	O
was	O
transferred	O
to	O
the	O

cardiac	O
surgery	O
recovery	O
unit	O
on	O
levophed	O
and	O
propofol	O
drips	O
.	O

he	O
was	O
extubated	O
on	O
the	O
evening	O
of	O
the	O
surgery	O
.	O

he	O
was	O
transferred	O
to	O
the	O
inpatient	O
floor	O
on	O
postoperative	O
day	O
one	O
.	O

on	O
postoperative	O
day	O
two	O
,	O
his	O
chest	O
tubes	O
and	O
wires	O
were	O

d	O
/	O
c'd	O
.	O

he	O
was	O
followed	O
throughout	O
his	O
hospital	O
course	O
by	O

physical	O
therapy	O
and	O
on	O
[	O
*	O
*	O
07	O
-	O
14	O
*	O
*	O
]	O
,	O
was	O
found	O
to	O
have	O
a	O
safe	O
level	O
for	O
discharge	O
home	O
with	O
use	O
of	O
a	O
cane	O
,	O
and	O
was	O
referred	O
to	O
outpatient	O
cardiac	O
rehab	O
.	O

discharge	O
condition	O
:	O
t	O
max	O
100	O
,	O
pulse	O
81	O
in	O
sinus	O
rhythm	O
,	O
blood	O
pressure	O
125	O
/	O
70	O
,	O
respiratory	O
rate	O
18	O
,	O
on	O
room	O
air	O
oxygen	O
saturation	O
100	O
percent	O
.	O

neurologic	O
:	O
awake	O
,	O
alert	O
,	O
and	O
oriented	O
times	O
three	O
.	O

cardiac	O
:	O
regular	O
,	O
rate	O
,	O
and	O
rhythm	O
.	O

no	O
murmurs	B
,	O
rubs	B
,	O
or	O
gallops	B
.	O

respiratory	O
:	O
lungs	O
sounds	O
are	O
clear	O
bilaterally	O
.	O

gi	O
:	O
positive	O
bowel	O
sounds	O
.	O

abdomen	O
is	O
soft	O
,	O
nontender	O
,	O
nondistended	O
.	O

incisions	O
:	O

sternal	O
incision	B
with	O
staples	O
intact	O
,	O
open	O
to	O
air	O
,	O
and	O
no	O
drainage	O
.	O

right	O
lower	O
extremity	O
harvest	O
site	O
with	O
steri	O
-	O

strips	O
intact	O
and	O
open	O
to	O
air	O
.	O

discharge	O
status	O
:	O
the	O
patient	O
will	O
be	O
discharged	O
home	O
today	O
,	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
15	O
*	O
*	O
]	O
in	O
stable	O
condition	O
with	O
visiting	O
nurse	O
to	O
follow	O
.	O

discharge	O
diagnosis	O
:	O
coronary	B
artery	I
disease	I
status	O
post	O
coronary	O
artery	O
bypass	O
graft	O
times	O
five	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
lasix	O
20	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O
for	O
seven	O
days	O
.	O

2	O
.	O
potassium	O
chloride	O
20	O
meq	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O
for	O
seven	O
days	O
.	O

3	O
.	O
aspirin	O
325	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

4	O
.	O
plavix	O
75	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

5	O
.	O
colace	O
100	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

6	O
.	O
flomax	O
0	O
.	O
4	O
mg	O
q	O
.	O
d	O
.	O

7	O
.	O
lopressor	O
25	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

8	O
.	O
lipitor	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

9	O
.	O
percocet	O
5	O
/	O
325	O
mg	O
1	O
-	O
2	O
tablets	O
p	O
.	O
o	O
.	O
q	O
.	O
4	O
-	O
6h	O
.	O
prn	O
.	O

follow	O
-	O
up	O
plans	O
:	O
follow	O
up	O
with	O
[	O
*	O
*	O
firstname	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
458	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
457	O
*	O
*	O
]	O
in	O
approximately	O
four	O
weeks	O
and	O
cardiologist	O
,	O
[	O
*	O
*	O
firstname	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
517	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
224	O
*	O
*	O
]	O
in	O
1	O
-	O
2	O
weeks	O
.	O

follow	O
up	O
[	O
*	O
*	O
firstname	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1623	O
*	O
*	O
]	O
in	O
1	O
-	O
2	O
weeks	O
.	O

visiting	O
nurses	O
will	O
also	O
follow	O
patient	O
as	O
an	O
outpatient	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
458	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
459	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
state	O
/	O
zipcode	O
460	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1624	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
15	O
*	O
*	O
]	O
11	O
:	O
16	O
:	O
09	O

t	O
:	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
15	O
*	O
*	O
]	O
11	O
:	O
38	O
:	O
46	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
1625	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
[	O
*	O
*	O
firstname	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
15	O
*	O
*	O
]	O
12	O
:	O
10	O
pm	O

(	O
end	O
of	O
report	O
)	O

13632	O
||||	O
20701	O
||||	O
17766	O
||||	O
discharge	O
_	O
summary	O
||||	O
2011	O
-	O
10	O
-	O
21	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
09	O
-	O
09	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
10	O
-	O
21	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1960	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
vascular	O

chief	O
complaint	O
:	O
abdominal	B
pain	I
.	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
a	O
51	O
year	O
old	O
man	O
who	O
was	O
recently	O
evaluated	O
by	O
his	O
primary	O
care	O
physician	O
for	O
complaints	O
of	O
atypical	O
left	O
upper	O
quadrant	O
abdominal	B
pain	I
.	O

a	O
ct	O
scan	O
was	O
obtained	O
which	O
detected	O
a	O
large	O
right	O
common	B
iliac	I
aneurysm	I
4	O
.	O
5	O
by	O
4	O
.	O
5	O
,	O
along	O
with	O
a	O
small	O
left	O
common	B
iliac	I
aneurysm	I
.	O

the	O
patient	O
had	O
a	O
cardiac	O
work	O
-	O
up	O
which	O
revealed	O
an	O
essentially	O
normal	O
echocardiogram	O
with	O
an	O
ejection	O
fraction	O
of	O
60	O
to	O
70%	O
along	O
with	O
no	O
ischemic	B
symptoms	O
by	O
exercise	O
tolerance	O
.	O

the	O
patient	O
underwent	O
an	O
arteriogram	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
08	O
-	O
11	O
*	O
*	O
]	O
which	O
demonstrated	O
a	O
right	O
pseudo	O
-	O
iliac	B
aneurysm	I
and	O
a	O
left	O
common	B
iliac	I
aneurysm	I
.	O

the	O
patient	O
now	O
is	O
admitted	O
electively	O
for	O
repair	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
hay	B
fever	I
.	O

2	O
.	O
no	O
previous	O
surgeries	O
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

medications	O
:	O
the	O
patient	O
is	O
not	O
on	O
any	O
medications	O
at	O
the	O
present	O
time	O
.	O

social	O
history	O
:	O
he	O
is	O
married	O
;	O
he	O
is	O
self	O
-	O
employed	O
as	O
a	O
tile	O
installer	O
.	O

he	O
lives	O
with	O
his	O
wife	O
.	O
[	O
*	O
*	O
name	O
(	O
ni	O
)	O
*	O
*	O
]	O
ambulates	O
independently	O
.	O

discharge	O
laboratory	O
:	O
pt	O
12	O
.	O
8	O
,	O
inr	O
1	O
.	O
1	O
,	O
ptt	O
32	O
.	O
7	O
.	O

cbc	O
with	O
white	O
blood	O
cell	O
count	O
of	O
9	O
.	O
9	O
,	O
hematocrit	O
31	O
.	O
0	O
,	O
platelets	O
745k	O
.	O

electrolytes	O
were	O
sodium	O
134	O
,	O
potassium	O
4	O
.	O
9	O
,	O
chloride	O
97	O
,	O
carbon	O
dioxide	O
24	O
,	O
bun	O
28	O
,	O
creatinine	O
0	O
.	O
7	O
,	O
glucose	O
103	O
,	O
calcium	O
8	O
.	O
5	O
,	O
phosphorus	O
5	O
.	O
7	O
,	O
magnesium	O
1	O
.	O
9	O
.	O

a	O
video	O
swallow	O
done	O
on	O
[	O
*	O
*	O
2011	O
-	O
06	O
-	O
17	O
*	O
*	O
]	O
,	O
demonstrated	O
decreased	B
bolus	I
control	I
with	O
premature	O
spillage	B
.	O

there	O
was	O
poor	B
epiglottic	I
dysflexion	I
throughout	O
the	O
entire	O
study	O
.	O

residue	O
remained	O
in	O
the	O
panniculi	O
with	O
nectar	O
liquids	O
and	O
there	O
was	O
trace	O
penetration	O
during	O
swallowing	O
of	O
nectar	O
liquids	O
.	O

with	O
thin	O
liquids	O
there	O
was	O
aspiration	B
;	O
the	O
patient	O
could	O
not	O
transfer	O
or	O
swallow	O
a	O
barium	O
tablet	O
.	O

bilateral	O
venous	O
studies	O
for	O
deep	B
vein	I
thrombosis	I
were	O
obtained	O
on	O
[	O
*	O
*	O
2011	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
,	O
which	O
showed	O
no	O
evidence	O
of	O
deep	B
vein	I
thrombosis	I
in	O
the	O
left	O
lower	O
extremity	O
from	O
the	O
inguinal	O
to	O
popliteal	O
region	O
as	O
well	O
as	O
the	O
right	O
common	O
femoral	O
vein	O
.	O

a	O
ct	O
scan	O
of	O
the	O
chest	O
attained	O
on	O
[	O
*	O
*	O
2011	O
-	O
09	O
-	O
14	O
*	O
*	O
]	O
for	O
persistent	B
fevers	I
demonstrated	O
heart	O
and	O
pericardium	O
were	O
unremarkable	O
.	O

anterior	O
mediastinum	O
was	O
clear	O
.	O

the	O
great	O
vessels	O
were	O
intact	O
.	O

there	O
was	O
no	O
significant	O
hilum	O
or	O
spinal	O
,	O
axillary	B
lymphadenopathy	I
.	O

there	O
are	O
bilateral	B
pleural	I
effusions	I
which	O
are	O
moderate	O
sized	O
.	O

there	O
is	O
bilateral	O
apical	O
patchy	O
infiltrates	B
seen	O
greater	O
on	O
the	O
right	O
than	O
on	O
the	O
left	O
.	O

there	O
is	O
a	O
left	O
subclavicular	O
and	O
jugular	O
line	O
in	O
the	O
inferior	O
aspect	O
of	O
the	O
superior	O
vena	O
cava	O
.	O

the	O
trachea	O
is	O
midline	O
with	O
an	O
et	O
in	O
place	O
and	O
a	O
nasogastric	O
tube	O
in	O
place	O
.	O

abdominal	O
ct	O
scan	O
:	O
the	O
liver	O
,	O
spleen	O
,	O
liver	O
and	O
pancreas	O
were	O
unremarkable	O
.	O

there	O
were	O
small	O
gallstones	B
in	O
the	O
dependent	O
portion	O
of	O
the	O
gallbladder	O
,	O
however	O
,	O
there	O
was	O
no	O
wall	B
thickening	I
or	O
pericholecystic	B
fluid	I
collection	I
.	O

the	O
left	O
kidney	O
showed	O
an	O
inferior	O
simple	O
cyst	O
.	O

there	O
was	O
free	B
fluid	I
in	O
the	O
abdomen	O
and	O
that	O
has	O
not	O
changed	O
significantly	O
in	O
amount	O
compared	O
to	O
previous	O
study	O
.	O

there	O
is	O
no	O
free	B
air	I
in	O
the	O
abdomen	O
.	O

ct	O
scan	O
of	O
the	O
pelvis	O
:	O
large	O
and	O
small	O
bowels	O
are	O
normal	O
caliber	O
and	O
course	O
.	O

fluid	O
throughout	O
the	O
pelvis	O
which	O
measures	O
approximately	O
16	O
hounds	O
filled	O
units	O
,	O
unchanged	O
from	O
previous	O
.	O

post	O
-	O
surgical	O
changes	O
were	O
seen	O
in	O
the	O
mesentery	O
on	O
the	O
left	O
side	O
.	O

the	O
infraradial	O
aorta	O
-	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
-	O
iliac	O
bypass	O
was	O
seen	O
with	O
a	O
small	O
amount	O
of	O
hematoma	B
around	O
the	O
graft	O
,	O
but	O
no	O
extravasation	B
,	O
but	O
there	O
is	O
a	O
peri	O
-	O
aortic	O
collection	B
which	O
has	O
expanded	O
since	O
the	O
previous	O
study	O
of	O
09	O
/	O
11	O
.	O

there	O
is	O
no	O
change	O
in	O
the	O
retroperitoneum	O
hematoma	B
on	O
the	O
left	O
.	O

preoperative	O
chest	O
x	O
-	O
ray	O
was	O
unremarkable	O
.	O

chest	O
x	O
-	O
ray	O
,	O
single	O
view	O
only	O
,	O
done	O
on	O
[	O
*	O
*	O
2011	O
-	O
10	O
-	O
08	O
*	O
*	O
]	O
,	O
did	O
demonstrate	O
low	B
lung	I
volumes	I
with	O
subsequent	O
atelectasis	B
in	O
the	O
left	O
lower	O
zones	O
.	O

no	O
evidence	O
of	O
pulmonary	B
edema	I
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
to	O
the	O

preoperative	O
holding	O
area	O
on	O
[	O
*	O
*	O
2011	O
-	O
09	O
-	O
09	O
*	O
*	O
]	O
.	O

he	O
underwent	O
bilateral	O
iliac	B
aneurysm	I
repair	O
with	O
an	O
aorta	O
-	O
bifemoral	O
bypass	O
.	O

interoperatively	O
,	O
the	O
iliac	O
vein	O
was	O
injured	O
with	O
repair	O
.	O

the	O
patient	O
had	O
open	O
bedside	O
laparotomy	O
on	O
[	O
*	O
*	O
09	O
-	O
09	O
*	O
*	O
]	O
,	O
later	O
that	O
day	O
and	O
returned	O
to	O
the	O
operating	O
room	O
for	O
intra	O
-	O
abdominal	O
sepsis	B
and	O
bleeding	B
of	O
the	O
iliac	O
vein	O
.	O

the	O
patient	O
remained	O
in	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
189	O
*	O
*	O
]	O
intubated	O
during	O
this	O
time	O
.	O

on	O
[	O
*	O
*	O
09	O
-	O
18	O
*	O
*	O
]	O
,	O
the	O
patient	O
had	O
bilateral	O
chest	O
tubes	O
placed	O
secondary	O
to	O
moderate	O
pleural	B
effusions	I
bilaterally	I
and	O
underwent	O
an	O
exploratory	O
laparotomy	O
which	O
was	O
unremarkable	O
.	O

on	O
[	O
*	O
*	O
09	O
-	O
23	O
*	O
*	O
]	O
,	O
he	O
underwent	O
abdominal	O
washout	O
with	O
fascial	O
partial	O
closure	O
and	O
then	O
returned	O
to	O
the	O
operating	O
room	O
on	O
[	O
*	O
*	O
09	O
-	O
26	O
*	O
*	O
]	O
for	O
exploratory	O
laparotomy	O
,	O
abdominal	O
washout	O
and	O
repair	O
of	O
a	O
serosal	B
small	I
bowel	I
tear	I
and	O
fascial	O
closing	O
with	O
silastic	O
.	O

during	O
his	O
hospitalization	O
,	O
he	O
required	O
total	O
parenteral	O
nutrition	O
and	O
nasogastric	O
tube	O
feeds	O
secondary	O
to	O
aspiration	B
.	O

he	O
was	O
initially	O
evaluated	O
by	O
speech	O
therapy	O
on	O
[	O
*	O
*	O
10	O
-	O
06	O
*	O
*	O
]	O
,	O
and	O
then	O
a	O
repeat	O
video	O
swallow	O
was	O
done	O
on	O
[	O
*	O
*	O
10	O
-	O
17	O
*	O
*	O
]	O
,	O
which	O
continued	O
to	O
show	O
aspiration	B
with	O
thin	O
liquids	O
.	O

recommendations	O
were	O
soft	O
solid	O
ground	O
foods	O
and	O
thickened	O
liquids	O
.	O

the	O
patient	O
underwent	O
,	O
on	O
[	O
*	O
*	O
10	O
-	O
07	O
*	O
*	O
]	O
,	O
a	O
venogram	O
with	O
ivc	O
filter	O
placement	O
.	O

he	O
was	O
begun	O
on	O
anti	O
-	O
coagulation	O
.	O

a	O
repeat	O
mrv	O
was	O
recommended	O
which	O
the	O
patient	O
refused	O
to	O
have	O
done	O
.	O

the	O
remaining	O
hospital	O
course	O
was	O
unremarkable	O
.	O

the	O
patient	O
was	O
discharged	O
to	O
rehabilitation	O
in	O
stable	O
condition	O
.	O

discharge	O
instructions	O
:	O

1	O
.	O
he	O
is	O
to	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1723	O
*	O
*	O
]	O
in	O
one	O
weeks	O
time	O
.	O

2	O
.	O
coumadin	O
2	O
.	O
5	O
mg	O
q	O
.	O
day	O
.	O

this	O
should	O
be	O
adjusted	O
for	O
a	O
goal	O
inr	O
of	O
2	O
.	O
0	O
to	O
2	O
.	O
5	O
.	O

3	O
.	O
his	O
diet	O
will	O
be	O
regular	O
soft	O
solids	O
with	O
thickened	O
liquids	O
.	O

his	O
tube	O
feeds	O
were	O
discontinued	O
on	O
[	O
*	O
*	O
2011	O
-	O
10	O
-	O
19	O
*	O
*	O
]	O
by	O
the	O
patient	O
.	O

4	O
.	O
the	O
patient	O
should	O
have	O
inr	O
drawn	O
on	O
saturday	O
and	O
this	O
should	O
be	O
called	O
to	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2614	O
*	O
*	O
]	O
office	O
at	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
2391	O
*	O
*	O
]	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
tomoxiprole	O
40	O
mg	O
subcutaneously	O
q	O
.	O

12	O
hours	O
.	O

2	O
.	O
protonix	O
40	O
mg	O
q	O
.	O
day	O
.	O

3	O
.	O
reglan	O
10	O
mg	O
a	O
.	O
c	O
.	O
and	O
h	O
.	O
s	O
.	O

4	O
.	O
lopressor	O
50	O
mg	O
three	O
times	O
a	O
day	O
;	O
hold	O
for	O
systolic	O
blood	O
pressure	O
less	O
than	O
100	O
and	O
heart	O
rate	O
less	O
than	O
60	O
.	O

5	O
.	O
dazolicine	O
60	O
mg	O
four	O
times	O
a	O
day	O
,	O
hold	O
for	O
heart	O
rate	O
less	O
than	O
60	O
,	O
systolic	O
blood	O
pressure	O
less	O
than	O
115	O
.	O

6	O
.	O
enalapril	O
5	O
mg	O
q	O
.	O
day	O
.	O

7	O
.	O
miconazole	O
powder	O
to	O
affected	O
areas	O
four	O
times	O
a	O
day	O
and	O
p	O
.	O
r	O
.	O
n	O
.	O

8	O
.	O
artificial	O
tears	O
one	O
to	O
two	O
drops	O
o	O
.	O
u	O
.	O
p	O
.	O
r	O
.	O
n	O
.	O

9	O
.	O
albuterol	O
multi	O
-	O
dose	O
inhalers	O
,	O
puffs	O
four	O
to	O
eight	O
p	O
.	O
r	O
.	O
n	O
.	O

10	O
.	O

insulin	O
sliding	O
scale	O
,	O
discontinued	O
.	O

11	O
.	O

lorazepam	O
intravenous	O
q	O
.	O
h	O
.	O
s	O
.	O
p	O
.	O
r	O
.	O
n	O
.	O
;	O
if	O
discharged	O
to	O
home	O
this	O
will	O
be	O
discontinued	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
bilateral	O
iliac	B
aneurysm	I
status	O
post	O
aorta	O
-	O
bifemoral	O
graft	O
with	O
right	O
iliac	B
vein	I
injury	I
status	O
post	O
repair	O
.	O

2	O
.	O
status	O
post	O
open	O
laparotomy	O
times	O
three	O
.	O

3	O
.	O
bilateral	B
pleural	I
effusions	I
,	O
status	O
post	O
chest	O
tubes	O
.	O

4	O
.	O
aspiration	B
status	O
post	O
video	O
swallow	O
.	O

5	O
.	O
questionable	O
iliac	O
thrombus	B
status	O
post	O
ivc	O
filter	O
placement	O
.	O

6	O
.	O
blood	B
loss	I
anemia	I
,	O
corrected	O
.	O

7	O
.	O
hypertension	B
,	O
stable	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
640	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
1836	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
3612	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2011	O
-	O
10	O
-	O
21	O
*	O
*	O
]	O
14	O
:	O
12	O

t	O
:	O
[	O
*	O
*	O
2011	O
-	O
10	O
-	O
21	O
*	O
*	O
]	O
16	O
:	O
52	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
5216	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
640	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2011	O
-	O
10	O
-	O
28	O
*	O
*	O
]	O
12	O
:	O
18	O
pm	O

(	O
end	O
of	O
report	O
)	O

9354	O
||||	O
20706	O
||||	O
18989	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
01	O
-	O
11	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
01	O
-	O
04	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
01	O
-	O
11	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1973	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
transplant	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
a	O
41	O
year	O
-	O
old	O
female	O
with	O
a	O
thirty	O
year	O
history	O
of	O
insulin	B
dependent	I
diabetes	I
mellitus	I
complicated	O
with	O
retinopathy	B
,	O
neuropathy	B
and	O
nephropathy	B
.	O

also	O
a	O
history	O
of	O
esrd	B
status	O
post	O
living	O
related	O
kidney	O
transplant	O
who	O
now	O
presents	O
for	O
elective	O
pancrease	O
after	O
kidney	O
transplant	O
.	O

past	O
medical	O
history	O
:	O
hypertension	B
.	O

past	O
surgical	O
history	O
:	O
status	O
post	O
kidney	O
transplant	O
[	O
*	O
*	O
2014	O
-	O
08	O
-	O
20	O
*	O
*	O
]	O
.	O

status	O
post	O
thyroidectomy	O
1988	O
for	O
questionable	O
papillary	B
cancer	I
.	O

status	O
post	O
hand	O
surgery	O
.	O

status	O
post	O
retinal	O
laser	O
treatment	O
.	O

allergies	O
:	O
the	O
patient	O
has	O
no	O
known	O
drug	O
allergies	O
.	O

medications	O
on	O
admission	O
:	O
prograf	O
3	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
imuran	O
50	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
lipitor	O
10	O
mg	O
po	O
q	O
.	O
h	O
.	O
s	O
.	O
,	O
vasotec	O
10	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O

insulin	O
,	O
synthroid	O
.	O
175	O
mg	O
po	O
q	O
.	O
d	O
.	O

initial	O
physical	O
examination	O
:	O
well	O
appearing	O
female	O
in	O
no	O
acute	B
distress	I
.	O

her	O
chest	O
was	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

heart	O
regular	O
rate	O
and	O
rhythm	O
.	O

adomen	O
was	O
soft	O
.	O

right	O
lower	O
quadrant	O
contained	O
a	O
kidney	O
incision	O
.	O

no	O
graft	O
tenderness	B
.	O

she	O
had	O
2	O
+	O
femoral	O
pulses	O
bilaterally	O
.	O

initial	O
laboratories	O
:	O
white	O
blood	O
cell	O
count	O
9	O
.	O
8	O
,	O
hematocrit	O
28	O
.	O
9	O
,	O
platelets	O
324	O
.	O

urinalysis	O
was	O
negative	O
.	O

coags	O
were	O
normal	O
.	O

chem	O
7	O
132	O
,	O
6	O
.	O
2	O
,	O
100	O
,	O
21	O
,	O
28	O
,	O
1	O
.	O
3	O
,	O
493	O
,	O
hemoglobin	O

a1c	O
was	O
7	O
.	O
9	O
,	O
sk	O
level	O
was	O
7	O
.	O
1	O
.	O

liver	O
function	O
tests	O
were	O
normal	O
.	O

beta	O
hcg	O
was	O
negative	O
.	O

electrocardiogram	O
showed	O
normal	O
sinus	O
rhythm	O
with	O
a	O
rate	O
of	O
91	O
.	O

chest	O
x	O
-	O
ray	O
was	O
negative	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
where	O
a	O
preoperative	O
workup	O
was	O
instituted	O
.	O

on	O
hospital	O
day	O
one	O
[	O
*	O
*	O
01	O
-	O
04	O
*	O
*	O
]	O
,	O
she	O
was	O
taken	O
to	O
the	O
operating	O
room	O
where	O
she	O
underwent	O
a	O
cadaveric	O
pancrease	O
transplant	O
of	O
an	O
enteric	O
drained	O
whole	O
organ	O
pancrease	O
to	O
the	O
left	O
iliac	O
artery	O
and	O
vein	O
.	O

the	O
patient	O
tolerated	O
the	O
procedure	O
well	O
.	O

there	O
were	O
no	O
complications	B
and	O
she	O
was	O
transferred	O
to	O
the	O
recovery	O
room	O
in	O
stable	O
condition	O
.	O

she	O
was	O
taken	O
to	O
the	O
intensive	O
care	O

unit	O
,	O
extubated	O
with	O
an	O
nasogastric	O
tube	O
in	O
place	O
.	O

initial	O
amylase	O
and	O
lipase	O
were	O
104	O
and	O
524	O
in	O
the	O
immediate	O
postoperative	O
period	O
.	O

her	O
hematocrit	O
was	O
28	O
.	O
9	O
immediately	O
postop	O
.	O

she	O
received	O
thyroglobulin	O
on	O
solu	O
-	O
medrol	O
intraoperatively	O
.	O

postoperatively	O
,	O
she	O
was	O
placed	O
on	O
48	O
hours	O
of	O
unasyn	O
,	O
fluconazole	O
and	O
a	O
solu	O
-	O
medrol	O
taper	O
.	O

her	O
thyroglobulin	O
was	O
continued	O
for	O
there	O
days	O
postoperative	O
and	O
then	O
she	O
was	O
started	O
on	O
prograf	O
and	O
rapamune	O
.	O

she	O
did	O
well	O
and	O
postoperatively	O
her	O
jp	O
drain	O
was	O
discontinued	O
on	O
postoperative	O
day	O
number	O
three	O
.	O

her	O
nasogastric	O
tube	O
was	O
also	O
discontinued	O
on	O
postoperative	O
day	O
number	O
three	O
.	O

the	O
patient	O
was	O
kept	O
npo	O
until	O
she	O
passed	B
flatus	I
.	O

she	O
was	O
started	O
on	O
a	O
diet	O
as	O
tolerated	O
.	O

postoperative	O
day	O
number	O
six	O
her	O
diet	O
was	O
advanced	O
without	O
incident	O
and	O
she	O
was	O
able	O
to	O
go	O
home	O
tolerating	O
a	O
full	O
regular	O
diet	O
.	O

she	O
remained	O
hemodynamically	O
stable	O
throughout	O
her	O
hospital	O
course	O
and	O
she	O
also	O
remained	O
afebrile	B
throughout	O
her	O
hospital	O
course	O
with	O
no	O
temperature	B
spikes	I
.	O

her	O
amylase	O
and	O
lipase	O
continued	O
to	O
come	O
down	O
from	O
postoperative	O
and	O
were	O
21	O
and	O
23	O
respectively	O
on	O
discharge	O
.	O

she	O
was	O
placed	O
on	O
ganciclovir	O
due	O
to	O
her	O
cmv	B
negative	O
status	O
with	O
a	O
cmv	B
positive	I
donor	O
.	O

her	O
sk	O
level	O
on	O
discharge	O
was	O
12	O
.	O
4	O
on	O
3	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O

at	O
the	O
time	O
of	O
discharge	O
the	O
patient	O
was	O
ambulating	O
independently	O
and	O
tolerating	O
a	O
regular	O
diet	O
,	O
afebrile	B
and	O
was	O
hemodynamically	O
stable	O
.	O

of	O
note	O
her	O
white	O
blood	O
cell	O
count	O
had	O
dropped	O
to	O
a	O
low	O
of	O
2	O
.	O
0	O
and	O
was	O
4	O
on	O
discharge	O
with	O
a	O
hematocrit	O
of	O
23	O
,	O
platelet	O
count	O
of	O
172	O
.	O

the	O
patient	O
was	O
also	O
postoperatively	O
placed	O
on	O
a	O
heparin	O
drip	O
at	O
300	O
units	O
per	O
hour	O
.	O

this	O
was	O
changed	O
to	O
po	O
aspirin	O
81	O
mg	O
po	O
q	O
.	O
d	O
.	O

condition	O
at	O
discharge	O
:	O
the	O
patient	O
stable	O
as	O
above	O
.	O

discharge	O
status	O
:	O
the	O
patient	O
is	O
discharged	O
to	O
home	O
.	O

follow	O
up	O
instructions	O
:	O
the	O
patient	O
is	O
to	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
5510	O
*	O
*	O
]	O
this	O
thursday	O
.	O

she	O
is	O
to	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2236	O
*	O
*	O
]	O
as	O
well	O
to	O
have	O
laboratories	O
drawn	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
status	O
post	O
pancrease	O
after	O
kidney	O
transplant	O
was	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
antigen	O
match	O
.	O

2	O
.	O
status	O
post	O
living	O
related	O
kidney	O
transplant	O
.	O

3	O
.	O
history	O
of	O
hypertension	B
.	O

4	O
.	O
history	O
of	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
papillary	B
cancer	I
of	O
the	O
thyroid	O
.	O

medications	O
on	O
discharge	O
:	O
dilaudid	O
2	O
to	O
4	O
mg	O
po	O
q	O
3	O
hours	O
prn	O
.	O

prednisone	O
20	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
zantac	O
150	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O

rapamune	O
5	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
prograf	O
3	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
vasotec	O
10	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
aspirin	O
81	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
bactrim	O
single	O
strength	O
one	O
po	O
q	O
.	O
d	O
.	O
,	O
nystatin	O
swish	O
and	O
swallow	O
,	O
synthroid	O
.	O
175	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
ganciclovir	O
1000	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
lipitor	O
10	O
mg	O
po	O
q	O
.	O
d	O
.	O

[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
,	O
md	O
[	O
*	O
*	O
md	O
number	O
5511	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
6611	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2015	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
08	O
:	O
09	O

t	O
:	O
[	O
*	O
*	O
2015	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
08	O
:	O
31	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
7014	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
197	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2015	O
-	O
01	O
-	O
26	O
*	O
*	O
]	O
7	O
:	O
41	O
pm	O

(	O
end	O
of	O
report	O
)	O

101632	O
||||	O
21115	O
||||	O
27449	O
||||	O
echo	O
_	O
report	O
||||	O
2018	O
-	O
06	O
-	O
08	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
hypertrophic	B
cardiomyopathy	I
.	O

left	B
ventricular	I
function	I
.	O

height	O
:	O
(	O
in	O
)	O
72	O

weight	O
(	O
lb	O
)	O
:	O
180	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
04	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
105	O
/	O
61	O

hr	O
(	O
bpm	O
)	O
:	O
113	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
08	O
*	O
*	O
]	O
at	O
13	O
:	O
43	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

this	O
study	O
was	O
compared	O
to	O
the	O
prior	O
study	O
of	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O
.	O

left	O
atrium	O
:	O
moderate	O
la	B
enlargement	I
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
mildly	O
dilated	B
ra	I
.	O

a	O
catheter	O
or	O
pacing	O
wire	O
is	O
seen	O
in	O
the	O
ra	O
and	O
extending	O
into	O
the	O
rv	O
.	O

dilated	B
ivc	O
(	O
>2	O
,	O
5cm	O
)	O
with	O
<50%	O
decrease	O
during	O
respiration	O
(	O
estimated	O
rap	O
16	O
-	O
20	O
mmhg	O
)	O
.	O

left	O
ventricle	O
:	O
severe	O
symmetric	O
lvh	B
.	O

severely	O
depressed	B
lvef	I
.	O

[	O
intrinsic	O
lv	O
systolic	O
function	O
likely	O
depressed	O
given	O
the	O
severity	O
of	O
valvular	B
regurgitation	I
.	O
]	O

no	O
resting	B
lvot	I
gradient	I
.	O

right	O
ventricle	O
:	O
rv	B
hypertrophy	I
.	O

dilated	B
rv	I
cavity	O
.	O

severe	O
global	O
rv	O
free	O
wall	O
hypokinesis	B
.	O

[	O
intrinsic	O
rv	O
systolic	O
function	O
likely	O
more	O
depressed	O
given	O
the	O
severity	O
of	O
tr	B
]	O
.	O

aorta	O
:	O
normal	O
aortic	O
diameter	O
at	O
the	O
sinus	O
level	O
.	O

normal	O
ascending	O
aorta	O
diameter	O
.	O

aortic	O
valve	O
:	O
mildly	O
thickened	B
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

moderate	O
(	O
2	O
+	O
)	O
mr	B
.	O

lv	O
inflow	O
pattern	O
c	O
/	O
w	O
restrictive	B
filling	I
abnormality	I
,	O
with	O
elevated	B
la	I
pressure	I
.	O

tricuspid	O
valve	O
:	O
moderate	O
[	O
2	O
+	O
]	O
tr	B
.	O

moderate	O
pa	O
systolic	B
hypertension	I
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
pulmonic	O
valve	O
not	O
well	O
seen	O
.	O

pericardium	O
:	O
trivial	O
/	O
physiologic	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

the	O
estimated	O
right	O
atrial	O
pressure	O
is	O
16	O
-	O
20	O
mmhg	O
.	O

there	O
is	O
severe	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
severely	O
depressed	O
.	O

[	O
intrinsic	O
left	O
ventricular	O
systolic	O
function	O
is	O
likely	O
more	O
depressed	O
given	O
the	O
severity	O
of	O
valvular	B
regurgitation	I
.	O
]	O

the	O
right	O
ventricular	O
free	O
wall	O
is	O
hypertrophied	O
.	O

the	O
right	O
ventricular	O
cavity	O
is	O
dilated	O
.	O

there	O
is	O
severe	O
global	O
right	O
ventricular	O
free	O
wall	O
hypokinesis	B
.	O

[	O
intrinsic	O
right	O
ventricular	O
systolic	O
function	O
is	O
likely	O
more	O
depressed	O
given	O
the	O
severity	O
of	O
tricuspid	B
regurgitation	I
.	O
]	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

no	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

moderate	O
(	O
2	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
left	O
ventricular	O
inflow	O
pattern	O
suggests	O
a	O
restrictive	B
filling	I
abnormality	I
,	O
with	O
elevated	B
left	I
atrial	I
pressure	I
.	O

moderate	O
[	O
2	O
+	O
]	O
tricuspid	B
regurgitation	I
is	O
seen	O
.	O

there	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

there	O
is	O
a	O
trivial	O
/	O
physiologic	O
pericardial	B
effusion	I
.	O

compared	O
with	O
the	O
prior	O
study	O
(	O
images	O
reviewed	O
)	O
of	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O
,	O
left	O
ventricular	O
systolic	O
function	O
appears	O
more	O
depressed	O
.	O

18707	O
||||	O
21312	O
||||	O
4802	O
||||	O
discharge	O
_	O
summary	O
||||	O
2010	O
-	O
11	O
-	O
21	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
17	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
21	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1936	O
-	O
06	O
-	O
25	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
medicine	O

history	O
of	O
the	O
present	O
illness	O
:	O
this	O
is	O
a	O
74	O
-	O
year	O
-	O
old	O
female	O
with	O
a	O
past	O
medical	O
history	O
of	O
hypertension	B
,	O
diabetes	B
mellitus	I
,	O
and	O
st	O
.	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
3191	O
*	O
*	O
]	O
aortic	O
valve	O
replacement	O
,	O
who	O
was	O
transferred	O
to	O
the	O
[	O
*	O
*	O
hospital1	O
225	O
*	O
*	O
]	O
intensive	O
care	O
unit	O
from	O
the	O
[	O
*	O
*	O
hospital	O
2076	O
*	O
*	O
]	O
after	O
a	O
large	O
black	B
stool	I
in	O
the	O
setting	O
of	O
abdominal	B
pain	I
.	O

the	O
patient	O
was	O
found	O
to	O
be	O
hypotensive	B
to	O
82	O
/	O
50	O
with	O
an	O
inr	O
of	O
3	O
.	O
5	O
.	O

the	O
blood	B
pressure	I
initially	O
improved	O
with	O
fluids	O
in	O
the	O
emergency	O
department	O
.	O

a	O
nasogastric	O
lavage	O
was	O
performed	O
which	O
demonstrated	O
coffee	B
ground	I
emesis	I
.	O

the	O
hematocrit	B
decreased	I
to	O
28	O
.	O
1	O
from	O
32	O
at	O
baseline	O
.	O

the	O
patient	O
received	O
high	O
-	O
dose	O
proton	O
pump	O
inhibitors	O
,	O
two	O
packed	O
red	O
blood	O
cell	O
transfusions	O
,	O
and	O
4	O
units	O
of	O
fresh	O
frozen	O
plasma	O
.	O

the	O
patient	O
then	O
had	O
an	O
endoscopy	O
in	O
the	O
intensive	O
care	O
unit	O
which	O
showed	O
two	O
esophageal	B
ulcers	I
without	O
active	O
bleeding	B
.	O

the	O
patient	O
was	O
hemodynamically	O
stable	O
for	O
over	O
24	O
hours	O
and	O
then	O
was	O
transferred	O
to	O
the	O
medical	O
floor	O
for	O
further	O
observation	O
.	O

the	O
patient	O
had	O
no	O
further	O
episodes	O
of	O
bleeding	B
while	O
in	O
the	O
hospital	O
.	O

the	O
patient	O
was	O
noted	O
to	O
have	O
a	O
urinary	B
tract	I
infection	I
while	O
in	O
the	O
intensive	O
care	O
unit	O
and	O
was	O
started	O
on	O
levaquin	O
on	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
18	O
*	O
*	O
]	O
.	O

on	O
transfer	O
to	O
the	O
floor	O
,	O
the	O
patient	O
was	O
without	O
complaints	B
.	O

she	O
denied	O
pain	B
.	O

the	O
patient	O
reported	O
that	O
her	O
breathing	O
was	O
comfortable	O
.	O

the	O
patient	O
had	O
no	O
chest	B
pain	I
.	O

no	O
pain	B
with	I
urination	I
.	O

the	O
patient	O
complained	O
of	O
hunger	B
and	O
demonstrated	O
good	O
appetite	O
when	O
served	O
her	O
dinner	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
avr	O
,	O
on	O
coumadin	O
.	O

2	O
.	O
depression	B
.	O

3	O
.	O
hypertension	B
.	O

4	O
.	O
diabetes	B
mellitus	I
.	O

5	O
.	O
aphasia	B
.	O

6	O
.	O
hypercholesterolemia	B
.	O

7	O
.	O
history	O
of	O
cva	B
in	O
[	O
*	O
*	O
1951	O
*	O
*	O
]	O
.	O

8	O
.	O
decubitus	B
ulcer	I
with	O
right	O
heel	O
osteomyelitis	B
.	O

9	O
.	O
diastolic	B
dysfunction	I
.	O

10	O
.	O

dementia	B
.	O

11	O
.	O

gallstones	B
.	O

12	O
.	O

spinal	B
stenosis	I
.	O

13	O
.	O

history	O
of	O
vre	O
urinary	B
infection	I
.	O

14	O
.	O

history	O
of	O
c	B
.	I
difficile	I
.	O

15	O
.	O

history	O
of	O
pulmonary	B
sarcoidosis	I
.	O

16	O
.	O

peripheral	B
vascular	I
disease	I
.	O

17	O
.	O

history	O
of	O
coronary	B
artery	I
disease	I
.	O

physical	O
examination	O
on	O
admission	O
:	O
vital	O
signs	O
:	O
the	O
patient	O
was	O
afebrile	B
,	O
heart	O
rate	O
tachycardiac	B
,	O
blood	O
pressure	O
hypotensive	B
to	O
82	O
/	O
50	O
,	O
respiratory	O
rate	O
tachypneic	B
.	O

the	O
patient	O
was	O
saturating	O
90%	O
on	O
several	O
liters	O
of	O
oxygen	O
.	O

general	O
:	O
the	O
patient	O
was	O
a	O
pleasant	O
overweight	B
female	O
.	O

the	O
pupils	O
were	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

her	O
heart	O
rate	O
was	O
tachycardiac	B
with	O
a	O
prominent	O
a2	O
from	O
st	O
.	O

jude's	O
valve	O
.	O

the	O
patient	O
demonstrated	O
good	O
air	O
movement	O
in	O
her	O
lungs	O
bilaterally	O
.	O

there	O
were	O
faint	O
crackles	B
at	O
the	O
bases	O
bilaterally	O
.	O

the	O
abdomen	O
was	O
large	O
with	O
active	O
bowel	O
sounds	O
,	O
nontender	O
,	O
nondistended	O
,	O
no	O
palpable	O
masses	B
,	O
no	O
hepatosplenomegaly	B
noted	O
.	O

extremities	O
:	O
thin	B
.	O

her	O
right	O
foot	O
is	O
in	O
a	O
brace	O
.	O

the	O
patient	O
had	O
a	O
right	O
leg	B
ulcer	I
on	O
the	O
posterior	O
distal	O
calf	O
proximal	O
to	O
the	O
ankle	O
.	O

it	O
was	O
open	O
,	O
discharge	O
on	O
dry	O
gauze	O
,	O
somewhat	O
bloody	O
in	O
appearance	O
.	O

laboratory	O
/	O
radiologic	O
data	O
:	O
the	O
patient's	O
hematocrit	O
was	O
noted	O
to	O
be	O
28	O
.	O
1	O
down	O
from	O
baseline	O
of	O
32	O
,	O
white	O
blood	O
cell	O
count	O
14	O
.	O
3	O
,	O
platelet	O
count	O
236	O
,	O
000	O
.	O

inr	O
3	O
.	O
5	O
on	O
admission	O
which	O
quickly	O
reversed	O
to	O
2	O
.	O
0	O
with	O
vitamin	O
k	O
.	O

sodium	O
140	O
,	O
potassium	O
initially	O
noted	O
to	O
be	O
5	O
.	O
9	O
which	O
is	O
hemolyzed	O
and	O
was	O
4	O
.	O
5	O
on	O
redraw	O
.	O

chloride	O
107	O
,	O
bicarbonate	O
23	O
,	O
bun	O
103	O
,	O
creatinine	O
1	O
.	O
5	O
,	O
blood	O
glucose	O
212	O
.	O

chest	O
x	O
-	O
ray	O
on	O
admission	O
showed	O
heart	O
and	O
mediastinal	O
contours	O
which	O
were	O
unremarkable	O
.	O

there	O
was	O
a	O
slight	O
elevation	O
of	O
the	O
right	O
hemidiaphragm	O
.	O

there	O
were	O
no	O
infiltrates	B
and	O
no	O
evidence	O
of	O
congestive	B
heart	I
failure	I
.	O

the	O
patient	O
was	O
status	O
post	O
a	O
median	O
sternotomy	O
.	O

hospital	O
course	O
:	O
1	O
.	O
upper	B
gastrointestinal	I
bleed	I
:	O
the	O
patient	O
underwent	O
an	O
endoscopy	O
in	O
the	O
intensive	O
care	O
unit	O
setting	O
which	O
documented	O
2	O
mm	O
ulcers	B
in	O
the	O
lower	O
one	O
-	O
third	O
of	O
the	O
esophagus	O
,	O
one	O
with	O
adherent	O
clot	B
.	O

there	O
was	O
no	O
evidence	O
of	O
oozing	B
.	O

there	O
was	O
some	O
evidence	O
of	O
gastritis	B
in	O
the	O
gastric	O
fundus	O
.	O

there	O
was	O
a	O
normal	O
duodenum	O
.	O

the	O
patient	O
was	O
started	O
on	O
pantoprazole	O
40	O
mg	O
iv	O
b	O
.	O
i	O
.	O
d	O
.	O
and	O
was	O
followed	O
with	O
serial	O
hematocrits	O
for	O
further	O
episodes	O
of	O
bleeding	B
which	O
were	O
not	O
noted	O
during	O
the	O
hospital	O
course	O
.	O

the	O
patient	O
received	O
2	O
units	O
of	O
blood	O
to	O
increase	O
her	O
hematocrit	O
back	O
into	O
the	O
mid	O
30s	O
.	O

on	O
transfer	O
to	O
the	O
floor	O
,	O
the	O
hematocrit	O
was	O
stable	O
at	O
34	O
.	O
3	O
.	O

2	O
.	O
urinary	B
tract	I
infection	I
:	O
the	O
patient	O
was	O
noted	O
to	O
have	O
a	O
urinary	B
tract	I
infection	I
in	O
the	O
intensive	O
care	O
unit	O
.	O

urine	O
culture	O
grew	O
out	O
greater	O
than	O
100	O
,	O
000	O
klebsiella	O
which	O
was	O
sensitive	O
to	O
levofloxacin	O
.	O

the	O
patient	O
was	O
started	O
on	O

levofloxacin	O
for	O
a	O
five	O
day	O
course	O
.	O

3	O
.	O
hypertension	B
:	O
the	O
patient	O
has	O
a	O
history	O
of	O
hypertension	B
.	O

initially	O
on	O
presentation	O
the	O
patient	O
was	O
found	O
to	O
be	O
somewhat	O
hypotensive	B
;	O
however	O
,	O
she	O
rapidly	O
responded	O
to	O
fluid	O
boluses	O
in	O
the	O
emergency	O
department	O
.	O

the	O
patient's	O
blood	O
pressure	O
medications	O
were	O
held	O
until	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
medical	O
floor	O
on	O
hospital	O
day	O
number	O
three	O
.	O

the	O
patient	O
was	O
restarted	O
on	O
atenolol	O
50	O
mg	O
q	O
.	O
d	O
.	O
and	O
lisinopril	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O
with	O
holding	O
parameters	O
for	O
blood	O
pressure	O
less	O
than	O
110	O
.	O

the	O
patient's	O
blood	O
pressure	O
remained	O
stable	O
throughout	O
the	O
remainder	O
of	O
her	O
hospital	O
course	O
.	O

4	O
.	O
history	O
of	O
gallstones	B
:	O
the	O
patient	O
was	O
continued	O
on	O
her	O
ursodiol	O
throughout	O
the	O
hospital	O
stay	O
.	O

5	O
.	O
depression	B
:	O
the	O
patient	O
had	O
a	O
history	O
of	O
depression	B
for	O
which	O
she	O
was	O
kept	O
on	O
fluoxetine	O
during	O
the	O
hospital	O
course	O
.	O

6	O
.	O
history	O
of	O
diabetes	B
mellitus	I
:	O
her	O
last	O
hemoglobin	O
a1c	O
was	O
6	O
.	O
7	O
in	O
[	O
*	O
*	O
2010	O
-	O
10	O
-	O
04	O
*	O
*	O
]	O
.	O

the	O
patient	O
was	O
on	O
an	O
insulin	O
sliding	O
scale	O
during	O
the	O
hospital	O
stay	O
as	O
well	O
as	O
placed	O
on	O
a	O
diabetic	B
diet	O
.	O

7	O
.	O
history	O
of	O
right	O
chronic	O
decubitus	B
foot	I
ulcer	I
:	O
the	O
patient	O
has	O
a	O
recent	O
history	O
of	O
right	O
heel	O
osteomyelitis	B
and	O
is	O
status	O
post	O
a	O
six	O
week	O
course	O
of	O
antibiotics	O
.	O

during	O
the	O
hospital	O
stay	O
,	O
the	O
right	O
foot	B
ulcer	I
had	O
b	O
.	O
i	O
.	O
d	O
.	O
wet	O
-	O
to	O
-	O
dry	O
sterile	O
dressing	O
changes	O
.	O

the	O
patient's	O
heel	B
ulcer	I
did	O
demonstrate	O
minimal	O
discharge	O
onto	O
the	O
gauze	O
dressing	O
.	O

podiatry	O
consult	O
was	O
discussed	O
while	O
the	O
patient	O
was	O
an	O
inpatient	O
;	O
however	O
,	O
[	O
*	O
*	O
hospital	O
3474	O
*	O
*	O
]	O
has	O
a	O
podiatrist	O
on	O
staff	O
and	O
it	O
was	O
felt	O
that	O
this	O
issue	O
was	O
not	O
an	O
acute	O
issue	O
and	O
could	O
be	O
followed	O
-	O
up	O
at	O
[	O
*	O
*	O
hospital	O
3474	O
*	O
*	O
]	O
on	O
discharge	O
.	O

condition	O
on	O
discharge	O
:	O
stable	O
.	O

discharge	O
status	O
:	O
to	O
[	O
*	O
*	O
hospital	O
3474	O
*	O
*	O
]	O
facility	O
.	O

discharge	O
diagnosis	O
:	O

1	O
.	O
upper	B
gastrointestinal	I
bleed	I
.	O

2	O
.	O
esophageal	B
ulcers	I
.	O

3	O
.	O
urinary	B
tract	I
infection	I
.	O

discharge	O
medications	O
:	O

1	O
.	O
multivitamin	O
one	O
cap	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

2	O
.	O
fluoxetine	O
20	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

3	O
.	O
risperidone	O
1	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

4	O
.	O
atorvostatin	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

5	O
.	O
ursodiol	O
600	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

6	O
.	O
insulin	O
sliding	O
scale	O
.	O

7	O
.	O
pantoprazole	O
40	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

8	O
.	O
levofloxacin	O
250	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O
times	O
two	O
days	O
,	O
last	O
dose	O
to	O
be	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
22	O
*	O
*	O
]	O
.	O

9	O
.	O
atenolol	O
50	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

10	O
.	O

lisinopril	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

follow	O
-	O
up	O
plans	O
:	O
the	O
patient	O
will	O
be	O
discharged	O
to	O
[	O
*	O
*	O
hospital	O
2076	O
*	O
*	O
]	O
for	O
follow	O
-	O
up	O
care	O
at	O
their	O
tcu	O
.	O

the	O
patient	O
will	O
return	O
for	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
7268	O
*	O
*	O
]	O
for	O
repeat	O
endoscopy	O
to	O
evaluate	O
healing	O
of	O
her	O
esophageal	B
ulcers	I
.	O

medna	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
7269	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
7270	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
20	O
*	O
*	O
]	O
08	O
:	O
45	O

t	O
:	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
21	O
*	O
*	O
]	O
09	O
:	O
33	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
7271	O
*	O
*	O
]	O

cc	O
:	O
[	O
*	O
*	O
cc	O
contact	O
info	O
7272	O
*	O
*	O
]	O

2962	O
||||	O
21815	O
||||	O
17518	O
||||	O
discharge	O
_	O
summary	O
||||	O
2011	O
-	O
01	O
-	O
08	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
01	O
-	O
05	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
01	O
-	O
08	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1936	O
-	O
04	O
-	O
18	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
ccu	O

history	O
of	O
present	O
illness	O
:	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
1488	O
*	O
*	O
]	O
is	O
a	O
74	O
-	O
year	O
-	O
old	O
man	O
with	O
a	O
history	O
of	O
coronary	B
artery	I
disease	I
,	O
dilated	B
cardiomyopathy	I
,	O
congestive	B
heart	I
failure	I
and	O
icd	O
implantation	O
who	O
was	O
brought	O
by	O
his	O
family	O
to	O
the	O
[	O
*	O
*	O
hospital	O
1489	O
*	O
*	O
]	O
emergency	O
department	O
for	O
evaluation	O
of	O
change	B
in	I
mental	I
status	I
.	O

routine	O
laboratories	O
were	O
sent	O
in	O
the	O

emergency	O
department	O
and	O
the	O
patient	O
was	O
found	O
to	O
have	O
a	O
chest	O
x	O
-	O
ray	O
consistent	O
with	O
a	O
right	B
middle	I
lobe	I
pneumonia	I
.	O

he	O
was	O
also	O
febrile	B
in	O
the	O
emergency	O
room	O
.	O

his	O
mental	B
status	I
improved	O
with	O
tylenol	O
and	O
defervescence	B
and	O
levaquin	O
was	O
started	O
.	O

the	O
patient's	O
family	O
stated	O
that	O
he	O
had	O
had	O
a	O
gradual	O
weight	B
loss	I
of	O
approximately	O
42	O
pounds	O
over	O
the	O
last	O
two	O
months	O
with	O
decreased	B
oral	I
intake	I
and	O
failure	B
to	I
thrive	I
at	O
home	O
.	O

his	O
initial	O
oxygen	O
saturation	O
was	O
87%	O
on	O
four	O
liters	O
nasal	O
cannula	O
,	O
however	O
,	O
this	O
improved	O
to	O
96%	O
on	O
a	O
nonrebreather	O
.	O

as	O
the	O
emergency	O
department	O
laboratories	O
were	O
returned	O
,	O
the	O
patient	O
was	O
noted	O
to	O
have	O
an	O
elevated	B
digoxin	I
level	I
at	O
3	O
.	O
0	O
and	O
elevated	B
cpk	I
at	O
209	O
with	O
a	O
negative	O
index	O
.	O

patient	O
also	O
became	O
intermittently	O
hypotensive	B
in	O
the	O

emergency	O
department	O
and	O
a	O
coronary	O
care	O
unit	O
consult	O
for	O
unit	O
admission	O
was	O
requested	O
.	O

patient	O
denied	O
fevers	B
,	O
chills	B
,	O
chest	B
pain	I
,	O
shortness	B
of	I
breath	I
or	O
abdominal	B
pain	I
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
coronary	B
artery	I
disease	I
,	O
status	O
post	O
catheterization	O
in	O

[	O
*	O
*	O
2009	O
-	O
11	O
-	O
27	O
*	O
*	O
]	O
indicating	O
70%	O
left	O
anterior	O
descending	O
stenosis	B
,	O
100%	O
right	O
coronary	B
artery	I
stenosis	I
and	O
a	O
50%	O
d1	O
stenosis	B
with	O
an	O
ejection	O
fraction	O
of	O
15	O
-	O
20%	O
.	O

2	O
.	O
congestive	B
heart	I
failure	I
.	O

3	O
.	O
status	O
post	O
icd	O
implantation	O
.	O

4	O
.	O
tricuspid	B
regurgitation	I
.	O

5	O
.	O
history	O
of	O
cerebral	B
vascular	I
accident	I
.	O

6	O
.	O
seizure	B
disorder	I
.	O

7	O
.	O
hypothyroidism	B
.	O

8	O
.	O
gout	B
.	O

9	O
.	O
benign	B
prostatic	I
hypertrophy	I
.	O

10	O
.	O

atrial	B
fibrillation	I
.	O

11	O
.	O

chronic	B
renal	I
insufficiency	I
with	O
a	O
baseline	O
creatinine	O
of	O
2	O
.	O
0	O
.	O

allergies	O
:	O
patient	O
is	O
allergic	O
to	O
penicillin	O
.	O

medications	O
on	O
admission	O
:	O
zestril	O
5	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
neurontin	O
100	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
coumadin	O
1	O
.	O
25	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
digoxin	O
0	O
.	O
125	O
mg	O
po	O
q	O
.	O
o	O
.	O
d	O
.	O
,	O
phenobarbital	O
60	O
mg	O
po	O
q	O
.	O
h	O
.	O
s	O
.	O
,	O
carvedilol	O
6	O
.	O
25	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
mexiletine	O
150	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
amiodarone	O
200	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
allopurinol	O
100	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
lasix	O
120	O
mg	O
po	O
q	O
.	O
a	O
.	O
m	O
.	O
,	O
40	O
mg	O
po	O
q	O
.	O
p	O
.	O
m	O
.	O
,	O
multivitamin	O
1	O
tablet	O
po	O
q	O
.	O
d	O
.	O
,	O
niferex	O
150	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
epogen	O
10	O
,	O
000	O
units	O
subcutaneous	O
q	O
.	O

saturday	O
,	O

levoxyl	O
0	O
.	O
125	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
flomax	O
0	O
.	O
4	O
mg	O
po	O
q	O
.	O
h	O
.	O
s	O
.	O
,	O
zaroxolyn	O
2	O
.	O
5	O
mg	O
po	O
q	O
.	O
d	O
.	O

social	O
history	O
:	O
the	O
patient	O
is	O
married	O
and	O
lives	O
with	O
his	O
wife	O
.	O
[	O
*	O
*	O
name	O
(	O
ni	O
)	O
*	O
*	O
]	O
denies	O
alcohol	O
use	O
and	O
has	O
a	O
remote	O
history	O
of	O
tobacco	O
use	O
.	O

family	O
history	O
:	O
positive	O
for	O
nasopharyngeal	B
carcinoma	I
.	O

physical	O
examination	O
:	O
temperature	O
100	O
.	O
4	O
.	O

heart	O
rate	O
70	O
.	O

blood	O
pressure	O
88	O
/	O
48	O
.	O

respiratory	O
rate	O
20	O
.	O

oxygen	O
saturation	O
97%	O
on	O
a	O
100%	O
nonrebreather	O
.	O

in	O
general	O
,	O
this	O
is	O
a	O
tremulous	B
elderly	O
gentlemen	O
lying	O
alert	O
in	O
bed	O
in	O
no	O
acute	B
distress	I
.	O

head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
exam	O
indicated	O
normocephalic	O
,	O
atraumatic	O
.	O

pupils	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
.	O

extraocular	O
muscles	O
were	O
intact	O
.	O

oral	O
mucosa	O
was	O
moist	O
.	O

neck	O
exam	O
indicated	O
a	O
jugular	B
venous	I
pressure	I
of	O
10	O
cm	O
.	O

there	O
was	O
no	O
thyromegaly	B
or	O
lymphadenopathy	B
.	O

pulmonary	O
exam	O
:	O
the	O
patient	O
had	O
decreased	I
breath	I
sounds	I
at	O
the	O
base	O
of	O
the	O
right	O
lung	O
field	O
and	O
scattered	O
bibasilar	O
rales	B
.	O

there	O
were	O
no	O
wheezes	B
or	O
rhonchi	B
.	O

cardiovascular	O
exam	O
indicated	O
regular	O
rhythm	O
,	O
normal	O
s1	O
,	O
s2	O
,	O
prominent	O
s4	O
.	O

point	O
of	O
maximal	O
impulse	O
was	O
at	O
the	O
mid	O
axillary	O
line	O
.	O

there	O
were	O
no	O
murmurs	B
.	O

the	O
abdomen	O
was	O
soft	O
,	O
nontender	O
,	O
nondistended	O
with	O
normal	O
bowel	O
sounds	O
.	O

extremities	O
:	O
patient	O
had	O
1	O
+	O
peripheral	O
pulses	O
bilaterally	O
with	O
no	O
cyanosis	B
,	O
clubbing	B
or	O
edema	B
.	O

neurological	O
exam	O
indicated	O
that	O
the	O
patient	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
,	O
although	O
slow	B
to	I
respond	I
.	O

the	O
rest	O
of	O
his	O
neurologic	O
exam	O
was	O
nonfocal	O
.	O

laboratory	O
studies	O
:	O
white	O
blood	O
cell	O
count	O
of	O
9	O
.	O
0	O
with	O
85%	O
neutrophils	O
,	O
0	O
bands	O
,	O
3	O
monocytes	O
and	O
5	O
eosinophils	O
.	O

hematocrit	O
was	O
44	O
.	O
8	O
with	O
a	O
platelet	O
count	O
of	O
130	O
,	O
000	O
.	O

chem	O
-	O
7	O
was	O
remarkable	O
for	O
a	O
bun	O
of	O
104	O
,	O
creatinine	O
of	O
2	O
.	O
6	O
.	O

ck	O
was	O
209	O
with	O
an	O
mb	O
of	O
11	O
and	O
an	O
index	O
of	O
5	O
.	O
3	O
.	O

digoxin	O
level	O
was	O
3	O
.	O
0	O
.	O

phenobarbital	O
level	O
was	O
20	O
.	O
4	O
.	O

urinalysis	O
was	O
negative	O
.	O

chest	O
x	O
-	O
ray	O
indicated	O
the	O
presence	O
of	O
an	O
infiltrate	B
in	O
the	O
right	O
middle	O
lobe	O
as	O
well	O
as	O
cardiomegaly	B
.	O

there	O
were	O
no	O
obvious	O
signs	O
of	O
congestive	B
heart	I
failure	I
.	O

electrocardiogram	O
indicated	O
a	O
paced	O
rhythm	O
at	O
70	O
beats	O
per	O
minute	O
with	O
a	O
wide	B
qrs	I
complex	I
and	O
no	O
st	O
or	O
t	B
wave	I
changes	I
.	O

there	O
were	O
no	O
changes	O
compared	O
to	O
a	O
prior	O
electrocardiogram	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
coronary	O

care	O
unit	O
for	O
rule	O
out	O
of	O
myocardial	B
infarction	I
and	O
treatment	O
of	O
pneumonia	B
with	O
possible	O
sepsis	B
.	O

he	O
received	O
gentle	O
intravenous	O
hydration	O
overnight	O
and	O
ruled	O
out	O
by	O
cardiac	O
enzymes	O
.	O

his	O
creatinine	O
returned	O
to	O
baseline	O
levels	O
with	O
hydration	O
.	O

his	O
antihypertensive	O
medications	O
were	O
initially	O
held	O
secondary	O
to	O
his	O
hypotension	B
,	O
however	O
,	O
as	O
the	O
patient	O
improved	O
hemodynamically	O
,	O
each	O
of	O
his	O
antihypertensive	O
medications	O
were	O
added	O
back	O
.	O

digoxin	O
was	O
held	O
during	O
his	O
hospital	O
stay	O
due	O
to	O
a	O
supratherapeutic	O
level	O
.	O

he	O
was	O
continued	O
on	O
a	O
ten	O
day	O
course	O
of	O
renal	O
dosed	O
levofloxacin	O
for	O
community	B
acquired	I
pneumonia	I
.	O

by	O
hospital	O
day	O
number	O
two	O
,	O
the	O
patient's	O
mental	B
status	I
had	O
improved	O
to	O
baseline	O
.	O

his	O
oxygen	O
requirement	O
had	O
diminished	O
and	O
as	O
he	O
was	O
hemodynamically	O
stable	O
,	O
he	O
was	O
transferred	O
to	O
the	O
floor	O
where	O
he	O
was	O
successfully	O
weaned	O
off	O
of	O
oxygen	O
.	O

he	O
was	O
seen	O
by	O
physical	O
therapy	O
and	O
cleared	O
for	O
safe	O
discharge	O
to	O
home	O
with	O
the	O
recommendation	O
of	O
a	O
home	O
safety	O
evaluation	O
.	O

he	O
was	O
to	O
follow	O
-	O
up	O
with	O
his	O
primary	O
care	O
physician	O
in	O
one	O
week	O
for	O
a	O
repeat	O
digoxin	O
level	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
pneumonia	B
.	O

2	O
.	O
coronary	B
artery	I
disease	I
.	O

3	O
.	O
congestive	B
heart	I
failure	I
.	O

4	O
.	O
status	O
post	O
icd	O
.	O

5	O
.	O
history	O
of	O
cerebral	B
vascular	I
accident	I
.	O

6	O
.	O
seizure	B
disorder	I
.	O

7	O
.	O
hypothyroidism	B
.	O

8	O
.	O
gout	B
.	O

9	O
.	O
benign	B
prostatic	I
hypertrophy	I
.	O

10	O
.	O

atrial	B
fibrillation	I
.	O

11	O
.	O

chronic	B
renal	I
insufficiency	I
.	O

medications	O
on	O
discharge	O
:	O
same	O
as	O
medications	O
on	O
admission	O
with	O
the	O
addition	O
of	O
levofloxacin	O
250	O
mg	O
po	O
q	O
.	O
d	O
.	O
times	O
six	O
days	O
for	O
a	O
total	O
ten	O
day	O
course	O
.	O

condition	O
on	O
discharge	O
:	O
improved	O
.	O

disposition	O
:	O
the	O
patient	O
was	O
discharged	O
to	O
home	O
with	O
his	O
wife	O
.	O
[	O
*	O
*	O
name	O
(	O
ni	O
)	O
*	O
*	O
]	O
was	O
to	O
follow	O
-	O
up	O
with	O
his	O
primary	O
care	O
provider	O
in	O
one	O
week	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
1490	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
1491	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1406	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2011	O
-	O
01	O
-	O
16	O
*	O
*	O
]	O
15	O
:	O
15	O

t	O
:	O
[	O
*	O
*	O
2011	O
-	O
01	O
-	O
16	O
*	O
*	O
]	O
15	O
:	O
15	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
1492	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
1490	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
979	O
*	O
*	O
]	O
[	O
*	O
*	O
2011	O
-	O
01	O
-	O
18	O
*	O
*	O
]	O
6	O
:	O
31	O
pm	O
(	O
end	O
of	O
report	O
)	O

203738	O
||||	O
21951	O
||||	O
28549	O
||||	O
radiology	O
_	O
report	O
||||	O
2016	O
-	O
03	O
-	O
08	O
10	O
:	O
17	O
:	O
00	O
.	O
0	O
||||	O
c11	O
chest	O
(	O
pa	O
&	O
lat	O
)	O
||||	O
||||	O
clip	O
#	O
338	O
-	O
7596	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
08	O
*	O
*	O
]	O
10	O
:	O
17	O
am	O

chest	O
(	O
pa	O
&	O
lat	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
8295	O
*	O
*	O
]	O
reason	O
:	O
s	O
/	O
p	O
cabg	O
w	O
/	O
decreased	B
bs	I
-	O
r	O
/	O
o	O
effusion	B
/	O
infiltrate	B
admitting	O
diagnosis	O
:	O
mitral	B
stenosis\cath	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

69	O
year	O
old	O
man	O
with	O

reason	O
for	O
this	O
examination	O
:	O

s	O
/	O
p	O
cabg	O
w	O
/	O
decreased	B
bs	I
-	O
r	O
/	O
o	O
effusion	B
/	O
infiltrate	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indications	O
:	O
status	O
post	O
cabg	O
with	O
decreased	B
breath	I
sounds	I
.	O

r	O
/	O
o	O
effusion	B
/	O
infiltrate	B
.	O

pa	O
and	O
lateral	O
chest	O
:	O
comparison	O
is	O
made	O
to	O
the	O
study	O
from	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
03	O
*	O
*	O
]	O
.	O

status	O
post	O
cabg	O
surgery	O
is	O
again	O
noted	O
with	O
sternal	O
sutures	O
and	O
cardiovascular	O
clips	O
demonstrated	O
.	O

there	O
is	O
evidence	O
of	O
an	O
enlarging	O
soft	O
tissue	O
opacity	B
in	O
the	O
right	O
mid	O
zone	O
anteriorly	O
.	O

it	O
measured	O
3	O
.	O
7	O
cm	O
in	O
diameter	O
previously	O
.	O

it	O
now	O
measures	O
approximately	O
6	O
cm	O
in	O
diameter	O
.	O

this	O
could	O
represent	O
a	O
localized	O
hematoma	B
or	O
possibly	O
an	O
area	O
of	O
edema	B
in	O
the	O
anterior	O
chest	O
wall	O
.	O

it	O
could	O
be	O
further	O
characterized	O
by	O
ct	O
evaluation	O
.	O

the	O
heart	O
otherwise	O
shows	O
slight	O
left	B
ventricular	I
enlargement	I
.	O

the	O
pulmonary	O
vessels	O
do	O
not	O
indicate	O
cardiac	B
failure	I
.	O

no	O
definite	O
pulmonary	B
infiltrates	I
or	O
pleural	B
effusions	I
are	O
seen	O
.	O

some	O
minor	O
linear	B
atelectasis	I
is	O
noted	O
at	O
the	O
left	O
base	O
laterally	O
.	O

impression	O
:	O

1	O
.	O
enlarging	O
soft	O
tissue	O
opacity	B
in	O
the	O
left	O
mid	O
zone	O
anteriorly	O
following	O
surgery	O
.	O

this	O
could	O
be	O
a	O
hematoma	B
.	O

10316	O
||||	O
21979	O
||||	O
18539	O
||||	O
discharge	O
_	O
summary	O
||||	O
2019	O
-	O
06	O
-	O
02	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1971	O
-	O
04	O
-	O
19	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
1871	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

admit	O
via	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
for	O
pna	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

48	O
year	O
old	O
man	O
with	O
mmp	O
including	O
downs	B
syndrome	I
was	O
referred	O
today	O
from	O
his	O
rehab	O
facility	O
with	O
increasing	O
resp	B
distress	I
.	O

by	O
report	O
via	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
,	O
he	O
had	O
an	O
event	O
this	O
am	O
where	O
he	O
desatureated	B
to	O
80%	O
.	O

he	O
was	O
recently	O
admitted	O
to	O
[	O
*	O
*	O
hospital1	O
16	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
05	O
-	O
21	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
05	O
-	O
28	O
*	O
*	O
]	O
for	O
pna	B
as	O
well	O
.	O

he	O
had	O
a	O
similar	O
presentation	O
,	O
with	O
an	O
o2	O
sat	O
in	O
the	O
80's	O
.	O

he	O
was	O
treated	O
for	O
a	O
lll	B
pna	I
with	O
zosyn	O
for	O
7	O
days	O
with	O
improvement	O
in	O
his	O
o2	B
sats	I
.	O

he	O
was	O
noted	O
to	O
have	O
difficulty	O
managing	O
his	O
secretions	O
.	O

dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
called	O
in	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
saying	O
that	O
the	O
patient	O
cannot	B
swallow	I
and	O
tha	O
the	O
guardian	O
would	O
want	O
a	O
g	O
-	O
tube	O
placed	O
if	O
needed	O
.	O

he	O
was	O
newly	O
made	O
npo	O
a	O
[	O
*	O
*	O
05	O
-	O
30	O
*	O
*	O
]	O
3pm	O
at	O
nh	O
for	O
unknown	O
reasons	O
.	O

in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
,	O
his	O
vitals	O
were	O
102	O
.	O
8	O
,	O
hr	O
130	O
,	O
bp	O
146	O
/	O
77	O
,	O
rr	O
28	O
,	O
100%	O
o2	O
sat	O
on	O
nrb	O
.	O

he	O
recieved	O
4l	O
ns	O
(	O
lactate	O
only	O
down	O
1	O
.	O
5	O
)	O
.	O

he	O
recieved	O
haldol	O
10	O
,	O
levofloxacin	O
,	O
vancomycin	O
,	O
flagyl	O
,	O
and	O
tylenol	O
in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
.	O

on	O
exam	O
in	O
the	O
ficu	O
,	O
he	O
is	O
a	O
middle	O
aged	O
gentleman	O
yelling	B
.	O

he	O
is	O
non	B
verbal	I
.	O

he	O
is	O
not	O
able	B
to	I
answer	I
questions	I
.	O

past	O
medical	O
history	O
:	O

-	O
downs	B
syndrome	I

-	O
alzheimer's	B
dementia	I

-	O
hepatitis	B
b	I

-	O
urinary	B
retention	I

-	O
uti	B
with	O
citrobacter	O
(	O
sensitive	O
to	O
fluoroquinolones	O
)	O
in	O

february	O

-	O
tonsilar	B
hypertrophy	I
,	O
requires	O
nectar	O
liquids	O
and	O
pureed	O
solid	O
diet	O
-	O
t9	O
-	O
t12	O
compression	B
fractures	I
and	O
bilateral	O
hip	B
fractures	I
dx'd	O
in	O
february	O
and	O
subacute	O
appearing	O
on	O
xrays	O
at	O
that	O
time	O

social	O
history	O
:	O

had	O
previously	O
lived	O
in	O
group	O
home	O
because	O
of	O
down's	B
syndrome	I
;	O
has	O
been	O
rosecommon	O
(	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
)	O
resident	O
since	O
february	O
because	O
of	O
need	O
for	O
pt	O
/	O
ot	O
following	O
diagnosis	O
of	O
subacute	O
hip	B
fractures	I

family	O
history	O
:	O

noncontributory	O

physical	O
exam	O
:	O

99	O
.	O
5	O
125	O
/	O
62	O
118	O
33	O
98%	O
50%	O
fm	O

gen	O
:	O
nonverbal	B
,	O
moans	B
when	I
touched	I
.	O
moderate	O
resp	B
distress	I
with	O
loud	O
upper	O
airway	O
secretion	O
sounds	O
.	O

heent	O
:	O
op	O
clear	O
,	O
mm	B
dry	I

cv	O
:	O
heart	O
sounds	O
obscurred	O
by	O
breath	O
sounds	O

pulm	O
:	O
transmitted	O
upper	O
airway	O
sounds	O
,	O
pt	O
unwilling	O
to	O
cooperate	O
with	O
exam	O

abd	O
:	O
scaphoid	O
,	O
soft	O
,	O
nabs	O

ext	O
:	O
le	O
contractures	B
,	O
decreased	B
bulk	I
,	O
min	O
edema	B
.	O
sitting	O
with	O
legs	O
crossed	O
.	O

skin	O
:	O
no	O
rashes	B

pertinent	O
results	O
:	O

[	O
*	O
*	O
2019	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
40pm	O
plt	O
smr	O
-	O
very	O
high	O
plt	O
count	O
-	O
651	O
*	O

[	O
*	O
*	O
2019	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
40pm	O
neuts	O
-	O
94	O
.	O
3	O
*	O
bands	O
-	O
0	O
lymphs	O
-	O
4	O
.	O
2	O
*	O
monos	O
-	O
1	O
.	O
3	O
*	O
eos	O
-	O
0	O
.	O
1	O
basos	O
-	O
0	O
.	O
1	O

[	O
*	O
*	O
2019	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
40pm	O
wbc	O
-	O
15	O
.	O
9	O
*	O
#	O
rbc	O
-	O
3	O
.	O
67	O
*	O
hgb	O
-	O
11	O
.	O
0	O
*	O
hct	O
-	O
33	O
.	O
8	O
*	O
mcv	O
-	O
92	O
mch	O
-	O
30	O
.	O
0	O
mchc	O
-	O
32	O
.	O
6	O
rdw	O
-	O
15	O
.	O
0	O

[	O
*	O
*	O
2019	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
40pm	O
calcium	O
-	O
8	O
.	O
6	O
phosphate	O
-	O
4	O
.	O
3	O
magnesium	O
-	O
2	O
.	O
1	O

[	O
*	O
*	O
2019	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
40pm	O
estgfr	O
-	O
using	O
this	O

[	O
*	O
*	O
2019	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
40pm	O
glucose	O
-	O
157	O
*	O
urea	O
n	O
-	O
15	O
creat	O
-	O
1	O
.	O
1	O
sodium	O
-	O
147	O
*	O
potassium	O
-	O
3	O
.	O
9	O
chloride	O
-	O
111	O
*	O
total	O
co2	O
-	O
20	O
*	O
anion	O
gap	O
-	O
20	O

[	O
*	O
*	O
2019	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
55pm	O
lactate	O
-	O
5	O
.	O
5	O
*	O
k	O
+	O
-	O
3	O
.	O
5	O

[	O
*	O
*	O
2019	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
55pm	O
type	O
-	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
17	O
*	O
*	O
]	O
comments	O
-	O
not	O
specif	O

[	O
*	O
*	O
2019	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
11	O
:	O
37pm	O
lactate	O
-	O
4	O
.	O
0	O
*	O

[	O
*	O
*	O
2019	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
11	O
:	O
37pm	O
comments	O
-	O
green	O
top	O

brief	O
hospital	O
course	O
:	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
2290	O
*	O
*	O
]	O
was	O
initially	O
kept	O
strictly	O
npo	O
due	O
to	O
his	O
suspected	O
aspiration	B
pneumonia	I
.	O

he	O
was	O
treated	O
with	O
vancomycin	O
and	O
zosyn	O
for	O
empiric	O
coverage	O
.	O

he	O
was	O
given	O
supplemental	O
oxygen	O
via	O
a	O
face	O
tent	O
with	O
standing	O
nebulizer	O
treatments	O
.	O

in	O
spite	O
of	O
his	O
npo	O
status	O
,	O
he	O
was	O
having	O
frequent	O
episodes	O
of	O
intermittent	O
hypoxia	B
requiring	O
suctioning	O
of	O
thick	O
,	O
tenacious	O
secretions	O
.	O

this	O
,	O
in	O
addition	O
to	O
serial	O
cxrs	O
revealed	O
that	O
he	O
was	O
clearly	O
aspirating	B
his	O
secretions	O
on	O
a	O
continuous	O
basis	O
in	O
spite	O
of	O
his	O
npo	O
status	O
.	O

due	O
to	O
this	O
as	O
well	O
as	O
his	O
baseline	O
dementia	B
,	O
it	O
was	O
thought	O
that	O
putting	O
in	O
a	O
peg	O
tube	O
for	O
nutrition	O
would	O
not	O
solve	O
the	O
problem	O
of	O
aspiration	B
since	O
he	O
was	O
clearly	O
unable	O
to	O
manage	O
his	O
own	O
secretions	O
.	O

furthermore	O
,	O
it	O
was	O
clear	O
that	O
he	O
would	O
need	O
constant	O
restraints	O
to	O
avoid	O
traumatic	O
removal	O
of	O
a	O
peg	O
,	O
which	O
was	O
thought	O
to	O
be	O
an	O
unacceptable	O
impairment	O
in	O
his	O
quality	O
of	O
life	O
.	O

in	O
the	O
setting	O
of	O
all	O
of	O
these	O
issues	O
and	O
his	O
severe	O
,	O
acute	O
,	O
worsening	O
aspiration	B
pneumonia	I
,	O
he	O
was	O
made	O
comfort	O
-	O
measures	O
-	O
only	O
by	O
his	O
family	O
and	O
legal	O
guardian	O
;	O
he	O
was	O
put	O
on	O
a	O
morphine	O
drip	O
to	O
help	O
with	O
his	O
obvious	O
discomfort	B
,	O
and	O
he	O
expired	O
shortly	O
thereafter	O
.	O

medications	O
on	O
admission	O
:	O

famotidine	O
20	O
mg	O
po	O
bid	O

hexavitamin	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

calcium	O
carbonate	O
500	O
mg	O
tablet	O
,	O
(	O
2	O
)	O
tablet	O
,	O
chewable	O
po	O
daily	O
cholecalciferol	O
(	O
vitamin	O
d3	O
)	O
400	O
unit	O
tablet	O
daily	O
)	O
.	O

haldol	O
1	O
bid	O

acetaminophen	O
325	O
mg	O
(	O
2	O
)	O
tablet	O
po	O
every	O
six	O
(	O
6	O
)	O
hours	O
as	O
needed	O
for	O
pain	B
.	O

celexa	O
10	O

discharge	O
disposition	O
:	O

expired	O

discharge	O
diagnosis	O
:	O

aspiration	B
pneumonia	I

down's	I
syndrome	I

alzheimer's	I
dementia	I

discharge	O
condition	O
:	O

expired	O

discharge	O
instructions	O
:	O

n	O
/	O
a	O

followup	O
instructions	O
:	O

n	O
/	O
a	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
1744	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
1876	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1877	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
189	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1990	O
*	O
*	O
]	O
[	O
*	O
*	O
name8	O
(	O
md	O
)	O
1991	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1992	O
*	O
*	O
]	O
[	O
*	O
*	O
2019	O
-	O
06	O
-	O
25	O
*	O
*	O
]	O
@	O
1632	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
1744	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2019	O
-	O
07	O
-	O
17	O
*	O
*	O
]	O
1	O
:	O
46	O
pm	O

(	O
end	O
of	O
report	O
)	O

4946	O
||||	O
22159	O
||||	O
20924	O
||||	O
discharge	O
_	O
summary	O
||||	O
2019	O
-	O
11	O
-	O
05	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
11	O
-	O
04	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
11	O
-	O
05	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1950	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

sulfa	O
(	O
sulfonamides	O
)	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
1897	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

carotid	B
stenosis	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

carotid	O
stent	O
placement	O

history	O
of	O
present	O
illness	O
:	O

69yo	O
m	O
with	O
htn	B
,	O
hyperlipidemia	B
,	O
diet	O
controlled	O
dm	B
,	O
?	O

tia	B
,	O
now	O
s	O
/	O
p	O
r	O
carotid	O
stent	O
placement	O
.	O

pt	O
was	O
well	O
until	O
6months	O
ago	O
where	O
he	O
reported	O
an	O
episode	O
where	O
a	O
clock	O
was	O
shifting	O
to	O
the	O
right	O
on	O
the	O
wall	O
of	O
his	O
bedroom	O
.	O

he	O
stood	O
up	O
and	O
felt	O
a	O
little	O
"dizzy"	O
or	O
"unsteady	O
.	O
"	O

these	O
symptoms	B
resolved	O
within	O
10	O
minutes	O
.	O

pt	O
also	O
notes	O
mild	O
l	B
sided	I
hearing	I
loss	I
since	O
january	O
,	O
however	O
no	O
tinnitus	B
.	O

he	O
denies	O
any	O
transient	B
visual	I
loss	I
or	O
scotomas	B
.	O

no	O
tingling	B
,	O
numbness	B
or	O
weakness	B
with	O
these	O
episodes	O
.	O

pt	O
was	O
told	O
by	O
opthalmologist	O
several	O
years	O
ago	O
that	O
he	O
had	O
"cholesterol	O
in	O
the	O
back	O
of	O
his	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
151	O
*	O
*	O
]	O
.	O
"	O

thus	O
eliciting	O
carotid	O
doppler	O
evaluation	O
revealing	O
71	O
-	O
90%stenosis	O
in	O
the	O
mid	O
right	O
ica	O
and	O
a	O
50	O
-	O
70%	O
stenosis	O
in	O
the	O
left	O
ica	O
.	O

pt	O
was	O
admitted	O
for	O
r	O
ica	O
stent	O
placement	O
.	O

pt	O
was	O
without	O
any	O
complaints	B
once	O
brought	O
the	O
the	O
ccu	O
.	O

sbp's	O
140's	O
on	O
nitroglycerin	O
drip	O
.	O

denied	O
any	O
dysarthria	B
,	O
weakness	B
,	O
numbness	B
,	O
paresthesias	B
,	O
ha	B
,	O
or	O
visual	B
changes	I
.	O

ros	O
:	O
denies	O
f	B
/	O
c	B
/	O
ns	B
,	O
no	O
wt	B
loss	I
,	O
no	O
cough	B
,	O
no	O
sob	B
or	O
cp	B
,	O
no	O
peripheral	B
edema	I
.	O
no	O
brbpr	B
/	O
melena	B
,	O
denies	O
claudication	B
,	O
pnd	B
,	O
orthopnea	B
.	O

can	O
climb	O
>	O
2	O
flights	O
of	O
stairs	O
without	O
difficulty	O
at	O
baseline	O
.	O

past	O
medical	O
history	O
:	O

htn	B

hyperlipidemia	I

dm	I
-	O
diet	O
controlled	O
.	O
am	O
bg's	O
110	O
per	O
pt	O
report	O
.	O

traumatic	B
glaucoma	I
with	O
cataract	B
-	O
s	O
/	O
p	O
os	O
cataract	B
removal	O
.	O
s	O
/	O
p	O
r	O
shoulder	O
basal	B
cell	I
carcinoma	I
excision	O
1998	O

social	O
history	O
:	O

divorced	O
,	O
lives	O
with	O
girlfriend	O
.	O

retired	O
machinist	O
.	O

he	O
has	O
one	O
grown	O
daughter	O
who	O
lives	O
in	O
[	O
*	O
*	O
state	O
5083	O
*	O
*	O
]	O
.	O

distant	O
tobacco	O
use	O
>	O
25yrs	O
ago	O
.	O

no	O
etoh	O
.	O

no	O
illicits	O
.	O

family	O
history	O
:	O

brother	O
-	O
d	O
.	O
74	O
cad	B
,	O
mi	B
at	O
63yo	O

brother	O
-	O
d	O
.	O
60	O
cad	B

physical	O
exam	O
:	O

vitals	O
:	O
t97	O
,	O
bp	O
153	O
/	O
90	O
,	O
hr	O
75	O
,	O
r	O
16	O
,	O
98%	O
ra	O

ht	O
:	O
6'2"	O
wt	O
:	O
205	O
lbs	O

gen	O
:	O
awake	O
,	O
alert	O
,	O
lying	O
flat	O
in	O
bed	O
,	O
pleasant	O
,	O
conversant	O
in	O
nad	B
.	O

heent	O
:	O
ncat	O
,	O
eom's	O
full	O
,	O
smooth	O
.	O

r	O
pupil	O
5	O
-	O
-	O
>3mm	O
,	O
afferent	B
pupillary	I
defect	I
.	O

l	O
5	O
-	O
-	O
>4mm	O
,	O
no	O
tonsillar	B
exudates	I
.	O

neck	O
:	O
no	O
bruits	B
b	O
,	O
no	O
thyromegaly	B

cv	O
:	O
nl	O
s1	O
and	O
s2	O
,	O
no	O
mrg	B

pulm	O
:	O
cta	O
b	O

abd	O
:	O
soft	O
,	O
nt	O
,	O
nd	O
,	O
bs	O
+	O
,	O
no	O
hsm	B
,	O
non	O
-	O
pulsatile	O

extrem	O
:	O
no	O
cce	B
,	O
2	O
+	O
dp	O
,	O
pt	O
pulses	O

groin	O
:	O
no	O
femoral	B
bruit	I
bilat	O
,	O
no	O
masses	B
b	O
,	O
excellent	O
peripheral	O
pulses	O
.	O

neuro	O
:	O
cn's	O
ii	O
-	O
xii	O
intact	O
,	O
l	O
apd	B
as	O
above	O
,	O
fst	O
-	O
[	O
*	O
*	O
05	O
-	O
24	O
*	O
*	O
]	O
globally	O
-	O
did	O
not	O
test	O
hipflexors	O
or	O
knee	O
f	O
/	O
e	O
since	O
pt	O
is	O
s	O
/	O
p	O
femoral	O
artery	O
cath	O
.	O

sensory	O
exam	O
intact	O
to	O
light	O
touch	O
.	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2019	O
-	O
10	O
-	O
17	O
*	O
*	O
]	O
:	O

5	O
.	O
7>	O
15	O
.	O
3	O
<	O
178	O
140	O
/	O
105	O
/	O
17	O
inr=1	O
.	O
0	O

44	O
4	O
.	O
3	O
/	O
29	O
/	O
1	O
.	O
0	O

ekg	O
:	O
nsr	O
60	O
,	O
nl	O
axis	O
,	O
no	O
q	B
-	I
waves	I
,	O
no	O
st	B
segment	I
changes	I
.	O

imaging	O
:	O

[	O
*	O
*	O
2019	O
-	O
09	O
-	O
27	O
*	O
*	O
]	O
:	O
ct	O
of	O
the	O
neck	O
revealed	O
an	O
80%	O
stenosis	B
of	O
the	O
proximal	O

right	O
ica	O
16	O
mm	O
from	O
the	O
origin	O
and	O
a	O
50%	O
stenosis	B
in	O
the	O
distal	O

left	O
common	O
carotid	O
artery	O
just	O
before	O
the	O
bifurcation	O
.	O

[	O
*	O
*	O
2019	O
-	O
09	O
-	O
03	O
*	O
*	O
]	O
:	O
carotid	O
duplex	O
series	O
demonstrated	O
heterogeneous	B
calcified	I
plaquing	I
in	O
both	O
carotid	O
systems	O
.	O

there	O
was	O
a	O
71	O
-	O
90%	O
stenosis	B
in	O
the	O
mid	O
right	O
ica	O
and	O
a	O
50	O
-	O
70%	O
stenosis	B
in	O
the	O
left	O

ica	O
.	O

vertebral	O
flow	O
is	O
antegrade	O
bilaterally	O
.	O

and	O
this	O
was	O
significantly	O
increased	O
in	O
the	O
right	O
ica	O
since	O
a	O
study	O
done	O
one	O

year	O
previously	O
.	O

exercise	O
stress	O
test	O
-	O
reportedly	O
normal	O
per	O
pt	O
.	O
report	O

head	O
ct	O
-	O
"normal"	O
per	O
pt	O
report	O
,	O
results	O
not	O
available	O
-	O
test	O
was	O
ordered	O
for	O
l	B
sided	I
hearing	I
loss	I
.	O
\	O

brief	O
hospital	O
course	O
:	O

69yo	O
m	O
with	O
htn	B
,	O
hyperlipidemia	B
,	O
diet	O
controlled	O
dm	B
,	O
?	O

tia	B
,	O
now	O
s	O
/	O
p	O
r	O
carotid	O
stent	O
placement	O
.	O

1	O
)	O
carotid	B
stenosis	I
-	O

patient	O
was	O
given	O
right	O
ica	O
stent	O
without	O
complication	O
.	O

the	O
patient	O
was	O
monitored	O
overnight	O
in	O
the	O
ccu	O
.	O

nitroglycerin	O
drip	O
was	O
used	O
to	O
maintain	O
sbp's	O
<	O
160	O
,	O
then	O
titrated	O
to	O
off	O
.	O

serial	O
neurological	O
exams	O
did	O
not	O
reveal	O
any	O
new	O
deficits	O
.	O

l	O
afferent	B
pupillary	I
defect	I
is	O
likely	O
secondary	O
to	O
chronic	O
low	B
vision	I
from	O
history	O
of	O
trauma	B
-	O
-	O
>cataract	O
pt	O
sustained	O
as	O
an	O
adolescent	O
.	O

the	O
patient	O
was	O
started	O
on	O
clopidogrel	O
75mg	O
daily	O
and	O
continued	O
on	O
asa	O
325	O
mg	O
daily	O
,	O
atorvastatin	O
10mg	O
qhs	O
,	O
he	O
was	O
re	O
-	O
started	O
on	O
losartan	O
at	O
time	O
of	O
discharge	O
.	O

a	O
lipid	O
panel	O
was	O
not	O
drawn	O
during	O
hospitalization	O
and	O
will	O
be	O
left	O
to	O
the	O
discretion	O
of	O
the	O
patient's	O
pcp	O
if	O
pt	O
is	O
at	O
goal	O
for	O
lipid	O
management	O
.	O

the	O
patient	O
was	O
scheduled	O
to	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
4	O
weeks	O
with	O
repeat	O
carotid	O
ultrasound	O
and	O
neurology	O
follow	O
-	O
up	O
.	O

2	O
)	O
diabetes	B
mellitus	I
-	O

patient	O
reported	O
adequate	O
control	O
with	O
diet	O
,	O
weight	B
loss	I
.	O

he	O
was	O
maintained	O
on	O
an	O
insulin	O
sliding	O
scale	O
and	O
diabetic	O
diet	O
.	O

we	O
did	O
not	O
check	O
a	O
hemoglobin	O
a1c	O
.	O

3	O
)	O
cardiac	O
-	O
no	O
known	O
cardiac	B
disease	I
,	O
reportedly	O
normal	O
cardiac	O
stress	O
test	O
.	O
no	O
anginal	B
sx	O
.	O

however	O
the	O
patient	O
has	O
multiple	O
cardiac	B
risk	I
factors	I
.	O

he	O
was	O
continued	O
on	O
asa	O
,	O
clopidogrel	O
,	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
144	O
*	O
*	O
]	O
,	O
atorvastatin	O
,	O
dm	B
control	O
.	O

4	O
)	O
renal	O
-	O

patient	O
had	O
normal	O
creatinine	O
at	O
baseline	O
and	O
was	O
given	O
hydration	O
for	O
contrast	O
(	O
~125cc	O
)	O
periprocedure	O
.	O

upon	O
arrival	O
in	O
the	O
unit	O
he	O
was	O
given	O
1	O
liter	O
ns	O
.	O

repeat	O
creatinine	O
the	O
morning	O
following	O
procedure	O
was	O
stable	O
.	O

5	O
)	O
heme	O
-	O

normal	O
baseline	O
hct	O
44	O
.	O

stable	O
the	O
morning	O
post	O
-	O
procedure	O
.	O

medications	O
on	O
admission	O
:	O

lipitor	O
10	O
mg	O
daily	O

doxazosin	O
8	O
mg	O
daily	O

cozaar	O
100	O
mg	O
daily	O

asa	O
325	O
mg	O
daily	O

mvi	O
daily	O

discharge	O
medications	O
:	O

1	O
.	O
clopidogrel	O
75	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
atorvastatin	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
.	O

3	O
.	O
aspirin	O
325	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

4	O
.	O
losartan	O
50	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

5	O
.	O
doxazosin	O
8mg	O
by	O
mouth	O
daily	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

primary	O
:	O
carotid	B
stenosis	I

secondary	O
:	O

hypertension	B

hyperlipidemia	I

discharge	O
condition	O
:	O

good	O
.	O

discharge	O
instructions	O
:	O

you	O
were	O
diagnosed	O
with	O
carotid	B
stenosis	I
and	O
had	O
a	O
carotid	O
stent	O
placed	O
.	O

you	O
should	O
take	O
all	O
of	O
your	O
medications	O
as	O
prescribed	O
.	O

especially	O
aspirin	O
and	O
plavix	O
-	O
failure	O
to	O
do	O
so	O
could	O
result	O
in	O
a	O
new	O
clot	B
forming	O
in	O
the	O
stent	O
,	O
stroke	B
,	O
or	O
even	O
death	B
.	O

call	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3698	O
*	O
*	O
]	O
or	O
911	O
if	O
you	O
experience	O
any	O
weakness	B
,	O
numbness	B
,	O
tingling	B
,	O
slurred	B
speech	I
,	O
chest	B
pain	I
or	O
shortness	B
of	I
breath	I
.	O

followup	O
instructions	O
:	O

you	O
should	O
see	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
4	O
weeks	O
for	O
follow	O
up	O
appointment	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
329	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
1901	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1902	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
1998	O
*	O
*	O
]	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1999	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
2000	O
*	O
*	O
]	O
[	O
*	O
*	O
2019	O
-	O
11	O
-	O
06	O
*	O
*	O
]	O
@	O
1051	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
329	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
328	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2019	O
-	O
11	O
-	O
08	O
*	O
*	O
]	O
7	O
:	O
33	O
am	O

(	O
end	O
of	O
report	O
)	O

21533	O
||||	O
22788	O
||||	O
7190	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
07	O
-	O
05	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
19	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
05	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1969	O
-	O
12	O
-	O
20	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
transplant	O
surgery	O

history	O
of	O
the	O
present	O
illness	O
:	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
5888	O
*	O
*	O
]	O
is	O
a	O
42	O
-	O
year	O
-	O
old	O
male	O
with	O
end	B
-	I
stage	I
renal	I
disease	I
secondary	O
to	O

fk506	O
toxicity	B
with	O
iga	B
nephropathy	I
who	O
has	O
been	O
on	O
hemodialysis	O
three	O
times	O
a	O
week	O
through	O
a	O
left	O
av	B
fistula	I
.	O

he	O
is	O
status	O
post	O
liver	O
transplant	O
from	O
[	O
*	O
*	O
2002	O
*	O
*	O
]	O
and	O
has	O
had	O
excellent	O
liver	O
graft	O
function	O
.	O

the	O
patient	O
presented	O
on	O
[	O
*	O
*	O
71	O
-	O
11	O
-	O
23	O
*	O
*	O
]	O
for	O
a	O
living	O
related	O
kidney	O
transplant	O
from	O
his	O
sister	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
status	O
post	O
liver	O
transplant	O
in	O
[	O
*	O
*	O
2002	O
*	O
*	O
]	O
secondary	O
to	O
chronic	B
hepatitis	I
b	I
.	O

2	O
.	O
hypertension	B
.	O

3	O
.	O
end	B
-	I
stage	I
renal	I
disease	I
secondary	O
to	O
fk506	O
toxicity	B
/	O
iga	B
nephropathy	I
.	O

4	O
.	O
rheumatoid	B
arthritis	I
.	O

5	O
.	O
depression	B
.	O

6	O
.	O
gerd	B
.	O

7	O
.	O
status	O
post	O
hernia	B
repair	O
times	O
two	O
.	O

8	O
.	O
status	O
post	O
av	B
fistula	I
in	O
[	O
*	O
*	O
2012	O
-	O
01	O
-	O
04	O
*	O
*	O
]	O
.	O

allergies	O
:	O
penicillin	O
.	O

admission	O
medications	O
:	O

1	O
.	O
neurontin	O
300	O
mg	O
q	O
.	O
o	O
.	O
d	O
.	O

2	O
.	O
zoloft	O
200	O
mg	O
q	O
.	O
a	O
.	O
m	O
.	O

3	O
.	O
wellbutrin	O
200	O
mg	O
q	O
.	O
a	O
.	O
m	O
.	O
,	O
100	O
mg	O
p	O
.	O
m	O
.	O

4	O
.	O
bactrim	O
one	O
tablet	O
three	O
times	O
a	O
week	O
.	O

5	O
.	O
renagel	O
400	O
mg	O
t	O
.	O
i	O
.	O
d	O
.	O

6	O
.	O
prednisone	O
25	O
mg	O
q	O
.	O
d	O
.	O

7	O
.	O
prograf	O
1	O
mg	O
.	O

8	O
.	O
diovan	O
80	O
mg	O
q	O
.	O
d	O
.	O

9	O
.	O
plaqueril	O
200	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O

10	O
.	O

metoprolol	O
100	O
mg	O
q	O
.	O
d	O
.	O

11	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O

0	O
.	O
1	O
mg	O
q	O
.	O
d	O
.	O

12	O
.	O

oxycontin	O
20	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O

13	O
.	O

lorazepam	O
0	O
.	O
5	O
mg	O
p	O
.	O
r	O
.	O
n	O
.	O

14	O
.	O

protonix	O
20	O
mg	O
q	O
.	O
d	O
.	O

15	O
.	O

lasix	O
20	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

physical	O
examination	O
on	O
admission	O
:	O
vitals	O
signs	O
:	O
97	O
.	O
8	O
,	O
blood	O
pressure	O
117	O
/	O
64	O
,	O
heart	O
rate	O
72	O
,	O
respiratory	O
rate	O
18	O
,	O
oxygen	O
saturation	O
97%	O
on	O
room	O
air	O
.	O

general	O
:	O
the	O
patient	O
was	O
a	O
well	O
-	O
developed	O
,	O
well	O
-	O
nourished	O
,	O
very	O
pleasant	O
man	O
in	O
no	O
acute	B
distress	I
.	O

heent	O
:	O
normocephalic	O
,	O
atraumatic	O
.	O

sclerae	O
were	O
anicteric	B
.	O

the	O
pupils	O
were	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

extraocular	O
movements	O
intact	O
.	O

neck	O
:	O
supple	O
,	O
no	O
lymphadenopathy	B
,	O
no	O
thyromegaly	B
.	O

chest	O
:	O

clear	O
to	O
auscultation	O
bilaterally	O
.	O

the	O
patient	O
was	O
noted	O
to	O
have	O
two	O
puncture	B
sites	I
that	O
were	O
well	O
healed	O
at	O
the	O
right	O
upper	O
chest	O
from	O
prior	O
perma	O
-	O
cath	O
placements	O
.	O

cardiac	O
:	O
normal	O
s1	O
,	O
s2	O
,	O
regular	O
rate	O
and	O
rhythm	O
.	O

abdomen	O
:	O
soft	O
,	O
nontender	O
.	O

the	O
liver	O
was	O
not	O
palpable	O
.	O

there	O
was	O
a	O
large	O
well	O
healed	O
scar	B
from	O
his	O
transplant	O
.	O

extremities	O
:	O
without	O
edema	B
,	O
2	O
+	O
pt	O
pulses	O
bilaterally	O
,	O
1	O
+	O
palpable	O
radial	O
on	O
the	O
left	O
.	O

there	O
was	O
a	O
left	O
av	B
fistula	I
with	O
bruit	B
and	O
thrill	B
.	O

laboratory	O
/	O
radiologic	O
data	O
:	O
white	O
count	O
15	O
.	O
2	O
,	O
hematocrit	O

34	O
.	O
9	O
,	O
platelets	O
409	O
,	O
000	O
,	O
inr	O
1	O
.	O
0	O
.	O

sodium	O
142	O
,	O
potassium	O
4	O
.	O
4	O
,	O
bun	O
20	O
,	O
creatinine	O
5	O
.	O
4	O
,	O
ast	O
15	O
,	O
alt	O
15	O
,	O
alkaline	O
phosphatase	O
68	O
,	O
t	O
bilirubin	O
0	O
.	O
2	O
,	O
tsh	O
0	O
.	O
78	O
,	O
albumin	O
3	O
.	O
4	O
,	O
calcium	O
9	O
.	O
1	O
,	O
phosphate	O
5	O
.	O
4	O
.	O

preoperative	O
chest	O
x	O
-	O
ray	O
indicated	O
no	O
cardiopulmonary	B
process	I
.	O

a	O
persantine	O
study	O
in	O
[	O
*	O
*	O
2012	O
-	O
02	O
-	O
04	O
*	O
*	O
]	O
indicated	O
no	O
angina	B
or	O
ischemic	B
ekg	I
changes	I
.	O

a	O
mibi	O
study	O
was	O
without	O
perfusion	B
defects	I
and	O
indicated	O
a	O
46%	O
ejection	O
fraction	O
.	O

an	O
echocardiogram	O
in	O
[	O
*	O
*	O
2012	O
-	O
02	O
-	O
04	O
*	O
*	O
]	O
showed	O
a	O
left	B
atrial	I
dilation	I
,	O
mild	O
lvh	B
,	O
left	O
ventricular	O
function	O
was	O
low	O
normal	O
.	O

laboratories	O
were	O
normal	O
.	O

there	O
was	O
mild	O
dilatation	B
of	O
the	O
aortic	O
arch	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
is	O
a	O
42	O
-	O
year	O
-	O
old	O
male	O
status	O
post	O
liver	O
transplant	O
in	O
[	O
*	O
*	O
2002	O
*	O
*	O
]	O
secondary	O
to	O
hepatitis	B
b	I
cirrhosis	I
who	O
now	O
presented	O
to	O
the	O
[	O
*	O
*	O
hospital	O
244	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
19	O
*	O
*	O
]	O
with	O
end	B
-	I
stage	I
renal	I
disease	I
secondary	O
to	O
either	O
fk506	O
toxicity	B
or	O
iga	B
nephropathy	I
.	O

he	O
also	O
has	O
hypertension	B
.	O

he	O
underwent	O
a	O
living	O
related	O
kidney	O
transplant	O
on	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
19	O
*	O
*	O
]	O
from	O
his	O
sister	O
.	O

the	O
procedure	O
was	O
uncomplicated	O
.	O

his	O
initial	O
postoperative	O
course	O
was	O
unremarkable	O
.	O

by	O
postoperative	O
day	O
number	O
three	O
,	O
he	O
was	O
7	O
liters	O
positive	O
.	O

his	O
creatinine	O
was	O
down	O
to	O
6	O
.	O
2	O
from	O
8	O
at	O
admission	O
.	O

later	O
that	O
day	O
,	O
he	O
developed	O
increasing	O
shortness	B
of	I
breath	I
and	O
he	O
dropped	O
his	O
oxygen	O
saturations	O
to	O
92%	O
.	O

he	O
demonstrated	O
a	O
p02	O
of	O
62	O
.	O

a	O
chest	O
x	O
-	O
ray	O
was	O
obtained	O
at	O
that	O
time	O
which	O
demonstrated	O
pulmonary	B
edema	I
.	O

an	O
ekg	O
and	O
cardiac	O
echocardiogram	O
was	O
negative	O
.	O

he	O
was	O
transferred	O
to	O
the	O
intensive	O
care	O
unit	O
and	O
placed	O
on	O
a	O
nitroglycerin	O
drip	O
,	O
cpap	O
and	O
lasix	O
.	O

over	O
the	O
next	O
24	O
hours	O
,	O
he	O
was	O
aggressively	O
diuresed	O
despite	O
being	O
negative	O
by	O
2	O
liters	O
for	O
24	O
hours	O
.	O

his	O
symptoms	B
did	O
not	O
improve	O
.	O

he	O
was	O
empirically	O
started	O
on	O
broad	O
spectrum	O
antibiotics	O
.	O

an	O
echocardiogram	O
at	O
that	O
time	O
obtained	O
demonstrated	O
normal	O
ejection	O
fraction	O
.	O

no	O
valvular	B
abnormalities	I
and	O
normal	O
left	O
ventricular	O
wall	O
thickness	O
.	O

despite	O
antibiotics	O
and	O
aggressive	O
diuresis	O
,	O
he	O
required	O
intubation	O
on	O
postoperative	O
day	O
number	O
five	O
.	O

bronchoscopy	O
at	O
that	O
time	O
showed	O
thick	B
secretions	I
.	O

over	O
the	O
next	O
five	O
days	O
,	O
he	O
was	O
diuresed	O
and	O
supported	O
until	O
he	O
was	O
extubated	O
on	O
postoperative	O
day	O
number	O
nine	O
.	O

at	O
that	O
point	O
,	O
he	O
remained	O
extubated	O
in	O
the	O
icu	O
and	O
his	O
creatinine	O
had	O
decreased	O
to	O
2	O
.	O
7	O
.	O

psychiatry	O
had	O
consulted	O
on	O
the	O
patient	O
for	O
agitation	B
which	O
eventually	O
resolved	O
.	O

a	O
head	O
ct	O
at	O
the	O
time	O
was	O
obtained	O
which	O
was	O
normal	O
.	O

the	O
patient	O
had	O
hypernatremia	B
with	O
a	O
free	O
water	O
deficit	O
of	O
around	O
4	O
liters	O
for	O
which	O
he	O
was	O
given	O
d5w	O
and	O
it	O
eventually	O
resolved	O
.	O

the	O
patient	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
postoperative	O
day	O
number	O
18	O
.	O

he	O
had	O
a	O
slight	O
increase	O
in	O
his	O
creatinine	O
from	O

2	O
.	O
6	O
to	O
2	O
.	O
9	O
for	O
which	O
a	O
biopsy	O
was	O
performed	O
which	O
was	O
read	O
as	O
as	O
noted	O
which	O
is	O
consistent	O
with	O
acute	O
failure	B
rejection	I
.	O

however	O
,	O
the	O
granulomatous	B
inflammation	I
was	O
not	O
typical	O
of	O
failure	B
rejection	I
and	O
its	O
significant	O
was	O
unclear	O
.	O

the	O
team	O
thought	O
that	O
he	O
was	O
clear	O
for	O
discharge	O
with	O
adequate	O
follow	O
-	O
up	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
630	O
*	O
*	O
]	O
from	O
the	O
renal	O
department	O
.	O

by	O
postoperative	O
day	O
number	O
16	O
,	O
the	O
patient	O
was	O
ambulating	O
,	O
tolerating	O
solids	O
,	O
and	O
was	O
stable	O
for	O
discharge	O
.	O

the	O
patient	O
did	O
leave	O
the	O
hospital	O
before	O
discharge	O
papers	O
were	O
finalized	O
.	O

however	O
,	O
we	O
contacted	O
the	O
patient	O
and	O
the	O
patient	O
returned	O
to	O
review	O
discharge	O
medications	O
and	O
discharge	O
instructions	O
as	O
well	O
as	O
follow	O
-	O
up	O
visits	O
.	O

discharge	O
status	O
:	O
stable	O
.	O

discharge	O
diagnosis	O
:	O

1	O
.	O
end	B
-	I
stage	I
renal	I
disease	I
secondary	O
to	O
fk506	O
toxicity	B
/	O
iga	B
nephropathy	I
,	O
status	O
post	O
living	O
related	O
kidney	O
transplant	O
on	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
19	O
*	O
*	O
]	O
for	O
which	O
he	O
has	O
had	O
excellent	O
graft	O
function	O
.	O

2	O
.	O
postoperative	B
pulmonary	I
edema	I
requiring	O
reintubation	O
.	O

3	O
.	O
hyponatremia	B
.	O

4	O
.	O
status	O
post	O
liver	O
transplant	O
,	O
excellent	O
liver	O
graft	O
function	O
,	O
in	O
[	O
*	O
*	O
2002	O
*	O
*	O
]	O
.	O

5	O
.	O
hypertension	B
.	O

6	O
.	O
depression	B
/	O
anxiety	B
.	O

discharge	O
medications	O
:	O

1	O
.	O
bactrim	O
one	O
tablet	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

2	O
.	O
tylenol	O
p	O
.	O
r	O
.	O
n	O
.	O

3	O
.	O
gabapentin	O
300	O
mg	O
tablet	O
p	O
.	O
o	O
.	O
q	O
.	O
o	O
.	O
d	O
.	O

4	O
.	O
valcyte	O
400	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
o	O
.	O
d	O
.	O

5	O
.	O
amlodipine	O
5	O
mg	O
tablet	O
,	O
two	O
tablets	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

6	O
.	O
metoprolol	O
50	O
mg	O
tablet	O
,	O
one	O
tablet	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

7	O
.	O
cellcept	O
1	O
,	O
000	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

8	O
.	O
reglan	O
10	O
mg	O
tablet	O
p	O
.	O
o	O
.	O
q	O
.	O
i	O
.	O
d	O
.	O

9	O
.	O
prednisone	O
20	O
mg	O
tablet	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

10	O
.	O

wellbutrin	O
100	O
mg	O
tablet	O
,	O
two	O
tablets	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

11	O
.	O

sertraline	O
100	O
mg	O
tablet	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

12	O
.	O

tacrolimus	O
6	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

13	O
.	O

percocet	O
one	O
to	O
two	O
tablets	O
p	O
.	O
o	O
.	O
q	O
.	O
four	O
to	O
six	O
hours	O
for	O
one	O
week	O
.	O

follow	O
-	O
up	O
:	O
the	O
patient	O
is	O
to	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
115	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
10	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
09	O
*	O
*	O
]	O
at	O
3	O
:	O
40	O
p	O
.	O
m	O
.	O
,	O
at	O
the	O
transplant	O

center	O
,	O
phone	O
number	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
736	O
*	O
*	O
]	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
1152	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
630	O
*	O
*	O
]	O
in	O
the	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
1191	O
*	O
*	O
]	O
building	O
transplant	O
center	O
,	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
736	O
*	O
*	O
]	O
,	O
on	O
[	O
*	O
*	O
71	O
-	O
11	O
-	O
23	O
*	O
*	O
]	O
at	O
10	O
:	O
40	O
a	O
.	O
m	O
.	O
as	O
well	O
as	O
the	O
bone	O
density	O
center	O
at	O
the	O
[	O
*	O
*	O
doctor	O
last	O
name	O
232	O
*	O
*	O
]	O
center	O
on	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
17	O
*	O
*	O
]	O
at	O
1	O
:	O
20	O
p	O
.	O
m	O
.	O

[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
1127	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1356	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2012	O
-	O
08	O
-	O
04	O
*	O
*	O
]	O
01	O
:	O
27	O

t	O
:	O
[	O
*	O
*	O
2012	O
-	O
08	O
-	O
11	O
*	O
*	O
]	O
20	O
:	O
24	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
5889	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2012	O
-	O
08	O
-	O
14	O
*	O
*	O
]	O
9	O
:	O
15	O
am	O

(	O
end	O
of	O
report	O
)	O

9748	O
||||	O
24307	O
||||	O
18250	O
||||	O
discharge	O
_	O
summary	O
||||	O
2011	O
-	O
01	O
-	O
19	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
01	O
-	O
19	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
sex	O
:	O

service	O
:	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
was	O
an	O
87	O
year	O
-	O
old	O
female	O
with	O
a	O
past	O
medical	O
history	O
of	O
coronary	B
artery	I
disease	I
status	O
post	O
myocardial	B
infarction	I
with	O
congestive	B
heart	I
failure	I
and	O
a	O
known	O
ef	O
of	O
20%	O
.	O

she	O
presented	O
with	O
increasing	O
back	B
pain	I
for	O
several	O
days	O
that	O
worsened	O
two	O
days	O
prior	O
to	O
admission	O
.	O

she	O
had	O
been	O
taking	O
increasing	O
doses	O
of	O
ibuprofen	O
as	O
frequently	O
as	O
400	O
mg	O
every	O
four	O
hours	O
.	O

on	O
the	O
day	O
prior	O
to	O
admission	O
she	O
had	O
nausea	B
and	O
vomiting	B
times	O
two	O
without	O
coffee	B
grounds	I
or	O
hematemesis	B
.	O

however	O
,	O
she	O
did	O
have	O
frequent	O
dark	B
tarry	I
stools	I
without	O
diarrhea	B
.	O

on	O
the	O
morning	O
of	O
admission	O
she	O
felt	O
increasing	O
dizzy	B
and	O
unsteady	B
and	O
was	O
seen	O
by	O
her	O
visiting	O
nurse	O
association	O
who	O
found	O
the	O
patient	O
to	O
be	O
presyncopal	B
with	O
low	B
blood	I
pressure	I
.	O

emt	O
was	O
called	O
.	O

her	O
blood	O
pressures	O
were	O
equal	O
in	O
both	O
arms	O
at	O
84	O
/	O
palp	O
.	O

she	O
was	O
given	O
500	O
cc	O
bolus	O
in	O
the	O
field	O
and	O
transferred	O
to	O
the	O
emergency	O
department	O
for	O
further	O
evaluation	O
where	O
a	O
rectal	O
examination	O
was	O
positive	O
for	O
ob	O
stool	O
.	O

nasogastric	O
lavage	O
showed	O
minimal	O
coffee	B
grounds	I
that	O
had	O
cleared	O
with	O
60	O
cc	O
.	O

she	O
was	O
given	O
5	O
mg	O
of	O
subcutaneous	O
vitamin	O
k	O
and	O
gentle	O
hydration	O
and	O
transferred	O
to	O
the	O
intensive	O
care	O
unit	O
for	O
further	O
monitoring	O
.	O

review	O
of	O
systems	O
:	O
negative	O
for	O
chest	B
pain	I
.	O

she	O
has	O
chronic	O
shortness	B
of	I
breath	I
on	I
exertion	I
that	O
is	O
stable	O
.	O

she	O
denies	O
any	O
abdominal	B
pain	I
or	O
rectal	B
pain	I
.	O

past	O
medical	O
history	O
:	O
1	O
.	O
coronary	B
artery	I
disease	I
status	O
post	O
inferior	B
myocardial	I
infarction	I
in	O
[	O
*	O
*	O
2010	O
-	O
03	O
-	O
18	O
*	O
*	O
]	O
,	O
status	O
post	O
catheterization	O
with	O
three	B
vessel	I
disease	I
,	O
status	O
post	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
with	O
stent	O
to	O
the	O
right	O
coronary	O
artery	O
.	O

2	O
.	O
congestive	B
heart	I
failure	I
with	O
an	O
ef	O
of	O
20	O
to	O
25%	O
.	O

3	O
.	O
chronic	B
atrial	I
fibrillation	I
on	O

coumadin	O
.	O

4	O
.	O
nonsustained	B
ventricular	I
tachycardia	I
status	O
post	O
an	O
aicd	O
placement	O
currently	O
on	O
amiodarone	O
.	O

5	O
.	O
hypertension	B
.	O

6	O
.	O
hypothyroidism	B
.	O

7	O
.	O
chronic	B
obstructive	I
pulmonary	I
disease	I
on	O
oxygen	O
at	O
home	O
.	O

8	O
.	O
type	B
2	I
diabetes	I
.	O

9	O
.	O
hearing	B
loss	I
.	O

10	O
.	O

history	O
of	O
cerebrovascular	B
accident	I
.	O

11	O
.	O

chronic	B
renal	I
insufficiency	I
with	O
a	O
baseline	O
creatinine	O
of	O
1	O
.	O
2	O
.	O

12	O
.	O

aortic	I
aneurysms	I
thoracic	I
4	O
cm	O
,	O
infrarenal	O
is	O
3	O
.	O
9	O
by	O
4	O
.	O
4	O
cm	O
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

social	O
history	O
:	O
she	O
lives	O
alone	O
.	O

she	O
is	O
dnr	O
/	O
dni	O
.	O

her	O
daughter	O
and	O
granddaughter	O
live	O
about	O
two	O
hours	O
away	O
and	O
are	O
her	O
closest	O
support	O
.	O

she	O
has	O
a	O
remote	O
history	O
of	O
tobacco	O
use	O
and	O
denies	O
alcohol	O
use	O
.	O

her	O
daughter	O
is	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
7999	O
*	O
*	O
]	O
,	O
phone	O
number	O
is	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
8000	O
*	O
*	O
]	O
and	O
her	O
granddaughter	O
is	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
8001	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
8002	O
*	O
*	O
]	O
.	O

physical	O
examination	O
on	O
admission	O
:	O
she	O
is	O
alert	O
and	O
oriented	O
times	O
three	O
and	O
in	O
no	O
acute	B
distress	I
.	O

temperature	O
97	O
.	O
6	O
.	O

heart	O
rate	O
60	O
.	O

blood	O
pressure	O
101	O
/	O
54	O
.	O

respirations	O
14	O
.	O

oxygen	O
saturation	O
98%	O
.	O

her	O
heent	O
examination	O
is	O
unremarkable	O
.	O

her	O
neck	O
is	O
supple	O
without	O
jvd	B
or	O
lymphadenopathy	B
.	O

her	O
lungs	O
are	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

her	O
cardiac	O
examination	O
is	O
irregularly	B
irregular	I
.	O

she	O
has	O
normal	O
s1	O
and	O
s2	O
with	O
a	O
2	O
out	O
of	O
6	O
systolic	B
murmur	I
at	O
the	O
left	O
sternal	O
border	O
without	O
radiation	O
.	O

her	O
adomen	O
was	O
obese	O
,	O
soft	O
,	O
nontender	O
,	O
nondistended	O
.	O

she	O
has	O
a	O
palpable	O
epigastric	O
pulsatile	O
mass	B
without	O
bruits	B
.	O

extremities	O
are	O
no	O
edema	B
.	O

she	O
has	O
2	O
+	O
femoral	O
and	O
dorsalis	O
pedis	O
pulses	O
bilaterally	O
.	O

neurological	O
examination	O
is	O
grossly	O
intact	O
.	O

rectal	O
examination	O
black	B
tarry	I
stool	I
,	O
guaiac	O
positive	O
.	O

laboratories	O
on	O
admission	O
:	O
hemoglobin	O
is	O
9	O
.	O
1	O
,	O
hematocrit	O

26	O
.	O
5	O
,	O
platelets	O
are	O
209	O
,	O
inr	O
1	O
.	O
9	O
,	O
creatinine	O
is	O
2	O
.	O
5	O
.	O

electrocardiogram	O
is	O
paced	O
at	O
64	O
beats	O
per	O
minute	O
.	O

st	B
segment	I
elevations	I
1	O
mm	O
in	O
2	O
,	O
3	O
and	O
avf	O
,	O
she	O
has	O
biphasic	B
t	I
waves	I
in	O
v5	O
and	O
6	O
as	O
well	O
as	O
3	O
and	O
f	O
.	O

poor	B
r	I
wave	I
progression	I
1	O
through	O
4	O
.	O
st	B
depressions	I
of	O
half	O
to	O
1	O
mm	O
in	O

v5	O
and	O
v6	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
had	O
her	O
inr	B
reversed	I
with	O
vitamin	O
k	O
and	O
bolus	O
with	O
intravenous	O
fluids	O
as	O
needed	O
.	O

she	O
eventually	O
went	O
for	O
an	O
esophagogastroduodenoscopy	O
that	O
was	O
without	O
evidence	O
for	O
a	O
clear	O
bleeding	B
source	O
,	O
although	O
the	O
gastrointestinal	O
service	O
felt	O
that	O
an	O
upper	B
gastrointestinal	I
bleed	I
secondary	O
to	O
non	B
-	I
steroidal	I
anti	I
-	I
inflammatory	I
drugs	I
was	O
the	O
most	O
likely	O
etiology	O
of	O
her	O
blood	B
loss	I
.	O

she	O
was	O
treated	O
with	O
proton	O
pump	O
inhibitor	O
and	O
transfused	O
as	O
needed	O
to	O
keep	O
over	O
30	O
without	O
recurrence	O
of	O
bleeding	B
.	O

the	O
patient	O
continued	O
to	O
have	O
atrial	B
fibrillation	I
and	O
was	O
reloaded	O
on	O
her	O
coumadin	O
prior	O
to	O
discharge	O
.	O

the	O
patient	O
ruled	O
in	O
for	O
a	O
myocardial	B
infarction	I
during	O
her	O
intensive	O

care	O
unit	O
stay	O
and	O
was	O
presumed	O
to	O
be	O
secondary	O
to	O
the	O
strain	B
of	I
aggressive	I
fluid	I
and	O
her	O
known	O
congestive	B
heart	I
failure	I
.	O

she	O
was	O
treated	O
medically	O
with	O
a	O
beta	O
blocker	O
and	O
an	O
ace	O
inhibitor	O
was	O
started	O
.	O

her	O
cks	O
peaked	O
at	O
411	O
with	O
a	O
troponin	O
of	O
6	O
.	O
3	O
.	O

the	O
mb	O
fraction	O
remained	O
negative	O
.	O

aspirin	O
was	O
held	O
throughout	O
,	O
because	O
the	O
process	O
was	O
not	O
thought	O
to	O
be	O
a	O
plaque	B
rupture	I
and	O
there	O
was	O
more	O
concern	O
for	O
her	O
bleeding	B
then	O
for	O
a	O
plaque	B
rupture	I
.	O

the	O
patient	O
did	O
subsequently	O
have	O
serology	O
that	O
was	O
positive	O
for	O
helicobacter	O
pylori	O
and	O
was	O
treated	O
appropriately	O
.	O

discharge	O
medications	O
:	O
multivitamin	O
,	O
levoxyl	O
0	O
.	O
1	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
protonix	O
40	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
amiodarone	O
100	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
atrovent	O

mdi	O
two	O
puffs	O
q	O
.	O
i	O
.	O
d	O
.	O
,	O
serevent	O
two	O
puffs	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
lasix	O
60	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
atenolol	O
12	O
.	O
5	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
coumadin	O
3	O
mg	O
po	O
q	O
.	O
h	O
.	O
s	O
.	O
,	O

glyburide	O
5	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
univasc	O
3	O
.	O
75	O
mg	O
po	O
q	O
.	O
d	O
.	O

the	O
patient	O
was	O
discharged	O
to	O
rehab	O
.	O

follow	O
up	O
will	O
be	O
with	O
her	O
primary	O
care	O
physician	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
.	O

[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
352	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
5824	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2011	O
-	O
09	O
-	O
07	O
*	O
*	O
]	O
13	O
:	O
49	O

t	O
:	O
[	O
*	O
*	O
2011	O
-	O
09	O
-	O
13	O
*	O
*	O
]	O
10	O
:	O
39	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
8003	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
170	O
*	O
*	O
]	O
[	O
*	O
*	O
2011	O
-	O
09	O
-	O
15	O
*	O
*	O
]	O
7	O
:	O
50	O
pm	O
(	O
end	O
of	O
report	O
)	O

622	O
||||	O
24435	O
||||	O
21375	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
11	O
-	O
05	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
04	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1924	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
cardiothoracic	O

history	O
of	O
present	O
illness	O
:	O
patient	O
is	O
an	O
80	O
year	O
-	O
old	O
male	O
with	O
worsening	O
dyspnea	B
on	I
exertion	I
times	O
one	O
year	O
.	O

his	O
symptoms	B
resolved	O
with	O
nitropaste	O
.	O

persantine	O
exercise	O

thallium	O
test	O
was	O
negative	O
.	O

ejection	O
fraction	O
was	O
estimated	O
to	O
be	O
36	O
percent	O
with	O
global	O
hypokinesis	B
.	O

catheterization	O
report	O
showed	O
a	O
left	O
main	O
was	O
patent	O
,	O
lad	O
60	O
to	O
70	O
percent	O
proximally	O
occluded	B
,	O
90	O
percent	O
mid	O
occluded	B
,	O
circumflex	O
collateral	O
to	O
om2	O
and	O
lpl	O
,	O
rca	O
bridges	O
collateral	O
.	O

patient	O
underwent	O
coronary	O
artery	O
bypass	O
graft	O
times	O
three	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
40	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2012	O
-	O
10	O
-	O
30	O
*	O
*	O
]	O
with	O
lima	O
to	O
lad	O
,	O
svg	O
to	O
om	O
,	O

svg	O
to	O
rpda	O
.	O

postoperatively	O
patient	O
did	O
well	O
.	O

patient	O
was	O
extubated	O
and	O
weaned	O
off	O
all	O
drips	O
without	O
incident	O
.	O

chest	O
tube	O
was	O
removed	O
on	O
postoperative	O
day	O
number	O
three	O
.	O

however	O
,	O
patient's	O
recovery	O
course	O
is	O
complicated	O
by	O
postoperative	O
atrial	B
fibrillation	I
.	O

patient	O
was	O
put	O
on	O
amiodarone	O
and	O
was	O
initially	O
rate	O
controlled	O
with	O
lopressor	O
.	O

his	O
vital	O
signs	O
were	O
stable	O
and	O
his	O
heart	O
rate	O
was	O
controlled	O
and	O
patient	O
was	O
in	O
sinus	O
when	O
transferred	O
to	O
the	O
floor	O
.	O

patient	O
essentially	O
had	O
no	O
other	O
events	O
and	O
recovered	O
well	O
on	O
the	O
floor	O
.	O

patient	O
was	O
ambulating	O
at	O
level	O
three	O
with	O
assistance	O
and	O
discharge	O
medications	O
includes	O
lopressor	O
12	O
.	O
5	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
aspirin	O
81	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
,	O
lasix	O
20	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
times	O
five	O
days	O
,	O
potassium	O
chloride	O
20	O
meq	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
times	O
five	O
days	O
,	O
amiodarone	O
400	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
times	O
four	O
then	O
switch	O
to	O
400	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O
and	O
percocet	O
1	O
to	O
2	O
tabs	O
p	O
.	O
o	O
.	O
q	O
.	O

4	O
to	O
6	O
h	O
p	O
.	O
r	O
.	O
n	O
.	O

the	O
patient	O
will	O
be	O
discharged	O
to	O
a	O
rehabilitation	O
facility	O
and	O
upon	O
discharge	O
his	O
physical	O
condition	O
was	O
stable	O
,	O
vital	O
signs	O
were	O
stable	O
,	O
afebrile	B
,	O
and	O
chest	O
was	O
clear	O
.	O

heart	O
regular	O
rate	O
and	O
rhythm	O
,	O
normal	O
sinus	O
.	O

incision	O
was	O
clean	O
,	O
dry	O
and	O
intact	O
,	O
no	O
drainage	O
,	O
no	O
pus	O
.	O

sternum	O
was	O
stable	O
.	O

patient	O
was	O
told	O
to	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
40	O
*	O
*	O
]	O
in	O
three	O
to	O
four	O
weeks	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
42	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
275	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1408	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
04	O
*	O
*	O
]	O
10	O
:	O
15	O

t	O
:	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
04	O
*	O
*	O
]	O
10	O
:	O
23	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
2084	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
42	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
05	O
*	O
*	O
]	O
11	O
:	O
48	O
am	O

(	O
end	O
of	O
report	O
)	O

14472	O
||||	O
24786	O
||||	O
293	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
08	O
-	O
08	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
08	O
-	O
06	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
08	O
-	O
08	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1959	O
-	O
07	O
-	O
02	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O

this	O
is	O
a	O
55	O
-	O
year	O
-	O
old	O
woman	O
mostly	O
[	O
*	O
*	O
ethnicity	O
*	O
*	O
]	O
speaking	O
with	O
a	O
past	O
medical	O
history	O
of	O
schizophrenia	B
,	O
osteoporosis	B
,	O
deep	B
vein	I
thrombosis	I
and	O
seizure	B
disorder	I
who	O
presented	O
with	O
two	O
days	O
of	O
dizziness	B
,	O
nausea	B
and	O
vomiting	B
prior	O
to	O
admission	O
.	O

she	O
fell	B
to	O
the	O
floor	O
and	O
has	O
no	O
history	O
of	O
trauma	B
,	O
no	O
loss	B
of	I
consciousness	I
or	O
seizure	B
and	O
called	O
ems	O
and	O
the	O
patient	O
was	O
referred	O
to	O
the	O
emergency	O
department	O
.	O

in	O
the	O
emergency	O
department	O
the	O
patient's	O
vital	O
signs	O
were	O
stable	O
.	O

she	O
was	O
given	O
one	O
liter	O
of	O
normal	O
saline	O
for	O
possible	O
hypovolemia	B
.	O

her	O
sodium	O
was	O
noted	O
to	O
be	O
117	O
with	O
urine	O
os	O
of	O
396	O
and	O
after	O
the	O
fluid	O
bolus	O
there	O
was	O
no	O
change	O
in	O
her	O
sodium	O
just	O
an	O
increase	O
to	O
118	O
.	O

at	O
that	O
point	O
the	O
patient	O
was	O
admitted	O
to	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
154	O
*	O
*	O
]	O
for	O
hyponatremia	B
and	O
monitoring	O
of	O
seizure	B
risk	O
.	O

past	O
medical	O
history	O
:	O
she	O
has	O
chronic	B
schizophrenia	I
,	O
she	O
has	O
dvts	B
with	O
pulmonary	B
embolus	I
,	O
status	O
post	O
an	O
ivc	O
filter	O
.	O

she	O
has	O
been	O
off	O
coumadin	O
for	O
three	O
years	O
.	O

she	O
has	O
a	O
seizure	B
disorder	I
and	O
osteoporosis	B
,	O
status	O
post	O
hip	B
fracture	I
,	O
chronic	O
dizziness	B
of	O
unknown	O
cause	O
,	O
chronic	B
abdominal	I
pain	I
with	O
a	O
negative	O
workup	O
thus	O
far	O
and	O
anxiety	B
.	O

medications	O
:	O

1	O
.	O
depakote	O
750	O
mg	O
monday	O
,	O
wednesday	O
and	O
friday	O
,	O
500	O
mg	O

tuesday	O
,	O
thursday	O
,	O
saturday	O
,	O
sunday	O
.	O

2	O
.	O
dilantin	O
300	O
mg	O
monday	O
,	O
wednesday	O
and	O
friday	O
,	O
200	O
mg	O

tuesday	O
,	O
thursday	O
,	O
saturday	O
,	O
sunday	O
.	O

3	O
.	O
meclizine	O
p	O
.	O
r	O
.	O
n	O
.	O

4	O
.	O
celebrex	O
p	O
.	O
r	O
.	O
n	O
.	O

5	O
.	O
aciphix	O
20	O
mg	O
one	O
time	O
a	O
day	O
.	O

6	O
.	O
risperdal	O
2	O
mg	O
one	O
time	O
a	O
day	O
.	O

7	O
.	O
zoloft	O
100	O
mg	O
one	O
time	O
a	O
day	O
.	O

8	O
.	O
ativan	O
4	O
mg	O
at	O
bedtime	O
.	O

9	O
.	O
caltrate	O
.	O

allergies	O
:	O
tegretol	O
.	O

primary	O
care	O
physician	O
:	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
55	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
.	O

she	O
lives	O
with	O
her	O
husband	O
who	O
is	O
currently	O
in	O
the	O
hospital	O
.	O

she	O
has	O
a	O
visiting	O
nurse	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
521	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
6944	O
*	O
*	O
]	O
's	O
corner	O
,	O
named	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
3268	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
6945	O
*	O
*	O
]	O
.	O

physical	O
examination	O
:	O
the	O
patient	O
was	O
noted	O
to	O
have	O
a	O
temperature	O
of	O
98	O
.	O
2	O
,	O
blood	O
pressure	O
106	O
/	O
72	O
,	O
heart	O
rate	O
90	O
,	O
respiratory	O
rate	O
11	O
and	O
98%	O
saturation	O
on	O
room	O
air	O
.	O

well	O
appearing	O
woman	O
interactive	O
,	O
no	O
acute	B
distress	I
.	O

oriented	O
to	O
hospital	O
,	O
oriented	O
to	O
month	O
[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
714	O
*	O
*	O
]	O
,	O
date	O
28th	O
,	O
years	O
2002	O
.	O

pupils	O
are	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
.	O

mucous	O
membranes	O
moist	O
.	O

no	O
lymphadenopathy	B
.	O

regular	O
rate	O
and	O
rhythm	O
on	O
cardiac	O
exam	O
.	O

chest	O
is	O
clear	O
to	O
auscultation	O
.	O

abdomen	O
is	O
soft	O
,	O
nontender	O
,	O
nondistended	O
,	O
positive	O
bowel	O
sounds	O
.	O

extremities	O
are	O
warm	O
,	O
distal	O
pulses	O
are	O
2	O
+	O
and	O
pneumo	O
boots	O
are	O
in	O
place	O
.	O

admission	O
labs	O
:	O
white	O
blood	O
count	O
is	O
5	O
.	O
2	O
,	O
hemoglobin	O
10	O
.	O
2	O
,	O
hematocrit	O
29	O
.	O
2	O
.	O

white	O
blood	O
cell	O
differential	O
81	O
neutrophils	O
,	O
3	O
bands	O
,	O
12	O
lymphs	O
,	O
4	O
monos	O
.	O

her	O
platelet	O
count	O
was	O
244	O
.	O

her	O
inr	O
was	O
1	O
.	O
2	O
.	O

a	O
urinalysis	O
was	O
negative	O
.	O

her	O
sodium	O
was	O
117	O
,	O
potassium	O
3	O
.	O
2	O
,	O
chloride	O
83	O
,	O
bicarbonate	O
22	O
,	O

bun	O
3	O
,	O
creatinine	O
0	O
.	O
3	O
,	O
glucose	O
137	O
.	O

her	O
calcium	O
was	O
8	O
.	O
2	O
,	O
potassium	O
2	O
.	O
0	O
,	O
magnesium	O
1	O
.	O
3	O
.	O

her	O
urine	O
osmolality	O
was	O
396	O
.	O

her	O
urine	O
sodium	O
133	O
.	O

her	O
dilantin	O
level	O
was	O
13	O
.	O
9	O
,	O
depakote	O
29	O
.	O

x	O
-	O
ray	O
done	O
on	O
the	O
abdomen	O
showed	O
no	O
evidence	O
of	O
obstruction	B
.	O

the	O
patient	O
was	O
put	O
on	O
fluid	O
restriction	O
of	O
less	O
than	O
1	O
.	O
5	O
liters	O
per	O
day	O
for	O
stress	O
induced	O
possibly	O
psychogenic	B
polydipsia	I
,	O
syndrome	B
of	I
inappropriate	I
diuretic	I
hormone	I
which	O
was	O
causing	O
her	O
hyponatremia	B
.	O

her	O
sodium	O
was	O
found	O
to	O
recover	O
quickly	O
with	O
fluid	O
restriction	O
going	O
from	O
117	O
to	O
130	O
in	O
less	O
than	O
24	O
hours	O
.	O

she	O
was	O
at	O
this	O
point	O
considered	O
stable	O
for	O
transfer	O
to	O
the	O
medicine	O
floor	O
and	O
on	O
[	O
*	O
*	O
2015	O
-	O
08	O
-	O
07	O
*	O
*	O
]	O
was	O
transferred	O
.	O

she	O
was	O
continued	O
on	O
a	O
fluid	O
restriction	O
of	O
1	O
.	O
5	O
liters	O
and	O
monitored	O
neurologically	O
given	O
her	O
fairly	O
rapid	O
sodium	O
correction	O
.	O

she	O
was	O
continued	O
on	O
her	O
seizure	B
medications	O
with	O
no	O
change	O
in	O
outpatient	O
regimen	O
.	O

her	O

depakote	O
level	O
was	O
subtherapeutic	O
however	O
,	O
alterations	O
of	O
these	O
medications	O
was	O
deferred	O
to	O
her	O
primary	O
care	O
physician	O
who	O
is	O
also	O
the	O
attending	O
for	O
alteration	O
as	O
an	O
outpatient	O
.	O

her	O
dilantin	O
level	O
was	O
however	O
therapeutic	O
.	O

she	O
continued	O
on	O
her	O
psychiatric	O
medications	O
with	O
no	O
change	O
from	O
her	O
outpatient	O
regimen	O
.	O

she	O
was	O
anemic	B
with	O
a	O
hematocrit	B
decreased	I
to	O
29	O
from	O
36	O
.	O
4	O
which	O
was	O
several	O
days	O
prior	O
to	O
admission	O
.	O

she	O
was	O
guaiac	O
negative	O
and	O
iron	O
study	O
follow	O
-	O
up	O
was	O
recommended	O
.	O

the	O
patient	O
a	O
was	O
put	O
on	O
pneumatic	O
boots	O
given	O
her	O
pulmonary	B
embolism	I
and	O
deep	B
vein	I
thrombosis	I
history	O
.	O

during	O
the	O
remainder	O
of	O
her	O
stay	O
her	O
white	B
blood	I
count	I
decreased	I
to	O
4	O
.	O
6	O
,	O
her	O
hemoglobin	O
was	O
10	O
.	O
8	O
,	O
platelets	O
266	O
.	O

her	O
sodium	B
increased	I
to	O
137	O
,	O
potassium	O
4	O
.	O
1	O
,	O
chloride	O
103	O
,	O
bicarbonate	O
24	O
.	O

her	O
bun	O
was	O
9	O
,	O
creatinine	O
0	O
.	O
4	O
,	O
glucose	O
73	O
.	O

calcium	O
was	O
8	O
.	O
6	O
,	O
potassium	O
3	O
.	O
0	O
.	O

magnesium	O
2	O
.	O
0	O
.	O

at	O
this	O
point	O
patient	O
considered	O
to	O
be	O
stable	O
for	O
discharge	O
to	O
home	O
with	O
follow	O
-	O
up	O
with	O
vna	O
.	O

the	O
patient's	O
vna	O
nurse	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
6946	O
*	O
*	O
]	O
and	O
agreed	O
the	O
meet	O
the	O
patient	O
at	O
home	O
to	O
go	O
over	O
her	O
medications	O
and	O
the	O
necessity	O
for	O
fluid	O
restriction	O
to	O
less	O
than	O
six	O
cups	O
of	O
liquid	O
per	O
day	O
.	O

vna	O
also	O
agreed	O
to	O
follow	O
-	O
up	O
with	O
the	O
patient	O
the	O
next	O
day	O
after	O
discharge	O
.	O

the	O
patient	O
was	O
given	O
one	O
prescription	O
for	O
ativan	O
4	O
mg	O
q	O
h	O
.	O
s	O
.	O
and	O
states	O
that	O
the	O
rest	O
of	O
her	O
supply	O
of	O
medications	O
is	O
adequate	O
.	O

the	O
patient	O
transferred	O
home	O
with	O
instructions	O
to	O
follow	O
-	O
up	O
with	O
her	O
primary	O
care	O
physician	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
3173	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
6809	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2015	O
-	O
08	O
-	O
09	O
*	O
*	O
]	O
13	O
:	O
20	O

t	O
:	O
[	O
*	O
*	O
2015	O
-	O
08	O
-	O
10	O
*	O
*	O
]	O
19	O
:	O
45	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
6947	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
19	O
*	O
*	O
]	O
[	O
*	O
*	O
2015	O
-	O
08	O
-	O
20	O
*	O
*	O
]	O
2	O
:	O
03	O
pm	O
(	O
end	O
of	O
report	O
)	O

27400	O
||||	O
25150	O
||||	O
20108	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
07	O
-	O
30	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
24	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
30	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1949	O
-	O
03	O
-	O
22	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
cardiothoracic	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
342	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

stent	B
re	I
-	I
occlusion	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

1	O
)	O
two	O
vessel	O
coronary	O
artery	O
bypass	O
grafting	O
utilizing	O
saphenous	O
vein	O
graft	O
to	O
left	O
anterior	O
descending	O
and	O
saphenous	O
vein	O
graft	O
to	O
obtuse	O
marginal	O
2	O
)	O
re	O
-	O
exploration	O
of	O
bleeding	B

history	O
of	O
present	O
illness	O
:	O

this	O
is	O
a	O
64	O
year	O
old	O
female	O
with	O
known	O
coronary	B
disease	I
who	O
has	O
undergone	O
multiple	O
pci	O
/	O
stent	O
procedures	O
over	O
the	O
past	O
year	O
.	O

repeat	O
cardiac	O
catheterization	O
in	O
[	O
*	O
*	O
2013	O
-	O
06	O
-	O
26	O
*	O
*	O
]	O
revealed	O
a	O
40	O
-	O
50%	O
left	O
main	O
lesion	B
;	O
90%	O
in	B
-	I
stent	I
stenosis	I
in	O
the	O
lad	O
;	O
60	O
-	O
70%	O
in	B
-	I
stent	I
stenosis	I
in	O
the	O
circumflex	O
and	O
a	O
normal	O
right	O
coronary	O
artery	O
.	O

her	O
ejection	O
fraction	O
was	O
normal	O
,	O
estimted	O
at	O
60%	O
.	O

based	O
on	O
the	O
above	O
results	O
,	O
she	O
was	O
referred	O
for	O
surgical	O
coronary	O
revascularization	O
.	O

past	O
medical	O
history	O
:	O

non	B
-	I
small	I
cell	I
lung	I
cancer	I
-	O
s	O
/	O
p	O
left	O
upper	O
lobe	O
resection	O
in	O
[	O
*	O
*	O
2006	O
*	O
*	O
]	O
followed	O
by	O
chemotherapy	O
and	O
radiation	O
,	O
thyroid	B
cancer	I
-	O
s	O
/	O
p	O
thyroidectomy	O
in	O
[	O
*	O
*	O
1998	O
*	O
*	O
]	O
now	O
hypothyroid	B
,	O
hypertension	B
,	O
elevated	B
cholesterol	I
,	O
former	O
smoker	O
,	O
hypopharyngeal	O
soft	B
tissue	I
mass	I
(	O
followed	O
at	O
[	O
*	O
*	O
hospital	O
305	O
*	O
*	O
]	O
)	O
,	O
varicose	B
veins	I
-	O
s	O
/	O
p	O
left	O
leg	O
vein	O
stripping	O

social	O
history	O
:	O

former	O
smoker	O
-	O
quit	O
tobacco	O
40	O
years	O
ago	O
.	O

denies	O
excessive	O
etoh	O
.	O

family	O
history	O
:	O

non	O
contributory	O

physical	O
exam	O
:	O

afebrile	O
,	O
vital	O
signs	O
stable	O

general	O
:	O
well	O
developed	O
female	O
in	O
no	B
acute	I
distress	I

heent	O
:	O
oropharynx	O
benign	O

neck	O
:	O
supple	O
,	O
no	O
jvd	B

chest	O
:	O
regular	O
rate	O
and	O
rhythm	O
,	O
normal	O
s1s2	O
without	O
murmur	B
or	O
rub	B

lungs	O
:	O
clear	O
bilaterally	O

abdomen	O
:	O
benign	O

ext	O
:	O
warm	O
,	O
no	O
edema	B

neuro	O
:	O
grossly	O
intact	O
;	O
no	O
focal	O
deficits	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2013	O
-	O
07	O
-	O
28	O
*	O
*	O
]	O
04	O
:	O
20am	O
blood	O
wbc	O
-	O
6	O
.	O
7	O
rbc	O
-	O
3	O
.	O
51	O
*	O
hgb	O
-	O
10	O
.	O
6	O
*	O
hct	O
-	O
30	O
.	O
7	O
*	O
mcv	O
-	O
87	O
mch	O
-	O
30	O
.	O
1	O
mchc	O
-	O
34	O
.	O
5	O
rdw	O
-	O
14	O
.	O
8	O
plt	O
ct	O
-	O
132	O
*	O

[	O
*	O
*	O
2013	O
-	O
07	O
-	O
28	O
*	O
*	O
]	O
04	O
:	O
20am	O
blood	O
glucose	O
-	O
96	O
urean	O
-	O
9	O
creat	O
-	O
0	O
.	O
7	O
na	O
-	O
137	O
k	O
-	O
3	O
.	O
9	O
cl	O
-	O
101	O
hco3	O
-	O
29	O
angap	O
-	O
11	O

[	O
*	O
*	O
2013	O
-	O
07	O
-	O
28	O
*	O
*	O
]	O
01	O
:	O
30pm	O
blood	O
tsh	O
-	O
27	O
.	O
8	O
*	O

[	O
*	O
*	O
2013	O
-	O
07	O
-	O
29	O
*	O
*	O
]	O
09	O
:	O
44am	O
blood	O
t4	O
-	O
3	O
.	O
1	O
*	O
t3	O
-	O
36	O
*	O

[	O
*	O
*	O
2013	O
-	O
07	O
-	O
26	O
*	O
*	O
]	O
04	O
:	O
07pm	O
blood	O
cortsol	O
-	O
19	O
.	O
6	O

brief	O
hospital	O
course	O
:	O

mrs	O
.	O
[	O
*	O
*	O
lastname	O
4545	O
*	O
*	O
]	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
was	O
admitted	O
and	O
underwent	O
two	O
vessel	O
coronary	O
artery	O
bypass	O
grafting	O
(	O
vein	O
graft	O
to	O
left	O
anterior	O
descending	O
and	O
vein	O
graft	O
to	O
obtuse	O
marginal	O
)	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
.	O

following	O
the	O
operation	O
,	O
she	O
was	O
brought	O
to	O
the	O
csru	O
.	O

on	O
postoperative	O
day	O
one	O
,	O
she	O
developed	O
hypotension	B
with	O
increasing	O
pressor	O
requirements	O
.	O

echo	O
performed	O
at	O
appr	O
.	O
16	O
hours	O
post	O
-	O
op	O
showed	O
signs	O
of	O
tamponade	B
and	O
was	O
taken	O
back	O
to	O
the	O
or	O
emergently	O
for	O
re	O
-	O
exploration	O
of	O
the	O
mediastinum	O
.	O

a	O
large	O
amount	O
of	O
clot	B
was	O
evacuated	O
,	O
both	O
pleura	O
were	O
irrigated	O
and	O
clot	B
also	O
removed	O
,	O
and	O
all	O
surgical	O
sites	O
were	O
inspected	O
.	O

there	O
remained	O
only	O
a	O
small	O
amount	O
of	O
oozing	B
from	O
the	O
om	O
graft	O
with	O
no	O
active	O
bleeding	B
.	O

pod	O
#2	O
-	O
on	O
levophed	O
drip	O
at	O
0	O
.	O
08	O
and	O
improving	O
.	O

swan	O
removed	O
,	O
in	O
sinus	B
tachycardia	I
,	O
received	O
2	O
units	O
of	O
prbcs	O
,	O
and	O
lasix	O
diuresis	O
was	O
started	O
.	O
hct	O
rose	O
to	O
33	O
post	O
-	O
transfusions	O
.	O
levophed	O
was	O
weaned	O
,	O
and	O
the	O
pt	O
.	O
was	O
transferred	O
out	O
to	O
the	O
floor	O
.	O

started	O
working	O
with	O
pt	O
on	O
ambulation	O
.	O

o2	O
sat	O
95%	O
on	O
room	O
air	O
.	O
alert	O
and	O
oriented	O
.	O

continued	O
to	O
improive	O
and	O
increase	O
ambulation	O
.	O

pacing	O
wires	O
pulled	O
on	O
pod	O
#6	O
,	O
chest	O
tubes	O
had	O
been	O
removed	O
the	O
day	O
prior	O
.	O

treated	O
with	O
benadryl	O
and	O
[	O
*	O
*	O
doctor	O
last	O
name	O
4546	O
*	O
*	O
]	O
lotion	O
for	O
skin	B
itchiness	I
.	O
low	O
dose	O
beta	O
blockade	O
decreased	B
hr	I
to	O
95	O
in	O
sinus	B
and	O
synthroid	O
had	O
been	O
restarted	O
.	O
had	O
good	O
pain	B
control	O
with	O
percocet	O
.	O
on	O
day	O
of	O
discharge	O
,	O
bp	O
100	O
/	O
44	O
,	O
o2	O
sat	O
96%	O
ra	O
,	O
t	O
98	O
.	O
3	O
,	O
t4	O
3	O
.	O
1	O
,	O
t3	O
36	O
,	O
tsh	O
done	O
on	O
[	O
*	O
*	O
07	O
-	O
28	O
*	O
*	O
]	O
27	O
.	O
8	O
.	O

discharged	O
in	O
good	O
condition	O
with	O
specific	O
instructions	O
to	O
follow	O
-	O
up	O
with	O
pcp	O
for	O
thyroid	B
condition	I
in	O
the	O
next	O
week	O
.	O

medications	O
on	O
admission	O
:	O

aspirin	O
325	O
qd	O
,	O
plavix	O
75	O
qd	O
,	O
toprol	O
25	O
qd	O
,	O
lipitor	O
80	O
qd	O
,	O

synthroid	O
,	O
vitamin	O
d	O

discharge	O
medications	O
:	O

1	O
.	O
potassium	O
chloride	O
10	O
meq	O
capsule	O
,	O
sustained	O
release	O
sig	O
:	O
two	O
(	O
2	O
)	O
capsule	O
,	O
sustained	O
release	O
po	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
.	O

disp	O
:	O
*	O
120	O
capsule	O
,	O
sustained	O
release	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

3	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

4	O
.	O
oxycodone	O
-	O
acetaminophen	O
5	O
-	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4h	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

5	O
.	O
atorvastatin	O
calcium	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

6	O
.	O
metoprolol	O
tartrate	O
25	O
mg	O
tablet	O
sig	O
:	O
0	O
.	O
5	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

7	O
.	O
lasix	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
twice	O
a	O
day	O
for	O
1	O
weeks	O
.	O

disp	O
:	O
*	O
14	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

8	O
.	O
levothyroxine	O
sodium	O
100	O
mcg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

coronary	B
artery	I
disease	I
-	O
s	O
/	O
p	O
cabg	O
x2	O

s	O
/	O
p	O
re	O
-	O
exploration	O
for	O
mediastinal	O
bleeding	B

hypothyroidism	I

lung	I
ca	I
with	O
xrt	O

s	O
/	O
p	O
left	O
leg	O
vein	O
stripping	O

hypertension	B

elev	I
.	I
cholesterol	I

thyroid	I
cancer	I
with	O
thyroidectomy	O

discharge	O
condition	O
:	O

good	O
,	O
stable	O

discharge	O
instructions	O
:	O

you	O
should	O
seek	O
medical	O
attention	O
if	O
you	O
have	O
increasing	O
chest	B
pain	I
,	O
drainage	O
from	O
your	O
wound	O
,	O
palpitation	B
,	O
lightheadedness	B
or	O
any	O
other	O
concering	B
sign	I
.	O

you	O
need	O
to	O
see	O
your	O
cardiologist	O
in	O
the	O
next	O
1	O
-	O
2	O
weeks	O
.	O

[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
742	O
*	O
*	O
]	O
p	O
instructions	O
:	O

see	O
your	O
cardiologist	O
in	O
the	O
next	O
week	O
or	O
two	O
.	O

see	O
your	O
primary	O
care	O
doctor	O
in	O
the	O
next	O
week	O
as	O
well	O
to	O
have	O
your	O
thyroid	O
medication	O
followed	O
.	O

see	O
dr	O
.	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
3	O
*	O
*	O
]	O
in	O
3	O
-	O
4	O
weeks	O
.	O

call	O
his	O
office	O
for	O
an	O
appointment	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1498	O
*	O
*	O
]	O

[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
351	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
751	O
*	O
*	O
]	O
np	O
80	O
-	O
aum	O
[	O
*	O
*	O
2013	O
-	O
08	O
-	O
21	O
*	O
*	O
]	O
@	O
0949	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2013	O
-	O
08	O
-	O
21	O
*	O
*	O
]	O
4	O
:	O
26	O
pm	O

(	O
end	O
of	O
report	O
)	O

7416	O
||||	O
25775	O
||||	O
16234	O
||||	O
discharge	O
_	O
summary	O
||||	O
2017	O
-	O
02	O
-	O
22	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
01	O
-	O
31	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
02	O
-	O
22	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1937	O
-	O
06	O
-	O
16	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
medicine	O

allergies	O
:	O

penicillins	O
/	O
cephalosporins	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
474	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

knee	B
pain	I
,	O
fever	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

incision	O
and	O
drainage	O
of	O
left	O
septic	B
knee	O
on	O
[	O
*	O
*	O
2017	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
.	O

history	O
of	O
present	O
illness	O
:	O

ms	O
.	O
[	O
*	O
*	O
lastname	O
475	O
*	O
*	O
]	O
is	O
a	O
79	O
yo	O
female	O
with	O
a	O
history	O
of	O
cad	B
and	O
chf	B
with	O
ef	O
of	O
20%	O
,	O
ckd	B
who	O
presents	O
wtih	O
left	O
knee	B
pain	I
.	O

patient	O
was	O
recently	O
admitted	O
[	O
*	O
*	O
date	O
range	O
(	O
1	O
)	O
476	O
*	O
*	O
]	O
with	O
mssa	B
sepsis	I
with	O
unknown	O
source	O
.	O

tee	O
was	O
negative	O
for	O
vegetations	B
,	O
but	O
since	O
she	O
has	O
a	O
pacemaker	O
she	O
was	O
treated	O
with	O
6	O
weeks	O
of	O
oxacillin	O
.	O

she	O
was	O
discharged	O
to	O
epoch	O
rehab	O
but	O
readmitted	O
[	O
*	O
*	O
12	O
-	O
26	O
*	O
*	O
]	O
with	O
fevers	B
.	O

blood	O
cultures	O
were	O
negative	O
.	O

picc	O
line	O
was	O
changed	O
and	O
did	O
not	O
grow	O
any	O
bacteria	O
.	O

tee	O
showed	O
fibrinous	B
material	I
on	O
the	O
pacer	O
lead	O
,	O
but	O
this	O
was	O
not	O
felt	O
to	O
be	O
the	O
cause	O
of	O
the	O
fevers	B
.	O

ct	O
showed	O
pleural	B
effusion	I
but	O
this	O
was	O
thought	O
to	O
be	O
due	O
to	O
chf	B
and	O
not	O
infection	B
.	O

there	O
was	O
some	O
thought	O
that	O
the	O
fevers	B
were	O
due	O
to	O
beta	O
lactam	O
allergy	B
.	O

the	O
patient	O
was	O
treated	O
with	O
vancomycin	O
for	O
two	O
weeks	O
.	O

patient	O
reports	O
that	O
four	O
days	O
prior	O
to	O
admission	O
she	O
began	O
to	O
participate	O
in	O
physical	O
therapy	O
and	O
two	O
days	O
prior	O
to	O
admission	O
she	O
began	O
to	O
note	O
left	O
knee	B
pain	I
.	O

this	O
has	O
been	O
progressing	O
over	O
the	O
past	O
day	O
.	O

on	O
the	O
day	O
of	O
admission	O
she	O
developed	O
a	O
temperature	B
of	O
99	O
.	O
2	O
and	O
shaking	B
chills	I
.	O

esr	O
was	O
79	O
and	O
a	O
portable	O
x	O
ray	O
showed	O
mild	O
arthritis	B
.	O

she	O
was	O
sent	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
77	O
*	O
*	O
]	O
for	O
evaluation	O
.	O

in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
77	O
*	O
*	O
]	O
she	O
was	O
afebrile	B
.	O

knee	O
was	O
visibly	O
swollen	O
,	O
erythematous	B
and	O
warm	B
.	O

arthrocentesis	O
was	O
performed	O
which	O
yielded	O
10	O
cc	O
of	O
yellow	O
fluid	O
.	O

ldh	O
1167	O
,	O
glucose	O
63	O
,	O
wbc	O
42900	O
rbc	O
1250	O
,	O
78	O
pmn	O
.	O

gram	O
stain	O
:	O
4	O
+	O
pmn	O
,	O
1	O
+	O
gram	O
positive	O
cocci	O
.	O
culture	O
pending	O
.	O

she	O
received	O
tylenol	O
,	O
vancomycin	O
one	O
gram	O
,	O
ceftriaxone	O
one	O
gram	O
and	O
3	O
[	O
*	O
*	O
location	O
477	O
*	O
*	O
]	O
.	O

upon	O
admission	O
to	O
the	O
floor	O
patient	O
was	O
without	O
any	O
localizing	O
symptoms	B
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
coronary	B
artery	I
disease	I
;	O
s	O
/	O
p	O
cabg	O
x4	O
2001	O
;	O
s	O
/	O
p	O
pca	O
with	O
stent	O

to	O
d1	O

-	O
[	O
*	O
*	O
03	O
-	O
17	O
*	O
*	O
]	O
ett	O
:	O
8	O
.	O
75	O
min	O
[	O
*	O
*	O
doctor	O
last	O
name	O
478	O
*	O
*	O
]	O
protocol	O
(	O
~5	O
.	O
5	O
mets	O
)	O
.	O

lv	B
dysfunction	I
in	O
the	O
absence	O
of	O
angina	B
or	O
ischemic	B
ekg	O

2	O
.	O
chf	B
-	O
ef	O
20%	O

[	O
*	O
*	O
2016	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
echo	O
:	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
479	O
*	O
*	O
]	O
dilated	O
,	O
ra	O
moderately	O
dilated	O
,	O
severe	O

global	O
lv	O
hypok	B
,	O
rv	O
sys	O
fxn	O
borderline	O
normal	O
,	O
trace	O
ar	B
,	O
3	O
+	O
mr	B
,	O

3	O
+	O
tr	B
,	O
no	O
mass	B
/	O
vegetation	B
visualized	O
.	O

3	O
.	O
htn	B

4	O
.	O
hypercholesterolemia	B
-	O
-	O
5	O
.	O
dm2	B
-	O
c	O
/	O
b	O
nephropathy	B
and	O
retinopathy	B
-	O
[	O
*	O
*	O
2016	O
-	O
11	O
-	O
25	O
*	O
*	O
]	O
hgba1c	O
6	O
.	O
1%	O

6	O
.	O
h	O
/	O
o	O
af	B
w	O
/	O
rvr	B
in	O
post	O
-	O
op	O
period	O
;	O
s	O
/	O
p	O
cardioversion	O

7	O
.	O
anemia	B
:	O
hct	O
28	O
-	O
31	O

-	O
iron	O
studies	O
[	O
*	O
*	O
04	O
-	O
14	O
*	O
*	O
]	O
low	B
iron	I
,	O
tibc	O
/	O
ferritin	O
nl	O
-	O
[	O
*	O
*	O
11	O
-	O
16	O
*	O
*	O
]	O
vit	O
b12	O
/	O
folate	O
wnl	O

8	O
.	O
chronic	B
renal	I
insufficiency	I
:	O
baseline	O
cr	O
1	O
.	O
4	O
-	O
1	O
.	O
6	O

9	O
.	O
gerd	B

10	O
.	O
s	O
/	O
p	O
ccy	O

11	O
.	O
s	O
/	O
p	O
hernia	B
repair	O
.	O

12	O
.	O

history	O
of	O
e	O
alloantibody	O
with	O
hemolytic	O
reaction	O
to	O
blood	O
transfusions	O
requiring	O
e	O
negative	O
blood	O
.	O

13	O
.	O
s	O
/	O
p	O
aicd	O

14	O
.	O

afib	B

social	O
history	O
:	O

lives	O
at	O
epoch	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
480	O
*	O
*	O
]	O

quit	O
smoking	O
40	O
years	O
ago	O

etoh	O
:	O
occasional	O

daughter	O
is	O
involved	O
with	O
pt's	O
care	O

family	O
history	O
:	O

noncontributory	O

physical	O
exam	O
:	O

vs	O
-	O
99	O
.	O
4	O
68	O
130	O
/	O
60	O
23	O
93%	O
ra	O

gen	O
-	O
pt	O
.	O
lying	O
supine	O
with	O
eyes	O
closed	O
at	O
30	O
degrees	O
hob	O
,	O
nad	B
heent	O
-	O
perrl	O
,	O
eomi	O
,	O
anicteric	B
,	O
mmm	O
,	O
op	O
clear	O
,	O
white	O
film	O
on	O
tongue	O
removable	O
by	O
patient	O
with	O
teeth	O
neck	O
-	O
no	O
[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
,	O
supple	O
,	O
non	O
tender	B
,	O
jvp	B
12cm	O
.	O

cv	O
-	O
irregular	B
,	O
+	O
s1	O
/	O
s2	O
,	O
no	O
s3	B
/	O
s4	B
,	O
ii	O
/	O
vii	O
late	O
diastolic	B
murmur	I
at	O
rusb	O
and	O
iii	O
/	O
vi	O
sem	B
at	O
llsb	O
.	O

lungs	O
-	O
decreased	B
bs	I
at	O
left	O
base	O
,	O
otherwise	O
clear	O
.	O

abd	O
-	O
soft	O
,	O
+	O
bs	O
,	O
nt	O
/	O
nd	O
/	O
nr	O
,	O
mild	O
bruising	B
over	O
abd	O
with	O
hyperpigementation	B
over	O
lower	O
abdomen	O
,	O
no	O
flank	O
tenderness	B
,	O
no	O
mass	B
,	O
no	O
pulsation	B
ext	O
-	O
left	O
knee	O
with	O
swelling	B
,	O
mild	O
erythema	B
,	O
significnat	O
warmth	B
,	O
pain	B
with	O
active	O
and	O
passive	O
rom	O
,	O
evidence	O
of	O
effusion	B
.	O

sensation	O
intact	O
.	O

2	O
+	O
dp	O
pulses	O
bilaterlly	O
.	O

1	O
+	O
pitting	B
edema	I
left	O
leg	O
,	O
trace	O
edema	B
right	O
leg	O

neuro	O
-	O
a&ox2	O
(	O
not	O
date	O
)	O

pertinent	O
results	O
:	O

heme	O

[	O
*	O
*	O
2017	O
-	O
01	O
-	O
31	O
*	O
*	O
]	O
03	O
:	O
30pm	O
blood	O
wbc	O
-	O
7	O
.	O
1	O
rbc	O
-	O
2	O
.	O
59	O
*	O
hgb	O
-	O
9	O
.	O
0	O
*	O
hct	O
-	O
26	O
.	O
6	O
*	O

mcv	O
-	O
103	O
*	O
mch	O
-	O
34	O
.	O
6	O
*	O
mchc	O
-	O
33	O
.	O
7	O
rdw	O
-	O
18	O
.	O
5	O
*	O
plt	O
ct	O
-	O
113	O
*	O

[	O
*	O
*	O
2017	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
06	O
:	O
05am	O
blood	O
wbc	O
-	O
8	O
.	O
8	O
rbc	O
-	O
2	O
.	O
48	O
*	O
hgb	O
-	O
8	O
.	O
4	O
*	O
hct	O
-	O
25	O
.	O
4	O
*	O
mcv	O
-	O
103	O
*	O
mch	O
-	O
33	O
.	O
8	O
*	O
mchc	O
-	O
32	O
.	O
9	O
rdw	O
-	O
18	O
.	O
2	O
*	O
plt	O
ct	O
-	O
100	O
*	O

[	O
*	O
*	O
2017	O
-	O
02	O
-	O
03	O
*	O
*	O
]	O
06	O
:	O
45am	O
blood	O
wbc	O
-	O
7	O
.	O
2	O
rbc	O
-	O
3	O
.	O
44	O
*	O
#	O
hgb	O
-	O
11	O
.	O
1	O
*	O
#	O
hct	O
-	O
33	O
.	O
7	O
*	O
mcv	O
-	O
98	O
mch	O
-	O
32	O
.	O
3	O
*	O
mchc	O
-	O
33	O
.	O
0	O
rdw	O
-	O
20	O
.	O
8	O
*	O
plt	O
ct	O
-	O
83	O
*	O

[	O
*	O
*	O
2017	O
-	O
02	O
-	O
03	O
*	O
*	O
]	O
06	O
:	O
45am	O
blood	O
neuts	O
-	O
64	O
.	O
6	O
bands	O
-	O
0	O
lymphs	O
-	O
27	O
.	O
1	O
monos	O
-	O
3	O
.	O
9	O
eos	O
-	O
3	O
.	O
8	O
baso	O
-	O
0	O
.	O
6	O

[	O
*	O
*	O
2017	O
-	O
02	O
-	O
03	O
*	O
*	O
]	O
06	O
:	O
45am	O
blood	O
hypochr	O
-	O
1	O
+	O
anisocy	O
-	O
1	O
+	O
poiklo	O
-	O
1	O
+	O
macrocy	O
-	O
2	O
+	O
microcy	O
-	O
normal	O
polychr	O
-	O
normal	O
ovalocy	O
-	O
occasional	O
target	O
-	O
occasional	O
burr	O
-	O
occasional	O

chem	O

[	O
*	O
*	O
2017	O
-	O
01	O
-	O
31	O
*	O
*	O
]	O
03	O
:	O
30pm	O
blood	O
glucose	O
-	O
144	O
*	O
urean	O
-	O
40	O
*	O
creat	O
-	O
1	O
.	O
7	O
*	O
na	O
-	O
135	O

k	O
-	O
5	O
.	O
2	O
*	O
cl	O
-	O
102	O
hco3	O
-	O
23	O
angap	O
-	O
15	O

[	O
*	O
*	O
2017	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
06	O
:	O
05am	O
blood	O
glucose	O
-	O
190	O
*	O
urean	O
-	O
41	O
*	O
creat	O
-	O
1	O
.	O
8	O
*	O
na	O
-	O
134	O
k	O
-	O
5	O
.	O
2	O
*	O
cl	O
-	O
103	O
hco3	O
-	O
22	O
angap	O
-	O
14	O

[	O
*	O
*	O
2017	O
-	O
02	O
-	O
03	O
*	O
*	O
]	O
06	O
:	O
45am	O
blood	O
glucose	O
-	O
117	O
*	O
urean	O
-	O
40	O
*	O
creat	O
-	O
1	O
.	O
7	O
*	O
na	O
-	O
136	O
k	O
-	O
5	O
.	O
3	O
*	O
cl	O
-	O
104	O
hco3	O
-	O
19	O
*	O
angap	O
-	O
18	O

lft	O

[	O
*	O
*	O
2017	O
-	O
02	O
-	O
02	O
*	O
*	O
]	O
05	O
:	O
35am	O
blood	O
alt	O
-	O
14	O
ast	O
-	O
18	O
ld	O
(	O
ldh	O
)	O
-	O
382	O
*	O
alkphos	O
-	O
127	O
*	O

totbili	O
-	O
0	O
.	O
7	O

lytes	O
/	O
iron	O
/	O
crp	O
/	O
tsh	O

[	O
*	O
*	O
2017	O
-	O
02	O
-	O
03	O
*	O
*	O
]	O
06	O
:	O
45am	O
blood	O
calcium	O
-	O
8	O
.	O
6	O
phos	O
-	O
3	O
.	O
1	O
mg	O
-	O
2	O
.	O
1	O

[	O
*	O
*	O
2017	O
-	O
02	O
-	O
02	O
*	O
*	O
]	O
05	O
:	O
35am	O
blood	O
caltibc	O
-	O
156	O
*	O
vitb12	O
-	O
607	O
folate	O
-	O
12	O
.	O
8	O
hapto	O
-	O
205	O
*	O
ferritn	O
-	O
1702	O
*	O
trf	O
-	O
120	O
*	O

[	O
*	O
*	O
2017	O
-	O
02	O
-	O
02	O
*	O
*	O
]	O
05	O
:	O
35am	O
blood	O
tsh	O
-	O
7	O
.	O
5	O
*	O

[	O
*	O
*	O
2017	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
06	O
:	O
05am	O
blood	O
crp	O
-	O
230	O
.	O
1	O
*	O

cxr	O

upright	O
ap	O
chest	O
:	O
a	O
pacemaker	O
icd	O
device	O
overlies	O
the	O
left	O
chest	O
,	O
with	O
leads	O
overlying	O
the	O
right	O
atrium	O
and	O
right	O
ventricle	O
.	O

the	O
patient	O
is	O
post	O
-	O
median	O
sternotomy	O
.	O

there	O
is	O
unchanged	O
cardiomegaly	B
.	O

mediastinal	O
and	O
hilar	O
contours	O
are	O
normal	O
.	O

since	O
the	O
prior	O
exam	O
,	O
there	O
is	O
no	O
significant	O
change	O
in	O
the	O
amount	O
of	O
interstitial	O
pulmonary	B
edema	I
.	O

the	O
right	O
pleural	B
effusion	I
may	O
be	O
slightly	O
enlarged	O
.	O

there	O
is	O
a	O
small	O
left	O
effusion	B
,	O
unchanged	O
.	O

impression	O
:	O
unchanged	O
degree	O
of	O
congestive	B
failure	I
.	O

knee	O
xray	O

left	O
knee	O
,	O
two	O
views	O
:	O
there	O
is	O
normal	O
mineralization	O
of	O
the	O
depicted	O
osseous	O
structures	O
.	O

osteophytes	I
are	O
seen	O
along	O
the	O
medial	O
tibial	O
plateau	O
as	O
well	O
as	O
the	O
superior	O
aspect	O
of	O
the	O
patella	O
.	O

there	O
are	O
no	O
definite	O
cortical	O
erosions	B
.	O

surgical	O
clips	O
are	O
seen	O
in	O
the	O
medial	O
aspects	O
of	O
the	O
calf	O
.	O

impression	O
:	O
no	O
definite	O
evidence	O
for	O
osteomyelitis	B
.	O

please	O
note	O
that	O
bone	O
scan	O
or	O
mri	O
is	O
more	O
sensitive	O
for	O
this	O
diagnosis	O
.	O

tte	O

conclusions	O
:	O

1	O
.	O
the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

the	O
right	O
atrium	O
is	O
markedly	O
dilated	O
.	O

2	O
.	O
the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

there	O
is	O
severe	O
global	O
left	O
ventricular	O
hypokinesis	B
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
severely	O
depressed	O
.	O

3	O
.	O
the	O
right	O
ventricular	O
cavity	O
is	O
dilated	O
.	O

right	O
ventricular	O
systolic	O
function	O
appears	O
depressed	O
.	O

4	O
.	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

no	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
rest	O
is	O
per	O
omr	O
.	O
.	O
.	O

brief	O
hospital	O
course	O
:	O

79	O
year	O
old	O
woman	O
with	O
history	O
of	O
cad	B
and	O
chf	B
,	O
recent	O
mssa	B
sepsis	I
s	O
/	O
p	O
6	O
weeks	O
iv	O
antibiotics	O
presents	O
with	O
septic	B
arthritis	I
,	O
anemia	B
,	O
thrombocytopenia	B
.	O

she	O
was	O
treated	O
with	O
iv	O
vancomycin	O
,	O
had	O
i&d	O
of	O
left	O
knee	O
and	O
washout	O
.	O

during	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
course	O
,	O
patient	O
was	O
grossly	O
volume	B
overloaded	I
to	O
her	O
resuscitation	O
for	O
sepsis	B
.	O

volume	O
management	O
ws	O
attempted	O
with	O
natrecor	O
drip	O
and	O
other	O
means	O
of	O
diuresis	O
as	O
it	O
was	O
primarily	O
due	O
to	O
chf	B
.	O

no	O
hd	O
was	O
offered	O
as	O
patient	O
as	O
there	O
was	O
no	O
clinical	O
indication	O
.	O

patient	O
was	O
dnr	B
/	O
dni	B
and	O
she	O
was	O
not	O
intubated	O
.	O

as	O
her	O
respiratory	B
status	I
worsened	O
,	O
family	O
meeting	O
was	O
held	O
and	O
it	O
was	O
decided	O
to	O
make	O
the	O
patient	O
cmo	B
.	O

she	O
expired	O
on	O
[	O
*	O
*	O
2017	O
-	O
02	O
-	O
22	O
*	O
*	O
]	O
.	O

respiratory	O
:	O

distress	B
:	O
most	O
likely	O
due	O
to	O
fluid	B
overload	I
for	O
chf	B
ef	O
15	O
-	O
20%	O
with	O
2	O
+	O
mr	B
,	O
she	O
had	O
minimal	O
diuresis	O
on	O
floor	O
and	O
was	O
given	O
ivf	O
for	O
her	O
worsening	O
renal	B
failure	I
.	O

patient	O
on	O
cxr	O
also	O
had	O
evidence	O
of	O
conolidation	B
/	O
atelctasis	B
on	O
rll	O
and	O
possible	O
rul	B
septic	I
emboli	I
which	O
could	O
be	O
source	O
of	O
resp	B
symptoms	I
.	O

pacer	O
rate	O
adjusted	O
by	O
ep	O
and	O
increased	O
to	O
70	O
.	O

patient	O
intially	O
improved	O
with	O
afterload	O
reduction	O
with	O
hydralazine	O
along	O
with	O
improved	O
diuresis	O
.	O

patient	O
continued	O
to	O
be	O
in	O
worsening	O
respiratory	B
dispress	I
requiring	O
prn	O
bipap	O
despite	O
natrecor	O
drip	O
started	O
with	O
cardiology	O
consulting	O
service	O
.	O

on	O
[	O
*	O
*	O
02	O
-	O
19	O
*	O
*	O
]	O
after	O
family	O
meeting	O
it	O
was	O
agreed	O
to	O
move	O
towards	O
dnr	B
/	O
dni	B
care	O
.	O

patient	O
was	O
subsequently	O
made	O
cmo	B
and	O
expired	O
on	O
[	O
*	O
*	O
2017	O
-	O
02	O
-	O
22	O
*	O
*	O
]	O
.	O

id	O
:	O
she	O
had	O
a	O
recent	O
bacteremia	B
of	O
unknown	O
source	O
,	O
for	O
which	O
she	O
completed	O
6	O
weeks	O
of	O
appropriate	O
antibiotic	O
therapy	O
.	O

she	O
presented	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
77	O
*	O
*	O
]	O
with	O
knee	B
pain	I
,	O
redness	B
,	O
warmth	B
,	O
and	O
was	O
found	O
to	O
have	O
a	O
septic	B
arthritis	I
with	O
significant	O
leukocytosis	B
in	O
the	O
aspirated	O
synovial	O
joint	O
.	O

she	O
was	O
intially	O
given	O
ceftriaxone	O
in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
77	O
*	O
*	O
]	O
with	O
vancomycin	O
.	O

on	O
admission	O
to	O
the	O
floor	O
,	O
the	O
ceftriaxone	O
was	O
stopped	O
and	O
the	O
vancomycin	O
was	O
continued	O
(	O
renally	O
dosed	O
)	O
.	O

orthopaedics	O
was	O
consulted	O
and	O
took	O
the	O
patient	O
to	O
the	O
or	O
on	O
[	O
*	O
*	O
2017	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
for	O
incision	O
and	O
drainage	O
of	O
the	O
left	O
knee	O
.	O

significant	O
pus	O
was	O
drained	O
from	O
the	O
knee	O
.	O

cultures	O
showed	O
methicillin	B
sensitive	I
staphylococcus	I
aureus	I
.	O

infectious	O
disease	O
was	O
consulted	O
,	O
who	O
agreed	O
with	O
initial	O
choice	O
of	O
antibiotics	O
.	O

the	O
only	O
source	O
of	O
recurrent	O
bacteremia	B
identified	O
was	O
her	O
pacemaker	O
wires	O
,	O
which	O
on	O
tee	O
in	O
october	O
had	O
fibrinous	O
material	O
noted	O
.	O

she	O
had	O
no	O
other	O
obvious	O
source	O
.	O

a	O
repeat	O
tte	O
was	O
done	O
on	O
[	O
*	O
*	O
2017	O
-	O
02	O
-	O
02	O
*	O
*	O
]	O
,	O
which	O
did	O
not	O
show	O
evidence	O
of	O
endocarditis	B
.	O

despite	O
continued	O
vancomycin	O
therapy	O
(	O
goal	O
trough	O
15	O
-	O
20	O
)	O
,	O
pt	O
continued	O
to	O
have	O
low	B
grade	I
fevers	I
to	O
100	O
.	O
5	O
daily	O
,	O
and	O
chest	O
xray	O
revealed	O
a	O
possible	O
consolidation	B
in	O
the	O
lower	O
lobe	O
.	O

therefore	O
,	O
pt	O
was	O
started	O
on	O
levofloxacin	O
in	O
addition	O
to	O
vancomycin	O
.	O

pt	O
was	O
taken	O
to	O
or	O
on	O
[	O
*	O
*	O
2017	O
-	O
02	O
-	O
09	O
*	O
*	O
]	O
for	O
pacer	O
extraction	O
by	O
the	O
electrophysiology	O
service	O
.	O

all	O
anticoagulants	O
except	O
aspirin	O
were	O
discontinued	O
prior	O
to	O
this	O
date	O
.	O

#	O
basilic	O
vein	O
thrombosis	B
:	O
on	O
hospital	O
day	O
7	O
,	O
pt	O
was	O
noted	O
to	O
have	O
upper	O
extremity	O
swelling	B
in	O
left>right	O
,	O
and	O
vascular	O
ultrasound	O
revealed	O
a	O
thrombosis	B
of	O
the	O
basilic	O
vein	O
.	O

despite	O
this	O
,	O
anticoagulation	O
was	O
discontinued	O
given	O
the	O
severe	O
risks	O
of	O
anticoagulation	B
in	O
the	O
setting	O
of	O
pacer	O
extraction	O
.	O

#	O
chf	B
:	O
ef	O
15	O
-	O
20%	O
initially	O
diuretics	O
held	O
given	O
renal	B
insufficiency	I
,	O
however	O
,	O
as	O
renal	O
function	O
stabilized	O
,	O
home	O
dose	O
furosemide	O
was	O
restarted	O
,	O
then	O
increased	O
as	O
needed	O
for	O
gentle	O
diuresis	O
.	O

pt	O
did	O
develop	O
pleural	B
effusions	I
as	O
a	O
result	O
of	O
mild	O
-	O
moderate	O
volume	B
overload	I
.	O

she	O
was	O
not	O
a	O
hemodialysis	O
candidate	O
after	O
discussion	O
with	O
the	O
family	O
,	O
with	O
respect	O
to	O
patient's	O
wishes	O
and	O
her	O
prognosis	O
.	O

patient's	O
diuresis	O
was	O
attempted	O
with	O
standing	O
diuretics	O
and	O
natrecor	O
drip	O
.	O

cardiology	O
service	O
was	O
consulted	O
to	O
help	O
manage	O
her	O
chf	B
.	O

patient	O
despite	O
the	O
natrecor	O
drip	O
continue	O
to	O
remain	O
volume	B
overloaded	I
with	O
a	O
progressively	O
compromised	O
pulmonary	B
status	I
.	O

#	O
afib	B
:	O
nsr	O
.	O

on	O
amiodarone	O
with	O
icd	O
/	O
pacer	O
.	O

continue	O
amiodarone	O
.	O

tsh	O
was	O
checked	O
as	O
monitor	O
on	O
drug	O
,	O
and	O
was	O
found	O
to	O
be	O
elevated	O
at	O
7	O
.	O
she	O
is	O
clinically	O
euthyroid	B
,	O
and	O
decision	O
to	O
treat	O
this	O
will	O
be	O
made	O
as	O
outpatient	O
.	O

ep	O
was	O
consulted	O
regarding	O
pacer	O
wires	O
,	O
and	O
the	O
pacer	O
was	O
interrogated	O
.	O

pacer	O
was	O
removed	O
on	O
[	O
*	O
*	O
2017	O
-	O
02	O
-	O
09	O
*	O
*	O
]	O
due	O
to	O
bactermia	B
.	O

cad	B
/	O
htn	B
:	O
continued	O
beta	O
blocker	O
,	O
aspirin	O
,	O
plavix	O
,	O
imdur	O
,	O
lipitor	O
.	O

she	O
did	O
not	O
have	O
any	O
chest	B
pain	I
or	O
difficulty	B
breathing	I
during	O
hospitalization	O
.	O

ckd	B
:	O
creatinine	O
at	O
baseline	O
.	O

clearance	O
19	O
on	O
admission	O
.	O

anemia	B
:	O
thought	O
to	O
be	O
due	O
to	O
ckd	B
with	O
decreased	O
epogen	O
,	O
and	O
iron	O
studies	O
revealed	O
an	O
anemia	B
of	I
chronic	I
disease	I
.	O

we	O
continued	O
procrit	O
,	O
and	O
she	O
was	O
transfused	O
on	O
[	O
*	O
*	O
2017	O
-	O
02	O
-	O
02	O
*	O
*	O
]	O
.	O

she	O
responded	O
well	O
to	O
the	O
transfusion	O
.	O

thrombocytopenia	B
:	O
she	O
has	O
a	O
chronically	O
low	O
level	O
of	O
platelets	O
.	O

they	O
usually	O
are	O
around	O
low	O
100s	O
.	O

on	O
[	O
*	O
*	O
2017	O
-	O
02	O
-	O
03	O
*	O
*	O
]	O
her	O
platelets	O
were	O
measured	O
as	O
80s	O
.	O

the	O
platelets	O
were	O
remeasured	O
in	O
a	O
yellow	O
top	O
tube	O
to	O
verify	O
a	O
true	O
drop	O
in	O
platelets	O
,	O
and	O
the	O
repeat	O
was	O
105	O
.	O

coagulopathy	B
:	O
chronically	O
elevated	B
inr	I
or	O
unclear	O
etiology	O
.	O

this	O
was	O
felt	O
to	O
likely	O
be	O
due	O
to	O
either	O
nutritional	B
deficiencies	I
or	O
to	O
a	O
factor	B
deficiency	I
.	O

there	O
was	O
no	O
evidence	O
of	O
bleeding	B
,	O
so	O
nothing	O
was	O
done	O
.	O

dm	B
2	I
:	O
continued	O
lantus	O
and	O
humalog	O
sliding	O
scale	O
.	O

preoperative	O
risk	O
:	O
in	O
terms	O
of	O
the	O
patient's	O
preoperative	O
risk	O
,	O
she	O
has	O
had	O
recent	O
revascularization	O
in	O
the	O
last	O
5	O
years	O
with	O
a	O
stress	O
test	O
in	O
[	O
*	O
*	O
2014	O
*	O
*	O
]	O
that	O
showed	O
no	O
ischemic	B
changes	O
with	O
exercise	O
.	O

she	O
is	O
currently	O
unable	O
to	O
exercise	O
,	O
but	O
based	O
on	O
these	O
previous	O
tests	O
she	O
does	O
not	O
require	O
further	O
testing	O
prior	O
to	O
surgery	O
.	O

the	O
surgery	O
is	O
an	O
intermediate	O
risk	O
.	O

however	O
,	O
she	O
does	O
have	O
severe	O
chf	B
with	O
ef	O
of	O
20%	O
,	O
ckd	B
and	O
diabetes	B
which	O
put	O
her	O
at	O
risk	O
for	O
perioperative	B
complications	I
such	O
as	O
hypoxia	B
,	O
elevated	B
blood	I
sugars	I
and	O
further	O
kidney	B
dysfunction	I
.	O

medications	O
on	O
admission	O
:	O

colace	O
100	O
mg	O
bid	O

amiodarone	O
200	O
mg	O
daily	O

imdur	O
30	O
mg	O
daily	O

procrit	O
4000	O
u	O
mwf	O

asa	O
81	O
mg	O
daily	O

mvi	O
with	O
minerals	O
daily	O

lsix	O
40	O
mg	O
daily	O
,	O
hold	O
wt	O
<	O
175	O

kcl	O
20	O
meq	O
with	O
lasix	O

lipitor	O
10	O
mg	O
daily	O

prilosec	O
20	O
mg	O
daily	O

plavix	O
75	O
mg	O
daily	O

tylenol	O
650	O
mg	O
bid	O

lopressor	O
50	O
mg	O
tid	O

hydralazine	O
10	O
mg	O
qid	O

calcium	O
600	O
mg	O
bid	O

lantus	O
20	O
u	O
sc	O
qhs	O

discharge	O
medications	O
:	O

expired	O

discharge	O
disposition	O
:	O

extended	O
care	O

discharge	O
diagnosis	O
:	O

expired	O

discharge	O
condition	O
:	O

expired	O

discharge	O
instructions	O
:	O

expired	O

followup	O
instructions	O
:	O

expired	O

[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name8	O
(	O
md	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
481	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
name6	O
(	O
md	O
)	O
482	O
*	O
*	O
]	O
[	O
*	O
*	O
name8	O
(	O
md	O
)	O
483	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
484	O
*	O
*	O
]	O
[	O
*	O
*	O
2017	O
-	O
05	O
-	O
24	O
*	O
*	O
]	O
@	O
0945	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
sun	O
[	O
*	O
*	O
2017	O
-	O
06	O
-	O
11	O
*	O
*	O
]	O
7	O
:	O
23	O
pm	O

(	O
end	O
of	O
report	O
)	O

11368	O
||||	O
26522	O
||||	O
10788	O
||||	O
discharge	O
_	O
summary	O
||||	O
2017	O
-	O
12	O
-	O
29	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
12	O
-	O
29	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1936	O
-	O
11	O
-	O
19	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
neurology	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
504	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

unresponsive	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

81	O
yo	O
woman	O
with	O
hx	O
htn	B
,	O
high	B
chol	I
,	O
sz	B
d	I
/	I
o	I
who	O
vomited	B
and	O
became	O
unresponsive	B
within	O
minutes	O
today	O
while	O
talking	O
with	O
her	O
family	O
.	O

she	O
had	O
been	O
in	O
her	O
usual	O
health	O
and	O
was	O
talking	O
with	O
her	O
husband	O
this	O
afternoon	O
when	O
she	O
appeared	O
"upset	O
,	O
"	O
.	O

she	O
got	O
up	O
to	O
do	O
the	O
dishes	O
,	O
and	O
when	O
she	O
sat	O
down	O
again	O
,	O
she	O
vomited	B
.	O

within	O
minutes	O
,	O
she	O
became	O
completely	O
unresponsive	B
.	O

she	O
was	O
taken	O
to	O
osh	O
(	O
[	O
*	O
*	O
hospital	O
5643	O
*	O
*	O
]	O
hosp	O
in	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
*	O
*	O
]	O
)	O
where	O
she	O
was	O
intubated	O
(	O
traumatic	O
intubation	O
)	O
;	O
neurosurgery	O
at	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
was	O
contacted	O
,	O
and	O
pt	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
urgently	O
for	O
further	O
w	O
/	O
u	O
and	O
care	O
.	O

upon	O
arrival	O
,	O
bp	O
250	O
systolic	O
,	O
yet	O
untreated	O
,	O
and	O
pt	O
lost	O
iv	O
access	O
.	O

when	O
seen	O
,	O
femoral	O
line	O
is	O
being	O
attempted	O
.	O

hx	O
is	O
obtained	O
from	O
daughter	O
,	O
granddaughter	O
and	O
husband	O
.	O

past	O
medical	O
history	O
:	O

htn	B

high	I
chol	I

seizure	I
d	I
/	I
o	I

social	O
history	O
:	O

lives	O
with	O
husband	O
,	O
no	O
[	O
*	O
*	O
name2	O
(	O
ni	O
)	O
*	O
*	O
]	O
;	O
daughter	O
involved	O
in	O
care	O
.	O

family	O
is	O
from	O
[	O
*	O
*	O
country	O
4435	O
*	O
*	O
]	O
and	O
all	O
speak	O
english	O
well	O
(	O
except	O
perhaps	O
husband	O
)	O
;	O
interpreter	O
offered	O
but	O
family	O
declined	O
.	O

family	O
history	O
:	O

unknown	O

physical	O
exam	O
:	O

7	O
:	O
30pm	O
:	O
temp	O
pending	O
current	O
bp	O
230	O
/	O
122	O
,	O
hr	O
53	O
,	O
rate	O
set	O
at	O
20	O
,	O
not	O
overbreathing	O
vent	O
,	O
99%	O
on	O
100%	O
fio2	O
seen	O
1hr	O
later	O
(	O
8	O
:	O
30pm	O
)	O
-	O
bp	O
now	O
61	O
systolic	O
,	O
up	O
to	O
70s	O
,	O
hr	O
50s	O
general	O
appearance	O
:	O
intubated	O
,	O
blood	O
on	O
et	O
tube	O
,	O
on	O
no	O
sedation	O
,	O
but	O
unresponsive	B

head	O
/	O
neck	O
:	O
et	O
tube	O
in	O
place	O
,	O
mmm	O

heart	O
:	O
regular	O

lungs	O
:	O
diminished	O
ant	O

abdomen	O
:	O
soft	O

extremities	O
:	O
warm	O

neuro	O
:	O

unresponsive	B
to	I
voice	I
,	O
sternal	O
rub	O

slight	O
blurring	O
of	O
disc	O
margins	O
bilat	O

l	O
pupil	O
5mm	O
,	O
r	O
pupil	O
6mm	O
,	O
both	O
unreactive	B

trace	O
corneal	B
on	I
r	I
,	O
none	O
on	O
l	O

negative	O
ocr	B
,	O
eyes	O
midline	O

negative	O
nasal	B
tickle	I

trace	O
gag	B

extensor	O
to	O
stim	O
bilat	O
ue	O

triple	O
flexion	O
bilat	O
le	O

toes	B
mute	I
,	O
depressed	B
dtrs	I

pertinent	O
results	O
:	O

[	O
*	O
*	O
2017	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
08	O
:	O
19pm	O
type	O
-	O
art	O
temp	O
-	O
36	O
.	O
1	O
rates	O
-	O
14	O
/	O
tidal	O
vol	O
-	O
480	O
po2	O
-	O
317	O
*	O
pco2	O
-	O
38	O
ph	O
-	O
7	O
.	O
45	O
total	O
co2	O
-	O
27	O
base	O
xs	O
-	O
3	O
-	O
assist	O
/	O
con	O
intubated	O
-	O
intubated	O

[	O
*	O
*	O
2017	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
08	O
:	O
00pm	O
glucose	O
-	O
221	O
*	O
urea	O
n	O
-	O
17	O
creat	O
-	O
1	O
.	O
1	O
sodium	O
-	O
138	O
potassium	O
-	O
4	O
.	O
7	O
chloride	O
-	O
98	O
total	O
co2	O
-	O
29	O
anion	O
gap	O
-	O
16	O

[	O
*	O
*	O
2017	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
08	O
:	O
00pm	O
estgfr	O
-	O
using	O
this	O

[	O
*	O
*	O
2017	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
08	O
:	O
00pm	O
ck	O
(	O
cpk	O
)	O
-	O
371	O
*	O

[	O
*	O
*	O
2017	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
08	O
:	O
00pm	O
ck	O
-	O
mb	O
-	O
6	O
ctropnt	O
-	O
<0	O
.	O
01	O

[	O
*	O
*	O
2017	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
08	O
:	O
00pm	O
calcium	O
-	O
9	O
.	O
2	O
phosphate	O
-	O
3	O
.	O
5	O
magnesium	O
-	O
2	O
.	O
5	O

[	O
*	O
*	O
2017	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
08	O
:	O
00pm	O
wbc	O
-	O
13	O
.	O
3	O
*	O
rbc	O
-	O
4	O
.	O
56	O
hgb	O
-	O
14	O
.	O
2	O
hct	O
-	O
42	O
.	O
1	O
mcv	O
-	O
92	O
mch	O
-	O
31	O
.	O
1	O
mchc	O
-	O
33	O
.	O
7	O
rdw	O
-	O
13	O
.	O
6	O

[	O
*	O
*	O
2017	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
08	O
:	O
00pm	O
neuts	O
-	O
86	O
.	O
0	O
*	O
lymphs	O
-	O
10	O
.	O
6	O
*	O
monos	O
-	O
2	O
.	O
2	O
eos	O
-	O
0	O
.	O
4	O
basos	O
-	O
0	O
.	O
9	O

[	O
*	O
*	O
2017	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
08	O
:	O
00pm	O
plt	O
count	O
-	O
244	O

[	O
*	O
*	O
2017	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
08	O
:	O
00pm	O
pt	O
-	O
13	O
.	O
9	O
*	O
ptt	O
-	O
51	O
.	O
3	O
*	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
2	O
*	O

[	O
*	O
*	O
2017	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
08	O
:	O
00pm	O
urine	O
color	O
-	O
yellow	O
appear	O
-	O
clear	O
sp	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
177	O
*	O
*	O
]	O
-	O
1	O
.	O
015	O

[	O
*	O
*	O
2017	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
08	O
:	O
00pm	O
urine	O
blood	O
-	O
lg	O
nitrite	O
-	O
neg	O
protein	O
-	O
500	O
glucose	O
-	O
250	O
ketone	O
-	O
tr	O
bilirubin	O
-	O
neg	O
urobilngn	O
-	O
neg	O
ph	O
-	O
8	O
.	O
0	O
leuk	O
-	O
neg	O

[	O
*	O
*	O
2017	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
08	O
:	O
00pm	O
urine	O
rbc	O
-	O
[	O
*	O
*	O
05	O
-	O
27	O
*	O
*	O
]	O
*	O
wbc	O
-	O
0	O
-	O
2	O
bacteria	O
-	O
few	O
yeast	O
-	O
none	O
epi	O
-	O
0	O

pcxr	O
:	O
findings	O
:	O
consistent	O
with	O
the	O
given	O
history	O
,	O
an	O
endotracheal	O
tube	O
is	O
identified	O
with	O
the	O
distal	O
tip	O
approximately	O
10	O
mm	O
from	O
the	O
carina	O
.	O

there	O
is	O
upward	B
retraction	I
of	O
the	O
right	O
hilum	O
.	O

there	O
is	O
a	O
right	O
apical	O
opacity	B
.	O

there	O
is	O
suggestion	O
of	O
traction	B
bronchiectasis	I
.	O

left	O
apical	O
pleural	B
thickening	I
is	O
also	O
seen	O
.	O

there	O
is	O
opacity	B
in	O
the	O
left	O
perihilar	O
and	O
retrocardiac	O
regions	O
which	O
may	O
represent	O
atelectasis	B
,	O
aspiration	B
,	O
or	O
early	O
developing	O
pneumonia	B
.	O

no	O
pneumothorax	B
is	O
evident	O
.	O

there	O
is	O
a	O
markedly	O
tortuous	B
aorta	I
.	O

the	O
cardiac	O
silhouette	O
is	O
enlarged	O
.	O

the	O
visualized	O
osseous	O
structures	O
are	O
unremarkable	O
.	O

impression	O
:	O
endotracheal	O
tube	O
placement	O
as	O
above	O
.	O

for	O
optimal	O
placement	O
,	O
consider	O
retracting	O
2	O
cm	O
.	O

there	O
are	O
left	O
perihilar	O
and	O
left	O
retrocardiac	O
opacities	B
which	O
may	O
indicate	O
aspiration	B
,	O
atelectasis	B
,	O
or	O
early	O
developing	O
pneumonia	B
.	O

nchct	O
:	O
findings	O
:	O
there	O
is	O
a	O
large	O
intraparenchymal	B
hematoma	I
centered	O
within	O
the	O
right	O
basal	O
ganglia	O
involving	O
the	O
right	O
frontal	O
,	O
parietal	O
,	O
and	O
temporal	O
lobes	O
.	O

this	O
measures	O
7	O
.	O
6	O
x	O
5	O
.	O
1	O
cm	O
in	O
greatest	O
dimension	O
.	O

there	O
is	O
considerable	O
associated	O
mass	B
effect	I
with	O
complete	B
effacement	I
of	O
the	O
right	O
lateral	O
ventricle	O
and	O
temporal	O
[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
.	O

contralateral	O
dilatation	B
of	O
the	O
left	O
lateral	O
ventricle	O
and	O
occipital	O
[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
is	O
consistent	O
with	O
"trapped	O
ventricle	B
.	O
"	O

there	O
is	O
1	O
.	O
7	O
-	O
cm	O
leftward	B
subfalcine	I
shift	I
.	O

subependymal	B
blood	I
is	O
seen	O
within	O
the	O
frontal	O
[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
of	O
the	O
left	O
lateral	O
ventricle	O
.	O

layering	O
interventricular	B
blood	I
is	O
seen	O
with	O
both	O
lateral	O
ventricles	O
.	O

a	O
clot	B
extebds	O
within	O
the	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
5644	O
*	O
*	O
]	O
of	O
right	O
lateral	O
ventricle	O
.	O

subarachnoid	B
hemorrhage	I
is	O
noted	O
within	O
the	O
sulci	O
of	O
the	O
right	O
frontal	O
,	O
parietal	O
,	O
and	O
temporal	O
lobes	O
.	O

there	O
is	O
mild	O
diffuse	O
vasogenic	B
cerebral	I
edema	I
.	O

blood	O
is	O
seen	O
within	O
effaced	O
suprasellar	O
,	O
ambien	O
,	O
and	O
basilar	O
cisterns	O
.	O

effacement	B
is	O
indicative	O
of	O
transtentorial	B
herniation	I
.	O

the	O
temporal	O
lobes	O
abut	O
the	O
brainstem	O
worrisome	O
for	O
impending	O
uncal	B
herniation	I
.	O

the	O
foramen	O
magnum	O
is	O
effaced	B
.	O

the	O
overlying	O
osseous	O
structures	O
are	O
unremarkable	O
.	O

air	B
-	I
fluid	I
levels	I
within	O
the	O
right	O
maxillary	O
and	O
ethmoid	O
sinuses	O
are	O
consistent	O
with	O
intubation	O
.	O

foci	O
of	O
air	O
are	O
seen	O
tracking	O
within	O
the	O
right	O
parapharyngeal	O
space	O
extending	O
to	O
the	O
right	O
mandible	O
and	O
posteriorly	O
into	O
the	O
prevertebral	O
space	O
.	O

impression	O
:	O

1	O
.	O
large	O
intraparenchymal	B
hematoma	I
centered	O
in	O
the	O
right	O
basal	O
ganglia	O
exerting	O
considerable	O
mass	B
effect	I
and	O
1	O
.	O
7	O
-	O
cm	O
leftward	B
subfalcine	I
shift	I
.	O

effacement	B
of	O
the	O
suprasellar	O
and	O
basilar	O
cisterns	O
is	O
consistent	O
with	O
transtentorial	B
hernation	I
.	O

the	O
temporal	O
lobes	O
abut	O
the	O
brainstem	O
worrisome	O
for	O
impending	O
uncal	B
herniation	I
.	O

2	O
.	O
subarachnoid	B
hemorrhage	I
,	O
predominantly	O
involving	O
the	O
right	O
frontal	O
,	O
parietal	O
,	O
and	O
temporal	O
lobes	O
.	O

brief	O
hospital	O
course	O
:	O

81	O
yo	O
woman	O
with	O
hx	O
htn	B
,	O
high	B
chol	I
,	O
sz	B
d	I
/	I
o	I
who	O
vomited	B
and	O
became	O
unresponsive	B
within	O
minutes	O
today	O
while	O
talking	O
with	O
family	O
,	O
found	O
to	O
have	O
massive	O
r	O
hemisphere	B
hemorrhage	I
with	O
shift	B
of	I
midline	I
structures	I
,	O
mass	B
effect	I
at	O
osh	O
(	O
[	O
*	O
*	O
hospital	O
5643	O
*	O
*	O
]	O
hosp	O
.	O
in	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
*	O
*	O
]	O
)	O
,	O
intubated	O
and	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
16	O
*	O
*	O
]	O
and	O
found	O
to	O
have	O
fixed	B
pupils	I
,	O
trace	O
r	B
corneal	I
only	O
(	O
absent	O
l	O
)	O
,	O
negative	O
ocr	O
,	O
trace	O
gag	B
,	O
triple	O
flexion	O
to	O
noxious	O
stimuli	O
in	O
le	O
bilat	O
,	O
and	O
extension	O
to	O
nox	O
stim	O
in	O
ue	O
bilat	O
.	O

repeat	O
ct	O
scan	O
at	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
shows	O
impending	O
herniation	B
through	O
the	O
foramen	O
magnum	O
,	O
and	O
enlargement	O
of	O
hemorrhage	B
.	O

she	O
presented	O
with	O
bp	O
in	O
250s	O
systolic	O
and	O
hr	O
in	O
50s	O
upon	O
arrival	O
,	O
not	O
overbreathing	O
the	O
vent	O
-	O
suggestive	O
of	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
2864	O
*	O
*	O
]	O
triad	O
.	O

within	O
1	O
hr	O
of	O
arrival	O
,	O
she	O
has	O
dropped	B
bp	I
in	O
response	O
to	O
nipride	O
gtt	O
,	O
to	O
60s	O
systolic	O
.	O

have	O
discussed	O
dismal	O
neurological	O
prognosis	O
with	O
family	O
given	O
current	O
exam	O
,	O
and	O
they	O
will	O
discuss	O
goals	O
of	O
care	O
.	O

no	O
neurosurgical	O
intervention	O
indicated	O
.	O

in	O
the	O
mean	O
time	O
,	O
will	O
admit	O
to	O
neurology	O
icu	O
for	O
closer	O
monitoring	O
,	O
and	O
supportive	O
care	O
until	O
family	O
able	O
to	O
discuss	O
further	O
and	O
speak	O
with	O
our	O
attg	O
.	O

patient	O
was	O
admitted	O
to	O
neurology	O
icu	O
and	O
monitored	O
closely	O
.	O

received	O
mannitol	O
50	O
g	O
now	O
,	O
then	O
25g	O
q6h	O
,	O
monitoring	O
osms	O
and	O
na	O
q6h	O
.	O

loaded	O
with	O
dilantin	O
1000mg	O
(	O
for	O
approx	O
50kg	O
female	O
)	O
slowly	O
,	O
to	O
prevent	O
risk	O
of	O
dropping	B
bp	I
further	O
and	O
cardiac	B
arrhythmia	I
,	O
then	O
started	O
100mg	O
q8h	O
.	O

monitored	O
lytes	O
,	O
coags	O
,	O
cbc	O
,	O
cardiac	O
enzymes	O
.	O

addressed	O
code	O
status	O
and	O
goals	O
of	O
care	O
via	O
further	O
family	O
discussions	O
.	O

met	O
with	O
family	O
husband	O
and	O
daughter	O
evening	O
@11	O
:	O
50pm	O
[	O
*	O
*	O
12	O
-	O
28	O
*	O
*	O
]	O
and	O
patient's	O
code	O
status	O
was	O
made	O
comfort	O
measures	O
only	O
.	O

confirmed	O
with	O
neuroicu	O
attending	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
and	O
icu	O
resident	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
.	O

patient	O
was	O
subsequently	O
extubated	O
and	O
passed	O
away	O
overnight	O
from	O
respiratory	B
failure	I
.	O

family	O
was	O
notified	O
and	O
declined	O
autopsy	O
.	O

medications	O
on	O
admission	O
:	O

lasix	O
20	O
mg	O
bid	O

lipitor	O
40	O
mg	O
qd	O

diovan	O
160	O
mg	O
qd	O

labetalol	O
200	O
mg	O
bid	O

asa	O
81	O
mg	O

carbamazepine	O
100mg	O
bid	O

discharge	O
medications	O
:	O

discharge	O
disposition	O
:	O

expired	O

discharge	O
diagnosis	O
:	O

ich	B

discharge	O
condition	O
:	O

expired	O

[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name8	O
(	O
md	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
511	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
name6	O
(	O
md	O
)	O
512	O
*	O
*	O
]	O
chu	O
md	O
[	O
*	O
*	O
md	O
number	O
513	O
*	O
*	O
]	O
[	O
*	O
*	O
2018	O
-	O
03	O
-	O
23	O
*	O
*	O
]	O
@	O
1548	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2018	O
-	O
04	O
-	O
06	O
*	O
*	O
]	O
4	O
:	O
39	O
pm	O

(	O
end	O
of	O
report	O
)	O

